primaryid,caseid,drug_seq,role_cod,drugname,prod_ai,val_vbm,route,dose_vbm,cum_dose_chr,cum_dose_unit,dechal,rechal,lot_num,exp_dt,nda_num,dose_amt,dose_unit,dose_form,dose_freq,year_x,quarter_x,pt,drug_rec_act,year_y,quarter_y,caseversion,i_f_code,event_dt,mfr_dt,init_fda_dt,fda_dt,rept_cod,auth_num,mfr_num,mfr_sndr,lit_ref,age,age_cod,age_grp,sex,e_sub,wt,wt_cod,rept_dt,to_mfr,occp_cod,reporter_country,occr_country,year,quarter,age_group
107626122,10762612,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2018,Q1,Febrile neutropenia,,2018,Q1,2,F,20130813.0,20151118.0,20150204,20180329,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-19551589,BRISTOL MYERS SQUIBB,,76.0,YR,,M,Y,,,20180329.0,,CN,JP,JP,2018,Q1,Elderly
107626122,10762612,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2018,Q1,Malignant neoplasm progression,,2018,Q1,2,F,20130813.0,20151118.0,20150204,20180329,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-19551589,BRISTOL MYERS SQUIBB,,76.0,YR,,M,Y,,,20180329.0,,CN,JP,JP,2018,Q1,Elderly
107626122,10762612,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2018,Q1,Pneumonia aspiration,,2018,Q1,2,F,20130813.0,20151118.0,20150204,20180329,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-19551589,BRISTOL MYERS SQUIBB,,76.0,YR,,M,Y,,,20180329.0,,CN,JP,JP,2018,Q1,Elderly
1142235111,11422351,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2018,Q1,Abdominal distension,,2018,Q1,11,F,20100930.0,20180116.0,20150827,20180119,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20180119.0,,OT,US,US,2018,Q1,Adult
1142235111,11422351,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2018,Q1,Cardiac failure,,2018,Q1,11,F,20100930.0,20180116.0,20150827,20180119,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20180119.0,,OT,US,US,2018,Q1,Adult
1142235111,11422351,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2018,Q1,Diabetes mellitus,,2018,Q1,11,F,20100930.0,20180116.0,20150827,20180119,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20180119.0,,OT,US,US,2018,Q1,Adult
1142235111,11422351,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2018,Q1,Diarrhoea,,2018,Q1,11,F,20100930.0,20180116.0,20150827,20180119,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20180119.0,,OT,US,US,2018,Q1,Adult
1142235111,11422351,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2018,Q1,Drug ineffective for unapproved indication,,2018,Q1,11,F,20100930.0,20180116.0,20150827,20180119,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20180119.0,,OT,US,US,2018,Q1,Adult
1142235111,11422351,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2018,Q1,Hypertension,,2018,Q1,11,F,20100930.0,20180116.0,20150827,20180119,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20180119.0,,OT,US,US,2018,Q1,Adult
1142235111,11422351,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2018,Q1,Impaired work ability,,2018,Q1,11,F,20100930.0,20180116.0,20150827,20180119,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20180119.0,,OT,US,US,2018,Q1,Adult
1142235111,11422351,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2018,Q1,Malaise,,2018,Q1,11,F,20100930.0,20180116.0,20150827,20180119,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20180119.0,,OT,US,US,2018,Q1,Adult
1142235111,11422351,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2018,Q1,Oedema peripheral,,2018,Q1,11,F,20100930.0,20180116.0,20150827,20180119,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20180119.0,,OT,US,US,2018,Q1,Adult
1142235111,11422351,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2018,Q1,Pain,,2018,Q1,11,F,20100930.0,20180116.0,20150827,20180119,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20180119.0,,OT,US,US,2018,Q1,Adult
1142235111,11422351,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2018,Q1,Pericardial effusion,,2018,Q1,11,F,20100930.0,20180116.0,20150827,20180119,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20180119.0,,OT,US,US,2018,Q1,Adult
1142235111,11422351,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2018,Q1,Sleep apnoea syndrome,,2018,Q1,11,F,20100930.0,20180116.0,20150827,20180119,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20180119.0,,OT,US,US,2018,Q1,Adult
1142235111,11422351,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2018,Q1,Spinal cord injury,,2018,Q1,11,F,20100930.0,20180116.0,20150827,20180119,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20180119.0,,OT,US,US,2018,Q1,Adult
122709265,12270926,13,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2018,Q1,Myocardial infarction,,2018,Q1,5,F,20150727.0,20180203.0,20160415,20180212,EXP,,US-CELGENEUS-USA-2015080052,CELGENE,,74.0,YR,,M,Y,76.2,KG,20180212.0,,OT,US,US,2018,Q1,Elderly
122709265,12270926,13,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2018,Q1,Pneumonia,,2018,Q1,5,F,20150727.0,20180203.0,20160415,20180212,EXP,,US-CELGENEUS-USA-2015080052,CELGENE,,74.0,YR,,M,Y,76.2,KG,20180212.0,,OT,US,US,2018,Q1,Elderly
122710462,12271046,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNKNOWN, UNKNOWN",,,,,,,,,,,,2018,Q1,Acute kidney injury,,2018,Q1,2,F,20090501.0,20180205.0,20160415,20180214,EXP,,US-ENDO PHARMACEUTICALS INC.-2016-000682,ENDO,,67.0,YR,,M,Y,113.38,KG,20180214.0,,LW,US,US,2018,Q1,Elderly
122710462,12271046,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNKNOWN, UNKNOWN",,,,,,,,,,,,2018,Q1,Cardiac failure congestive,,2018,Q1,2,F,20090501.0,20180205.0,20160415,20180214,EXP,,US-ENDO PHARMACEUTICALS INC.-2016-000682,ENDO,,67.0,YR,,M,Y,113.38,KG,20180214.0,,LW,US,US,2018,Q1,Elderly
122710462,12271046,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNKNOWN, UNKNOWN",,,,,,,,,,,,2018,Q1,Chronic obstructive pulmonary disease,,2018,Q1,2,F,20090501.0,20180205.0,20160415,20180214,EXP,,US-ENDO PHARMACEUTICALS INC.-2016-000682,ENDO,,67.0,YR,,M,Y,113.38,KG,20180214.0,,LW,US,US,2018,Q1,Elderly
122710462,12271046,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNKNOWN, UNKNOWN",,,,,,,,,,,,2018,Q1,Deep vein thrombosis,,2018,Q1,2,F,20090501.0,20180205.0,20160415,20180214,EXP,,US-ENDO PHARMACEUTICALS INC.-2016-000682,ENDO,,67.0,YR,,M,Y,113.38,KG,20180214.0,,LW,US,US,2018,Q1,Elderly
122710462,12271046,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNKNOWN, UNKNOWN",,,,,,,,,,,,2018,Q1,Escherichia infection,,2018,Q1,2,F,20090501.0,20180205.0,20160415,20180214,EXP,,US-ENDO PHARMACEUTICALS INC.-2016-000682,ENDO,,67.0,YR,,M,Y,113.38,KG,20180214.0,,LW,US,US,2018,Q1,Elderly
122710462,12271046,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNKNOWN, UNKNOWN",,,,,,,,,,,,2018,Q1,Prostatitis,,2018,Q1,2,F,20090501.0,20180205.0,20160415,20180214,EXP,,US-ENDO PHARMACEUTICALS INC.-2016-000682,ENDO,,67.0,YR,,M,Y,113.38,KG,20180214.0,,LW,US,US,2018,Q1,Elderly
122710462,12271046,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNKNOWN, UNKNOWN",,,,,,,,,,,,2018,Q1,Ventricular tachycardia,,2018,Q1,2,F,20090501.0,20180205.0,20160415,20180214,EXP,,US-ENDO PHARMACEUTICALS INC.-2016-000682,ENDO,,67.0,YR,,M,Y,113.38,KG,20180214.0,,LW,US,US,2018,Q1,Elderly
124218523,12421852,18,C,Insulin Lispro-sliding Scale for HumaLOG,,2,Unknown,,,,,,,,,,,,Q4H,2018,Q1,Haemorrhagic anaemia,,2018,Q1,3,F,20150831.0,20180111.0,20160531,20180118,PER,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-33991BI",BOEHRINGER INGELHEIM,,72.0,YR,,F,Y,124.73,KG,20180118.0,,CN,US,US,2018,Q1,Elderly
124218523,12421852,18,C,Insulin Lispro-sliding Scale for HumaLOG,,2,Unknown,,,,,,,,,,,,Q4H,2018,Q1,Internal haemorrhage,,2018,Q1,3,F,20150831.0,20180111.0,20160531,20180118,PER,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-33991BI",BOEHRINGER INGELHEIM,,72.0,YR,,F,Y,124.73,KG,20180118.0,,CN,US,US,2018,Q1,Elderly
126781576,12678157,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,100 U / ML-AS SCHEDULED,,,,,,,,,,,TID,2018,Q1,Bacterial sepsis,,2018,Q1,6,F,201412.0,20180125.0,20160823,20180131,EXP,,NL-ABBVIE-16P-114-1707289-00,ABBVIE,,66.0,YR,,M,Y,94.0,KG,20180131.0,,CN,NL,NL,2018,Q1,Elderly
126781576,12678157,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,100 U / ML-AS SCHEDULED,,,,,,,,,,,TID,2018,Q1,Fatigue,,2018,Q1,6,F,201412.0,20180125.0,20160823,20180131,EXP,,NL-ABBVIE-16P-114-1707289-00,ABBVIE,,66.0,YR,,M,Y,94.0,KG,20180131.0,,CN,NL,NL,2018,Q1,Elderly
126781576,12678157,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,100 U / ML-AS SCHEDULED,,,,,,,,,,,TID,2018,Q1,Hot flush,,2018,Q1,6,F,201412.0,20180125.0,20160823,20180131,EXP,,NL-ABBVIE-16P-114-1707289-00,ABBVIE,,66.0,YR,,M,Y,94.0,KG,20180131.0,,CN,NL,NL,2018,Q1,Elderly
126781576,12678157,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,100 U / ML-AS SCHEDULED,,,,,,,,,,,TID,2018,Q1,Prostate cancer,,2018,Q1,6,F,201412.0,20180125.0,20160823,20180131,EXP,,NL-ABBVIE-16P-114-1707289-00,ABBVIE,,66.0,YR,,M,Y,94.0,KG,20180131.0,,CN,NL,NL,2018,Q1,Elderly
126781576,12678157,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,100 U / ML-AS SCHEDULED,,,,,,,,,,,TID,2018,Q1,Prostatic specific antigen increased,,2018,Q1,6,F,201412.0,20180125.0,20160823,20180131,EXP,,NL-ABBVIE-16P-114-1707289-00,ABBVIE,,66.0,YR,,M,Y,94.0,KG,20180131.0,,CN,NL,NL,2018,Q1,Elderly
128056742,12805674,5,C,LISPRO,INSULIN LISPRO,1,Subcutaneous,DAILY DOSE: MEAN,,,,,,,,53.0,IU,,QD,2018,Q1,Hyperglycaemia,,2018,Q1,2,F,20160624.0,20180110.0,20161004,20180110,EXP,,"FR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-51361BI",BOEHRINGER INGELHEIM,,27.0,YR,,F,Y,60.0,KG,20180110.0,,MD,FR,FR,2018,Q1,Young Adult
128056742,12805674,5,C,LISPRO,INSULIN LISPRO,1,Subcutaneous,DAILY DOSE: MEAN,,,,,,,,53.0,IU,,QD,2018,Q1,Pharyngitis,,2018,Q1,2,F,20160624.0,20180110.0,20161004,20180110,EXP,,"FR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-51361BI",BOEHRINGER INGELHEIM,,27.0,YR,,F,Y,60.0,KG,20180110.0,,MD,FR,FR,2018,Q1,Young Adult
128056742,12805674,5,C,LISPRO,INSULIN LISPRO,1,Subcutaneous,DAILY DOSE: MEAN,,,,,,,,53.0,IU,,QD,2018,Q1,Skin mass,,2018,Q1,2,F,20160624.0,20180110.0,20161004,20180110,EXP,,"FR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-51361BI",BOEHRINGER INGELHEIM,,27.0,YR,,F,Y,60.0,KG,20180110.0,,MD,FR,FR,2018,Q1,Young Adult
128471742,12847174,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,, UNK,,,,,,,2018,Q1,Angiopathy,,2018,Q1,2,F,,20180221.0,20161014,20180227,EXP,,US-SA-2016SA187461,AVENTIS,,68.0,YR,E,M,Y,,,20180227.0,,CN,US,US,2018,Q1,Elderly
128471742,12847174,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,, UNK,,,,,,,2018,Q1,Coronary artery disease,,2018,Q1,2,F,,20180221.0,20161014,20180227,EXP,,US-SA-2016SA187461,AVENTIS,,68.0,YR,E,M,Y,,,20180227.0,,CN,US,US,2018,Q1,Elderly
128471742,12847174,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,, UNK,,,,,,,2018,Q1,Hyperglycaemia,,2018,Q1,2,F,,20180221.0,20161014,20180227,EXP,,US-SA-2016SA187461,AVENTIS,,68.0,YR,E,M,Y,,,20180227.0,,CN,US,US,2018,Q1,Elderly
128471742,12847174,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,, UNK,,,,,,,2018,Q1,Malaise,,2018,Q1,2,F,,20180221.0,20161014,20180227,EXP,,US-SA-2016SA187461,AVENTIS,,68.0,YR,E,M,Y,,,20180227.0,,CN,US,US,2018,Q1,Elderly
128471742,12847174,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,, UNK,,,,,,,2018,Q1,Skin discolouration,,2018,Q1,2,F,,20180221.0,20161014,20180227,EXP,,US-SA-2016SA187461,AVENTIS,,68.0,YR,E,M,Y,,,20180227.0,,CN,US,US,2018,Q1,Elderly
128471742,12847174,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,, UNK,,,,,,,2018,Q1,Somnolence,,2018,Q1,2,F,,20180221.0,20161014,20180227,EXP,,US-SA-2016SA187461,AVENTIS,,68.0,YR,E,M,Y,,,20180227.0,,CN,US,US,2018,Q1,Elderly
128471742,12847174,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,, UNK,,,,,,,2018,Q1,Wrong technique in product usage process,,2018,Q1,2,F,,20180221.0,20161014,20180227,EXP,,US-SA-2016SA187461,AVENTIS,,68.0,YR,E,M,Y,,,20180227.0,,CN,US,US,2018,Q1,Elderly
1296291711,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2018,Q1,Acute respiratory failure,,2018,Q1,11,F,20160826.0,20180117.0,20161122,20180124,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180124.0,,MD,US,US,2018,Q1,Elderly
1296291711,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2018,Q1,Fluid overload,,2018,Q1,11,F,20160826.0,20180117.0,20161122,20180124,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180124.0,,MD,US,US,2018,Q1,Elderly
1296291711,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2018,Q1,Haemoptysis,,2018,Q1,11,F,20160826.0,20180117.0,20161122,20180124,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180124.0,,MD,US,US,2018,Q1,Elderly
1296291711,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2018,Q1,Hyperkalaemia,,2018,Q1,11,F,20160826.0,20180117.0,20161122,20180124,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180124.0,,MD,US,US,2018,Q1,Elderly
1296291711,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2018,Q1,Iron deficiency anaemia,,2018,Q1,11,F,20160826.0,20180117.0,20161122,20180124,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180124.0,,MD,US,US,2018,Q1,Elderly
1296291711,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2018,Q1,Pleural effusion,,2018,Q1,11,F,20160826.0,20180117.0,20161122,20180124,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180124.0,,MD,US,US,2018,Q1,Elderly
1296291711,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2018,Q1,Pneumonia,,2018,Q1,11,F,20160826.0,20180117.0,20161122,20180124,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180124.0,,MD,US,US,2018,Q1,Elderly
1296291711,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2018,Q1,Pulmonary oedema,,2018,Q1,11,F,20160826.0,20180117.0,20161122,20180124,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180124.0,,MD,US,US,2018,Q1,Elderly
1296291711,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2018,Q1,Sepsis,,2018,Q1,11,F,20160826.0,20180117.0,20161122,20180124,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180124.0,,MD,US,US,2018,Q1,Elderly
1296291711,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2018,Q1,Tumour lysis syndrome,,2018,Q1,11,F,20160826.0,20180117.0,20161122,20180124,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180124.0,,MD,US,US,2018,Q1,Elderly
1296291711,12962917,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2018,Q1,Acute respiratory failure,,2018,Q1,11,F,20160826.0,20180117.0,20161122,20180124,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180124.0,,MD,US,US,2018,Q1,Elderly
1296291711,12962917,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2018,Q1,Fluid overload,,2018,Q1,11,F,20160826.0,20180117.0,20161122,20180124,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180124.0,,MD,US,US,2018,Q1,Elderly
1296291711,12962917,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2018,Q1,Haemoptysis,,2018,Q1,11,F,20160826.0,20180117.0,20161122,20180124,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180124.0,,MD,US,US,2018,Q1,Elderly
1296291711,12962917,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2018,Q1,Hyperkalaemia,,2018,Q1,11,F,20160826.0,20180117.0,20161122,20180124,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180124.0,,MD,US,US,2018,Q1,Elderly
1296291711,12962917,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2018,Q1,Iron deficiency anaemia,,2018,Q1,11,F,20160826.0,20180117.0,20161122,20180124,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180124.0,,MD,US,US,2018,Q1,Elderly
1296291711,12962917,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2018,Q1,Pleural effusion,,2018,Q1,11,F,20160826.0,20180117.0,20161122,20180124,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180124.0,,MD,US,US,2018,Q1,Elderly
1296291711,12962917,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2018,Q1,Pneumonia,,2018,Q1,11,F,20160826.0,20180117.0,20161122,20180124,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180124.0,,MD,US,US,2018,Q1,Elderly
1296291711,12962917,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2018,Q1,Pulmonary oedema,,2018,Q1,11,F,20160826.0,20180117.0,20161122,20180124,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180124.0,,MD,US,US,2018,Q1,Elderly
1296291711,12962917,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2018,Q1,Sepsis,,2018,Q1,11,F,20160826.0,20180117.0,20161122,20180124,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180124.0,,MD,US,US,2018,Q1,Elderly
1296291711,12962917,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2018,Q1,Tumour lysis syndrome,,2018,Q1,11,F,20160826.0,20180117.0,20161122,20180124,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180124.0,,MD,US,US,2018,Q1,Elderly
130051783,13005178,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QD,2018,Q1,Blindness,,2018,Q1,3,F,20161203.0,20180207.0,20161207,20180209,EXP,,MX-ROCHE-1864501,ROCHE,,41.0,YR,,M,Y,69.0,KG,20180210.0,,MD,MX,MX,2018,Q1,Adult
130051783,13005178,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QD,2018,Q1,Endophthalmitis,,2018,Q1,3,F,20161203.0,20180207.0,20161207,20180209,EXP,,MX-ROCHE-1864501,ROCHE,,41.0,YR,,M,Y,69.0,KG,20180210.0,,MD,MX,MX,2018,Q1,Adult
130051783,13005178,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QD,2018,Q1,Eye oedema,,2018,Q1,3,F,20161203.0,20180207.0,20161207,20180209,EXP,,MX-ROCHE-1864501,ROCHE,,41.0,YR,,M,Y,69.0,KG,20180210.0,,MD,MX,MX,2018,Q1,Adult
130051783,13005178,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QD,2018,Q1,Off label use,,2018,Q1,3,F,20161203.0,20180207.0,20161207,20180209,EXP,,MX-ROCHE-1864501,ROCHE,,41.0,YR,,M,Y,69.0,KG,20180210.0,,MD,MX,MX,2018,Q1,Adult
130051783,13005178,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QD,2018,Q1,Pain,,2018,Q1,3,F,20161203.0,20180207.0,20161207,20180209,EXP,,MX-ROCHE-1864501,ROCHE,,41.0,YR,,M,Y,69.0,KG,20180210.0,,MD,MX,MX,2018,Q1,Adult
130051783,13005178,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QD,2018,Q1,Suspected counterfeit product,,2018,Q1,3,F,20161203.0,20180207.0,20161207,20180209,EXP,,MX-ROCHE-1864501,ROCHE,,41.0,YR,,M,Y,69.0,KG,20180210.0,,MD,MX,MX,2018,Q1,Adult
130051783,13005178,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QD,2018,Q1,Suspected transmission of an infectious agent via product,,2018,Q1,3,F,20161203.0,20180207.0,20161207,20180209,EXP,,MX-ROCHE-1864501,ROCHE,,41.0,YR,,M,Y,69.0,KG,20180210.0,,MD,MX,MX,2018,Q1,Adult
1309584218,13095842,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q1,Conjunctivitis,,2018,Q1,18,F,20161231.0,20180228.0,20170109,20180302,EXP,,US-ROCHE-1874437,ROCHE,,68.0,YR,,F,Y,51.5,KG,20180302.0,,MD,US,US,2018,Q1,Elderly
1309584218,13095842,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q1,Death,,2018,Q1,18,F,20161231.0,20180228.0,20170109,20180302,EXP,,US-ROCHE-1874437,ROCHE,,68.0,YR,,F,Y,51.5,KG,20180302.0,,MD,US,US,2018,Q1,Elderly
1309584218,13095842,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q1,Drug eruption,,2018,Q1,18,F,20161231.0,20180228.0,20170109,20180302,EXP,,US-ROCHE-1874437,ROCHE,,68.0,YR,,F,Y,51.5,KG,20180302.0,,MD,US,US,2018,Q1,Elderly
1309584218,13095842,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q1,Haemolytic uraemic syndrome,,2018,Q1,18,F,20161231.0,20180228.0,20170109,20180302,EXP,,US-ROCHE-1874437,ROCHE,,68.0,YR,,F,Y,51.5,KG,20180302.0,,MD,US,US,2018,Q1,Elderly
1309584218,13095842,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q1,Mucosal inflammation,,2018,Q1,18,F,20161231.0,20180228.0,20170109,20180302,EXP,,US-ROCHE-1874437,ROCHE,,68.0,YR,,F,Y,51.5,KG,20180302.0,,MD,US,US,2018,Q1,Elderly
133076682,13307668,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"32 IU, QD",,,,,,,,32.0,IU,,QD,2018,Q1,Hypoglycaemic unconsciousness,,2018,Q1,2,F,20160627.0,20180201.0,20170308,20180206,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201703000683,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20180206.0,,CN,IT,IT,2018,Q1,Adult
133606316,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q1,Acute respiratory failure,,2018,Q1,6,F,20150120.0,20180306.0,20170322,20180314,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180314.0,,MD,US,US,2018,Q1,Elderly
133606316,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q1,Anaemia,,2018,Q1,6,F,20150120.0,20180306.0,20170322,20180314,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180314.0,,MD,US,US,2018,Q1,Elderly
133606316,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q1,Asthenia,,2018,Q1,6,F,20150120.0,20180306.0,20170322,20180314,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180314.0,,MD,US,US,2018,Q1,Elderly
133606316,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q1,Bronchial secretion retention,,2018,Q1,6,F,20150120.0,20180306.0,20170322,20180314,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180314.0,,MD,US,US,2018,Q1,Elderly
133606316,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q1,Bronchitis,,2018,Q1,6,F,20150120.0,20180306.0,20170322,20180314,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180314.0,,MD,US,US,2018,Q1,Elderly
133606316,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q1,Candida infection,,2018,Q1,6,F,20150120.0,20180306.0,20170322,20180314,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180314.0,,MD,US,US,2018,Q1,Elderly
133606316,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q1,Chest pain,,2018,Q1,6,F,20150120.0,20180306.0,20170322,20180314,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180314.0,,MD,US,US,2018,Q1,Elderly
133606316,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q1,Chronic obstructive pulmonary disease,,2018,Q1,6,F,20150120.0,20180306.0,20170322,20180314,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180314.0,,MD,US,US,2018,Q1,Elderly
133606316,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q1,Condition aggravated,,2018,Q1,6,F,20150120.0,20180306.0,20170322,20180314,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180314.0,,MD,US,US,2018,Q1,Elderly
133606316,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q1,Cough,,2018,Q1,6,F,20150120.0,20180306.0,20170322,20180314,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180314.0,,MD,US,US,2018,Q1,Elderly
133606316,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q1,Disease progression,,2018,Q1,6,F,20150120.0,20180306.0,20170322,20180314,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180314.0,,MD,US,US,2018,Q1,Elderly
133606316,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q1,Drug intolerance,,2018,Q1,6,F,20150120.0,20180306.0,20170322,20180314,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180314.0,,MD,US,US,2018,Q1,Elderly
133606316,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q1,Dyspnoea,,2018,Q1,6,F,20150120.0,20180306.0,20170322,20180314,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180314.0,,MD,US,US,2018,Q1,Elderly
133606316,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q1,Lung adenocarcinoma recurrent,,2018,Q1,6,F,20150120.0,20180306.0,20170322,20180314,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180314.0,,MD,US,US,2018,Q1,Elderly
133606316,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q1,Metastases to kidney,,2018,Q1,6,F,20150120.0,20180306.0,20170322,20180314,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180314.0,,MD,US,US,2018,Q1,Elderly
133606316,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q1,Packed red blood cell transfusion,,2018,Q1,6,F,20150120.0,20180306.0,20170322,20180314,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180314.0,,MD,US,US,2018,Q1,Elderly
133606316,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q1,Platelet transfusion,,2018,Q1,6,F,20150120.0,20180306.0,20170322,20180314,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180314.0,,MD,US,US,2018,Q1,Elderly
133606316,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q1,Pneumonia,,2018,Q1,6,F,20150120.0,20180306.0,20170322,20180314,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180314.0,,MD,US,US,2018,Q1,Elderly
133606316,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q1,Pneumonia pseudomonal,,2018,Q1,6,F,20150120.0,20180306.0,20170322,20180314,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180314.0,,MD,US,US,2018,Q1,Elderly
133606316,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q1,Productive cough,,2018,Q1,6,F,20150120.0,20180306.0,20170322,20180314,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180314.0,,MD,US,US,2018,Q1,Elderly
133606316,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q1,Pseudomonas test positive,,2018,Q1,6,F,20150120.0,20180306.0,20170322,20180314,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180314.0,,MD,US,US,2018,Q1,Elderly
133606316,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q1,Pulmonary congestion,,2018,Q1,6,F,20150120.0,20180306.0,20170322,20180314,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180314.0,,MD,US,US,2018,Q1,Elderly
133606316,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q1,Pulmonary mass,,2018,Q1,6,F,20150120.0,20180306.0,20170322,20180314,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180314.0,,MD,US,US,2018,Q1,Elderly
133606316,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q1,Pyrexia,,2018,Q1,6,F,20150120.0,20180306.0,20170322,20180314,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180314.0,,MD,US,US,2018,Q1,Elderly
133606316,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q1,Renal cell carcinoma,,2018,Q1,6,F,20150120.0,20180306.0,20170322,20180314,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180314.0,,MD,US,US,2018,Q1,Elderly
133606316,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q1,Respiratory distress,,2018,Q1,6,F,20150120.0,20180306.0,20170322,20180314,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180314.0,,MD,US,US,2018,Q1,Elderly
133606316,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q1,Secretion discharge,,2018,Q1,6,F,20150120.0,20180306.0,20170322,20180314,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180314.0,,MD,US,US,2018,Q1,Elderly
133606316,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q1,Small cell lung cancer metastatic,,2018,Q1,6,F,20150120.0,20180306.0,20170322,20180314,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180314.0,,MD,US,US,2018,Q1,Elderly
133606316,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q1,Sputum culture positive,,2018,Q1,6,F,20150120.0,20180306.0,20170322,20180314,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180314.0,,MD,US,US,2018,Q1,Elderly
133606316,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q1,Stenotrophomonas infection,,2018,Q1,6,F,20150120.0,20180306.0,20170322,20180314,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180314.0,,MD,US,US,2018,Q1,Elderly
133606316,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q1,Tachypnoea,,2018,Q1,6,F,20150120.0,20180306.0,20170322,20180314,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180314.0,,MD,US,US,2018,Q1,Elderly
133606316,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q1,Transfusion,,2018,Q1,6,F,20150120.0,20180306.0,20170322,20180314,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180314.0,,MD,US,US,2018,Q1,Elderly
134883442,13488344,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,WITH EACH MEAL,,,,,,,,2.0,IU,UNKNOWN,,2018,Q1,Acute kidney injury,,2018,Q1,2,F,,20170829.0,20170412,20180103,EXP,,US-MICRO LABS LIMITED-BB2017-00412,MICRO LABS,"CHAROKOPOS A, MUHAMMAD T, SURBHI S, BRATEANU A. WEAKNESS AND PAIN IN ARMS AND LEGS DARK URINE. HISTORY OF VERTEBRAL OSTEOMYELITIS. 2017;66(3):170-173.",76.0,YR,,F,Y,,,20180103.0,,MD,US,US,2018,Q1,Elderly
134883442,13488344,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,WITH EACH MEAL,,,,,,,,2.0,IU,UNKNOWN,,2018,Q1,Drug interaction,,2018,Q1,2,F,,20170829.0,20170412,20180103,EXP,,US-MICRO LABS LIMITED-BB2017-00412,MICRO LABS,"CHAROKOPOS A, MUHAMMAD T, SURBHI S, BRATEANU A. WEAKNESS AND PAIN IN ARMS AND LEGS DARK URINE. HISTORY OF VERTEBRAL OSTEOMYELITIS. 2017;66(3):170-173.",76.0,YR,,F,Y,,,20180103.0,,MD,US,US,2018,Q1,Elderly
134883442,13488344,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,WITH EACH MEAL,,,,,,,,2.0,IU,UNKNOWN,,2018,Q1,Rhabdomyolysis,,2018,Q1,2,F,,20170829.0,20170412,20180103,EXP,,US-MICRO LABS LIMITED-BB2017-00412,MICRO LABS,"CHAROKOPOS A, MUHAMMAD T, SURBHI S, BRATEANU A. WEAKNESS AND PAIN IN ARMS AND LEGS DARK URINE. HISTORY OF VERTEBRAL OSTEOMYELITIS. 2017;66(3):170-173.",76.0,YR,,F,Y,,,20180103.0,,MD,US,US,2018,Q1,Elderly
135069865,13506986,18,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Contusion,,2018,Q1,5,F,20170323.0,20180326.0,20170503,20180331,EXP,,US-ABBVIE-17K-163-1955787-00,ABBVIE,,56.0,YR,,F,Y,87.17,KG,20180330.0,,MD,US,US,2018,Q1,Adult
135069865,13506986,18,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Dermatitis allergic,,2018,Q1,5,F,20170323.0,20180326.0,20170503,20180331,EXP,,US-ABBVIE-17K-163-1955787-00,ABBVIE,,56.0,YR,,F,Y,87.17,KG,20180330.0,,MD,US,US,2018,Q1,Adult
135069865,13506986,18,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Diabetic gastroparesis,,2018,Q1,5,F,20170323.0,20180326.0,20170503,20180331,EXP,,US-ABBVIE-17K-163-1955787-00,ABBVIE,,56.0,YR,,F,Y,87.17,KG,20180330.0,,MD,US,US,2018,Q1,Adult
135069865,13506986,18,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Diarrhoea,,2018,Q1,5,F,20170323.0,20180326.0,20170503,20180331,EXP,,US-ABBVIE-17K-163-1955787-00,ABBVIE,,56.0,YR,,F,Y,87.17,KG,20180330.0,,MD,US,US,2018,Q1,Adult
135069865,13506986,18,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Drug hypersensitivity,,2018,Q1,5,F,20170323.0,20180326.0,20170503,20180331,EXP,,US-ABBVIE-17K-163-1955787-00,ABBVIE,,56.0,YR,,F,Y,87.17,KG,20180330.0,,MD,US,US,2018,Q1,Adult
135069865,13506986,18,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Gastrostomy,,2018,Q1,5,F,20170323.0,20180326.0,20170503,20180331,EXP,,US-ABBVIE-17K-163-1955787-00,ABBVIE,,56.0,YR,,F,Y,87.17,KG,20180330.0,,MD,US,US,2018,Q1,Adult
135069865,13506986,18,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Impaired gastric emptying,,2018,Q1,5,F,20170323.0,20180326.0,20170503,20180331,EXP,,US-ABBVIE-17K-163-1955787-00,ABBVIE,,56.0,YR,,F,Y,87.17,KG,20180330.0,,MD,US,US,2018,Q1,Adult
135069865,13506986,18,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Post procedural fever,,2018,Q1,5,F,20170323.0,20180326.0,20170503,20180331,EXP,,US-ABBVIE-17K-163-1955787-00,ABBVIE,,56.0,YR,,F,Y,87.17,KG,20180330.0,,MD,US,US,2018,Q1,Adult
135069865,13506986,18,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Proteinuria,,2018,Q1,5,F,20170323.0,20180326.0,20170503,20180331,EXP,,US-ABBVIE-17K-163-1955787-00,ABBVIE,,56.0,YR,,F,Y,87.17,KG,20180330.0,,MD,US,US,2018,Q1,Adult
135069865,13506986,18,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Skin exfoliation,,2018,Q1,5,F,20170323.0,20180326.0,20170503,20180331,EXP,,US-ABBVIE-17K-163-1955787-00,ABBVIE,,56.0,YR,,F,Y,87.17,KG,20180330.0,,MD,US,US,2018,Q1,Adult
135069865,13506986,18,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Stoma site extravasation,,2018,Q1,5,F,20170323.0,20180326.0,20170503,20180331,EXP,,US-ABBVIE-17K-163-1955787-00,ABBVIE,,56.0,YR,,F,Y,87.17,KG,20180330.0,,MD,US,US,2018,Q1,Adult
135176165,13517616,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 IU, DAILY, SOLUTION",,,,,,,,100.0,IU,SOLUTION FOR INJECTION,,2018,Q1,Drug interaction,,2018,Q1,5,F,201704.0,20180122.0,20170505,20180126,EXP,,DE-PFIZER INC-2017193290,PFIZER,,67.0,YR,,F,Y,74.0,KG,20180126.0,,MD,DE,DE,2018,Q1,Elderly
135176165,13517616,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 IU, DAILY, SOLUTION",,,,,,,,100.0,IU,SOLUTION FOR INJECTION,,2018,Q1,Rhabdomyolysis,,2018,Q1,5,F,201704.0,20180122.0,20170505,20180126,EXP,,DE-PFIZER INC-2017193290,PFIZER,,67.0,YR,,F,Y,74.0,KG,20180126.0,,MD,DE,DE,2018,Q1,Elderly
136336182,13633618,4,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,40 UNITS,,,,,,,,,,,,2018,Q1,Gastrointestinal haemorrhage,,2018,Q1,2,F,20120426.0,20180227.0,20170609,20180306,PER,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-BI-032016",BOEHRINGER INGELHEIM,,70.0,YR,,F,Y,,,20180306.0,,MD,US,US,2018,Q1,Elderly
136429113,13642911,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,2 IU,,,,,,,,,,INJECTION,,2018,Q1,Pneumonitis,,2018,Q1,3,F,20170619.0,20180326.0,20170612,20180330,EXP,,US-ASTRAZENECA-2017SE61032,ASTRAZENECA,,26038.0,DY,,F,Y,49.8,KG,20180330.0,,MD,US,US,2018,Q1,Elderly
137477933,13747793,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q1,Abdominal distension,,2018,Q1,3,F,20121118.0,20180301.0,20170713,20180304,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-BI-038501",BOEHRINGER INGELHEIM,,66.0,YR,,F,Y,58.97,KG,20180304.0,,MD,US,US,2018,Q1,Elderly
137477933,13747793,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q1,Dyspnoea paroxysmal nocturnal,,2018,Q1,3,F,20121118.0,20180301.0,20170713,20180304,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-BI-038501",BOEHRINGER INGELHEIM,,66.0,YR,,F,Y,58.97,KG,20180304.0,,MD,US,US,2018,Q1,Elderly
137477933,13747793,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q1,Epistaxis,,2018,Q1,3,F,20121118.0,20180301.0,20170713,20180304,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-BI-038501",BOEHRINGER INGELHEIM,,66.0,YR,,F,Y,58.97,KG,20180304.0,,MD,US,US,2018,Q1,Elderly
137477933,13747793,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q1,Gastrointestinal haemorrhage,,2018,Q1,3,F,20121118.0,20180301.0,20170713,20180304,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-BI-038501",BOEHRINGER INGELHEIM,,66.0,YR,,F,Y,58.97,KG,20180304.0,,MD,US,US,2018,Q1,Elderly
137477933,13747793,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q1,Oedema peripheral,,2018,Q1,3,F,20121118.0,20180301.0,20170713,20180304,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-BI-038501",BOEHRINGER INGELHEIM,,66.0,YR,,F,Y,58.97,KG,20180304.0,,MD,US,US,2018,Q1,Elderly
137477933,13747793,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q1,Orthopnoea,,2018,Q1,3,F,20121118.0,20180301.0,20170713,20180304,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-BI-038501",BOEHRINGER INGELHEIM,,66.0,YR,,F,Y,58.97,KG,20180304.0,,MD,US,US,2018,Q1,Elderly
137605908,13760590,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q1,Cutaneous vasculitis,,2018,Q1,8,F,20170501.0,20180326.0,20170717,20180330,EXP,,DE-TEVA-785054GER,TEVA,,76.0,YR,,M,Y,97.4,KG,20180331.0,,MD,DE,DE,2018,Q1,Elderly
137605908,13760590,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q1,Nephrotic syndrome,,2018,Q1,8,F,20170501.0,20180326.0,20170717,20180330,EXP,,DE-TEVA-785054GER,TEVA,,76.0,YR,,M,Y,97.4,KG,20180331.0,,MD,DE,DE,2018,Q1,Elderly
138394933,13839493,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1-6 UNIT,,,,,,,,,,,,2018,Q1,Neutropenia,,2018,Q1,3,F,20170626.0,20180118.0,20170807,20180122,EXP,,US-ROCHE-1956870,ROCHE,,78.0,YR,,M,Y,67.59,KG,20180122.0,,MD,US,US,2018,Q1,Elderly
138394933,13839493,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1-6 UNIT,,,,,,,,,,,,2018,Q1,Urosepsis,,2018,Q1,3,F,20170626.0,20180118.0,20170807,20180122,EXP,,US-ROCHE-1956870,ROCHE,,78.0,YR,,M,Y,67.59,KG,20180122.0,,MD,US,US,2018,Q1,Elderly
138394933,13839493,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1-4 UNIT,,,,,,,,,,,,2018,Q1,Neutropenia,,2018,Q1,3,F,20170626.0,20180118.0,20170807,20180122,EXP,,US-ROCHE-1956870,ROCHE,,78.0,YR,,M,Y,67.59,KG,20180122.0,,MD,US,US,2018,Q1,Elderly
138394933,13839493,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1-4 UNIT,,,,,,,,,,,,2018,Q1,Urosepsis,,2018,Q1,3,F,20170626.0,20180118.0,20170807,20180122,EXP,,US-ROCHE-1956870,ROCHE,,78.0,YR,,M,Y,67.59,KG,20180122.0,,MD,US,US,2018,Q1,Elderly
139344962,13934496,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,,,,,2018,Q1,Cardiac arrest,,2018,Q1,2,F,,20180213.0,20170905,20180226,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-078879,BRISTOL MYERS SQUIBB,,54.0,YR,,F,Y,,,20180226.0,,OT,US,US,2018,Q1,Adult
139344962,13934496,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,,,,,2018,Q1,Cardiogenic shock,,2018,Q1,2,F,,20180213.0,20170905,20180226,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-078879,BRISTOL MYERS SQUIBB,,54.0,YR,,F,Y,,,20180226.0,,OT,US,US,2018,Q1,Adult
139344962,13934496,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,,,,,2018,Q1,Drug level increased,,2018,Q1,2,F,,20180213.0,20170905,20180226,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-078879,BRISTOL MYERS SQUIBB,,54.0,YR,,F,Y,,,20180226.0,,OT,US,US,2018,Q1,Adult
139344962,13934496,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,,,,,2018,Q1,Lactic acidosis,,2018,Q1,2,F,,20180213.0,20170905,20180226,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-078879,BRISTOL MYERS SQUIBB,,54.0,YR,,F,Y,,,20180226.0,,OT,US,US,2018,Q1,Adult
139344962,13934496,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,,,,,2018,Q1,Pulseless electrical activity,,2018,Q1,2,F,,20180213.0,20170905,20180226,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-078879,BRISTOL MYERS SQUIBB,,54.0,YR,,F,Y,,,20180226.0,,OT,US,US,2018,Q1,Adult
139344962,13934496,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,,,,,2018,Q1,Respiratory failure,,2018,Q1,2,F,,20180213.0,20170905,20180226,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-078879,BRISTOL MYERS SQUIBB,,54.0,YR,,F,Y,,,20180226.0,,OT,US,US,2018,Q1,Adult
140191556,14019155,33,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,1 IU (INTERNATIONAL UNIT),,,,,,,,1.0,IU,UNKNOWN,,2018,Q1,Acute kidney injury,Acute kidney injury,2018,Q1,6,F,20170913.0,20180206.0,20170928,20180212,EXP,,US-CELGENEUS-USA-20170904150,CELGENE,,71.0,YR,,M,Y,113.0,KG,20180212.0,,MD,US,US,2018,Q1,Elderly
140191556,14019155,33,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,1 IU (INTERNATIONAL UNIT),,,,,,,,1.0,IU,UNKNOWN,,2018,Q1,Alanine aminotransferase increased,,2018,Q1,6,F,20170913.0,20180206.0,20170928,20180212,EXP,,US-CELGENEUS-USA-20170904150,CELGENE,,71.0,YR,,M,Y,113.0,KG,20180212.0,,MD,US,US,2018,Q1,Elderly
140191556,14019155,33,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,1 IU (INTERNATIONAL UNIT),,,,,,,,1.0,IU,UNKNOWN,,2018,Q1,Aspartate aminotransferase increased,,2018,Q1,6,F,20170913.0,20180206.0,20170928,20180212,EXP,,US-CELGENEUS-USA-20170904150,CELGENE,,71.0,YR,,M,Y,113.0,KG,20180212.0,,MD,US,US,2018,Q1,Elderly
140960513,14096051,10,C,Insulin LisproDi,,2,Subcutaneous,,,,,,,,,,,,,2018,Q1,Blood pressure decreased,,2018,Q1,3,F,201709.0,20171228.0,20171017,20180109,EXP,,CO-BAXTER-2017BAX035313,BAXTER,,85.0,YR,,F,Y,55.0,KG,20180109.0,,OT,CO,CO,2018,Q1,Elderly
140960513,14096051,10,C,Insulin LisproDi,,2,Subcutaneous,,,,,,,,,,,,,2018,Q1,Decubitus ulcer,,2018,Q1,3,F,201709.0,20171228.0,20171017,20180109,EXP,,CO-BAXTER-2017BAX035313,BAXTER,,85.0,YR,,F,Y,55.0,KG,20180109.0,,OT,CO,CO,2018,Q1,Elderly
140960513,14096051,10,C,Insulin LisproDi,,2,Subcutaneous,,,,,,,,,,,,,2018,Q1,Diabetic complication,,2018,Q1,3,F,201709.0,20171228.0,20171017,20180109,EXP,,CO-BAXTER-2017BAX035313,BAXTER,,85.0,YR,,F,Y,55.0,KG,20180109.0,,OT,CO,CO,2018,Q1,Elderly
140960513,14096051,10,C,Insulin LisproDi,,2,Subcutaneous,,,,,,,,,,,,,2018,Q1,Diabetic foot,,2018,Q1,3,F,201709.0,20171228.0,20171017,20180109,EXP,,CO-BAXTER-2017BAX035313,BAXTER,,85.0,YR,,F,Y,55.0,KG,20180109.0,,OT,CO,CO,2018,Q1,Elderly
140960513,14096051,10,C,Insulin LisproDi,,2,Subcutaneous,,,,,,,,,,,,,2018,Q1,General physical health deterioration,,2018,Q1,3,F,201709.0,20171228.0,20171017,20180109,EXP,,CO-BAXTER-2017BAX035313,BAXTER,,85.0,YR,,F,Y,55.0,KG,20180109.0,,OT,CO,CO,2018,Q1,Elderly
140960513,14096051,10,C,Insulin LisproDi,,2,Subcutaneous,,,,,,,,,,,,,2018,Q1,Hypoglycaemia,,2018,Q1,3,F,201709.0,20171228.0,20171017,20180109,EXP,,CO-BAXTER-2017BAX035313,BAXTER,,85.0,YR,,F,Y,55.0,KG,20180109.0,,OT,CO,CO,2018,Q1,Elderly
140960513,14096051,10,C,Insulin LisproDi,,2,Subcutaneous,,,,,,,,,,,,,2018,Q1,Hypotension,,2018,Q1,3,F,201709.0,20171228.0,20171017,20180109,EXP,,CO-BAXTER-2017BAX035313,BAXTER,,85.0,YR,,F,Y,55.0,KG,20180109.0,,OT,CO,CO,2018,Q1,Elderly
140960513,14096051,10,C,Insulin LisproDi,,2,Subcutaneous,,,,,,,,,,,,,2018,Q1,Osteomyelitis,,2018,Q1,3,F,201709.0,20171228.0,20171017,20180109,EXP,,CO-BAXTER-2017BAX035313,BAXTER,,85.0,YR,,F,Y,55.0,KG,20180109.0,,OT,CO,CO,2018,Q1,Elderly
140960513,14096051,10,C,Insulin LisproDi,,2,Subcutaneous,,,,,,,,,,,,,2018,Q1,Postoperative wound infection,,2018,Q1,3,F,201709.0,20171228.0,20171017,20180109,EXP,,CO-BAXTER-2017BAX035313,BAXTER,,85.0,YR,,F,Y,55.0,KG,20180109.0,,OT,CO,CO,2018,Q1,Elderly
140995997,14099599,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 U, TID",,,,,,,,15.0,IU,,TID,2018,Q1,Dysuria,,2018,Q1,7,F,20171001.0,20180308.0,20171017,20180313,EXP,,US-BAYER-2017-192283,BAYER,,76.0,YR,E,M,Y,89.8,KG,20180313.0,,MD,US,US,2018,Q1,Elderly
141203144,14120314,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"PER BLOOD GLUCOSE LEVEL, WITH MEALS",,,U,U,,,,,,,,2018,Q1,Colitis,,2018,Q1,4,F,20171011.0,20180111.0,20171024,20180123,EXP,,PHHO2017US014657,SANDOZ,,13.0,YR,,F,Y,,,20180124.0,,CN,US,US,2018,Q1,Child
141549563,14154956,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SLIDING SCALE WITH MEAL,,,U,U,,,,,,,,2018,Q1,Acute kidney injury,,2018,Q1,3,F,20170919.0,20180119.0,20171102,20180124,EXP,,PHHO2017US015008,NOVARTIS,,61.0,YR,,M,Y,,,20180124.0,,MD,US,US,2018,Q1,Adult
141549563,14154956,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SLIDING SCALE WITH MEAL,,,U,U,,,,,,,,2018,Q1,Respiratory failure,,2018,Q1,3,F,20170919.0,20180119.0,20171102,20180124,EXP,,PHHO2017US015008,NOVARTIS,,61.0,YR,,M,Y,,,20180124.0,,MD,US,US,2018,Q1,Adult
141549563,14154956,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SLIDING SCALE WITH MEAL,,,U,U,,,,,,,,2018,Q1,Urinary retention,,2018,Q1,3,F,20170919.0,20180119.0,20171102,20180124,EXP,,PHHO2017US015008,NOVARTIS,,61.0,YR,,M,Y,,,20180124.0,,MD,US,US,2018,Q1,Adult
141566334,14156633,15,C,"INSULIN LISPRO, INSULIN LISPRO PROTAMINE SUSPENSION",,2,Unknown,"AS NEEDED, TWICE PER DAY",,,,,,,,,,,,2018,Q1,Pneumocystis jirovecii pneumonia,,2018,Q1,4,F,20171017.0,20180314.0,20171103,20180322,EXP,,PL-ASTRAZENECA-2017SF06792,ASTRAZENECA,,65.0,YR,,F,Y,,,20180322.0,,MD,PL,PL,2018,Q1,Elderly
141621524,14162152,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2018,Q1,Myocardial infarction,,2018,Q1,4,F,20171019.0,20180212.0,20171106,20180220,EXP,,PHHO2017US015238,SANDOZ,,44.0,YR,,F,Y,,,20180220.0,,CN,US,US,2018,Q1,Adult
141621524,14162152,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2018,Q1,Pulmonary embolism,,2018,Q1,4,F,20171019.0,20180212.0,20171106,20180220,EXP,,PHHO2017US015238,SANDOZ,,44.0,YR,,F,Y,,,20180220.0,,CN,US,US,2018,Q1,Adult
141621524,14162152,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2018,Q1,Retroperitoneal haematoma,,2018,Q1,4,F,20171019.0,20180212.0,20171106,20180220,EXP,,PHHO2017US015238,SANDOZ,,44.0,YR,,F,Y,,,20180220.0,,CN,US,US,2018,Q1,Adult
141834002,14183400,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 UNITS/ML, 4 UNITS, 0.04 ML THRICE A DAY (TID) WITH MEALS",,,D,,,,,,,INJECTION,,2018,Q1,Acute kidney injury,,2018,Q1,2,F,201511.0,20180112.0,20171113,20180116,EXP,,US-JNJFOC-20171110908,JANSSEN,,72.0,YR,E,F,Y,,,20180116.0,,CN,US,US,2018,Q1,Elderly
141834002,14183400,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 UNITS/ML, 4 UNITS, 0.04 ML THRICE A DAY (TID) WITH MEALS",,,D,,,,,,,INJECTION,,2018,Q1,Diabetic ketoacidosis,,2018,Q1,2,F,201511.0,20180112.0,20171113,20180116,EXP,,US-JNJFOC-20171110908,JANSSEN,,72.0,YR,E,F,Y,,,20180116.0,,CN,US,US,2018,Q1,Elderly
141834002,14183400,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 UNITS/ML, 4 UNITS, 0.04 ML THRICE A DAY (TID) WITH MEALS",,,D,,,,,,,INJECTION,,2018,Q1,Sepsis,,2018,Q1,2,F,201511.0,20180112.0,20171113,20180116,EXP,,US-JNJFOC-20171110908,JANSSEN,,72.0,YR,E,F,Y,,,20180116.0,,CN,US,US,2018,Q1,Elderly
142508282,14250828,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 IU, DAILY",,,,,,,,10.0,IU,SOLUTION FOR INJECTION,,2018,Q1,Blood pressure increased,,2018,Q1,2,F,,20180226.0,20171205,20180306,PER,,US-PFIZER INC-2017518526,PFIZER,,56.0,YR,,F,Y,104.0,KG,20180306.0,,OT,US,US,2018,Q1,Adult
142508282,14250828,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 IU, DAILY",,,,,,,,10.0,IU,SOLUTION FOR INJECTION,,2018,Q1,Dysgeusia,,2018,Q1,2,F,,20180226.0,20171205,20180306,PER,,US-PFIZER INC-2017518526,PFIZER,,56.0,YR,,F,Y,104.0,KG,20180306.0,,OT,US,US,2018,Q1,Adult
142508282,14250828,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 IU, DAILY",,,,,,,,10.0,IU,SOLUTION FOR INJECTION,,2018,Q1,Fatigue,,2018,Q1,2,F,,20180226.0,20171205,20180306,PER,,US-PFIZER INC-2017518526,PFIZER,,56.0,YR,,F,Y,104.0,KG,20180306.0,,OT,US,US,2018,Q1,Adult
142508282,14250828,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 IU, DAILY",,,,,,,,10.0,IU,SOLUTION FOR INJECTION,,2018,Q1,Onycholysis,,2018,Q1,2,F,,20180226.0,20171205,20180306,PER,,US-PFIZER INC-2017518526,PFIZER,,56.0,YR,,F,Y,104.0,KG,20180306.0,,OT,US,US,2018,Q1,Adult
142508282,14250828,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 IU, DAILY",,,,,,,,10.0,IU,SOLUTION FOR INJECTION,,2018,Q1,Stevens-Johnson syndrome,,2018,Q1,2,F,,20180226.0,20171205,20180306,PER,,US-PFIZER INC-2017518526,PFIZER,,56.0,YR,,F,Y,104.0,KG,20180306.0,,OT,US,US,2018,Q1,Adult
142514995,14251499,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Abdominal discomfort,,2018,Q1,5,F,2017.0,20171229.0,20171205,20180111,EXP,,US-VIFOR (INTERNATIONAL) INC.-VIT-2017-13039,VIFOR,,65.0,YR,,M,Y,,,20180112.0,,CN,US,US,2018,Q1,Elderly
142514995,14251499,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Blood potassium abnormal,,2018,Q1,5,F,2017.0,20171229.0,20171205,20180111,EXP,,US-VIFOR (INTERNATIONAL) INC.-VIT-2017-13039,VIFOR,,65.0,YR,,M,Y,,,20180112.0,,CN,US,US,2018,Q1,Elderly
142514995,14251499,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Impaired gastric emptying,,2018,Q1,5,F,2017.0,20171229.0,20171205,20180111,EXP,,US-VIFOR (INTERNATIONAL) INC.-VIT-2017-13039,VIFOR,,65.0,YR,,M,Y,,,20180112.0,,CN,US,US,2018,Q1,Elderly
142514995,14251499,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Liver transplant,,2018,Q1,5,F,2017.0,20171229.0,20171205,20180111,EXP,,US-VIFOR (INTERNATIONAL) INC.-VIT-2017-13039,VIFOR,,65.0,YR,,M,Y,,,20180112.0,,CN,US,US,2018,Q1,Elderly
142514995,14251499,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Pain,,2018,Q1,5,F,2017.0,20171229.0,20171205,20180111,EXP,,US-VIFOR (INTERNATIONAL) INC.-VIT-2017-13039,VIFOR,,65.0,YR,,M,Y,,,20180112.0,,CN,US,US,2018,Q1,Elderly
142555612,14255561,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DAILY DOSE 18 U,,,,,,,,18.0,IU,,,2018,Q1,Gangrene,,2018,Q1,2,F,20171111.0,20180107.0,20171206,20180110,EXP,,CN-BAYER-2017-220367,BAYER,,81.0,YR,E,M,Y,54.3,KG,20180110.0,,MD,CN,CN,2018,Q1,Elderly
142622604,14262260,5,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Malaise,,2018,Q1,4,F,20171101.0,20180220.0,20171208,20180226,EXP,,US-GILEAD-2017-0308964,GILEAD,,64.0,YR,,F,Y,,,20180226.0,,MD,US,US,2018,Q1,Adult
142622604,14262260,5,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Oedema,,2018,Q1,4,F,20171101.0,20180220.0,20171208,20180226,EXP,,US-GILEAD-2017-0308964,GILEAD,,64.0,YR,,F,Y,,,20180226.0,,MD,US,US,2018,Q1,Adult
142672393,14267239,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q1,Asthenia,,2018,Q1,3,F,2017.0,20180212.0,20171211,20180216,EXP,,US-PFIZER INC-2017525167,PFIZER,,84.0,YR,,M,Y,,,20180216.0,,MD,US,US,2018,Q1,Elderly
142672393,14267239,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q1,Condition aggravated,,2018,Q1,3,F,2017.0,20180212.0,20171211,20180216,EXP,,US-PFIZER INC-2017525167,PFIZER,,84.0,YR,,M,Y,,,20180216.0,,MD,US,US,2018,Q1,Elderly
142672393,14267239,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q1,Decreased appetite,,2018,Q1,3,F,2017.0,20180212.0,20171211,20180216,EXP,,US-PFIZER INC-2017525167,PFIZER,,84.0,YR,,M,Y,,,20180216.0,,MD,US,US,2018,Q1,Elderly
142672393,14267239,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q1,Fall,,2018,Q1,3,F,2017.0,20180212.0,20171211,20180216,EXP,,US-PFIZER INC-2017525167,PFIZER,,84.0,YR,,M,Y,,,20180216.0,,MD,US,US,2018,Q1,Elderly
142672393,14267239,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q1,Fatigue,,2018,Q1,3,F,2017.0,20180212.0,20171211,20180216,EXP,,US-PFIZER INC-2017525167,PFIZER,,84.0,YR,,M,Y,,,20180216.0,,MD,US,US,2018,Q1,Elderly
142672393,14267239,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q1,Hypertension,,2018,Q1,3,F,2017.0,20180212.0,20171211,20180216,EXP,,US-PFIZER INC-2017525167,PFIZER,,84.0,YR,,M,Y,,,20180216.0,,MD,US,US,2018,Q1,Elderly
142672393,14267239,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q1,Hypomagnesaemia,,2018,Q1,3,F,2017.0,20180212.0,20171211,20180216,EXP,,US-PFIZER INC-2017525167,PFIZER,,84.0,YR,,M,Y,,,20180216.0,,MD,US,US,2018,Q1,Elderly
142672393,14267239,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q1,Hypovolaemia,,2018,Q1,3,F,2017.0,20180212.0,20171211,20180216,EXP,,US-PFIZER INC-2017525167,PFIZER,,84.0,YR,,M,Y,,,20180216.0,,MD,US,US,2018,Q1,Elderly
142672393,14267239,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q1,Inappropriate antidiuretic hormone secretion,,2018,Q1,3,F,2017.0,20180212.0,20171211,20180216,EXP,,US-PFIZER INC-2017525167,PFIZER,,84.0,YR,,M,Y,,,20180216.0,,MD,US,US,2018,Q1,Elderly
142672393,14267239,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q1,Nausea,,2018,Q1,3,F,2017.0,20180212.0,20171211,20180216,EXP,,US-PFIZER INC-2017525167,PFIZER,,84.0,YR,,M,Y,,,20180216.0,,MD,US,US,2018,Q1,Elderly
142672393,14267239,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q1,Neoplasm progression,,2018,Q1,3,F,2017.0,20180212.0,20171211,20180216,EXP,,US-PFIZER INC-2017525167,PFIZER,,84.0,YR,,M,Y,,,20180216.0,,MD,US,US,2018,Q1,Elderly
142672393,14267239,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q1,Orthostatic hypotension,,2018,Q1,3,F,2017.0,20180212.0,20171211,20180216,EXP,,US-PFIZER INC-2017525167,PFIZER,,84.0,YR,,M,Y,,,20180216.0,,MD,US,US,2018,Q1,Elderly
142672393,14267239,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q1,Subgaleal haematoma,,2018,Q1,3,F,2017.0,20180212.0,20171211,20180216,EXP,,US-PFIZER INC-2017525167,PFIZER,,84.0,YR,,M,Y,,,20180216.0,,MD,US,US,2018,Q1,Elderly
142672393,14267239,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q1,Syncope,,2018,Q1,3,F,2017.0,20180212.0,20171211,20180216,EXP,,US-PFIZER INC-2017525167,PFIZER,,84.0,YR,,M,Y,,,20180216.0,,MD,US,US,2018,Q1,Elderly
142672393,14267239,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q1,Thrombocytopenia,,2018,Q1,3,F,2017.0,20180212.0,20171211,20180216,EXP,,US-PFIZER INC-2017525167,PFIZER,,84.0,YR,,M,Y,,,20180216.0,,MD,US,US,2018,Q1,Elderly
142672393,14267239,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q1,Troponin increased,,2018,Q1,3,F,2017.0,20180212.0,20171211,20180216,EXP,,US-PFIZER INC-2017525167,PFIZER,,84.0,YR,,M,Y,,,20180216.0,,MD,US,US,2018,Q1,Elderly
142974973,14297497,2,SS,Liprolog Lispro,INSULIN LISPRO,1,Unknown,"UNK, PRN",,,U,U,,,,,,,,2018,Q1,Subcutaneous abscess,Subcutaneous abscess,2018,Q1,3,F,20170723.0,20180115.0,20171218,20180124,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201712005566,ELI LILLY AND CO,,45.0,YR,,M,Y,115.0,KG,20180124.0,,OT,DE,DE,2018,Q1,Adult
142976872,14297687,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q1,Acute kidney injury,,2018,Q1,2,F,20171202.0,20180129.0,20171218,20180207,EXP,,CN-NOVOPROD-576975,NOVO NORDISK,,62.0,YR,A,M,Y,,,20180207.0,,MD,CN,CN,2018,Q1,Adult
142976872,14297687,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q1,Liver injury,,2018,Q1,2,F,20171202.0,20180129.0,20171218,20180207,EXP,,CN-NOVOPROD-576975,NOVO NORDISK,,62.0,YR,A,M,Y,,,20180207.0,,MD,CN,CN,2018,Q1,Adult
142976872,14297687,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q1,Respiratory tract infection,,2018,Q1,2,F,20171202.0,20180129.0,20171218,20180207,EXP,,CN-NOVOPROD-576975,NOVO NORDISK,,62.0,YR,A,M,Y,,,20180207.0,,MD,CN,CN,2018,Q1,Adult
142976872,14297687,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,DOSE WAS REDUCED,,,,,,,,,,,,2018,Q1,Acute kidney injury,,2018,Q1,2,F,20171202.0,20180129.0,20171218,20180207,EXP,,CN-NOVOPROD-576975,NOVO NORDISK,,62.0,YR,A,M,Y,,,20180207.0,,MD,CN,CN,2018,Q1,Adult
142976872,14297687,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,DOSE WAS REDUCED,,,,,,,,,,,,2018,Q1,Liver injury,,2018,Q1,2,F,20171202.0,20180129.0,20171218,20180207,EXP,,CN-NOVOPROD-576975,NOVO NORDISK,,62.0,YR,A,M,Y,,,20180207.0,,MD,CN,CN,2018,Q1,Adult
142976872,14297687,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,DOSE WAS REDUCED,,,,,,,,,,,,2018,Q1,Respiratory tract infection,,2018,Q1,2,F,20171202.0,20180129.0,20171218,20180207,EXP,,CN-NOVOPROD-576975,NOVO NORDISK,,62.0,YR,A,M,Y,,,20180207.0,,MD,CN,CN,2018,Q1,Adult
143008253,14300825,6,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2018,Q1,Sepsis,,2018,Q1,3,F,20171203.0,20180106.0,20171219,20180111,EXP,,US-CELGENEUS-USA-20171202584,CELGENE,,74.0,YR,,F,Y,87.9,KG,20180111.0,,MD,US,US,2018,Q1,Elderly
143104132,14310413,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Intramuscular,"10 ML, UNKNOWN",,,U,U,,,20563.0,10.0,ML,INJECTION,,2018,Q1,Drug abuse,,2018,Q1,2,F,20171204.0,20180201.0,20171220,20180214,EXP,IT-MINISAL02-441298,IT-ELI_LILLY_AND_COMPANY-IT201712004107,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20180214.0,,CN,IT,IT,2018,Q1,Elderly
143104132,14310413,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Intramuscular,"10 ML, UNKNOWN",,,U,U,,,20563.0,10.0,ML,INJECTION,,2018,Q1,Hypoglycaemia,,2018,Q1,2,F,20171204.0,20180201.0,20171220,20180214,EXP,IT-MINISAL02-441298,IT-ELI_LILLY_AND_COMPANY-IT201712004107,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20180214.0,,CN,IT,IT,2018,Q1,Elderly
143104132,14310413,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Intramuscular,"10 ML, UNKNOWN",,,U,U,,,20563.0,10.0,ML,INJECTION,,2018,Q1,Off label use,,2018,Q1,2,F,20171204.0,20180201.0,20171220,20180214,EXP,IT-MINISAL02-441298,IT-ELI_LILLY_AND_COMPANY-IT201712004107,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20180214.0,,CN,IT,IT,2018,Q1,Elderly
143237662,14323766,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 IU, QD",,,,,,,,100.0,IU,SOLUTION FOR INJECTION,QD,2018,Q1,Drug interaction,,2018,Q1,2,F,201704.0,20180115.0,20171226,20180125,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2017-07436,LUPIN,,67.0,YR,,F,Y,74.0,KG,20180125.0,,MD,DE,DE,2018,Q1,Elderly
143237662,14323766,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 IU, QD",,,,,,,,100.0,IU,SOLUTION FOR INJECTION,QD,2018,Q1,Rhabdomyolysis,,2018,Q1,2,F,201704.0,20180115.0,20171226,20180125,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2017-07436,LUPIN,,67.0,YR,,F,Y,74.0,KG,20180125.0,,MD,DE,DE,2018,Q1,Elderly
143301023,14330102,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 IU, DAILY, SOLUTION",,,D,,,,,100.0,IU,,QD,2018,Q1,Drug interaction,,2018,Q1,3,F,201704.0,20180119.0,20171227,20180201,EXP,,DE-MYLANLABS-2017M1082207,MYLAN,,67.0,YR,,F,Y,74.0,KG,20180130.0,,CN,DE,DE,2018,Q1,Elderly
143301023,14330102,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 IU, DAILY, SOLUTION",,,D,,,,,100.0,IU,,QD,2018,Q1,Rhabdomyolysis,,2018,Q1,3,F,201704.0,20180119.0,20171227,20180201,EXP,,DE-MYLANLABS-2017M1082207,MYLAN,,67.0,YR,,F,Y,74.0,KG,20180130.0,,CN,DE,DE,2018,Q1,Elderly
143362862,14336286,4,C,insulin lispro,INSULIN LISPRO,1,,"100 IU, DAILY, SOLUTION",,,,,,,,100.0,IU,SOLUTION FOR INJECTION,,2018,Q1,Drug interaction,,2018,Q1,2,F,20170401.0,20180314.0,20171229,20180328,EXP,,DE-DRREDDYS-GER/GER/17/0095491,DR REDDYS,,67.0,YR,,F,Y,74.0,KG,20180328.0,,MD,DE,DE,2018,Q1,Elderly
143362862,14336286,4,C,insulin lispro,INSULIN LISPRO,1,,"100 IU, DAILY, SOLUTION",,,,,,,,100.0,IU,SOLUTION FOR INJECTION,,2018,Q1,Rhabdomyolysis,,2018,Q1,2,F,20170401.0,20180314.0,20171229,20180328,EXP,,DE-DRREDDYS-GER/GER/17/0095491,DR REDDYS,,67.0,YR,,F,Y,74.0,KG,20180328.0,,MD,DE,DE,2018,Q1,Elderly
143409432,14340943,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"4- 5 U, EACH MORNING",,,,,,,20563.0,5.0,IU,INJECTION,QD,2018,Q1,Incorrect dose administered,,2018,Q1,2,F,20170927.0,20171227.0,20180102,20180112,PER,,US-ELI_LILLY_AND_COMPANY-US201712012192,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20180112.0,,CN,US,US,2018,Q1,Adult
143409432,14340943,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"4- 5 U, EACH MORNING",,,,,,,20563.0,5.0,IU,INJECTION,QD,2018,Q1,Incorrect drug administration duration,,2018,Q1,2,F,20170927.0,20171227.0,20180102,20180112,PER,,US-ELI_LILLY_AND_COMPANY-US201712012192,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20180112.0,,CN,US,US,2018,Q1,Adult
143424811,14342481,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,D,,,,,36.0,KIU,,,2018,Q1,Conduct disorder,,2018,Q1,1,I,20171121.0,20171218.0,20180102,20180102,EXP,IT-MINISAL02-442954,IT-MYLANLABS-2017M1083695,MYLAN,,89.0,YR,,F,Y,,,20180102.0,,MD,IT,IT,2018,Q1,Elderly
143424811,14342481,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,D,,,,,36.0,KIU,,,2018,Q1,Confusional state,,2018,Q1,1,I,20171121.0,20171218.0,20180102,20180102,EXP,IT-MINISAL02-442954,IT-MYLANLABS-2017M1083695,MYLAN,,89.0,YR,,F,Y,,,20180102.0,,MD,IT,IT,2018,Q1,Elderly
143424811,14342481,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,D,,,,,36.0,KIU,,,2018,Q1,Disorientation,,2018,Q1,1,I,20171121.0,20171218.0,20180102,20180102,EXP,IT-MINISAL02-442954,IT-MYLANLABS-2017M1083695,MYLAN,,89.0,YR,,F,Y,,,20180102.0,,MD,IT,IT,2018,Q1,Elderly
143424811,14342481,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,D,,,,,36.0,KIU,,,2018,Q1,"Hallucination, visual",,2018,Q1,1,I,20171121.0,20171218.0,20180102,20180102,EXP,IT-MINISAL02-442954,IT-MYLANLABS-2017M1083695,MYLAN,,89.0,YR,,F,Y,,,20180102.0,,MD,IT,IT,2018,Q1,Elderly
143438711,14343871,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,7-10 UNITS AC,,,,,,,,,,,,2018,Q1,Contrast media reaction,,2018,Q1,1,I,20171003.0,20171222.0,20180102,20180102,PER,,US-GEHC-2017CSU004222,GE HEALTHCARE,,45.0,YR,,M,Y,170.0,KG,20180102.0,,PH,US,US,2018,Q1,Adult
143533701,14353370,13,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,1.0,IU,,,2018,Q1,Arterial occlusive disease,,2018,Q1,1,I,20171228.0,20171228.0,20180105,20180105,EXP,,CO-BAXTER-2017BAX046038,BAXTER,,71.0,YR,,F,Y,54.0,KG,20180105.0,,OT,CO,CO,2018,Q1,Elderly
143533701,14353370,13,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,1.0,IU,,,2018,Q1,Death,,2018,Q1,1,I,20171228.0,20171228.0,20180105,20180105,EXP,,CO-BAXTER-2017BAX046038,BAXTER,,71.0,YR,,F,Y,54.0,KG,20180105.0,,OT,CO,CO,2018,Q1,Elderly
143602971,14360297,7,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,Subcutaneous,,,,,U,,,,2.0,DF,,,2018,Q1,Encephalopathy,,2018,Q1,1,I,,20171222.0,20180106,20180106,EXP,,CA-AUROBINDO-AUR-APL-2018-001010,AUROBINDO,,82.0,YR,,M,Y,,,20180106.0,,MD,CA,CA,2018,Q1,Elderly
143602971,14360297,7,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,Subcutaneous,,,,,U,,,,2.0,DF,,,2018,Q1,Fall,,2018,Q1,1,I,,20171222.0,20180106,20180106,EXP,,CA-AUROBINDO-AUR-APL-2018-001010,AUROBINDO,,82.0,YR,,M,Y,,,20180106.0,,MD,CA,CA,2018,Q1,Elderly
143618882,14361888,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, UNK",,,U,,,,,1.0,DF,,,2018,Q1,Diabetes mellitus inadequate control,,2018,Q1,2,F,,20180108.0,20180108,20180122,EXP,,CZ-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-120364,BRISTOL MYERS SQUIBB,NEVRLA J. RETINOPATHY AS AN EARLY COMPLICATION OF DIABETES MELLITUS. KAZUISTIKY V DIABETOLOGII 15. 2017;MS1:14-15,43.0,YR,,F,Y,107.0,KG,20180121.0,,MD,CZ,CZ,2018,Q1,Adult
143618882,14361888,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, UNK",,,U,,,,,1.0,DF,,,2018,Q1,Drug ineffective,,2018,Q1,2,F,,20180108.0,20180108,20180122,EXP,,CZ-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-120364,BRISTOL MYERS SQUIBB,NEVRLA J. RETINOPATHY AS AN EARLY COMPLICATION OF DIABETES MELLITUS. KAZUISTIKY V DIABETOLOGII 15. 2017;MS1:14-15,43.0,YR,,F,Y,107.0,KG,20180121.0,,MD,CZ,CZ,2018,Q1,Adult
143659904,14365990,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 IU, DAILY, SOLUTION",,,,,,,,100.0,IU,,,2018,Q1,Drug interaction,,2018,Q1,4,F,201704.0,20180214.0,20180109,20180226,EXP,,DE-TEVA-2017-DE-841777,TEVA,,67.0,YR,,F,Y,74.0,KG,20180226.0,,MD,DE,DE,2018,Q1,Elderly
143659904,14365990,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 IU, DAILY, SOLUTION",,,,,,,,100.0,IU,,,2018,Q1,Rhabdomyolysis,,2018,Q1,4,F,201704.0,20180214.0,20180109,20180226,EXP,,DE-TEVA-2017-DE-841777,TEVA,,67.0,YR,,F,Y,74.0,KG,20180226.0,,MD,DE,DE,2018,Q1,Elderly
143802562,14380256,10,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q1,Colitis,,2018,Q1,2,F,20171011.0,20180220.0,20180112,20180226,EXP,,US-PFIZER INC-2018012072,PFIZER,,13.0,YR,,F,Y,72.7,KG,20180226.0,,MD,US,US,2018,Q1,Child
143847544,14384754,5,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Bacterial infection,,2018,Q1,4,F,20171225.0,20180124.0,20180115,20180126,EXP,,BR-ABBVIE-18P-020-2221820-00,ABBVIE,,71.0,YR,,F,Y,41.0,KG,20180126.0,,MD,BR,BR,2018,Q1,Elderly
143847544,14384754,5,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Klebsiella infection,,2018,Q1,4,F,20171225.0,20180124.0,20180115,20180126,EXP,,BR-ABBVIE-18P-020-2221820-00,ABBVIE,,71.0,YR,,F,Y,41.0,KG,20180126.0,,MD,BR,BR,2018,Q1,Elderly
143847544,14384754,5,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Sepsis,,2018,Q1,4,F,20171225.0,20180124.0,20180115,20180126,EXP,,BR-ABBVIE-18P-020-2221820-00,ABBVIE,,71.0,YR,,F,Y,41.0,KG,20180126.0,,MD,BR,BR,2018,Q1,Elderly
143847544,14384754,5,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Urinary tract infection bacterial,,2018,Q1,4,F,20171225.0,20180124.0,20180115,20180126,EXP,,BR-ABBVIE-18P-020-2221820-00,ABBVIE,,71.0,YR,,F,Y,41.0,KG,20180126.0,,MD,BR,BR,2018,Q1,Elderly
143860731,14386073,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"20 U, EACH MORNING",,,U,U,,,20563.0,20.0,IU,,QD,2018,Q1,Blood glucose decreased,,2018,Q1,1,I,20171220.0,20180109.0,20180115,20180115,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201801005373,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20180115.0,,CN,IN,IN,2018,Q1,Elderly
143860731,14386073,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"20 U, EACH MORNING",,,U,U,,,20563.0,20.0,IU,,QD,2018,Q1,Hypotension,,2018,Q1,1,I,20171220.0,20180109.0,20180115,20180115,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201801005373,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20180115.0,,CN,IN,IN,2018,Q1,Elderly
143860731,14386073,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"20 U, EACH MORNING",,,U,U,,,20563.0,20.0,IU,,QD,2018,Q1,Liver injury,,2018,Q1,1,I,20171220.0,20180109.0,20180115,20180115,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201801005373,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20180115.0,,CN,IN,IN,2018,Q1,Elderly
143860731,14386073,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"20 U, EACH MORNING",,,U,U,,,20563.0,20.0,IU,,QD,2018,Q1,Renal injury,,2018,Q1,1,I,20171220.0,20180109.0,20180115,20180115,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201801005373,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20180115.0,,CN,IN,IN,2018,Q1,Elderly
143860731,14386073,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"20 U, EACH MORNING",,,U,U,,,20563.0,20.0,IU,,QD,2018,Q1,Swelling,,2018,Q1,1,I,20171220.0,20180109.0,20180115,20180115,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201801005373,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20180115.0,,CN,IN,IN,2018,Q1,Elderly
143860731,14386073,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 U, EACH EVENING",,,U,U,,,20563.0,10.0,IU,,QD,2018,Q1,Blood glucose decreased,,2018,Q1,1,I,20171220.0,20180109.0,20180115,20180115,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201801005373,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20180115.0,,CN,IN,IN,2018,Q1,Elderly
143860731,14386073,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 U, EACH EVENING",,,U,U,,,20563.0,10.0,IU,,QD,2018,Q1,Hypotension,,2018,Q1,1,I,20171220.0,20180109.0,20180115,20180115,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201801005373,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20180115.0,,CN,IN,IN,2018,Q1,Elderly
143860731,14386073,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 U, EACH EVENING",,,U,U,,,20563.0,10.0,IU,,QD,2018,Q1,Liver injury,,2018,Q1,1,I,20171220.0,20180109.0,20180115,20180115,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201801005373,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20180115.0,,CN,IN,IN,2018,Q1,Elderly
143860731,14386073,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 U, EACH EVENING",,,U,U,,,20563.0,10.0,IU,,QD,2018,Q1,Renal injury,,2018,Q1,1,I,20171220.0,20180109.0,20180115,20180115,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201801005373,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20180115.0,,CN,IN,IN,2018,Q1,Elderly
143860731,14386073,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 U, EACH EVENING",,,U,U,,,20563.0,10.0,IU,,QD,2018,Q1,Swelling,,2018,Q1,1,I,20171220.0,20180109.0,20180115,20180115,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201801005373,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20180115.0,,CN,IN,IN,2018,Q1,Elderly
143945972,14394597,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,3-18 UNITS EVERY 4 HOURS,,,,,,,,,,,,2018,Q1,Hepatic failure,,2018,Q1,2,F,20140219.0,20180113.0,20180116,20180117,EXP,,US-PFIZER INC-2014072008,PFIZER,"DEANGELO, D.J.. INOTUZUMAB OZOGAMICIN IN ADULTS WITH RELAPSED OR REFRACTORY CD22-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: A PHASE 1/2 STUDY. BLOOD ADVANCES. 2017;1(15):1167-1180",53.0,YR,,M,Y,79.0,KG,20180117.0,,MD,US,US,2018,Q1,Adult
143945972,14394597,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,3-18 UNITS EVERY 4 HOURS,,,,,,,,,,,,2018,Q1,Venoocclusive liver disease,,2018,Q1,2,F,20140219.0,20180113.0,20180116,20180117,EXP,,US-PFIZER INC-2014072008,PFIZER,"DEANGELO, D.J.. INOTUZUMAB OZOGAMICIN IN ADULTS WITH RELAPSED OR REFRACTORY CD22-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: A PHASE 1/2 STUDY. BLOOD ADVANCES. 2017;1(15):1167-1180",53.0,YR,,M,Y,79.0,KG,20180117.0,,MD,US,US,2018,Q1,Adult
144018952,14401895,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Cardiac arrest,,2018,Q1,2,F,20180109.0,20180122.0,20180117,20180123,EXP,,US-FRESENIUS MEDICAL CARE RENAL THERAPIES GROUP-FMC-1801-000083,FRESENIUS MEDICAL CARE,,71.0,YR,,M,Y,84.9,KG,20180123.0,,OT,US,US,2018,Q1,Elderly
144042941,14404294,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Death,,2018,Q1,1,I,20180103.0,20180110.0,20180117,20180117,EXP,,US-EXELIXIS-CABO-18011976,EXELIXIS,,63.0,YR,,M,Y,,,20180117.0,,CN,US,US,2018,Q1,Adult
144126384,14412638,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, (ACCORDING TO PLAN, BEFORE THE INTERVENTION, AFTER THE INTERVENTION)",,,,,,,,,,,,2018,Q1,Drug interaction,,2018,Q1,4,F,,20180208.0,20180119,20180213,EXP,,DE-PFIZER INC-2018025098,PFIZER,"GASSNER, C.. KEEP THE RHYTHM DRUGS AND THE PROLONGATION OF THE QT INTERVAL - AN UNDERESTIMATED RISK?. THE CLINICO-PHARMACEUTICAL CASE. 2017;38(11):513-515",76.0,YR,,M,Y,,,20180213.0,,OT,DE,DE,2018,Q1,Elderly
144126384,14412638,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, (ACCORDING TO PLAN, BEFORE THE INTERVENTION, AFTER THE INTERVENTION)",,,,,,,,,,,,2018,Q1,Electrocardiogram QT prolonged,,2018,Q1,4,F,,20180208.0,20180119,20180213,EXP,,DE-PFIZER INC-2018025098,PFIZER,"GASSNER, C.. KEEP THE RHYTHM DRUGS AND THE PROLONGATION OF THE QT INTERVAL - AN UNDERESTIMATED RISK?. THE CLINICO-PHARMACEUTICAL CASE. 2017;38(11):513-515",76.0,YR,,M,Y,,,20180213.0,,OT,DE,DE,2018,Q1,Elderly
144133704,14413370,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,12-12-10 U (ADAPTED ACCORDING TO THE SACCHARIDES IN FOOD),,,U,,,,,,,,TID,2018,Q1,Diabetes mellitus inadequate control,,2018,Q1,4,F,2006.0,20180313.0,20180119,20180323,EXP,,CZ-BAUSCH-BL-2018-001146,BAUSCH AND LOMB,NEVRLA J. RETINOPATHY AS AN EARLY COMPLICATION OF TYPE 2 DIABETES MELLITUS. CASE REPORTS IN DIABETOLOGY. 2017;15:14-15.,43.0,YR,,F,Y,107.5,KG,20180323.0,,MD,CZ,CZ,2018,Q1,Adult
144133704,14413370,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,12-12-10 U (ADAPTED ACCORDING TO THE SACCHARIDES IN FOOD),,,U,,,,,,,,TID,2018,Q1,Exposure during pregnancy,,2018,Q1,4,F,2006.0,20180313.0,20180119,20180323,EXP,,CZ-BAUSCH-BL-2018-001146,BAUSCH AND LOMB,NEVRLA J. RETINOPATHY AS AN EARLY COMPLICATION OF TYPE 2 DIABETES MELLITUS. CASE REPORTS IN DIABETOLOGY. 2017;15:14-15.,43.0,YR,,F,Y,107.5,KG,20180323.0,,MD,CZ,CZ,2018,Q1,Adult
144133704,14413370,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,12-12-10 U (ADAPTED ACCORDING TO THE SACCHARIDES IN FOOD),,,U,,,,,,,,TID,2018,Q1,Normal newborn,,2018,Q1,4,F,2006.0,20180313.0,20180119,20180323,EXP,,CZ-BAUSCH-BL-2018-001146,BAUSCH AND LOMB,NEVRLA J. RETINOPATHY AS AN EARLY COMPLICATION OF TYPE 2 DIABETES MELLITUS. CASE REPORTS IN DIABETOLOGY. 2017;15:14-15.,43.0,YR,,F,Y,107.5,KG,20180323.0,,MD,CZ,CZ,2018,Q1,Adult
144139421,14413942,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q1,Dehydration,,2018,Q1,1,I,20180103.0,20180112.0,20180119,20180119,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-003740,BRISTOL MYERS SQUIBB,,61.0,YR,,M,Y,94.5,KG,20180119.0,,OT,US,US,2018,Q1,Adult
144139421,14413942,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q1,Hyperglycaemia,,2018,Q1,1,I,20180103.0,20180112.0,20180119,20180119,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-003740,BRISTOL MYERS SQUIBB,,61.0,YR,,M,Y,94.5,KG,20180119.0,,OT,US,US,2018,Q1,Adult
144213071,14421307,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,INJECTION,,2018,Q1,Blood glucose decreased,,2018,Q1,1,I,20171231.0,20180110.0,20180122,20180122,EXP,,US-ELI_LILLY_AND_COMPANY-US201801004811,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20180122.0,,CN,US,US,2018,Q1,Adult
144213071,14421307,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,INJECTION,,2018,Q1,Syncope,,2018,Q1,1,I,20171231.0,20180110.0,20180122,20180122,EXP,,US-ELI_LILLY_AND_COMPANY-US201801004811,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20180122.0,,CN,US,US,2018,Q1,Adult
144233971,14423397,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,UNSPECIFIED,,2018,Q1,Complication associated with device,,2018,Q1,1,I,20171227.0,20180110.0,20180123,20180123,PER,,US-JNJFOC-20180112139,JANSSEN,,59.0,YR,A,F,Y,75.75,KG,20180123.0,,CN,US,US,2018,Q1,Adult
144233971,14423397,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,UNSPECIFIED,,2018,Q1,Drug dose omission,,2018,Q1,1,I,20171227.0,20180110.0,20180123,20180123,PER,,US-JNJFOC-20180112139,JANSSEN,,59.0,YR,A,F,Y,75.75,KG,20180123.0,,CN,US,US,2018,Q1,Adult
144233971,14423397,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,UNSPECIFIED,,2018,Q1,Poor venous access,,2018,Q1,1,I,20171227.0,20180110.0,20180123,20180123,PER,,US-JNJFOC-20180112139,JANSSEN,,59.0,YR,A,F,Y,75.75,KG,20180123.0,,CN,US,US,2018,Q1,Adult
144257463,14425746,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"36 KIU, UNK",,,U,, UNKNOWN,,,36.0,KIU,,,2018,Q1,Conduct disorder,,2018,Q1,3,F,20171121.0,20180125.0,20180123,20180206,EXP,,PHHY2017IT199434,SANDOZ,,89.0,YR,,F,Y,,,20180206.0,,OT,IT,IT,2018,Q1,Elderly
144257463,14425746,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"36 KIU, UNK",,,U,, UNKNOWN,,,36.0,KIU,,,2018,Q1,Confusional state,,2018,Q1,3,F,20171121.0,20180125.0,20180123,20180206,EXP,,PHHY2017IT199434,SANDOZ,,89.0,YR,,F,Y,,,20180206.0,,OT,IT,IT,2018,Q1,Elderly
144257463,14425746,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"36 KIU, UNK",,,U,, UNKNOWN,,,36.0,KIU,,,2018,Q1,Disorientation,,2018,Q1,3,F,20171121.0,20180125.0,20180123,20180206,EXP,,PHHY2017IT199434,SANDOZ,,89.0,YR,,F,Y,,,20180206.0,,OT,IT,IT,2018,Q1,Elderly
144257463,14425746,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"36 KIU, UNK",,,U,, UNKNOWN,,,36.0,KIU,,,2018,Q1,"Hallucination, visual",,2018,Q1,3,F,20171121.0,20180125.0,20180123,20180206,EXP,,PHHY2017IT199434,SANDOZ,,89.0,YR,,F,Y,,,20180206.0,,OT,IT,IT,2018,Q1,Elderly
144345031,14434503,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 U, EACH MORNING",,,,,,,20563.0,10.0,IU,,QD,2018,Q1,Dizziness,,2018,Q1,1,I,,20180115.0,20180124,20180124,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201801007047,ELI LILLY AND CO,,31.0,YR,,F,Y,60.0,KG,20180124.0,,CN,CN,CN,2018,Q1,Young Adult
144345031,14434503,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 U, EACH MORNING",,,,,,,20563.0,10.0,IU,,QD,2018,Q1,Hypoglycaemia,,2018,Q1,1,I,,20180115.0,20180124,20180124,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201801007047,ELI LILLY AND CO,,31.0,YR,,F,Y,60.0,KG,20180124.0,,CN,CN,CN,2018,Q1,Young Adult
144345031,14434503,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"6 U, NOON",,,,,,,20563.0,6.0,IU,,QD,2018,Q1,Dizziness,,2018,Q1,1,I,,20180115.0,20180124,20180124,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201801007047,ELI LILLY AND CO,,31.0,YR,,F,Y,60.0,KG,20180124.0,,CN,CN,CN,2018,Q1,Young Adult
144345031,14434503,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"6 U, NOON",,,,,,,20563.0,6.0,IU,,QD,2018,Q1,Hypoglycaemia,,2018,Q1,1,I,,20180115.0,20180124,20180124,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201801007047,ELI LILLY AND CO,,31.0,YR,,F,Y,60.0,KG,20180124.0,,CN,CN,CN,2018,Q1,Young Adult
144345031,14434503,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"8 U, EACH EVENING",,,,,,,20563.0,8.0,IU,,QD,2018,Q1,Dizziness,,2018,Q1,1,I,,20180115.0,20180124,20180124,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201801007047,ELI LILLY AND CO,,31.0,YR,,F,Y,60.0,KG,20180124.0,,CN,CN,CN,2018,Q1,Young Adult
144345031,14434503,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"8 U, EACH EVENING",,,,,,,20563.0,8.0,IU,,QD,2018,Q1,Hypoglycaemia,,2018,Q1,1,I,,20180115.0,20180124,20180124,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201801007047,ELI LILLY AND CO,,31.0,YR,,F,Y,60.0,KG,20180124.0,,CN,CN,CN,2018,Q1,Young Adult
144345031,14434503,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"12 U, EACH MORNING",,,,,,,20563.0,12.0,IU,,QD,2018,Q1,Dizziness,,2018,Q1,1,I,,20180115.0,20180124,20180124,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201801007047,ELI LILLY AND CO,,31.0,YR,,F,Y,60.0,KG,20180124.0,,CN,CN,CN,2018,Q1,Young Adult
144345031,14434503,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"12 U, EACH MORNING",,,,,,,20563.0,12.0,IU,,QD,2018,Q1,Hypoglycaemia,,2018,Q1,1,I,,20180115.0,20180124,20180124,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201801007047,ELI LILLY AND CO,,31.0,YR,,F,Y,60.0,KG,20180124.0,,CN,CN,CN,2018,Q1,Young Adult
144345031,14434503,5,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"8 U, NOON",,,,,,,20563.0,8.0,IU,,QD,2018,Q1,Dizziness,,2018,Q1,1,I,,20180115.0,20180124,20180124,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201801007047,ELI LILLY AND CO,,31.0,YR,,F,Y,60.0,KG,20180124.0,,CN,CN,CN,2018,Q1,Young Adult
144345031,14434503,5,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"8 U, NOON",,,,,,,20563.0,8.0,IU,,QD,2018,Q1,Hypoglycaemia,,2018,Q1,1,I,,20180115.0,20180124,20180124,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201801007047,ELI LILLY AND CO,,31.0,YR,,F,Y,60.0,KG,20180124.0,,CN,CN,CN,2018,Q1,Young Adult
144345031,14434503,6,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 U, EACH EVENING",,,,,,,20563.0,10.0,IU,,QD,2018,Q1,Dizziness,,2018,Q1,1,I,,20180115.0,20180124,20180124,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201801007047,ELI LILLY AND CO,,31.0,YR,,F,Y,60.0,KG,20180124.0,,CN,CN,CN,2018,Q1,Young Adult
144345031,14434503,6,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 U, EACH EVENING",,,,,,,20563.0,10.0,IU,,QD,2018,Q1,Hypoglycaemia,,2018,Q1,1,I,,20180115.0,20180124,20180124,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201801007047,ELI LILLY AND CO,,31.0,YR,,F,Y,60.0,KG,20180124.0,,CN,CN,CN,2018,Q1,Young Adult
144358581,14435858,23,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2018,Q1,Abdominal pain,,2018,Q1,1,I,20180111.0,,20180124,20180124,DIR,,,FDA-CTU,,77.0,YR,,M,N,110.47,KG,20180124.0,Y,OT,US,US,2018,Q1,Elderly
144358581,14435858,23,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2018,Q1,Colitis,,2018,Q1,1,I,20180111.0,,20180124,20180124,DIR,,,FDA-CTU,,77.0,YR,,M,N,110.47,KG,20180124.0,Y,OT,US,US,2018,Q1,Elderly
144358581,14435858,23,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2018,Q1,Colitis ulcerative,,2018,Q1,1,I,20180111.0,,20180124,20180124,DIR,,,FDA-CTU,,77.0,YR,,M,N,110.47,KG,20180124.0,Y,OT,US,US,2018,Q1,Elderly
144358581,14435858,23,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2018,Q1,Diverticulum,,2018,Q1,1,I,20180111.0,,20180124,20180124,DIR,,,FDA-CTU,,77.0,YR,,M,N,110.47,KG,20180124.0,Y,OT,US,US,2018,Q1,Elderly
144358581,14435858,23,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2018,Q1,Rectal haemorrhage,,2018,Q1,1,I,20180111.0,,20180124,20180124,DIR,,,FDA-CTU,,77.0,YR,,M,N,110.47,KG,20180124.0,Y,OT,US,US,2018,Q1,Elderly
144422202,14442220,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,U,,,,,,,,2018,Q1,Diabetes mellitus inadequate control,,2018,Q1,2,F,2006.0,20180123.0,20180125,20180131,EXP,,CZ-MYLANLABS-2018M1005550,MYLAN,NEVRLA J.. RETINOPATHY AS AN EARLY COMPLICATION OF DIABETES MELLITUS.. KAZUISTIKY V DIABETOLOGII. 2017;15:14-5,43.0,YR,,F,Y,107.5,KG,20180131.0,,MD,CZ,CZ,2018,Q1,Adult
144422202,14442220,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,U,,,,,,,,2018,Q1,Drug ineffective,,2018,Q1,2,F,2006.0,20180123.0,20180125,20180131,EXP,,CZ-MYLANLABS-2018M1005550,MYLAN,NEVRLA J.. RETINOPATHY AS AN EARLY COMPLICATION OF DIABETES MELLITUS.. KAZUISTIKY V DIABETOLOGII. 2017;15:14-5,43.0,YR,,F,Y,107.5,KG,20180131.0,,MD,CZ,CZ,2018,Q1,Adult
144532382,14453238,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Off label use,,2018,Q1,2,F,20171206.0,20180130.0,20180129,20180206,EXP,,US-GILEAD-2017-0311955,GILEAD,,67.0,YR,E,M,Y,126.53,KG,20180206.0,,CN,US,US,2018,Q1,Elderly
144532382,14453238,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Sepsis,,2018,Q1,2,F,20171206.0,20180130.0,20180129,20180206,EXP,,US-GILEAD-2017-0311955,GILEAD,,67.0,YR,E,M,Y,126.53,KG,20180206.0,,CN,US,US,2018,Q1,Elderly
144532382,14453238,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Septic shock,,2018,Q1,2,F,20171206.0,20180130.0,20180129,20180206,EXP,,US-GILEAD-2017-0311955,GILEAD,,67.0,YR,E,M,Y,126.53,KG,20180206.0,,CN,US,US,2018,Q1,Elderly
144534391,14453439,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q1,Abdominal pain,,2018,Q1,1,I,20171019.0,20180118.0,20180129,20180129,EXP,,US-SA-2018SA019973,AVENTIS,,44.0,YR,A,F,Y,98.0,KG,20180129.0,,MD,US,US,2018,Q1,Adult
144534391,14453439,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q1,Dyspnoea,,2018,Q1,1,I,20171019.0,20180118.0,20180129,20180129,EXP,,US-SA-2018SA019973,AVENTIS,,44.0,YR,A,F,Y,98.0,KG,20180129.0,,MD,US,US,2018,Q1,Adult
144534391,14453439,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q1,Myocardial infarction,,2018,Q1,1,I,20171019.0,20180118.0,20180129,20180129,EXP,,US-SA-2018SA019973,AVENTIS,,44.0,YR,A,F,Y,98.0,KG,20180129.0,,MD,US,US,2018,Q1,Adult
144534391,14453439,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q1,Pulmonary embolism,,2018,Q1,1,I,20171019.0,20180118.0,20180129,20180129,EXP,,US-SA-2018SA019973,AVENTIS,,44.0,YR,A,F,Y,98.0,KG,20180129.0,,MD,US,US,2018,Q1,Adult
144534391,14453439,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q1,Retroperitoneal haematoma,,2018,Q1,1,I,20171019.0,20180118.0,20180129,20180129,EXP,,US-SA-2018SA019973,AVENTIS,,44.0,YR,A,F,Y,98.0,KG,20180129.0,,MD,US,US,2018,Q1,Adult
144544701,14454470,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Abdominal pain,,2018,Q1,1,I,20171223.0,,20180128,20180128,DIR,,,FDA-CTU,,60.0,YR,,F,N,61.3,KG,20180128.0,N,PH,US,US,2018,Q1,Adult
144544701,14454470,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Gastrointestinal haemorrhage,,2018,Q1,1,I,20171223.0,,20180128,20180128,DIR,,,FDA-CTU,,60.0,YR,,F,N,61.3,KG,20180128.0,N,PH,US,US,2018,Q1,Adult
144544701,14454470,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Haematemesis,,2018,Q1,1,I,20171223.0,,20180128,20180128,DIR,,,FDA-CTU,,60.0,YR,,F,N,61.3,KG,20180128.0,N,PH,US,US,2018,Q1,Adult
144544701,14454470,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,International normalised ratio increased,,2018,Q1,1,I,20171223.0,,20180128,20180128,DIR,,,FDA-CTU,,60.0,YR,,F,N,61.3,KG,20180128.0,N,PH,US,US,2018,Q1,Adult
144544701,14454470,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Nausea,,2018,Q1,1,I,20171223.0,,20180128,20180128,DIR,,,FDA-CTU,,60.0,YR,,F,N,61.3,KG,20180128.0,N,PH,US,US,2018,Q1,Adult
144544701,14454470,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Occult blood positive,,2018,Q1,1,I,20171223.0,,20180128,20180128,DIR,,,FDA-CTU,,60.0,YR,,F,N,61.3,KG,20180128.0,N,PH,US,US,2018,Q1,Adult
144544701,14454470,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Vomiting,,2018,Q1,1,I,20171223.0,,20180128,20180128,DIR,,,FDA-CTU,,60.0,YR,,F,N,61.3,KG,20180128.0,N,PH,US,US,2018,Q1,Adult
144563951,14456395,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 DF, TID",,,U,U,,,,8.0,DF,,TID,2018,Q1,Acute kidney injury,,2018,Q1,1,I,,20180108.0,20180130,20180130,EXP,,US-APOTEX-2018AP005473,APOTEX,,40.0,YR,,F,Y,70.7,KG,20180122.0,,CN,US,US,2018,Q1,Adult
144594381,14459438,13,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q1,Blood glucose increased,,2018,Q1,1,I,20170222.0,20170321.0,20180130,20180130,PER,,US-ACORDA-ACO_135770_2017,ACORDA,,70.0,YR,,F,Y,,,20180130.0,,PH,US,US,2018,Q1,Elderly
144594381,14459438,13,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q1,Creatinine renal clearance decreased,,2018,Q1,1,I,20170222.0,20170321.0,20180130,20180130,PER,,US-ACORDA-ACO_135770_2017,ACORDA,,70.0,YR,,F,Y,,,20180130.0,,PH,US,US,2018,Q1,Elderly
144594381,14459438,13,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q1,Culture urine positive,,2018,Q1,1,I,20170222.0,20170321.0,20180130,20180130,PER,,US-ACORDA-ACO_135770_2017,ACORDA,,70.0,YR,,F,Y,,,20180130.0,,PH,US,US,2018,Q1,Elderly
144594381,14459438,13,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q1,Escherichia urinary tract infection,,2018,Q1,1,I,20170222.0,20170321.0,20180130,20180130,PER,,US-ACORDA-ACO_135770_2017,ACORDA,,70.0,YR,,F,Y,,,20180130.0,,PH,US,US,2018,Q1,Elderly
144594381,14459438,13,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q1,Glycosylated haemoglobin increased,,2018,Q1,1,I,20170222.0,20170321.0,20180130,20180130,PER,,US-ACORDA-ACO_135770_2017,ACORDA,,70.0,YR,,F,Y,,,20180130.0,,PH,US,US,2018,Q1,Elderly
144594381,14459438,13,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q1,Oesophagitis,,2018,Q1,1,I,20170222.0,20170321.0,20180130,20180130,PER,,US-ACORDA-ACO_135770_2017,ACORDA,,70.0,YR,,F,Y,,,20180130.0,,PH,US,US,2018,Q1,Elderly
144594381,14459438,13,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q1,Therapy cessation,,2018,Q1,1,I,20170222.0,20170321.0,20180130,20180130,PER,,US-ACORDA-ACO_135770_2017,ACORDA,,70.0,YR,,F,Y,,,20180130.0,,PH,US,US,2018,Q1,Elderly
144594381,14459438,13,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q1,Urinary tract infection,,2018,Q1,1,I,20170222.0,20170321.0,20180130,20180130,PER,,US-ACORDA-ACO_135770_2017,ACORDA,,70.0,YR,,F,Y,,,20180130.0,,PH,US,US,2018,Q1,Elderly
144594381,14459438,13,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q1,Urinary tract infection enterococcal,,2018,Q1,1,I,20170222.0,20170321.0,20180130,20180130,PER,,US-ACORDA-ACO_135770_2017,ACORDA,,70.0,YR,,F,Y,,,20180130.0,,PH,US,US,2018,Q1,Elderly
144594381,14459438,13,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q1,Urinary tract infection pseudomonal,,2018,Q1,1,I,20170222.0,20170321.0,20180130,20180130,PER,,US-ACORDA-ACO_135770_2017,ACORDA,,70.0,YR,,F,Y,,,20180130.0,,PH,US,US,2018,Q1,Elderly
144594381,14459438,13,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q1,Urine analysis abnormal,,2018,Q1,1,I,20170222.0,20170321.0,20180130,20180130,PER,,US-ACORDA-ACO_135770_2017,ACORDA,,70.0,YR,,F,Y,,,20180130.0,,PH,US,US,2018,Q1,Elderly
144597042,14459704,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q1,Myocardial infarction,,2018,Q1,2,F,20171025.0,20180319.0,20180130,20180328,EXP,,US-SA-2018SA019634,AVENTIS,,44.0,YR,A,F,Y,98.8,KG,20180328.0,,OT,US,US,2018,Q1,Adult
144597042,14459704,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q1,Pulmonary embolism,,2018,Q1,2,F,20171025.0,20180319.0,20180130,20180328,EXP,,US-SA-2018SA019634,AVENTIS,,44.0,YR,A,F,Y,98.8,KG,20180328.0,,OT,US,US,2018,Q1,Adult
144597042,14459704,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q1,Retroperitoneal haematoma,,2018,Q1,2,F,20171025.0,20180319.0,20180130,20180328,EXP,,US-SA-2018SA019634,AVENTIS,,44.0,YR,A,F,Y,98.8,KG,20180328.0,,OT,US,US,2018,Q1,Adult
144917283,14491728,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Atrial fibrillation,,2018,Q1,3,F,20180123.0,20180302.0,20180206,20180307,EXP,,US-GILEAD-2018-0318642,GILEAD,,72.0,YR,E,F,Y,102.4,KG,20180307.0,,CN,US,US,2018,Q1,Elderly
144917283,14491728,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Cardiac failure congestive,,2018,Q1,3,F,20180123.0,20180302.0,20180206,20180307,EXP,,US-GILEAD-2018-0318642,GILEAD,,72.0,YR,E,F,Y,102.4,KG,20180307.0,,CN,US,US,2018,Q1,Elderly
144917283,14491728,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Chronic obstructive pulmonary disease,,2018,Q1,3,F,20180123.0,20180302.0,20180206,20180307,EXP,,US-GILEAD-2018-0318642,GILEAD,,72.0,YR,E,F,Y,102.4,KG,20180307.0,,CN,US,US,2018,Q1,Elderly
144917283,14491728,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Fluid retention,,2018,Q1,3,F,20180123.0,20180302.0,20180206,20180307,EXP,,US-GILEAD-2018-0318642,GILEAD,,72.0,YR,E,F,Y,102.4,KG,20180307.0,,CN,US,US,2018,Q1,Elderly
144917283,14491728,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Pneumonia,,2018,Q1,3,F,20180123.0,20180302.0,20180206,20180307,EXP,,US-GILEAD-2018-0318642,GILEAD,,72.0,YR,E,F,Y,102.4,KG,20180307.0,,CN,US,US,2018,Q1,Elderly
144917283,14491728,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Pulmonary fibrosis,,2018,Q1,3,F,20180123.0,20180302.0,20180206,20180307,EXP,,US-GILEAD-2018-0318642,GILEAD,,72.0,YR,E,F,Y,102.4,KG,20180307.0,,CN,US,US,2018,Q1,Elderly
144984781,14498478,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,36.0,KIU,,,2018,Q1,Conduct disorder,,2018,Q1,1,I,20171121.0,20180125.0,20180207,20180207,EXP,IT-MINISAL02-442954,IT-TEVA-2018-IT-853221,TEVA,,89.0,YR,,F,Y,,,20180207.0,,MD,IT,IT,2018,Q1,Elderly
144984781,14498478,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,36.0,KIU,,,2018,Q1,Confusional state,,2018,Q1,1,I,20171121.0,20180125.0,20180207,20180207,EXP,IT-MINISAL02-442954,IT-TEVA-2018-IT-853221,TEVA,,89.0,YR,,F,Y,,,20180207.0,,MD,IT,IT,2018,Q1,Elderly
144984781,14498478,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,36.0,KIU,,,2018,Q1,Disorientation,,2018,Q1,1,I,20171121.0,20180125.0,20180207,20180207,EXP,IT-MINISAL02-442954,IT-TEVA-2018-IT-853221,TEVA,,89.0,YR,,F,Y,,,20180207.0,,MD,IT,IT,2018,Q1,Elderly
144984781,14498478,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,36.0,KIU,,,2018,Q1,"Hallucination, visual",,2018,Q1,1,I,20171121.0,20180125.0,20180207,20180207,EXP,IT-MINISAL02-442954,IT-TEVA-2018-IT-853221,TEVA,,89.0,YR,,F,Y,,,20180207.0,,MD,IT,IT,2018,Q1,Elderly
145138982,14513898,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Blood glucose increased,,2018,Q1,2,F,20180120.0,20180215.0,20180209,20180216,EXP,,US-FRESENIUS MEDICAL CARE RENAL THERAPIES GROUP-FMC-1802-000233,FRESENIUS MEDICAL CARE,,81.0,YR,,M,Y,70.82,KG,20180216.0,,OT,US,US,2018,Q1,Elderly
145141522,14514152,10,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Colitis,,2018,Q1,2,F,20171011.0,20180221.0,20180209,20180228,EXP,,US-SHIRE-US201737328,SHIRE,,13.0,YR,,F,Y,72.0,KG,20180227.0,,MD,US,US,2018,Q1,Child
145184181,14518418,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2018,Q1,Acute graft versus host disease,,2018,Q1,1,I,201602.0,20180202.0,20180212,20180212,EXP,,US-JNJFOC-20180213297,PHARMACYCLICS,,40.0,YR,A,M,Y,,,20180212.0,,MD,US,US,2018,Q1,Adult
145184181,14518418,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2018,Q1,Acute kidney injury,,2018,Q1,1,I,201602.0,20180202.0,20180212,20180212,EXP,,US-JNJFOC-20180213297,PHARMACYCLICS,,40.0,YR,A,M,Y,,,20180212.0,,MD,US,US,2018,Q1,Adult
145184181,14518418,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2018,Q1,Acute respiratory failure,,2018,Q1,1,I,201602.0,20180202.0,20180212,20180212,EXP,,US-JNJFOC-20180213297,PHARMACYCLICS,,40.0,YR,A,M,Y,,,20180212.0,,MD,US,US,2018,Q1,Adult
145184181,14518418,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2018,Q1,Cerebrovascular accident,,2018,Q1,1,I,201602.0,20180202.0,20180212,20180212,EXP,,US-JNJFOC-20180213297,PHARMACYCLICS,,40.0,YR,A,M,Y,,,20180212.0,,MD,US,US,2018,Q1,Adult
145184181,14518418,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2018,Q1,Chylothorax,,2018,Q1,1,I,201602.0,20180202.0,20180212,20180212,EXP,,US-JNJFOC-20180213297,PHARMACYCLICS,,40.0,YR,A,M,Y,,,20180212.0,,MD,US,US,2018,Q1,Adult
145184181,14518418,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2018,Q1,Dizziness postural,,2018,Q1,1,I,201602.0,20180202.0,20180212,20180212,EXP,,US-JNJFOC-20180213297,PHARMACYCLICS,,40.0,YR,A,M,Y,,,20180212.0,,MD,US,US,2018,Q1,Adult
145184181,14518418,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2018,Q1,Fall,,2018,Q1,1,I,201602.0,20180202.0,20180212,20180212,EXP,,US-JNJFOC-20180213297,PHARMACYCLICS,,40.0,YR,A,M,Y,,,20180212.0,,MD,US,US,2018,Q1,Adult
145184181,14518418,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2018,Q1,Head injury,,2018,Q1,1,I,201602.0,20180202.0,20180212,20180212,EXP,,US-JNJFOC-20180213297,PHARMACYCLICS,,40.0,YR,A,M,Y,,,20180212.0,,MD,US,US,2018,Q1,Adult
145184181,14518418,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2018,Q1,Hyperglycaemia,,2018,Q1,1,I,201602.0,20180202.0,20180212,20180212,EXP,,US-JNJFOC-20180213297,PHARMACYCLICS,,40.0,YR,A,M,Y,,,20180212.0,,MD,US,US,2018,Q1,Adult
145184181,14518418,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2018,Q1,Methaemoglobinaemia,,2018,Q1,1,I,201602.0,20180202.0,20180212,20180212,EXP,,US-JNJFOC-20180213297,PHARMACYCLICS,,40.0,YR,A,M,Y,,,20180212.0,,MD,US,US,2018,Q1,Adult
145184181,14518418,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2018,Q1,Muscle spasms,,2018,Q1,1,I,201602.0,20180202.0,20180212,20180212,EXP,,US-JNJFOC-20180213297,PHARMACYCLICS,,40.0,YR,A,M,Y,,,20180212.0,,MD,US,US,2018,Q1,Adult
145184181,14518418,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2018,Q1,Parainfluenzae virus infection,,2018,Q1,1,I,201602.0,20180202.0,20180212,20180212,EXP,,US-JNJFOC-20180213297,PHARMACYCLICS,,40.0,YR,A,M,Y,,,20180212.0,,MD,US,US,2018,Q1,Adult
145184181,14518418,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2018,Q1,Sepsis,,2018,Q1,1,I,201602.0,20180202.0,20180212,20180212,EXP,,US-JNJFOC-20180213297,PHARMACYCLICS,,40.0,YR,A,M,Y,,,20180212.0,,MD,US,US,2018,Q1,Adult
145267291,14526729,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2018,Q1,Drug interaction,,2018,Q1,1,I,,20180130.0,20180213,20180213,EXP,,PHHY2017DE200468,SANDOZ,,76.0,YR,,M,Y,,,20180213.0,,OT,DE,DE,2018,Q1,Elderly
145267291,14526729,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2018,Q1,Electrocardiogram QT prolonged,,2018,Q1,1,I,,20180130.0,20180213,20180213,EXP,,PHHY2017DE200468,SANDOZ,,76.0,YR,,M,Y,,,20180213.0,,OT,DE,DE,2018,Q1,Elderly
145303311,14530331,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, DAILY",,,,,,,,1.0,IU,,,2018,Q1,Diabetic complication,,2018,Q1,1,I,200505.0,20151119.0,20180214,20180214,EXP,,US-PFIZER INC-2015401526,PFIZER,,49.0,YR,,M,Y,98.0,KG,20180214.0,,CN,US,US,2018,Q1,Adult
145303932,14530393,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Rash,,2018,Q1,2,F,20180206.0,20180308.0,20180214,20180312,EXP,,US-GLAXOSMITHKLINE-US2018GSK022952,GLAXOSMITHKLINE,,39.0,YR,,F,Y,78.0,KG,20180312.0,,MD,US,US,2018,Q1,Adult
145390451,14539045,13,C,MIXED PROTAMINE ZINC RECOMBINANT HUMAN INSULIN LISPRO,,2,,"HYPODERMIC ROUTE, 32 UNIT TWO TIMES A DAY",,,,,,,,,,INJECTION,,2018,Q1,Cerebral infarction,,2018,Q1,1,I,20171211.0,20180209.0,20180216,20180216,EXP,,CN-ASTRAZENECA-2018SE19353,ASTRAZENECA,,26268.0,DY,,M,Y,76.0,KG,20180216.0,,MD,CN,CN,2018,Q1,Elderly
145432711,14543271,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,MEDIUM DOSE SLIDING SCALE,,,,,,,,,,SOLUTION,,2018,Q1,Groin pain,,2018,Q1,1,I,20171013.0,20171013.0,20180216,20180216,PER,,US-LANTHEUS-LMI-2017-00524,LANTHEUS MEDICAL IMAGING,,88.0,YR,,M,Y,95.0,KG,20180202.0,,CN,US,US,2018,Q1,Elderly
145494521,14549452,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,1.0,DF,,,2018,Q1,Confusional state,,2018,Q1,1,I,20180131.0,20180205.0,20180219,20180219,EXP,IT-MINISAL02-454764,IT-CONCORDIA PHARMACEUTICALS INC.-E2B_00009934,CONCORDIA,,82.0,YR,,F,Y,,,20180219.0,,MD,IT,IT,2018,Q1,Elderly
145494521,14549452,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,1.0,DF,,,2018,Q1,Dysarthria,,2018,Q1,1,I,20180131.0,20180205.0,20180219,20180219,EXP,IT-MINISAL02-454764,IT-CONCORDIA PHARMACEUTICALS INC.-E2B_00009934,CONCORDIA,,82.0,YR,,F,Y,,,20180219.0,,MD,IT,IT,2018,Q1,Elderly
145494521,14549452,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,1.0,DF,,,2018,Q1,Toxicity to various agents,,2018,Q1,1,I,20180131.0,20180205.0,20180219,20180219,EXP,IT-MINISAL02-454764,IT-CONCORDIA PHARMACEUTICALS INC.-E2B_00009934,CONCORDIA,,82.0,YR,,F,Y,,,20180219.0,,MD,IT,IT,2018,Q1,Elderly
145521712,14552171,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,INJECTION,TID,2018,Q1,Behcet's syndrome,,2018,Q1,2,F,201707.0,20180216.0,20180220,20180222,EXP,,JP-ABBVIE-17K-087-2112930-00,ABBVIE,,51.0,YR,,F,Y,50.8,KG,20180222.0,,CN,JP,JP,2018,Q1,Adult
145521712,14552171,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,INJECTION,TID,2018,Q1,Epstein-Barr virus infection,,2018,Q1,2,F,201707.0,20180216.0,20180220,20180222,EXP,,JP-ABBVIE-17K-087-2112930-00,ABBVIE,,51.0,YR,,F,Y,50.8,KG,20180222.0,,CN,JP,JP,2018,Q1,Adult
145521712,14552171,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,INJECTION,TID,2018,Q1,General physical health deterioration,,2018,Q1,2,F,201707.0,20180216.0,20180220,20180222,EXP,,JP-ABBVIE-17K-087-2112930-00,ABBVIE,,51.0,YR,,F,Y,50.8,KG,20180222.0,,CN,JP,JP,2018,Q1,Adult
145521712,14552171,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,INJECTION,TID,2018,Q1,Lymphoma,,2018,Q1,2,F,201707.0,20180216.0,20180220,20180222,EXP,,JP-ABBVIE-17K-087-2112930-00,ABBVIE,,51.0,YR,,F,Y,50.8,KG,20180222.0,,CN,JP,JP,2018,Q1,Adult
145521712,14552171,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,INJECTION,TID,2018,Q1,Lymphoproliferative disorder,,2018,Q1,2,F,201707.0,20180216.0,20180220,20180222,EXP,,JP-ABBVIE-17K-087-2112930-00,ABBVIE,,51.0,YR,,F,Y,50.8,KG,20180222.0,,CN,JP,JP,2018,Q1,Adult
145521712,14552171,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,INJECTION,TID,2018,Q1,Nausea,,2018,Q1,2,F,201707.0,20180216.0,20180220,20180222,EXP,,JP-ABBVIE-17K-087-2112930-00,ABBVIE,,51.0,YR,,F,Y,50.8,KG,20180222.0,,CN,JP,JP,2018,Q1,Adult
145521712,14552171,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,INJECTION,TID,2018,Q1,Pneumonia,,2018,Q1,2,F,201707.0,20180216.0,20180220,20180222,EXP,,JP-ABBVIE-17K-087-2112930-00,ABBVIE,,51.0,YR,,F,Y,50.8,KG,20180222.0,,CN,JP,JP,2018,Q1,Adult
145521712,14552171,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,INJECTION,TID,2018,Q1,Respiratory disorder,,2018,Q1,2,F,201707.0,20180216.0,20180220,20180222,EXP,,JP-ABBVIE-17K-087-2112930-00,ABBVIE,,51.0,YR,,F,Y,50.8,KG,20180222.0,,CN,JP,JP,2018,Q1,Adult
145538051,14553805,1,PS,Lispro,INSULIN LISPRO,1,Subcutaneous,"18 IU, DAILY",,,U,U,,,20563.0,18.0,IU,,QD,2018,Q1,Hypoglycaemia,,2018,Q1,1,I,20170309.0,20180209.0,20180220,20180220,EXP,IT-MINISAL02-404737,IT-ELI_LILLY_AND_COMPANY-IT201802004396,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20180220.0,,CN,IT,IT,2018,Q1,Elderly
145538051,14553805,1,PS,Lispro,INSULIN LISPRO,1,Subcutaneous,"18 IU, DAILY",,,U,U,,,20563.0,18.0,IU,,QD,2018,Q1,Syncope,,2018,Q1,1,I,20170309.0,20180209.0,20180220,20180220,EXP,IT-MINISAL02-404737,IT-ELI_LILLY_AND_COMPANY-IT201802004396,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20180220.0,,CN,IT,IT,2018,Q1,Elderly
145579661,14557966,3,C,insulin lispro,INSULIN LISPRO,1,Unknown,THREE TIMES DAILY BEFORE MEALS,,,,,,,,28.0,IU,,,2018,Q1,Blood chromogranin A increased,,2018,Q1,1,I,,20171123.0,20180221,20180221,EXP,,US-DRREDDYS-USA/USA/17/0094957,DR REDDYS,"INZUCCHI S, SPOLLETT G. MYSTERIOUS HYPERGLYCEMIA: DISEASE VERSUS DEVICE. CLIN DIABETES. 2017;35(4):253-6.",77.0,YR,,F,Y,,,20180220.0,,OT,COUNTRY NOT SPECIFIED,US,2018,Q1,Elderly
145579661,14557966,3,C,insulin lispro,INSULIN LISPRO,1,Unknown,THREE TIMES DAILY BEFORE MEALS,,,,,,,,28.0,IU,,,2018,Q1,Diabetic retinopathy,,2018,Q1,1,I,,20171123.0,20180221,20180221,EXP,,US-DRREDDYS-USA/USA/17/0094957,DR REDDYS,"INZUCCHI S, SPOLLETT G. MYSTERIOUS HYPERGLYCEMIA: DISEASE VERSUS DEVICE. CLIN DIABETES. 2017;35(4):253-6.",77.0,YR,,F,Y,,,20180220.0,,OT,COUNTRY NOT SPECIFIED,US,2018,Q1,Elderly
145579661,14557966,3,C,insulin lispro,INSULIN LISPRO,1,Unknown,THREE TIMES DAILY BEFORE MEALS,,,,,,,,28.0,IU,,,2018,Q1,Fatigue,,2018,Q1,1,I,,20171123.0,20180221,20180221,EXP,,US-DRREDDYS-USA/USA/17/0094957,DR REDDYS,"INZUCCHI S, SPOLLETT G. MYSTERIOUS HYPERGLYCEMIA: DISEASE VERSUS DEVICE. CLIN DIABETES. 2017;35(4):253-6.",77.0,YR,,F,Y,,,20180220.0,,OT,COUNTRY NOT SPECIFIED,US,2018,Q1,Elderly
145579661,14557966,3,C,insulin lispro,INSULIN LISPRO,1,Unknown,THREE TIMES DAILY BEFORE MEALS,,,,,,,,28.0,IU,,,2018,Q1,Glycosylated haemoglobin increased,,2018,Q1,1,I,,20171123.0,20180221,20180221,EXP,,US-DRREDDYS-USA/USA/17/0094957,DR REDDYS,"INZUCCHI S, SPOLLETT G. MYSTERIOUS HYPERGLYCEMIA: DISEASE VERSUS DEVICE. CLIN DIABETES. 2017;35(4):253-6.",77.0,YR,,F,Y,,,20180220.0,,OT,COUNTRY NOT SPECIFIED,US,2018,Q1,Elderly
145579661,14557966,3,C,insulin lispro,INSULIN LISPRO,1,Unknown,THREE TIMES DAILY BEFORE MEALS,,,,,,,,28.0,IU,,,2018,Q1,Hyperglycaemia,,2018,Q1,1,I,,20171123.0,20180221,20180221,EXP,,US-DRREDDYS-USA/USA/17/0094957,DR REDDYS,"INZUCCHI S, SPOLLETT G. MYSTERIOUS HYPERGLYCEMIA: DISEASE VERSUS DEVICE. CLIN DIABETES. 2017;35(4):253-6.",77.0,YR,,F,Y,,,20180220.0,,OT,COUNTRY NOT SPECIFIED,US,2018,Q1,Elderly
145579661,14557966,3,C,insulin lispro,INSULIN LISPRO,1,Unknown,THREE TIMES DAILY BEFORE MEALS,,,,,,,,28.0,IU,,,2018,Q1,Neuropathy peripheral,,2018,Q1,1,I,,20171123.0,20180221,20180221,EXP,,US-DRREDDYS-USA/USA/17/0094957,DR REDDYS,"INZUCCHI S, SPOLLETT G. MYSTERIOUS HYPERGLYCEMIA: DISEASE VERSUS DEVICE. CLIN DIABETES. 2017;35(4):253-6.",77.0,YR,,F,Y,,,20180220.0,,OT,COUNTRY NOT SPECIFIED,US,2018,Q1,Elderly
145598871,14559887,19,C,INSULIN LISPRO PROTAMINE-INSULIN LISPRO,,2,,,,,,,,,,,,,,2018,Q1,Dehydration,,2018,Q1,1,I,20171123.0,,20180220,20180220,DIR,,,FDA-CTU,,72.0,YR,,M,N,50.6,KG,20180205.0,N,CN,US,US,2018,Q1,Elderly
145598871,14559887,19,C,INSULIN LISPRO PROTAMINE-INSULIN LISPRO,,2,,,,,,,,,,,,,,2018,Q1,Fatigue,,2018,Q1,1,I,20171123.0,,20180220,20180220,DIR,,,FDA-CTU,,72.0,YR,,M,N,50.6,KG,20180205.0,N,CN,US,US,2018,Q1,Elderly
145598871,14559887,19,C,INSULIN LISPRO PROTAMINE-INSULIN LISPRO,,2,,,,,,,,,,,,,,2018,Q1,Mental status changes,,2018,Q1,1,I,20171123.0,,20180220,20180220,DIR,,,FDA-CTU,,72.0,YR,,M,N,50.6,KG,20180205.0,N,CN,US,US,2018,Q1,Elderly
145608101,14560810,2,C,Insulin lispro,INSULIN LISPRO,1,Unknown,17 UNITS BEFORE DINNER,,,Y,,,,,,,,,2018,Q1,Hypoglycaemia,,2018,Q1,1,I,,20180212.0,20180222,20180222,PER,,US-TEVA-2018-US-861944,TEVA,"RANEY E, JACKOWSKI R, HUME D.",52.0,YR,,M,Y,,,20180222.0,,OT,US,US,2018,Q1,Adult
145623412,14562341,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q1,Drug interaction,,2018,Q1,2,F,20180126.0,20180222.0,20180222,20180305,EXP,,IT-WEST-WARD PHARMACEUTICALS CORP.-IT-H14001-18-01254,WESTWARD,,70.0,YR,,M,Y,60.0,KG,20180305.0,,PH,IT,IT,2018,Q1,Elderly
145623412,14562341,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q1,Electrocardiogram QT prolonged,,2018,Q1,2,F,20180126.0,20180222.0,20180222,20180305,EXP,,IT-WEST-WARD PHARMACEUTICALS CORP.-IT-H14001-18-01254,WESTWARD,,70.0,YR,,M,Y,60.0,KG,20180305.0,,PH,IT,IT,2018,Q1,Elderly
145623412,14562341,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q1,Pneumonia,,2018,Q1,2,F,20180126.0,20180222.0,20180222,20180305,EXP,,IT-WEST-WARD PHARMACEUTICALS CORP.-IT-H14001-18-01254,WESTWARD,,70.0,YR,,M,Y,60.0,KG,20180305.0,,PH,IT,IT,2018,Q1,Elderly
145632141,14563214,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,,"UNK UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2018,Q1,Blood glucose increased,,2018,Q1,1,I,201712.0,20180212.0,20180222,20180222,EXP,,US-ELI_LILLY_AND_COMPANY-US201802005403,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20180222.0,,CN,US,US,2018,Q1,Elderly
145632141,14563214,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,,"UNK UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2018,Q1,Drug ineffective,,2018,Q1,1,I,201712.0,20180212.0,20180222,20180222,EXP,,US-ELI_LILLY_AND_COMPANY-US201802005403,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20180222.0,,CN,US,US,2018,Q1,Elderly
145632141,14563214,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,,"UNK UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2018,Q1,Fall,,2018,Q1,1,I,201712.0,20180212.0,20180222,20180222,EXP,,US-ELI_LILLY_AND_COMPANY-US201802005403,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20180222.0,,CN,US,US,2018,Q1,Elderly
145632141,14563214,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,,"UNK UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2018,Q1,Head injury,,2018,Q1,1,I,201712.0,20180212.0,20180222,20180222,EXP,,US-ELI_LILLY_AND_COMPANY-US201802005403,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20180222.0,,CN,US,US,2018,Q1,Elderly
145632141,14563214,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,,"UNK UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2018,Q1,Hypoglycaemia,,2018,Q1,1,I,201712.0,20180212.0,20180222,20180222,EXP,,US-ELI_LILLY_AND_COMPANY-US201802005403,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20180222.0,,CN,US,US,2018,Q1,Elderly
145632141,14563214,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,,"UNK UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2018,Q1,Loss of consciousness,,2018,Q1,1,I,201712.0,20180212.0,20180222,20180222,EXP,,US-ELI_LILLY_AND_COMPANY-US201802005403,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20180222.0,,CN,US,US,2018,Q1,Elderly
145632141,14563214,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,,"UNK UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2018,Q1,Rotator cuff syndrome,,2018,Q1,1,I,201712.0,20180212.0,20180222,20180222,EXP,,US-ELI_LILLY_AND_COMPANY-US201802005403,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20180222.0,,CN,US,US,2018,Q1,Elderly
145632141,14563214,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, C749661C,,20563.0,,,INJECTION,,2018,Q1,Blood glucose increased,,2018,Q1,1,I,201712.0,20180212.0,20180222,20180222,EXP,,US-ELI_LILLY_AND_COMPANY-US201802005403,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20180222.0,,CN,US,US,2018,Q1,Elderly
145632141,14563214,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, C749661C,,20563.0,,,INJECTION,,2018,Q1,Drug ineffective,,2018,Q1,1,I,201712.0,20180212.0,20180222,20180222,EXP,,US-ELI_LILLY_AND_COMPANY-US201802005403,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20180222.0,,CN,US,US,2018,Q1,Elderly
145632141,14563214,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, C749661C,,20563.0,,,INJECTION,,2018,Q1,Fall,,2018,Q1,1,I,201712.0,20180212.0,20180222,20180222,EXP,,US-ELI_LILLY_AND_COMPANY-US201802005403,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20180222.0,,CN,US,US,2018,Q1,Elderly
145632141,14563214,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, C749661C,,20563.0,,,INJECTION,,2018,Q1,Head injury,,2018,Q1,1,I,201712.0,20180212.0,20180222,20180222,EXP,,US-ELI_LILLY_AND_COMPANY-US201802005403,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20180222.0,,CN,US,US,2018,Q1,Elderly
145632141,14563214,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, C749661C,,20563.0,,,INJECTION,,2018,Q1,Hypoglycaemia,,2018,Q1,1,I,201712.0,20180212.0,20180222,20180222,EXP,,US-ELI_LILLY_AND_COMPANY-US201802005403,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20180222.0,,CN,US,US,2018,Q1,Elderly
145632141,14563214,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, C749661C,,20563.0,,,INJECTION,,2018,Q1,Loss of consciousness,,2018,Q1,1,I,201712.0,20180212.0,20180222,20180222,EXP,,US-ELI_LILLY_AND_COMPANY-US201802005403,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20180222.0,,CN,US,US,2018,Q1,Elderly
145632141,14563214,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, C749661C,,20563.0,,,INJECTION,,2018,Q1,Rotator cuff syndrome,,2018,Q1,1,I,201712.0,20180212.0,20180222,20180222,EXP,,US-ELI_LILLY_AND_COMPANY-US201802005403,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20180222.0,,CN,US,US,2018,Q1,Elderly
145632141,14563214,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, C804600A,,20563.0,,,INJECTION,,2018,Q1,Blood glucose increased,,2018,Q1,1,I,201712.0,20180212.0,20180222,20180222,EXP,,US-ELI_LILLY_AND_COMPANY-US201802005403,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20180222.0,,CN,US,US,2018,Q1,Elderly
145632141,14563214,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, C804600A,,20563.0,,,INJECTION,,2018,Q1,Drug ineffective,,2018,Q1,1,I,201712.0,20180212.0,20180222,20180222,EXP,,US-ELI_LILLY_AND_COMPANY-US201802005403,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20180222.0,,CN,US,US,2018,Q1,Elderly
145632141,14563214,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, C804600A,,20563.0,,,INJECTION,,2018,Q1,Fall,,2018,Q1,1,I,201712.0,20180212.0,20180222,20180222,EXP,,US-ELI_LILLY_AND_COMPANY-US201802005403,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20180222.0,,CN,US,US,2018,Q1,Elderly
145632141,14563214,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, C804600A,,20563.0,,,INJECTION,,2018,Q1,Head injury,,2018,Q1,1,I,201712.0,20180212.0,20180222,20180222,EXP,,US-ELI_LILLY_AND_COMPANY-US201802005403,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20180222.0,,CN,US,US,2018,Q1,Elderly
145632141,14563214,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, C804600A,,20563.0,,,INJECTION,,2018,Q1,Hypoglycaemia,,2018,Q1,1,I,201712.0,20180212.0,20180222,20180222,EXP,,US-ELI_LILLY_AND_COMPANY-US201802005403,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20180222.0,,CN,US,US,2018,Q1,Elderly
145632141,14563214,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, C804600A,,20563.0,,,INJECTION,,2018,Q1,Loss of consciousness,,2018,Q1,1,I,201712.0,20180212.0,20180222,20180222,EXP,,US-ELI_LILLY_AND_COMPANY-US201802005403,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20180222.0,,CN,US,US,2018,Q1,Elderly
145632141,14563214,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, C804600A,,20563.0,,,INJECTION,,2018,Q1,Rotator cuff syndrome,,2018,Q1,1,I,201712.0,20180212.0,20180222,20180222,EXP,,US-ELI_LILLY_AND_COMPANY-US201802005403,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20180222.0,,CN,US,US,2018,Q1,Elderly
145632141,14563214,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"1 U, UNKNOWN",,,,, C682258F,,20563.0,1.0,IU,INJECTION,,2018,Q1,Blood glucose increased,,2018,Q1,1,I,201712.0,20180212.0,20180222,20180222,EXP,,US-ELI_LILLY_AND_COMPANY-US201802005403,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20180222.0,,CN,US,US,2018,Q1,Elderly
145632141,14563214,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"1 U, UNKNOWN",,,,, C682258F,,20563.0,1.0,IU,INJECTION,,2018,Q1,Drug ineffective,,2018,Q1,1,I,201712.0,20180212.0,20180222,20180222,EXP,,US-ELI_LILLY_AND_COMPANY-US201802005403,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20180222.0,,CN,US,US,2018,Q1,Elderly
145632141,14563214,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"1 U, UNKNOWN",,,,, C682258F,,20563.0,1.0,IU,INJECTION,,2018,Q1,Fall,,2018,Q1,1,I,201712.0,20180212.0,20180222,20180222,EXP,,US-ELI_LILLY_AND_COMPANY-US201802005403,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20180222.0,,CN,US,US,2018,Q1,Elderly
145632141,14563214,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"1 U, UNKNOWN",,,,, C682258F,,20563.0,1.0,IU,INJECTION,,2018,Q1,Head injury,,2018,Q1,1,I,201712.0,20180212.0,20180222,20180222,EXP,,US-ELI_LILLY_AND_COMPANY-US201802005403,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20180222.0,,CN,US,US,2018,Q1,Elderly
145632141,14563214,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"1 U, UNKNOWN",,,,, C682258F,,20563.0,1.0,IU,INJECTION,,2018,Q1,Hypoglycaemia,,2018,Q1,1,I,201712.0,20180212.0,20180222,20180222,EXP,,US-ELI_LILLY_AND_COMPANY-US201802005403,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20180222.0,,CN,US,US,2018,Q1,Elderly
145632141,14563214,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"1 U, UNKNOWN",,,,, C682258F,,20563.0,1.0,IU,INJECTION,,2018,Q1,Loss of consciousness,,2018,Q1,1,I,201712.0,20180212.0,20180222,20180222,EXP,,US-ELI_LILLY_AND_COMPANY-US201802005403,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20180222.0,,CN,US,US,2018,Q1,Elderly
145632141,14563214,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"1 U, UNKNOWN",,,,, C682258F,,20563.0,1.0,IU,INJECTION,,2018,Q1,Rotator cuff syndrome,,2018,Q1,1,I,201712.0,20180212.0,20180222,20180222,EXP,,US-ELI_LILLY_AND_COMPANY-US201802005403,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20180222.0,,CN,US,US,2018,Q1,Elderly
145663272,14566327,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q1,Drug interaction,,2018,Q1,2,F,20180126.0,20180222.0,20180223,20180309,EXP,,IT-AUROBINDO-AUR-APL-2018-009842,AUROBINDO,,70.0,YR,,M,Y,175.0,KG,20180309.0,,PH,IT,IT,2018,Q1,Elderly
145663272,14566327,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q1,Electrocardiogram QT prolonged,,2018,Q1,2,F,20180126.0,20180222.0,20180223,20180309,EXP,,IT-AUROBINDO-AUR-APL-2018-009842,AUROBINDO,,70.0,YR,,M,Y,175.0,KG,20180309.0,,PH,IT,IT,2018,Q1,Elderly
145670651,14567065,5,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q1,Foot amputation,,2018,Q1,1,I,20170810.0,20180216.0,20180223,20180223,EXP,,"FR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-BI-009933",BOEHRINGER INGELHEIM,"KHOURI C, CRACOWSKI J, ROUSTIT M. SGLT-2 INHIBITORS AND THE RISK OF LOWER-LIMB AMPUTATION: IS THIS A CLASS EFFECT?. DIABETES OBESITY AND METABOLISM. 2018;.",82.0,YR,,M,Y,,,20180223.0,,MD,FR,DE,2018,Q1,Elderly
145713071,14571307,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Enterocolitis,,2018,Q1,1,I,20180208.0,,20180223,20180223,DIR,,,FDA-CTU,,3.0,YR,,M,N,15.9,KG,20180216.0,N,MD,COUNTRY NOT SPECIFIED,US,2018,Q1,Child
145713071,14571307,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Haematemesis,,2018,Q1,1,I,20180208.0,,20180223,20180223,DIR,,,FDA-CTU,,3.0,YR,,M,N,15.9,KG,20180216.0,N,MD,COUNTRY NOT SPECIFIED,US,2018,Q1,Child
145713071,14571307,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Haemoglobin decreased,,2018,Q1,1,I,20180208.0,,20180223,20180223,DIR,,,FDA-CTU,,3.0,YR,,M,N,15.9,KG,20180216.0,N,MD,COUNTRY NOT SPECIFIED,US,2018,Q1,Child
145713071,14571307,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Hypotension,,2018,Q1,1,I,20180208.0,,20180223,20180223,DIR,,,FDA-CTU,,3.0,YR,,M,N,15.9,KG,20180216.0,N,MD,COUNTRY NOT SPECIFIED,US,2018,Q1,Child
145713071,14571307,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Oesophagitis,,2018,Q1,1,I,20180208.0,,20180223,20180223,DIR,,,FDA-CTU,,3.0,YR,,M,N,15.9,KG,20180216.0,N,MD,COUNTRY NOT SPECIFIED,US,2018,Q1,Child
145713071,14571307,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Pneumatosis intestinalis,,2018,Q1,1,I,20180208.0,,20180223,20180223,DIR,,,FDA-CTU,,3.0,YR,,M,N,15.9,KG,20180216.0,N,MD,COUNTRY NOT SPECIFIED,US,2018,Q1,Child
145713071,14571307,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Small intestinal perforation,,2018,Q1,1,I,20180208.0,,20180223,20180223,DIR,,,FDA-CTU,,3.0,YR,,M,N,15.9,KG,20180216.0,N,MD,COUNTRY NOT SPECIFIED,US,2018,Q1,Child
145789743,14578974,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Hernia repair,,2018,Q1,3,F,20180226.0,20180313.0,20180227,20180314,EXP,,US-FRESENIUS MEDICAL CARE RENAL THERAPIES GROUP-FMC-1802-000394,FRESENIUS MEDICAL CARE,,50.0,YR,,F,Y,120.5,KG,20180314.0,,OT,US,US,2018,Q1,Adult
145789743,14578974,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Peritonitis,,2018,Q1,3,F,20180226.0,20180313.0,20180227,20180314,EXP,,US-FRESENIUS MEDICAL CARE RENAL THERAPIES GROUP-FMC-1802-000394,FRESENIUS MEDICAL CARE,,50.0,YR,,F,Y,120.5,KG,20180314.0,,OT,US,US,2018,Q1,Adult
145789743,14578974,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Sepsis,,2018,Q1,3,F,20180226.0,20180313.0,20180227,20180314,EXP,,US-FRESENIUS MEDICAL CARE RENAL THERAPIES GROUP-FMC-1802-000394,FRESENIUS MEDICAL CARE,,50.0,YR,,F,Y,120.5,KG,20180314.0,,OT,US,US,2018,Q1,Adult
145789743,14578974,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Vomiting,,2018,Q1,3,F,20180226.0,20180313.0,20180227,20180314,EXP,,US-FRESENIUS MEDICAL CARE RENAL THERAPIES GROUP-FMC-1802-000394,FRESENIUS MEDICAL CARE,,50.0,YR,,F,Y,120.5,KG,20180314.0,,OT,US,US,2018,Q1,Adult
145835353,14583535,22,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,1-8 UNITS,,,,,,,,,,INJECTION,QID,2018,Q1,Acute kidney injury,,2018,Q1,3,F,20180214.0,20180314.0,20180228,20180321,EXP,,US-CELGENEUS-USA-20180208527,CELGENE,,75.0,YR,,M,Y,71.9,KG,20180321.0,,MD,US,US,2018,Q1,Elderly
145835353,14583535,22,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,1-8 UNITS,,,,,,,,,,INJECTION,QID,2018,Q1,Pneumonia,,2018,Q1,3,F,20180214.0,20180314.0,20180228,20180321,EXP,,US-CELGENEUS-USA-20180208527,CELGENE,,75.0,YR,,M,Y,71.9,KG,20180321.0,,MD,US,US,2018,Q1,Elderly
145835353,14583535,23,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,11 IU (INTERNATIONAL UNIT),,,,,,,,11.0,IU,INJECTION,QD,2018,Q1,Acute kidney injury,,2018,Q1,3,F,20180214.0,20180314.0,20180228,20180321,EXP,,US-CELGENEUS-USA-20180208527,CELGENE,,75.0,YR,,M,Y,71.9,KG,20180321.0,,MD,US,US,2018,Q1,Elderly
145835353,14583535,23,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,11 IU (INTERNATIONAL UNIT),,,,,,,,11.0,IU,INJECTION,QD,2018,Q1,Pneumonia,,2018,Q1,3,F,20180214.0,20180314.0,20180228,20180321,EXP,,US-CELGENEUS-USA-20180208527,CELGENE,,75.0,YR,,M,Y,71.9,KG,20180321.0,,MD,US,US,2018,Q1,Elderly
145835353,14583535,24,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,2-10 UNITS,,,,,,,,,,INJECTION,QID,2018,Q1,Acute kidney injury,,2018,Q1,3,F,20180214.0,20180314.0,20180228,20180321,EXP,,US-CELGENEUS-USA-20180208527,CELGENE,,75.0,YR,,M,Y,71.9,KG,20180321.0,,MD,US,US,2018,Q1,Elderly
145835353,14583535,24,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,2-10 UNITS,,,,,,,,,,INJECTION,QID,2018,Q1,Pneumonia,,2018,Q1,3,F,20180214.0,20180314.0,20180228,20180321,EXP,,US-CELGENEUS-USA-20180208527,CELGENE,,75.0,YR,,M,Y,71.9,KG,20180321.0,,MD,US,US,2018,Q1,Elderly
145835353,14583535,25,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,2-12 UNITS,,,,,,,,,,INJECTION,QID,2018,Q1,Acute kidney injury,,2018,Q1,3,F,20180214.0,20180314.0,20180228,20180321,EXP,,US-CELGENEUS-USA-20180208527,CELGENE,,75.0,YR,,M,Y,71.9,KG,20180321.0,,MD,US,US,2018,Q1,Elderly
145835353,14583535,25,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,2-12 UNITS,,,,,,,,,,INJECTION,QID,2018,Q1,Pneumonia,,2018,Q1,3,F,20180214.0,20180314.0,20180228,20180321,EXP,,US-CELGENEUS-USA-20180208527,CELGENE,,75.0,YR,,M,Y,71.9,KG,20180321.0,,MD,US,US,2018,Q1,Elderly
145835353,14583535,26,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,14 IU (INTERNATIONAL UNIT),,,,,,,,14.0,IU,INJECTION,QD,2018,Q1,Acute kidney injury,,2018,Q1,3,F,20180214.0,20180314.0,20180228,20180321,EXP,,US-CELGENEUS-USA-20180208527,CELGENE,,75.0,YR,,M,Y,71.9,KG,20180321.0,,MD,US,US,2018,Q1,Elderly
145835353,14583535,26,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,14 IU (INTERNATIONAL UNIT),,,,,,,,14.0,IU,INJECTION,QD,2018,Q1,Pneumonia,,2018,Q1,3,F,20180214.0,20180314.0,20180228,20180321,EXP,,US-CELGENEUS-USA-20180208527,CELGENE,,75.0,YR,,M,Y,71.9,KG,20180321.0,,MD,US,US,2018,Q1,Elderly
145836132,14583613,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 IU, AS NEEDED",,,,,,,,100.0,IU,,,2018,Q1,Dehydration,,2018,Q1,2,F,20180216.0,20180306.0,20180228,20180313,EXP,,US-PFIZER INC-2018077154,PFIZER,,62.0,YR,,F,Y,127.0,KG,20180313.0,,OT,US,US,2018,Q1,Adult
145836132,14583613,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 IU, AS NEEDED",,,,,,,,100.0,IU,,,2018,Q1,Syncope,,2018,Q1,2,F,20180216.0,20180306.0,20180228,20180313,EXP,,US-PFIZER INC-2018077154,PFIZER,,62.0,YR,,F,Y,127.0,KG,20180313.0,,OT,US,US,2018,Q1,Adult
145930341,14593034,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,, UNK,,209196.0,31.8,IU,,QD,2018,Q1,Diabetes mellitus inadequate control,,2018,Q1,1,I,20161201.0,20180216.0,20180302,20180302,EXP,,FR-SA-2018SA045545,AVENTIS,,36.0,YR,A,F,Y,70.0,KG,20180302.0,,CN,FR,FR,2018,Q1,Adult
145930341,14593034,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,, UNK,,209196.0,31.8,IU,,QD,2018,Q1,Diabetic retinopathy,,2018,Q1,1,I,20161201.0,20180216.0,20180302,20180302,EXP,,FR-SA-2018SA045545,AVENTIS,,36.0,YR,A,F,Y,70.0,KG,20180302.0,,CN,FR,FR,2018,Q1,Adult
145930341,14593034,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,, UNK,,209196.0,31.8,IU,,QD,2018,Q1,Failed induction of labour,,2018,Q1,1,I,20161201.0,20180216.0,20180302,20180302,EXP,,FR-SA-2018SA045545,AVENTIS,,36.0,YR,A,F,Y,70.0,KG,20180302.0,,CN,FR,FR,2018,Q1,Adult
145930341,14593034,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,, UNK,,209196.0,31.8,IU,,QD,2018,Q1,Hypoglycaemia,,2018,Q1,1,I,20161201.0,20180216.0,20180302,20180302,EXP,,FR-SA-2018SA045545,AVENTIS,,36.0,YR,A,F,Y,70.0,KG,20180302.0,,CN,FR,FR,2018,Q1,Adult
145930341,14593034,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,, UNK,,209196.0,31.8,IU,,QD,2018,Q1,Maternal exposure during breast feeding,,2018,Q1,1,I,20161201.0,20180216.0,20180302,20180302,EXP,,FR-SA-2018SA045545,AVENTIS,,36.0,YR,A,F,Y,70.0,KG,20180302.0,,CN,FR,FR,2018,Q1,Adult
145930341,14593034,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,, UNK,,209196.0,31.8,IU,,QD,2018,Q1,Maternal exposure during pregnancy,,2018,Q1,1,I,20161201.0,20180216.0,20180302,20180302,EXP,,FR-SA-2018SA045545,AVENTIS,,36.0,YR,A,F,Y,70.0,KG,20180302.0,,CN,FR,FR,2018,Q1,Adult
145930341,14593034,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,, UNK,,209196.0,45.18,IU,,QD,2018,Q1,Diabetes mellitus inadequate control,,2018,Q1,1,I,20161201.0,20180216.0,20180302,20180302,EXP,,FR-SA-2018SA045545,AVENTIS,,36.0,YR,A,F,Y,70.0,KG,20180302.0,,CN,FR,FR,2018,Q1,Adult
145930341,14593034,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,, UNK,,209196.0,45.18,IU,,QD,2018,Q1,Diabetic retinopathy,,2018,Q1,1,I,20161201.0,20180216.0,20180302,20180302,EXP,,FR-SA-2018SA045545,AVENTIS,,36.0,YR,A,F,Y,70.0,KG,20180302.0,,CN,FR,FR,2018,Q1,Adult
145930341,14593034,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,, UNK,,209196.0,45.18,IU,,QD,2018,Q1,Failed induction of labour,,2018,Q1,1,I,20161201.0,20180216.0,20180302,20180302,EXP,,FR-SA-2018SA045545,AVENTIS,,36.0,YR,A,F,Y,70.0,KG,20180302.0,,CN,FR,FR,2018,Q1,Adult
145930341,14593034,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,, UNK,,209196.0,45.18,IU,,QD,2018,Q1,Hypoglycaemia,,2018,Q1,1,I,20161201.0,20180216.0,20180302,20180302,EXP,,FR-SA-2018SA045545,AVENTIS,,36.0,YR,A,F,Y,70.0,KG,20180302.0,,CN,FR,FR,2018,Q1,Adult
145930341,14593034,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,, UNK,,209196.0,45.18,IU,,QD,2018,Q1,Maternal exposure during breast feeding,,2018,Q1,1,I,20161201.0,20180216.0,20180302,20180302,EXP,,FR-SA-2018SA045545,AVENTIS,,36.0,YR,A,F,Y,70.0,KG,20180302.0,,CN,FR,FR,2018,Q1,Adult
145930341,14593034,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,, UNK,,209196.0,45.18,IU,,QD,2018,Q1,Maternal exposure during pregnancy,,2018,Q1,1,I,20161201.0,20180216.0,20180302,20180302,EXP,,FR-SA-2018SA045545,AVENTIS,,36.0,YR,A,F,Y,70.0,KG,20180302.0,,CN,FR,FR,2018,Q1,Adult
145930341,14593034,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,, UNK,,209196.0,29.4,IU,,QD,2018,Q1,Diabetes mellitus inadequate control,,2018,Q1,1,I,20161201.0,20180216.0,20180302,20180302,EXP,,FR-SA-2018SA045545,AVENTIS,,36.0,YR,A,F,Y,70.0,KG,20180302.0,,CN,FR,FR,2018,Q1,Adult
145930341,14593034,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,, UNK,,209196.0,29.4,IU,,QD,2018,Q1,Diabetic retinopathy,,2018,Q1,1,I,20161201.0,20180216.0,20180302,20180302,EXP,,FR-SA-2018SA045545,AVENTIS,,36.0,YR,A,F,Y,70.0,KG,20180302.0,,CN,FR,FR,2018,Q1,Adult
145930341,14593034,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,, UNK,,209196.0,29.4,IU,,QD,2018,Q1,Failed induction of labour,,2018,Q1,1,I,20161201.0,20180216.0,20180302,20180302,EXP,,FR-SA-2018SA045545,AVENTIS,,36.0,YR,A,F,Y,70.0,KG,20180302.0,,CN,FR,FR,2018,Q1,Adult
145930341,14593034,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,, UNK,,209196.0,29.4,IU,,QD,2018,Q1,Hypoglycaemia,,2018,Q1,1,I,20161201.0,20180216.0,20180302,20180302,EXP,,FR-SA-2018SA045545,AVENTIS,,36.0,YR,A,F,Y,70.0,KG,20180302.0,,CN,FR,FR,2018,Q1,Adult
145930341,14593034,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,, UNK,,209196.0,29.4,IU,,QD,2018,Q1,Maternal exposure during breast feeding,,2018,Q1,1,I,20161201.0,20180216.0,20180302,20180302,EXP,,FR-SA-2018SA045545,AVENTIS,,36.0,YR,A,F,Y,70.0,KG,20180302.0,,CN,FR,FR,2018,Q1,Adult
145930341,14593034,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,, UNK,,209196.0,29.4,IU,,QD,2018,Q1,Maternal exposure during pregnancy,,2018,Q1,1,I,20161201.0,20180216.0,20180302,20180302,EXP,,FR-SA-2018SA045545,AVENTIS,,36.0,YR,A,F,Y,70.0,KG,20180302.0,,CN,FR,FR,2018,Q1,Adult
145930341,14593034,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,, UNK,,209196.0,119.9,IU,,QD,2018,Q1,Diabetes mellitus inadequate control,,2018,Q1,1,I,20161201.0,20180216.0,20180302,20180302,EXP,,FR-SA-2018SA045545,AVENTIS,,36.0,YR,A,F,Y,70.0,KG,20180302.0,,CN,FR,FR,2018,Q1,Adult
145930341,14593034,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,, UNK,,209196.0,119.9,IU,,QD,2018,Q1,Diabetic retinopathy,,2018,Q1,1,I,20161201.0,20180216.0,20180302,20180302,EXP,,FR-SA-2018SA045545,AVENTIS,,36.0,YR,A,F,Y,70.0,KG,20180302.0,,CN,FR,FR,2018,Q1,Adult
145930341,14593034,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,, UNK,,209196.0,119.9,IU,,QD,2018,Q1,Failed induction of labour,,2018,Q1,1,I,20161201.0,20180216.0,20180302,20180302,EXP,,FR-SA-2018SA045545,AVENTIS,,36.0,YR,A,F,Y,70.0,KG,20180302.0,,CN,FR,FR,2018,Q1,Adult
145930341,14593034,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,, UNK,,209196.0,119.9,IU,,QD,2018,Q1,Hypoglycaemia,,2018,Q1,1,I,20161201.0,20180216.0,20180302,20180302,EXP,,FR-SA-2018SA045545,AVENTIS,,36.0,YR,A,F,Y,70.0,KG,20180302.0,,CN,FR,FR,2018,Q1,Adult
145930341,14593034,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,, UNK,,209196.0,119.9,IU,,QD,2018,Q1,Maternal exposure during breast feeding,,2018,Q1,1,I,20161201.0,20180216.0,20180302,20180302,EXP,,FR-SA-2018SA045545,AVENTIS,,36.0,YR,A,F,Y,70.0,KG,20180302.0,,CN,FR,FR,2018,Q1,Adult
145930341,14593034,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,, UNK,,209196.0,119.9,IU,,QD,2018,Q1,Maternal exposure during pregnancy,,2018,Q1,1,I,20161201.0,20180216.0,20180302,20180302,EXP,,FR-SA-2018SA045545,AVENTIS,,36.0,YR,A,F,Y,70.0,KG,20180302.0,,CN,FR,FR,2018,Q1,Adult
145955431,14595543,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,TID,2018,Q1,Pneumonia,,2018,Q1,1,I,201802.0,20180228.0,20180303,20180303,EXP,,NL-ABBVIE-18S-114-2274753-00,ABBVIE,,69.0,YR,,M,Y,94.0,KG,20180302.0,,CN,NL,NL,2018,Q1,Elderly
145958882,14595888,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,U,,,,,,,,2018,Q1,Drug interaction,,2018,Q1,2,F,20180126.0,20180305.0,20180303,20180319,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2018RR-164193,RANBAXY,,70.0,YR,,M,Y,60.0,KG,20180319.0,,OT,GB,IT,2018,Q1,Elderly
145958882,14595888,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,U,,,,,,,,2018,Q1,Electrocardiogram QT prolonged,,2018,Q1,2,F,20180126.0,20180305.0,20180303,20180319,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2018RR-164193,RANBAXY,,70.0,YR,,M,Y,60.0,KG,20180319.0,,OT,GB,IT,2018,Q1,Elderly
145985651,14598565,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,UNSPECIFIED,,2018,Q1,Cellulitis,,2018,Q1,1,I,201612.0,20180227.0,20180305,20180305,EXP,,US-JNJFOC-20180239856,JANSSEN,,67.0,YR,E,M,Y,,,20180305.0,,CN,US,US,2018,Q1,Elderly
145985651,14598565,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,UNSPECIFIED,,2018,Q1,Gangrene,,2018,Q1,1,I,201612.0,20180227.0,20180305,20180305,EXP,,US-JNJFOC-20180239856,JANSSEN,,67.0,YR,E,M,Y,,,20180305.0,,CN,US,US,2018,Q1,Elderly
145985651,14598565,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,UNSPECIFIED,,2018,Q1,Leg amputation,,2018,Q1,1,I,201612.0,20180227.0,20180305,20180305,EXP,,US-JNJFOC-20180239856,JANSSEN,,67.0,YR,E,M,Y,,,20180305.0,,CN,US,US,2018,Q1,Elderly
145985651,14598565,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,UNSPECIFIED,,2018,Q1,Sepsis,,2018,Q1,1,I,201612.0,20180227.0,20180305,20180305,EXP,,US-JNJFOC-20180239856,JANSSEN,,67.0,YR,E,M,Y,,,20180305.0,,CN,US,US,2018,Q1,Elderly
146067832,14606783,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2018,Q1,Abdominal pain,,2018,Q1,2,F,20150912.0,20180308.0,20180307,20180314,EXP,,SE-ROCHE-1634898,ROCHE,,73.0,YR,,F,Y,72.2,KG,20180314.0,,MD,SE,SE,2018,Q1,Elderly
146067832,14606783,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2018,Q1,Atrial fibrillation,,2018,Q1,2,F,20150912.0,20180308.0,20180307,20180314,EXP,,SE-ROCHE-1634898,ROCHE,,73.0,YR,,F,Y,72.2,KG,20180314.0,,MD,SE,SE,2018,Q1,Elderly
146067832,14606783,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2018,Q1,Colorectal cancer,,2018,Q1,2,F,20150912.0,20180308.0,20180307,20180314,EXP,,SE-ROCHE-1634898,ROCHE,,73.0,YR,,F,Y,72.2,KG,20180314.0,,MD,SE,SE,2018,Q1,Elderly
146067832,14606783,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2018,Q1,Colorectal cancer metastatic,,2018,Q1,2,F,20150912.0,20180308.0,20180307,20180314,EXP,,SE-ROCHE-1634898,ROCHE,,73.0,YR,,F,Y,72.2,KG,20180314.0,,MD,SE,SE,2018,Q1,Elderly
146067832,14606783,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2018,Q1,Escherichia sepsis,,2018,Q1,2,F,20150912.0,20180308.0,20180307,20180314,EXP,,SE-ROCHE-1634898,ROCHE,,73.0,YR,,F,Y,72.2,KG,20180314.0,,MD,SE,SE,2018,Q1,Elderly
146067832,14606783,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2018,Q1,Listeria sepsis,,2018,Q1,2,F,20150912.0,20180308.0,20180307,20180314,EXP,,SE-ROCHE-1634898,ROCHE,,73.0,YR,,F,Y,72.2,KG,20180314.0,,MD,SE,SE,2018,Q1,Elderly
146067832,14606783,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2018,Q1,Sepsis,,2018,Q1,2,F,20150912.0,20180308.0,20180307,20180314,EXP,,SE-ROCHE-1634898,ROCHE,,73.0,YR,,F,Y,72.2,KG,20180314.0,,MD,SE,SE,2018,Q1,Elderly
146067832,14606783,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2018,Q1,Urinary tract infection,,2018,Q1,2,F,20150912.0,20180308.0,20180307,20180314,EXP,,SE-ROCHE-1634898,ROCHE,,73.0,YR,,F,Y,72.2,KG,20180314.0,,MD,SE,SE,2018,Q1,Elderly
146104962,14610496,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,, DESCONHECIDO,,,1.0,DF,,,2018,Q1,Back pain,,2018,Q1,2,F,20180219.0,20180314.0,20180307,20180319,EXP,PT-INFARMED-H201802-636,"PT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-12-000832",BOEHRINGER INGELHEIM,,39.0,YR,,F,Y,70.0,KG,20180320.0,,MD,PT,PT,2018,Q1,Adult
146104962,14610496,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,, DESCONHECIDO,,,1.0,DF,,,2018,Q1,Balance disorder,,2018,Q1,2,F,20180219.0,20180314.0,20180307,20180319,EXP,PT-INFARMED-H201802-636,"PT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-12-000832",BOEHRINGER INGELHEIM,,39.0,YR,,F,Y,70.0,KG,20180320.0,,MD,PT,PT,2018,Q1,Adult
146104962,14610496,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,, DESCONHECIDO,,,1.0,DF,,,2018,Q1,Dizziness,,2018,Q1,2,F,20180219.0,20180314.0,20180307,20180319,EXP,PT-INFARMED-H201802-636,"PT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-12-000832",BOEHRINGER INGELHEIM,,39.0,YR,,F,Y,70.0,KG,20180320.0,,MD,PT,PT,2018,Q1,Adult
146104962,14610496,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,, DESCONHECIDO,,,1.0,DF,,,2018,Q1,Fatigue,,2018,Q1,2,F,20180219.0,20180314.0,20180307,20180319,EXP,PT-INFARMED-H201802-636,"PT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-12-000832",BOEHRINGER INGELHEIM,,39.0,YR,,F,Y,70.0,KG,20180320.0,,MD,PT,PT,2018,Q1,Adult
146104962,14610496,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,, DESCONHECIDO,,,1.0,DF,,,2018,Q1,Hypoglycaemia,,2018,Q1,2,F,20180219.0,20180314.0,20180307,20180319,EXP,PT-INFARMED-H201802-636,"PT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-12-000832",BOEHRINGER INGELHEIM,,39.0,YR,,F,Y,70.0,KG,20180320.0,,MD,PT,PT,2018,Q1,Adult
146104962,14610496,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,, DESCONHECIDO,,,1.0,DF,,,2018,Q1,Nausea,,2018,Q1,2,F,20180219.0,20180314.0,20180307,20180319,EXP,PT-INFARMED-H201802-636,"PT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-12-000832",BOEHRINGER INGELHEIM,,39.0,YR,,F,Y,70.0,KG,20180320.0,,MD,PT,PT,2018,Q1,Adult
146104962,14610496,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,, DESCONHECIDO,,,1.0,DF,,,2018,Q1,Pain,,2018,Q1,2,F,20180219.0,20180314.0,20180307,20180319,EXP,PT-INFARMED-H201802-636,"PT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-12-000832",BOEHRINGER INGELHEIM,,39.0,YR,,F,Y,70.0,KG,20180320.0,,MD,PT,PT,2018,Q1,Adult
146128571,14612857,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,, UNK,,209196.0,,,,,2018,Q1,Abdominal pain,,2018,Q1,1,I,201609.0,20180223.0,20180308,20180308,EXP,,FR-SA-2018SA052960,AVENTIS,,21.0,YR,A,F,Y,59.0,KG,20180308.0,,CN,FR,FR,2018,Q1,Youth
146128571,14612857,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,, UNK,,209196.0,,,,,2018,Q1,Diabetes mellitus,,2018,Q1,1,I,201609.0,20180223.0,20180308,20180308,EXP,,FR-SA-2018SA052960,AVENTIS,,21.0,YR,A,F,Y,59.0,KG,20180308.0,,CN,FR,FR,2018,Q1,Youth
146128571,14612857,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,, UNK,,209196.0,,,,,2018,Q1,Exposure during pregnancy,,2018,Q1,1,I,201609.0,20180223.0,20180308,20180308,EXP,,FR-SA-2018SA052960,AVENTIS,,21.0,YR,A,F,Y,59.0,KG,20180308.0,,CN,FR,FR,2018,Q1,Youth
146128571,14612857,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,, UNK,,209196.0,,,,,2018,Q1,Abdominal pain,,2018,Q1,1,I,201609.0,20180223.0,20180308,20180308,EXP,,FR-SA-2018SA052960,AVENTIS,,21.0,YR,A,F,Y,59.0,KG,20180308.0,,CN,FR,FR,2018,Q1,Youth
146128571,14612857,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,, UNK,,209196.0,,,,,2018,Q1,Diabetes mellitus,,2018,Q1,1,I,201609.0,20180223.0,20180308,20180308,EXP,,FR-SA-2018SA052960,AVENTIS,,21.0,YR,A,F,Y,59.0,KG,20180308.0,,CN,FR,FR,2018,Q1,Youth
146128571,14612857,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,, UNK,,209196.0,,,,,2018,Q1,Exposure during pregnancy,,2018,Q1,1,I,201609.0,20180223.0,20180308,20180308,EXP,,FR-SA-2018SA052960,AVENTIS,,21.0,YR,A,F,Y,59.0,KG,20180308.0,,CN,FR,FR,2018,Q1,Youth
146128571,14612857,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,, UNK,,209196.0,7.5,IU,,QD,2018,Q1,Abdominal pain,,2018,Q1,1,I,201609.0,20180223.0,20180308,20180308,EXP,,FR-SA-2018SA052960,AVENTIS,,21.0,YR,A,F,Y,59.0,KG,20180308.0,,CN,FR,FR,2018,Q1,Youth
146128571,14612857,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,, UNK,,209196.0,7.5,IU,,QD,2018,Q1,Diabetes mellitus,,2018,Q1,1,I,201609.0,20180223.0,20180308,20180308,EXP,,FR-SA-2018SA052960,AVENTIS,,21.0,YR,A,F,Y,59.0,KG,20180308.0,,CN,FR,FR,2018,Q1,Youth
146128571,14612857,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,, UNK,,209196.0,7.5,IU,,QD,2018,Q1,Exposure during pregnancy,,2018,Q1,1,I,201609.0,20180223.0,20180308,20180308,EXP,,FR-SA-2018SA052960,AVENTIS,,21.0,YR,A,F,Y,59.0,KG,20180308.0,,CN,FR,FR,2018,Q1,Youth
146128571,14612857,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,, UNK,,209196.0,7.5,IU,,QD,2018,Q1,Abdominal pain,,2018,Q1,1,I,201609.0,20180223.0,20180308,20180308,EXP,,FR-SA-2018SA052960,AVENTIS,,21.0,YR,A,F,Y,59.0,KG,20180308.0,,CN,FR,FR,2018,Q1,Youth
146128571,14612857,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,, UNK,,209196.0,7.5,IU,,QD,2018,Q1,Diabetes mellitus,,2018,Q1,1,I,201609.0,20180223.0,20180308,20180308,EXP,,FR-SA-2018SA052960,AVENTIS,,21.0,YR,A,F,Y,59.0,KG,20180308.0,,CN,FR,FR,2018,Q1,Youth
146128571,14612857,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,, UNK,,209196.0,7.5,IU,,QD,2018,Q1,Exposure during pregnancy,,2018,Q1,1,I,201609.0,20180223.0,20180308,20180308,EXP,,FR-SA-2018SA052960,AVENTIS,,21.0,YR,A,F,Y,59.0,KG,20180308.0,,CN,FR,FR,2018,Q1,Youth
146128571,14612857,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,, UNK,,209196.0,31.5,IU,,QD,2018,Q1,Abdominal pain,,2018,Q1,1,I,201609.0,20180223.0,20180308,20180308,EXP,,FR-SA-2018SA052960,AVENTIS,,21.0,YR,A,F,Y,59.0,KG,20180308.0,,CN,FR,FR,2018,Q1,Youth
146128571,14612857,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,, UNK,,209196.0,31.5,IU,,QD,2018,Q1,Diabetes mellitus,,2018,Q1,1,I,201609.0,20180223.0,20180308,20180308,EXP,,FR-SA-2018SA052960,AVENTIS,,21.0,YR,A,F,Y,59.0,KG,20180308.0,,CN,FR,FR,2018,Q1,Youth
146128571,14612857,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,, UNK,,209196.0,31.5,IU,,QD,2018,Q1,Exposure during pregnancy,,2018,Q1,1,I,201609.0,20180223.0,20180308,20180308,EXP,,FR-SA-2018SA052960,AVENTIS,,21.0,YR,A,F,Y,59.0,KG,20180308.0,,CN,FR,FR,2018,Q1,Youth
146128571,14612857,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,, UNK,,209196.0,31.5,IU,,QD,2018,Q1,Abdominal pain,,2018,Q1,1,I,201609.0,20180223.0,20180308,20180308,EXP,,FR-SA-2018SA052960,AVENTIS,,21.0,YR,A,F,Y,59.0,KG,20180308.0,,CN,FR,FR,2018,Q1,Youth
146128571,14612857,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,, UNK,,209196.0,31.5,IU,,QD,2018,Q1,Diabetes mellitus,,2018,Q1,1,I,201609.0,20180223.0,20180308,20180308,EXP,,FR-SA-2018SA052960,AVENTIS,,21.0,YR,A,F,Y,59.0,KG,20180308.0,,CN,FR,FR,2018,Q1,Youth
146128571,14612857,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,, UNK,,209196.0,31.5,IU,,QD,2018,Q1,Exposure during pregnancy,,2018,Q1,1,I,201609.0,20180223.0,20180308,20180308,EXP,,FR-SA-2018SA052960,AVENTIS,,21.0,YR,A,F,Y,59.0,KG,20180308.0,,CN,FR,FR,2018,Q1,Youth
146137621,14613762,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6 U, UNK",,,U,,,,,6.0,DF,,,2018,Q1,Memory impairment,,2018,Q1,1,I,,20180223.0,20180308,20180308,EXP,,PHHY2018US032687,SANDOZ,,60.0,YR,,M,Y,,,20180308.0,,OT,US,US,2018,Q1,Adult
146144092,14614409,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q1,Drug interaction,,2018,Q1,2,F,20180126.0,20180305.0,20180308,20180316,EXP,,IT-PFIZER INC-2018075259,PFIZER,,70.0,YR,,M,Y,,,20180316.0,,PH,IT,IT,2018,Q1,Elderly
146144092,14614409,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q1,Electrocardiogram QT prolonged,,2018,Q1,2,F,20180126.0,20180305.0,20180308,20180316,EXP,,IT-PFIZER INC-2018075259,PFIZER,,70.0,YR,,M,Y,,,20180316.0,,PH,IT,IT,2018,Q1,Elderly
146150711,14615071,1,PS,LISPRO,INSULIN LISPRO,1,,"UNK, UNKNOWN",,,,,,,20563.0,,,,,2018,Q1,Accidental overdose,,2018,Q1,1,I,,20180301.0,20180308,20180308,EXP,,US-ELI_LILLY_AND_COMPANY-US201803002516,ELI LILLY AND CO,THRASHER J.; SURKS H.; NOWOTNY I.; PIERRE S.; ROTTHAEUSER B.; WERNICKE-PANTEN K.; GARG S..SAFETY OF INSULIN LISPRO AND A BIOSIMILAR INSULIN LISPRO WHEN ADMINISTERED THROUGH AN INSULIN PUMP..JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY. 2018;:NO PAGINATION.,57.0,YR,,F,Y,,,20180308.0,,MD,US,US,2018,Q1,Adult
146150711,14615071,1,PS,LISPRO,INSULIN LISPRO,1,,"UNK, UNKNOWN",,,,,,,20563.0,,,,,2018,Q1,Cardio-respiratory arrest,,2018,Q1,1,I,,20180301.0,20180308,20180308,EXP,,US-ELI_LILLY_AND_COMPANY-US201803002516,ELI LILLY AND CO,THRASHER J.; SURKS H.; NOWOTNY I.; PIERRE S.; ROTTHAEUSER B.; WERNICKE-PANTEN K.; GARG S..SAFETY OF INSULIN LISPRO AND A BIOSIMILAR INSULIN LISPRO WHEN ADMINISTERED THROUGH AN INSULIN PUMP..JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY. 2018;:NO PAGINATION.,57.0,YR,,F,Y,,,20180308.0,,MD,US,US,2018,Q1,Adult
146150711,14615071,1,PS,LISPRO,INSULIN LISPRO,1,,"UNK, UNKNOWN",,,,,,,20563.0,,,,,2018,Q1,Hypoglycaemia,,2018,Q1,1,I,,20180301.0,20180308,20180308,EXP,,US-ELI_LILLY_AND_COMPANY-US201803002516,ELI LILLY AND CO,THRASHER J.; SURKS H.; NOWOTNY I.; PIERRE S.; ROTTHAEUSER B.; WERNICKE-PANTEN K.; GARG S..SAFETY OF INSULIN LISPRO AND A BIOSIMILAR INSULIN LISPRO WHEN ADMINISTERED THROUGH AN INSULIN PUMP..JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY. 2018;:NO PAGINATION.,57.0,YR,,F,Y,,,20180308.0,,MD,US,US,2018,Q1,Adult
146188432,14618843,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q1,Blood cholesterol increased,,2018,Q1,2,F,,20180309.0,20180309,20180315,EXP,,US-PFIZER INC-2018092435,PFIZER,"SAGVAND, B.. PSEUDOHYPONATREMIA SECONDARY TO CHOLESTASIS IN A PATIENT WITH DRUG-INDUCED LIVER INJURY. THE AMERICAN JOURNAL OF GASTROENTEROLOGY. 2017;112 (SUPPL 1):S1225-S1226",69.0,YR,,M,Y,,,20180315.0,,MD,US,US,2018,Q1,Elderly
146188432,14618843,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q1,Blood glucose increased,,2018,Q1,2,F,,20180309.0,20180309,20180315,EXP,,US-PFIZER INC-2018092435,PFIZER,"SAGVAND, B.. PSEUDOHYPONATREMIA SECONDARY TO CHOLESTASIS IN A PATIENT WITH DRUG-INDUCED LIVER INJURY. THE AMERICAN JOURNAL OF GASTROENTEROLOGY. 2017;112 (SUPPL 1):S1225-S1226",69.0,YR,,M,Y,,,20180315.0,,MD,US,US,2018,Q1,Elderly
146188432,14618843,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q1,Blood triglycerides increased,,2018,Q1,2,F,,20180309.0,20180309,20180315,EXP,,US-PFIZER INC-2018092435,PFIZER,"SAGVAND, B.. PSEUDOHYPONATREMIA SECONDARY TO CHOLESTASIS IN A PATIENT WITH DRUG-INDUCED LIVER INJURY. THE AMERICAN JOURNAL OF GASTROENTEROLOGY. 2017;112 (SUPPL 1):S1225-S1226",69.0,YR,,M,Y,,,20180315.0,,MD,US,US,2018,Q1,Elderly
146188432,14618843,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q1,Cholestatic liver injury,,2018,Q1,2,F,,20180309.0,20180309,20180315,EXP,,US-PFIZER INC-2018092435,PFIZER,"SAGVAND, B.. PSEUDOHYPONATREMIA SECONDARY TO CHOLESTASIS IN A PATIENT WITH DRUG-INDUCED LIVER INJURY. THE AMERICAN JOURNAL OF GASTROENTEROLOGY. 2017;112 (SUPPL 1):S1225-S1226",69.0,YR,,M,Y,,,20180315.0,,MD,US,US,2018,Q1,Elderly
146188432,14618843,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q1,Drug-induced liver injury,,2018,Q1,2,F,,20180309.0,20180309,20180315,EXP,,US-PFIZER INC-2018092435,PFIZER,"SAGVAND, B.. PSEUDOHYPONATREMIA SECONDARY TO CHOLESTASIS IN A PATIENT WITH DRUG-INDUCED LIVER INJURY. THE AMERICAN JOURNAL OF GASTROENTEROLOGY. 2017;112 (SUPPL 1):S1225-S1226",69.0,YR,,M,Y,,,20180315.0,,MD,US,US,2018,Q1,Elderly
146188432,14618843,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q1,High density lipoprotein decreased,,2018,Q1,2,F,,20180309.0,20180309,20180315,EXP,,US-PFIZER INC-2018092435,PFIZER,"SAGVAND, B.. PSEUDOHYPONATREMIA SECONDARY TO CHOLESTASIS IN A PATIENT WITH DRUG-INDUCED LIVER INJURY. THE AMERICAN JOURNAL OF GASTROENTEROLOGY. 2017;112 (SUPPL 1):S1225-S1226",69.0,YR,,M,Y,,,20180315.0,,MD,US,US,2018,Q1,Elderly
146188432,14618843,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q1,Hyponatraemia,,2018,Q1,2,F,,20180309.0,20180309,20180315,EXP,,US-PFIZER INC-2018092435,PFIZER,"SAGVAND, B.. PSEUDOHYPONATREMIA SECONDARY TO CHOLESTASIS IN A PATIENT WITH DRUG-INDUCED LIVER INJURY. THE AMERICAN JOURNAL OF GASTROENTEROLOGY. 2017;112 (SUPPL 1):S1225-S1226",69.0,YR,,M,Y,,,20180315.0,,MD,US,US,2018,Q1,Elderly
146188432,14618843,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q1,International normalised ratio increased,,2018,Q1,2,F,,20180309.0,20180309,20180315,EXP,,US-PFIZER INC-2018092435,PFIZER,"SAGVAND, B.. PSEUDOHYPONATREMIA SECONDARY TO CHOLESTASIS IN A PATIENT WITH DRUG-INDUCED LIVER INJURY. THE AMERICAN JOURNAL OF GASTROENTEROLOGY. 2017;112 (SUPPL 1):S1225-S1226",69.0,YR,,M,Y,,,20180315.0,,MD,US,US,2018,Q1,Elderly
146188432,14618843,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q1,Liver transplant,,2018,Q1,2,F,,20180309.0,20180309,20180315,EXP,,US-PFIZER INC-2018092435,PFIZER,"SAGVAND, B.. PSEUDOHYPONATREMIA SECONDARY TO CHOLESTASIS IN A PATIENT WITH DRUG-INDUCED LIVER INJURY. THE AMERICAN JOURNAL OF GASTROENTEROLOGY. 2017;112 (SUPPL 1):S1225-S1226",69.0,YR,,M,Y,,,20180315.0,,MD,US,US,2018,Q1,Elderly
146188432,14618843,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q1,Low density lipoprotein increased,,2018,Q1,2,F,,20180309.0,20180309,20180315,EXP,,US-PFIZER INC-2018092435,PFIZER,"SAGVAND, B.. PSEUDOHYPONATREMIA SECONDARY TO CHOLESTASIS IN A PATIENT WITH DRUG-INDUCED LIVER INJURY. THE AMERICAN JOURNAL OF GASTROENTEROLOGY. 2017;112 (SUPPL 1):S1225-S1226",69.0,YR,,M,Y,,,20180315.0,,MD,US,US,2018,Q1,Elderly
146188432,14618843,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q1,Pseudohyponatraemia,,2018,Q1,2,F,,20180309.0,20180309,20180315,EXP,,US-PFIZER INC-2018092435,PFIZER,"SAGVAND, B.. PSEUDOHYPONATREMIA SECONDARY TO CHOLESTASIS IN A PATIENT WITH DRUG-INDUCED LIVER INJURY. THE AMERICAN JOURNAL OF GASTROENTEROLOGY. 2017;112 (SUPPL 1):S1225-S1226",69.0,YR,,M,Y,,,20180315.0,,MD,US,US,2018,Q1,Elderly
146188432,14618843,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q1,Vanishing bile duct syndrome,,2018,Q1,2,F,,20180309.0,20180309,20180315,EXP,,US-PFIZER INC-2018092435,PFIZER,"SAGVAND, B.. PSEUDOHYPONATREMIA SECONDARY TO CHOLESTASIS IN A PATIENT WITH DRUG-INDUCED LIVER INJURY. THE AMERICAN JOURNAL OF GASTROENTEROLOGY. 2017;112 (SUPPL 1):S1225-S1226",69.0,YR,,M,Y,,,20180315.0,,MD,US,US,2018,Q1,Elderly
146188432,14618843,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q1,Very low density lipoprotein increased,,2018,Q1,2,F,,20180309.0,20180309,20180315,EXP,,US-PFIZER INC-2018092435,PFIZER,"SAGVAND, B.. PSEUDOHYPONATREMIA SECONDARY TO CHOLESTASIS IN A PATIENT WITH DRUG-INDUCED LIVER INJURY. THE AMERICAN JOURNAL OF GASTROENTEROLOGY. 2017;112 (SUPPL 1):S1225-S1226",69.0,YR,,M,Y,,,20180315.0,,MD,US,US,2018,Q1,Elderly
146196941,14619694,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q1,Blood glucose increased,,2018,Q1,1,I,,20171128.0,20180309,20180309,EXP,,IT-PFIZER INC-2018020645,PFIZER,,46.0,YR,,M,Y,,,20180309.0,,MD,IT,IT,2018,Q1,Adult
146196941,14619694,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q1,Blood pressure inadequately controlled,,2018,Q1,1,I,,20171128.0,20180309,20180309,EXP,,IT-PFIZER INC-2018020645,PFIZER,,46.0,YR,,M,Y,,,20180309.0,,MD,IT,IT,2018,Q1,Adult
146196941,14619694,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q1,Blood triglycerides increased,,2018,Q1,1,I,,20171128.0,20180309,20180309,EXP,,IT-PFIZER INC-2018020645,PFIZER,,46.0,YR,,M,Y,,,20180309.0,,MD,IT,IT,2018,Q1,Adult
146196941,14619694,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q1,Glycosylated haemoglobin increased,,2018,Q1,1,I,,20171128.0,20180309,20180309,EXP,,IT-PFIZER INC-2018020645,PFIZER,,46.0,YR,,M,Y,,,20180309.0,,MD,IT,IT,2018,Q1,Adult
146196941,14619694,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q1,Hypoglycaemia,,2018,Q1,1,I,,20171128.0,20180309,20180309,EXP,,IT-PFIZER INC-2018020645,PFIZER,,46.0,YR,,M,Y,,,20180309.0,,MD,IT,IT,2018,Q1,Adult
146196941,14619694,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q1,Postprandial hypoglycaemia,,2018,Q1,1,I,,20171128.0,20180309,20180309,EXP,,IT-PFIZER INC-2018020645,PFIZER,,46.0,YR,,M,Y,,,20180309.0,,MD,IT,IT,2018,Q1,Adult
146305572,14630557,16,C,INSULINA LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q1,Blood creatinine increased,,2018,Q1,2,F,20170727.0,20180302.0,20180313,20180315,EXP,,PHHY2018IT017480,SANDOZ,,75.0,YR,,F,Y,69.3,KG,20180315.0,,MD,IT,IT,2018,Q1,Elderly
146305572,14630557,16,C,INSULINA LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q1,Breath sounds abnormal,,2018,Q1,2,F,20170727.0,20180302.0,20180313,20180315,EXP,,PHHY2018IT017480,SANDOZ,,75.0,YR,,F,Y,69.3,KG,20180315.0,,MD,IT,IT,2018,Q1,Elderly
146305572,14630557,16,C,INSULINA LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q1,Catarrh,,2018,Q1,2,F,20170727.0,20180302.0,20180313,20180315,EXP,,PHHY2018IT017480,SANDOZ,,75.0,YR,,F,Y,69.3,KG,20180315.0,,MD,IT,IT,2018,Q1,Elderly
146305572,14630557,16,C,INSULINA LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q1,Cerebrovascular disorder,,2018,Q1,2,F,20170727.0,20180302.0,20180313,20180315,EXP,,PHHY2018IT017480,SANDOZ,,75.0,YR,,F,Y,69.3,KG,20180315.0,,MD,IT,IT,2018,Q1,Elderly
146305572,14630557,16,C,INSULINA LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q1,Cough,,2018,Q1,2,F,20170727.0,20180302.0,20180313,20180315,EXP,,PHHY2018IT017480,SANDOZ,,75.0,YR,,F,Y,69.3,KG,20180315.0,,MD,IT,IT,2018,Q1,Elderly
146305572,14630557,16,C,INSULINA LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q1,Dyspnoea,,2018,Q1,2,F,20170727.0,20180302.0,20180313,20180315,EXP,,PHHY2018IT017480,SANDOZ,,75.0,YR,,F,Y,69.3,KG,20180315.0,,MD,IT,IT,2018,Q1,Elderly
146305572,14630557,16,C,INSULINA LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q1,Electrolyte imbalance,,2018,Q1,2,F,20170727.0,20180302.0,20180313,20180315,EXP,,PHHY2018IT017480,SANDOZ,,75.0,YR,,F,Y,69.3,KG,20180315.0,,MD,IT,IT,2018,Q1,Elderly
146305572,14630557,16,C,INSULINA LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q1,Generalised oedema,,2018,Q1,2,F,20170727.0,20180302.0,20180313,20180315,EXP,,PHHY2018IT017480,SANDOZ,,75.0,YR,,F,Y,69.3,KG,20180315.0,,MD,IT,IT,2018,Q1,Elderly
146305572,14630557,16,C,INSULINA LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q1,Iron deficiency,,2018,Q1,2,F,20170727.0,20180302.0,20180313,20180315,EXP,,PHHY2018IT017480,SANDOZ,,75.0,YR,,F,Y,69.3,KG,20180315.0,,MD,IT,IT,2018,Q1,Elderly
146305572,14630557,16,C,INSULINA LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q1,Lymphangitis,,2018,Q1,2,F,20170727.0,20180302.0,20180313,20180315,EXP,,PHHY2018IT017480,SANDOZ,,75.0,YR,,F,Y,69.3,KG,20180315.0,,MD,IT,IT,2018,Q1,Elderly
146305572,14630557,16,C,INSULINA LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q1,Pneumonia,,2018,Q1,2,F,20170727.0,20180302.0,20180313,20180315,EXP,,PHHY2018IT017480,SANDOZ,,75.0,YR,,F,Y,69.3,KG,20180315.0,,MD,IT,IT,2018,Q1,Elderly
146305572,14630557,16,C,INSULINA LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q1,Pyrexia,,2018,Q1,2,F,20170727.0,20180302.0,20180313,20180315,EXP,,PHHY2018IT017480,SANDOZ,,75.0,YR,,F,Y,69.3,KG,20180315.0,,MD,IT,IT,2018,Q1,Elderly
146305572,14630557,16,C,INSULINA LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q1,Renal impairment,,2018,Q1,2,F,20170727.0,20180302.0,20180313,20180315,EXP,,PHHY2018IT017480,SANDOZ,,75.0,YR,,F,Y,69.3,KG,20180315.0,,MD,IT,IT,2018,Q1,Elderly
146305572,14630557,16,C,INSULINA LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q1,Sensory disturbance,,2018,Q1,2,F,20170727.0,20180302.0,20180313,20180315,EXP,,PHHY2018IT017480,SANDOZ,,75.0,YR,,F,Y,69.3,KG,20180315.0,,MD,IT,IT,2018,Q1,Elderly
146305572,14630557,16,C,INSULINA LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q1,Skin lesion,,2018,Q1,2,F,20170727.0,20180302.0,20180313,20180315,EXP,,PHHY2018IT017480,SANDOZ,,75.0,YR,,F,Y,69.3,KG,20180315.0,,MD,IT,IT,2018,Q1,Elderly
146305572,14630557,16,C,INSULINA LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q1,Urinary tract infection,,2018,Q1,2,F,20170727.0,20180302.0,20180313,20180315,EXP,,PHHY2018IT017480,SANDOZ,,75.0,YR,,F,Y,69.3,KG,20180315.0,,MD,IT,IT,2018,Q1,Elderly
146305572,14630557,16,C,INSULINA LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q1,Vascular parkinsonism,,2018,Q1,2,F,20170727.0,20180302.0,20180313,20180315,EXP,,PHHY2018IT017480,SANDOZ,,75.0,YR,,F,Y,69.3,KG,20180315.0,,MD,IT,IT,2018,Q1,Elderly
146305572,14630557,16,C,INSULINA LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q1,Weight decreased,,2018,Q1,2,F,20170727.0,20180302.0,20180313,20180315,EXP,,PHHY2018IT017480,SANDOZ,,75.0,YR,,F,Y,69.3,KG,20180315.0,,MD,IT,IT,2018,Q1,Elderly
146324041,14632404,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,INJECTION,,2018,Q1,Blood glucose decreased,,2018,Q1,1,I,20180102.0,20180301.0,20180313,20180313,EXP,,US-ELI_LILLY_AND_COMPANY-US201803000790,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20180313.0,,CN,US,US,2018,Q1,Elderly
146324041,14632404,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,INJECTION,,2018,Q1,Cerebral haemorrhage,,2018,Q1,1,I,20180102.0,20180301.0,20180313,20180313,EXP,,US-ELI_LILLY_AND_COMPANY-US201803000790,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20180313.0,,CN,US,US,2018,Q1,Elderly
146324041,14632404,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,INJECTION,,2018,Q1,Fall,,2018,Q1,1,I,20180102.0,20180301.0,20180313,20180313,EXP,,US-ELI_LILLY_AND_COMPANY-US201803000790,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20180313.0,,CN,US,US,2018,Q1,Elderly
146324041,14632404,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,INJECTION,,2018,Q1,Loss of consciousness,,2018,Q1,1,I,20180102.0,20180301.0,20180313,20180313,EXP,,US-ELI_LILLY_AND_COMPANY-US201803000790,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20180313.0,,CN,US,US,2018,Q1,Elderly
146470761,14647076,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,8 TO 20 UNITS WITH MEALS AS DIRECTED,,,U,,,,,,,UNSPECIFIED,,2018,Q1,Diabetic ketoacidosis,,2018,Q1,1,I,20160103.0,20180313.0,20180316,20180316,EXP,,US-JNJFOC-20180319027,JANSSEN,,47.0,YR,A,F,Y,108.86,KG,20180316.0,,CN,US,US,2018,Q1,Adult
146470761,14647076,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,8 TO 20 UNITS WITH MEALS AS DIRECTED,,,U,,,,,,,UNSPECIFIED,,2018,Q1,Fungal infection,,2018,Q1,1,I,20160103.0,20180313.0,20180316,20180316,EXP,,US-JNJFOC-20180319027,JANSSEN,,47.0,YR,A,F,Y,108.86,KG,20180316.0,,CN,US,US,2018,Q1,Adult
146507421,14650742,16,C,INSULINA LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q1,Blood creatinine increased,,2018,Q1,1,I,20170727.0,20180302.0,20180316,20180316,EXP,,PHHY2018IT038221,SANDOZ,,75.0,YR,,F,Y,69.3,KG,20180316.0,,MD,IT,IT,2018,Q1,Elderly
146507421,14650742,16,C,INSULINA LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q1,Breath sounds abnormal,,2018,Q1,1,I,20170727.0,20180302.0,20180316,20180316,EXP,,PHHY2018IT038221,SANDOZ,,75.0,YR,,F,Y,69.3,KG,20180316.0,,MD,IT,IT,2018,Q1,Elderly
146507421,14650742,16,C,INSULINA LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q1,Catarrh,,2018,Q1,1,I,20170727.0,20180302.0,20180316,20180316,EXP,,PHHY2018IT038221,SANDOZ,,75.0,YR,,F,Y,69.3,KG,20180316.0,,MD,IT,IT,2018,Q1,Elderly
146507421,14650742,16,C,INSULINA LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q1,Cerebrovascular disorder,,2018,Q1,1,I,20170727.0,20180302.0,20180316,20180316,EXP,,PHHY2018IT038221,SANDOZ,,75.0,YR,,F,Y,69.3,KG,20180316.0,,MD,IT,IT,2018,Q1,Elderly
146507421,14650742,16,C,INSULINA LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q1,Cough,,2018,Q1,1,I,20170727.0,20180302.0,20180316,20180316,EXP,,PHHY2018IT038221,SANDOZ,,75.0,YR,,F,Y,69.3,KG,20180316.0,,MD,IT,IT,2018,Q1,Elderly
146507421,14650742,16,C,INSULINA LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q1,Dyspnoea,,2018,Q1,1,I,20170727.0,20180302.0,20180316,20180316,EXP,,PHHY2018IT038221,SANDOZ,,75.0,YR,,F,Y,69.3,KG,20180316.0,,MD,IT,IT,2018,Q1,Elderly
146507421,14650742,16,C,INSULINA LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q1,Electrolyte imbalance,,2018,Q1,1,I,20170727.0,20180302.0,20180316,20180316,EXP,,PHHY2018IT038221,SANDOZ,,75.0,YR,,F,Y,69.3,KG,20180316.0,,MD,IT,IT,2018,Q1,Elderly
146507421,14650742,16,C,INSULINA LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q1,Generalised oedema,,2018,Q1,1,I,20170727.0,20180302.0,20180316,20180316,EXP,,PHHY2018IT038221,SANDOZ,,75.0,YR,,F,Y,69.3,KG,20180316.0,,MD,IT,IT,2018,Q1,Elderly
146507421,14650742,16,C,INSULINA LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q1,Iron deficiency,,2018,Q1,1,I,20170727.0,20180302.0,20180316,20180316,EXP,,PHHY2018IT038221,SANDOZ,,75.0,YR,,F,Y,69.3,KG,20180316.0,,MD,IT,IT,2018,Q1,Elderly
146507421,14650742,16,C,INSULINA LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q1,Lymphangitis,,2018,Q1,1,I,20170727.0,20180302.0,20180316,20180316,EXP,,PHHY2018IT038221,SANDOZ,,75.0,YR,,F,Y,69.3,KG,20180316.0,,MD,IT,IT,2018,Q1,Elderly
146507421,14650742,16,C,INSULINA LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q1,Pneumonia,,2018,Q1,1,I,20170727.0,20180302.0,20180316,20180316,EXP,,PHHY2018IT038221,SANDOZ,,75.0,YR,,F,Y,69.3,KG,20180316.0,,MD,IT,IT,2018,Q1,Elderly
146507421,14650742,16,C,INSULINA LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q1,Pyrexia,,2018,Q1,1,I,20170727.0,20180302.0,20180316,20180316,EXP,,PHHY2018IT038221,SANDOZ,,75.0,YR,,F,Y,69.3,KG,20180316.0,,MD,IT,IT,2018,Q1,Elderly
146507421,14650742,16,C,INSULINA LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q1,Renal impairment,,2018,Q1,1,I,20170727.0,20180302.0,20180316,20180316,EXP,,PHHY2018IT038221,SANDOZ,,75.0,YR,,F,Y,69.3,KG,20180316.0,,MD,IT,IT,2018,Q1,Elderly
146507421,14650742,16,C,INSULINA LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q1,Sensory disturbance,,2018,Q1,1,I,20170727.0,20180302.0,20180316,20180316,EXP,,PHHY2018IT038221,SANDOZ,,75.0,YR,,F,Y,69.3,KG,20180316.0,,MD,IT,IT,2018,Q1,Elderly
146507421,14650742,16,C,INSULINA LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q1,Skin lesion,,2018,Q1,1,I,20170727.0,20180302.0,20180316,20180316,EXP,,PHHY2018IT038221,SANDOZ,,75.0,YR,,F,Y,69.3,KG,20180316.0,,MD,IT,IT,2018,Q1,Elderly
146507421,14650742,16,C,INSULINA LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q1,Urinary tract infection,,2018,Q1,1,I,20170727.0,20180302.0,20180316,20180316,EXP,,PHHY2018IT038221,SANDOZ,,75.0,YR,,F,Y,69.3,KG,20180316.0,,MD,IT,IT,2018,Q1,Elderly
146507421,14650742,16,C,INSULINA LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q1,Vascular parkinsonism,,2018,Q1,1,I,20170727.0,20180302.0,20180316,20180316,EXP,,PHHY2018IT038221,SANDOZ,,75.0,YR,,F,Y,69.3,KG,20180316.0,,MD,IT,IT,2018,Q1,Elderly
146507421,14650742,16,C,INSULINA LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q1,Weight decreased,,2018,Q1,1,I,20170727.0,20180302.0,20180316,20180316,EXP,,PHHY2018IT038221,SANDOZ,,75.0,YR,,F,Y,69.3,KG,20180316.0,,MD,IT,IT,2018,Q1,Elderly
146527251,14652725,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q1,Hypoglycaemia,,2018,Q1,1,I,,20180124.0,20180319,20180319,PER,,US-LUPIN PHARMACEUTICALS INC.-2018-00524,LUPIN,,52.0,YR,,M,Y,,,20180319.0,,OT,US,US,2018,Q1,Adult
146535441,14653544,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q1,Cholestatic liver injury,,2018,Q1,1,I,,20180305.0,20180319,20180319,EXP,,US-LUPIN PHARMACEUTICALS INC.-2018-02124,LUPIN,,69.0,YR,,M,Y,,,20180319.0,,MD,US,US,2018,Q1,Elderly
146535441,14653544,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q1,Pseudohyponatraemia,,2018,Q1,1,I,,20180305.0,20180319,20180319,EXP,,US-LUPIN PHARMACEUTICALS INC.-2018-02124,LUPIN,,69.0,YR,,M,Y,,,20180319.0,,MD,US,US,2018,Q1,Elderly
146535441,14653544,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q1,Vanishing bile duct syndrome,,2018,Q1,1,I,,20180305.0,20180319,20180319,EXP,,US-LUPIN PHARMACEUTICALS INC.-2018-02124,LUPIN,,69.0,YR,,M,Y,,,20180319.0,,MD,US,US,2018,Q1,Elderly
146620771,14662077,3,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,,U,,,,,,,,2018,Q1,Cholestasis,,2018,Q1,1,I,,20180307.0,20180321,20180321,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2018US-166854,RANBAXY,"SAGVAND BT, LINDENMEYER C, SUTTON R, ADHAMI T. PSEUDOHYPONATREMIA SECONDARY TO CHOLESTASIS IN A PATIENT WITH DRUG-INDUCED LIVER INJURY. AM J GASTROENTEROL. 2017;112 (SUPPL. 1):S1225-S1226",69.0,YR,,M,Y,,,20180321.0,,OT,US,US,2018,Q1,Elderly
146620771,14662077,3,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,,U,,,,,,,,2018,Q1,Drug-induced liver injury,,2018,Q1,1,I,,20180307.0,20180321,20180321,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2018US-166854,RANBAXY,"SAGVAND BT, LINDENMEYER C, SUTTON R, ADHAMI T. PSEUDOHYPONATREMIA SECONDARY TO CHOLESTASIS IN A PATIENT WITH DRUG-INDUCED LIVER INJURY. AM J GASTROENTEROL. 2017;112 (SUPPL. 1):S1225-S1226",69.0,YR,,M,Y,,,20180321.0,,OT,US,US,2018,Q1,Elderly
146620771,14662077,3,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,,U,,,,,,,,2018,Q1,Liver transplant,,2018,Q1,1,I,,20180307.0,20180321,20180321,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2018US-166854,RANBAXY,"SAGVAND BT, LINDENMEYER C, SUTTON R, ADHAMI T. PSEUDOHYPONATREMIA SECONDARY TO CHOLESTASIS IN A PATIENT WITH DRUG-INDUCED LIVER INJURY. AM J GASTROENTEROL. 2017;112 (SUPPL. 1):S1225-S1226",69.0,YR,,M,Y,,,20180321.0,,OT,US,US,2018,Q1,Elderly
146620771,14662077,3,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,,U,,,,,,,,2018,Q1,Pseudohyponatraemia,,2018,Q1,1,I,,20180307.0,20180321,20180321,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2018US-166854,RANBAXY,"SAGVAND BT, LINDENMEYER C, SUTTON R, ADHAMI T. PSEUDOHYPONATREMIA SECONDARY TO CHOLESTASIS IN A PATIENT WITH DRUG-INDUCED LIVER INJURY. AM J GASTROENTEROL. 2017;112 (SUPPL. 1):S1225-S1226",69.0,YR,,M,Y,,,20180321.0,,OT,US,US,2018,Q1,Elderly
146642601,14664260,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 UNITS, THRICE DAILY",,,D,U,,,,,,FORMULATION UNKNOWN,TID,2018,Q1,Cardiac disorder,,2018,Q1,1,I,,20180314.0,20180321,20180321,EXP,,CO-ASTELLAS-2018US013861,ASTELLAS,,74.0,YR,,M,Y,,,20180321.0,,CN,CO,CO,2018,Q1,Elderly
146642601,14664260,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 UNITS, THRICE DAILY",,,D,U,,,,,,FORMULATION UNKNOWN,TID,2018,Q1,Diabetes mellitus,,2018,Q1,1,I,,20180314.0,20180321,20180321,EXP,,CO-ASTELLAS-2018US013861,ASTELLAS,,74.0,YR,,M,Y,,,20180321.0,,CN,CO,CO,2018,Q1,Elderly
146642601,14664260,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 UNITS, THRICE DAILY",,,D,U,,,,,,FORMULATION UNKNOWN,TID,2018,Q1,Fungal infection,,2018,Q1,1,I,,20180314.0,20180321,20180321,EXP,,CO-ASTELLAS-2018US013861,ASTELLAS,,74.0,YR,,M,Y,,,20180321.0,,CN,CO,CO,2018,Q1,Elderly
146658271,14665827,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,, UNKNOWN,,,1.0,DF,,QD,2018,Q1,Back pain,,2018,Q1,1,I,20180219.0,20180314.0,20180321,20180321,EXP,PT-INFARMED-H201802-636,PT-SA-2018SA078745,AVENTIS,,39.0,YR,A,F,Y,70.0,KG,20180321.0,,MD,PT,PT,2018,Q1,Adult
146658271,14665827,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,, UNKNOWN,,,1.0,DF,,QD,2018,Q1,Balance disorder,,2018,Q1,1,I,20180219.0,20180314.0,20180321,20180321,EXP,PT-INFARMED-H201802-636,PT-SA-2018SA078745,AVENTIS,,39.0,YR,A,F,Y,70.0,KG,20180321.0,,MD,PT,PT,2018,Q1,Adult
146658271,14665827,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,, UNKNOWN,,,1.0,DF,,QD,2018,Q1,Dizziness,,2018,Q1,1,I,20180219.0,20180314.0,20180321,20180321,EXP,PT-INFARMED-H201802-636,PT-SA-2018SA078745,AVENTIS,,39.0,YR,A,F,Y,70.0,KG,20180321.0,,MD,PT,PT,2018,Q1,Adult
146658271,14665827,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,, UNKNOWN,,,1.0,DF,,QD,2018,Q1,Fatigue,,2018,Q1,1,I,20180219.0,20180314.0,20180321,20180321,EXP,PT-INFARMED-H201802-636,PT-SA-2018SA078745,AVENTIS,,39.0,YR,A,F,Y,70.0,KG,20180321.0,,MD,PT,PT,2018,Q1,Adult
146658271,14665827,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,, UNKNOWN,,,1.0,DF,,QD,2018,Q1,Hypoglycaemia,,2018,Q1,1,I,20180219.0,20180314.0,20180321,20180321,EXP,PT-INFARMED-H201802-636,PT-SA-2018SA078745,AVENTIS,,39.0,YR,A,F,Y,70.0,KG,20180321.0,,MD,PT,PT,2018,Q1,Adult
146658271,14665827,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,, UNKNOWN,,,1.0,DF,,QD,2018,Q1,Nausea,,2018,Q1,1,I,20180219.0,20180314.0,20180321,20180321,EXP,PT-INFARMED-H201802-636,PT-SA-2018SA078745,AVENTIS,,39.0,YR,A,F,Y,70.0,KG,20180321.0,,MD,PT,PT,2018,Q1,Adult
146658271,14665827,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,, UNKNOWN,,,1.0,DF,,QD,2018,Q1,Pain,,2018,Q1,1,I,20180219.0,20180314.0,20180321,20180321,EXP,PT-INFARMED-H201802-636,PT-SA-2018SA078745,AVENTIS,,39.0,YR,A,F,Y,70.0,KG,20180321.0,,MD,PT,PT,2018,Q1,Adult
146695321,14669532,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 UT, QD WITH EACH MEAL",,,,,,,,,,,,2018,Q1,Acute kidney injury,,2018,Q1,1,I,,20170329.0,20180322,20180322,PER,,US-GLENMARK PHARMACEUTICALS-2017GMK026991,GLENMARK,"CHAROKOPOS A, MUHAMMAD T, SURBHI S, BRATEANU A.. CASE REPORT. THE JOURNAL OF FAMILY PRACTICE.. 2017;66(3):170-170",76.0,YR,,F,Y,,,20180322.0,,MD,US,US,2018,Q1,Elderly
146695321,14669532,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 UT, QD WITH EACH MEAL",,,,,,,,,,,,2018,Q1,Drug interaction,,2018,Q1,1,I,,20170329.0,20180322,20180322,PER,,US-GLENMARK PHARMACEUTICALS-2017GMK026991,GLENMARK,"CHAROKOPOS A, MUHAMMAD T, SURBHI S, BRATEANU A.. CASE REPORT. THE JOURNAL OF FAMILY PRACTICE.. 2017;66(3):170-170",76.0,YR,,F,Y,,,20180322.0,,MD,US,US,2018,Q1,Elderly
146695321,14669532,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 UT, QD WITH EACH MEAL",,,,,,,,,,,,2018,Q1,Rhabdomyolysis,,2018,Q1,1,I,,20170329.0,20180322,20180322,PER,,US-GLENMARK PHARMACEUTICALS-2017GMK026991,GLENMARK,"CHAROKOPOS A, MUHAMMAD T, SURBHI S, BRATEANU A.. CASE REPORT. THE JOURNAL OF FAMILY PRACTICE.. 2017;66(3):170-170",76.0,YR,,F,Y,,,20180322.0,,MD,US,US,2018,Q1,Elderly
146696531,14669653,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2018,Q1,Drug-induced liver injury,,2018,Q1,1,I,,20180307.0,20180322,20180322,EXP,,US-MYLANLABS-2018M1017136,MYLAN,"SAGVAND BT, LINDENMEYER C, SUTTON R, ADHAMI T. PSEUDOHYPONATREMIA SECONDARY TO CHOLESTASIS IN A PATIENT WITH DRUG-INDUCED LIVER INJURY. AM-J-GASTROENTEROL 2017;112 (SUPPL. 1):S1225-S1226.",69.0,YR,,M,Y,,,20180322.0,,OT,US,US,2018,Q1,Elderly
146696531,14669653,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2018,Q1,Pseudohyponatraemia,,2018,Q1,1,I,,20180307.0,20180322,20180322,EXP,,US-MYLANLABS-2018M1017136,MYLAN,"SAGVAND BT, LINDENMEYER C, SUTTON R, ADHAMI T. PSEUDOHYPONATREMIA SECONDARY TO CHOLESTASIS IN A PATIENT WITH DRUG-INDUCED LIVER INJURY. AM-J-GASTROENTEROL 2017;112 (SUPPL. 1):S1225-S1226.",69.0,YR,,M,Y,,,20180322.0,,OT,US,US,2018,Q1,Elderly
146696531,14669653,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2018,Q1,Vanishing bile duct syndrome,,2018,Q1,1,I,,20180307.0,20180322,20180322,EXP,,US-MYLANLABS-2018M1017136,MYLAN,"SAGVAND BT, LINDENMEYER C, SUTTON R, ADHAMI T. PSEUDOHYPONATREMIA SECONDARY TO CHOLESTASIS IN A PATIENT WITH DRUG-INDUCED LIVER INJURY. AM-J-GASTROENTEROL 2017;112 (SUPPL. 1):S1225-S1226.",69.0,YR,,M,Y,,,20180322.0,,OT,US,US,2018,Q1,Elderly
146701571,14670157,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"1 DF, DAILY",,,U,U, DESCONHECIDO,,20563.0,1.0,DF,,QD,2018,Q1,Back pain,,2018,Q1,1,I,20180219.0,20180314.0,20180322,20180322,EXP,PT-INFARMED-H201802-636,PT-ELI_LILLY_AND_COMPANY-PT201803006597,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20180322.0,,CN,PT,PT,2018,Q1,Adult
146701571,14670157,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"1 DF, DAILY",,,U,U, DESCONHECIDO,,20563.0,1.0,DF,,QD,2018,Q1,Balance disorder,,2018,Q1,1,I,20180219.0,20180314.0,20180322,20180322,EXP,PT-INFARMED-H201802-636,PT-ELI_LILLY_AND_COMPANY-PT201803006597,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20180322.0,,CN,PT,PT,2018,Q1,Adult
146701571,14670157,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"1 DF, DAILY",,,U,U, DESCONHECIDO,,20563.0,1.0,DF,,QD,2018,Q1,Dizziness,,2018,Q1,1,I,20180219.0,20180314.0,20180322,20180322,EXP,PT-INFARMED-H201802-636,PT-ELI_LILLY_AND_COMPANY-PT201803006597,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20180322.0,,CN,PT,PT,2018,Q1,Adult
146701571,14670157,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"1 DF, DAILY",,,U,U, DESCONHECIDO,,20563.0,1.0,DF,,QD,2018,Q1,Drug interaction,,2018,Q1,1,I,20180219.0,20180314.0,20180322,20180322,EXP,PT-INFARMED-H201802-636,PT-ELI_LILLY_AND_COMPANY-PT201803006597,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20180322.0,,CN,PT,PT,2018,Q1,Adult
146701571,14670157,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"1 DF, DAILY",,,U,U, DESCONHECIDO,,20563.0,1.0,DF,,QD,2018,Q1,Fatigue,,2018,Q1,1,I,20180219.0,20180314.0,20180322,20180322,EXP,PT-INFARMED-H201802-636,PT-ELI_LILLY_AND_COMPANY-PT201803006597,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20180322.0,,CN,PT,PT,2018,Q1,Adult
146701571,14670157,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"1 DF, DAILY",,,U,U, DESCONHECIDO,,20563.0,1.0,DF,,QD,2018,Q1,Hypoglycaemia,,2018,Q1,1,I,20180219.0,20180314.0,20180322,20180322,EXP,PT-INFARMED-H201802-636,PT-ELI_LILLY_AND_COMPANY-PT201803006597,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20180322.0,,CN,PT,PT,2018,Q1,Adult
146701571,14670157,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"1 DF, DAILY",,,U,U, DESCONHECIDO,,20563.0,1.0,DF,,QD,2018,Q1,Nausea,,2018,Q1,1,I,20180219.0,20180314.0,20180322,20180322,EXP,PT-INFARMED-H201802-636,PT-ELI_LILLY_AND_COMPANY-PT201803006597,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20180322.0,,CN,PT,PT,2018,Q1,Adult
146701571,14670157,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"1 DF, DAILY",,,U,U, DESCONHECIDO,,20563.0,1.0,DF,,QD,2018,Q1,Pain,,2018,Q1,1,I,20180219.0,20180314.0,20180322,20180322,EXP,PT-INFARMED-H201802-636,PT-ELI_LILLY_AND_COMPANY-PT201803006597,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20180322.0,,CN,PT,PT,2018,Q1,Adult
146710191,14671019,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Cardiac failure congestive,,2018,Q1,1,I,201802.0,20180314.0,20180322,20180322,EXP,,US-VIFOR (INTERNATIONAL) INC.-VIT-2018-02698,VIFOR,,72.0,YR,,F,Y,,,20180323.0,,CN,US,US,2018,Q1,Elderly
146710191,14671019,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Oedema,,2018,Q1,1,I,201802.0,20180314.0,20180322,20180322,EXP,,US-VIFOR (INTERNATIONAL) INC.-VIT-2018-02698,VIFOR,,72.0,YR,,F,Y,,,20180323.0,,CN,US,US,2018,Q1,Elderly
146754521,14675452,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, TID",,,U,U,,,20563.0,,,,TID,2018,Q1,Hyperglycaemia,,2018,Q1,1,I,20180311.0,20180312.0,20180323,20180323,EXP,,CH-ELI_LILLY_AND_COMPANY-CH201803005616,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20180323.0,,CN,CH,CH,2018,Q1,Elderly
146754521,14675452,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, TID",,,U,U,,,20563.0,,,,TID,2018,Q1,Staphylococcal infection,,2018,Q1,1,I,20180311.0,20180312.0,20180323,20180323,EXP,,CH-ELI_LILLY_AND_COMPANY-CH201803005616,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20180323.0,,CN,CH,CH,2018,Q1,Elderly
146810411,14681041,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"10 U, UNKNOWN",,,,,,,20563.0,10.0,IU,,,2018,Q1,Blood glucose increased,,2018,Q1,1,I,,20180314.0,20180326,20180326,EXP,,US-ELI_LILLY_AND_COMPANY-US201803009663,ELI LILLY AND CO,,56.0,YR,,M,Y,93.0,KG,20180326.0,,CN,US,US,2018,Q1,Adult
146810411,14681041,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"20 U, UNKNOWN",,,,,,,20563.0,20.0,IU,,,2018,Q1,Blood glucose increased,,2018,Q1,1,I,,20180314.0,20180326,20180326,EXP,,US-ELI_LILLY_AND_COMPANY-US201803009663,ELI LILLY AND CO,,56.0,YR,,M,Y,93.0,KG,20180326.0,,CN,US,US,2018,Q1,Adult
146814091,14681409,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2018,Q1,Blood creatinine increased,,2018,Q1,1,I,20170727.0,20180314.0,20180326,20180326,EXP,IT-NOVPHSZ-PHHY2018IT017480,IT-VALIDUS PHARMACEUTICALS LLC-IT-2018VAL000565,VALIDUS,,75.0,YR,,F,Y,,,20180326.0,,OT,IT,IT,2018,Q1,Elderly
146814091,14681409,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2018,Q1,Breath sounds abnormal,,2018,Q1,1,I,20170727.0,20180314.0,20180326,20180326,EXP,IT-NOVPHSZ-PHHY2018IT017480,IT-VALIDUS PHARMACEUTICALS LLC-IT-2018VAL000565,VALIDUS,,75.0,YR,,F,Y,,,20180326.0,,OT,IT,IT,2018,Q1,Elderly
146814091,14681409,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2018,Q1,Catarrh,,2018,Q1,1,I,20170727.0,20180314.0,20180326,20180326,EXP,IT-NOVPHSZ-PHHY2018IT017480,IT-VALIDUS PHARMACEUTICALS LLC-IT-2018VAL000565,VALIDUS,,75.0,YR,,F,Y,,,20180326.0,,OT,IT,IT,2018,Q1,Elderly
146814091,14681409,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2018,Q1,Cerebrovascular disorder,,2018,Q1,1,I,20170727.0,20180314.0,20180326,20180326,EXP,IT-NOVPHSZ-PHHY2018IT017480,IT-VALIDUS PHARMACEUTICALS LLC-IT-2018VAL000565,VALIDUS,,75.0,YR,,F,Y,,,20180326.0,,OT,IT,IT,2018,Q1,Elderly
146814091,14681409,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2018,Q1,Cough,,2018,Q1,1,I,20170727.0,20180314.0,20180326,20180326,EXP,IT-NOVPHSZ-PHHY2018IT017480,IT-VALIDUS PHARMACEUTICALS LLC-IT-2018VAL000565,VALIDUS,,75.0,YR,,F,Y,,,20180326.0,,OT,IT,IT,2018,Q1,Elderly
146814091,14681409,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2018,Q1,Dyspnoea,,2018,Q1,1,I,20170727.0,20180314.0,20180326,20180326,EXP,IT-NOVPHSZ-PHHY2018IT017480,IT-VALIDUS PHARMACEUTICALS LLC-IT-2018VAL000565,VALIDUS,,75.0,YR,,F,Y,,,20180326.0,,OT,IT,IT,2018,Q1,Elderly
146814091,14681409,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2018,Q1,Electrolyte imbalance,,2018,Q1,1,I,20170727.0,20180314.0,20180326,20180326,EXP,IT-NOVPHSZ-PHHY2018IT017480,IT-VALIDUS PHARMACEUTICALS LLC-IT-2018VAL000565,VALIDUS,,75.0,YR,,F,Y,,,20180326.0,,OT,IT,IT,2018,Q1,Elderly
146814091,14681409,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2018,Q1,Generalised oedema,,2018,Q1,1,I,20170727.0,20180314.0,20180326,20180326,EXP,IT-NOVPHSZ-PHHY2018IT017480,IT-VALIDUS PHARMACEUTICALS LLC-IT-2018VAL000565,VALIDUS,,75.0,YR,,F,Y,,,20180326.0,,OT,IT,IT,2018,Q1,Elderly
146814091,14681409,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2018,Q1,Iron deficiency,,2018,Q1,1,I,20170727.0,20180314.0,20180326,20180326,EXP,IT-NOVPHSZ-PHHY2018IT017480,IT-VALIDUS PHARMACEUTICALS LLC-IT-2018VAL000565,VALIDUS,,75.0,YR,,F,Y,,,20180326.0,,OT,IT,IT,2018,Q1,Elderly
146814091,14681409,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2018,Q1,Lymphangitis,,2018,Q1,1,I,20170727.0,20180314.0,20180326,20180326,EXP,IT-NOVPHSZ-PHHY2018IT017480,IT-VALIDUS PHARMACEUTICALS LLC-IT-2018VAL000565,VALIDUS,,75.0,YR,,F,Y,,,20180326.0,,OT,IT,IT,2018,Q1,Elderly
146814091,14681409,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2018,Q1,Pneumonia,,2018,Q1,1,I,20170727.0,20180314.0,20180326,20180326,EXP,IT-NOVPHSZ-PHHY2018IT017480,IT-VALIDUS PHARMACEUTICALS LLC-IT-2018VAL000565,VALIDUS,,75.0,YR,,F,Y,,,20180326.0,,OT,IT,IT,2018,Q1,Elderly
146814091,14681409,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2018,Q1,Pyrexia,,2018,Q1,1,I,20170727.0,20180314.0,20180326,20180326,EXP,IT-NOVPHSZ-PHHY2018IT017480,IT-VALIDUS PHARMACEUTICALS LLC-IT-2018VAL000565,VALIDUS,,75.0,YR,,F,Y,,,20180326.0,,OT,IT,IT,2018,Q1,Elderly
146814091,14681409,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2018,Q1,Renal impairment,,2018,Q1,1,I,20170727.0,20180314.0,20180326,20180326,EXP,IT-NOVPHSZ-PHHY2018IT017480,IT-VALIDUS PHARMACEUTICALS LLC-IT-2018VAL000565,VALIDUS,,75.0,YR,,F,Y,,,20180326.0,,OT,IT,IT,2018,Q1,Elderly
146814091,14681409,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2018,Q1,Sensory disturbance,,2018,Q1,1,I,20170727.0,20180314.0,20180326,20180326,EXP,IT-NOVPHSZ-PHHY2018IT017480,IT-VALIDUS PHARMACEUTICALS LLC-IT-2018VAL000565,VALIDUS,,75.0,YR,,F,Y,,,20180326.0,,OT,IT,IT,2018,Q1,Elderly
146814091,14681409,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2018,Q1,Skin lesion,,2018,Q1,1,I,20170727.0,20180314.0,20180326,20180326,EXP,IT-NOVPHSZ-PHHY2018IT017480,IT-VALIDUS PHARMACEUTICALS LLC-IT-2018VAL000565,VALIDUS,,75.0,YR,,F,Y,,,20180326.0,,OT,IT,IT,2018,Q1,Elderly
146814091,14681409,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2018,Q1,Urinary tract infection,,2018,Q1,1,I,20170727.0,20180314.0,20180326,20180326,EXP,IT-NOVPHSZ-PHHY2018IT017480,IT-VALIDUS PHARMACEUTICALS LLC-IT-2018VAL000565,VALIDUS,,75.0,YR,,F,Y,,,20180326.0,,OT,IT,IT,2018,Q1,Elderly
146814091,14681409,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2018,Q1,Vascular parkinsonism,,2018,Q1,1,I,20170727.0,20180314.0,20180326,20180326,EXP,IT-NOVPHSZ-PHHY2018IT017480,IT-VALIDUS PHARMACEUTICALS LLC-IT-2018VAL000565,VALIDUS,,75.0,YR,,F,Y,,,20180326.0,,OT,IT,IT,2018,Q1,Elderly
146814091,14681409,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2018,Q1,Weight decreased,,2018,Q1,1,I,20170727.0,20180314.0,20180326,20180326,EXP,IT-NOVPHSZ-PHHY2018IT017480,IT-VALIDUS PHARMACEUTICALS LLC-IT-2018VAL000565,VALIDUS,,75.0,YR,,F,Y,,,20180326.0,,OT,IT,IT,2018,Q1,Elderly
146837022,14683702,14,C,insulin lispro,INSULIN LISPRO,1,Unknown,(),,,U,,,,,,,,,2018,Q1,Blood creatinine increased,,2018,Q1,2,F,20170727.0,20180320.0,20180327,20180330,EXP,,IT-BAXTER-2018BAX009300,BAXTER,,75.0,YR,,F,Y,69.3,KG,20180330.0,,MD,IT,IT,2018,Q1,Elderly
146837022,14683702,14,C,insulin lispro,INSULIN LISPRO,1,Unknown,(),,,U,,,,,,,,,2018,Q1,Breath sounds abnormal,,2018,Q1,2,F,20170727.0,20180320.0,20180327,20180330,EXP,,IT-BAXTER-2018BAX009300,BAXTER,,75.0,YR,,F,Y,69.3,KG,20180330.0,,MD,IT,IT,2018,Q1,Elderly
146837022,14683702,14,C,insulin lispro,INSULIN LISPRO,1,Unknown,(),,,U,,,,,,,,,2018,Q1,Catarrh,,2018,Q1,2,F,20170727.0,20180320.0,20180327,20180330,EXP,,IT-BAXTER-2018BAX009300,BAXTER,,75.0,YR,,F,Y,69.3,KG,20180330.0,,MD,IT,IT,2018,Q1,Elderly
146837022,14683702,14,C,insulin lispro,INSULIN LISPRO,1,Unknown,(),,,U,,,,,,,,,2018,Q1,Cerebrovascular disorder,,2018,Q1,2,F,20170727.0,20180320.0,20180327,20180330,EXP,,IT-BAXTER-2018BAX009300,BAXTER,,75.0,YR,,F,Y,69.3,KG,20180330.0,,MD,IT,IT,2018,Q1,Elderly
146837022,14683702,14,C,insulin lispro,INSULIN LISPRO,1,Unknown,(),,,U,,,,,,,,,2018,Q1,Cough,,2018,Q1,2,F,20170727.0,20180320.0,20180327,20180330,EXP,,IT-BAXTER-2018BAX009300,BAXTER,,75.0,YR,,F,Y,69.3,KG,20180330.0,,MD,IT,IT,2018,Q1,Elderly
146837022,14683702,14,C,insulin lispro,INSULIN LISPRO,1,Unknown,(),,,U,,,,,,,,,2018,Q1,Dyspnoea,,2018,Q1,2,F,20170727.0,20180320.0,20180327,20180330,EXP,,IT-BAXTER-2018BAX009300,BAXTER,,75.0,YR,,F,Y,69.3,KG,20180330.0,,MD,IT,IT,2018,Q1,Elderly
146837022,14683702,14,C,insulin lispro,INSULIN LISPRO,1,Unknown,(),,,U,,,,,,,,,2018,Q1,Electrolyte imbalance,,2018,Q1,2,F,20170727.0,20180320.0,20180327,20180330,EXP,,IT-BAXTER-2018BAX009300,BAXTER,,75.0,YR,,F,Y,69.3,KG,20180330.0,,MD,IT,IT,2018,Q1,Elderly
146837022,14683702,14,C,insulin lispro,INSULIN LISPRO,1,Unknown,(),,,U,,,,,,,,,2018,Q1,Generalised oedema,,2018,Q1,2,F,20170727.0,20180320.0,20180327,20180330,EXP,,IT-BAXTER-2018BAX009300,BAXTER,,75.0,YR,,F,Y,69.3,KG,20180330.0,,MD,IT,IT,2018,Q1,Elderly
146837022,14683702,14,C,insulin lispro,INSULIN LISPRO,1,Unknown,(),,,U,,,,,,,,,2018,Q1,Iron deficiency,,2018,Q1,2,F,20170727.0,20180320.0,20180327,20180330,EXP,,IT-BAXTER-2018BAX009300,BAXTER,,75.0,YR,,F,Y,69.3,KG,20180330.0,,MD,IT,IT,2018,Q1,Elderly
146837022,14683702,14,C,insulin lispro,INSULIN LISPRO,1,Unknown,(),,,U,,,,,,,,,2018,Q1,Lymphangitis,,2018,Q1,2,F,20170727.0,20180320.0,20180327,20180330,EXP,,IT-BAXTER-2018BAX009300,BAXTER,,75.0,YR,,F,Y,69.3,KG,20180330.0,,MD,IT,IT,2018,Q1,Elderly
146837022,14683702,14,C,insulin lispro,INSULIN LISPRO,1,Unknown,(),,,U,,,,,,,,,2018,Q1,Pneumonia,,2018,Q1,2,F,20170727.0,20180320.0,20180327,20180330,EXP,,IT-BAXTER-2018BAX009300,BAXTER,,75.0,YR,,F,Y,69.3,KG,20180330.0,,MD,IT,IT,2018,Q1,Elderly
146837022,14683702,14,C,insulin lispro,INSULIN LISPRO,1,Unknown,(),,,U,,,,,,,,,2018,Q1,Pyrexia,,2018,Q1,2,F,20170727.0,20180320.0,20180327,20180330,EXP,,IT-BAXTER-2018BAX009300,BAXTER,,75.0,YR,,F,Y,69.3,KG,20180330.0,,MD,IT,IT,2018,Q1,Elderly
146837022,14683702,14,C,insulin lispro,INSULIN LISPRO,1,Unknown,(),,,U,,,,,,,,,2018,Q1,Renal impairment,,2018,Q1,2,F,20170727.0,20180320.0,20180327,20180330,EXP,,IT-BAXTER-2018BAX009300,BAXTER,,75.0,YR,,F,Y,69.3,KG,20180330.0,,MD,IT,IT,2018,Q1,Elderly
146837022,14683702,14,C,insulin lispro,INSULIN LISPRO,1,Unknown,(),,,U,,,,,,,,,2018,Q1,Sensory disturbance,,2018,Q1,2,F,20170727.0,20180320.0,20180327,20180330,EXP,,IT-BAXTER-2018BAX009300,BAXTER,,75.0,YR,,F,Y,69.3,KG,20180330.0,,MD,IT,IT,2018,Q1,Elderly
146837022,14683702,14,C,insulin lispro,INSULIN LISPRO,1,Unknown,(),,,U,,,,,,,,,2018,Q1,Skin lesion,,2018,Q1,2,F,20170727.0,20180320.0,20180327,20180330,EXP,,IT-BAXTER-2018BAX009300,BAXTER,,75.0,YR,,F,Y,69.3,KG,20180330.0,,MD,IT,IT,2018,Q1,Elderly
146837022,14683702,14,C,insulin lispro,INSULIN LISPRO,1,Unknown,(),,,U,,,,,,,,,2018,Q1,Urinary tract infection,,2018,Q1,2,F,20170727.0,20180320.0,20180327,20180330,EXP,,IT-BAXTER-2018BAX009300,BAXTER,,75.0,YR,,F,Y,69.3,KG,20180330.0,,MD,IT,IT,2018,Q1,Elderly
146837022,14683702,14,C,insulin lispro,INSULIN LISPRO,1,Unknown,(),,,U,,,,,,,,,2018,Q1,Vascular parkinsonism,,2018,Q1,2,F,20170727.0,20180320.0,20180327,20180330,EXP,,IT-BAXTER-2018BAX009300,BAXTER,,75.0,YR,,F,Y,69.3,KG,20180330.0,,MD,IT,IT,2018,Q1,Elderly
146837022,14683702,14,C,insulin lispro,INSULIN LISPRO,1,Unknown,(),,,U,,,,,,,,,2018,Q1,Weight decreased,,2018,Q1,2,F,20170727.0,20180320.0,20180327,20180330,EXP,,IT-BAXTER-2018BAX009300,BAXTER,,75.0,YR,,F,Y,69.3,KG,20180330.0,,MD,IT,IT,2018,Q1,Elderly
146864361,14686436,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2018,Q1,Blood creatinine increased,,2018,Q1,1,I,20170728.0,20180319.0,20180327,20180327,EXP,IT-NOVPHSZ-PHHY2018IT038221,IT-VALIDUS PHARMACEUTICALS LLC-IT-2018VAL000567,VALIDUS,,75.0,YR,,F,Y,,,20180327.0,,MD,IT,IT,2018,Q1,Elderly
146864361,14686436,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2018,Q1,Breath sounds abnormal,,2018,Q1,1,I,20170728.0,20180319.0,20180327,20180327,EXP,IT-NOVPHSZ-PHHY2018IT038221,IT-VALIDUS PHARMACEUTICALS LLC-IT-2018VAL000567,VALIDUS,,75.0,YR,,F,Y,,,20180327.0,,MD,IT,IT,2018,Q1,Elderly
146864361,14686436,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2018,Q1,Catarrh,,2018,Q1,1,I,20170728.0,20180319.0,20180327,20180327,EXP,IT-NOVPHSZ-PHHY2018IT038221,IT-VALIDUS PHARMACEUTICALS LLC-IT-2018VAL000567,VALIDUS,,75.0,YR,,F,Y,,,20180327.0,,MD,IT,IT,2018,Q1,Elderly
146864361,14686436,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2018,Q1,Cerebrovascular disorder,,2018,Q1,1,I,20170728.0,20180319.0,20180327,20180327,EXP,IT-NOVPHSZ-PHHY2018IT038221,IT-VALIDUS PHARMACEUTICALS LLC-IT-2018VAL000567,VALIDUS,,75.0,YR,,F,Y,,,20180327.0,,MD,IT,IT,2018,Q1,Elderly
146864361,14686436,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2018,Q1,Cough,,2018,Q1,1,I,20170728.0,20180319.0,20180327,20180327,EXP,IT-NOVPHSZ-PHHY2018IT038221,IT-VALIDUS PHARMACEUTICALS LLC-IT-2018VAL000567,VALIDUS,,75.0,YR,,F,Y,,,20180327.0,,MD,IT,IT,2018,Q1,Elderly
146864361,14686436,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2018,Q1,Dyspnoea,,2018,Q1,1,I,20170728.0,20180319.0,20180327,20180327,EXP,IT-NOVPHSZ-PHHY2018IT038221,IT-VALIDUS PHARMACEUTICALS LLC-IT-2018VAL000567,VALIDUS,,75.0,YR,,F,Y,,,20180327.0,,MD,IT,IT,2018,Q1,Elderly
146864361,14686436,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2018,Q1,Electrolyte imbalance,,2018,Q1,1,I,20170728.0,20180319.0,20180327,20180327,EXP,IT-NOVPHSZ-PHHY2018IT038221,IT-VALIDUS PHARMACEUTICALS LLC-IT-2018VAL000567,VALIDUS,,75.0,YR,,F,Y,,,20180327.0,,MD,IT,IT,2018,Q1,Elderly
146864361,14686436,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2018,Q1,Generalised oedema,,2018,Q1,1,I,20170728.0,20180319.0,20180327,20180327,EXP,IT-NOVPHSZ-PHHY2018IT038221,IT-VALIDUS PHARMACEUTICALS LLC-IT-2018VAL000567,VALIDUS,,75.0,YR,,F,Y,,,20180327.0,,MD,IT,IT,2018,Q1,Elderly
146864361,14686436,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2018,Q1,Iron deficiency,,2018,Q1,1,I,20170728.0,20180319.0,20180327,20180327,EXP,IT-NOVPHSZ-PHHY2018IT038221,IT-VALIDUS PHARMACEUTICALS LLC-IT-2018VAL000567,VALIDUS,,75.0,YR,,F,Y,,,20180327.0,,MD,IT,IT,2018,Q1,Elderly
146864361,14686436,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2018,Q1,Lymphangitis,,2018,Q1,1,I,20170728.0,20180319.0,20180327,20180327,EXP,IT-NOVPHSZ-PHHY2018IT038221,IT-VALIDUS PHARMACEUTICALS LLC-IT-2018VAL000567,VALIDUS,,75.0,YR,,F,Y,,,20180327.0,,MD,IT,IT,2018,Q1,Elderly
146864361,14686436,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2018,Q1,Pneumonia,,2018,Q1,1,I,20170728.0,20180319.0,20180327,20180327,EXP,IT-NOVPHSZ-PHHY2018IT038221,IT-VALIDUS PHARMACEUTICALS LLC-IT-2018VAL000567,VALIDUS,,75.0,YR,,F,Y,,,20180327.0,,MD,IT,IT,2018,Q1,Elderly
146864361,14686436,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2018,Q1,Pyrexia,,2018,Q1,1,I,20170728.0,20180319.0,20180327,20180327,EXP,IT-NOVPHSZ-PHHY2018IT038221,IT-VALIDUS PHARMACEUTICALS LLC-IT-2018VAL000567,VALIDUS,,75.0,YR,,F,Y,,,20180327.0,,MD,IT,IT,2018,Q1,Elderly
146864361,14686436,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2018,Q1,Renal impairment,,2018,Q1,1,I,20170728.0,20180319.0,20180327,20180327,EXP,IT-NOVPHSZ-PHHY2018IT038221,IT-VALIDUS PHARMACEUTICALS LLC-IT-2018VAL000567,VALIDUS,,75.0,YR,,F,Y,,,20180327.0,,MD,IT,IT,2018,Q1,Elderly
146864361,14686436,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2018,Q1,Sensory disturbance,,2018,Q1,1,I,20170728.0,20180319.0,20180327,20180327,EXP,IT-NOVPHSZ-PHHY2018IT038221,IT-VALIDUS PHARMACEUTICALS LLC-IT-2018VAL000567,VALIDUS,,75.0,YR,,F,Y,,,20180327.0,,MD,IT,IT,2018,Q1,Elderly
146864361,14686436,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2018,Q1,Skin lesion,,2018,Q1,1,I,20170728.0,20180319.0,20180327,20180327,EXP,IT-NOVPHSZ-PHHY2018IT038221,IT-VALIDUS PHARMACEUTICALS LLC-IT-2018VAL000567,VALIDUS,,75.0,YR,,F,Y,,,20180327.0,,MD,IT,IT,2018,Q1,Elderly
146864361,14686436,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2018,Q1,Urinary tract infection,,2018,Q1,1,I,20170728.0,20180319.0,20180327,20180327,EXP,IT-NOVPHSZ-PHHY2018IT038221,IT-VALIDUS PHARMACEUTICALS LLC-IT-2018VAL000567,VALIDUS,,75.0,YR,,F,Y,,,20180327.0,,MD,IT,IT,2018,Q1,Elderly
146864361,14686436,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2018,Q1,Vascular parkinsonism,,2018,Q1,1,I,20170728.0,20180319.0,20180327,20180327,EXP,IT-NOVPHSZ-PHHY2018IT038221,IT-VALIDUS PHARMACEUTICALS LLC-IT-2018VAL000567,VALIDUS,,75.0,YR,,F,Y,,,20180327.0,,MD,IT,IT,2018,Q1,Elderly
146864361,14686436,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2018,Q1,Weight decreased,,2018,Q1,1,I,20170728.0,20180319.0,20180327,20180327,EXP,IT-NOVPHSZ-PHHY2018IT038221,IT-VALIDUS PHARMACEUTICALS LLC-IT-2018VAL000567,VALIDUS,,75.0,YR,,F,Y,,,20180327.0,,MD,IT,IT,2018,Q1,Elderly
146944841,14694484,5,C,INSULIN LISPRO PROTAMINE/INSULIN LISPRO,,2,Subcutaneous,75%/25% MIXTURE SUBCUTANEOUSLY TWICE DAILY,,,,,,,,,,,BID,2018,Q1,Toxic encephalopathy,,2018,Q1,1,I,,20170404.0,20180329,20180329,PER,,CA--2017-CA-000006,VIVIMED LABS,"LILIAN LY. VIVAS MD, WAYNE L GOLD MD, DANIEL M. MANDELL MD, PETER E. WU MD.AN 82-YEAR-OLD MAN WITH ATAXIA AND DYSARTHRIA..CANADIAN MEDICAL ASSOCIATION JOURNAL.2016;188(17-18):1251-1254.",82.0,YR,E,M,Y,,,20180329.0,,OT,CA,CA,2018,Q1,Elderly
146954171,14695417,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q1,Drug-induced liver injury,,2018,Q1,1,I,,20180319.0,20180329,20180329,EXP,,US-TEVA-2018-US-874811,TEVA,"SAGVAND B, LINDENMEYER C, SUTTON R, ADHAMI T.",69.0,YR,,M,Y,,,20180329.0,,OT,US,US,2018,Q1,Elderly
146954171,14695417,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q1,Pseudohyponatraemia,,2018,Q1,1,I,,20180319.0,20180329,20180329,EXP,,US-TEVA-2018-US-874811,TEVA,"SAGVAND B, LINDENMEYER C, SUTTON R, ADHAMI T.",69.0,YR,,M,Y,,,20180329.0,,OT,US,US,2018,Q1,Elderly
146954171,14695417,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q1,Vanishing bile duct syndrome,,2018,Q1,1,I,,20180319.0,20180329,20180329,EXP,,US-TEVA-2018-US-874811,TEVA,"SAGVAND B, LINDENMEYER C, SUTTON R, ADHAMI T.",69.0,YR,,M,Y,,,20180329.0,,OT,US,US,2018,Q1,Elderly
146955561,14695556,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Haemoglobin decreased,,2018,Q1,1,I,20180102.0,,20180327,20180327,DIR,,,FDA-CTU,,79.0,YR,,M,N,,,20180125.0,N,PH,US,US,2018,Q1,Elderly
146955561,14695556,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q1,Procedural haemorrhage,,2018,Q1,1,I,20180102.0,,20180327,20180327,DIR,,,FDA-CTU,,79.0,YR,,M,N,,,20180125.0,N,PH,US,US,2018,Q1,Elderly
80128902,8012890,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,U,U, C728461D,,,,,INJECTION,,2018,Q1,Blindness,,2018,Q1,2,F,1980.0,20171228.0,20110628,20180109,EXP,,US-ELI_LILLY_AND_COMPANY-US201106006006,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20180109.0,,CN,US,US,2018,Q1,Elderly
80128902,8012890,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,U,U, C728461D,,,,,INJECTION,,2018,Q1,Macular degeneration,,2018,Q1,2,F,1980.0,20171228.0,20110628,20180109,EXP,,US-ELI_LILLY_AND_COMPANY-US201106006006,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20180109.0,,CN,US,US,2018,Q1,Elderly
80128902,8012890,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,U,U, C728461D,,,,,INJECTION,,2018,Q1,Visual impairment,,2018,Q1,2,F,1980.0,20171228.0,20110628,20180109,EXP,,US-ELI_LILLY_AND_COMPANY-US201106006006,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20180109.0,,CN,US,US,2018,Q1,Elderly
101208654,10120865,6,SS,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,THRICE-A-DAY,,,Y,U, UNKNOWN,,,,,,,2018,Q2,Alcoholic pancreatitis,,2018,Q2,4,F,201010.0,20180416.0,20140425,20180429,EXP,,JP-NOVOPROD-407313,NOVO NORDISK,"HOTAKA YAMADA, ET.AL. A CASE OF A PATIENT WITH TYPE 2 DIABETES WHERE DIABETIC KETOACIDOSIS CAUSED BY HIGH TITER OF ANTI-INSULIN ANTIBODIES DURING INSULIN THERAPY. THE 87TH ANNUAL MEETING OF THE JAPAN ENDOCRINE SOCIETY.",82.0,YR,E,M,Y,56.0,KG,20180430.0,,MD,JP,JP,2018,Q2,Elderly
101208654,10120865,6,SS,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,THRICE-A-DAY,,,Y,U, UNKNOWN,,,,,,,2018,Q2,Anti-insulin antibody positive,,2018,Q2,4,F,201010.0,20180416.0,20140425,20180429,EXP,,JP-NOVOPROD-407313,NOVO NORDISK,"HOTAKA YAMADA, ET.AL. A CASE OF A PATIENT WITH TYPE 2 DIABETES WHERE DIABETIC KETOACIDOSIS CAUSED BY HIGH TITER OF ANTI-INSULIN ANTIBODIES DURING INSULIN THERAPY. THE 87TH ANNUAL MEETING OF THE JAPAN ENDOCRINE SOCIETY.",82.0,YR,E,M,Y,56.0,KG,20180430.0,,MD,JP,JP,2018,Q2,Elderly
101208654,10120865,6,SS,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,THRICE-A-DAY,,,Y,U, UNKNOWN,,,,,,,2018,Q2,Diabetes mellitus inadequate control,,2018,Q2,4,F,201010.0,20180416.0,20140425,20180429,EXP,,JP-NOVOPROD-407313,NOVO NORDISK,"HOTAKA YAMADA, ET.AL. A CASE OF A PATIENT WITH TYPE 2 DIABETES WHERE DIABETIC KETOACIDOSIS CAUSED BY HIGH TITER OF ANTI-INSULIN ANTIBODIES DURING INSULIN THERAPY. THE 87TH ANNUAL MEETING OF THE JAPAN ENDOCRINE SOCIETY.",82.0,YR,E,M,Y,56.0,KG,20180430.0,,MD,JP,JP,2018,Q2,Elderly
101208654,10120865,6,SS,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,THRICE-A-DAY,,,Y,U, UNKNOWN,,,,,,,2018,Q2,Diabetic ketoacidosis,,2018,Q2,4,F,201010.0,20180416.0,20140425,20180429,EXP,,JP-NOVOPROD-407313,NOVO NORDISK,"HOTAKA YAMADA, ET.AL. A CASE OF A PATIENT WITH TYPE 2 DIABETES WHERE DIABETIC KETOACIDOSIS CAUSED BY HIGH TITER OF ANTI-INSULIN ANTIBODIES DURING INSULIN THERAPY. THE 87TH ANNUAL MEETING OF THE JAPAN ENDOCRINE SOCIETY.",82.0,YR,E,M,Y,56.0,KG,20180430.0,,MD,JP,JP,2018,Q2,Elderly
101208654,10120865,7,SS,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,48-0-32 UNITS (TWICE DAILY),,,Y,U, UNKNOWN,,,,,,,2018,Q2,Alcoholic pancreatitis,,2018,Q2,4,F,201010.0,20180416.0,20140425,20180429,EXP,,JP-NOVOPROD-407313,NOVO NORDISK,"HOTAKA YAMADA, ET.AL. A CASE OF A PATIENT WITH TYPE 2 DIABETES WHERE DIABETIC KETOACIDOSIS CAUSED BY HIGH TITER OF ANTI-INSULIN ANTIBODIES DURING INSULIN THERAPY. THE 87TH ANNUAL MEETING OF THE JAPAN ENDOCRINE SOCIETY.",82.0,YR,E,M,Y,56.0,KG,20180430.0,,MD,JP,JP,2018,Q2,Elderly
101208654,10120865,7,SS,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,48-0-32 UNITS (TWICE DAILY),,,Y,U, UNKNOWN,,,,,,,2018,Q2,Anti-insulin antibody positive,,2018,Q2,4,F,201010.0,20180416.0,20140425,20180429,EXP,,JP-NOVOPROD-407313,NOVO NORDISK,"HOTAKA YAMADA, ET.AL. A CASE OF A PATIENT WITH TYPE 2 DIABETES WHERE DIABETIC KETOACIDOSIS CAUSED BY HIGH TITER OF ANTI-INSULIN ANTIBODIES DURING INSULIN THERAPY. THE 87TH ANNUAL MEETING OF THE JAPAN ENDOCRINE SOCIETY.",82.0,YR,E,M,Y,56.0,KG,20180430.0,,MD,JP,JP,2018,Q2,Elderly
101208654,10120865,7,SS,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,48-0-32 UNITS (TWICE DAILY),,,Y,U, UNKNOWN,,,,,,,2018,Q2,Diabetes mellitus inadequate control,,2018,Q2,4,F,201010.0,20180416.0,20140425,20180429,EXP,,JP-NOVOPROD-407313,NOVO NORDISK,"HOTAKA YAMADA, ET.AL. A CASE OF A PATIENT WITH TYPE 2 DIABETES WHERE DIABETIC KETOACIDOSIS CAUSED BY HIGH TITER OF ANTI-INSULIN ANTIBODIES DURING INSULIN THERAPY. THE 87TH ANNUAL MEETING OF THE JAPAN ENDOCRINE SOCIETY.",82.0,YR,E,M,Y,56.0,KG,20180430.0,,MD,JP,JP,2018,Q2,Elderly
101208654,10120865,7,SS,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,48-0-32 UNITS (TWICE DAILY),,,Y,U, UNKNOWN,,,,,,,2018,Q2,Diabetic ketoacidosis,,2018,Q2,4,F,201010.0,20180416.0,20140425,20180429,EXP,,JP-NOVOPROD-407313,NOVO NORDISK,"HOTAKA YAMADA, ET.AL. A CASE OF A PATIENT WITH TYPE 2 DIABETES WHERE DIABETIC KETOACIDOSIS CAUSED BY HIGH TITER OF ANTI-INSULIN ANTIBODIES DURING INSULIN THERAPY. THE 87TH ANNUAL MEETING OF THE JAPAN ENDOCRINE SOCIETY.",82.0,YR,E,M,Y,56.0,KG,20180430.0,,MD,JP,JP,2018,Q2,Elderly
101208654,10120865,8,SS,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"38 U, QD BEFORE BREAKFAST 30 U AND DINNER 8 U",,,Y,U, UNKNOWN,,,38.0,DF,,QD,2018,Q2,Alcoholic pancreatitis,,2018,Q2,4,F,201010.0,20180416.0,20140425,20180429,EXP,,JP-NOVOPROD-407313,NOVO NORDISK,"HOTAKA YAMADA, ET.AL. A CASE OF A PATIENT WITH TYPE 2 DIABETES WHERE DIABETIC KETOACIDOSIS CAUSED BY HIGH TITER OF ANTI-INSULIN ANTIBODIES DURING INSULIN THERAPY. THE 87TH ANNUAL MEETING OF THE JAPAN ENDOCRINE SOCIETY.",82.0,YR,E,M,Y,56.0,KG,20180430.0,,MD,JP,JP,2018,Q2,Elderly
101208654,10120865,8,SS,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"38 U, QD BEFORE BREAKFAST 30 U AND DINNER 8 U",,,Y,U, UNKNOWN,,,38.0,DF,,QD,2018,Q2,Anti-insulin antibody positive,,2018,Q2,4,F,201010.0,20180416.0,20140425,20180429,EXP,,JP-NOVOPROD-407313,NOVO NORDISK,"HOTAKA YAMADA, ET.AL. A CASE OF A PATIENT WITH TYPE 2 DIABETES WHERE DIABETIC KETOACIDOSIS CAUSED BY HIGH TITER OF ANTI-INSULIN ANTIBODIES DURING INSULIN THERAPY. THE 87TH ANNUAL MEETING OF THE JAPAN ENDOCRINE SOCIETY.",82.0,YR,E,M,Y,56.0,KG,20180430.0,,MD,JP,JP,2018,Q2,Elderly
101208654,10120865,8,SS,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"38 U, QD BEFORE BREAKFAST 30 U AND DINNER 8 U",,,Y,U, UNKNOWN,,,38.0,DF,,QD,2018,Q2,Diabetes mellitus inadequate control,,2018,Q2,4,F,201010.0,20180416.0,20140425,20180429,EXP,,JP-NOVOPROD-407313,NOVO NORDISK,"HOTAKA YAMADA, ET.AL. A CASE OF A PATIENT WITH TYPE 2 DIABETES WHERE DIABETIC KETOACIDOSIS CAUSED BY HIGH TITER OF ANTI-INSULIN ANTIBODIES DURING INSULIN THERAPY. THE 87TH ANNUAL MEETING OF THE JAPAN ENDOCRINE SOCIETY.",82.0,YR,E,M,Y,56.0,KG,20180430.0,,MD,JP,JP,2018,Q2,Elderly
101208654,10120865,8,SS,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"38 U, QD BEFORE BREAKFAST 30 U AND DINNER 8 U",,,Y,U, UNKNOWN,,,38.0,DF,,QD,2018,Q2,Diabetic ketoacidosis,,2018,Q2,4,F,201010.0,20180416.0,20140425,20180429,EXP,,JP-NOVOPROD-407313,NOVO NORDISK,"HOTAKA YAMADA, ET.AL. A CASE OF A PATIENT WITH TYPE 2 DIABETES WHERE DIABETIC KETOACIDOSIS CAUSED BY HIGH TITER OF ANTI-INSULIN ANTIBODIES DURING INSULIN THERAPY. THE 87TH ANNUAL MEETING OF THE JAPAN ENDOCRINE SOCIETY.",82.0,YR,E,M,Y,56.0,KG,20180430.0,,MD,JP,JP,2018,Q2,Elderly
115148014,11514801,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,DOSE PER APPLICATION: 0-9 UNITS,,,,,,,,,,,TID,2018,Q2,Diabetic ketoacidosis,,2018,Q2,4,F,20150904.0,20180501.0,20150916,20180503,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2015-BI-49967BP",BOEHRINGER INGELHEIM,,46.0,YR,,F,Y,72.12,KG,20180503.0,,OT,US,US,2018,Q2,Adult
115764574,11576457,21,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,Y,U,,,,,,,,2018,Q2,Renal impairment,,2018,Q2,4,F,20150906.0,20180516.0,20150930,20180523,PER,,US-ALEXION-A201503798,ALEXION,,21.0,YR,,F,Y,,,20180523.0,,OT,US,US,2018,Q2,Youth
115764574,11576457,21,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,Y,U,,,,,,,,2018,Q2,Thrombotic microangiopathy,,2018,Q2,4,F,20150906.0,20180516.0,20150930,20180523,PER,,US-ALEXION-A201503798,ALEXION,,21.0,YR,,F,Y,,,20180523.0,,OT,US,US,2018,Q2,Youth
1296291712,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2018,Q2,Acute respiratory failure,,2018,Q2,12,F,20160826.0,20180602.0,20161122,20180608,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180608.0,,MD,US,US,2018,Q2,Elderly
1296291712,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2018,Q2,Fluid overload,,2018,Q2,12,F,20160826.0,20180602.0,20161122,20180608,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180608.0,,MD,US,US,2018,Q2,Elderly
1296291712,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2018,Q2,Haemoptysis,,2018,Q2,12,F,20160826.0,20180602.0,20161122,20180608,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180608.0,,MD,US,US,2018,Q2,Elderly
1296291712,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2018,Q2,Hyperkalaemia,,2018,Q2,12,F,20160826.0,20180602.0,20161122,20180608,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180608.0,,MD,US,US,2018,Q2,Elderly
1296291712,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2018,Q2,Iron deficiency anaemia,,2018,Q2,12,F,20160826.0,20180602.0,20161122,20180608,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180608.0,,MD,US,US,2018,Q2,Elderly
1296291712,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2018,Q2,Pleural effusion,,2018,Q2,12,F,20160826.0,20180602.0,20161122,20180608,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180608.0,,MD,US,US,2018,Q2,Elderly
1296291712,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2018,Q2,Pneumonia,,2018,Q2,12,F,20160826.0,20180602.0,20161122,20180608,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180608.0,,MD,US,US,2018,Q2,Elderly
1296291712,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2018,Q2,Pulmonary oedema,,2018,Q2,12,F,20160826.0,20180602.0,20161122,20180608,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180608.0,,MD,US,US,2018,Q2,Elderly
1296291712,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2018,Q2,Sepsis,,2018,Q2,12,F,20160826.0,20180602.0,20161122,20180608,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180608.0,,MD,US,US,2018,Q2,Elderly
1296291712,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2018,Q2,Tumour lysis syndrome,,2018,Q2,12,F,20160826.0,20180602.0,20161122,20180608,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180608.0,,MD,US,US,2018,Q2,Elderly
1296291712,12962917,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2018,Q2,Acute respiratory failure,,2018,Q2,12,F,20160826.0,20180602.0,20161122,20180608,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180608.0,,MD,US,US,2018,Q2,Elderly
1296291712,12962917,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2018,Q2,Fluid overload,,2018,Q2,12,F,20160826.0,20180602.0,20161122,20180608,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180608.0,,MD,US,US,2018,Q2,Elderly
1296291712,12962917,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2018,Q2,Haemoptysis,,2018,Q2,12,F,20160826.0,20180602.0,20161122,20180608,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180608.0,,MD,US,US,2018,Q2,Elderly
1296291712,12962917,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2018,Q2,Hyperkalaemia,,2018,Q2,12,F,20160826.0,20180602.0,20161122,20180608,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180608.0,,MD,US,US,2018,Q2,Elderly
1296291712,12962917,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2018,Q2,Iron deficiency anaemia,,2018,Q2,12,F,20160826.0,20180602.0,20161122,20180608,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180608.0,,MD,US,US,2018,Q2,Elderly
1296291712,12962917,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2018,Q2,Pleural effusion,,2018,Q2,12,F,20160826.0,20180602.0,20161122,20180608,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180608.0,,MD,US,US,2018,Q2,Elderly
1296291712,12962917,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2018,Q2,Pneumonia,,2018,Q2,12,F,20160826.0,20180602.0,20161122,20180608,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180608.0,,MD,US,US,2018,Q2,Elderly
1296291712,12962917,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2018,Q2,Pulmonary oedema,,2018,Q2,12,F,20160826.0,20180602.0,20161122,20180608,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180608.0,,MD,US,US,2018,Q2,Elderly
1296291712,12962917,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2018,Q2,Sepsis,,2018,Q2,12,F,20160826.0,20180602.0,20161122,20180608,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180608.0,,MD,US,US,2018,Q2,Elderly
1296291712,12962917,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2018,Q2,Tumour lysis syndrome,,2018,Q2,12,F,20160826.0,20180602.0,20161122,20180608,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180608.0,,MD,US,US,2018,Q2,Elderly
129689133,12968913,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,,,INJECTION,,2018,Q2,Blood creatine phosphokinase increased,,2018,Q2,3,F,20160824.0,20180430.0,20161123,20180503,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-097628,BRISTOL MYERS SQUIBB,,53.0,YR,,M,Y,124.7,KG,20180503.0,,MD,US,US,2018,Q2,Adult
129689133,12968913,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,,,INJECTION,,2018,Q2,Hypersensitivity,,2018,Q2,3,F,20160824.0,20180430.0,20161123,20180503,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-097628,BRISTOL MYERS SQUIBB,,53.0,YR,,M,Y,124.7,KG,20180503.0,,MD,US,US,2018,Q2,Adult
1321425112,13214251,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q2,Hepatotoxicity,,2018,Q2,12,F,20170122.0,20180613.0,20170210,20180615,EXP,,US-ROCHE-1891552,ROCHE,,58.0,YR,,F,Y,58.3,KG,20180615.0,,MD,US,US,2018,Q2,Adult
1321425112,13214251,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q2,Pneumonitis,,2018,Q2,12,F,20170122.0,20180613.0,20170210,20180615,EXP,,US-ROCHE-1891552,ROCHE,,58.0,YR,,F,Y,58.3,KG,20180615.0,,MD,US,US,2018,Q2,Adult
1325990912,13259909,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"30 DF, UNK",,,,,,,,30.0,DF,INJECTION,,2018,Q2,Cholecystitis,,2018,Q2,12,F,20170212.0,20180517.0,20170222,20180525,EXP,,US-PFIZER INC-2017075056,PFIZER,,70.0,YR,,M,Y,111.9,KG,20180525.0,,MD,US,US,2018,Q2,Elderly
133516892,13351689,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, 1X/DAY (22 UNITS INJECTABLES, ONCE DAILY IN THE EVENING)",,,,,,,,,,INJECTION,QD,2018,Q2,Chromaturia,,2018,Q2,2,F,201612.0,20180531.0,20170320,20180605,EXP,,US-PFIZER INC-2017113498,PFIZER,,61.0,YR,,M,Y,82.55,KG,20180605.0,,CN,US,US,2018,Q2,Adult
133516892,13351689,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, 1X/DAY (22 UNITS INJECTABLES, ONCE DAILY IN THE EVENING)",,,,,,,,,,INJECTION,QD,2018,Q2,Memory impairment,,2018,Q2,2,F,201612.0,20180531.0,20170320,20180605,EXP,,US-PFIZER INC-2017113498,PFIZER,,61.0,YR,,M,Y,82.55,KG,20180605.0,,CN,US,US,2018,Q2,Adult
133516892,13351689,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, 1X/DAY (22 UNITS INJECTABLES, ONCE DAILY IN THE EVENING)",,,,,,,,,,INJECTION,QD,2018,Q2,Weight increased,,2018,Q2,2,F,201612.0,20180531.0,20170320,20180605,EXP,,US-PFIZER INC-2017113498,PFIZER,,61.0,YR,,M,Y,82.55,KG,20180605.0,,CN,US,US,2018,Q2,Adult
134266777,13426677,13,C,Lispro Insulin,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2018,Q2,Hypercalcaemia,,2018,Q2,7,F,20170329.0,20180522.0,20170411,20180601,EXP,,JP-CELGENEUS-JPN-20170401659,CELGENE,,68.0,YR,,M,Y,,,20180601.0,,MD,JP,JP,2018,Q2,Elderly
135564352,13556435,7,C,LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q2,Blood glucose increased,,2018,Q2,2,F,20170303.0,20170810.0,20170517,20180515,PER,,US-SA-2017SA041034,AVENTIS,,39.0,YR,A,F,Y,117.0,KG,20180515.0,,CN,US,US,2018,Q2,Adult
135721153,13572115,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",36540.0,DF,Y,U,,,,30.0,DF,,TID,2018,Q2,Encephalopathy,,2018,Q2,3,F,20170503.0,20180417.0,20170523,20180426,EXP,,PHHO2017US008155,NOVARTIS,,66.0,YR,,F,Y,73.7,KG,20180426.0,,OT,US,US,2018,Q2,Elderly
135721153,13572115,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",36540.0,DF,Y,U,,,,30.0,DF,,TID,2018,Q2,Infectious colitis,,2018,Q2,3,F,20170503.0,20180417.0,20170523,20180426,EXP,,PHHO2017US008155,NOVARTIS,,66.0,YR,,F,Y,73.7,KG,20180426.0,,OT,US,US,2018,Q2,Elderly
135721153,13572115,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",36540.0,DF,Y,U,,,,30.0,DF,,TID,2018,Q2,Viral infection,,2018,Q2,3,F,20170503.0,20180417.0,20170523,20180426,EXP,,PHHO2017US008155,NOVARTIS,,66.0,YR,,F,Y,73.7,KG,20180426.0,,OT,US,US,2018,Q2,Elderly
138293493,13829349,13,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q2,Infusion site discharge,,2018,Q2,3,F,,20180530.0,20170803,20180606,EXP,,CA-PFIZER INC-2017332361,PFIZER,,53.0,YR,,F,Y,48.0,KG,20180606.0,,PH,CA,CA,2018,Q2,Adult
138293493,13829349,13,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q2,Infusion site erythema,,2018,Q2,3,F,,20180530.0,20170803,20180606,EXP,,CA-PFIZER INC-2017332361,PFIZER,,53.0,YR,,F,Y,48.0,KG,20180606.0,,PH,CA,CA,2018,Q2,Adult
138293493,13829349,13,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q2,Neutrophil count decreased,,2018,Q2,3,F,,20180530.0,20170803,20180606,EXP,,CA-PFIZER INC-2017332361,PFIZER,,53.0,YR,,F,Y,48.0,KG,20180606.0,,PH,CA,CA,2018,Q2,Adult
138473864,13847386,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),,,,D,, UNKNOWN,,,,,INJECTION,,2018,Q2,Asthenia,,2018,Q2,4,F,20170624.0,20180528.0,20170808,20180605,EXP,IT-MINISAL02-420982,IT-MYLANLABS-2017M1047809,MYLAN,,73.0,YR,,M,Y,,,20180601.0,,MD,IT,IT,2018,Q2,Elderly
138473864,13847386,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),,,,D,, UNKNOWN,,,,,INJECTION,,2018,Q2,Bradycardia,,2018,Q2,4,F,20170624.0,20180528.0,20170808,20180605,EXP,IT-MINISAL02-420982,IT-MYLANLABS-2017M1047809,MYLAN,,73.0,YR,,M,Y,,,20180601.0,,MD,IT,IT,2018,Q2,Elderly
138473864,13847386,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),,,,D,, UNKNOWN,,,,,INJECTION,,2018,Q2,Hypotension,,2018,Q2,4,F,20170624.0,20180528.0,20170808,20180605,EXP,IT-MINISAL02-420982,IT-MYLANLABS-2017M1047809,MYLAN,,73.0,YR,,M,Y,,,20180601.0,,MD,IT,IT,2018,Q2,Elderly
138557952,13855795,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Angina unstable,,2018,Q2,2,F,20160313.0,20180404.0,20170810,20180404,EXP,,US-EISAI MEDICAL RESEARCH-EC-2016-015280,EISAI,,67.0,YR,,M,Y,95.8,KG,20180404.0,,MD,US,US,2018,Q2,Elderly
138557952,13855795,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Coronary artery disease,,2018,Q2,2,F,20160313.0,20180404.0,20170810,20180404,EXP,,US-EISAI MEDICAL RESEARCH-EC-2016-015280,EISAI,,67.0,YR,,M,Y,95.8,KG,20180404.0,,MD,US,US,2018,Q2,Elderly
139032257,13903225,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,U,U,,,,,,,,2018,Q2,Arthralgia,,2018,Q2,7,F,,20180207.0,20170824,20180422,EXP,,CA-APOTEX-2017AP016919,APOTEX,,62.0,YR,,M,Y,,,20180222.0,,CN,CA,CA,2018,Q2,Adult
139032257,13903225,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,U,U,,,,,,,,2018,Q2,Drug ineffective,,2018,Q2,7,F,,20180207.0,20170824,20180422,EXP,,CA-APOTEX-2017AP016919,APOTEX,,62.0,YR,,M,Y,,,20180222.0,,CN,CA,CA,2018,Q2,Adult
139032257,13903225,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,U,U,,,,,,,,2018,Q2,Gait disturbance,,2018,Q2,7,F,,20180207.0,20170824,20180422,EXP,,CA-APOTEX-2017AP016919,APOTEX,,62.0,YR,,M,Y,,,20180222.0,,CN,CA,CA,2018,Q2,Adult
139032257,13903225,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,U,U,,,,,,,,2018,Q2,Hepatic enzyme increased,,2018,Q2,7,F,,20180207.0,20170824,20180422,EXP,,CA-APOTEX-2017AP016919,APOTEX,,62.0,YR,,M,Y,,,20180222.0,,CN,CA,CA,2018,Q2,Adult
139032257,13903225,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,U,U,,,,,,,,2018,Q2,Musculoskeletal stiffness,,2018,Q2,7,F,,20180207.0,20170824,20180422,EXP,,CA-APOTEX-2017AP016919,APOTEX,,62.0,YR,,M,Y,,,20180222.0,,CN,CA,CA,2018,Q2,Adult
139032257,13903225,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,U,U,,,,,,,,2018,Q2,Oedema peripheral,,2018,Q2,7,F,,20180207.0,20170824,20180422,EXP,,CA-APOTEX-2017AP016919,APOTEX,,62.0,YR,,M,Y,,,20180222.0,,CN,CA,CA,2018,Q2,Adult
139032257,13903225,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,U,U,,,,,,,,2018,Q2,Pain in extremity,,2018,Q2,7,F,,20180207.0,20170824,20180422,EXP,,CA-APOTEX-2017AP016919,APOTEX,,62.0,YR,,M,Y,,,20180222.0,,CN,CA,CA,2018,Q2,Adult
139032257,13903225,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,U,U,,,,,,,,2018,Q2,Peripheral swelling,,2018,Q2,7,F,,20180207.0,20170824,20180422,EXP,,CA-APOTEX-2017AP016919,APOTEX,,62.0,YR,,M,Y,,,20180222.0,,CN,CA,CA,2018,Q2,Adult
139032257,13903225,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,U,U,,,,,,,,2018,Q2,Pharyngitis,,2018,Q2,7,F,,20180207.0,20170824,20180422,EXP,,CA-APOTEX-2017AP016919,APOTEX,,62.0,YR,,M,Y,,,20180222.0,,CN,CA,CA,2018,Q2,Adult
139032257,13903225,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,U,U,,,,,,,,2018,Q2,Poor venous access,,2018,Q2,7,F,,20180207.0,20170824,20180422,EXP,,CA-APOTEX-2017AP016919,APOTEX,,62.0,YR,,M,Y,,,20180222.0,,CN,CA,CA,2018,Q2,Adult
139032257,13903225,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,U,U,,,,,,,,2018,Q2,Pruritus,,2018,Q2,7,F,,20180207.0,20170824,20180422,EXP,,CA-APOTEX-2017AP016919,APOTEX,,62.0,YR,,M,Y,,,20180222.0,,CN,CA,CA,2018,Q2,Adult
139032257,13903225,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,U,U,,,,,,,,2018,Q2,Swelling,,2018,Q2,7,F,,20180207.0,20170824,20180422,EXP,,CA-APOTEX-2017AP016919,APOTEX,,62.0,YR,,M,Y,,,20180222.0,,CN,CA,CA,2018,Q2,Adult
139032257,13903225,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,U,U,,,,,,,,2018,Q2,Therapeutic response decreased,,2018,Q2,7,F,,20180207.0,20170824,20180422,EXP,,CA-APOTEX-2017AP016919,APOTEX,,62.0,YR,,M,Y,,,20180222.0,,CN,CA,CA,2018,Q2,Adult
139032257,13903225,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,U,U,,,,,,,,2018,Q2,Tremor,,2018,Q2,7,F,,20180207.0,20170824,20180422,EXP,,CA-APOTEX-2017AP016919,APOTEX,,62.0,YR,,M,Y,,,20180222.0,,CN,CA,CA,2018,Q2,Adult
139032257,13903225,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,U,U,,,,,,,,2018,Q2,Vomiting,,2018,Q2,7,F,,20180207.0,20170824,20180422,EXP,,CA-APOTEX-2017AP016919,APOTEX,,62.0,YR,,M,Y,,,20180222.0,,CN,CA,CA,2018,Q2,Adult
140088873,14008887,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q2,Pemphigoid,,2018,Q2,3,F,20170829.0,20180614.0,20170925,20180625,EXP,,US-ASTRAZENECA-2017SE94779,ASTRAZENECA,,24323.0,DY,,F,Y,49.2,KG,20180625.0,,MD,US,US,2018,Q2,Elderly
140088873,14008887,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q2,Pemphigoid,,2018,Q2,3,F,20170829.0,20180614.0,20170925,20180625,EXP,,US-ASTRAZENECA-2017SE94779,ASTRAZENECA,,24323.0,DY,,F,Y,49.2,KG,20180625.0,,MD,US,US,2018,Q2,Elderly
140172034,14017203,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 U, PRN",,,Y,,,,,100.0,DF,,,2018,Q2,Balance disorder,,2018,Q2,4,F,20170919.0,20180515.0,20170927,20180523,EXP,,PHHY2017US139531,NOVARTIS,,68.0,YR,,F,Y,55.8,KG,20180523.0,,MD,US,US,2018,Q2,Elderly
140172034,14017203,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 U, PRN",,,Y,,,,,100.0,DF,,,2018,Q2,Bundle branch block right,,2018,Q2,4,F,20170919.0,20180515.0,20170927,20180523,EXP,,PHHY2017US139531,NOVARTIS,,68.0,YR,,F,Y,55.8,KG,20180523.0,,MD,US,US,2018,Q2,Elderly
140172034,14017203,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 U, PRN",,,Y,,,,,100.0,DF,,,2018,Q2,Demyelination,,2018,Q2,4,F,20170919.0,20180515.0,20170927,20180523,EXP,,PHHY2017US139531,NOVARTIS,,68.0,YR,,F,Y,55.8,KG,20180523.0,,MD,US,US,2018,Q2,Elderly
140172034,14017203,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 U, PRN",,,Y,,,,,100.0,DF,,,2018,Q2,Loss of consciousness,,2018,Q2,4,F,20170919.0,20180515.0,20170927,20180523,EXP,,PHHY2017US139531,NOVARTIS,,68.0,YR,,F,Y,55.8,KG,20180523.0,,MD,US,US,2018,Q2,Elderly
140172034,14017203,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 U, PRN",,,Y,,,,,100.0,DF,,,2018,Q2,Lymphocyte count decreased,,2018,Q2,4,F,20170919.0,20180515.0,20170927,20180523,EXP,,PHHY2017US139531,NOVARTIS,,68.0,YR,,F,Y,55.8,KG,20180523.0,,MD,US,US,2018,Q2,Elderly
140172034,14017203,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 U, PRN",,,Y,,,,,100.0,DF,,,2018,Q2,Malignant melanoma in situ,,2018,Q2,4,F,20170919.0,20180515.0,20170927,20180523,EXP,,PHHY2017US139531,NOVARTIS,,68.0,YR,,F,Y,55.8,KG,20180523.0,,MD,US,US,2018,Q2,Elderly
140172034,14017203,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 U, PRN",,,Y,,,,,100.0,DF,,,2018,Q2,Syncope,,2018,Q2,4,F,20170919.0,20180515.0,20170927,20180523,EXP,,PHHY2017US139531,NOVARTIS,,68.0,YR,,F,Y,55.8,KG,20180523.0,,MD,US,US,2018,Q2,Elderly
140172034,14017203,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 U, PRN",,,Y,,,,,100.0,DF,,,2018,Q2,White blood cell count decreased,,2018,Q2,4,F,20170919.0,20180515.0,20170927,20180523,EXP,,PHHY2017US139531,NOVARTIS,,68.0,YR,,F,Y,55.8,KG,20180523.0,,MD,US,US,2018,Q2,Elderly
141581855,14158185,11,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,,,,UNKNOWN,,2018,Q2,Hepatic encephalopathy,,2018,Q2,5,F,20171022.0,20180413.0,20171103,20180420,EXP,,US-CELGENEUS-USA-20171100230,CELGENE,,81.0,YR,,M,Y,80.0,KG,20180420.0,,OT,US,US,2018,Q2,Elderly
141664797,14166479,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, UNK",,,U,,,,,1.0,DF,,,2018,Q2,Anaemia,,2018,Q2,7,F,20170704.0,20171114.0,20171107,20180503,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-076832,BRISTOL MYERS SQUIBB,,65.0,YR,,M,Y,,,20180503.0,,OT,DE,DE,2018,Q2,Elderly
141664797,14166479,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, UNK",,,U,,,,,1.0,DF,,,2018,Q2,Bronchitis,,2018,Q2,7,F,20170704.0,20171114.0,20171107,20180503,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-076832,BRISTOL MYERS SQUIBB,,65.0,YR,,M,Y,,,20180503.0,,OT,DE,DE,2018,Q2,Elderly
141664797,14166479,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, UNK",,,U,,,,,1.0,DF,,,2018,Q2,Cough,,2018,Q2,7,F,20170704.0,20171114.0,20171107,20180503,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-076832,BRISTOL MYERS SQUIBB,,65.0,YR,,M,Y,,,20180503.0,,OT,DE,DE,2018,Q2,Elderly
141664797,14166479,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, UNK",,,U,,,,,1.0,DF,,,2018,Q2,Dizziness,,2018,Q2,7,F,20170704.0,20171114.0,20171107,20180503,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-076832,BRISTOL MYERS SQUIBB,,65.0,YR,,M,Y,,,20180503.0,,OT,DE,DE,2018,Q2,Elderly
141664797,14166479,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, UNK",,,U,,,,,1.0,DF,,,2018,Q2,Epistaxis,,2018,Q2,7,F,20170704.0,20171114.0,20171107,20180503,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-076832,BRISTOL MYERS SQUIBB,,65.0,YR,,M,Y,,,20180503.0,,OT,DE,DE,2018,Q2,Elderly
141664797,14166479,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, UNK",,,U,,,,,1.0,DF,,,2018,Q2,Fall,,2018,Q2,7,F,20170704.0,20171114.0,20171107,20180503,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-076832,BRISTOL MYERS SQUIBB,,65.0,YR,,M,Y,,,20180503.0,,OT,DE,DE,2018,Q2,Elderly
141664797,14166479,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, UNK",,,U,,,,,1.0,DF,,,2018,Q2,Fatigue,,2018,Q2,7,F,20170704.0,20171114.0,20171107,20180503,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-076832,BRISTOL MYERS SQUIBB,,65.0,YR,,M,Y,,,20180503.0,,OT,DE,DE,2018,Q2,Elderly
141664797,14166479,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, UNK",,,U,,,,,1.0,DF,,,2018,Q2,General physical health deterioration,,2018,Q2,7,F,20170704.0,20171114.0,20171107,20180503,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-076832,BRISTOL MYERS SQUIBB,,65.0,YR,,M,Y,,,20180503.0,,OT,DE,DE,2018,Q2,Elderly
141664797,14166479,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, UNK",,,U,,,,,1.0,DF,,,2018,Q2,Headache,,2018,Q2,7,F,20170704.0,20171114.0,20171107,20180503,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-076832,BRISTOL MYERS SQUIBB,,65.0,YR,,M,Y,,,20180503.0,,OT,DE,DE,2018,Q2,Elderly
141664797,14166479,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, UNK",,,U,,,,,1.0,DF,,,2018,Q2,Hyperthyroidism,,2018,Q2,7,F,20170704.0,20171114.0,20171107,20180503,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-076832,BRISTOL MYERS SQUIBB,,65.0,YR,,M,Y,,,20180503.0,,OT,DE,DE,2018,Q2,Elderly
141664797,14166479,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, UNK",,,U,,,,,1.0,DF,,,2018,Q2,Hypothyroidism,,2018,Q2,7,F,20170704.0,20171114.0,20171107,20180503,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-076832,BRISTOL MYERS SQUIBB,,65.0,YR,,M,Y,,,20180503.0,,OT,DE,DE,2018,Q2,Elderly
141664797,14166479,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, UNK",,,U,,,,,1.0,DF,,,2018,Q2,Pyrexia,,2018,Q2,7,F,20170704.0,20171114.0,20171107,20180503,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-076832,BRISTOL MYERS SQUIBB,,65.0,YR,,M,Y,,,20180503.0,,OT,DE,DE,2018,Q2,Elderly
141664797,14166479,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, UNK",,,U,,,,,1.0,DF,,,2018,Q2,Skin infection,,2018,Q2,7,F,20170704.0,20171114.0,20171107,20180503,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-076832,BRISTOL MYERS SQUIBB,,65.0,YR,,M,Y,,,20180503.0,,OT,DE,DE,2018,Q2,Elderly
141686062,14168606,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Oral,,35904.0,IU,,,,,,102.0,IU,,QD,2018,Q2,Acute kidney injury,,2018,Q2,2,F,20171012.0,20180326.0,20171108,20180405,EXP,GB-MHRA-ADR 24225544,GB-ACCORD-060710,ACCORD,,78.0,YR,,M,Y,,,20180405.0,,MD,GB,GB,2018,Q2,Elderly
141686062,14168606,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Oral,,35904.0,IU,,,,,,102.0,IU,,QD,2018,Q2,Epididymitis,,2018,Q2,2,F,20171012.0,20180326.0,20171108,20180405,EXP,GB-MHRA-ADR 24225544,GB-ACCORD-060710,ACCORD,,78.0,YR,,M,Y,,,20180405.0,,MD,GB,GB,2018,Q2,Elderly
141686062,14168606,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Oral,,35904.0,IU,,,,,,102.0,IU,,QD,2018,Q2,Feeling hot,,2018,Q2,2,F,20171012.0,20180326.0,20171108,20180405,EXP,GB-MHRA-ADR 24225544,GB-ACCORD-060710,ACCORD,,78.0,YR,,M,Y,,,20180405.0,,MD,GB,GB,2018,Q2,Elderly
141686062,14168606,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Oral,,35904.0,IU,,,,,,102.0,IU,,QD,2018,Q2,Groin pain,,2018,Q2,2,F,20171012.0,20180326.0,20171108,20180405,EXP,GB-MHRA-ADR 24225544,GB-ACCORD-060710,ACCORD,,78.0,YR,,M,Y,,,20180405.0,,MD,GB,GB,2018,Q2,Elderly
141686062,14168606,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Oral,,35904.0,IU,,,,,,102.0,IU,,QD,2018,Q2,Hypotension,,2018,Q2,2,F,20171012.0,20180326.0,20171108,20180405,EXP,GB-MHRA-ADR 24225544,GB-ACCORD-060710,ACCORD,,78.0,YR,,M,Y,,,20180405.0,,MD,GB,GB,2018,Q2,Elderly
142434088,14243408,11,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,100 IU (INTERNATIONAL UNIT),,,,,,,,100.0,IU,INJECTION,QD,2018,Q2,Cardiac arrest,,2018,Q2,8,F,20171115.0,20180515.0,20171201,20180523,EXP,,US-CELGENEUS-USA-20171109702,CELGENE,,76.0,YR,,M,Y,112.1,KG,20180523.0,,OT,US,US,2018,Q2,Elderly
142434088,14243408,11,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,100 IU (INTERNATIONAL UNIT),,,,,,,,100.0,IU,INJECTION,QD,2018,Q2,Syncope,,2018,Q2,8,F,20171115.0,20180515.0,20171201,20180523,EXP,,US-CELGENEUS-USA-20171109702,CELGENE,,76.0,YR,,M,Y,112.1,KG,20180523.0,,OT,US,US,2018,Q2,Elderly
142962763,14296276,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2018,Q2,Cutaneous vasculitis,,2018,Q2,3,F,20170501.0,20180418.0,20171218,20180426,EXP,DE-EMA-DD-20171130-SANDEVHP-123700,PHHY2017DE183999,SANDOZ,,76.0,YR,,M,Y,97.4,KG,20180426.0,,MD,DE,DE,2018,Q2,Elderly
142962763,14296276,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2018,Q2,Nephrotic syndrome,,2018,Q2,3,F,20170501.0,20180418.0,20171218,20180426,EXP,DE-EMA-DD-20171130-SANDEVHP-123700,PHHY2017DE183999,SANDOZ,,76.0,YR,,M,Y,97.4,KG,20180426.0,,MD,DE,DE,2018,Q2,Elderly
143272303,14327230,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Intramuscular,8 U TID,,,,,,,,,,INJECTION,,2018,Q2,Hepatic function abnormal,,2018,Q2,3,F,20171127.0,20180325.0,20171227,20180402,EXP,,CN-ASTRAZENECA-2017SF32042,ASTRAZENECA,,26652.0,DY,,M,Y,,,20180402.0,,MD,CN,CN,2018,Q2,Elderly
143328552,14332855,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 IU, DAILY, SOLUTION",,,D,,,,,100.0,IU,SOLUTION FOR INJECTION,QD,2018,Q2,Drug interaction,,2018,Q2,2,F,201704.0,20180412.0,20171228,20180427,EXP,,DE-AUROBINDO-AUR-APL-2017-47420,AUROBINDO,,67.0,YR,,F,Y,74.0,KG,20180427.0,,CN,DE,DE,2018,Q2,Elderly
143328552,14332855,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 IU, DAILY, SOLUTION",,,D,,,,,100.0,IU,SOLUTION FOR INJECTION,QD,2018,Q2,Rhabdomyolysis,,2018,Q2,2,F,201704.0,20180412.0,20171228,20180427,EXP,,DE-AUROBINDO-AUR-APL-2017-47420,AUROBINDO,,67.0,YR,,F,Y,74.0,KG,20180427.0,,CN,DE,DE,2018,Q2,Elderly
143815272,14381527,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ACCORDING TO PLAN,,,D,,,,,,,,,2018,Q2,Drug interaction,,2018,Q2,2,F,,20180319.0,20180112,20180402,EXP,,DE-MYLANLABS-2018M1002633,MYLAN,GASSNER C.. KEEP THE RHYTHM. DRUGS AND THE PROLONGATION OF THE QT INTERVAL AN UNDERESTIMATED RISK?. DER KLINISCHPHARMAZEUTISCHE FALL. 2017;38:513-15,76.0,YR,,M,Y,,,20180328.0,,MD,DE,DE,2018,Q2,Elderly
143815272,14381527,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ACCORDING TO PLAN,,,D,,,,,,,,,2018,Q2,Electrocardiogram QT prolonged,,2018,Q2,2,F,,20180319.0,20180112,20180402,EXP,,DE-MYLANLABS-2018M1002633,MYLAN,GASSNER C.. KEEP THE RHYTHM. DRUGS AND THE PROLONGATION OF THE QT INTERVAL AN UNDERESTIMATED RISK?. DER KLINISCHPHARMAZEUTISCHE FALL. 2017;38:513-15,76.0,YR,,M,Y,,,20180328.0,,MD,DE,DE,2018,Q2,Elderly
144139422,14413942,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q2,Dehydration,,2018,Q2,2,F,20180103.0,20180524.0,20180119,20180529,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-003740,BRISTOL MYERS SQUIBB,,61.0,YR,,M,Y,94.5,KG,20180529.0,,OT,US,US,2018,Q2,Adult
144139422,14413942,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q2,Hyperglycaemia,,2018,Q2,2,F,20180103.0,20180524.0,20180119,20180529,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-003740,BRISTOL MYERS SQUIBB,,61.0,YR,,M,Y,94.5,KG,20180529.0,,OT,US,US,2018,Q2,Adult
144528444,14452844,5,C,Insulin Lispro Humalog,,2,Subcutaneous,"20 IE, UNK",,,,,,,,,,,,2018,Q2,Acute kidney injury,,2018,Q2,4,F,20171229.0,20180326.0,20180129,20180403,EXP,,"DE-AEGERION PHARMACEUTICAL, INC-AEGR003555",AEGERION,,45.0,YR,,F,Y,59.0,KG,20180403.0,,MD,DE,DE,2018,Q2,Adult
144528444,14452844,5,C,Insulin Lispro Humalog,,2,Subcutaneous,"20 IE, UNK",,,,,,,,,,,,2018,Q2,Acute myocardial infarction,,2018,Q2,4,F,20171229.0,20180326.0,20180129,20180403,EXP,,"DE-AEGERION PHARMACEUTICAL, INC-AEGR003555",AEGERION,,45.0,YR,,F,Y,59.0,KG,20180403.0,,MD,DE,DE,2018,Q2,Adult
144528444,14452844,5,C,Insulin Lispro Humalog,,2,Subcutaneous,"20 IE, UNK",,,,,,,,,,,,2018,Q2,Cardiogenic shock,,2018,Q2,4,F,20171229.0,20180326.0,20180129,20180403,EXP,,"DE-AEGERION PHARMACEUTICAL, INC-AEGR003555",AEGERION,,45.0,YR,,F,Y,59.0,KG,20180403.0,,MD,DE,DE,2018,Q2,Adult
144528444,14452844,5,C,Insulin Lispro Humalog,,2,Subcutaneous,"20 IE, UNK",,,,,,,,,,,,2018,Q2,Therapy cessation,,2018,Q2,4,F,20171229.0,20180326.0,20180129,20180403,EXP,,"DE-AEGERION PHARMACEUTICAL, INC-AEGR003555",AEGERION,,45.0,YR,,F,Y,59.0,KG,20180403.0,,MD,DE,DE,2018,Q2,Adult
144544222,14454422,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,3.0,ML,INJECTION,,2018,Q2,Haematuria,,2018,Q2,2,F,2017.0,20180406.0,20180129,20180417,EXP,,US-VIFOR (INTERNATIONAL) INC.-VIT-2018-00889,VIFOR,,72.0,YR,,M,Y,,,20180417.0,,MD,US,US,2018,Q2,Elderly
144544222,14454422,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,3.0,ML,INJECTION,,2018,Q2,Hospitalisation,,2018,Q2,2,F,2017.0,20180406.0,20180129,20180417,EXP,,US-VIFOR (INTERNATIONAL) INC.-VIT-2018-00889,VIFOR,,72.0,YR,,M,Y,,,20180417.0,,MD,US,US,2018,Q2,Elderly
144544222,14454422,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,3.0,ML,INJECTION,,2018,Q2,Hypoglycaemia,,2018,Q2,2,F,2017.0,20180406.0,20180129,20180417,EXP,,US-VIFOR (INTERNATIONAL) INC.-VIT-2018-00889,VIFOR,,72.0,YR,,M,Y,,,20180417.0,,MD,US,US,2018,Q2,Elderly
144544222,14454422,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,3.0,ML,INJECTION,,2018,Q2,Oedema peripheral,,2018,Q2,2,F,2017.0,20180406.0,20180129,20180417,EXP,,US-VIFOR (INTERNATIONAL) INC.-VIT-2018-00889,VIFOR,,72.0,YR,,M,Y,,,20180417.0,,MD,US,US,2018,Q2,Elderly
144544222,14454422,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,3.0,ML,INJECTION,,2018,Q2,Off label use,,2018,Q2,2,F,2017.0,20180406.0,20180129,20180417,EXP,,US-VIFOR (INTERNATIONAL) INC.-VIT-2018-00889,VIFOR,,72.0,YR,,M,Y,,,20180417.0,,MD,US,US,2018,Q2,Elderly
144544222,14454422,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,3.0,ML,INJECTION,,2018,Q2,Pyrexia,,2018,Q2,2,F,2017.0,20180406.0,20180129,20180417,EXP,,US-VIFOR (INTERNATIONAL) INC.-VIT-2018-00889,VIFOR,,72.0,YR,,M,Y,,,20180417.0,,MD,US,US,2018,Q2,Elderly
144544222,14454422,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,3.0,ML,INJECTION,,2018,Q2,Urinary retention,,2018,Q2,2,F,2017.0,20180406.0,20180129,20180417,EXP,,US-VIFOR (INTERNATIONAL) INC.-VIT-2018-00889,VIFOR,,72.0,YR,,M,Y,,,20180417.0,,MD,US,US,2018,Q2,Elderly
144544222,14454422,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,3.0,ML,INJECTION,,2018,Q2,Haematuria,,2018,Q2,2,F,2017.0,20180406.0,20180129,20180417,EXP,,US-VIFOR (INTERNATIONAL) INC.-VIT-2018-00889,VIFOR,,72.0,YR,,M,Y,,,20180417.0,,MD,US,US,2018,Q2,Elderly
144544222,14454422,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,3.0,ML,INJECTION,,2018,Q2,Hospitalisation,,2018,Q2,2,F,2017.0,20180406.0,20180129,20180417,EXP,,US-VIFOR (INTERNATIONAL) INC.-VIT-2018-00889,VIFOR,,72.0,YR,,M,Y,,,20180417.0,,MD,US,US,2018,Q2,Elderly
144544222,14454422,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,3.0,ML,INJECTION,,2018,Q2,Hypoglycaemia,,2018,Q2,2,F,2017.0,20180406.0,20180129,20180417,EXP,,US-VIFOR (INTERNATIONAL) INC.-VIT-2018-00889,VIFOR,,72.0,YR,,M,Y,,,20180417.0,,MD,US,US,2018,Q2,Elderly
144544222,14454422,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,3.0,ML,INJECTION,,2018,Q2,Oedema peripheral,,2018,Q2,2,F,2017.0,20180406.0,20180129,20180417,EXP,,US-VIFOR (INTERNATIONAL) INC.-VIT-2018-00889,VIFOR,,72.0,YR,,M,Y,,,20180417.0,,MD,US,US,2018,Q2,Elderly
144544222,14454422,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,3.0,ML,INJECTION,,2018,Q2,Off label use,,2018,Q2,2,F,2017.0,20180406.0,20180129,20180417,EXP,,US-VIFOR (INTERNATIONAL) INC.-VIT-2018-00889,VIFOR,,72.0,YR,,M,Y,,,20180417.0,,MD,US,US,2018,Q2,Elderly
144544222,14454422,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,3.0,ML,INJECTION,,2018,Q2,Pyrexia,,2018,Q2,2,F,2017.0,20180406.0,20180129,20180417,EXP,,US-VIFOR (INTERNATIONAL) INC.-VIT-2018-00889,VIFOR,,72.0,YR,,M,Y,,,20180417.0,,MD,US,US,2018,Q2,Elderly
144544222,14454422,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,3.0,ML,INJECTION,,2018,Q2,Urinary retention,,2018,Q2,2,F,2017.0,20180406.0,20180129,20180417,EXP,,US-VIFOR (INTERNATIONAL) INC.-VIT-2018-00889,VIFOR,,72.0,YR,,M,Y,,,20180417.0,,MD,US,US,2018,Q2,Elderly
144544222,14454422,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,5.0,IU,INJECTION,,2018,Q2,Haematuria,,2018,Q2,2,F,2017.0,20180406.0,20180129,20180417,EXP,,US-VIFOR (INTERNATIONAL) INC.-VIT-2018-00889,VIFOR,,72.0,YR,,M,Y,,,20180417.0,,MD,US,US,2018,Q2,Elderly
144544222,14454422,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,5.0,IU,INJECTION,,2018,Q2,Hospitalisation,,2018,Q2,2,F,2017.0,20180406.0,20180129,20180417,EXP,,US-VIFOR (INTERNATIONAL) INC.-VIT-2018-00889,VIFOR,,72.0,YR,,M,Y,,,20180417.0,,MD,US,US,2018,Q2,Elderly
144544222,14454422,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,5.0,IU,INJECTION,,2018,Q2,Hypoglycaemia,,2018,Q2,2,F,2017.0,20180406.0,20180129,20180417,EXP,,US-VIFOR (INTERNATIONAL) INC.-VIT-2018-00889,VIFOR,,72.0,YR,,M,Y,,,20180417.0,,MD,US,US,2018,Q2,Elderly
144544222,14454422,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,5.0,IU,INJECTION,,2018,Q2,Oedema peripheral,,2018,Q2,2,F,2017.0,20180406.0,20180129,20180417,EXP,,US-VIFOR (INTERNATIONAL) INC.-VIT-2018-00889,VIFOR,,72.0,YR,,M,Y,,,20180417.0,,MD,US,US,2018,Q2,Elderly
144544222,14454422,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,5.0,IU,INJECTION,,2018,Q2,Off label use,,2018,Q2,2,F,2017.0,20180406.0,20180129,20180417,EXP,,US-VIFOR (INTERNATIONAL) INC.-VIT-2018-00889,VIFOR,,72.0,YR,,M,Y,,,20180417.0,,MD,US,US,2018,Q2,Elderly
144544222,14454422,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,5.0,IU,INJECTION,,2018,Q2,Pyrexia,,2018,Q2,2,F,2017.0,20180406.0,20180129,20180417,EXP,,US-VIFOR (INTERNATIONAL) INC.-VIT-2018-00889,VIFOR,,72.0,YR,,M,Y,,,20180417.0,,MD,US,US,2018,Q2,Elderly
144544222,14454422,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,5.0,IU,INJECTION,,2018,Q2,Urinary retention,,2018,Q2,2,F,2017.0,20180406.0,20180129,20180417,EXP,,US-VIFOR (INTERNATIONAL) INC.-VIT-2018-00889,VIFOR,,72.0,YR,,M,Y,,,20180417.0,,MD,US,US,2018,Q2,Elderly
144741222,14474122,1,C,Insulin lispro,INSULIN LISPRO,1,Unknown,ACCORDING TO PLAN,,,U,, UNKNOWN,,,,,,,2018,Q2,Drug interaction,,2018,Q2,2,F,,20180405.0,20180201,20180417,EXP,DE-LUNDBECK-DKLU2041713,DE-TORRENT-00007704,TORRENT,,76.0,YR,E,M,Y,,,20180417.0,,MD,DE,DE,2018,Q2,Elderly
144741222,14474122,1,C,Insulin lispro,INSULIN LISPRO,1,Unknown,ACCORDING TO PLAN,,,U,, UNKNOWN,,,,,,,2018,Q2,Electrocardiogram QT prolonged,,2018,Q2,2,F,,20180405.0,20180201,20180417,EXP,DE-LUNDBECK-DKLU2041713,DE-TORRENT-00007704,TORRENT,,76.0,YR,E,M,Y,,,20180417.0,,MD,DE,DE,2018,Q2,Elderly
144919123,14491912,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,D,,,,,,,UNSPECIFIED,,2018,Q2,Asthenia,,2018,Q2,3,F,20171107.0,20180327.0,20180206,20180405,EXP,,RU-JNJFOC-20180201007,JANSSEN,,67.0,YR,E,F,Y,95.0,KG,20180405.0,,MD,RU,RU,2018,Q2,Elderly
144919123,14491912,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,D,,,,,,,UNSPECIFIED,,2018,Q2,Blood pressure increased,,2018,Q2,3,F,20171107.0,20180327.0,20180206,20180405,EXP,,RU-JNJFOC-20180201007,JANSSEN,,67.0,YR,E,F,Y,95.0,KG,20180405.0,,MD,RU,RU,2018,Q2,Elderly
144919123,14491912,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,D,,,,,,,UNSPECIFIED,,2018,Q2,Hyperglycaemia,,2018,Q2,3,F,20171107.0,20180327.0,20180206,20180405,EXP,,RU-JNJFOC-20180201007,JANSSEN,,67.0,YR,E,F,Y,95.0,KG,20180405.0,,MD,RU,RU,2018,Q2,Elderly
144919123,14491912,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,D,,,,,,,UNSPECIFIED,,2018,Q2,Malaise,,2018,Q2,3,F,20171107.0,20180327.0,20180206,20180405,EXP,,RU-JNJFOC-20180201007,JANSSEN,,67.0,YR,E,F,Y,95.0,KG,20180405.0,,MD,RU,RU,2018,Q2,Elderly
144919123,14491912,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,D,,,,,,,UNSPECIFIED,,2018,Q2,Pain in extremity,,2018,Q2,3,F,20171107.0,20180327.0,20180206,20180405,EXP,,RU-JNJFOC-20180201007,JANSSEN,,67.0,YR,E,F,Y,95.0,KG,20180405.0,,MD,RU,RU,2018,Q2,Elderly
145109063,14510906,13,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,18 IU (INTERNATIONAL UNIT),,,,,,,,18.0,IU,UNKNOWN,QD,2018,Q2,Hypoglycaemia,,2018,Q2,3,F,20180118.0,20180329.0,20180209,20180404,EXP,,JP-CELGENEUS-JPN-20180201576,CELGENE,,74.0,YR,,M,Y,58.0,KG,20180404.0,,PH,JP,JP,2018,Q2,Elderly
145109063,14510906,13,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,18 IU (INTERNATIONAL UNIT),,,,,,,,18.0,IU,UNKNOWN,QD,2018,Q2,Pancreatic carcinoma metastatic,,2018,Q2,3,F,20180118.0,20180329.0,20180209,20180404,EXP,,JP-CELGENEUS-JPN-20180201576,CELGENE,,74.0,YR,,M,Y,58.0,KG,20180404.0,,PH,JP,JP,2018,Q2,Elderly
145109063,14510906,13,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,18 IU (INTERNATIONAL UNIT),,,,,,,,18.0,IU,UNKNOWN,QD,2018,Q2,Pneumonia,,2018,Q2,3,F,20180118.0,20180329.0,20180209,20180404,EXP,,JP-CELGENEUS-JPN-20180201576,CELGENE,,74.0,YR,,M,Y,58.0,KG,20180404.0,,PH,JP,JP,2018,Q2,Elderly
145109063,14510906,13,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,18 IU (INTERNATIONAL UNIT),,,,,,,,18.0,IU,UNKNOWN,QD,2018,Q2,Pneumonitis,,2018,Q2,3,F,20180118.0,20180329.0,20180209,20180404,EXP,,JP-CELGENEUS-JPN-20180201576,CELGENE,,74.0,YR,,M,Y,58.0,KG,20180404.0,,PH,JP,JP,2018,Q2,Elderly
145390452,14539045,13,C,MIXED PROTAMINE ZINC RECOMBINANT HUMAN INSULIN LISPRO,,2,,"HYPODERMIC ROUTE, 32 UNIT TWO TIMES A DAY",,,,,,,,,,INJECTION,,2018,Q2,Cerebrovascular accident,,2018,Q2,2,F,20171211.0,20180601.0,20180216,20180608,EXP,,CN-ASTRAZENECA-2018SE19353,ASTRAZENECA,,26268.0,DY,,M,Y,76.0,KG,20180608.0,,MD,CN,CN,2018,Q2,Elderly
145390452,14539045,13,C,MIXED PROTAMINE ZINC RECOMBINANT HUMAN INSULIN LISPRO,,2,,"HYPODERMIC ROUTE, 32 UNIT TWO TIMES A DAY",,,,,,,,,,INJECTION,,2018,Q2,Urogenital haemorrhage,,2018,Q2,2,F,20171211.0,20180601.0,20180216,20180608,EXP,,CN-ASTRAZENECA-2018SE19353,ASTRAZENECA,,26268.0,DY,,M,Y,76.0,KG,20180608.0,,MD,CN,CN,2018,Q2,Elderly
145402802,14540280,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2018,Q2,Death,,2018,Q2,2,F,201801.0,20180402.0,20180216,20180410,EXP,,US-JNJFOC-20180220716,PHARMACYCLICS,,81.0,YR,E,M,Y,,,20180410.0,,OT,US,US,2018,Q2,Elderly
145402802,14540280,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2018,Q2,Fall,,2018,Q2,2,F,201801.0,20180402.0,20180216,20180410,EXP,,US-JNJFOC-20180220716,PHARMACYCLICS,,81.0,YR,E,M,Y,,,20180410.0,,OT,US,US,2018,Q2,Elderly
145402802,14540280,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2018,Q2,Hip fracture,,2018,Q2,2,F,201801.0,20180402.0,20180216,20180410,EXP,,US-JNJFOC-20180220716,PHARMACYCLICS,,81.0,YR,E,M,Y,,,20180410.0,,OT,US,US,2018,Q2,Elderly
145521713,14552171,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,INJECTION,TID,2018,Q2,Behcet's syndrome,,2018,Q2,3,F,2015.0,20180530.0,20180220,20180531,EXP,,JP-ABBVIE-17K-087-2112930-00,ABBVIE,,52.0,YR,,F,Y,50.8,KG,20180531.0,,CN,JP,JP,2018,Q2,Adult
145521713,14552171,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,INJECTION,TID,2018,Q2,Epstein-Barr virus infection,,2018,Q2,3,F,2015.0,20180530.0,20180220,20180531,EXP,,JP-ABBVIE-17K-087-2112930-00,ABBVIE,,52.0,YR,,F,Y,50.8,KG,20180531.0,,CN,JP,JP,2018,Q2,Adult
145521713,14552171,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,INJECTION,TID,2018,Q2,General physical health deterioration,,2018,Q2,3,F,2015.0,20180530.0,20180220,20180531,EXP,,JP-ABBVIE-17K-087-2112930-00,ABBVIE,,52.0,YR,,F,Y,50.8,KG,20180531.0,,CN,JP,JP,2018,Q2,Adult
145521713,14552171,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,INJECTION,TID,2018,Q2,Lymphoma,,2018,Q2,3,F,2015.0,20180530.0,20180220,20180531,EXP,,JP-ABBVIE-17K-087-2112930-00,ABBVIE,,52.0,YR,,F,Y,50.8,KG,20180531.0,,CN,JP,JP,2018,Q2,Adult
145521713,14552171,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,INJECTION,TID,2018,Q2,Lymphoproliferative disorder,,2018,Q2,3,F,2015.0,20180530.0,20180220,20180531,EXP,,JP-ABBVIE-17K-087-2112930-00,ABBVIE,,52.0,YR,,F,Y,50.8,KG,20180531.0,,CN,JP,JP,2018,Q2,Adult
145521713,14552171,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,INJECTION,TID,2018,Q2,Nausea,,2018,Q2,3,F,2015.0,20180530.0,20180220,20180531,EXP,,JP-ABBVIE-17K-087-2112930-00,ABBVIE,,52.0,YR,,F,Y,50.8,KG,20180531.0,,CN,JP,JP,2018,Q2,Adult
145521713,14552171,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,INJECTION,TID,2018,Q2,Pneumonia,,2018,Q2,3,F,2015.0,20180530.0,20180220,20180531,EXP,,JP-ABBVIE-17K-087-2112930-00,ABBVIE,,52.0,YR,,F,Y,50.8,KG,20180531.0,,CN,JP,JP,2018,Q2,Adult
145521713,14552171,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,INJECTION,TID,2018,Q2,Respiratory disorder,,2018,Q2,3,F,2015.0,20180530.0,20180220,20180531,EXP,,JP-ABBVIE-17K-087-2112930-00,ABBVIE,,52.0,YR,,F,Y,50.8,KG,20180531.0,,CN,JP,JP,2018,Q2,Adult
145521713,14552171,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,INJECTION,TID,2018,Q2,Skin mass,,2018,Q2,3,F,2015.0,20180530.0,20180220,20180531,EXP,,JP-ABBVIE-17K-087-2112930-00,ABBVIE,,52.0,YR,,F,Y,50.8,KG,20180531.0,,CN,JP,JP,2018,Q2,Adult
145540335,14554033,40,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2018,Q2,Diarrhoea,,2018,Q2,5,F,20180211.0,20180329.0,20180220,20180404,EXP,,CA-CELGENEUS-CAN-20180205858,CELGENE,,77.0,YR,,M,Y,67.6,KG,20180404.0,,OT,CA,CA,2018,Q2,Elderly
145540335,14554033,40,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2018,Q2,Klebsiella infection,,2018,Q2,5,F,20180211.0,20180329.0,20180220,20180404,EXP,,CA-CELGENEUS-CAN-20180205858,CELGENE,,77.0,YR,,M,Y,67.6,KG,20180404.0,,OT,CA,CA,2018,Q2,Elderly
145540335,14554033,40,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2018,Q2,Sepsis,,2018,Q2,5,F,20180211.0,20180329.0,20180220,20180404,EXP,,CA-CELGENEUS-CAN-20180205858,CELGENE,,77.0,YR,,M,Y,67.6,KG,20180404.0,,OT,CA,CA,2018,Q2,Elderly
145932772,14593277,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,12-12-10 U (ADAPTED ACCORDING TO THE SACCHARIDES IN FOOD),,,U,, UNK,,209196.0,,,,TID,2018,Q2,Diabetes mellitus inadequate control,,2018,Q2,2,F,2006.0,20180416.0,20180302,20180425,EXP,,CZ-SA-2018SA004307,AVENTIS,"NEVRLA J. RETINOPATHY AS AN EARLY COMPLICATION OF DIABETES MELLITUS. KAZUISTIKY V DIABETOLOGII. 2017;15,MS1:14-5.",43.0,YR,A,F,Y,107.5,KG,20180425.0,,MD,CZ,CZ,2018,Q2,Adult
145932772,14593277,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,12-12-10 U (ADAPTED ACCORDING TO THE SACCHARIDES IN FOOD),,,U,, UNK,,209196.0,,,,TID,2018,Q2,Diabetic metabolic decompensation,,2018,Q2,2,F,2006.0,20180416.0,20180302,20180425,EXP,,CZ-SA-2018SA004307,AVENTIS,"NEVRLA J. RETINOPATHY AS AN EARLY COMPLICATION OF DIABETES MELLITUS. KAZUISTIKY V DIABETOLOGII. 2017;15,MS1:14-5.",43.0,YR,A,F,Y,107.5,KG,20180425.0,,MD,CZ,CZ,2018,Q2,Adult
145932772,14593277,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,12-12-10 U (ADAPTED ACCORDING TO THE SACCHARIDES IN FOOD),,,U,, UNK,,209196.0,,,,TID,2018,Q2,Diabetic retinopathy,,2018,Q2,2,F,2006.0,20180416.0,20180302,20180425,EXP,,CZ-SA-2018SA004307,AVENTIS,"NEVRLA J. RETINOPATHY AS AN EARLY COMPLICATION OF DIABETES MELLITUS. KAZUISTIKY V DIABETOLOGII. 2017;15,MS1:14-5.",43.0,YR,A,F,Y,107.5,KG,20180425.0,,MD,CZ,CZ,2018,Q2,Adult
145932772,14593277,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,12-12-10 U (ADAPTED ACCORDING TO THE SACCHARIDES IN FOOD),,,U,, UNK,,209196.0,,,,TID,2018,Q2,Drug ineffective,,2018,Q2,2,F,2006.0,20180416.0,20180302,20180425,EXP,,CZ-SA-2018SA004307,AVENTIS,"NEVRLA J. RETINOPATHY AS AN EARLY COMPLICATION OF DIABETES MELLITUS. KAZUISTIKY V DIABETOLOGII. 2017;15,MS1:14-5.",43.0,YR,A,F,Y,107.5,KG,20180425.0,,MD,CZ,CZ,2018,Q2,Adult
145932772,14593277,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,12-12-10 U (ADAPTED ACCORDING TO THE SACCHARIDES IN FOOD),,,U,, UNK,,209196.0,,,,TID,2018,Q2,Live birth,,2018,Q2,2,F,2006.0,20180416.0,20180302,20180425,EXP,,CZ-SA-2018SA004307,AVENTIS,"NEVRLA J. RETINOPATHY AS AN EARLY COMPLICATION OF DIABETES MELLITUS. KAZUISTIKY V DIABETOLOGII. 2017;15,MS1:14-5.",43.0,YR,A,F,Y,107.5,KG,20180425.0,,MD,CZ,CZ,2018,Q2,Adult
145932772,14593277,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,12-12-10 U (ADAPTED ACCORDING TO THE SACCHARIDES IN FOOD),,,U,, UNK,,209196.0,,,,TID,2018,Q2,Maternal exposure during pregnancy,,2018,Q2,2,F,2006.0,20180416.0,20180302,20180425,EXP,,CZ-SA-2018SA004307,AVENTIS,"NEVRLA J. RETINOPATHY AS AN EARLY COMPLICATION OF DIABETES MELLITUS. KAZUISTIKY V DIABETOLOGII. 2017;15,MS1:14-5.",43.0,YR,A,F,Y,107.5,KG,20180425.0,,MD,CZ,CZ,2018,Q2,Adult
145985652,14598565,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,UNSPECIFIED,,2018,Q2,Cellulitis,,2018,Q2,2,F,201612.0,20180517.0,20180305,20180523,EXP,,US-JNJFOC-20180239856,JANSSEN,,67.0,YR,E,M,Y,,,20180523.0,,CN,US,US,2018,Q2,Elderly
145985652,14598565,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,UNSPECIFIED,,2018,Q2,Gangrene,,2018,Q2,2,F,201612.0,20180517.0,20180305,20180523,EXP,,US-JNJFOC-20180239856,JANSSEN,,67.0,YR,E,M,Y,,,20180523.0,,CN,US,US,2018,Q2,Elderly
145985652,14598565,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,UNSPECIFIED,,2018,Q2,Leg amputation,,2018,Q2,2,F,201612.0,20180517.0,20180305,20180523,EXP,,US-JNJFOC-20180239856,JANSSEN,,67.0,YR,E,M,Y,,,20180523.0,,CN,US,US,2018,Q2,Elderly
145985652,14598565,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,UNSPECIFIED,,2018,Q2,Sepsis,,2018,Q2,2,F,201612.0,20180517.0,20180305,20180523,EXP,,US-JNJFOC-20180239856,JANSSEN,,67.0,YR,E,M,Y,,,20180523.0,,CN,US,US,2018,Q2,Elderly
146092962,14609296,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q2,Autonomic nervous system imbalance,,2018,Q2,2,F,20180213.0,20180518.0,20180307,20180522,EXP,,US-LUNDBECK-DKLU2045045,LUNDBECK,,68.0,YR,,M,Y,,,20180522.0,,PH,US,US,2018,Q2,Elderly
146092962,14609296,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q2,Cardiogenic shock,,2018,Q2,2,F,20180213.0,20180518.0,20180307,20180522,EXP,,US-LUNDBECK-DKLU2045045,LUNDBECK,,68.0,YR,,M,Y,,,20180522.0,,PH,US,US,2018,Q2,Elderly
146092962,14609296,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q2,Renal failure,,2018,Q2,2,F,20180213.0,20180518.0,20180307,20180522,EXP,,US-LUNDBECK-DKLU2045045,LUNDBECK,,68.0,YR,,M,Y,,,20180522.0,,PH,US,US,2018,Q2,Elderly
146207254,14620725,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0 - 5 WITH MEALS,,,,U,,,,,,,TID,2018,Q2,Acute kidney injury,,2018,Q2,4,F,20180301.0,20180517.0,20180309,20180531,EXP,,US-ACTELION-A-NJ2018-168815,ACTELION,,43.0,YR,A,F,Y,95.69,KG,20180531.0,,OT,US,US,2018,Q2,Adult
146207254,14620725,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0 - 5 WITH MEALS,,,,U,,,,,,,TID,2018,Q2,Chronic kidney disease,,2018,Q2,4,F,20180301.0,20180517.0,20180309,20180531,EXP,,US-ACTELION-A-NJ2018-168815,ACTELION,,43.0,YR,A,F,Y,95.69,KG,20180531.0,,OT,US,US,2018,Q2,Adult
146207254,14620725,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0 - 5 WITH MEALS,,,,U,,,,,,,TID,2018,Q2,Chronic right ventricular failure,,2018,Q2,4,F,20180301.0,20180517.0,20180309,20180531,EXP,,US-ACTELION-A-NJ2018-168815,ACTELION,,43.0,YR,A,F,Y,95.69,KG,20180531.0,,OT,US,US,2018,Q2,Adult
146207254,14620725,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0 - 5 WITH MEALS,,,,U,,,,,,,TID,2018,Q2,Computerised tomogram abnormal,,2018,Q2,4,F,20180301.0,20180517.0,20180309,20180531,EXP,,US-ACTELION-A-NJ2018-168815,ACTELION,,43.0,YR,A,F,Y,95.69,KG,20180531.0,,OT,US,US,2018,Q2,Adult
146207254,14620725,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0 - 5 WITH MEALS,,,,U,,,,,,,TID,2018,Q2,Cough,,2018,Q2,4,F,20180301.0,20180517.0,20180309,20180531,EXP,,US-ACTELION-A-NJ2018-168815,ACTELION,,43.0,YR,A,F,Y,95.69,KG,20180531.0,,OT,US,US,2018,Q2,Adult
146207254,14620725,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0 - 5 WITH MEALS,,,,U,,,,,,,TID,2018,Q2,Dyspnoea,,2018,Q2,4,F,20180301.0,20180517.0,20180309,20180531,EXP,,US-ACTELION-A-NJ2018-168815,ACTELION,,43.0,YR,A,F,Y,95.69,KG,20180531.0,,OT,US,US,2018,Q2,Adult
146207254,14620725,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0 - 5 WITH MEALS,,,,U,,,,,,,TID,2018,Q2,Fungal infection,,2018,Q2,4,F,20180301.0,20180517.0,20180309,20180531,EXP,,US-ACTELION-A-NJ2018-168815,ACTELION,,43.0,YR,A,F,Y,95.69,KG,20180531.0,,OT,US,US,2018,Q2,Adult
146207254,14620725,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0 - 5 WITH MEALS,,,,U,,,,,,,TID,2018,Q2,Headache,,2018,Q2,4,F,20180301.0,20180517.0,20180309,20180531,EXP,,US-ACTELION-A-NJ2018-168815,ACTELION,,43.0,YR,A,F,Y,95.69,KG,20180531.0,,OT,US,US,2018,Q2,Adult
146207254,14620725,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0 - 5 WITH MEALS,,,,U,,,,,,,TID,2018,Q2,Mitral valve incompetence,,2018,Q2,4,F,20180301.0,20180517.0,20180309,20180531,EXP,,US-ACTELION-A-NJ2018-168815,ACTELION,,43.0,YR,A,F,Y,95.69,KG,20180531.0,,OT,US,US,2018,Q2,Adult
146207254,14620725,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0 - 5 WITH MEALS,,,,U,,,,,,,TID,2018,Q2,Mitral valve stenosis,,2018,Q2,4,F,20180301.0,20180517.0,20180309,20180531,EXP,,US-ACTELION-A-NJ2018-168815,ACTELION,,43.0,YR,A,F,Y,95.69,KG,20180531.0,,OT,US,US,2018,Q2,Adult
146207254,14620725,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0 - 5 WITH MEALS,,,,U,,,,,,,TID,2018,Q2,Pain in jaw,,2018,Q2,4,F,20180301.0,20180517.0,20180309,20180531,EXP,,US-ACTELION-A-NJ2018-168815,ACTELION,,43.0,YR,A,F,Y,95.69,KG,20180531.0,,OT,US,US,2018,Q2,Adult
146207254,14620725,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0 - 5 WITH MEALS,,,,U,,,,,,,TID,2018,Q2,Pneumonia,,2018,Q2,4,F,20180301.0,20180517.0,20180309,20180531,EXP,,US-ACTELION-A-NJ2018-168815,ACTELION,,43.0,YR,A,F,Y,95.69,KG,20180531.0,,OT,US,US,2018,Q2,Adult
146207254,14620725,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0 - 5 WITH MEALS,,,,U,,,,,,,TID,2018,Q2,Pulmonary hypertension,,2018,Q2,4,F,20180301.0,20180517.0,20180309,20180531,EXP,,US-ACTELION-A-NJ2018-168815,ACTELION,,43.0,YR,A,F,Y,95.69,KG,20180531.0,,OT,US,US,2018,Q2,Adult
146207254,14620725,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0 - 5 WITH MEALS,,,,U,,,,,,,TID,2018,Q2,Pyrexia,,2018,Q2,4,F,20180301.0,20180517.0,20180309,20180531,EXP,,US-ACTELION-A-NJ2018-168815,ACTELION,,43.0,YR,A,F,Y,95.69,KG,20180531.0,,OT,US,US,2018,Q2,Adult
146207254,14620725,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0 - 5 WITH MEALS,,,,U,,,,,,,TID,2018,Q2,Septic embolus,,2018,Q2,4,F,20180301.0,20180517.0,20180309,20180531,EXP,,US-ACTELION-A-NJ2018-168815,ACTELION,,43.0,YR,A,F,Y,95.69,KG,20180531.0,,OT,US,US,2018,Q2,Adult
146207254,14620725,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0 - 5 WITH MEALS,,,,U,,,,,,,TID,2018,Q2,Systemic lupus erythematosus,,2018,Q2,4,F,20180301.0,20180517.0,20180309,20180531,EXP,,US-ACTELION-A-NJ2018-168815,ACTELION,,43.0,YR,A,F,Y,95.69,KG,20180531.0,,OT,US,US,2018,Q2,Adult
146207254,14620725,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0 - 5 WITH MEALS,,,,U,,,,,,,TID,2018,Q2,Transplant evaluation,,2018,Q2,4,F,20180301.0,20180517.0,20180309,20180531,EXP,,US-ACTELION-A-NJ2018-168815,ACTELION,,43.0,YR,A,F,Y,95.69,KG,20180531.0,,OT,US,US,2018,Q2,Adult
146207254,14620725,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0 - 5 WITH MEALS,,,,U,,,,,,,TID,2018,Q2,Tubulointerstitial nephritis,,2018,Q2,4,F,20180301.0,20180517.0,20180309,20180531,EXP,,US-ACTELION-A-NJ2018-168815,ACTELION,,43.0,YR,A,F,Y,95.69,KG,20180531.0,,OT,US,US,2018,Q2,Adult
146207254,14620725,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0 - 5 WITH MEALS,,,,U,,,,,,,TID,2018,Q2,Urinary retention,,2018,Q2,4,F,20180301.0,20180517.0,20180309,20180531,EXP,,US-ACTELION-A-NJ2018-168815,ACTELION,,43.0,YR,A,F,Y,95.69,KG,20180531.0,,OT,US,US,2018,Q2,Adult
146478662,14647866,31,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Abdominal discomfort,,2018,Q2,2,F,,20180329.0,20180316,20180405,EXP,,US-GILEAD-2017-0300914,GILEAD,,59.0,YR,A,M,Y,84.5,KG,20180405.0,,OT,US,US,2018,Q2,Adult
146478662,14647866,31,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Abdominal distension,,2018,Q2,2,F,,20180329.0,20180316,20180405,EXP,,US-GILEAD-2017-0300914,GILEAD,,59.0,YR,A,M,Y,84.5,KG,20180405.0,,OT,US,US,2018,Q2,Adult
146478662,14647866,31,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Dyspnoea,,2018,Q2,2,F,,20180329.0,20180316,20180405,EXP,,US-GILEAD-2017-0300914,GILEAD,,59.0,YR,A,M,Y,84.5,KG,20180405.0,,OT,US,US,2018,Q2,Adult
146478662,14647866,31,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Fluid overload,,2018,Q2,2,F,,20180329.0,20180316,20180405,EXP,,US-GILEAD-2017-0300914,GILEAD,,59.0,YR,A,M,Y,84.5,KG,20180405.0,,OT,US,US,2018,Q2,Adult
146478662,14647866,31,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Haemoptysis,,2018,Q2,2,F,,20180329.0,20180316,20180405,EXP,,US-GILEAD-2017-0300914,GILEAD,,59.0,YR,A,M,Y,84.5,KG,20180405.0,,OT,US,US,2018,Q2,Adult
146478662,14647866,31,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Hypoxia,,2018,Q2,2,F,,20180329.0,20180316,20180405,EXP,,US-GILEAD-2017-0300914,GILEAD,,59.0,YR,A,M,Y,84.5,KG,20180405.0,,OT,US,US,2018,Q2,Adult
146478662,14647866,31,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Limb injury,,2018,Q2,2,F,,20180329.0,20180316,20180405,EXP,,US-GILEAD-2017-0300914,GILEAD,,59.0,YR,A,M,Y,84.5,KG,20180405.0,,OT,US,US,2018,Q2,Adult
146478662,14647866,31,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Peripheral swelling,,2018,Q2,2,F,,20180329.0,20180316,20180405,EXP,,US-GILEAD-2017-0300914,GILEAD,,59.0,YR,A,M,Y,84.5,KG,20180405.0,,OT,US,US,2018,Q2,Adult
146478662,14647866,31,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Pulmonary hypertension,,2018,Q2,2,F,,20180329.0,20180316,20180405,EXP,,US-GILEAD-2017-0300914,GILEAD,,59.0,YR,A,M,Y,84.5,KG,20180405.0,,OT,US,US,2018,Q2,Adult
146478662,14647866,31,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Right ventricular failure,,2018,Q2,2,F,,20180329.0,20180316,20180405,EXP,,US-GILEAD-2017-0300914,GILEAD,,59.0,YR,A,M,Y,84.5,KG,20180405.0,,OT,US,US,2018,Q2,Adult
146478662,14647866,31,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Treatment noncompliance,,2018,Q2,2,F,,20180329.0,20180316,20180405,EXP,,US-GILEAD-2017-0300914,GILEAD,,59.0,YR,A,M,Y,84.5,KG,20180405.0,,OT,US,US,2018,Q2,Adult
146620772,14662077,3,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,,U,,,,,,,,2018,Q2,Cholestasis,,2018,Q2,2,F,,20180501.0,20180321,20180514,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2018US-166854,RANBAXY,"SAGVAND BT, LINDENMEYER C, SUTTON R, ADHAMI T. PSEUDOHYPONATREMIA SECONDARY TO CHOLESTASIS IN A PATIENT WITH DRUG-INDUCED LIVER INJURY. AM J GASTROENTEROL. 2017;OCT;112(SUPL 1):S1225-S1226 (ABSTRACT 2227)",69.0,YR,,M,Y,,,20180514.0,,MD,US,US,2018,Q2,Elderly
146620772,14662077,3,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,,U,,,,,,,,2018,Q2,Drug-induced liver injury,,2018,Q2,2,F,,20180501.0,20180321,20180514,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2018US-166854,RANBAXY,"SAGVAND BT, LINDENMEYER C, SUTTON R, ADHAMI T. PSEUDOHYPONATREMIA SECONDARY TO CHOLESTASIS IN A PATIENT WITH DRUG-INDUCED LIVER INJURY. AM J GASTROENTEROL. 2017;OCT;112(SUPL 1):S1225-S1226 (ABSTRACT 2227)",69.0,YR,,M,Y,,,20180514.0,,MD,US,US,2018,Q2,Elderly
146620772,14662077,3,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,,U,,,,,,,,2018,Q2,Liver transplant,,2018,Q2,2,F,,20180501.0,20180321,20180514,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2018US-166854,RANBAXY,"SAGVAND BT, LINDENMEYER C, SUTTON R, ADHAMI T. PSEUDOHYPONATREMIA SECONDARY TO CHOLESTASIS IN A PATIENT WITH DRUG-INDUCED LIVER INJURY. AM J GASTROENTEROL. 2017;OCT;112(SUPL 1):S1225-S1226 (ABSTRACT 2227)",69.0,YR,,M,Y,,,20180514.0,,MD,US,US,2018,Q2,Elderly
146620772,14662077,3,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,,U,,,,,,,,2018,Q2,Pseudohyponatraemia,,2018,Q2,2,F,,20180501.0,20180321,20180514,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2018US-166854,RANBAXY,"SAGVAND BT, LINDENMEYER C, SUTTON R, ADHAMI T. PSEUDOHYPONATREMIA SECONDARY TO CHOLESTASIS IN A PATIENT WITH DRUG-INDUCED LIVER INJURY. AM J GASTROENTEROL. 2017;OCT;112(SUPL 1):S1225-S1226 (ABSTRACT 2227)",69.0,YR,,M,Y,,,20180514.0,,MD,US,US,2018,Q2,Elderly
146661292,14666129,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"14 U, EACH MORNING(AT BREAKFAST)",,,Y,U, C764281C,,20563.0,14.0,IU,INJECTION,QD,2018,Q2,Blood glucose increased,,2018,Q2,2,F,20180314.0,20180319.0,20180321,20180418,PER,,US-ELI_LILLY_AND_COMPANY-US201803006970,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20180418.0,,CN,US,US,2018,Q2,Elderly
146661292,14666129,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"14 U, EACH MORNING(AT BREAKFAST)",,,Y,U, C764281C,,20563.0,14.0,IU,INJECTION,QD,2018,Q2,Drug dose omission,,2018,Q2,2,F,20180314.0,20180319.0,20180321,20180418,PER,,US-ELI_LILLY_AND_COMPANY-US201803006970,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20180418.0,,CN,US,US,2018,Q2,Elderly
146661292,14666129,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"14 U, EACH MORNING(AT BREAKFAST)",,,Y,U, C764281C,,20563.0,14.0,IU,INJECTION,QD,2018,Q2,Drug ineffective,,2018,Q2,2,F,20180314.0,20180319.0,20180321,20180418,PER,,US-ELI_LILLY_AND_COMPANY-US201803006970,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20180418.0,,CN,US,US,2018,Q2,Elderly
146661292,14666129,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"16 U, EACH EVENING(AT DINNER)",,,Y,U, C764281C,,20563.0,16.0,IU,INJECTION,QD,2018,Q2,Blood glucose increased,,2018,Q2,2,F,20180314.0,20180319.0,20180321,20180418,PER,,US-ELI_LILLY_AND_COMPANY-US201803006970,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20180418.0,,CN,US,US,2018,Q2,Elderly
146661292,14666129,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"16 U, EACH EVENING(AT DINNER)",,,Y,U, C764281C,,20563.0,16.0,IU,INJECTION,QD,2018,Q2,Drug dose omission,,2018,Q2,2,F,20180314.0,20180319.0,20180321,20180418,PER,,US-ELI_LILLY_AND_COMPANY-US201803006970,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20180418.0,,CN,US,US,2018,Q2,Elderly
146661292,14666129,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"16 U, EACH EVENING(AT DINNER)",,,Y,U, C764281C,,20563.0,16.0,IU,INJECTION,QD,2018,Q2,Drug ineffective,,2018,Q2,2,F,20180314.0,20180319.0,20180321,20180418,PER,,US-ELI_LILLY_AND_COMPANY-US201803006970,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20180418.0,,CN,US,US,2018,Q2,Elderly
146901093,14690109,30,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2018,Q2,Abdominal wall haematoma,,2018,Q2,3,F,20161017.0,20180523.0,20180328,20180529,EXP,,US-CELGENEUS-USA-20180307895,CELGENE,,68.0,YR,,F,Y,46.44,KG,20180529.0,,MD,US,US,2018,Q2,Elderly
146901093,14690109,30,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2018,Q2,Gastrointestinal fistula,,2018,Q2,3,F,20161017.0,20180523.0,20180328,20180529,EXP,,US-CELGENEUS-USA-20180307895,CELGENE,,68.0,YR,,F,Y,46.44,KG,20180529.0,,MD,US,US,2018,Q2,Elderly
146957192,14695719,18,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,150 IU (INTERNATIONAL UNIT),,,,,,,,50.0,IU,UNKNOWN,TID,2018,Q2,Hypertensive crisis,,2018,Q2,2,F,20180314.0,20180406.0,20180329,20180411,EXP,,US-CELGENEUS-USA-20180310176,CELGENE,,64.0,YR,,M,Y,,,20180411.0,,MD,US,US,2018,Q2,Adult
147092531,14709253,3,C,LISPRO INSULIN,INSULIN LISPRO,1,,"160 DF, UNK",,,D,,,,,160.0,DF,,,2018,Q2,Acute kidney injury,,2018,Q2,1,I,,20180323.0,20180403,20180403,EXP,,"US-ARBOR PHARMACEUTICALS, LLC-US-2018ARB000402",ARBOR,"AL-SOFIANI M, STEPHEN J. ACUTE RENAL FAILURE ASSOCIATED WITH THE CONCURRENT USE OF SGLT-2 INHIBITOR AND CHLORTHALIDONE. ENDOCRINE SOCIETY. 2016",44.0,YR,,M,Y,,,20180403.0,,OT,US,US,2018,Q2,Adult
147092531,14709253,3,C,LISPRO INSULIN,INSULIN LISPRO,1,,"160 DF, UNK",,,D,,,,,160.0,DF,,,2018,Q2,Hypovolaemia,,2018,Q2,1,I,,20180323.0,20180403,20180403,EXP,,"US-ARBOR PHARMACEUTICALS, LLC-US-2018ARB000402",ARBOR,"AL-SOFIANI M, STEPHEN J. ACUTE RENAL FAILURE ASSOCIATED WITH THE CONCURRENT USE OF SGLT-2 INHIBITOR AND CHLORTHALIDONE. ENDOCRINE SOCIETY. 2016",44.0,YR,,M,Y,,,20180403.0,,OT,US,US,2018,Q2,Adult
147092531,14709253,4,C,LISPRO INSULIN,INSULIN LISPRO,1,,"55 DF, UNK",,,D,,,,,55.0,DF,,,2018,Q2,Acute kidney injury,,2018,Q2,1,I,,20180323.0,20180403,20180403,EXP,,"US-ARBOR PHARMACEUTICALS, LLC-US-2018ARB000402",ARBOR,"AL-SOFIANI M, STEPHEN J. ACUTE RENAL FAILURE ASSOCIATED WITH THE CONCURRENT USE OF SGLT-2 INHIBITOR AND CHLORTHALIDONE. ENDOCRINE SOCIETY. 2016",44.0,YR,,M,Y,,,20180403.0,,OT,US,US,2018,Q2,Adult
147092531,14709253,4,C,LISPRO INSULIN,INSULIN LISPRO,1,,"55 DF, UNK",,,D,,,,,55.0,DF,,,2018,Q2,Hypovolaemia,,2018,Q2,1,I,,20180323.0,20180403,20180403,EXP,,"US-ARBOR PHARMACEUTICALS, LLC-US-2018ARB000402",ARBOR,"AL-SOFIANI M, STEPHEN J. ACUTE RENAL FAILURE ASSOCIATED WITH THE CONCURRENT USE OF SGLT-2 INHIBITOR AND CHLORTHALIDONE. ENDOCRINE SOCIETY. 2016",44.0,YR,,M,Y,,,20180403.0,,OT,US,US,2018,Q2,Adult
147112411,14711241,10,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,1 DOSAGE FORMS,,,,,,,,1.0,DF,INJECTION,,2018,Q2,Cholangitis,,2018,Q2,1,I,20171016.0,20180319.0,20180403,20180403,EXP,,JP-CELGENEUS-JPN-20180311068,CELGENE,,74.0,YR,,M,Y,62.0,KG,20180403.0,,MD,JP,JP,2018,Q2,Elderly
147293751,14729375,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,, C844864,,209196.0,,,,,2018,Q2,Autoimmune thyroiditis,,2018,Q2,1,I,,20180329.0,20180406,20180406,EXP,,DE-SA-2018SA095422,AVENTIS,,56.0,YR,A,F,Y,,,20180406.0,,CN,DE,DE,2018,Q2,Adult
147293751,14729375,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,, C844864,,209196.0,,,,,2018,Q2,Blood glucose fluctuation,,2018,Q2,1,I,,20180329.0,20180406,20180406,EXP,,DE-SA-2018SA095422,AVENTIS,,56.0,YR,A,F,Y,,,20180406.0,,CN,DE,DE,2018,Q2,Adult
147293751,14729375,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,, C844864,,209196.0,,,,,2018,Q2,Nipple infection,,2018,Q2,1,I,,20180329.0,20180406,20180406,EXP,,DE-SA-2018SA095422,AVENTIS,,56.0,YR,A,F,Y,,,20180406.0,,CN,DE,DE,2018,Q2,Adult
147329421,14732942,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q2,Haemolytic anaemia,,2018,Q2,1,I,,20171120.0,20180409,20180409,PER,US-MLMSERVICE-20171123-0975475-1,US-LUPIN PHARMACEUTICALS INC.-2017-06968,LUPIN,,47.0,YR,,F,Y,,,20180409.0,,PH,US,US,2018,Q2,Adult
147353222,14735322,13,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,5 UNITS,,,,,,,,,,UNKNOWN,TID,2018,Q2,Asthenia,,2018,Q2,2,F,20180314.0,20180411.0,20180409,20180416,PER,,US-CELGENEUS-USA-20180402090,CELGENE,,87.0,YR,,F,Y,,,20180416.0,,MD,US,US,2018,Q2,Elderly
147353222,14735322,13,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,5 UNITS,,,,,,,,,,UNKNOWN,TID,2018,Q2,Haemoglobin decreased,,2018,Q2,2,F,20180314.0,20180411.0,20180409,20180416,PER,,US-CELGENEUS-USA-20180402090,CELGENE,,87.0,YR,,F,Y,,,20180416.0,,MD,US,US,2018,Q2,Elderly
147353222,14735322,14,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,0-9 UNITS,,,,,,,,,,UNKNOWN,QID,2018,Q2,Asthenia,,2018,Q2,2,F,20180314.0,20180411.0,20180409,20180416,PER,,US-CELGENEUS-USA-20180402090,CELGENE,,87.0,YR,,F,Y,,,20180416.0,,MD,US,US,2018,Q2,Elderly
147353222,14735322,14,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,0-9 UNITS,,,,,,,,,,UNKNOWN,QID,2018,Q2,Haemoglobin decreased,,2018,Q2,2,F,20180314.0,20180411.0,20180409,20180416,PER,,US-CELGENEUS-USA-20180402090,CELGENE,,87.0,YR,,F,Y,,,20180416.0,,MD,US,US,2018,Q2,Elderly
147418141,14741814,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, DAILY",,,Y,U, C607012,,20563.0,2.0,ML,,QD,2018,Q2,Muscle spasms,,2018,Q2,1,I,20180116.0,20180328.0,20180410,20180410,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201804000473,ELI LILLY AND CO,,61.0,YR,,F,Y,55.0,KG,20180410.0,,CN,CN,CN,2018,Q2,Adult
147418141,14741814,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, DAILY",,,Y,U, C607012,,20563.0,2.0,ML,,QD,2018,Q2,Pruritus,,2018,Q2,1,I,20180116.0,20180328.0,20180410,20180410,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201804000473,ELI LILLY AND CO,,61.0,YR,,F,Y,55.0,KG,20180410.0,,CN,CN,CN,2018,Q2,Adult
147418141,14741814,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, DAILY",,,Y,U, C607012,,20563.0,2.0,ML,,QD,2018,Q2,Swelling,,2018,Q2,1,I,20180116.0,20180328.0,20180410,20180410,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201804000473,ELI LILLY AND CO,,61.0,YR,,F,Y,55.0,KG,20180410.0,,CN,CN,CN,2018,Q2,Adult
147418141,14741814,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, DAILY",,,Y,U, C607012,,20563.0,2.0,ML,,QD,2018,Q2,Vertigo,,2018,Q2,1,I,20180116.0,20180328.0,20180410,20180410,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201804000473,ELI LILLY AND CO,,61.0,YR,,F,Y,55.0,KG,20180410.0,,CN,CN,CN,2018,Q2,Adult
147418141,14741814,2,SS,Insulin Lispro,INSULIN LISPRO,1,,,,,Y,U,,,20563.0,,,,,2018,Q2,Muscle spasms,,2018,Q2,1,I,20180116.0,20180328.0,20180410,20180410,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201804000473,ELI LILLY AND CO,,61.0,YR,,F,Y,55.0,KG,20180410.0,,CN,CN,CN,2018,Q2,Adult
147418141,14741814,2,SS,Insulin Lispro,INSULIN LISPRO,1,,,,,Y,U,,,20563.0,,,,,2018,Q2,Pruritus,,2018,Q2,1,I,20180116.0,20180328.0,20180410,20180410,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201804000473,ELI LILLY AND CO,,61.0,YR,,F,Y,55.0,KG,20180410.0,,CN,CN,CN,2018,Q2,Adult
147418141,14741814,2,SS,Insulin Lispro,INSULIN LISPRO,1,,,,,Y,U,,,20563.0,,,,,2018,Q2,Swelling,,2018,Q2,1,I,20180116.0,20180328.0,20180410,20180410,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201804000473,ELI LILLY AND CO,,61.0,YR,,F,Y,55.0,KG,20180410.0,,CN,CN,CN,2018,Q2,Adult
147418141,14741814,2,SS,Insulin Lispro,INSULIN LISPRO,1,,,,,Y,U,,,20563.0,,,,,2018,Q2,Vertigo,,2018,Q2,1,I,20180116.0,20180328.0,20180410,20180410,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201804000473,ELI LILLY AND CO,,61.0,YR,,F,Y,55.0,KG,20180410.0,,CN,CN,CN,2018,Q2,Adult
147482371,14748237,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Hypoglycaemia,,2018,Q2,1,I,,20180405.0,20180411,20180411,EXP,,SE-ANIPHARMA-2018-JP-000048,ANI,,63.0,YR,,M,Y,,,20180411.0,,CN,SE,JP,2018,Q2,Adult
147531402,14753140,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,Y,, UNK,,209196.0,20.0,IU,,QD,2018,Q2,Diabetes mellitus,,2018,Q2,2,F,201702.0,20180416.0,20180412,20180424,EXP,,FR-SA-2018SA105195,AVENTIS,,27.0,YR,A,F,Y,67.0,KG,20180424.0,,CN,FR,FR,2018,Q2,Young Adult
147531402,14753140,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,Y,, UNK,,209196.0,20.0,IU,,QD,2018,Q2,Diabetes mellitus inadequate control,,2018,Q2,2,F,201702.0,20180416.0,20180412,20180424,EXP,,FR-SA-2018SA105195,AVENTIS,,27.0,YR,A,F,Y,67.0,KG,20180424.0,,CN,FR,FR,2018,Q2,Young Adult
147531402,14753140,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,Y,, UNK,,209196.0,20.0,IU,,QD,2018,Q2,Diplopia,,2018,Q2,2,F,201702.0,20180416.0,20180412,20180424,EXP,,FR-SA-2018SA105195,AVENTIS,,27.0,YR,A,F,Y,67.0,KG,20180424.0,,CN,FR,FR,2018,Q2,Young Adult
147531402,14753140,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,Y,, UNK,,209196.0,20.0,IU,,QD,2018,Q2,Headache,,2018,Q2,2,F,201702.0,20180416.0,20180412,20180424,EXP,,FR-SA-2018SA105195,AVENTIS,,27.0,YR,A,F,Y,67.0,KG,20180424.0,,CN,FR,FR,2018,Q2,Young Adult
147531402,14753140,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,Y,, UNK,,209196.0,20.0,IU,,QD,2018,Q2,Hypoglycaemia,,2018,Q2,2,F,201702.0,20180416.0,20180412,20180424,EXP,,FR-SA-2018SA105195,AVENTIS,,27.0,YR,A,F,Y,67.0,KG,20180424.0,,CN,FR,FR,2018,Q2,Young Adult
147531402,14753140,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,Y,, UNK,,209196.0,20.0,IU,,QD,2018,Q2,Maternal exposure during pregnancy,,2018,Q2,2,F,201702.0,20180416.0,20180412,20180424,EXP,,FR-SA-2018SA105195,AVENTIS,,27.0,YR,A,F,Y,67.0,KG,20180424.0,,CN,FR,FR,2018,Q2,Young Adult
147531402,14753140,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,Y,, UNK,,209196.0,20.0,IU,,QD,2018,Q2,Seizure,,2018,Q2,2,F,201702.0,20180416.0,20180412,20180424,EXP,,FR-SA-2018SA105195,AVENTIS,,27.0,YR,A,F,Y,67.0,KG,20180424.0,,CN,FR,FR,2018,Q2,Young Adult
147531402,14753140,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,Y,, UNK,,209196.0,,,,,2018,Q2,Diabetes mellitus,,2018,Q2,2,F,201702.0,20180416.0,20180412,20180424,EXP,,FR-SA-2018SA105195,AVENTIS,,27.0,YR,A,F,Y,67.0,KG,20180424.0,,CN,FR,FR,2018,Q2,Young Adult
147531402,14753140,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,Y,, UNK,,209196.0,,,,,2018,Q2,Diabetes mellitus inadequate control,,2018,Q2,2,F,201702.0,20180416.0,20180412,20180424,EXP,,FR-SA-2018SA105195,AVENTIS,,27.0,YR,A,F,Y,67.0,KG,20180424.0,,CN,FR,FR,2018,Q2,Young Adult
147531402,14753140,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,Y,, UNK,,209196.0,,,,,2018,Q2,Diplopia,,2018,Q2,2,F,201702.0,20180416.0,20180412,20180424,EXP,,FR-SA-2018SA105195,AVENTIS,,27.0,YR,A,F,Y,67.0,KG,20180424.0,,CN,FR,FR,2018,Q2,Young Adult
147531402,14753140,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,Y,, UNK,,209196.0,,,,,2018,Q2,Headache,,2018,Q2,2,F,201702.0,20180416.0,20180412,20180424,EXP,,FR-SA-2018SA105195,AVENTIS,,27.0,YR,A,F,Y,67.0,KG,20180424.0,,CN,FR,FR,2018,Q2,Young Adult
147531402,14753140,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,Y,, UNK,,209196.0,,,,,2018,Q2,Hypoglycaemia,,2018,Q2,2,F,201702.0,20180416.0,20180412,20180424,EXP,,FR-SA-2018SA105195,AVENTIS,,27.0,YR,A,F,Y,67.0,KG,20180424.0,,CN,FR,FR,2018,Q2,Young Adult
147531402,14753140,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,Y,, UNK,,209196.0,,,,,2018,Q2,Maternal exposure during pregnancy,,2018,Q2,2,F,201702.0,20180416.0,20180412,20180424,EXP,,FR-SA-2018SA105195,AVENTIS,,27.0,YR,A,F,Y,67.0,KG,20180424.0,,CN,FR,FR,2018,Q2,Young Adult
147531402,14753140,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,Y,, UNK,,209196.0,,,,,2018,Q2,Seizure,,2018,Q2,2,F,201702.0,20180416.0,20180412,20180424,EXP,,FR-SA-2018SA105195,AVENTIS,,27.0,YR,A,F,Y,67.0,KG,20180424.0,,CN,FR,FR,2018,Q2,Young Adult
147536241,14753624,4,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Cardio-respiratory arrest,,2018,Q2,1,I,20180123.0,,20180406,20180406,DIR,,,FDA-CTU,,51.0,YR,,F,N,,,20180406.0,N,PH,US,US,2018,Q2,Adult
147536241,14753624,4,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Cough,,2018,Q2,1,I,20180123.0,,20180406,20180406,DIR,,,FDA-CTU,,51.0,YR,,F,N,,,20180406.0,N,PH,US,US,2018,Q2,Adult
147536241,14753624,4,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Dizziness,,2018,Q2,1,I,20180123.0,,20180406,20180406,DIR,,,FDA-CTU,,51.0,YR,,F,N,,,20180406.0,N,PH,US,US,2018,Q2,Adult
147536241,14753624,4,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Dyspnoea,,2018,Q2,1,I,20180123.0,,20180406,20180406,DIR,,,FDA-CTU,,51.0,YR,,F,N,,,20180406.0,N,PH,US,US,2018,Q2,Adult
147536241,14753624,4,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Heart rate increased,,2018,Q2,1,I,20180123.0,,20180406,20180406,DIR,,,FDA-CTU,,51.0,YR,,F,N,,,20180406.0,N,PH,US,US,2018,Q2,Adult
147536241,14753624,4,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Hyperhidrosis,,2018,Q2,1,I,20180123.0,,20180406,20180406,DIR,,,FDA-CTU,,51.0,YR,,F,N,,,20180406.0,N,PH,US,US,2018,Q2,Adult
147536241,14753624,4,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Hypotension,,2018,Q2,1,I,20180123.0,,20180406,20180406,DIR,,,FDA-CTU,,51.0,YR,,F,N,,,20180406.0,N,PH,US,US,2018,Q2,Adult
147536241,14753624,4,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Neutropenia,,2018,Q2,1,I,20180123.0,,20180406,20180406,DIR,,,FDA-CTU,,51.0,YR,,F,N,,,20180406.0,N,PH,US,US,2018,Q2,Adult
147582471,14758247,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q2,Contraindicated product administered,,2018,Q2,1,I,,20180412.0,20180413,20180413,EXP,,DE-SYNTHON BV-NL01PV18_46843,SYNTHON,,68.0,YR,,M,Y,,,20180413.0,,PH,GB,DE,2018,Q2,Elderly
147582471,14758247,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q2,Dyspnoea,,2018,Q2,1,I,,20180412.0,20180413,20180413,EXP,,DE-SYNTHON BV-NL01PV18_46843,SYNTHON,,68.0,YR,,M,Y,,,20180413.0,,PH,GB,DE,2018,Q2,Elderly
147582471,14758247,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q2,Oedema peripheral,,2018,Q2,1,I,,20180412.0,20180413,20180413,EXP,,DE-SYNTHON BV-NL01PV18_46843,SYNTHON,,68.0,YR,,M,Y,,,20180413.0,,PH,GB,DE,2018,Q2,Elderly
147596371,14759637,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,, UNKNOWN,,,,,,,2018,Q2,Depression,,2018,Q2,1,I,20140810.0,20180406.0,20180413,20180413,EXP,,IT-ABBVIE-18S-083-2316572-00,ABBVIE,,51.0,YR,,F,Y,48.0,KG,20180413.0,,OT,IT,IT,2018,Q2,Adult
147596371,14759637,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,, UNKNOWN,,,,,,,2018,Q2,Diabetes mellitus,,2018,Q2,1,I,20140810.0,20180406.0,20180413,20180413,EXP,,IT-ABBVIE-18S-083-2316572-00,ABBVIE,,51.0,YR,,F,Y,48.0,KG,20180413.0,,OT,IT,IT,2018,Q2,Adult
147596371,14759637,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,, UNKNOWN,,,,,,,2018,Q2,Foot fracture,,2018,Q2,1,I,20140810.0,20180406.0,20180413,20180413,EXP,,IT-ABBVIE-18S-083-2316572-00,ABBVIE,,51.0,YR,,F,Y,48.0,KG,20180413.0,,OT,IT,IT,2018,Q2,Adult
147596371,14759637,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,, UNKNOWN,,,,,,,2018,Q2,Hypercholesterolaemia,,2018,Q2,1,I,20140810.0,20180406.0,20180413,20180413,EXP,,IT-ABBVIE-18S-083-2316572-00,ABBVIE,,51.0,YR,,F,Y,48.0,KG,20180413.0,,OT,IT,IT,2018,Q2,Adult
147596371,14759637,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,, UNKNOWN,,,,,,,2018,Q2,Hypertension,,2018,Q2,1,I,20140810.0,20180406.0,20180413,20180413,EXP,,IT-ABBVIE-18S-083-2316572-00,ABBVIE,,51.0,YR,,F,Y,48.0,KG,20180413.0,,OT,IT,IT,2018,Q2,Adult
147596371,14759637,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,, UNKNOWN,,,,,,,2018,Q2,Insomnia,,2018,Q2,1,I,20140810.0,20180406.0,20180413,20180413,EXP,,IT-ABBVIE-18S-083-2316572-00,ABBVIE,,51.0,YR,,F,Y,48.0,KG,20180413.0,,OT,IT,IT,2018,Q2,Adult
147596371,14759637,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,, UNKNOWN,,,,,,,2018,Q2,Nightmare,,2018,Q2,1,I,20140810.0,20180406.0,20180413,20180413,EXP,,IT-ABBVIE-18S-083-2316572-00,ABBVIE,,51.0,YR,,F,Y,48.0,KG,20180413.0,,OT,IT,IT,2018,Q2,Adult
147596371,14759637,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,, UNKNOWN,,,,,,,2018,Q2,Osteoporosis,,2018,Q2,1,I,20140810.0,20180406.0,20180413,20180413,EXP,,IT-ABBVIE-18S-083-2316572-00,ABBVIE,,51.0,YR,,F,Y,48.0,KG,20180413.0,,OT,IT,IT,2018,Q2,Adult
147596371,14759637,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,, UNKNOWN,,,,,,,2018,Q2,Vitamin D deficiency,,2018,Q2,1,I,20140810.0,20180406.0,20180413,20180413,EXP,,IT-ABBVIE-18S-083-2316572-00,ABBVIE,,51.0,YR,,F,Y,48.0,KG,20180413.0,,OT,IT,IT,2018,Q2,Adult
147639842,14763984,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2018,Q2,Oedema peripheral,,2018,Q2,2,F,20180409.0,20180418.0,20180416,20180424,EXP,,DE-ROCHE-2105781,ROCHE,,75.0,YR,,M,Y,118.0,KG,20180424.0,,MD,DE,DE,2018,Q2,Elderly
147655609,14765560,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"18 UNIT, BEFORE LUNCH",,,,,,,,18.0,DF,,,2018,Q2,Dyspnoea exertional,,2018,Q2,9,F,201804.0,20180524.0,20180416,20180601,EXP,,US-UNITED THERAPEUTICS-UNT-2018-005015,UNITED THERAPEUTICS,,48.0,YR,,F,Y,70.3,KG,20180601.0,,OT,US,US,2018,Q2,Adult
147655609,14765560,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"18 UNIT, BEFORE LUNCH",,,,,,,,18.0,DF,,,2018,Q2,Electrolyte imbalance,,2018,Q2,9,F,201804.0,20180524.0,20180416,20180601,EXP,,US-UNITED THERAPEUTICS-UNT-2018-005015,UNITED THERAPEUTICS,,48.0,YR,,F,Y,70.3,KG,20180601.0,,OT,US,US,2018,Q2,Adult
147655609,14765560,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"18 UNIT, BEFORE LUNCH",,,,,,,,18.0,DF,,,2018,Q2,Fluid overload,,2018,Q2,9,F,201804.0,20180524.0,20180416,20180601,EXP,,US-UNITED THERAPEUTICS-UNT-2018-005015,UNITED THERAPEUTICS,,48.0,YR,,F,Y,70.3,KG,20180601.0,,OT,US,US,2018,Q2,Adult
147655609,14765560,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"18 UNIT, BEFORE LUNCH",,,,,,,,18.0,DF,,,2018,Q2,Headache,,2018,Q2,9,F,201804.0,20180524.0,20180416,20180601,EXP,,US-UNITED THERAPEUTICS-UNT-2018-005015,UNITED THERAPEUTICS,,48.0,YR,,F,Y,70.3,KG,20180601.0,,OT,US,US,2018,Q2,Adult
147655609,14765560,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"18 UNIT, BEFORE LUNCH",,,,,,,,18.0,DF,,,2018,Q2,Hypokalaemia,,2018,Q2,9,F,201804.0,20180524.0,20180416,20180601,EXP,,US-UNITED THERAPEUTICS-UNT-2018-005015,UNITED THERAPEUTICS,,48.0,YR,,F,Y,70.3,KG,20180601.0,,OT,US,US,2018,Q2,Adult
147655609,14765560,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"18 UNIT, BEFORE LUNCH",,,,,,,,18.0,DF,,,2018,Q2,Oxygen saturation decreased,,2018,Q2,9,F,201804.0,20180524.0,20180416,20180601,EXP,,US-UNITED THERAPEUTICS-UNT-2018-005015,UNITED THERAPEUTICS,,48.0,YR,,F,Y,70.3,KG,20180601.0,,OT,US,US,2018,Q2,Adult
147655609,14765560,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"18 UNIT, BEFORE LUNCH",,,,,,,,18.0,DF,,,2018,Q2,Pain in jaw,,2018,Q2,9,F,201804.0,20180524.0,20180416,20180601,EXP,,US-UNITED THERAPEUTICS-UNT-2018-005015,UNITED THERAPEUTICS,,48.0,YR,,F,Y,70.3,KG,20180601.0,,OT,US,US,2018,Q2,Adult
147655609,14765560,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"18 UNIT, BEFORE LUNCH",,,,,,,,18.0,DF,,,2018,Q2,Parainfluenzae virus infection,,2018,Q2,9,F,201804.0,20180524.0,20180416,20180601,EXP,,US-UNITED THERAPEUTICS-UNT-2018-005015,UNITED THERAPEUTICS,,48.0,YR,,F,Y,70.3,KG,20180601.0,,OT,US,US,2018,Q2,Adult
147655609,14765560,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 UNIT, BEFORE DINNER",,,,,,,,12.0,DF,,,2018,Q2,Dyspnoea exertional,,2018,Q2,9,F,201804.0,20180524.0,20180416,20180601,EXP,,US-UNITED THERAPEUTICS-UNT-2018-005015,UNITED THERAPEUTICS,,48.0,YR,,F,Y,70.3,KG,20180601.0,,OT,US,US,2018,Q2,Adult
147655609,14765560,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 UNIT, BEFORE DINNER",,,,,,,,12.0,DF,,,2018,Q2,Electrolyte imbalance,,2018,Q2,9,F,201804.0,20180524.0,20180416,20180601,EXP,,US-UNITED THERAPEUTICS-UNT-2018-005015,UNITED THERAPEUTICS,,48.0,YR,,F,Y,70.3,KG,20180601.0,,OT,US,US,2018,Q2,Adult
147655609,14765560,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 UNIT, BEFORE DINNER",,,,,,,,12.0,DF,,,2018,Q2,Fluid overload,,2018,Q2,9,F,201804.0,20180524.0,20180416,20180601,EXP,,US-UNITED THERAPEUTICS-UNT-2018-005015,UNITED THERAPEUTICS,,48.0,YR,,F,Y,70.3,KG,20180601.0,,OT,US,US,2018,Q2,Adult
147655609,14765560,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 UNIT, BEFORE DINNER",,,,,,,,12.0,DF,,,2018,Q2,Headache,,2018,Q2,9,F,201804.0,20180524.0,20180416,20180601,EXP,,US-UNITED THERAPEUTICS-UNT-2018-005015,UNITED THERAPEUTICS,,48.0,YR,,F,Y,70.3,KG,20180601.0,,OT,US,US,2018,Q2,Adult
147655609,14765560,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 UNIT, BEFORE DINNER",,,,,,,,12.0,DF,,,2018,Q2,Hypokalaemia,,2018,Q2,9,F,201804.0,20180524.0,20180416,20180601,EXP,,US-UNITED THERAPEUTICS-UNT-2018-005015,UNITED THERAPEUTICS,,48.0,YR,,F,Y,70.3,KG,20180601.0,,OT,US,US,2018,Q2,Adult
147655609,14765560,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 UNIT, BEFORE DINNER",,,,,,,,12.0,DF,,,2018,Q2,Oxygen saturation decreased,,2018,Q2,9,F,201804.0,20180524.0,20180416,20180601,EXP,,US-UNITED THERAPEUTICS-UNT-2018-005015,UNITED THERAPEUTICS,,48.0,YR,,F,Y,70.3,KG,20180601.0,,OT,US,US,2018,Q2,Adult
147655609,14765560,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 UNIT, BEFORE DINNER",,,,,,,,12.0,DF,,,2018,Q2,Pain in jaw,,2018,Q2,9,F,201804.0,20180524.0,20180416,20180601,EXP,,US-UNITED THERAPEUTICS-UNT-2018-005015,UNITED THERAPEUTICS,,48.0,YR,,F,Y,70.3,KG,20180601.0,,OT,US,US,2018,Q2,Adult
147655609,14765560,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 UNIT, BEFORE DINNER",,,,,,,,12.0,DF,,,2018,Q2,Parainfluenzae virus infection,,2018,Q2,9,F,201804.0,20180524.0,20180416,20180601,EXP,,US-UNITED THERAPEUTICS-UNT-2018-005015,UNITED THERAPEUTICS,,48.0,YR,,F,Y,70.3,KG,20180601.0,,OT,US,US,2018,Q2,Adult
147655609,14765560,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 UNIT, BEFORE MEALS TID WITH SNACKS",,,,,,,,3.0,DF,,,2018,Q2,Dyspnoea exertional,,2018,Q2,9,F,201804.0,20180524.0,20180416,20180601,EXP,,US-UNITED THERAPEUTICS-UNT-2018-005015,UNITED THERAPEUTICS,,48.0,YR,,F,Y,70.3,KG,20180601.0,,OT,US,US,2018,Q2,Adult
147655609,14765560,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 UNIT, BEFORE MEALS TID WITH SNACKS",,,,,,,,3.0,DF,,,2018,Q2,Electrolyte imbalance,,2018,Q2,9,F,201804.0,20180524.0,20180416,20180601,EXP,,US-UNITED THERAPEUTICS-UNT-2018-005015,UNITED THERAPEUTICS,,48.0,YR,,F,Y,70.3,KG,20180601.0,,OT,US,US,2018,Q2,Adult
147655609,14765560,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 UNIT, BEFORE MEALS TID WITH SNACKS",,,,,,,,3.0,DF,,,2018,Q2,Fluid overload,,2018,Q2,9,F,201804.0,20180524.0,20180416,20180601,EXP,,US-UNITED THERAPEUTICS-UNT-2018-005015,UNITED THERAPEUTICS,,48.0,YR,,F,Y,70.3,KG,20180601.0,,OT,US,US,2018,Q2,Adult
147655609,14765560,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 UNIT, BEFORE MEALS TID WITH SNACKS",,,,,,,,3.0,DF,,,2018,Q2,Headache,,2018,Q2,9,F,201804.0,20180524.0,20180416,20180601,EXP,,US-UNITED THERAPEUTICS-UNT-2018-005015,UNITED THERAPEUTICS,,48.0,YR,,F,Y,70.3,KG,20180601.0,,OT,US,US,2018,Q2,Adult
147655609,14765560,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 UNIT, BEFORE MEALS TID WITH SNACKS",,,,,,,,3.0,DF,,,2018,Q2,Hypokalaemia,,2018,Q2,9,F,201804.0,20180524.0,20180416,20180601,EXP,,US-UNITED THERAPEUTICS-UNT-2018-005015,UNITED THERAPEUTICS,,48.0,YR,,F,Y,70.3,KG,20180601.0,,OT,US,US,2018,Q2,Adult
147655609,14765560,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 UNIT, BEFORE MEALS TID WITH SNACKS",,,,,,,,3.0,DF,,,2018,Q2,Oxygen saturation decreased,,2018,Q2,9,F,201804.0,20180524.0,20180416,20180601,EXP,,US-UNITED THERAPEUTICS-UNT-2018-005015,UNITED THERAPEUTICS,,48.0,YR,,F,Y,70.3,KG,20180601.0,,OT,US,US,2018,Q2,Adult
147655609,14765560,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 UNIT, BEFORE MEALS TID WITH SNACKS",,,,,,,,3.0,DF,,,2018,Q2,Pain in jaw,,2018,Q2,9,F,201804.0,20180524.0,20180416,20180601,EXP,,US-UNITED THERAPEUTICS-UNT-2018-005015,UNITED THERAPEUTICS,,48.0,YR,,F,Y,70.3,KG,20180601.0,,OT,US,US,2018,Q2,Adult
147655609,14765560,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 UNIT, BEFORE MEALS TID WITH SNACKS",,,,,,,,3.0,DF,,,2018,Q2,Parainfluenzae virus infection,,2018,Q2,9,F,201804.0,20180524.0,20180416,20180601,EXP,,US-UNITED THERAPEUTICS-UNT-2018-005015,UNITED THERAPEUTICS,,48.0,YR,,F,Y,70.3,KG,20180601.0,,OT,US,US,2018,Q2,Adult
147668271,14766827,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"17 UT, OD, BEFORE DINNER",,,,,,,,,,,QD,2018,Q2,Hypoglycaemia,,2018,Q2,1,I,,20180124.0,20180417,20180417,PER,,US-GLENMARK PHARMACEUTICALS-2018GMK031566,GLENMARK,"RANEY E, JACKOWSKI RM, HUME D ET AL.. LINEZOLID-ASSOCIATED HYPOGLYCEMIA IN A PATIENT WITH TYPE 2 DIABETES MELLITUS: A CASE REPORT.. 2017 ANNUAL MEETING OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, ACCP 2017.. 2017;37(12):E229",52.0,YR,,M,Y,,,20180417.0,,PH,US,US,2018,Q2,Adult
147695031,14769503,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,, UNK,,209196.0,,,,,2018,Q2,Dizziness,,2018,Q2,1,I,201704.0,20180413.0,20180417,20180417,EXP,,FI-SA-2018SA109408,AVENTIS,,59.0,YR,A,F,Y,,,20180417.0,,CN,FI,FI,2018,Q2,Adult
147695031,14769503,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,, UNK,,209196.0,,,,,2018,Q2,Fall,,2018,Q2,1,I,201704.0,20180413.0,20180417,20180417,EXP,,FI-SA-2018SA109408,AVENTIS,,59.0,YR,A,F,Y,,,20180417.0,,CN,FI,FI,2018,Q2,Adult
147695031,14769503,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,, UNK,,209196.0,,,,,2018,Q2,Memory impairment,,2018,Q2,1,I,201704.0,20180413.0,20180417,20180417,EXP,,FI-SA-2018SA109408,AVENTIS,,59.0,YR,A,F,Y,,,20180417.0,,CN,FI,FI,2018,Q2,Adult
147695031,14769503,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,, UNK,,209196.0,,,,,2018,Q2,Shock,,2018,Q2,1,I,201704.0,20180413.0,20180417,20180417,EXP,,FI-SA-2018SA109408,AVENTIS,,59.0,YR,A,F,Y,,,20180417.0,,CN,FI,FI,2018,Q2,Adult
147695031,14769503,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,, UNK,,209196.0,,,,,2018,Q2,Visual impairment,,2018,Q2,1,I,201704.0,20180413.0,20180417,20180417,EXP,,FI-SA-2018SA109408,AVENTIS,,59.0,YR,A,F,Y,,,20180417.0,,CN,FI,FI,2018,Q2,Adult
147753151,14775315,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q2,Contraindicated product administered,,2018,Q2,1,I,,20180412.0,20180418,20180418,EXP,DE-BFARM-18005572,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-BI-021155",BOEHRINGER INGELHEIM,,68.0,YR,,M,Y,,,20180418.0,,PH,DE,DE,2018,Q2,Elderly
147753151,14775315,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q2,Dyspnoea,,2018,Q2,1,I,,20180412.0,20180418,20180418,EXP,DE-BFARM-18005572,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-BI-021155",BOEHRINGER INGELHEIM,,68.0,YR,,M,Y,,,20180418.0,,PH,DE,DE,2018,Q2,Elderly
147753151,14775315,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q2,Oedema peripheral,,2018,Q2,1,I,,20180412.0,20180418,20180418,EXP,DE-BFARM-18005572,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-BI-021155",BOEHRINGER INGELHEIM,,68.0,YR,,M,Y,,,20180418.0,,PH,DE,DE,2018,Q2,Elderly
147759952,14775995,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,5 IU (INTERNATIONAL UNIT),,,,,,,,5.0,IU,UNKNOWN,QD,2018,Q2,Squamous cell carcinoma of the tongue,,2018,Q2,2,F,20180323.0,20180423.0,20180418,20180501,EXP,,IT-CELGENEUS-ITA-20180404331,CELGENE,,46.0,YR,,M,Y,66.0,KG,20180501.0,,OT,IT,IT,2018,Q2,Adult
147759952,14775995,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,6 IU (INTERNATIONAL UNIT),,,,,,,,6.0,IU,UNKNOWN,QD,2018,Q2,Squamous cell carcinoma of the tongue,,2018,Q2,2,F,20180323.0,20180423.0,20180418,20180501,EXP,,IT-CELGENEUS-ITA-20180404331,CELGENE,,46.0,YR,,M,Y,66.0,KG,20180501.0,,OT,IT,IT,2018,Q2,Adult
147759952,14775995,12,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,4 IU (INTERNATIONAL UNIT),,,,,,,,4.0,IU,UNKNOWN,QD,2018,Q2,Squamous cell carcinoma of the tongue,,2018,Q2,2,F,20180323.0,20180423.0,20180418,20180501,EXP,,IT-CELGENEUS-ITA-20180404331,CELGENE,,46.0,YR,,M,Y,66.0,KG,20180501.0,,OT,IT,IT,2018,Q2,Adult
147768181,14776818,4,C,Insulin lispro,INSULIN LISPRO,1,,"17 IU, QD (BEFORE DINNER)",,,,,,,,17.0,IU,,QD,2018,Q2,Hypoglycaemia,,2018,Q2,1,I,,20180130.0,20180419,20180419,EXP,,US-ALKEM LABORATORIES LIMITED-US-ALKEM-2018-00411,ALKEM,"RANEY E, JACKOWSKI RM AND HUME D. LINEZOLID-ASSOCIATED HYPOGLYCEMIA IN A PATIENT WITH TYPE 2 DIABETES MELLITUS: A CASE REPORT. PHARMACOTHERAPY. 2017;37(12):E229",52.0,YR,,M,Y,,,20180418.0,,PH,US,US,2018,Q2,Adult
147789811,14778981,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, DAILY",,,,,,,20563.0,,,,QD,2018,Q2,Blood glucose increased,,2018,Q2,1,I,,20180410.0,20180419,20180419,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201804005810,ELI LILLY AND CO,,52.0,YR,,M,Y,,,20180419.0,,CN,CN,CN,2018,Q2,Adult
147789811,14778981,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, DAILY",,,,,,,20563.0,,,,QD,2018,Q2,Blood uric acid increased,,2018,Q2,1,I,,20180410.0,20180419,20180419,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201804005810,ELI LILLY AND CO,,52.0,YR,,M,Y,,,20180419.0,,CN,CN,CN,2018,Q2,Adult
147789811,14778981,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, DAILY",,,,,,,20563.0,,,,QD,2018,Q2,Hyperlipidaemia,,2018,Q2,1,I,,20180410.0,20180419,20180419,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201804005810,ELI LILLY AND CO,,52.0,YR,,M,Y,,,20180419.0,,CN,CN,CN,2018,Q2,Adult
147789811,14778981,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, DAILY",,,,,,,20563.0,,,,QD,2018,Q2,Hypertension,,2018,Q2,1,I,,20180410.0,20180419,20180419,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201804005810,ELI LILLY AND CO,,52.0,YR,,M,Y,,,20180419.0,,CN,CN,CN,2018,Q2,Adult
147789811,14778981,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, DAILY",,,,,,,20563.0,,,,QD,2018,Q2,Peripheral swelling,,2018,Q2,1,I,,20180410.0,20180419,20180419,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201804005810,ELI LILLY AND CO,,52.0,YR,,M,Y,,,20180419.0,,CN,CN,CN,2018,Q2,Adult
147791622,14779162,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q2,Neutrophil count decreased,,2018,Q2,2,F,20180403.0,20180430.0,20180419,20180504,EXP,,KR-PFIZER INC-2018152883,PFIZER,,64.0,YR,,M,Y,85.0,KG,20180504.0,,MD,KR,KR,2018,Q2,Adult
147791622,14779162,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q2,Pneumonia,,2018,Q2,2,F,20180403.0,20180430.0,20180419,20180504,EXP,,KR-PFIZER INC-2018152883,PFIZER,,64.0,YR,,M,Y,85.0,KG,20180504.0,,MD,KR,KR,2018,Q2,Adult
147821822,14782182,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,USE AS DIRECTED,,,U,,,,,,,,,2018,Q2,Dermatitis allergic,,2018,Q2,2,F,20180209.0,20180531.0,20180420,20180608,EXP,GB-MHRA-TPP14085087C943750YC1518692852705,GB-TEVA-2018-GB-883567,TEVA,,85.0,YR,,M,Y,76.0,KG,20180609.0,,MD,GB,GB,2018,Q2,Elderly
147821822,14782182,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,USE AS DIRECTED,,,U,,,,,,,,,2018,Q2,Dermatitis allergic,,2018,Q2,2,F,20180209.0,20180531.0,20180420,20180608,EXP,GB-MHRA-TPP14085087C943750YC1518692852705,GB-TEVA-2018-GB-883567,TEVA,,85.0,YR,,M,Y,76.0,KG,20180609.0,,MD,GB,GB,2018,Q2,Elderly
147890341,14789034,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Diarrhoea,Diarrhoea,2018,Q2,1,I,20180101.0,20180103.0,20180423,20180423,PER,,US-ALVOGEN-2018-ALVOGEN-094773,ALVOGEN,,45.0,YR,,F,Y,,,20180423.0,,CN,US,US,2018,Q2,Adult
147890341,14789034,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Faeces hard,Faeces hard,2018,Q2,1,I,20180101.0,20180103.0,20180423,20180423,PER,,US-ALVOGEN-2018-ALVOGEN-094773,ALVOGEN,,45.0,YR,,F,Y,,,20180423.0,,CN,US,US,2018,Q2,Adult
147890341,14789034,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Nausea,Nausea,2018,Q2,1,I,20180101.0,20180103.0,20180423,20180423,PER,,US-ALVOGEN-2018-ALVOGEN-094773,ALVOGEN,,45.0,YR,,F,Y,,,20180423.0,,CN,US,US,2018,Q2,Adult
147890341,14789034,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Pain,Pain,2018,Q2,1,I,20180101.0,20180103.0,20180423,20180423,PER,,US-ALVOGEN-2018-ALVOGEN-094773,ALVOGEN,,45.0,YR,,F,Y,,,20180423.0,,CN,US,US,2018,Q2,Adult
148015391,14801539,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"10 IU, TID",,,,,,,,10.0,IU,,TID,2018,Q2,Abdominal pain,,2018,Q2,1,I,20180223.0,20180417.0,20180424,20180424,EXP,,PHHY2018US068888,NOVARTIS,,65.0,YR,,M,Y,65.6,KG,20180424.0,,CN,US,US,2018,Q2,Elderly
148015391,14801539,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"10 IU, TID",,,,,,,,10.0,IU,,TID,2018,Q2,Anaemia,,2018,Q2,1,I,20180223.0,20180417.0,20180424,20180424,EXP,,PHHY2018US068888,NOVARTIS,,65.0,YR,,M,Y,65.6,KG,20180424.0,,CN,US,US,2018,Q2,Elderly
148015391,14801539,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"10 IU, TID",,,,,,,,10.0,IU,,TID,2018,Q2,Cellulitis,,2018,Q2,1,I,20180223.0,20180417.0,20180424,20180424,EXP,,PHHY2018US068888,NOVARTIS,,65.0,YR,,M,Y,65.6,KG,20180424.0,,CN,US,US,2018,Q2,Elderly
148015391,14801539,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"10 IU, TID",,,,,,,,10.0,IU,,TID,2018,Q2,Confusional state,,2018,Q2,1,I,20180223.0,20180417.0,20180424,20180424,EXP,,PHHY2018US068888,NOVARTIS,,65.0,YR,,M,Y,65.6,KG,20180424.0,,CN,US,US,2018,Q2,Elderly
148015391,14801539,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"10 IU, TID",,,,,,,,10.0,IU,,TID,2018,Q2,Decreased appetite,,2018,Q2,1,I,20180223.0,20180417.0,20180424,20180424,EXP,,PHHY2018US068888,NOVARTIS,,65.0,YR,,M,Y,65.6,KG,20180424.0,,CN,US,US,2018,Q2,Elderly
148015391,14801539,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"10 IU, TID",,,,,,,,10.0,IU,,TID,2018,Q2,Diarrhoea,,2018,Q2,1,I,20180223.0,20180417.0,20180424,20180424,EXP,,PHHY2018US068888,NOVARTIS,,65.0,YR,,M,Y,65.6,KG,20180424.0,,CN,US,US,2018,Q2,Elderly
148015391,14801539,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"10 IU, TID",,,,,,,,10.0,IU,,TID,2018,Q2,Electrocardiogram abnormal,,2018,Q2,1,I,20180223.0,20180417.0,20180424,20180424,EXP,,PHHY2018US068888,NOVARTIS,,65.0,YR,,M,Y,65.6,KG,20180424.0,,CN,US,US,2018,Q2,Elderly
148015391,14801539,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"10 IU, TID",,,,,,,,10.0,IU,,TID,2018,Q2,Encephalopathy,,2018,Q2,1,I,20180223.0,20180417.0,20180424,20180424,EXP,,PHHY2018US068888,NOVARTIS,,65.0,YR,,M,Y,65.6,KG,20180424.0,,CN,US,US,2018,Q2,Elderly
148015391,14801539,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"10 IU, TID",,,,,,,,10.0,IU,,TID,2018,Q2,Fatigue,,2018,Q2,1,I,20180223.0,20180417.0,20180424,20180424,EXP,,PHHY2018US068888,NOVARTIS,,65.0,YR,,M,Y,65.6,KG,20180424.0,,CN,US,US,2018,Q2,Elderly
148015391,14801539,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"10 IU, TID",,,,,,,,10.0,IU,,TID,2018,Q2,Hypokalaemia,,2018,Q2,1,I,20180223.0,20180417.0,20180424,20180424,EXP,,PHHY2018US068888,NOVARTIS,,65.0,YR,,M,Y,65.6,KG,20180424.0,,CN,US,US,2018,Q2,Elderly
148015391,14801539,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"10 IU, TID",,,,,,,,10.0,IU,,TID,2018,Q2,Leukopenia,,2018,Q2,1,I,20180223.0,20180417.0,20180424,20180424,EXP,,PHHY2018US068888,NOVARTIS,,65.0,YR,,M,Y,65.6,KG,20180424.0,,CN,US,US,2018,Q2,Elderly
148015391,14801539,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"10 IU, TID",,,,,,,,10.0,IU,,TID,2018,Q2,Mental status changes,,2018,Q2,1,I,20180223.0,20180417.0,20180424,20180424,EXP,,PHHY2018US068888,NOVARTIS,,65.0,YR,,M,Y,65.6,KG,20180424.0,,CN,US,US,2018,Q2,Elderly
148015391,14801539,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"10 IU, TID",,,,,,,,10.0,IU,,TID,2018,Q2,Neutropenia,,2018,Q2,1,I,20180223.0,20180417.0,20180424,20180424,EXP,,PHHY2018US068888,NOVARTIS,,65.0,YR,,M,Y,65.6,KG,20180424.0,,CN,US,US,2018,Q2,Elderly
148015391,14801539,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"10 IU, TID",,,,,,,,10.0,IU,,TID,2018,Q2,Thrombocytopenia,,2018,Q2,1,I,20180223.0,20180417.0,20180424,20180424,EXP,,PHHY2018US068888,NOVARTIS,,65.0,YR,,M,Y,65.6,KG,20180424.0,,CN,US,US,2018,Q2,Elderly
148015391,14801539,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"10 IU, TID",,,,,,,,10.0,IU,,TID,2018,Q2,Urinary tract infection staphylococcal,,2018,Q2,1,I,20180223.0,20180417.0,20180424,20180424,EXP,,PHHY2018US068888,NOVARTIS,,65.0,YR,,M,Y,65.6,KG,20180424.0,,CN,US,US,2018,Q2,Elderly
148027621,14802762,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,"2 IU, 3X/DAY",,,,,,,,2.0,IU,,TID,2018,Q2,Death,,2018,Q2,1,I,20180414.0,20180322.0,20180424,20180424,EXP,,US-PFIZER INC-2018124136,PFIZER,,52.0,YR,,F,Y,68.0,KG,20180424.0,,OT,US,US,2018,Q2,Adult
148027621,14802762,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,"2 IU, 3X/DAY",,,,,,,,2.0,IU,,TID,2018,Q2,Product use in unapproved indication,,2018,Q2,1,I,20180414.0,20180322.0,20180424,20180424,EXP,,US-PFIZER INC-2018124136,PFIZER,,52.0,YR,,F,Y,68.0,KG,20180424.0,,OT,US,US,2018,Q2,Adult
148071923,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q2,Acute kidney injury,,2018,Q2,3,F,20170105.0,20180601.0,20180425,20180612,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,A,F,Y,71.66,KG,20180612.0,,OT,US,US,2018,Q2,Adult
148071923,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q2,Alanine aminotransferase increased,,2018,Q2,3,F,20170105.0,20180601.0,20180425,20180612,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,A,F,Y,71.66,KG,20180612.0,,OT,US,US,2018,Q2,Adult
148071923,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q2,Aspartate aminotransferase increased,,2018,Q2,3,F,20170105.0,20180601.0,20180425,20180612,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,A,F,Y,71.66,KG,20180612.0,,OT,US,US,2018,Q2,Adult
148071923,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q2,Blood magnesium decreased,,2018,Q2,3,F,20170105.0,20180601.0,20180425,20180612,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,A,F,Y,71.66,KG,20180612.0,,OT,US,US,2018,Q2,Adult
148071923,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q2,Blood potassium increased,,2018,Q2,3,F,20170105.0,20180601.0,20180425,20180612,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,A,F,Y,71.66,KG,20180612.0,,OT,US,US,2018,Q2,Adult
148071923,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q2,Chest discomfort,,2018,Q2,3,F,20170105.0,20180601.0,20180425,20180612,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,A,F,Y,71.66,KG,20180612.0,,OT,US,US,2018,Q2,Adult
148071923,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q2,Condition aggravated,,2018,Q2,3,F,20170105.0,20180601.0,20180425,20180612,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,A,F,Y,71.66,KG,20180612.0,,OT,US,US,2018,Q2,Adult
148071923,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q2,Dizziness,,2018,Q2,3,F,20170105.0,20180601.0,20180425,20180612,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,A,F,Y,71.66,KG,20180612.0,,OT,US,US,2018,Q2,Adult
148071923,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q2,Dyspnoea,,2018,Q2,3,F,20170105.0,20180601.0,20180425,20180612,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,A,F,Y,71.66,KG,20180612.0,,OT,US,US,2018,Q2,Adult
148071923,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q2,Flank pain,,2018,Q2,3,F,20170105.0,20180601.0,20180425,20180612,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,A,F,Y,71.66,KG,20180612.0,,OT,US,US,2018,Q2,Adult
148071923,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q2,Fluid retention,,2018,Q2,3,F,20170105.0,20180601.0,20180425,20180612,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,A,F,Y,71.66,KG,20180612.0,,OT,US,US,2018,Q2,Adult
148071923,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q2,Headache,,2018,Q2,3,F,20170105.0,20180601.0,20180425,20180612,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,A,F,Y,71.66,KG,20180612.0,,OT,US,US,2018,Q2,Adult
148071923,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q2,Hypovolaemia,,2018,Q2,3,F,20170105.0,20180601.0,20180425,20180612,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,A,F,Y,71.66,KG,20180612.0,,OT,US,US,2018,Q2,Adult
148071923,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q2,Hypoxia,,2018,Q2,3,F,20170105.0,20180601.0,20180425,20180612,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,A,F,Y,71.66,KG,20180612.0,,OT,US,US,2018,Q2,Adult
148071923,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q2,Malaise,,2018,Q2,3,F,20170105.0,20180601.0,20180425,20180612,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,A,F,Y,71.66,KG,20180612.0,,OT,US,US,2018,Q2,Adult
148071923,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q2,Mental status changes,,2018,Q2,3,F,20170105.0,20180601.0,20180425,20180612,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,A,F,Y,71.66,KG,20180612.0,,OT,US,US,2018,Q2,Adult
148071923,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q2,Nephrolithiasis,,2018,Q2,3,F,20170105.0,20180601.0,20180425,20180612,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,A,F,Y,71.66,KG,20180612.0,,OT,US,US,2018,Q2,Adult
148071923,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q2,Oxygen saturation decreased,,2018,Q2,3,F,20170105.0,20180601.0,20180425,20180612,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,A,F,Y,71.66,KG,20180612.0,,OT,US,US,2018,Q2,Adult
148071923,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q2,Pain in extremity,,2018,Q2,3,F,20170105.0,20180601.0,20180425,20180612,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,A,F,Y,71.66,KG,20180612.0,,OT,US,US,2018,Q2,Adult
148071923,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q2,Paraesthesia oral,,2018,Q2,3,F,20170105.0,20180601.0,20180425,20180612,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,A,F,Y,71.66,KG,20180612.0,,OT,US,US,2018,Q2,Adult
148071923,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q2,Presyncope,,2018,Q2,3,F,20170105.0,20180601.0,20180425,20180612,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,A,F,Y,71.66,KG,20180612.0,,OT,US,US,2018,Q2,Adult
148071923,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q2,Productive cough,,2018,Q2,3,F,20170105.0,20180601.0,20180425,20180612,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,A,F,Y,71.66,KG,20180612.0,,OT,US,US,2018,Q2,Adult
148071923,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q2,Pulmonary arterial hypertension,,2018,Q2,3,F,20170105.0,20180601.0,20180425,20180612,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,A,F,Y,71.66,KG,20180612.0,,OT,US,US,2018,Q2,Adult
148071923,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q2,Pyrexia,,2018,Q2,3,F,20170105.0,20180601.0,20180425,20180612,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,A,F,Y,71.66,KG,20180612.0,,OT,US,US,2018,Q2,Adult
148071923,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q2,Sinusitis,,2018,Q2,3,F,20170105.0,20180601.0,20180425,20180612,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,A,F,Y,71.66,KG,20180612.0,,OT,US,US,2018,Q2,Adult
148071923,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q2,Urinary tract infection,,2018,Q2,3,F,20170105.0,20180601.0,20180425,20180612,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,A,F,Y,71.66,KG,20180612.0,,OT,US,US,2018,Q2,Adult
148071923,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q2,Viral infection,,2018,Q2,3,F,20170105.0,20180601.0,20180425,20180612,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,A,F,Y,71.66,KG,20180612.0,,OT,US,US,2018,Q2,Adult
148071923,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q2,White blood cell count increased,,2018,Q2,3,F,20170105.0,20180601.0,20180425,20180612,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,A,F,Y,71.66,KG,20180612.0,,OT,US,US,2018,Q2,Adult
148147501,14814750,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,NACH SCHEMA (),,,,, UNKNOWN,,,,,,,2018,Q2,Contraindicated product administered,,2018,Q2,1,I,,20180412.0,20180426,20180426,EXP,,DE-AUROBINDO-AUR-APL-2018-021160,AUROBINDO,,68.0,YR,,M,Y,,,20180426.0,,PH,DE,DE,2018,Q2,Elderly
148147501,14814750,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,NACH SCHEMA (),,,,, UNKNOWN,,,,,,,2018,Q2,Dyspnoea,,2018,Q2,1,I,,20180412.0,20180426,20180426,EXP,,DE-AUROBINDO-AUR-APL-2018-021160,AUROBINDO,,68.0,YR,,M,Y,,,20180426.0,,PH,DE,DE,2018,Q2,Elderly
148147501,14814750,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,NACH SCHEMA (),,,,, UNKNOWN,,,,,,,2018,Q2,Oedema peripheral,,2018,Q2,1,I,,20180412.0,20180426,20180426,EXP,,DE-AUROBINDO-AUR-APL-2018-021160,AUROBINDO,,68.0,YR,,M,Y,,,20180426.0,,PH,DE,DE,2018,Q2,Elderly
148181071,14818107,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,12-12-10 U (ADAPTED ACCORDING TO THE SACCHARIDES IN FOOD) (),,,U,U,,,,,,,,2018,Q2,Diabetic metabolic decompensation,,2018,Q2,1,I,,20180412.0,20180427,20180427,EXP,,CZ-AUROBINDO-AUR-APL-2018-022080,AUROBINDO,NEVRLA J.. RETINOPATHY AS AN EARLY COMPLICATION OF DIABETES MELLITUS.. KAZUISTIKY V DIABETOLOGII. 2017,43.0,YR,,F,Y,,,20180427.0,,MD,CZ,CZ,2018,Q2,Adult
148181071,14818107,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,12-12-10 U (ADAPTED ACCORDING TO THE SACCHARIDES IN FOOD) (),,,U,U,,,,,,,,2018,Q2,Drug ineffective,,2018,Q2,1,I,,20180412.0,20180427,20180427,EXP,,CZ-AUROBINDO-AUR-APL-2018-022080,AUROBINDO,NEVRLA J.. RETINOPATHY AS AN EARLY COMPLICATION OF DIABETES MELLITUS.. KAZUISTIKY V DIABETOLOGII. 2017,43.0,YR,,F,Y,,,20180427.0,,MD,CZ,CZ,2018,Q2,Adult
148198931,14819893,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2018,Q2,Electrolyte imbalance,,2018,Q2,1,I,,20180416.0,20180427,20180427,EXP,,DE-VALIDUS PHARMACEUTICALS LLC-DE-2018VAL000700,VALIDUS,,83.0,YR,,M,Y,,,20180427.0,,MD,DE,DE,2018,Q2,Elderly
148198931,14819893,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2018,Q2,Pain,,2018,Q2,1,I,,20180416.0,20180427,20180427,EXP,,DE-VALIDUS PHARMACEUTICALS LLC-DE-2018VAL000700,VALIDUS,,83.0,YR,,M,Y,,,20180427.0,,MD,DE,DE,2018,Q2,Elderly
148198931,14819893,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2018,Q2,Skin ulcer,,2018,Q2,1,I,,20180416.0,20180427,20180427,EXP,,DE-VALIDUS PHARMACEUTICALS LLC-DE-2018VAL000700,VALIDUS,,83.0,YR,,M,Y,,,20180427.0,,MD,DE,DE,2018,Q2,Elderly
148201781,14820178,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2018,Q2,Drug interaction,,2018,Q2,1,I,20180126.0,20180403.0,20180427,20180427,EXP,,PHHY2018IT061106,SANDOZ,,70.0,YR,,M,Y,60.0,KG,20180427.0,,OT,IT,IT,2018,Q2,Elderly
148201781,14820178,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2018,Q2,Electrocardiogram QT prolonged,,2018,Q2,1,I,20180126.0,20180403.0,20180427,20180427,EXP,,PHHY2018IT061106,SANDOZ,,70.0,YR,,M,Y,60.0,KG,20180427.0,,OT,IT,IT,2018,Q2,Elderly
148214971,14821497,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,NACH BZ,,,,,,,,,,,,2018,Q2,Diarrhoea,,2018,Q2,1,I,,20180414.0,20180427,20180427,EXP,,DE-AUROBINDO-AUR-APL-2018-022354,AUROBINDO,,59.0,YR,,M,Y,,,20180427.0,,PH,DE,DE,2018,Q2,Adult
148214971,14821497,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,NACH BZ,,,,,,,,,,,,2018,Q2,Haematuria,,2018,Q2,1,I,,20180414.0,20180427,20180427,EXP,,DE-AUROBINDO-AUR-APL-2018-022354,AUROBINDO,,59.0,YR,,M,Y,,,20180427.0,,PH,DE,DE,2018,Q2,Adult
148254761,14825476,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"33 IU, TID",,,,,,,,99.0,IU,,,2018,Q2,Gastritis erosive,,2018,Q2,1,I,20161030.0,20180415.0,20180430,20180430,EXP,,DE-AUROBINDO-AUR-APL-2018-022583,AUROBINDO,,64.0,YR,,M,Y,101.0,KG,20180430.0,,MD,DE,DE,2018,Q2,Adult
148254761,14825476,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"33 IU, TID",,,,,,,,99.0,IU,,,2018,Q2,Melaena,,2018,Q2,1,I,20161030.0,20180415.0,20180430,20180430,EXP,,DE-AUROBINDO-AUR-APL-2018-022583,AUROBINDO,,64.0,YR,,M,Y,101.0,KG,20180430.0,,MD,DE,DE,2018,Q2,Adult
148277012,14827701,13,C,INSULIN LISPRO(GENETICAL RECOMBINATION),,2,Parenteral,"12 DF, TID",,,U,,,,,12.0,DF,INJECTION,TID,2018,Q2,Atrial fibrillation,,2018,Q2,2,F,20171002.0,20180508.0,20180430,20180515,EXP,,JP-009507513-1803JPN000430J,MERCK,,76.0,YR,,M,Y,73.0,KG,20180515.0,,MD,JP,JP,2018,Q2,Elderly
148277012,14827701,13,C,INSULIN LISPRO(GENETICAL RECOMBINATION),,2,Parenteral,"12 DF, TID",,,U,,,,,12.0,DF,INJECTION,TID,2018,Q2,Malignant neoplasm progression,,2018,Q2,2,F,20171002.0,20180508.0,20180430,20180515,EXP,,JP-009507513-1803JPN000430J,MERCK,,76.0,YR,,M,Y,73.0,KG,20180515.0,,MD,JP,JP,2018,Q2,Elderly
148277012,14827701,13,C,INSULIN LISPRO(GENETICAL RECOMBINATION),,2,Parenteral,"12 DF, TID",,,U,,,,,12.0,DF,INJECTION,TID,2018,Q2,Thyroiditis,,2018,Q2,2,F,20171002.0,20180508.0,20180430,20180515,EXP,,JP-009507513-1803JPN000430J,MERCK,,76.0,YR,,M,Y,73.0,KG,20180515.0,,MD,JP,JP,2018,Q2,Elderly
148313611,14831361,10,C,Insulin lispro,INSULIN LISPRO,1,Unknown,NACH SCHEMA,,,,U,,,,,,,,2018,Q2,Contraindicated product administered,,2018,Q2,1,I,,20180418.0,20180501,20180501,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2018R1-171108,RANBAXY,,68.0,YR,,M,Y,,,20180501.0,,OT,DE,DE,2018,Q2,Elderly
148313611,14831361,10,C,Insulin lispro,INSULIN LISPRO,1,Unknown,NACH SCHEMA,,,,U,,,,,,,,2018,Q2,Dyspnoea,,2018,Q2,1,I,,20180418.0,20180501,20180501,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2018R1-171108,RANBAXY,,68.0,YR,,M,Y,,,20180501.0,,OT,DE,DE,2018,Q2,Elderly
148313611,14831361,10,C,Insulin lispro,INSULIN LISPRO,1,Unknown,NACH SCHEMA,,,,U,,,,,,,,2018,Q2,Oedema peripheral,,2018,Q2,1,I,,20180418.0,20180501,20180501,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2018R1-171108,RANBAXY,,68.0,YR,,M,Y,,,20180501.0,,OT,DE,DE,2018,Q2,Elderly
148328521,14832852,4,C,"insulin lispro 8 units breakfast, 8 units lunch, 10 units dinner",,2,,,,,,,,,,,,,,2018,Q2,Abdominal discomfort,,2018,Q2,1,I,20180121.0,,20180411,20180411,DIR,,,FDA-CTU,,64.0,YR,,F,N,60.05,KG,20180411.0,N,PH,US,US,2018,Q2,Adult
148328521,14832852,4,C,"insulin lispro 8 units breakfast, 8 units lunch, 10 units dinner",,2,,,,,,,,,,,,,,2018,Q2,Abdominal pain,,2018,Q2,1,I,20180121.0,,20180411,20180411,DIR,,,FDA-CTU,,64.0,YR,,F,N,60.05,KG,20180411.0,N,PH,US,US,2018,Q2,Adult
148328521,14832852,4,C,"insulin lispro 8 units breakfast, 8 units lunch, 10 units dinner",,2,,,,,,,,,,,,,,2018,Q2,Back pain,,2018,Q2,1,I,20180121.0,,20180411,20180411,DIR,,,FDA-CTU,,64.0,YR,,F,N,60.05,KG,20180411.0,N,PH,US,US,2018,Q2,Adult
148328521,14832852,4,C,"insulin lispro 8 units breakfast, 8 units lunch, 10 units dinner",,2,,,,,,,,,,,,,,2018,Q2,Decreased appetite,,2018,Q2,1,I,20180121.0,,20180411,20180411,DIR,,,FDA-CTU,,64.0,YR,,F,N,60.05,KG,20180411.0,N,PH,US,US,2018,Q2,Adult
148328521,14832852,4,C,"insulin lispro 8 units breakfast, 8 units lunch, 10 units dinner",,2,,,,,,,,,,,,,,2018,Q2,Gastrooesophageal reflux disease,,2018,Q2,1,I,20180121.0,,20180411,20180411,DIR,,,FDA-CTU,,64.0,YR,,F,N,60.05,KG,20180411.0,N,PH,US,US,2018,Q2,Adult
148328521,14832852,4,C,"insulin lispro 8 units breakfast, 8 units lunch, 10 units dinner",,2,,,,,,,,,,,,,,2018,Q2,Helicobacter test positive,,2018,Q2,1,I,20180121.0,,20180411,20180411,DIR,,,FDA-CTU,,64.0,YR,,F,N,60.05,KG,20180411.0,N,PH,US,US,2018,Q2,Adult
148328521,14832852,4,C,"insulin lispro 8 units breakfast, 8 units lunch, 10 units dinner",,2,,,,,,,,,,,,,,2018,Q2,Hiatus hernia,,2018,Q2,1,I,20180121.0,,20180411,20180411,DIR,,,FDA-CTU,,64.0,YR,,F,N,60.05,KG,20180411.0,N,PH,US,US,2018,Q2,Adult
148328521,14832852,4,C,"insulin lispro 8 units breakfast, 8 units lunch, 10 units dinner",,2,,,,,,,,,,,,,,2018,Q2,Hyperglycaemia,,2018,Q2,1,I,20180121.0,,20180411,20180411,DIR,,,FDA-CTU,,64.0,YR,,F,N,60.05,KG,20180411.0,N,PH,US,US,2018,Q2,Adult
148328521,14832852,4,C,"insulin lispro 8 units breakfast, 8 units lunch, 10 units dinner",,2,,,,,,,,,,,,,,2018,Q2,Hypophagia,,2018,Q2,1,I,20180121.0,,20180411,20180411,DIR,,,FDA-CTU,,64.0,YR,,F,N,60.05,KG,20180411.0,N,PH,US,US,2018,Q2,Adult
148328521,14832852,4,C,"insulin lispro 8 units breakfast, 8 units lunch, 10 units dinner",,2,,,,,,,,,,,,,,2018,Q2,Melaena,,2018,Q2,1,I,20180121.0,,20180411,20180411,DIR,,,FDA-CTU,,64.0,YR,,F,N,60.05,KG,20180411.0,N,PH,US,US,2018,Q2,Adult
148328521,14832852,4,C,"insulin lispro 8 units breakfast, 8 units lunch, 10 units dinner",,2,,,,,,,,,,,,,,2018,Q2,Nausea,,2018,Q2,1,I,20180121.0,,20180411,20180411,DIR,,,FDA-CTU,,64.0,YR,,F,N,60.05,KG,20180411.0,N,PH,US,US,2018,Q2,Adult
148328521,14832852,4,C,"insulin lispro 8 units breakfast, 8 units lunch, 10 units dinner",,2,,,,,,,,,,,,,,2018,Q2,Pain,,2018,Q2,1,I,20180121.0,,20180411,20180411,DIR,,,FDA-CTU,,64.0,YR,,F,N,60.05,KG,20180411.0,N,PH,US,US,2018,Q2,Adult
148328521,14832852,4,C,"insulin lispro 8 units breakfast, 8 units lunch, 10 units dinner",,2,,,,,,,,,,,,,,2018,Q2,Small intestinal obstruction,,2018,Q2,1,I,20180121.0,,20180411,20180411,DIR,,,FDA-CTU,,64.0,YR,,F,N,60.05,KG,20180411.0,N,PH,US,US,2018,Q2,Adult
148378081,14837808,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"12 U, TID (MORNING, NOON AND NIGHT)",,,,,,,20563.0,12.0,IU,,TID,2018,Q2,Incorrect dose administered,,2018,Q2,1,I,,20180420.0,20180502,20180502,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201804011753,ELI LILLY AND CO,,73.0,YR,,M,Y,76.0,KG,20180502.0,,CN,CN,CN,2018,Q2,Elderly
148378081,14837808,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"12 U, TID (MORNING, NOON AND NIGHT)",,,,,,,20563.0,12.0,IU,,TID,2018,Q2,Nephropathy,,2018,Q2,1,I,,20180420.0,20180502,20180502,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201804011753,ELI LILLY AND CO,,73.0,YR,,M,Y,76.0,KG,20180502.0,,CN,CN,CN,2018,Q2,Elderly
148381701,14838170,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,D,,,,,33.0,IU,UNSPECIFIED,TID,2018,Q2,Gastritis erosive,,2018,Q2,1,I,20161030.0,20180418.0,20180502,20180502,EXP,,DE-JNJFOC-20180424146,JOHNSON AND JOHNSON,,64.0,YR,A,M,Y,101.0,KG,20180502.0,,MD,DE,DE,2018,Q2,Adult
148381701,14838170,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,D,,,,,33.0,IU,UNSPECIFIED,TID,2018,Q2,Melaena,,2018,Q2,1,I,20161030.0,20180418.0,20180502,20180502,EXP,,DE-JNJFOC-20180424146,JOHNSON AND JOHNSON,,64.0,YR,A,M,Y,101.0,KG,20180502.0,,MD,DE,DE,2018,Q2,Adult
148388491,14838849,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q2,Acute kidney injury,,2018,Q2,1,I,,20180423.0,20180502,20180502,EXP,,DE-PFIZER INC-2018179075,PFIZER,,67.0,YR,,F,Y,,,20180502.0,,MD,DE,DE,2018,Q2,Elderly
148388491,14838849,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q2,General physical health deterioration,,2018,Q2,1,I,,20180423.0,20180502,20180502,EXP,,DE-PFIZER INC-2018179075,PFIZER,,67.0,YR,,F,Y,,,20180502.0,,MD,DE,DE,2018,Q2,Elderly
148388491,14838849,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q2,Renal impairment,,2018,Q2,1,I,,20180423.0,20180502,20180502,EXP,,DE-PFIZER INC-2018179075,PFIZER,,67.0,YR,,F,Y,,,20180502.0,,MD,DE,DE,2018,Q2,Elderly
148393661,14839366,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,Y,,,,20563.0,,,,,2018,Q2,Diabetic ketoacidosis,,2018,Q2,1,I,,20180419.0,20180502,20180502,EXP,,US-ELI_LILLY_AND_COMPANY-US201804011807,ELI LILLY AND CO,"MURRAY B.R., JEWELL J.R., JACKSON K.J., AGBOOLA O., ALEXANDER B.R., SHARMA P..TYPE III HYPERSENSITIVITY REACTION TO SUBCUTANEOUS INSULIN PREPARATIONS IN A TYPE 1 DIABETIC.JOURNAL OF GENERAL INTERNAL MEDICINE 2017;32 (7):841-845.",23.0,YR,,F,Y,,,20180502.0,,OT,US,US,2018,Q2,Youth
148393661,14839366,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,Y,,,,20563.0,,,,,2018,Q2,Hypersensitivity vasculitis,,2018,Q2,1,I,,20180419.0,20180502,20180502,EXP,,US-ELI_LILLY_AND_COMPANY-US201804011807,ELI LILLY AND CO,"MURRAY B.R., JEWELL J.R., JACKSON K.J., AGBOOLA O., ALEXANDER B.R., SHARMA P..TYPE III HYPERSENSITIVITY REACTION TO SUBCUTANEOUS INSULIN PREPARATIONS IN A TYPE 1 DIABETIC.JOURNAL OF GENERAL INTERNAL MEDICINE 2017;32 (7):841-845.",23.0,YR,,F,Y,,,20180502.0,,OT,US,US,2018,Q2,Youth
148422741,14842274,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2018,Q2,Oedema peripheral,,2018,Q2,1,I,2017.0,20180423.0,20180503,20180503,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201804013314,ELI LILLY AND CO,,35.0,YR,,F,Y,,,20180503.0,,CN,CN,CN,2018,Q2,Adult
148464281,14846428,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2018,Q2,Ankle fracture,,2018,Q2,1,I,,20180501.0,20180504,20180504,PER,,US-ELI_LILLY_AND_COMPANY-US201805000771,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20180504.0,,CN,US,US,2018,Q2,Adult
148464281,14846428,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2018,Q2,Fall,,2018,Q2,1,I,,20180501.0,20180504,20180504,PER,,US-ELI_LILLY_AND_COMPANY-US201805000771,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20180504.0,,CN,US,US,2018,Q2,Adult
148599881,14859988,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,, UNK,,209196.0,,,,,2018,Q2,Blood glucose abnormal,,2018,Q2,1,I,,20180424.0,20180508,20180508,EXP,,GB-SA-2018SA119352,AVENTIS,,51.0,YR,A,M,Y,,,20180508.0,,CN,GB,GB,2018,Q2,Adult
148599881,14859988,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,, UNK,,209196.0,,,,,2018,Q2,Blood glucose decreased,,2018,Q2,1,I,,20180424.0,20180508,20180508,EXP,,GB-SA-2018SA119352,AVENTIS,,51.0,YR,A,M,Y,,,20180508.0,,CN,GB,GB,2018,Q2,Adult
148599881,14859988,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,, UNK,,209196.0,,,,,2018,Q2,Feeding disorder,,2018,Q2,1,I,,20180424.0,20180508,20180508,EXP,,GB-SA-2018SA119352,AVENTIS,,51.0,YR,A,M,Y,,,20180508.0,,CN,GB,GB,2018,Q2,Adult
148599881,14859988,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,, UNK,,209196.0,,,,,2018,Q2,Feeling hot,,2018,Q2,1,I,,20180424.0,20180508,20180508,EXP,,GB-SA-2018SA119352,AVENTIS,,51.0,YR,A,M,Y,,,20180508.0,,CN,GB,GB,2018,Q2,Adult
148599881,14859988,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,, UNK,,209196.0,,,,,2018,Q2,Hiatus hernia,,2018,Q2,1,I,,20180424.0,20180508,20180508,EXP,,GB-SA-2018SA119352,AVENTIS,,51.0,YR,A,M,Y,,,20180508.0,,CN,GB,GB,2018,Q2,Adult
148599881,14859988,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,, UNK,,209196.0,,,,,2018,Q2,Malaise,,2018,Q2,1,I,,20180424.0,20180508,20180508,EXP,,GB-SA-2018SA119352,AVENTIS,,51.0,YR,A,M,Y,,,20180508.0,,CN,GB,GB,2018,Q2,Adult
148599881,14859988,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,, UNK,,209196.0,,,,,2018,Q2,Pain,,2018,Q2,1,I,,20180424.0,20180508,20180508,EXP,,GB-SA-2018SA119352,AVENTIS,,51.0,YR,A,M,Y,,,20180508.0,,CN,GB,GB,2018,Q2,Adult
148599881,14859988,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,, UNK,,209196.0,,,,,2018,Q2,Rash erythematous,,2018,Q2,1,I,,20180424.0,20180508,20180508,EXP,,GB-SA-2018SA119352,AVENTIS,,51.0,YR,A,M,Y,,,20180508.0,,CN,GB,GB,2018,Q2,Adult
148612791,14861279,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q2,Arteriosclerosis,,2018,Q2,1,I,20180216.0,20180320.0,20180508,20180508,EXP,,PHHY2018US059119,SANDOZ,,62.0,YR,,F,Y,126.98,KG,20180508.0,,MD,US,US,2018,Q2,Adult
148612791,14861279,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q2,Blood creatinine increased,,2018,Q2,1,I,20180216.0,20180320.0,20180508,20180508,EXP,,PHHY2018US059119,SANDOZ,,62.0,YR,,F,Y,126.98,KG,20180508.0,,MD,US,US,2018,Q2,Adult
148612791,14861279,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q2,Blood glucose increased,,2018,Q2,1,I,20180216.0,20180320.0,20180508,20180508,EXP,,PHHY2018US059119,SANDOZ,,62.0,YR,,F,Y,126.98,KG,20180508.0,,MD,US,US,2018,Q2,Adult
148612791,14861279,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q2,Blood urea increased,,2018,Q2,1,I,20180216.0,20180320.0,20180508,20180508,EXP,,PHHY2018US059119,SANDOZ,,62.0,YR,,F,Y,126.98,KG,20180508.0,,MD,US,US,2018,Q2,Adult
148612791,14861279,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q2,Dehydration,,2018,Q2,1,I,20180216.0,20180320.0,20180508,20180508,EXP,,PHHY2018US059119,SANDOZ,,62.0,YR,,F,Y,126.98,KG,20180508.0,,MD,US,US,2018,Q2,Adult
148612791,14861279,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q2,Haematocrit decreased,,2018,Q2,1,I,20180216.0,20180320.0,20180508,20180508,EXP,,PHHY2018US059119,SANDOZ,,62.0,YR,,F,Y,126.98,KG,20180508.0,,MD,US,US,2018,Q2,Adult
148612791,14861279,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q2,Syncope,,2018,Q2,1,I,20180216.0,20180320.0,20180508,20180508,EXP,,PHHY2018US059119,SANDOZ,,62.0,YR,,F,Y,126.98,KG,20180508.0,,MD,US,US,2018,Q2,Adult
148612791,14861279,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q2,White blood cell count increased,,2018,Q2,1,I,20180216.0,20180320.0,20180508,20180508,EXP,,PHHY2018US059119,SANDOZ,,62.0,YR,,F,Y,126.98,KG,20180508.0,,MD,US,US,2018,Q2,Adult
148765441,14876544,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"12-13 U, EACH MORNING",,,,,,,20563.0,13.0,IU,,QD,2018,Q2,Blindness,,2018,Q2,1,I,2016.0,20180428.0,20180510,20180510,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201805000901,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20180510.0,,CN,CN,CN,2018,Q2,Elderly
148765441,14876544,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"12-13 U, EACH MORNING",,,,,,,20563.0,13.0,IU,,QD,2018,Q2,Blood glucose increased,,2018,Q2,1,I,2016.0,20180428.0,20180510,20180510,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201805000901,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20180510.0,,CN,CN,CN,2018,Q2,Elderly
148765441,14876544,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"12-13 U, EACH MORNING",,,,,,,20563.0,13.0,IU,,QD,2018,Q2,Drug dose omission,,2018,Q2,1,I,2016.0,20180428.0,20180510,20180510,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201805000901,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20180510.0,,CN,CN,CN,2018,Q2,Elderly
148765441,14876544,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"12-13 U, EACH MORNING",,,,,,,20563.0,13.0,IU,,QD,2018,Q2,Fat tissue increased,,2018,Q2,1,I,2016.0,20180428.0,20180510,20180510,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201805000901,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20180510.0,,CN,CN,CN,2018,Q2,Elderly
148765441,14876544,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"12-13 U, AT NIGHT",,,,,,,20563.0,13.0,IU,,QD,2018,Q2,Blindness,,2018,Q2,1,I,2016.0,20180428.0,20180510,20180510,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201805000901,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20180510.0,,CN,CN,CN,2018,Q2,Elderly
148765441,14876544,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"12-13 U, AT NIGHT",,,,,,,20563.0,13.0,IU,,QD,2018,Q2,Blood glucose increased,,2018,Q2,1,I,2016.0,20180428.0,20180510,20180510,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201805000901,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20180510.0,,CN,CN,CN,2018,Q2,Elderly
148765441,14876544,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"12-13 U, AT NIGHT",,,,,,,20563.0,13.0,IU,,QD,2018,Q2,Drug dose omission,,2018,Q2,1,I,2016.0,20180428.0,20180510,20180510,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201805000901,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20180510.0,,CN,CN,CN,2018,Q2,Elderly
148765441,14876544,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"12-13 U, AT NIGHT",,,,,,,20563.0,13.0,IU,,QD,2018,Q2,Fat tissue increased,,2018,Q2,1,I,2016.0,20180428.0,20180510,20180510,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201805000901,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20180510.0,,CN,CN,CN,2018,Q2,Elderly
148765441,14876544,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, EACH MORNING",,,,,,,20563.0,15.0,IU,,QD,2018,Q2,Blindness,,2018,Q2,1,I,2016.0,20180428.0,20180510,20180510,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201805000901,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20180510.0,,CN,CN,CN,2018,Q2,Elderly
148765441,14876544,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, EACH MORNING",,,,,,,20563.0,15.0,IU,,QD,2018,Q2,Blood glucose increased,,2018,Q2,1,I,2016.0,20180428.0,20180510,20180510,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201805000901,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20180510.0,,CN,CN,CN,2018,Q2,Elderly
148765441,14876544,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, EACH MORNING",,,,,,,20563.0,15.0,IU,,QD,2018,Q2,Drug dose omission,,2018,Q2,1,I,2016.0,20180428.0,20180510,20180510,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201805000901,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20180510.0,,CN,CN,CN,2018,Q2,Elderly
148765441,14876544,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, EACH MORNING",,,,,,,20563.0,15.0,IU,,QD,2018,Q2,Fat tissue increased,,2018,Q2,1,I,2016.0,20180428.0,20180510,20180510,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201805000901,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20180510.0,,CN,CN,CN,2018,Q2,Elderly
148765441,14876544,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, AT NIGHT",,,,,,,20563.0,15.0,IU,,QD,2018,Q2,Blindness,,2018,Q2,1,I,2016.0,20180428.0,20180510,20180510,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201805000901,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20180510.0,,CN,CN,CN,2018,Q2,Elderly
148765441,14876544,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, AT NIGHT",,,,,,,20563.0,15.0,IU,,QD,2018,Q2,Blood glucose increased,,2018,Q2,1,I,2016.0,20180428.0,20180510,20180510,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201805000901,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20180510.0,,CN,CN,CN,2018,Q2,Elderly
148765441,14876544,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, AT NIGHT",,,,,,,20563.0,15.0,IU,,QD,2018,Q2,Drug dose omission,,2018,Q2,1,I,2016.0,20180428.0,20180510,20180510,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201805000901,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20180510.0,,CN,CN,CN,2018,Q2,Elderly
148765441,14876544,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, AT NIGHT",,,,,,,20563.0,15.0,IU,,QD,2018,Q2,Fat tissue increased,,2018,Q2,1,I,2016.0,20180428.0,20180510,20180510,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201805000901,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20180510.0,,CN,CN,CN,2018,Q2,Elderly
148791412,14879141,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,BENEATH THE SKIN AT BEDTIME,,,,,,,,,,,,2018,Q2,Atrial fibrillation,,2018,Q2,2,F,20180503.0,20180510.0,20180511,20180523,EXP,,US-ROCHE-2120287,ROCHE,,75.0,YR,,M,Y,91.71,KG,20180523.0,,MD,US,US,2018,Q2,Elderly
148797291,14879729,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"1 U, DAILY BEFORE BREAKFAST",,,,,,,20563.0,1.0,IU,,QD,2018,Q2,Hypoglycaemia,,2018,Q2,1,I,20180428.0,20180430.0,20180511,20180511,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201805000146,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20180511.0,,CN,IN,IN,2018,Q2,Adult
148797291,14879729,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"1 U, DAILY BEFORE BREAKFAST",,,,,,,20563.0,1.0,IU,,QD,2018,Q2,Syncope,,2018,Q2,1,I,20180428.0,20180430.0,20180511,20180511,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201805000146,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20180511.0,,CN,IN,IN,2018,Q2,Adult
148797291,14879729,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"1 U, DAILY BEFORE DINNER",,,,,,,20563.0,1.0,IU,,QD,2018,Q2,Hypoglycaemia,,2018,Q2,1,I,20180428.0,20180430.0,20180511,20180511,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201805000146,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20180511.0,,CN,IN,IN,2018,Q2,Adult
148797291,14879729,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"1 U, DAILY BEFORE DINNER",,,,,,,20563.0,1.0,IU,,QD,2018,Q2,Syncope,,2018,Q2,1,I,20180428.0,20180430.0,20180511,20180511,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201805000146,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20180511.0,,CN,IN,IN,2018,Q2,Adult
148799671,14879967,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNIT/ML,,,U,,,,,,,INJECTION,,2018,Q2,Diabetic ketoacidosis,,2018,Q2,1,I,20150603.0,20170815.0,20180511,20180511,EXP,,US-JNJFOC-20170816186,JANSSEN,,33.0,YR,A,M,Y,74.84,KG,20180511.0,,CN,US,US,2018,Q2,Young Adult
148823671,14882367,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q2,Blood glucose abnormal,,2018,Q2,1,I,,20180427.0,20180511,20180511,EXP,,BG-SA-2018SA123840,AVENTIS,,7.0,YR,C,M,Y,,,20180511.0,,MD,BG,BG,2018,Q2,Child
148823671,14882367,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q2,Glycosylated haemoglobin increased,,2018,Q2,1,I,,20180427.0,20180511,20180511,EXP,,BG-SA-2018SA123840,AVENTIS,,7.0,YR,C,M,Y,,,20180511.0,,MD,BG,BG,2018,Q2,Child
148823671,14882367,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q2,Hypoglycaemia,,2018,Q2,1,I,,20180427.0,20180511,20180511,EXP,,BG-SA-2018SA123840,AVENTIS,,7.0,YR,C,M,Y,,,20180511.0,,MD,BG,BG,2018,Q2,Child
148823671,14882367,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q2,Neuropathy peripheral,,2018,Q2,1,I,,20180427.0,20180511,20180511,EXP,,BG-SA-2018SA123840,AVENTIS,,7.0,YR,C,M,Y,,,20180511.0,,MD,BG,BG,2018,Q2,Child
148918791,14891879,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,, UNK,,,,,,,2018,Q2,Asthenia,,2018,Q2,1,I,20150829.0,20180503.0,20180514,20180514,EXP,IT-MINISAL02-472189,IT-SA-2018SA128726,AVENTIS,,83.0,YR,E,M,Y,,,20180514.0,,MD,IT,IT,2018,Q2,Elderly
148918791,14891879,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,, UNK,,,,,,,2018,Q2,Cold sweat,,2018,Q2,1,I,20150829.0,20180503.0,20180514,20180514,EXP,IT-MINISAL02-472189,IT-SA-2018SA128726,AVENTIS,,83.0,YR,E,M,Y,,,20180514.0,,MD,IT,IT,2018,Q2,Elderly
148918791,14891879,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,, UNK,,,,,,,2018,Q2,Hypoglycaemia,,2018,Q2,1,I,20150829.0,20180503.0,20180514,20180514,EXP,IT-MINISAL02-472189,IT-SA-2018SA128726,AVENTIS,,83.0,YR,E,M,Y,,,20180514.0,,MD,IT,IT,2018,Q2,Elderly
148918791,14891879,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,, UNK,,,,,,,2018,Q2,Presyncope,,2018,Q2,1,I,20150829.0,20180503.0,20180514,20180514,EXP,IT-MINISAL02-472189,IT-SA-2018SA128726,AVENTIS,,83.0,YR,E,M,Y,,,20180514.0,,MD,IT,IT,2018,Q2,Elderly
148918791,14891879,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,, UNK,,,,,,,2018,Q2,Vomiting,,2018,Q2,1,I,20150829.0,20180503.0,20180514,20180514,EXP,IT-MINISAL02-472189,IT-SA-2018SA128726,AVENTIS,,83.0,YR,E,M,Y,,,20180514.0,,MD,IT,IT,2018,Q2,Elderly
149053181,14905318,3,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Amnesia,,2018,Q2,1,I,19980101.0,20171211.0,20180517,20180517,PER,,US-SA-2017SA247295,AVENTIS,,68.0,YR,A,M,Y,104.33,KG,20180517.0,,CN,US,US,2018,Q2,Elderly
149053181,14905318,3,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Hyperglycaemia,,2018,Q2,1,I,19980101.0,20171211.0,20180517,20180517,PER,,US-SA-2017SA247295,AVENTIS,,68.0,YR,A,M,Y,104.33,KG,20180517.0,,CN,US,US,2018,Q2,Elderly
149053181,14905318,3,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Muscle spasms,,2018,Q2,1,I,19980101.0,20171211.0,20180517,20180517,PER,,US-SA-2017SA247295,AVENTIS,,68.0,YR,A,M,Y,104.33,KG,20180517.0,,CN,US,US,2018,Q2,Elderly
149053181,14905318,3,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Product use issue,,2018,Q2,1,I,19980101.0,20171211.0,20180517,20180517,PER,,US-SA-2017SA247295,AVENTIS,,68.0,YR,A,M,Y,104.33,KG,20180517.0,,CN,US,US,2018,Q2,Elderly
149071551,14907155,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2018,Q2,Blood glucose decreased,,2018,Q2,1,I,,20180515.0,20180517,20180517,PER,,US-ELI_LILLY_AND_COMPANY-US201805006743,ELI LILLY AND CO,,62.0,YR,,,Y,,,20180517.0,,CN,US,US,2018,Q2,Adult
149071551,14907155,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2018,Q2,Blood glucose increased,,2018,Q2,1,I,,20180515.0,20180517,20180517,PER,,US-ELI_LILLY_AND_COMPANY-US201805006743,ELI LILLY AND CO,,62.0,YR,,,Y,,,20180517.0,,CN,US,US,2018,Q2,Adult
149071551,14907155,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2018,Q2,Glycosylated haemoglobin increased,,2018,Q2,1,I,,20180515.0,20180517,20180517,PER,,US-ELI_LILLY_AND_COMPANY-US201805006743,ELI LILLY AND CO,,62.0,YR,,,Y,,,20180517.0,,CN,US,US,2018,Q2,Adult
149112231,14911223,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2018,Q2,Blood glucose increased,,2018,Q2,1,I,,20180515.0,20180518,20180518,PER,,US-ELI_LILLY_AND_COMPANY-US201805006770,ELI LILLY AND CO,,59.0,YR,,,Y,,,20180518.0,,CN,US,US,2018,Q2,Adult
149155061,14915506,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,,,,20563.0,,,,,2018,Q2,Drug administration error,,2018,Q2,1,I,20170516.0,20180507.0,20180518,20180518,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201805003021,ELI LILLY AND CO,,85.0,YR,,M,Y,70.0,KG,20180518.0,,CN,DE,DE,2018,Q2,Elderly
149155061,14915506,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,,,,20563.0,,,,,2018,Q2,Hyperglycaemia,,2018,Q2,1,I,20170516.0,20180507.0,20180518,20180518,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201805003021,ELI LILLY AND CO,,85.0,YR,,M,Y,70.0,KG,20180518.0,,CN,DE,DE,2018,Q2,Elderly
149190622,14919062,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"99 IU, 1X/DAY",,,,,,,,99.0,IU,,QD,2018,Q2,Gastritis erosive,,2018,Q2,2,F,20161030.0,20180517.0,20180521,20180523,EXP,,DE-PFIZER INC-2018205861,PFIZER,,64.0,YR,,M,Y,101.0,KG,20180523.0,,MD,DE,DE,2018,Q2,Adult
149190622,14919062,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"99 IU, 1X/DAY",,,,,,,,99.0,IU,,QD,2018,Q2,Melaena,,2018,Q2,2,F,20161030.0,20180517.0,20180521,20180523,EXP,,DE-PFIZER INC-2018205861,PFIZER,,64.0,YR,,M,Y,101.0,KG,20180523.0,,MD,DE,DE,2018,Q2,Adult
149195901,14919590,2,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,D,U,,,,,,FORMULATION UNKNOWN,,2018,Q2,Exposure during pregnancy,,2018,Q2,1,I,,20180514.0,20180521,20180521,EXP,,BR-ASTELLAS-2018US022792,ASTELLAS,"PETENUCI J, GOREJKO KVI, FRANCISCO DM, PENA JTM, DE SOUZA RG, KUPFER R. PREGNANCY AFTER KIDNEY TRANSPLANT IN PATIENTS WITH TYPE 1 DIABETES. DIABETOLOGY + METABOLIC SYNDROME. 2018;10(1): A317:138-9",34.0,YR,,F,Y,,,20180521.0,,OT,BR,BR,2018,Q2,Young Adult
149195901,14919590,2,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,D,U,,,,,,FORMULATION UNKNOWN,,2018,Q2,Hypertension,,2018,Q2,1,I,,20180514.0,20180521,20180521,EXP,,BR-ASTELLAS-2018US022792,ASTELLAS,"PETENUCI J, GOREJKO KVI, FRANCISCO DM, PENA JTM, DE SOUZA RG, KUPFER R. PREGNANCY AFTER KIDNEY TRANSPLANT IN PATIENTS WITH TYPE 1 DIABETES. DIABETOLOGY + METABOLIC SYNDROME. 2018;10(1): A317:138-9",34.0,YR,,F,Y,,,20180521.0,,OT,BR,BR,2018,Q2,Young Adult
149195901,14919590,2,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,D,U,,,,,,FORMULATION UNKNOWN,,2018,Q2,Pre-eclampsia,,2018,Q2,1,I,,20180514.0,20180521,20180521,EXP,,BR-ASTELLAS-2018US022792,ASTELLAS,"PETENUCI J, GOREJKO KVI, FRANCISCO DM, PENA JTM, DE SOUZA RG, KUPFER R. PREGNANCY AFTER KIDNEY TRANSPLANT IN PATIENTS WITH TYPE 1 DIABETES. DIABETOLOGY + METABOLIC SYNDROME. 2018;10(1): A317:138-9",34.0,YR,,F,Y,,,20180521.0,,OT,BR,BR,2018,Q2,Young Adult
149195901,14919590,2,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,D,U,,,,,,FORMULATION UNKNOWN,,2018,Q2,Premature delivery,,2018,Q2,1,I,,20180514.0,20180521,20180521,EXP,,BR-ASTELLAS-2018US022792,ASTELLAS,"PETENUCI J, GOREJKO KVI, FRANCISCO DM, PENA JTM, DE SOUZA RG, KUPFER R. PREGNANCY AFTER KIDNEY TRANSPLANT IN PATIENTS WITH TYPE 1 DIABETES. DIABETOLOGY + METABOLIC SYNDROME. 2018;10(1): A317:138-9",34.0,YR,,F,Y,,,20180521.0,,OT,BR,BR,2018,Q2,Young Adult
149195901,14919590,2,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,D,U,,,,,,FORMULATION UNKNOWN,,2018,Q2,Renal failure,,2018,Q2,1,I,,20180514.0,20180521,20180521,EXP,,BR-ASTELLAS-2018US022792,ASTELLAS,"PETENUCI J, GOREJKO KVI, FRANCISCO DM, PENA JTM, DE SOUZA RG, KUPFER R. PREGNANCY AFTER KIDNEY TRANSPLANT IN PATIENTS WITH TYPE 1 DIABETES. DIABETOLOGY + METABOLIC SYNDROME. 2018;10(1): A317:138-9",34.0,YR,,F,Y,,,20180521.0,,OT,BR,BR,2018,Q2,Young Adult
149195901,14919590,2,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,D,U,,,,,,FORMULATION UNKNOWN,,2018,Q2,Weight increased,,2018,Q2,1,I,,20180514.0,20180521,20180521,EXP,,BR-ASTELLAS-2018US022792,ASTELLAS,"PETENUCI J, GOREJKO KVI, FRANCISCO DM, PENA JTM, DE SOUZA RG, KUPFER R. PREGNANCY AFTER KIDNEY TRANSPLANT IN PATIENTS WITH TYPE 1 DIABETES. DIABETOLOGY + METABOLIC SYNDROME. 2018;10(1): A317:138-9",34.0,YR,,F,Y,,,20180521.0,,OT,BR,BR,2018,Q2,Young Adult
149222801,14922280,4,C,Insulin lispro,INSULIN LISPRO,1,,"NK IE, NACH BZ",,,,,,,,,,,,2018,Q2,Fatigue,,2018,Q2,1,I,,20180507.0,20180522,20180522,EXP,,DE-CONCORDIA PHARMACEUTICALS INC.-E2B_00011740,CONCORDIA,,56.0,YR,,M,Y,,,20180522.0,,OT,GB,DE,2018,Q2,Adult
149222801,14922280,4,C,Insulin lispro,INSULIN LISPRO,1,,"NK IE, NACH BZ",,,,,,,,,,,,2018,Q2,General physical health deterioration,,2018,Q2,1,I,,20180507.0,20180522,20180522,EXP,,DE-CONCORDIA PHARMACEUTICALS INC.-E2B_00011740,CONCORDIA,,56.0,YR,,M,Y,,,20180522.0,,OT,GB,DE,2018,Q2,Adult
149222801,14922280,4,C,Insulin lispro,INSULIN LISPRO,1,,"NK IE, NACH BZ",,,,,,,,,,,,2018,Q2,Nausea,,2018,Q2,1,I,,20180507.0,20180522,20180522,EXP,,DE-CONCORDIA PHARMACEUTICALS INC.-E2B_00011740,CONCORDIA,,56.0,YR,,M,Y,,,20180522.0,,OT,GB,DE,2018,Q2,Adult
149267281,14926728,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, PRN (12 UNITS 3 TIMES A DAY SLIDING SCALE)",,,U,U,,,,,,,,2018,Q2,Blood glucose increased,,2018,Q2,1,I,201712.0,20180423.0,20180523,20180523,PER,,US-ELI_LILLY_AND_COMPANY-US201804012357,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20180523.0,,CN,US,US,2018,Q2,Elderly
149267281,14926728,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, PRN (12 UNITS 3 TIMES A DAY SLIDING SCALE)",,,U,U,,,,,,,,2018,Q2,Drug dose omission,,2018,Q2,1,I,201712.0,20180423.0,20180523,20180523,PER,,US-ELI_LILLY_AND_COMPANY-US201804012357,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20180523.0,,CN,US,US,2018,Q2,Elderly
149267281,14926728,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, PRN (12 UNITS 3 TIMES A DAY SLIDING SCALE)",,,U,U,,,,,,,,2018,Q2,Facial paralysis,,2018,Q2,1,I,201712.0,20180423.0,20180523,20180523,PER,,US-ELI_LILLY_AND_COMPANY-US201804012357,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20180523.0,,CN,US,US,2018,Q2,Elderly
149298442,14929844,4,C,INSULIN LISPRO RECOMBINANT,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,INJECTION,,2018,Q2,Choking,,2018,Q2,2,F,20180504.0,20180611.0,20180523,20180621,EXP,,CN-NOVOPROD-600670,NOVO NORDISK,,44.0,YR,A,M,Y,100.0,KG,20180621.0,,CN,CN,CN,2018,Q2,Adult
149298442,14929844,4,C,INSULIN LISPRO RECOMBINANT,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,INJECTION,,2018,Q2,Drug titration error,,2018,Q2,2,F,20180504.0,20180611.0,20180523,20180621,EXP,,CN-NOVOPROD-600670,NOVO NORDISK,,44.0,YR,A,M,Y,100.0,KG,20180621.0,,CN,CN,CN,2018,Q2,Adult
149298442,14929844,4,C,INSULIN LISPRO RECOMBINANT,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,INJECTION,,2018,Q2,Gastrooesophageal reflux disease,,2018,Q2,2,F,20180504.0,20180611.0,20180523,20180621,EXP,,CN-NOVOPROD-600670,NOVO NORDISK,,44.0,YR,A,M,Y,100.0,KG,20180621.0,,CN,CN,CN,2018,Q2,Adult
149298442,14929844,4,C,INSULIN LISPRO RECOMBINANT,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,INJECTION,,2018,Q2,Headache,,2018,Q2,2,F,20180504.0,20180611.0,20180523,20180621,EXP,,CN-NOVOPROD-600670,NOVO NORDISK,,44.0,YR,A,M,Y,100.0,KG,20180621.0,,CN,CN,CN,2018,Q2,Adult
149298442,14929844,4,C,INSULIN LISPRO RECOMBINANT,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,INJECTION,,2018,Q2,Respiratory disorder,,2018,Q2,2,F,20180504.0,20180611.0,20180523,20180621,EXP,,CN-NOVOPROD-600670,NOVO NORDISK,,44.0,YR,A,M,Y,100.0,KG,20180621.0,,CN,CN,CN,2018,Q2,Adult
149331701,14933170,4,SS,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,,,,U,U,,,,,,,,2018,Q2,Maternal exposure during pregnancy,,2018,Q2,1,I,,20180516.0,20180524,20180524,EXP,,PHHY2018BR002259,SANDOZ,"PETENUCI J, GOREJKO KVI, MACHADO DF, PENA JTM, DE SOUZA RG, KUPFER R. PREGNANCY AFTER KIDNEY TRANSPLANT IN PATIENTS WITH TYPE 1 DIABETES. DIABETOLOGY AND METABOLIC SYNDROME. 2018;10",34.0,YR,,F,Y,,,20180524.0,,OT,BR,BR,2018,Q2,Young Adult
149331701,14933170,4,SS,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,,,,U,U,,,,,,,,2018,Q2,Premature delivery,,2018,Q2,1,I,,20180516.0,20180524,20180524,EXP,,PHHY2018BR002259,SANDOZ,"PETENUCI J, GOREJKO KVI, MACHADO DF, PENA JTM, DE SOUZA RG, KUPFER R. PREGNANCY AFTER KIDNEY TRANSPLANT IN PATIENTS WITH TYPE 1 DIABETES. DIABETOLOGY AND METABOLIC SYNDROME. 2018;10",34.0,YR,,F,Y,,,20180524.0,,OT,BR,BR,2018,Q2,Young Adult
149335121,14933512,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,,,,20563.0,10.0,IU,,BID,2018,Q2,Nephropathy,,2018,Q2,1,I,2017.0,20180515.0,20180524,20180524,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201805007261,ELI LILLY AND CO,,76.0,YR,,M,Y,45.0,KG,20180524.0,,CN,CN,CN,2018,Q2,Elderly
149335121,14933512,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,,,,20563.0,10.0,IU,,BID,2018,Q2,Peripheral swelling,,2018,Q2,1,I,2017.0,20180515.0,20180524,20180524,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201805007261,ELI LILLY AND CO,,76.0,YR,,M,Y,45.0,KG,20180524.0,,CN,CN,CN,2018,Q2,Elderly
149353581,14935358,19,C,Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Abdominal discomfort,,2018,Q2,1,I,20180410.0,,20180507,20180507,DIR,,,FDA-CTU,,74.0,YR,,M,N,76.5,KG,20180507.0,N,CN,US,US,2018,Q2,Elderly
149353581,14935358,19,C,Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Blood test abnormal,,2018,Q2,1,I,20180410.0,,20180507,20180507,DIR,,,FDA-CTU,,74.0,YR,,M,N,76.5,KG,20180507.0,N,CN,US,US,2018,Q2,Elderly
149353581,14935358,19,C,Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Cough,,2018,Q2,1,I,20180410.0,,20180507,20180507,DIR,,,FDA-CTU,,74.0,YR,,M,N,76.5,KG,20180507.0,N,CN,US,US,2018,Q2,Elderly
149353581,14935358,19,C,Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Decreased appetite,,2018,Q2,1,I,20180410.0,,20180507,20180507,DIR,,,FDA-CTU,,74.0,YR,,M,N,76.5,KG,20180507.0,N,CN,US,US,2018,Q2,Elderly
149353581,14935358,19,C,Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Dialysis,,2018,Q2,1,I,20180410.0,,20180507,20180507,DIR,,,FDA-CTU,,74.0,YR,,M,N,76.5,KG,20180507.0,N,CN,US,US,2018,Q2,Elderly
149353581,14935358,19,C,Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Diarrhoea,,2018,Q2,1,I,20180410.0,,20180507,20180507,DIR,,,FDA-CTU,,74.0,YR,,M,N,76.5,KG,20180507.0,N,CN,US,US,2018,Q2,Elderly
149353581,14935358,19,C,Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Fatigue,,2018,Q2,1,I,20180410.0,,20180507,20180507,DIR,,,FDA-CTU,,74.0,YR,,M,N,76.5,KG,20180507.0,N,CN,US,US,2018,Q2,Elderly
149353581,14935358,19,C,Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Heart rate irregular,,2018,Q2,1,I,20180410.0,,20180507,20180507,DIR,,,FDA-CTU,,74.0,YR,,M,N,76.5,KG,20180507.0,N,CN,US,US,2018,Q2,Elderly
149353581,14935358,19,C,Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Hypertension,,2018,Q2,1,I,20180410.0,,20180507,20180507,DIR,,,FDA-CTU,,74.0,YR,,M,N,76.5,KG,20180507.0,N,CN,US,US,2018,Q2,Elderly
149353581,14935358,19,C,Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Pleural effusion,,2018,Q2,1,I,20180410.0,,20180507,20180507,DIR,,,FDA-CTU,,74.0,YR,,M,N,76.5,KG,20180507.0,N,CN,US,US,2018,Q2,Elderly
149353581,14935358,19,C,Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Pneumonia,,2018,Q2,1,I,20180410.0,,20180507,20180507,DIR,,,FDA-CTU,,74.0,YR,,M,N,76.5,KG,20180507.0,N,CN,US,US,2018,Q2,Elderly
149353581,14935358,19,C,Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Pneumopericardium,,2018,Q2,1,I,20180410.0,,20180507,20180507,DIR,,,FDA-CTU,,74.0,YR,,M,N,76.5,KG,20180507.0,N,CN,US,US,2018,Q2,Elderly
149353581,14935358,19,C,Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Pyrexia,,2018,Q2,1,I,20180410.0,,20180507,20180507,DIR,,,FDA-CTU,,74.0,YR,,M,N,76.5,KG,20180507.0,N,CN,US,US,2018,Q2,Elderly
149353581,14935358,19,C,Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Rash,,2018,Q2,1,I,20180410.0,,20180507,20180507,DIR,,,FDA-CTU,,74.0,YR,,M,N,76.5,KG,20180507.0,N,CN,US,US,2018,Q2,Elderly
149353581,14935358,19,C,Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Renal failure,,2018,Q2,1,I,20180410.0,,20180507,20180507,DIR,,,FDA-CTU,,74.0,YR,,M,N,76.5,KG,20180507.0,N,CN,US,US,2018,Q2,Elderly
149353581,14935358,19,C,Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Swelling,,2018,Q2,1,I,20180410.0,,20180507,20180507,DIR,,,FDA-CTU,,74.0,YR,,M,N,76.5,KG,20180507.0,N,CN,US,US,2018,Q2,Elderly
149353581,14935358,19,C,Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Urine output decreased,,2018,Q2,1,I,20180410.0,,20180507,20180507,DIR,,,FDA-CTU,,74.0,YR,,M,N,76.5,KG,20180507.0,N,CN,US,US,2018,Q2,Elderly
149382871,14938287,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"FIVE TIMES A DAY, OTHER",,,U,U,,,20563.0,,,,,2018,Q2,Blood glucose abnormal,,2018,Q2,1,I,,20180514.0,20180525,20180525,EXP,,GB-ELI_LILLY_AND_COMPANY-GB201805006292,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20180525.0,,CN,GB,GB,2018,Q2,Elderly
149382871,14938287,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"FIVE TIMES A DAY, OTHER",,,U,U,,,20563.0,,,,,2018,Q2,Blood glucose decreased,,2018,Q2,1,I,,20180514.0,20180525,20180525,EXP,,GB-ELI_LILLY_AND_COMPANY-GB201805006292,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20180525.0,,CN,GB,GB,2018,Q2,Elderly
149382871,14938287,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"FIVE TIMES A DAY, OTHER",,,U,U,,,20563.0,,,,,2018,Q2,Blood glucose increased,,2018,Q2,1,I,,20180514.0,20180525,20180525,EXP,,GB-ELI_LILLY_AND_COMPANY-GB201805006292,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20180525.0,,CN,GB,GB,2018,Q2,Elderly
149382871,14938287,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"FIVE TIMES A DAY, OTHER",,,U,U,,,20563.0,,,,,2018,Q2,Tremor,,2018,Q2,1,I,,20180514.0,20180525,20180525,EXP,,GB-ELI_LILLY_AND_COMPANY-GB201805006292,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20180525.0,,CN,GB,GB,2018,Q2,Elderly
149453371,14945337,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Blood glucose increased,,2018,Q2,1,I,201712.0,20180119.0,20180529,20180529,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2018BDSI0023,BIODELIVERY SCIENCES INTERNATIONAL,,51.0,YR,,M,Y,104.42,KG,20180525.0,,CN,US,US,2018,Q2,Adult
149453371,14945337,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Decreased appetite,,2018,Q2,1,I,201712.0,20180119.0,20180529,20180529,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2018BDSI0023,BIODELIVERY SCIENCES INTERNATIONAL,,51.0,YR,,M,Y,104.42,KG,20180525.0,,CN,US,US,2018,Q2,Adult
149453371,14945337,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Vision blurred,,2018,Q2,1,I,201712.0,20180119.0,20180529,20180529,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2018BDSI0023,BIODELIVERY SCIENCES INTERNATIONAL,,51.0,YR,,M,Y,104.42,KG,20180525.0,,CN,US,US,2018,Q2,Adult
149453371,14945337,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Vomiting,,2018,Q2,1,I,201712.0,20180119.0,20180529,20180529,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2018BDSI0023,BIODELIVERY SCIENCES INTERNATIONAL,,51.0,YR,,M,Y,104.42,KG,20180525.0,,CN,US,US,2018,Q2,Adult
149453371,14945337,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Weight decreased,,2018,Q2,1,I,201712.0,20180119.0,20180529,20180529,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2018BDSI0023,BIODELIVERY SCIENCES INTERNATIONAL,,51.0,YR,,M,Y,104.42,KG,20180525.0,,CN,US,US,2018,Q2,Adult
149455711,14945571,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"NK IE, NACH BZ ()",,,U,U, UNKNOWN,,,,,,,2018,Q2,Anaemia,,2018,Q2,1,I,,20180516.0,20180529,20180529,EXP,,DE-AUROBINDO-AUR-APL-2018-027618,AUROBINDO,,77.0,YR,,M,Y,,,20180529.0,,PH,DE,DE,2018,Q2,Elderly
149455711,14945571,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"NK IE, NACH BZ ()",,,U,U, UNKNOWN,,,,,,,2018,Q2,Dyspnoea,,2018,Q2,1,I,,20180516.0,20180529,20180529,EXP,,DE-AUROBINDO-AUR-APL-2018-027618,AUROBINDO,,77.0,YR,,M,Y,,,20180529.0,,PH,DE,DE,2018,Q2,Elderly
149455711,14945571,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"NK IE, NACH BZ ()",,,U,U, UNKNOWN,,,,,,,2018,Q2,Haematochezia,,2018,Q2,1,I,,20180516.0,20180529,20180529,EXP,,DE-AUROBINDO-AUR-APL-2018-027618,AUROBINDO,,77.0,YR,,M,Y,,,20180529.0,,PH,DE,DE,2018,Q2,Elderly
149464732,14946473,26,C,INSULIN LISPRO,INSULIN LISPRO,1,,PRN MAXIMUM BU,,,D,,,,,,,,,2018,Q2,Pneumonia,,2018,Q2,2,F,20180517.0,20180518.0,20180529,20180601,EXP,,JP-JNJFOC-20180529055,JANSSEN,,78.0,YR,E,F,Y,43.4,KG,20180601.0,,MD,JP,JP,2018,Q2,Elderly
149476902,14947690,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Death,,2018,Q2,2,F,20180430.0,20180606.0,20180529,20180614,EXP,,US-VIFOR (INTERNATIONAL) INC.-VIT-2018-04935,VIFOR,,70.0,YR,,M,Y,,,20180615.0,,CN,US,US,2018,Q2,Elderly
149476902,14947690,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Finger amputation,,2018,Q2,2,F,20180430.0,20180606.0,20180529,20180614,EXP,,US-VIFOR (INTERNATIONAL) INC.-VIT-2018-04935,VIFOR,,70.0,YR,,M,Y,,,20180615.0,,CN,US,US,2018,Q2,Elderly
149476902,14947690,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Foot amputation,,2018,Q2,2,F,20180430.0,20180606.0,20180529,20180614,EXP,,US-VIFOR (INTERNATIONAL) INC.-VIT-2018-04935,VIFOR,,70.0,YR,,M,Y,,,20180615.0,,CN,US,US,2018,Q2,Elderly
149499301,14949930,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),AT EACH MEALS  13 IU + 17 IU + 21 IU,,,,U,,,,,,INJECTION,,2018,Q2,Blood pressure increased,,2018,Q2,1,I,,20170206.0,20180530,20180530,EXP,,IT-AUROBINDO-AUR-APL-2017-30007,AUROBINDO,SANTANGELO M. EFLICACLA DI DAPAGLIFLOZLN NEL TRATTAMENTO DI UN CASO DLFLICLLE DI DIABETE MELLITO TLPO 2. MEDIA. 2016;16:177-178,53.0,YR,,F,Y,,,20180530.0,,OT,IT,IT,2018,Q2,Adult
149499301,14949930,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),AT EACH MEALS  13 IU + 17 IU + 21 IU,,,,U,,,,,,INJECTION,,2018,Q2,Diabetes mellitus,,2018,Q2,1,I,,20170206.0,20180530,20180530,EXP,,IT-AUROBINDO-AUR-APL-2017-30007,AUROBINDO,SANTANGELO M. EFLICACLA DI DAPAGLIFLOZLN NEL TRATTAMENTO DI UN CASO DLFLICLLE DI DIABETE MELLITO TLPO 2. MEDIA. 2016;16:177-178,53.0,YR,,F,Y,,,20180530.0,,OT,IT,IT,2018,Q2,Adult
149499301,14949930,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),AT EACH MEALS  13 IU + 17 IU + 21 IU,,,,U,,,,,,INJECTION,,2018,Q2,Drug ineffective,,2018,Q2,1,I,,20170206.0,20180530,20180530,EXP,,IT-AUROBINDO-AUR-APL-2017-30007,AUROBINDO,SANTANGELO M. EFLICACLA DI DAPAGLIFLOZLN NEL TRATTAMENTO DI UN CASO DLFLICLLE DI DIABETE MELLITO TLPO 2. MEDIA. 2016;16:177-178,53.0,YR,,F,Y,,,20180530.0,,OT,IT,IT,2018,Q2,Adult
149499301,14949930,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),AT EACH MEALS  13 IU + 17 IU + 21 IU,,,,U,,,,,,INJECTION,,2018,Q2,Hypoglycaemia,,2018,Q2,1,I,,20170206.0,20180530,20180530,EXP,,IT-AUROBINDO-AUR-APL-2017-30007,AUROBINDO,SANTANGELO M. EFLICACLA DI DAPAGLIFLOZLN NEL TRATTAMENTO DI UN CASO DLFLICLLE DI DIABETE MELLITO TLPO 2. MEDIA. 2016;16:177-178,53.0,YR,,F,Y,,,20180530.0,,OT,IT,IT,2018,Q2,Adult
149509171,14950917,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"NK IE, NACH BZ",,,,,,,,,,,,2018,Q2,Fatigue,,2018,Q2,1,I,,20180515.0,20180530,20180530,EXP,,DE-WEST-WARD PHARMACEUTICALS CORP.-DE-H14001-18-04252,WESTWARD,,56.0,YR,,M,Y,,,20180530.0,,PH,DE,DE,2018,Q2,Adult
149509171,14950917,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"NK IE, NACH BZ",,,,,,,,,,,,2018,Q2,General physical health deterioration,,2018,Q2,1,I,,20180515.0,20180530,20180530,EXP,,DE-WEST-WARD PHARMACEUTICALS CORP.-DE-H14001-18-04252,WESTWARD,,56.0,YR,,M,Y,,,20180530.0,,PH,DE,DE,2018,Q2,Adult
149509171,14950917,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"NK IE, NACH BZ",,,,,,,,,,,,2018,Q2,Nausea,,2018,Q2,1,I,,20180515.0,20180530,20180530,EXP,,DE-WEST-WARD PHARMACEUTICALS CORP.-DE-H14001-18-04252,WESTWARD,,56.0,YR,,M,Y,,,20180530.0,,PH,DE,DE,2018,Q2,Adult
149528611,14952861,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,NOT  MORE THAN 6 UNITS/DAY,,,,,,,,,,,,2018,Q2,Bronchitis,,2018,Q2,1,I,20180412.0,20180423.0,20180530,20180530,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2018BDSI0161,BIODELIVERY SCIENCES INTERNATIONAL,,65.0,YR,,F,Y,87.17,KG,20180530.0,,CN,US,US,2018,Q2,Elderly
149528611,14952861,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,NOT  MORE THAN 6 UNITS/DAY,,,,,,,,,,,,2018,Q2,Haematochezia,,2018,Q2,1,I,20180412.0,20180423.0,20180530,20180530,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2018BDSI0161,BIODELIVERY SCIENCES INTERNATIONAL,,65.0,YR,,F,Y,87.17,KG,20180530.0,,CN,US,US,2018,Q2,Elderly
149528611,14952861,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,NOT  MORE THAN 6 UNITS/DAY,,,,,,,,,,,,2018,Q2,Nausea,,2018,Q2,1,I,20180412.0,20180423.0,20180530,20180530,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2018BDSI0161,BIODELIVERY SCIENCES INTERNATIONAL,,65.0,YR,,F,Y,87.17,KG,20180530.0,,CN,US,US,2018,Q2,Elderly
149528611,14952861,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,NOT  MORE THAN 6 UNITS/DAY,,,,,,,,,,,,2018,Q2,Neuralgia,,2018,Q2,1,I,20180412.0,20180423.0,20180530,20180530,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2018BDSI0161,BIODELIVERY SCIENCES INTERNATIONAL,,65.0,YR,,F,Y,87.17,KG,20180530.0,,CN,US,US,2018,Q2,Elderly
149528611,14952861,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,NOT  MORE THAN 6 UNITS/DAY,,,,,,,,,,,,2018,Q2,Platelet count decreased,,2018,Q2,1,I,20180412.0,20180423.0,20180530,20180530,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2018BDSI0161,BIODELIVERY SCIENCES INTERNATIONAL,,65.0,YR,,F,Y,87.17,KG,20180530.0,,CN,US,US,2018,Q2,Elderly
149528611,14952861,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,NOT  MORE THAN 6 UNITS/DAY,,,,,,,,,,,,2018,Q2,Visual brightness,,2018,Q2,1,I,20180412.0,20180423.0,20180530,20180530,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2018BDSI0161,BIODELIVERY SCIENCES INTERNATIONAL,,65.0,YR,,F,Y,87.17,KG,20180530.0,,CN,US,US,2018,Q2,Elderly
149528611,14952861,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,NOT  MORE THAN 6 UNITS/DAY,,,,,,,,,,,,2018,Q2,Vomiting,,2018,Q2,1,I,20180412.0,20180423.0,20180530,20180530,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2018BDSI0161,BIODELIVERY SCIENCES INTERNATIONAL,,65.0,YR,,F,Y,87.17,KG,20180530.0,,CN,US,US,2018,Q2,Elderly
149528611,14952861,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,NOT  MORE THAN 6 UNITS/DAY,,,,,,,,,,,,2018,Q2,Wrong technique in product usage process,,2018,Q2,1,I,20180412.0,20180423.0,20180530,20180530,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2018BDSI0161,BIODELIVERY SCIENCES INTERNATIONAL,,65.0,YR,,F,Y,87.17,KG,20180530.0,,CN,US,US,2018,Q2,Elderly
149543492,14954349,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, TID",,,,,,,,,,,TID,2018,Q2,Injection site pain,,2018,Q2,2,F,20180410.0,20180530.0,20180530,20180620,PER,,US-GE HEALTHCARE LIFE SCIENCES-2018CSU001410,GE HEALTHCARE,,60.0,YR,,F,Y,,,20180620.0,,OT,US,US,2018,Q2,Adult
149610814,14961081,18,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,0-5 UNITS,,,,,,,,,,INJECTION,QID,2018,Q2,Acute kidney injury,,2018,Q2,4,F,20180512.0,20180611.0,20180531,20180619,EXP,,US-CELGENEUS-USA-20180508363,CELGENE,,77.0,YR,,M,Y,99.8,KG,20180619.0,,PH,US,US,2018,Q2,Elderly
149610814,14961081,18,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,0-5 UNITS,,,,,,,,,,INJECTION,QID,2018,Q2,Cardio-respiratory arrest,,2018,Q2,4,F,20180512.0,20180611.0,20180531,20180619,EXP,,US-CELGENEUS-USA-20180508363,CELGENE,,77.0,YR,,M,Y,99.8,KG,20180619.0,,PH,US,US,2018,Q2,Elderly
149610814,14961081,18,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,0-5 UNITS,,,,,,,,,,INJECTION,QID,2018,Q2,Neutropenia,,2018,Q2,4,F,20180512.0,20180611.0,20180531,20180619,EXP,,US-CELGENEUS-USA-20180508363,CELGENE,,77.0,YR,,M,Y,99.8,KG,20180619.0,,PH,US,US,2018,Q2,Elderly
149610814,14961081,18,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,0-5 UNITS,,,,,,,,,,INJECTION,QID,2018,Q2,Septic shock,,2018,Q2,4,F,20180512.0,20180611.0,20180531,20180619,EXP,,US-CELGENEUS-USA-20180508363,CELGENE,,77.0,YR,,M,Y,99.8,KG,20180619.0,,PH,US,US,2018,Q2,Elderly
149610814,14961081,19,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,1 IU (INTERNATIONAL UNIT),,,,,,,,1.0,IU,INJECTION,QID,2018,Q2,Acute kidney injury,,2018,Q2,4,F,20180512.0,20180611.0,20180531,20180619,EXP,,US-CELGENEUS-USA-20180508363,CELGENE,,77.0,YR,,M,Y,99.8,KG,20180619.0,,PH,US,US,2018,Q2,Elderly
149610814,14961081,19,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,1 IU (INTERNATIONAL UNIT),,,,,,,,1.0,IU,INJECTION,QID,2018,Q2,Cardio-respiratory arrest,,2018,Q2,4,F,20180512.0,20180611.0,20180531,20180619,EXP,,US-CELGENEUS-USA-20180508363,CELGENE,,77.0,YR,,M,Y,99.8,KG,20180619.0,,PH,US,US,2018,Q2,Elderly
149610814,14961081,19,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,1 IU (INTERNATIONAL UNIT),,,,,,,,1.0,IU,INJECTION,QID,2018,Q2,Neutropenia,,2018,Q2,4,F,20180512.0,20180611.0,20180531,20180619,EXP,,US-CELGENEUS-USA-20180508363,CELGENE,,77.0,YR,,M,Y,99.8,KG,20180619.0,,PH,US,US,2018,Q2,Elderly
149610814,14961081,19,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,1 IU (INTERNATIONAL UNIT),,,,,,,,1.0,IU,INJECTION,QID,2018,Q2,Septic shock,,2018,Q2,4,F,20180512.0,20180611.0,20180531,20180619,EXP,,US-CELGENEUS-USA-20180508363,CELGENE,,77.0,YR,,M,Y,99.8,KG,20180619.0,,PH,US,US,2018,Q2,Elderly
149610814,14961081,20,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,0-10 UNITES,,,,,,,,,,INJECTION,TID,2018,Q2,Acute kidney injury,,2018,Q2,4,F,20180512.0,20180611.0,20180531,20180619,EXP,,US-CELGENEUS-USA-20180508363,CELGENE,,77.0,YR,,M,Y,99.8,KG,20180619.0,,PH,US,US,2018,Q2,Elderly
149610814,14961081,20,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,0-10 UNITES,,,,,,,,,,INJECTION,TID,2018,Q2,Cardio-respiratory arrest,,2018,Q2,4,F,20180512.0,20180611.0,20180531,20180619,EXP,,US-CELGENEUS-USA-20180508363,CELGENE,,77.0,YR,,M,Y,99.8,KG,20180619.0,,PH,US,US,2018,Q2,Elderly
149610814,14961081,20,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,0-10 UNITES,,,,,,,,,,INJECTION,TID,2018,Q2,Neutropenia,,2018,Q2,4,F,20180512.0,20180611.0,20180531,20180619,EXP,,US-CELGENEUS-USA-20180508363,CELGENE,,77.0,YR,,M,Y,99.8,KG,20180619.0,,PH,US,US,2018,Q2,Elderly
149610814,14961081,20,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,0-10 UNITES,,,,,,,,,,INJECTION,TID,2018,Q2,Septic shock,,2018,Q2,4,F,20180512.0,20180611.0,20180531,20180619,EXP,,US-CELGENEUS-USA-20180508363,CELGENE,,77.0,YR,,M,Y,99.8,KG,20180619.0,,PH,US,US,2018,Q2,Elderly
149610814,14961081,21,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,0-6 UNITES,,,,,,,,,,INJECTION,BID,2018,Q2,Acute kidney injury,,2018,Q2,4,F,20180512.0,20180611.0,20180531,20180619,EXP,,US-CELGENEUS-USA-20180508363,CELGENE,,77.0,YR,,M,Y,99.8,KG,20180619.0,,PH,US,US,2018,Q2,Elderly
149610814,14961081,21,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,0-6 UNITES,,,,,,,,,,INJECTION,BID,2018,Q2,Cardio-respiratory arrest,,2018,Q2,4,F,20180512.0,20180611.0,20180531,20180619,EXP,,US-CELGENEUS-USA-20180508363,CELGENE,,77.0,YR,,M,Y,99.8,KG,20180619.0,,PH,US,US,2018,Q2,Elderly
149610814,14961081,21,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,0-6 UNITES,,,,,,,,,,INJECTION,BID,2018,Q2,Neutropenia,,2018,Q2,4,F,20180512.0,20180611.0,20180531,20180619,EXP,,US-CELGENEUS-USA-20180508363,CELGENE,,77.0,YR,,M,Y,99.8,KG,20180619.0,,PH,US,US,2018,Q2,Elderly
149610814,14961081,21,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,0-6 UNITES,,,,,,,,,,INJECTION,BID,2018,Q2,Septic shock,,2018,Q2,4,F,20180512.0,20180611.0,20180531,20180619,EXP,,US-CELGENEUS-USA-20180508363,CELGENE,,77.0,YR,,M,Y,99.8,KG,20180619.0,,PH,US,US,2018,Q2,Elderly
149613111,14961311,5,SS,Lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2018,Q2,Blood pressure increased,,2018,Q2,1,I,,20180519.0,20180601,20180601,EXP,,BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2018R1-174250,RANBAXY,"PETENUCI J, GOREJKO KVI, MACHADO DF, PENA JTM, DE SOUZA RG, KUPFER R. PREGNANCY AFTER KIDNEY TRANSPLANT IN PATIENTS WITH TYPE 1 DIABETES. DIABET METAB SYNDR. 2018;10 (SUPPL. 1):ABSTR: A317;138-139",34.0,YR,,F,Y,,,20180601.0,,OT,BR,BR,2018,Q2,Young Adult
149613111,14961311,5,SS,Lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2018,Q2,Exposure during pregnancy,,2018,Q2,1,I,,20180519.0,20180601,20180601,EXP,,BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2018R1-174250,RANBAXY,"PETENUCI J, GOREJKO KVI, MACHADO DF, PENA JTM, DE SOUZA RG, KUPFER R. PREGNANCY AFTER KIDNEY TRANSPLANT IN PATIENTS WITH TYPE 1 DIABETES. DIABET METAB SYNDR. 2018;10 (SUPPL. 1):ABSTR: A317;138-139",34.0,YR,,F,Y,,,20180601.0,,OT,BR,BR,2018,Q2,Young Adult
149613111,14961311,5,SS,Lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2018,Q2,Maternal exposure during pregnancy,,2018,Q2,1,I,,20180519.0,20180601,20180601,EXP,,BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2018R1-174250,RANBAXY,"PETENUCI J, GOREJKO KVI, MACHADO DF, PENA JTM, DE SOUZA RG, KUPFER R. PREGNANCY AFTER KIDNEY TRANSPLANT IN PATIENTS WITH TYPE 1 DIABETES. DIABET METAB SYNDR. 2018;10 (SUPPL. 1):ABSTR: A317;138-139",34.0,YR,,F,Y,,,20180601.0,,OT,BR,BR,2018,Q2,Young Adult
149613111,14961311,5,SS,Lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2018,Q2,Premature delivery,,2018,Q2,1,I,,20180519.0,20180601,20180601,EXP,,BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2018R1-174250,RANBAXY,"PETENUCI J, GOREJKO KVI, MACHADO DF, PENA JTM, DE SOUZA RG, KUPFER R. PREGNANCY AFTER KIDNEY TRANSPLANT IN PATIENTS WITH TYPE 1 DIABETES. DIABET METAB SYNDR. 2018;10 (SUPPL. 1):ABSTR: A317;138-139",34.0,YR,,F,Y,,,20180601.0,,OT,BR,BR,2018,Q2,Young Adult
149613111,14961311,5,SS,Lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2018,Q2,Renal failure,,2018,Q2,1,I,,20180519.0,20180601,20180601,EXP,,BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2018R1-174250,RANBAXY,"PETENUCI J, GOREJKO KVI, MACHADO DF, PENA JTM, DE SOUZA RG, KUPFER R. PREGNANCY AFTER KIDNEY TRANSPLANT IN PATIENTS WITH TYPE 1 DIABETES. DIABET METAB SYNDR. 2018;10 (SUPPL. 1):ABSTR: A317;138-139",34.0,YR,,F,Y,,,20180601.0,,OT,BR,BR,2018,Q2,Young Adult
149613111,14961311,5,SS,Lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2018,Q2,Treatment noncompliance,,2018,Q2,1,I,,20180519.0,20180601,20180601,EXP,,BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2018R1-174250,RANBAXY,"PETENUCI J, GOREJKO KVI, MACHADO DF, PENA JTM, DE SOUZA RG, KUPFER R. PREGNANCY AFTER KIDNEY TRANSPLANT IN PATIENTS WITH TYPE 1 DIABETES. DIABET METAB SYNDR. 2018;10 (SUPPL. 1):ABSTR: A317;138-139",34.0,YR,,F,Y,,,20180601.0,,OT,BR,BR,2018,Q2,Young Adult
149622201,14962220,5,C,HUMALOG MIX [INSULIN LISPRO],,2,,,,,,,,,,,,,,2018,Q2,Cardiac arrest,,2018,Q2,1,I,201703.0,20180523.0,20180601,20180601,EXP,,US-BAYER-2018-099417,BAYER,,49.0,YR,A,M,Y,,,20180601.0,,OT,US,US,2018,Q2,Adult
149622201,14962220,5,C,HUMALOG MIX [INSULIN LISPRO],,2,,,,,,,,,,,,,,2018,Q2,Diabetes mellitus inadequate control,,2018,Q2,1,I,201703.0,20180523.0,20180601,20180601,EXP,,US-BAYER-2018-099417,BAYER,,49.0,YR,A,M,Y,,,20180601.0,,OT,US,US,2018,Q2,Adult
149622201,14962220,5,C,HUMALOG MIX [INSULIN LISPRO],,2,,,,,,,,,,,,,,2018,Q2,Localised infection,,2018,Q2,1,I,201703.0,20180523.0,20180601,20180601,EXP,,US-BAYER-2018-099417,BAYER,,49.0,YR,A,M,Y,,,20180601.0,,OT,US,US,2018,Q2,Adult
149622201,14962220,5,C,HUMALOG MIX [INSULIN LISPRO],,2,,,,,,,,,,,,,,2018,Q2,Toe amputation,,2018,Q2,1,I,201703.0,20180523.0,20180601,20180601,EXP,,US-BAYER-2018-099417,BAYER,,49.0,YR,A,M,Y,,,20180601.0,,OT,US,US,2018,Q2,Adult
149645861,14964586,24,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2018,Q2,Autoimmune hepatitis,,2018,Q2,1,I,20170619.0,20180521.0,20180601,20180601,EXP,,JP-CELGENEUS-JPN-20180507948,CELGENE,,79.0,YR,,M,Y,54.8,KG,20180601.0,,OT,JP,JP,2018,Q2,Elderly
149651922,14965192,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"25 U, EACH MORNING",,,,,,,20563.0,25.0,IU,,QD,2018,Q2,Pain in extremity,,2018,Q2,2,F,,20180601.0,20180601,20180613,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201805011391,ELI LILLY AND CO,,61.0,YR,,M,Y,,,20180613.0,,CN,CN,CN,2018,Q2,Adult
149651922,14965192,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"25 U, EACH MORNING",,,,,,,20563.0,25.0,IU,,QD,2018,Q2,Peripheral swelling,,2018,Q2,2,F,,20180601.0,20180601,20180613,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201805011391,ELI LILLY AND CO,,61.0,YR,,M,Y,,,20180613.0,,CN,CN,CN,2018,Q2,Adult
149651922,14965192,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"25 U, EACH MORNING",,,,,,,20563.0,25.0,IU,,QD,2018,Q2,Skin lesion,,2018,Q2,2,F,,20180601.0,20180601,20180613,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201805011391,ELI LILLY AND CO,,61.0,YR,,M,Y,,,20180613.0,,CN,CN,CN,2018,Q2,Adult
149651922,14965192,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"30 U, EACH EVENING (NIGHT)",,,,,,,20563.0,30.0,IU,,QD,2018,Q2,Pain in extremity,,2018,Q2,2,F,,20180601.0,20180601,20180613,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201805011391,ELI LILLY AND CO,,61.0,YR,,M,Y,,,20180613.0,,CN,CN,CN,2018,Q2,Adult
149651922,14965192,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"30 U, EACH EVENING (NIGHT)",,,,,,,20563.0,30.0,IU,,QD,2018,Q2,Peripheral swelling,,2018,Q2,2,F,,20180601.0,20180601,20180613,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201805011391,ELI LILLY AND CO,,61.0,YR,,M,Y,,,20180613.0,,CN,CN,CN,2018,Q2,Adult
149651922,14965192,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"30 U, EACH EVENING (NIGHT)",,,,,,,20563.0,30.0,IU,,QD,2018,Q2,Skin lesion,,2018,Q2,2,F,,20180601.0,20180601,20180613,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201805011391,ELI LILLY AND CO,,61.0,YR,,M,Y,,,20180613.0,,CN,CN,CN,2018,Q2,Adult
149680911,14968091,4,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,,2,,"100 IU, DAILY, SOLUTION",,,,,,,,100.0,IU,SOLUTION,,2018,Q2,Drug interaction,,2018,Q2,1,I,201704.0,20180521.0,20180604,20180604,EXP,DE-EMA-DD-20171212-AJEVHP-102703,DE-ACCORD-067834,ACCORD,,67.0,YR,E,F,Y,74.0,KG,20180604.0,,MD,DE,DE,2018,Q2,Elderly
149680911,14968091,4,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,,2,,"100 IU, DAILY, SOLUTION",,,,,,,,100.0,IU,SOLUTION,,2018,Q2,Rhabdomyolysis,,2018,Q2,1,I,201704.0,20180521.0,20180604,20180604,EXP,DE-EMA-DD-20171212-AJEVHP-102703,DE-ACCORD-067834,ACCORD,,67.0,YR,E,F,Y,74.0,KG,20180604.0,,MD,DE,DE,2018,Q2,Elderly
149699471,14969947,2,SS,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,U, UNKNOWN,,,,,,,2018,Q2,Chronic kidney disease,,2018,Q2,1,I,,20180524.0,20180604,20180604,EXP,,BR-NOVOPROD-603035,NOVO NORDISK,JANAINA PETENUCI ET ALL.. PREGNANCY AFTER KIDNEY TRANSPLANT IN PATIENTS WITH TYPE 1 DIABETES. JOURNAL OF DIABETOLOGY + METABOLIC SYNDROME. 2018;10 (SUPP 1):A31:138-139,34.0,YR,A,F,Y,,,20180604.0,,OT,BR,BR,2018,Q2,Young Adult
149699471,14969947,2,SS,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,U, UNKNOWN,,,,,,,2018,Q2,Diabetes mellitus inadequate control,,2018,Q2,1,I,,20180524.0,20180604,20180604,EXP,,BR-NOVOPROD-603035,NOVO NORDISK,JANAINA PETENUCI ET ALL.. PREGNANCY AFTER KIDNEY TRANSPLANT IN PATIENTS WITH TYPE 1 DIABETES. JOURNAL OF DIABETOLOGY + METABOLIC SYNDROME. 2018;10 (SUPP 1):A31:138-139,34.0,YR,A,F,Y,,,20180604.0,,OT,BR,BR,2018,Q2,Young Adult
149699471,14969947,2,SS,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,U, UNKNOWN,,,,,,,2018,Q2,Exposure during pregnancy,,2018,Q2,1,I,,20180524.0,20180604,20180604,EXP,,BR-NOVOPROD-603035,NOVO NORDISK,JANAINA PETENUCI ET ALL.. PREGNANCY AFTER KIDNEY TRANSPLANT IN PATIENTS WITH TYPE 1 DIABETES. JOURNAL OF DIABETOLOGY + METABOLIC SYNDROME. 2018;10 (SUPP 1):A31:138-139,34.0,YR,A,F,Y,,,20180604.0,,OT,BR,BR,2018,Q2,Young Adult
149699471,14969947,2,SS,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,U, UNKNOWN,,,,,,,2018,Q2,Pre-eclampsia,,2018,Q2,1,I,,20180524.0,20180604,20180604,EXP,,BR-NOVOPROD-603035,NOVO NORDISK,JANAINA PETENUCI ET ALL.. PREGNANCY AFTER KIDNEY TRANSPLANT IN PATIENTS WITH TYPE 1 DIABETES. JOURNAL OF DIABETOLOGY + METABOLIC SYNDROME. 2018;10 (SUPP 1):A31:138-139,34.0,YR,A,F,Y,,,20180604.0,,OT,BR,BR,2018,Q2,Young Adult
149699471,14969947,2,SS,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,U, UNKNOWN,,,,,,,2018,Q2,Premature delivery,,2018,Q2,1,I,,20180524.0,20180604,20180604,EXP,,BR-NOVOPROD-603035,NOVO NORDISK,JANAINA PETENUCI ET ALL.. PREGNANCY AFTER KIDNEY TRANSPLANT IN PATIENTS WITH TYPE 1 DIABETES. JOURNAL OF DIABETOLOGY + METABOLIC SYNDROME. 2018;10 (SUPP 1):A31:138-139,34.0,YR,A,F,Y,,,20180604.0,,OT,BR,BR,2018,Q2,Young Adult
149726181,14972618,5,C,LISPRO INSULIN,INSULIN LISPRO,1,,"UNK, AS NEEDED (PRN)",,,,,,,,,,,,2018,Q2,Blood glucose increased,,2018,Q2,1,I,20180507.0,20180508.0,20180605,20180605,PER,,US-PFIZER INC-2018190017,PFIZER,,53.0,YR,,F,Y,81.0,KG,20180605.0,,OT,US,US,2018,Q2,Adult
149726181,14972618,5,C,LISPRO INSULIN,INSULIN LISPRO,1,,"UNK, AS NEEDED (PRN)",,,,,,,,,,,,2018,Q2,Incorrect dose administered,,2018,Q2,1,I,20180507.0,20180508.0,20180605,20180605,PER,,US-PFIZER INC-2018190017,PFIZER,,53.0,YR,,F,Y,81.0,KG,20180605.0,,OT,US,US,2018,Q2,Adult
149753271,14975327,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,25 UNITS TID,,,,,,,,,,,,2018,Q2,Sepsis,,2018,Q2,1,I,20180430.0,20180530.0,20180605,20180605,EXP,,US-ASTRAZENECA-2018SE72104,ASTRAZENECA,,19478.0,DY,,M,Y,,,20180605.0,,MD,US,US,2018,Q2,Elderly
149766262,14976626,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,U,,,,,,,BID,2018,Q2,Acute kidney injury,,2018,Q2,2,F,20180517.0,20180608.0,20180605,20180620,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,78.0,YR,E,M,Y,,,20180620.0,,OT,US,US,2018,Q2,Elderly
149766262,14976626,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,U,,,,,,,BID,2018,Q2,Anaemia,,2018,Q2,2,F,20180517.0,20180608.0,20180605,20180620,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,78.0,YR,E,M,Y,,,20180620.0,,OT,US,US,2018,Q2,Elderly
149766262,14976626,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,U,,,,,,,BID,2018,Q2,Asthenia,,2018,Q2,2,F,20180517.0,20180608.0,20180605,20180620,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,78.0,YR,E,M,Y,,,20180620.0,,OT,US,US,2018,Q2,Elderly
149766262,14976626,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,U,,,,,,,BID,2018,Q2,Bacteraemia,,2018,Q2,2,F,20180517.0,20180608.0,20180605,20180620,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,78.0,YR,E,M,Y,,,20180620.0,,OT,US,US,2018,Q2,Elderly
149766262,14976626,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,U,,,,,,,BID,2018,Q2,Cardiac arrest,,2018,Q2,2,F,20180517.0,20180608.0,20180605,20180620,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,78.0,YR,E,M,Y,,,20180620.0,,OT,US,US,2018,Q2,Elderly
149766262,14976626,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,U,,,,,,,BID,2018,Q2,Cardiac failure congestive,,2018,Q2,2,F,20180517.0,20180608.0,20180605,20180620,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,78.0,YR,E,M,Y,,,20180620.0,,OT,US,US,2018,Q2,Elderly
149766262,14976626,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,U,,,,,,,BID,2018,Q2,Condition aggravated,,2018,Q2,2,F,20180517.0,20180608.0,20180605,20180620,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,78.0,YR,E,M,Y,,,20180620.0,,OT,US,US,2018,Q2,Elderly
149766262,14976626,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,U,,,,,,,BID,2018,Q2,Diarrhoea,,2018,Q2,2,F,20180517.0,20180608.0,20180605,20180620,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,78.0,YR,E,M,Y,,,20180620.0,,OT,US,US,2018,Q2,Elderly
149766262,14976626,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,U,,,,,,,BID,2018,Q2,Dizziness,,2018,Q2,2,F,20180517.0,20180608.0,20180605,20180620,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,78.0,YR,E,M,Y,,,20180620.0,,OT,US,US,2018,Q2,Elderly
149766262,14976626,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,U,,,,,,,BID,2018,Q2,Dyspnoea exertional,,2018,Q2,2,F,20180517.0,20180608.0,20180605,20180620,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,78.0,YR,E,M,Y,,,20180620.0,,OT,US,US,2018,Q2,Elderly
149766262,14976626,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,U,,,,,,,BID,2018,Q2,Fatigue,,2018,Q2,2,F,20180517.0,20180608.0,20180605,20180620,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,78.0,YR,E,M,Y,,,20180620.0,,OT,US,US,2018,Q2,Elderly
149766262,14976626,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,U,,,,,,,BID,2018,Q2,Food poisoning,,2018,Q2,2,F,20180517.0,20180608.0,20180605,20180620,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,78.0,YR,E,M,Y,,,20180620.0,,OT,US,US,2018,Q2,Elderly
149766262,14976626,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,U,,,,,,,BID,2018,Q2,Loss of consciousness,,2018,Q2,2,F,20180517.0,20180608.0,20180605,20180620,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,78.0,YR,E,M,Y,,,20180620.0,,OT,US,US,2018,Q2,Elderly
149766262,14976626,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,U,,,,,,,BID,2018,Q2,Peripheral swelling,,2018,Q2,2,F,20180517.0,20180608.0,20180605,20180620,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,78.0,YR,E,M,Y,,,20180620.0,,OT,US,US,2018,Q2,Elderly
149766262,14976626,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,U,,,,,,,BID,2018,Q2,Urinary tract infection,,2018,Q2,2,F,20180517.0,20180608.0,20180605,20180620,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,78.0,YR,E,M,Y,,,20180620.0,,OT,US,US,2018,Q2,Elderly
149766262,14976626,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,U,,,,,,,BID,2018,Q2,Viral infection,,2018,Q2,2,F,20180517.0,20180608.0,20180605,20180620,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,78.0,YR,E,M,Y,,,20180620.0,,OT,US,US,2018,Q2,Elderly
149766262,14976626,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,U,,,,,,,BID,2018,Q2,Vomiting,,2018,Q2,2,F,20180517.0,20180608.0,20180605,20180620,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,78.0,YR,E,M,Y,,,20180620.0,,OT,US,US,2018,Q2,Elderly
149766262,14976626,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,U,,,,,,,BID,2018,Q2,Wheezing,,2018,Q2,2,F,20180517.0,20180608.0,20180605,20180620,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,78.0,YR,E,M,Y,,,20180620.0,,OT,US,US,2018,Q2,Elderly
149778612,14977861,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU, QD (6 UNITS SUBCUTANEOUSLY WITH MEALS)",,,,,,,,6.0,IU,,,2018,Q2,Accidental overdose,,2018,Q2,2,F,,20180601.0,20180606,20180611,EXP,,CA-GLENMARK PHARMACEUTICALS-2018GMK035894,GLENMARK,,56.0,YR,,M,Y,,,20180611.0,,OT,CA,CA,2018,Q2,Adult
149778612,14977861,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU, QD (6 UNITS SUBCUTANEOUSLY WITH MEALS)",,,,,,,,6.0,IU,,,2018,Q2,Drug interaction,,2018,Q2,2,F,,20180601.0,20180606,20180611,EXP,,CA-GLENMARK PHARMACEUTICALS-2018GMK035894,GLENMARK,,56.0,YR,,M,Y,,,20180611.0,,OT,CA,CA,2018,Q2,Adult
149778612,14977861,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU, QD (6 UNITS SUBCUTANEOUSLY WITH MEALS)",,,,,,,,6.0,IU,,,2018,Q2,Hypoglycaemia,,2018,Q2,2,F,,20180601.0,20180606,20180611,EXP,,CA-GLENMARK PHARMACEUTICALS-2018GMK035894,GLENMARK,,56.0,YR,,M,Y,,,20180611.0,,OT,CA,CA,2018,Q2,Adult
149778612,14977861,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU, QD (6 UNITS SUBCUTANEOUSLY WITH MEALS)",,,,,,,,6.0,IU,,,2018,Q2,Toxicity to various agents,,2018,Q2,2,F,,20180601.0,20180606,20180611,EXP,,CA-GLENMARK PHARMACEUTICALS-2018GMK035894,GLENMARK,,56.0,YR,,M,Y,,,20180611.0,,OT,CA,CA,2018,Q2,Adult
149784271,14978427,4,C,Insulin Lispro Protamine-Insulin Lispro (HumaLOG MIX),,2,,,,,,,,,,,,,,2018,Q2,Asthenia,,2018,Q2,1,I,20171101.0,,20180515,20180515,DIR,,,FDA-CTU,,73.0,YR,,M,N,54.0,KG,,N,CN,US,US,2018,Q2,Elderly
149784271,14978427,4,C,Insulin Lispro Protamine-Insulin Lispro (HumaLOG MIX),,2,,,,,,,,,,,,,,2018,Q2,Cough,,2018,Q2,1,I,20171101.0,,20180515,20180515,DIR,,,FDA-CTU,,73.0,YR,,M,N,54.0,KG,,N,CN,US,US,2018,Q2,Elderly
149784271,14978427,4,C,Insulin Lispro Protamine-Insulin Lispro (HumaLOG MIX),,2,,,,,,,,,,,,,,2018,Q2,Dehydration,,2018,Q2,1,I,20171101.0,,20180515,20180515,DIR,,,FDA-CTU,,73.0,YR,,M,N,54.0,KG,,N,CN,US,US,2018,Q2,Elderly
149784271,14978427,4,C,Insulin Lispro Protamine-Insulin Lispro (HumaLOG MIX),,2,,,,,,,,,,,,,,2018,Q2,Diarrhoea,,2018,Q2,1,I,20171101.0,,20180515,20180515,DIR,,,FDA-CTU,,73.0,YR,,M,N,54.0,KG,,N,CN,US,US,2018,Q2,Elderly
149784271,14978427,4,C,Insulin Lispro Protamine-Insulin Lispro (HumaLOG MIX),,2,,,,,,,,,,,,,,2018,Q2,Fall,,2018,Q2,1,I,20171101.0,,20180515,20180515,DIR,,,FDA-CTU,,73.0,YR,,M,N,54.0,KG,,N,CN,US,US,2018,Q2,Elderly
149784271,14978427,4,C,Insulin Lispro Protamine-Insulin Lispro (HumaLOG MIX),,2,,,,,,,,,,,,,,2018,Q2,Fatigue,,2018,Q2,1,I,20171101.0,,20180515,20180515,DIR,,,FDA-CTU,,73.0,YR,,M,N,54.0,KG,,N,CN,US,US,2018,Q2,Elderly
149784271,14978427,4,C,Insulin Lispro Protamine-Insulin Lispro (HumaLOG MIX),,2,,,,,,,,,,,,,,2018,Q2,Febrile neutropenia,,2018,Q2,1,I,20171101.0,,20180515,20180515,DIR,,,FDA-CTU,,73.0,YR,,M,N,54.0,KG,,N,CN,US,US,2018,Q2,Elderly
149784271,14978427,4,C,Insulin Lispro Protamine-Insulin Lispro (HumaLOG MIX),,2,,,,,,,,,,,,,,2018,Q2,Gait disturbance,,2018,Q2,1,I,20171101.0,,20180515,20180515,DIR,,,FDA-CTU,,73.0,YR,,M,N,54.0,KG,,N,CN,US,US,2018,Q2,Elderly
149784271,14978427,4,C,Insulin Lispro Protamine-Insulin Lispro (HumaLOG MIX),,2,,,,,,,,,,,,,,2018,Q2,Head injury,,2018,Q2,1,I,20171101.0,,20180515,20180515,DIR,,,FDA-CTU,,73.0,YR,,M,N,54.0,KG,,N,CN,US,US,2018,Q2,Elderly
149784271,14978427,4,C,Insulin Lispro Protamine-Insulin Lispro (HumaLOG MIX),,2,,,,,,,,,,,,,,2018,Q2,Malnutrition,,2018,Q2,1,I,20171101.0,,20180515,20180515,DIR,,,FDA-CTU,,73.0,YR,,M,N,54.0,KG,,N,CN,US,US,2018,Q2,Elderly
149784271,14978427,4,C,Insulin Lispro Protamine-Insulin Lispro (HumaLOG MIX),,2,,,,,,,,,,,,,,2018,Q2,Mental disorder,,2018,Q2,1,I,20171101.0,,20180515,20180515,DIR,,,FDA-CTU,,73.0,YR,,M,N,54.0,KG,,N,CN,US,US,2018,Q2,Elderly
149799531,14979953,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Dyspnoea,,2018,Q2,1,I,201805.0,20180604.0,20180606,20180606,EXP,,US-ABBVIE-18P-163-2378479-00,ABBVIE,,57.0,YR,,F,Y,,,20180606.0,,CN,US,US,2018,Q2,Adult
149854351,14985435,10,C,Insulin lispro,INSULIN LISPRO,1,Unknown,NACH SCHEMA,,,,,,,,,,,,2018,Q2,Contraindicated product administered,,2018,Q2,1,I,,20180531.0,20180607,20180607,EXP,,DE-TEVA-2018-DE-902275,TEVA,,68.0,YR,,M,Y,,,20180607.0,,PH,DE,DE,2018,Q2,Elderly
149854351,14985435,10,C,Insulin lispro,INSULIN LISPRO,1,Unknown,NACH SCHEMA,,,,,,,,,,,,2018,Q2,Dyspnoea,,2018,Q2,1,I,,20180531.0,20180607,20180607,EXP,,DE-TEVA-2018-DE-902275,TEVA,,68.0,YR,,M,Y,,,20180607.0,,PH,DE,DE,2018,Q2,Elderly
149854351,14985435,10,C,Insulin lispro,INSULIN LISPRO,1,Unknown,NACH SCHEMA,,,,,,,,,,,,2018,Q2,Oedema peripheral,,2018,Q2,1,I,,20180531.0,20180607,20180607,EXP,,DE-TEVA-2018-DE-902275,TEVA,,68.0,YR,,M,Y,,,20180607.0,,PH,DE,DE,2018,Q2,Elderly
149881771,14988177,5,C,LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q2,Pain,,2018,Q2,1,I,,20170802.0,20180608,20180608,PER,,US-PFIZER INC-2017338564,PFIZER,,53.0,YR,,M,Y,,,20180608.0,,CN,US,US,2018,Q2,Adult
149881771,14988177,5,C,LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q2,Product use issue,,2018,Q2,1,I,,20170802.0,20180608,20180608,PER,,US-PFIZER INC-2017338564,PFIZER,,53.0,YR,,M,Y,,,20180608.0,,CN,US,US,2018,Q2,Adult
149908281,14990828,2,I,Liprolog Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C858466,,,,,,,2018,Q2,Drug interaction,,2018,Q2,1,I,20180526.0,20180528.0,20180608,20180608,EXP,,PL-ELI_LILLY_AND_COMPANY-PL201805013724,ELI LILLY AND CO,,60.0,YR,,F,Y,52.0,KG,20180608.0,,CN,PL,PL,2018,Q2,Adult
149908281,14990828,2,I,Liprolog Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C858466,,,,,,,2018,Q2,Hyperglycaemia,,2018,Q2,1,I,20180526.0,20180528.0,20180608,20180608,EXP,,PL-ELI_LILLY_AND_COMPANY-PL201805013724,ELI LILLY AND CO,,60.0,YR,,F,Y,52.0,KG,20180608.0,,CN,PL,PL,2018,Q2,Adult
149908281,14990828,2,I,Liprolog Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C858466,,,,,,,2018,Q2,Hypoglycaemia,,2018,Q2,1,I,20180526.0,20180528.0,20180608,20180608,EXP,,PL-ELI_LILLY_AND_COMPANY-PL201805013724,ELI LILLY AND CO,,60.0,YR,,F,Y,52.0,KG,20180608.0,,CN,PL,PL,2018,Q2,Adult
149908281,14990828,2,I,Liprolog Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C858466,,,,,,,2018,Q2,Osteomyelitis,,2018,Q2,1,I,20180526.0,20180528.0,20180608,20180608,EXP,,PL-ELI_LILLY_AND_COMPANY-PL201805013724,ELI LILLY AND CO,,60.0,YR,,F,Y,52.0,KG,20180608.0,,CN,PL,PL,2018,Q2,Adult
149908281,14990828,2,I,Liprolog Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C858466,,,,,,,2018,Q2,Wrong drug administered,,2018,Q2,1,I,20180526.0,20180528.0,20180608,20180608,EXP,,PL-ELI_LILLY_AND_COMPANY-PL201805013724,ELI LILLY AND CO,,60.0,YR,,F,Y,52.0,KG,20180608.0,,CN,PL,PL,2018,Q2,Adult
149926381,14992638,6,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,PRE-FILLED SYRINGES,,,,,,,,,,,,2018,Q2,Electrolyte imbalance,,2018,Q2,1,I,,20180531.0,20180609,20180609,EXP,,DE-TEVA-2018-DE-903644,TEVA,,83.0,YR,,M,Y,70.0,KG,20180609.0,,MD,DE,DE,2018,Q2,Elderly
149926381,14992638,6,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,PRE-FILLED SYRINGES,,,,,,,,,,,,2018,Q2,Pain,,2018,Q2,1,I,,20180531.0,20180609,20180609,EXP,,DE-TEVA-2018-DE-903644,TEVA,,83.0,YR,,M,Y,70.0,KG,20180609.0,,MD,DE,DE,2018,Q2,Elderly
149926381,14992638,6,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,PRE-FILLED SYRINGES,,,,,,,,,,,,2018,Q2,Skin ulcer,,2018,Q2,1,I,,20180531.0,20180609,20180609,EXP,,DE-TEVA-2018-DE-903644,TEVA,,83.0,YR,,M,Y,70.0,KG,20180609.0,,MD,DE,DE,2018,Q2,Elderly
149996582,14999658,4,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"TO BZ, INJECTION/INFUSION SOLUTION",,,,,,,,,,,,2018,Q2,Acute kidney injury,,2018,Q2,2,F,,20180614.0,20180612,20180621,EXP,,DE-TEVA-2018-DE-904431,TEVA,,67.0,YR,,F,Y,83.0,KG,20180622.0,,MD,DE,DE,2018,Q2,Elderly
149996582,14999658,4,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"TO BZ, INJECTION/INFUSION SOLUTION",,,,,,,,,,,,2018,Q2,General physical health deterioration,,2018,Q2,2,F,,20180614.0,20180612,20180621,EXP,,DE-TEVA-2018-DE-904431,TEVA,,67.0,YR,,F,Y,83.0,KG,20180622.0,,MD,DE,DE,2018,Q2,Elderly
149996582,14999658,4,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"TO BZ, INJECTION/INFUSION SOLUTION",,,,,,,,,,,,2018,Q2,Renal impairment,,2018,Q2,2,F,,20180614.0,20180612,20180621,EXP,,DE-TEVA-2018-DE-904431,TEVA,,67.0,YR,,F,Y,83.0,KG,20180622.0,,MD,DE,DE,2018,Q2,Elderly
150037291,15003729,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS WITH MEALS,,,Y,U,,,,,,INJECTION,,2018,Q2,Drug interaction,,2018,Q2,1,I,,20180529.0,20180613,20180613,EXP,,CA-APOTEX-2018AP015733,APOTEX,,56.0,YR,,M,Y,,,20180613.0,,OT,CA,CA,2018,Q2,Adult
150037291,15003729,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS WITH MEALS,,,Y,U,,,,,,INJECTION,,2018,Q2,Enzyme inhibition,,2018,Q2,1,I,,20180529.0,20180613,20180613,EXP,,CA-APOTEX-2018AP015733,APOTEX,,56.0,YR,,M,Y,,,20180613.0,,OT,CA,CA,2018,Q2,Adult
150037291,15003729,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS WITH MEALS,,,Y,U,,,,,,INJECTION,,2018,Q2,Hallucination,,2018,Q2,1,I,,20180529.0,20180613,20180613,EXP,,CA-APOTEX-2018AP015733,APOTEX,,56.0,YR,,M,Y,,,20180613.0,,OT,CA,CA,2018,Q2,Adult
150037291,15003729,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS WITH MEALS,,,Y,U,,,,,,INJECTION,,2018,Q2,Hypoglycaemia,,2018,Q2,1,I,,20180529.0,20180613,20180613,EXP,,CA-APOTEX-2018AP015733,APOTEX,,56.0,YR,,M,Y,,,20180613.0,,OT,CA,CA,2018,Q2,Adult
150037291,15003729,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS WITH MEALS,,,Y,U,,,,,,INJECTION,,2018,Q2,Lethargy,,2018,Q2,1,I,,20180529.0,20180613,20180613,EXP,,CA-APOTEX-2018AP015733,APOTEX,,56.0,YR,,M,Y,,,20180613.0,,OT,CA,CA,2018,Q2,Adult
150037291,15003729,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS WITH MEALS,,,Y,U,,,,,,INJECTION,,2018,Q2,Toxicity to various agents,,2018,Q2,1,I,,20180529.0,20180613,20180613,EXP,,CA-APOTEX-2018AP015733,APOTEX,,56.0,YR,,M,Y,,,20180613.0,,OT,CA,CA,2018,Q2,Adult
150037291,15003729,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS WITH MEALS,,,Y,U,,,,,,INJECTION,,2018,Q2,Visual impairment,,2018,Q2,1,I,,20180529.0,20180613,20180613,EXP,,CA-APOTEX-2018AP015733,APOTEX,,56.0,YR,,M,Y,,,20180613.0,,OT,CA,CA,2018,Q2,Adult
150055541,15005554,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,U,U,,,,,,,,2018,Q2,Bone pain,,2018,Q2,1,I,,20180601.0,20180613,20180613,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201806000146,ELI LILLY AND CO,,43.0,YR,,M,Y,,,20180613.0,,CN,DE,DE,2018,Q2,Adult
150055541,15005554,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,U,U,,,,,,,,2018,Q2,Cartilage injury,,2018,Q2,1,I,,20180601.0,20180613,20180613,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201806000146,ELI LILLY AND CO,,43.0,YR,,M,Y,,,20180613.0,,CN,DE,DE,2018,Q2,Adult
150055541,15005554,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,U,U,,,,,,,,2018,Q2,Diabetes mellitus inadequate control,,2018,Q2,1,I,,20180601.0,20180613,20180613,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201806000146,ELI LILLY AND CO,,43.0,YR,,M,Y,,,20180613.0,,CN,DE,DE,2018,Q2,Adult
150055541,15005554,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,U,U,,,,,,,,2018,Q2,Injection site haematoma,,2018,Q2,1,I,,20180601.0,20180613,20180613,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201806000146,ELI LILLY AND CO,,43.0,YR,,M,Y,,,20180613.0,,CN,DE,DE,2018,Q2,Adult
150071361,15007136,7,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Skin discolouration,,2018,Q2,1,I,20180221.0,,20180521,20180521,DIR,,,FDA-CTU,,54.0,YR,,M,N,,,20180221.0,N,PH,US,US,2018,Q2,Adult
150096671,15009667,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS SUBCUTANEOUSLY WITH MEALS,,,U,,,,,6.0,IU,,,2018,Q2,Accidental overdose,,2018,Q2,1,I,,20180601.0,20180614,20180614,EXP,,CA-AUROBINDO-AUR-APL-2018-031477,AUROBINDO,,56.0,YR,,M,Y,,,20180614.0,,MD,CA,CA,2018,Q2,Adult
150096671,15009667,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS SUBCUTANEOUSLY WITH MEALS,,,U,,,,,6.0,IU,,,2018,Q2,Drug interaction,,2018,Q2,1,I,,20180601.0,20180614,20180614,EXP,,CA-AUROBINDO-AUR-APL-2018-031477,AUROBINDO,,56.0,YR,,M,Y,,,20180614.0,,MD,CA,CA,2018,Q2,Adult
150096671,15009667,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS SUBCUTANEOUSLY WITH MEALS,,,U,,,,,6.0,IU,,,2018,Q2,Hypoglycaemia,,2018,Q2,1,I,,20180601.0,20180614,20180614,EXP,,CA-AUROBINDO-AUR-APL-2018-031477,AUROBINDO,,56.0,YR,,M,Y,,,20180614.0,,MD,CA,CA,2018,Q2,Adult
150096671,15009667,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS SUBCUTANEOUSLY WITH MEALS,,,U,,,,,6.0,IU,,,2018,Q2,Toxicity to various agents,,2018,Q2,1,I,,20180601.0,20180614,20180614,EXP,,CA-AUROBINDO-AUR-APL-2018-031477,AUROBINDO,,56.0,YR,,M,Y,,,20180614.0,,MD,CA,CA,2018,Q2,Adult
150157932,15015793,2,C,INSULIN PUMP LISPRO,,2,,,,,,,,,,,,,,2018,Q2,Febrile neutropenia,,2018,Q2,2,F,20180612.0,20180615.0,20180615,20180618,PER,,US-EISAI MEDICAL RESEARCH-EC-2018-041246,EISAI,,57.0,YR,,F,Y,60.1,KG,20180618.0,,OT,US,US,2018,Q2,Adult
150157932,15015793,2,C,INSULIN PUMP LISPRO,,2,,,,,,,,,,,,,,2018,Q2,Mucosal inflammation,,2018,Q2,2,F,20180612.0,20180615.0,20180615,20180618,PER,,US-EISAI MEDICAL RESEARCH-EC-2018-041246,EISAI,,57.0,YR,,F,Y,60.1,KG,20180618.0,,OT,US,US,2018,Q2,Adult
150164791,15016479,10,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Cystoscopy abnormal,,2018,Q2,1,I,20180530.0,,20180531,20180531,DIR,,,FDA-CTU,,67.0,YR,,M,N,81.6,KG,20180531.0,N,PH,US,US,2018,Q2,Elderly
150164791,15016479,10,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Haematuria,,2018,Q2,1,I,20180530.0,,20180531,20180531,DIR,,,FDA-CTU,,67.0,YR,,M,N,81.6,KG,20180531.0,N,PH,US,US,2018,Q2,Elderly
150164791,15016479,10,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Platelet count decreased,,2018,Q2,1,I,20180530.0,,20180531,20180531,DIR,,,FDA-CTU,,67.0,YR,,M,N,81.6,KG,20180531.0,N,PH,US,US,2018,Q2,Elderly
150187792,15018779,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Dizziness,,2018,Q2,2,F,201805.0,20180620.0,20180616,20180628,PER,,US-ASTRAZENECA-2018SE70597,ASTRAZENECA,,924.0,MON,,F,Y,122.0,KG,20180628.0,,MD,US,US,2018,Q2,Elderly
150187792,15018779,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Drug dispensing error,,2018,Q2,2,F,201805.0,20180620.0,20180616,20180628,PER,,US-ASTRAZENECA-2018SE70597,ASTRAZENECA,,924.0,MON,,F,Y,122.0,KG,20180628.0,,MD,US,US,2018,Q2,Elderly
150187792,15018779,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Drug ineffective,,2018,Q2,2,F,201805.0,20180620.0,20180616,20180628,PER,,US-ASTRAZENECA-2018SE70597,ASTRAZENECA,,924.0,MON,,F,Y,122.0,KG,20180628.0,,MD,US,US,2018,Q2,Elderly
150187792,15018779,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Injection site erythema,,2018,Q2,2,F,201805.0,20180620.0,20180616,20180628,PER,,US-ASTRAZENECA-2018SE70597,ASTRAZENECA,,924.0,MON,,F,Y,122.0,KG,20180628.0,,MD,US,US,2018,Q2,Elderly
150187792,15018779,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Injection site infection,,2018,Q2,2,F,201805.0,20180620.0,20180616,20180628,PER,,US-ASTRAZENECA-2018SE70597,ASTRAZENECA,,924.0,MON,,F,Y,122.0,KG,20180628.0,,MD,US,US,2018,Q2,Elderly
150187792,15018779,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Injection site pain,,2018,Q2,2,F,201805.0,20180620.0,20180616,20180628,PER,,US-ASTRAZENECA-2018SE70597,ASTRAZENECA,,924.0,MON,,F,Y,122.0,KG,20180628.0,,MD,US,US,2018,Q2,Elderly
150187792,15018779,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Injection site pruritus,,2018,Q2,2,F,201805.0,20180620.0,20180616,20180628,PER,,US-ASTRAZENECA-2018SE70597,ASTRAZENECA,,924.0,MON,,F,Y,122.0,KG,20180628.0,,MD,US,US,2018,Q2,Elderly
150187792,15018779,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Injection site rash,,2018,Q2,2,F,201805.0,20180620.0,20180616,20180628,PER,,US-ASTRAZENECA-2018SE70597,ASTRAZENECA,,924.0,MON,,F,Y,122.0,KG,20180628.0,,MD,US,US,2018,Q2,Elderly
150187792,15018779,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Injection site urticaria,,2018,Q2,2,F,201805.0,20180620.0,20180616,20180628,PER,,US-ASTRAZENECA-2018SE70597,ASTRAZENECA,,924.0,MON,,F,Y,122.0,KG,20180628.0,,MD,US,US,2018,Q2,Elderly
150268761,15026876,4,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q2,Fatigue,,2018,Q2,1,I,,20180613.0,20180619,20180619,EXP,,DE-TEVA-2018-DE-908632,TEVA,,56.0,YR,,M,Y,,,20180619.0,,PH,DE,DE,2018,Q2,Adult
150268761,15026876,4,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q2,General physical health deterioration,,2018,Q2,1,I,,20180613.0,20180619,20180619,EXP,,DE-TEVA-2018-DE-908632,TEVA,,56.0,YR,,M,Y,,,20180619.0,,PH,DE,DE,2018,Q2,Adult
150268761,15026876,4,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q2,Nausea,,2018,Q2,1,I,,20180613.0,20180619,20180619,EXP,,DE-TEVA-2018-DE-908632,TEVA,,56.0,YR,,M,Y,,,20180619.0,,PH,DE,DE,2018,Q2,Adult
150301571,15030157,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,U,,,20563.0,,,,,2018,Q2,Blood glucose increased,,2018,Q2,1,I,,20180615.0,20180619,20180619,PER,,US-ELI_LILLY_AND_COMPANY-US201806007694,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20180619.0,,CN,US,US,2018,Q2,Elderly
150307581,15030758,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Acute hepatic failure,,2018,Q2,1,I,20180515.0,20180611.0,20180619,20180619,EXP,GB-MHRA-EYC 00179969,GB-BAYER-2018-110859,BAYER,,48.0,YR,A,F,Y,86.0,KG,20180619.0,,PH,GB,GB,2018,Q2,Adult
150360332,15036033,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"14 IU, QD",,,,,,,,14.0,IU,,QD,2018,Q2,Sudden cardiac death,,2018,Q2,2,F,20180602.0,20180612.0,20180620,20180627,EXP,,CN-AMGEN-CHNCT2018083274,AMGEN,,74.0,YR,E,M,Y,,,20180627.0,,MD,CN,CN,2018,Q2,Elderly
150361731,15036173,8,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,QD",,,,,,,21081.0,,,SOLUTION FOR INJECTION,QD,2018,Q2,Altered state of consciousness,,2018,Q2,1,I,201706.0,20170912.0,20180620,20180620,EXP,,PL-SA-2017SA171404,SANOFI AVENTIS,,8.0,YR,C,M,Y,30.0,KG,20180620.0,,MD,PL,PL,2018,Q2,Child
150361731,15036173,8,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,QD",,,,,,,21081.0,,,SOLUTION FOR INJECTION,QD,2018,Q2,Epilepsy,,2018,Q2,1,I,201706.0,20170912.0,20180620,20180620,EXP,,PL-SA-2017SA171404,SANOFI AVENTIS,,8.0,YR,C,M,Y,30.0,KG,20180620.0,,MD,PL,PL,2018,Q2,Child
150361731,15036173,8,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,QD",,,,,,,21081.0,,,SOLUTION FOR INJECTION,QD,2018,Q2,Headache,,2018,Q2,1,I,201706.0,20170912.0,20180620,20180620,EXP,,PL-SA-2017SA171404,SANOFI AVENTIS,,8.0,YR,C,M,Y,30.0,KG,20180620.0,,MD,PL,PL,2018,Q2,Child
150361731,15036173,8,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,QD",,,,,,,21081.0,,,SOLUTION FOR INJECTION,QD,2018,Q2,Hyperglycaemia,,2018,Q2,1,I,201706.0,20170912.0,20180620,20180620,EXP,,PL-SA-2017SA171404,SANOFI AVENTIS,,8.0,YR,C,M,Y,30.0,KG,20180620.0,,MD,PL,PL,2018,Q2,Child
150361731,15036173,8,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,QD",,,,,,,21081.0,,,SOLUTION FOR INJECTION,QD,2018,Q2,Hypoglycaemia,,2018,Q2,1,I,201706.0,20170912.0,20180620,20180620,EXP,,PL-SA-2017SA171404,SANOFI AVENTIS,,8.0,YR,C,M,Y,30.0,KG,20180620.0,,MD,PL,PL,2018,Q2,Child
150361731,15036173,8,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,QD",,,,,,,21081.0,,,SOLUTION FOR INJECTION,QD,2018,Q2,Seizure,,2018,Q2,1,I,201706.0,20170912.0,20180620,20180620,EXP,,PL-SA-2017SA171404,SANOFI AVENTIS,,8.0,YR,C,M,Y,30.0,KG,20180620.0,,MD,PL,PL,2018,Q2,Child
150361731,15036173,8,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,QD",,,,,,,21081.0,,,SOLUTION FOR INJECTION,QD,2018,Q2,Therapy change,,2018,Q2,1,I,201706.0,20170912.0,20180620,20180620,EXP,,PL-SA-2017SA171404,SANOFI AVENTIS,,8.0,YR,C,M,Y,30.0,KG,20180620.0,,MD,PL,PL,2018,Q2,Child
150361731,15036173,9,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,QD",,,,,,,21081.0,,,SOLUTION FOR INJECTION,QD,2018,Q2,Altered state of consciousness,,2018,Q2,1,I,201706.0,20170912.0,20180620,20180620,EXP,,PL-SA-2017SA171404,SANOFI AVENTIS,,8.0,YR,C,M,Y,30.0,KG,20180620.0,,MD,PL,PL,2018,Q2,Child
150361731,15036173,9,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,QD",,,,,,,21081.0,,,SOLUTION FOR INJECTION,QD,2018,Q2,Epilepsy,,2018,Q2,1,I,201706.0,20170912.0,20180620,20180620,EXP,,PL-SA-2017SA171404,SANOFI AVENTIS,,8.0,YR,C,M,Y,30.0,KG,20180620.0,,MD,PL,PL,2018,Q2,Child
150361731,15036173,9,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,QD",,,,,,,21081.0,,,SOLUTION FOR INJECTION,QD,2018,Q2,Headache,,2018,Q2,1,I,201706.0,20170912.0,20180620,20180620,EXP,,PL-SA-2017SA171404,SANOFI AVENTIS,,8.0,YR,C,M,Y,30.0,KG,20180620.0,,MD,PL,PL,2018,Q2,Child
150361731,15036173,9,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,QD",,,,,,,21081.0,,,SOLUTION FOR INJECTION,QD,2018,Q2,Hyperglycaemia,,2018,Q2,1,I,201706.0,20170912.0,20180620,20180620,EXP,,PL-SA-2017SA171404,SANOFI AVENTIS,,8.0,YR,C,M,Y,30.0,KG,20180620.0,,MD,PL,PL,2018,Q2,Child
150361731,15036173,9,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,QD",,,,,,,21081.0,,,SOLUTION FOR INJECTION,QD,2018,Q2,Hypoglycaemia,,2018,Q2,1,I,201706.0,20170912.0,20180620,20180620,EXP,,PL-SA-2017SA171404,SANOFI AVENTIS,,8.0,YR,C,M,Y,30.0,KG,20180620.0,,MD,PL,PL,2018,Q2,Child
150361731,15036173,9,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,QD",,,,,,,21081.0,,,SOLUTION FOR INJECTION,QD,2018,Q2,Seizure,,2018,Q2,1,I,201706.0,20170912.0,20180620,20180620,EXP,,PL-SA-2017SA171404,SANOFI AVENTIS,,8.0,YR,C,M,Y,30.0,KG,20180620.0,,MD,PL,PL,2018,Q2,Child
150361731,15036173,9,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,QD",,,,,,,21081.0,,,SOLUTION FOR INJECTION,QD,2018,Q2,Therapy change,,2018,Q2,1,I,201706.0,20170912.0,20180620,20180620,EXP,,PL-SA-2017SA171404,SANOFI AVENTIS,,8.0,YR,C,M,Y,30.0,KG,20180620.0,,MD,PL,PL,2018,Q2,Child
150361731,15036173,18,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,PRN",,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q2,Altered state of consciousness,,2018,Q2,1,I,201706.0,20170912.0,20180620,20180620,EXP,,PL-SA-2017SA171404,SANOFI AVENTIS,,8.0,YR,C,M,Y,30.0,KG,20180620.0,,MD,PL,PL,2018,Q2,Child
150361731,15036173,18,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,PRN",,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q2,Epilepsy,,2018,Q2,1,I,201706.0,20170912.0,20180620,20180620,EXP,,PL-SA-2017SA171404,SANOFI AVENTIS,,8.0,YR,C,M,Y,30.0,KG,20180620.0,,MD,PL,PL,2018,Q2,Child
150361731,15036173,18,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,PRN",,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q2,Headache,,2018,Q2,1,I,201706.0,20170912.0,20180620,20180620,EXP,,PL-SA-2017SA171404,SANOFI AVENTIS,,8.0,YR,C,M,Y,30.0,KG,20180620.0,,MD,PL,PL,2018,Q2,Child
150361731,15036173,18,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,PRN",,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q2,Hyperglycaemia,,2018,Q2,1,I,201706.0,20170912.0,20180620,20180620,EXP,,PL-SA-2017SA171404,SANOFI AVENTIS,,8.0,YR,C,M,Y,30.0,KG,20180620.0,,MD,PL,PL,2018,Q2,Child
150361731,15036173,18,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,PRN",,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q2,Hypoglycaemia,,2018,Q2,1,I,201706.0,20170912.0,20180620,20180620,EXP,,PL-SA-2017SA171404,SANOFI AVENTIS,,8.0,YR,C,M,Y,30.0,KG,20180620.0,,MD,PL,PL,2018,Q2,Child
150361731,15036173,18,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,PRN",,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q2,Seizure,,2018,Q2,1,I,201706.0,20170912.0,20180620,20180620,EXP,,PL-SA-2017SA171404,SANOFI AVENTIS,,8.0,YR,C,M,Y,30.0,KG,20180620.0,,MD,PL,PL,2018,Q2,Child
150361731,15036173,18,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,PRN",,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q2,Therapy change,,2018,Q2,1,I,201706.0,20170912.0,20180620,20180620,EXP,,PL-SA-2017SA171404,SANOFI AVENTIS,,8.0,YR,C,M,Y,30.0,KG,20180620.0,,MD,PL,PL,2018,Q2,Child
150361731,15036173,19,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,PRN",,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q2,Altered state of consciousness,,2018,Q2,1,I,201706.0,20170912.0,20180620,20180620,EXP,,PL-SA-2017SA171404,SANOFI AVENTIS,,8.0,YR,C,M,Y,30.0,KG,20180620.0,,MD,PL,PL,2018,Q2,Child
150361731,15036173,19,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,PRN",,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q2,Epilepsy,,2018,Q2,1,I,201706.0,20170912.0,20180620,20180620,EXP,,PL-SA-2017SA171404,SANOFI AVENTIS,,8.0,YR,C,M,Y,30.0,KG,20180620.0,,MD,PL,PL,2018,Q2,Child
150361731,15036173,19,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,PRN",,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q2,Headache,,2018,Q2,1,I,201706.0,20170912.0,20180620,20180620,EXP,,PL-SA-2017SA171404,SANOFI AVENTIS,,8.0,YR,C,M,Y,30.0,KG,20180620.0,,MD,PL,PL,2018,Q2,Child
150361731,15036173,19,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,PRN",,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q2,Hyperglycaemia,,2018,Q2,1,I,201706.0,20170912.0,20180620,20180620,EXP,,PL-SA-2017SA171404,SANOFI AVENTIS,,8.0,YR,C,M,Y,30.0,KG,20180620.0,,MD,PL,PL,2018,Q2,Child
150361731,15036173,19,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,PRN",,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q2,Hypoglycaemia,,2018,Q2,1,I,201706.0,20170912.0,20180620,20180620,EXP,,PL-SA-2017SA171404,SANOFI AVENTIS,,8.0,YR,C,M,Y,30.0,KG,20180620.0,,MD,PL,PL,2018,Q2,Child
150361731,15036173,19,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,PRN",,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q2,Seizure,,2018,Q2,1,I,201706.0,20170912.0,20180620,20180620,EXP,,PL-SA-2017SA171404,SANOFI AVENTIS,,8.0,YR,C,M,Y,30.0,KG,20180620.0,,MD,PL,PL,2018,Q2,Child
150361731,15036173,19,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,PRN",,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q2,Therapy change,,2018,Q2,1,I,201706.0,20170912.0,20180620,20180620,EXP,,PL-SA-2017SA171404,SANOFI AVENTIS,,8.0,YR,C,M,Y,30.0,KG,20180620.0,,MD,PL,PL,2018,Q2,Child
150367991,15036799,6,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"NK IE, NACH BZ",,,,,,,,,,,,2018,Q2,Anaemia,,2018,Q2,1,I,,20180614.0,20180620,20180620,EXP,,DE-TEVA-2018-DE-911765,TEVA,,77.0,YR,,M,Y,,,20180620.0,,PH,DE,DE,2018,Q2,Elderly
150367991,15036799,6,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"NK IE, NACH BZ",,,,,,,,,,,,2018,Q2,Dyspnoea,,2018,Q2,1,I,,20180614.0,20180620,20180620,EXP,,DE-TEVA-2018-DE-911765,TEVA,,77.0,YR,,M,Y,,,20180620.0,,PH,DE,DE,2018,Q2,Elderly
150367991,15036799,6,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"NK IE, NACH BZ",,,,,,,,,,,,2018,Q2,Haematochezia,,2018,Q2,1,I,,20180614.0,20180620,20180620,EXP,,DE-TEVA-2018-DE-911765,TEVA,,77.0,YR,,M,Y,,,20180620.0,,PH,DE,DE,2018,Q2,Elderly
150371101,15037110,8,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"38 DF,QD",8071.606,DF,N,,,,21081.0,38.0,DF,SOLUTION FOR INJECTION,QD,2018,Q2,Alanine aminotransferase increased,,2018,Q2,1,I,20171227.0,20171229.0,20180620,20180620,EXP,,CL-SA-2018SA000328,SANOFI AVENTIS,,14.0,YR,T,F,Y,58.0,KG,20180620.0,,MD,CL,CL,2018,Q2,Youth
150371101,15037110,9,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"38 DF,QD",8071.606,DF,N,,,,21081.0,38.0,DF,SOLUTION FOR INJECTION,QD,2018,Q2,Alanine aminotransferase increased,,2018,Q2,1,I,20171227.0,20171229.0,20180620,20180620,EXP,,CL-SA-2018SA000328,SANOFI AVENTIS,,14.0,YR,T,F,Y,58.0,KG,20180620.0,,MD,CL,CL,2018,Q2,Youth
150417241,15041724,1,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"28 U, EACH MORNING",,,Y,U,,,,28.0,IU,INJECTION,QD,2018,Q2,Blood glucose decreased,,2018,Q2,1,I,201708.0,20180608.0,20180621,20180621,EXP,,GR-ELI_LILLY_AND_COMPANY-GR201806005233,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20180621.0,,CN,GR,GR,2018,Q2,Elderly
150417241,15041724,1,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"28 U, EACH MORNING",,,Y,U,,,,28.0,IU,INJECTION,QD,2018,Q2,Blood glucose increased,,2018,Q2,1,I,201708.0,20180608.0,20180621,20180621,EXP,,GR-ELI_LILLY_AND_COMPANY-GR201806005233,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20180621.0,,CN,GR,GR,2018,Q2,Elderly
150417241,15041724,1,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"28 U, EACH MORNING",,,Y,U,,,,28.0,IU,INJECTION,QD,2018,Q2,Dyspnoea,,2018,Q2,1,I,201708.0,20180608.0,20180621,20180621,EXP,,GR-ELI_LILLY_AND_COMPANY-GR201806005233,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20180621.0,,CN,GR,GR,2018,Q2,Elderly
150417241,15041724,1,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"28 U, EACH MORNING",,,Y,U,,,,28.0,IU,INJECTION,QD,2018,Q2,Monoplegia,,2018,Q2,1,I,201708.0,20180608.0,20180621,20180621,EXP,,GR-ELI_LILLY_AND_COMPANY-GR201806005233,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20180621.0,,CN,GR,GR,2018,Q2,Elderly
150417241,15041724,1,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"28 U, EACH MORNING",,,Y,U,,,,28.0,IU,INJECTION,QD,2018,Q2,Oxygen saturation decreased,,2018,Q2,1,I,201708.0,20180608.0,20180621,20180621,EXP,,GR-ELI_LILLY_AND_COMPANY-GR201806005233,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20180621.0,,CN,GR,GR,2018,Q2,Elderly
150417241,15041724,1,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"28 U, EACH MORNING",,,Y,U,,,,28.0,IU,INJECTION,QD,2018,Q2,Presyncope,,2018,Q2,1,I,201708.0,20180608.0,20180621,20180621,EXP,,GR-ELI_LILLY_AND_COMPANY-GR201806005233,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20180621.0,,CN,GR,GR,2018,Q2,Elderly
150417241,15041724,1,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"28 U, EACH MORNING",,,Y,U,,,,28.0,IU,INJECTION,QD,2018,Q2,Vomiting,,2018,Q2,1,I,201708.0,20180608.0,20180621,20180621,EXP,,GR-ELI_LILLY_AND_COMPANY-GR201806005233,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20180621.0,,CN,GR,GR,2018,Q2,Elderly
150417241,15041724,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"28 U, DAILY AT NIGHT",,,Y,U,,,,28.0,IU,INJECTION,QD,2018,Q2,Blood glucose decreased,,2018,Q2,1,I,201708.0,20180608.0,20180621,20180621,EXP,,GR-ELI_LILLY_AND_COMPANY-GR201806005233,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20180621.0,,CN,GR,GR,2018,Q2,Elderly
150417241,15041724,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"28 U, DAILY AT NIGHT",,,Y,U,,,,28.0,IU,INJECTION,QD,2018,Q2,Blood glucose increased,,2018,Q2,1,I,201708.0,20180608.0,20180621,20180621,EXP,,GR-ELI_LILLY_AND_COMPANY-GR201806005233,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20180621.0,,CN,GR,GR,2018,Q2,Elderly
150417241,15041724,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"28 U, DAILY AT NIGHT",,,Y,U,,,,28.0,IU,INJECTION,QD,2018,Q2,Dyspnoea,,2018,Q2,1,I,201708.0,20180608.0,20180621,20180621,EXP,,GR-ELI_LILLY_AND_COMPANY-GR201806005233,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20180621.0,,CN,GR,GR,2018,Q2,Elderly
150417241,15041724,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"28 U, DAILY AT NIGHT",,,Y,U,,,,28.0,IU,INJECTION,QD,2018,Q2,Monoplegia,,2018,Q2,1,I,201708.0,20180608.0,20180621,20180621,EXP,,GR-ELI_LILLY_AND_COMPANY-GR201806005233,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20180621.0,,CN,GR,GR,2018,Q2,Elderly
150417241,15041724,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"28 U, DAILY AT NIGHT",,,Y,U,,,,28.0,IU,INJECTION,QD,2018,Q2,Oxygen saturation decreased,,2018,Q2,1,I,201708.0,20180608.0,20180621,20180621,EXP,,GR-ELI_LILLY_AND_COMPANY-GR201806005233,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20180621.0,,CN,GR,GR,2018,Q2,Elderly
150417241,15041724,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"28 U, DAILY AT NIGHT",,,Y,U,,,,28.0,IU,INJECTION,QD,2018,Q2,Presyncope,,2018,Q2,1,I,201708.0,20180608.0,20180621,20180621,EXP,,GR-ELI_LILLY_AND_COMPANY-GR201806005233,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20180621.0,,CN,GR,GR,2018,Q2,Elderly
150417241,15041724,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"28 U, DAILY AT NIGHT",,,Y,U,,,,28.0,IU,INJECTION,QD,2018,Q2,Vomiting,,2018,Q2,1,I,201708.0,20180608.0,20180621,20180621,EXP,,GR-ELI_LILLY_AND_COMPANY-GR201806005233,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20180621.0,,CN,GR,GR,2018,Q2,Elderly
150417241,15041724,3,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"28 U, EACH MORNING",,,U,U,,,20563.0,28.0,IU,,QD,2018,Q2,Blood glucose decreased,,2018,Q2,1,I,201708.0,20180608.0,20180621,20180621,EXP,,GR-ELI_LILLY_AND_COMPANY-GR201806005233,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20180621.0,,CN,GR,GR,2018,Q2,Elderly
150417241,15041724,3,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"28 U, EACH MORNING",,,U,U,,,20563.0,28.0,IU,,QD,2018,Q2,Blood glucose increased,,2018,Q2,1,I,201708.0,20180608.0,20180621,20180621,EXP,,GR-ELI_LILLY_AND_COMPANY-GR201806005233,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20180621.0,,CN,GR,GR,2018,Q2,Elderly
150417241,15041724,3,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"28 U, EACH MORNING",,,U,U,,,20563.0,28.0,IU,,QD,2018,Q2,Dyspnoea,,2018,Q2,1,I,201708.0,20180608.0,20180621,20180621,EXP,,GR-ELI_LILLY_AND_COMPANY-GR201806005233,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20180621.0,,CN,GR,GR,2018,Q2,Elderly
150417241,15041724,3,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"28 U, EACH MORNING",,,U,U,,,20563.0,28.0,IU,,QD,2018,Q2,Monoplegia,,2018,Q2,1,I,201708.0,20180608.0,20180621,20180621,EXP,,GR-ELI_LILLY_AND_COMPANY-GR201806005233,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20180621.0,,CN,GR,GR,2018,Q2,Elderly
150417241,15041724,3,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"28 U, EACH MORNING",,,U,U,,,20563.0,28.0,IU,,QD,2018,Q2,Oxygen saturation decreased,,2018,Q2,1,I,201708.0,20180608.0,20180621,20180621,EXP,,GR-ELI_LILLY_AND_COMPANY-GR201806005233,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20180621.0,,CN,GR,GR,2018,Q2,Elderly
150417241,15041724,3,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"28 U, EACH MORNING",,,U,U,,,20563.0,28.0,IU,,QD,2018,Q2,Presyncope,,2018,Q2,1,I,201708.0,20180608.0,20180621,20180621,EXP,,GR-ELI_LILLY_AND_COMPANY-GR201806005233,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20180621.0,,CN,GR,GR,2018,Q2,Elderly
150417241,15041724,3,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"28 U, EACH MORNING",,,U,U,,,20563.0,28.0,IU,,QD,2018,Q2,Vomiting,,2018,Q2,1,I,201708.0,20180608.0,20180621,20180621,EXP,,GR-ELI_LILLY_AND_COMPANY-GR201806005233,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20180621.0,,CN,GR,GR,2018,Q2,Elderly
150417241,15041724,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"28 U, DAILY AT NIGHT",,,U,U,,,20563.0,28.0,IU,,QD,2018,Q2,Blood glucose decreased,,2018,Q2,1,I,201708.0,20180608.0,20180621,20180621,EXP,,GR-ELI_LILLY_AND_COMPANY-GR201806005233,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20180621.0,,CN,GR,GR,2018,Q2,Elderly
150417241,15041724,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"28 U, DAILY AT NIGHT",,,U,U,,,20563.0,28.0,IU,,QD,2018,Q2,Blood glucose increased,,2018,Q2,1,I,201708.0,20180608.0,20180621,20180621,EXP,,GR-ELI_LILLY_AND_COMPANY-GR201806005233,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20180621.0,,CN,GR,GR,2018,Q2,Elderly
150417241,15041724,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"28 U, DAILY AT NIGHT",,,U,U,,,20563.0,28.0,IU,,QD,2018,Q2,Dyspnoea,,2018,Q2,1,I,201708.0,20180608.0,20180621,20180621,EXP,,GR-ELI_LILLY_AND_COMPANY-GR201806005233,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20180621.0,,CN,GR,GR,2018,Q2,Elderly
150417241,15041724,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"28 U, DAILY AT NIGHT",,,U,U,,,20563.0,28.0,IU,,QD,2018,Q2,Monoplegia,,2018,Q2,1,I,201708.0,20180608.0,20180621,20180621,EXP,,GR-ELI_LILLY_AND_COMPANY-GR201806005233,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20180621.0,,CN,GR,GR,2018,Q2,Elderly
150417241,15041724,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"28 U, DAILY AT NIGHT",,,U,U,,,20563.0,28.0,IU,,QD,2018,Q2,Oxygen saturation decreased,,2018,Q2,1,I,201708.0,20180608.0,20180621,20180621,EXP,,GR-ELI_LILLY_AND_COMPANY-GR201806005233,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20180621.0,,CN,GR,GR,2018,Q2,Elderly
150417241,15041724,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"28 U, DAILY AT NIGHT",,,U,U,,,20563.0,28.0,IU,,QD,2018,Q2,Presyncope,,2018,Q2,1,I,201708.0,20180608.0,20180621,20180621,EXP,,GR-ELI_LILLY_AND_COMPANY-GR201806005233,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20180621.0,,CN,GR,GR,2018,Q2,Elderly
150417241,15041724,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"28 U, DAILY AT NIGHT",,,U,U,,,20563.0,28.0,IU,,QD,2018,Q2,Vomiting,,2018,Q2,1,I,201708.0,20180608.0,20180621,20180621,EXP,,GR-ELI_LILLY_AND_COMPANY-GR201806005233,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20180621.0,,CN,GR,GR,2018,Q2,Elderly
150423991,15042399,12,C,insulin lispro (Humalog),,2,,,,,,,,,,,,,,2018,Q2,Intestinal haemorrhage,,2018,Q2,1,I,20180427.0,,20180531,20180531,DIR,,,FDA-CTU,,76.0,YR,,M,N,122.47,KG,20180518.0,N,CN,US,US,2018,Q2,Elderly
150531551,15053155,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q2,Fatigue,,2018,Q2,1,I,,20180613.0,20180622,20180622,EXP,,DE-PFIZER INC-2018250291,PFIZER,,56.0,YR,,M,Y,,,20180622.0,,PH,DE,DE,2018,Q2,Adult
150531551,15053155,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q2,General physical health deterioration,,2018,Q2,1,I,,20180613.0,20180622,20180622,EXP,,DE-PFIZER INC-2018250291,PFIZER,,56.0,YR,,M,Y,,,20180622.0,,PH,DE,DE,2018,Q2,Adult
150531551,15053155,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q2,Nausea,,2018,Q2,1,I,,20180613.0,20180622,20180622,EXP,,DE-PFIZER INC-2018250291,PFIZER,,56.0,YR,,M,Y,,,20180622.0,,PH,DE,DE,2018,Q2,Adult
150619981,15061998,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,Y,U, UNKNOWN,,,,,,,2018,Q2,Hypoglycaemia,,2018,Q2,1,I,20180522.0,20180615.0,20180625,20180625,EXP,IT-MINISAL02-482560,IT-NOVOPROD-606642,NOVO NORDISK,,17.0,YR,T,F,Y,,,20180625.0,,CN,IT,IT,2018,Q2,Youth
150619981,15061998,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,Y,U, UNKNOWN,,,,,,,2018,Q2,Hypotension,,2018,Q2,1,I,20180522.0,20180615.0,20180625,20180625,EXP,IT-MINISAL02-482560,IT-NOVOPROD-606642,NOVO NORDISK,,17.0,YR,T,F,Y,,,20180625.0,,CN,IT,IT,2018,Q2,Youth
150659751,15065975,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 DF, QD",,,U,, C790148,,,1.0,DF,INJECTION,QD,2018,Q2,Diabetic ketoacidosis,,2018,Q2,1,I,20180410.0,20180612.0,20180626,20180626,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-057579,BRISTOL MYERS SQUIBB,,17.0,YR,,F,Y,52.0,KG,20180626.0,,OT,CN,CN,2018,Q2,Youth
150659751,15065975,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 DF, QD",,,U,, C790148,,,1.0,DF,INJECTION,QD,2018,Q2,Product use in unapproved indication,,2018,Q2,1,I,20180410.0,20180612.0,20180626,20180626,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-057579,BRISTOL MYERS SQUIBB,,17.0,YR,,F,Y,52.0,KG,20180626.0,,OT,CN,CN,2018,Q2,Youth
150807711,15080771,3,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"80 UNITS, 3X/DAY (TID)",,,,U,,,,,,,TID,2018,Q2,Pyrexia,,2018,Q2,1,I,20180601.0,20180618.0,20180628,20180628,EXP,,CO-UCBSA-2018027939,UCB,,69.0,YR,,F,Y,88.0,KG,20180628.0,,CN,CO,CO,2018,Q2,Elderly
150827491,15082749,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 INTERNATIONAL UNIT, DAILY",1020.0,IU,Y,U, UNK,,,15.0,IU,,,2018,Q2,Cold sweat,,2018,Q2,1,I,20180529.0,20180614.0,20180628,20180628,EXP,,IT-AUROBINDO-AUR-APL-2018-032529,AUROBINDO,,84.0,YR,,M,Y,,,20180628.0,,MD,IT,IT,2018,Q2,Elderly
150827491,15082749,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 INTERNATIONAL UNIT, DAILY",1020.0,IU,Y,U, UNK,,,15.0,IU,,,2018,Q2,Confusional state,,2018,Q2,1,I,20180529.0,20180614.0,20180628,20180628,EXP,,IT-AUROBINDO-AUR-APL-2018-032529,AUROBINDO,,84.0,YR,,M,Y,,,20180628.0,,MD,IT,IT,2018,Q2,Elderly
150827491,15082749,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 INTERNATIONAL UNIT, DAILY",1020.0,IU,Y,U, UNK,,,15.0,IU,,,2018,Q2,Hypoglycaemic coma,,2018,Q2,1,I,20180529.0,20180614.0,20180628,20180628,EXP,,IT-AUROBINDO-AUR-APL-2018-032529,AUROBINDO,,84.0,YR,,M,Y,,,20180628.0,,MD,IT,IT,2018,Q2,Elderly
150850461,15085046,9,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Skin burning sensation,,2018,Q2,1,I,20180210.0,20180219.0,20180628,20180628,PER,,US-GALDERMA-US18012944,GALDERMA,,22.0,YR,,F,Y,,,20180628.0,,CN,US,US,2018,Q2,Youth
150881001,15088100,4,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,,,,20563.0,,,,,2018,Q2,Wrong drug administered,,2018,Q2,1,I,20180627.0,20180628.0,20180629,20180629,PER,,US-ELI_LILLY_AND_COMPANY-US201806013704,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20180629.0,,CN,US,US,2018,Q2,Adult
150931061,15093106,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,27.0,IU,,QD,2018,Q2,Agitation,,2018,Q2,1,I,20180201.0,20180625.0,20180629,20180629,EXP,IT-MINISAL02-482047,IT-009507513-1806ITA010615,MERCK,,52.0,YR,,M,Y,,,20180629.0,,MD,IT,IT,2018,Q2,Adult
150931061,15093106,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,27.0,IU,,QD,2018,Q2,Confusional state,,2018,Q2,1,I,20180201.0,20180625.0,20180629,20180629,EXP,IT-MINISAL02-482047,IT-009507513-1806ITA010615,MERCK,,52.0,YR,,M,Y,,,20180629.0,,MD,IT,IT,2018,Q2,Adult
150931061,15093106,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,27.0,IU,,QD,2018,Q2,"Hallucination, visual",,2018,Q2,1,I,20180201.0,20180625.0,20180629,20180629,EXP,IT-MINISAL02-482047,IT-009507513-1806ITA010615,MERCK,,52.0,YR,,M,Y,,,20180629.0,,MD,IT,IT,2018,Q2,Adult
151092861,15109286,5,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Abdominal pain,,2018,Q2,1,I,,,20180611,20180611,DIR,,,FDA-CTU,,65.0,YR,,F,N,61.69,KG,,N,CN,US,US,2018,Q2,Elderly
151092861,15109286,5,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Dyspnoea,,2018,Q2,1,I,,,20180611,20180611,DIR,,,FDA-CTU,,65.0,YR,,F,N,61.69,KG,,N,CN,US,US,2018,Q2,Elderly
151092861,15109286,5,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Malaise,,2018,Q2,1,I,,,20180611,20180611,DIR,,,FDA-CTU,,65.0,YR,,F,N,61.69,KG,,N,CN,US,US,2018,Q2,Elderly
151092861,15109286,5,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q2,Pneumonia,,2018,Q2,1,I,,,20180611,20180611,DIR,,,FDA-CTU,,65.0,YR,,F,N,61.69,KG,,N,CN,US,US,2018,Q2,Elderly
98621375,9862137,43,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,BID,2018,Q2,Appendicitis,,2018,Q2,5,F,20131029.0,20180423.0,20140203,20180501,EXP,,US-ROCHE-1328108,ROCHE,,34.0,YR,,F,Y,,,20180502.0,,MD,US,US,2018,Q2,Young Adult
98621375,9862137,43,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,BID,2018,Q2,Diabetic ketoacidosis,,2018,Q2,5,F,20131029.0,20180423.0,20140203,20180501,EXP,,US-ROCHE-1328108,ROCHE,,34.0,YR,,F,Y,,,20180502.0,,MD,US,US,2018,Q2,Young Adult
98621375,9862137,43,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,BID,2018,Q2,Gastroenteritis,,2018,Q2,5,F,20131029.0,20180423.0,20140203,20180501,EXP,,US-ROCHE-1328108,ROCHE,,34.0,YR,,F,Y,,,20180502.0,,MD,US,US,2018,Q2,Young Adult
98621375,9862137,43,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,BID,2018,Q2,Hypertension,,2018,Q2,5,F,20131029.0,20180423.0,20140203,20180501,EXP,,US-ROCHE-1328108,ROCHE,,34.0,YR,,F,Y,,,20180502.0,,MD,US,US,2018,Q2,Young Adult
98621375,9862137,43,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,BID,2018,Q2,Hypoglycaemia,,2018,Q2,5,F,20131029.0,20180423.0,20140203,20180501,EXP,,US-ROCHE-1328108,ROCHE,,34.0,YR,,F,Y,,,20180502.0,,MD,US,US,2018,Q2,Young Adult
98621375,9862137,43,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,BID,2018,Q2,Impaired gastric emptying,,2018,Q2,5,F,20131029.0,20180423.0,20140203,20180501,EXP,,US-ROCHE-1328108,ROCHE,,34.0,YR,,F,Y,,,20180502.0,,MD,US,US,2018,Q2,Young Adult
98621375,9862137,43,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,BID,2018,Q2,Leukocytosis,,2018,Q2,5,F,20131029.0,20180423.0,20140203,20180501,EXP,,US-ROCHE-1328108,ROCHE,,34.0,YR,,F,Y,,,20180502.0,,MD,US,US,2018,Q2,Young Adult
98621375,9862137,43,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,BID,2018,Q2,Pancreatitis,,2018,Q2,5,F,20131029.0,20180423.0,20140203,20180501,EXP,,US-ROCHE-1328108,ROCHE,,34.0,YR,,F,Y,,,20180502.0,,MD,US,US,2018,Q2,Young Adult
107026834,10702683,42,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q3,Anaemia,,2018,Q3,4,F,20140802.0,20180917.0,20150109,20180925,EXP,,US-ASTRAZENECA-2015SE02757,ASTRAZENECA,,24401.0,DY,,M,Y,,,20180925.0,,MD,US,US,2018,Q3,Elderly
107026834,10702683,42,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q3,Gastrointestinal haemorrhage,,2018,Q3,4,F,20140802.0,20180917.0,20150109,20180925,EXP,,US-ASTRAZENECA-2015SE02757,ASTRAZENECA,,24401.0,DY,,M,Y,,,20180925.0,,MD,US,US,2018,Q3,Elderly
1142235114,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2018,Q3,Abdominal distension,,2018,Q3,14,F,20100930.0,20180827.0,20150827,20180914,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20180914.0,,MD,US,US,2018,Q3,Adult
1142235114,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2018,Q3,Cardiac disorder,,2018,Q3,14,F,20100930.0,20180827.0,20150827,20180914,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20180914.0,,MD,US,US,2018,Q3,Adult
1142235114,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2018,Q3,Cardiac failure,,2018,Q3,14,F,20100930.0,20180827.0,20150827,20180914,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20180914.0,,MD,US,US,2018,Q3,Adult
1142235114,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2018,Q3,Condition aggravated,,2018,Q3,14,F,20100930.0,20180827.0,20150827,20180914,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20180914.0,,MD,US,US,2018,Q3,Adult
1142235114,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2018,Q3,Diabetes mellitus,,2018,Q3,14,F,20100930.0,20180827.0,20150827,20180914,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20180914.0,,MD,US,US,2018,Q3,Adult
1142235114,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2018,Q3,Diarrhoea,,2018,Q3,14,F,20100930.0,20180827.0,20150827,20180914,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20180914.0,,MD,US,US,2018,Q3,Adult
1142235114,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2018,Q3,Drug ineffective for unapproved indication,,2018,Q3,14,F,20100930.0,20180827.0,20150827,20180914,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20180914.0,,MD,US,US,2018,Q3,Adult
1142235114,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2018,Q3,End stage renal disease,,2018,Q3,14,F,20100930.0,20180827.0,20150827,20180914,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20180914.0,,MD,US,US,2018,Q3,Adult
1142235114,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2018,Q3,Hypertension,,2018,Q3,14,F,20100930.0,20180827.0,20150827,20180914,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20180914.0,,MD,US,US,2018,Q3,Adult
1142235114,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2018,Q3,Impaired work ability,,2018,Q3,14,F,20100930.0,20180827.0,20150827,20180914,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20180914.0,,MD,US,US,2018,Q3,Adult
1142235114,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2018,Q3,Malaise,,2018,Q3,14,F,20100930.0,20180827.0,20150827,20180914,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20180914.0,,MD,US,US,2018,Q3,Adult
1142235114,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2018,Q3,Oedema peripheral,,2018,Q3,14,F,20100930.0,20180827.0,20150827,20180914,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20180914.0,,MD,US,US,2018,Q3,Adult
1142235114,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2018,Q3,Pain,,2018,Q3,14,F,20100930.0,20180827.0,20150827,20180914,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20180914.0,,MD,US,US,2018,Q3,Adult
1142235114,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2018,Q3,Pericardial effusion,,2018,Q3,14,F,20100930.0,20180827.0,20150827,20180914,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20180914.0,,MD,US,US,2018,Q3,Adult
1142235114,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2018,Q3,Renal failure,,2018,Q3,14,F,20100930.0,20180827.0,20150827,20180914,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20180914.0,,MD,US,US,2018,Q3,Adult
1142235114,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2018,Q3,Sleep apnoea syndrome,,2018,Q3,14,F,20100930.0,20180827.0,20150827,20180914,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20180914.0,,MD,US,US,2018,Q3,Adult
1142235114,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2018,Q3,Spinal cord injury,,2018,Q3,14,F,20100930.0,20180827.0,20150827,20180914,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20180914.0,,MD,US,US,2018,Q3,Adult
1159190515,11591905,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DOSE: 100 (UNIT: OTHER),,,,,,,,,,,QID,2018,Q3,Hypercalcaemia,,2018,Q3,15,F,20150922.0,20180913.0,20151005,20180917,EXP,,US-ROCHE-1641435,ROCHE,,72.0,YR,,M,Y,81.37,KG,20180917.0,,MD,US,US,2018,Q3,Elderly
1159190515,11591905,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DOSE: 100 (UNIT: OTHER),,,,,,,,,,,QID,2018,Q3,Hyperthyroidism,,2018,Q3,15,F,20150922.0,20180913.0,20151005,20180917,EXP,,US-ROCHE-1641435,ROCHE,,72.0,YR,,M,Y,81.37,KG,20180917.0,,MD,US,US,2018,Q3,Elderly
1159190515,11591905,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DOSE: 100 (UNIT: OTHER),,,,,,,,,,,QID,2018,Q3,Hypophosphataemia,,2018,Q3,15,F,20150922.0,20180913.0,20151005,20180917,EXP,,US-ROCHE-1641435,ROCHE,,72.0,YR,,M,Y,81.37,KG,20180917.0,,MD,US,US,2018,Q3,Elderly
1159190515,11591905,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DOSE: 100 (UNIT: OTHER),,,,,,,,,,,QID,2018,Q3,Immune-mediated hepatitis,,2018,Q3,15,F,20150922.0,20180913.0,20151005,20180917,EXP,,US-ROCHE-1641435,ROCHE,,72.0,YR,,M,Y,81.37,KG,20180917.0,,MD,US,US,2018,Q3,Elderly
118238162,11823816,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?15 IU, QHS AND AC",,,U,,,,,,,,,2018,Q3,Abdominal pain,,2018,Q3,2,F,2015.0,20151202.0,20151210,20180815,EXP,,"US-KERYX BIOPHARMACEUTICALS, INC.-2015US001096",KERYX BIOPHARMACEUTICALS,,55.0,YR,,M,Y,75.7,KG,20180815.0,,OT,US,US,2018,Q3,Adult
118238162,11823816,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?15 IU, QHS AND AC",,,U,,,,,,,,,2018,Q3,Anaemia,,2018,Q3,2,F,2015.0,20151202.0,20151210,20180815,EXP,,"US-KERYX BIOPHARMACEUTICALS, INC.-2015US001096",KERYX BIOPHARMACEUTICALS,,55.0,YR,,M,Y,75.7,KG,20180815.0,,OT,US,US,2018,Q3,Adult
118238162,11823816,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?15 IU, QHS AND AC",,,U,,,,,,,,,2018,Q3,Asthenia,,2018,Q3,2,F,2015.0,20151202.0,20151210,20180815,EXP,,"US-KERYX BIOPHARMACEUTICALS, INC.-2015US001096",KERYX BIOPHARMACEUTICALS,,55.0,YR,,M,Y,75.7,KG,20180815.0,,OT,US,US,2018,Q3,Adult
118238162,11823816,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?15 IU, QHS AND AC",,,U,,,,,,,,,2018,Q3,Atrioventricular block second degree,,2018,Q3,2,F,2015.0,20151202.0,20151210,20180815,EXP,,"US-KERYX BIOPHARMACEUTICALS, INC.-2015US001096",KERYX BIOPHARMACEUTICALS,,55.0,YR,,M,Y,75.7,KG,20180815.0,,OT,US,US,2018,Q3,Adult
118238162,11823816,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?15 IU, QHS AND AC",,,U,,,,,,,,,2018,Q3,Bradycardia,,2018,Q3,2,F,2015.0,20151202.0,20151210,20180815,EXP,,"US-KERYX BIOPHARMACEUTICALS, INC.-2015US001096",KERYX BIOPHARMACEUTICALS,,55.0,YR,,M,Y,75.7,KG,20180815.0,,OT,US,US,2018,Q3,Adult
118238162,11823816,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?15 IU, QHS AND AC",,,U,,,,,,,,,2018,Q3,Conjunctival pallor,,2018,Q3,2,F,2015.0,20151202.0,20151210,20180815,EXP,,"US-KERYX BIOPHARMACEUTICALS, INC.-2015US001096",KERYX BIOPHARMACEUTICALS,,55.0,YR,,M,Y,75.7,KG,20180815.0,,OT,US,US,2018,Q3,Adult
118238162,11823816,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?15 IU, QHS AND AC",,,U,,,,,,,,,2018,Q3,Dizziness,,2018,Q3,2,F,2015.0,20151202.0,20151210,20180815,EXP,,"US-KERYX BIOPHARMACEUTICALS, INC.-2015US001096",KERYX BIOPHARMACEUTICALS,,55.0,YR,,M,Y,75.7,KG,20180815.0,,OT,US,US,2018,Q3,Adult
118238162,11823816,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?15 IU, QHS AND AC",,,U,,,,,,,,,2018,Q3,Dyspnoea exertional,,2018,Q3,2,F,2015.0,20151202.0,20151210,20180815,EXP,,"US-KERYX BIOPHARMACEUTICALS, INC.-2015US001096",KERYX BIOPHARMACEUTICALS,,55.0,YR,,M,Y,75.7,KG,20180815.0,,OT,US,US,2018,Q3,Adult
118238162,11823816,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?15 IU, QHS AND AC",,,U,,,,,,,,,2018,Q3,Faeces discoloured,,2018,Q3,2,F,2015.0,20151202.0,20151210,20180815,EXP,,"US-KERYX BIOPHARMACEUTICALS, INC.-2015US001096",KERYX BIOPHARMACEUTICALS,,55.0,YR,,M,Y,75.7,KG,20180815.0,,OT,US,US,2018,Q3,Adult
118238162,11823816,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?15 IU, QHS AND AC",,,U,,,,,,,,,2018,Q3,Fatigue,,2018,Q3,2,F,2015.0,20151202.0,20151210,20180815,EXP,,"US-KERYX BIOPHARMACEUTICALS, INC.-2015US001096",KERYX BIOPHARMACEUTICALS,,55.0,YR,,M,Y,75.7,KG,20180815.0,,OT,US,US,2018,Q3,Adult
118238162,11823816,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?15 IU, QHS AND AC",,,U,,,,,,,,,2018,Q3,Gastrointestinal haemorrhage,,2018,Q3,2,F,2015.0,20151202.0,20151210,20180815,EXP,,"US-KERYX BIOPHARMACEUTICALS, INC.-2015US001096",KERYX BIOPHARMACEUTICALS,,55.0,YR,,M,Y,75.7,KG,20180815.0,,OT,US,US,2018,Q3,Adult
118238162,11823816,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?15 IU, QHS AND AC",,,U,,,,,,,,,2018,Q3,Haemoglobin decreased,,2018,Q3,2,F,2015.0,20151202.0,20151210,20180815,EXP,,"US-KERYX BIOPHARMACEUTICALS, INC.-2015US001096",KERYX BIOPHARMACEUTICALS,,55.0,YR,,M,Y,75.7,KG,20180815.0,,OT,US,US,2018,Q3,Adult
118238162,11823816,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?15 IU, QHS AND AC",,,U,,,,,,,,,2018,Q3,Lethargy,,2018,Q3,2,F,2015.0,20151202.0,20151210,20180815,EXP,,"US-KERYX BIOPHARMACEUTICALS, INC.-2015US001096",KERYX BIOPHARMACEUTICALS,,55.0,YR,,M,Y,75.7,KG,20180815.0,,OT,US,US,2018,Q3,Adult
118238162,11823816,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?15 IU, QHS AND AC",,,U,,,,,,,,,2018,Q3,Malaise,,2018,Q3,2,F,2015.0,20151202.0,20151210,20180815,EXP,,"US-KERYX BIOPHARMACEUTICALS, INC.-2015US001096",KERYX BIOPHARMACEUTICALS,,55.0,YR,,M,Y,75.7,KG,20180815.0,,OT,US,US,2018,Q3,Adult
118238162,11823816,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?15 IU, QHS AND AC",,,U,,,,,,,,,2018,Q3,Melaena,,2018,Q3,2,F,2015.0,20151202.0,20151210,20180815,EXP,,"US-KERYX BIOPHARMACEUTICALS, INC.-2015US001096",KERYX BIOPHARMACEUTICALS,,55.0,YR,,M,Y,75.7,KG,20180815.0,,OT,US,US,2018,Q3,Adult
118238162,11823816,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?15 IU, QHS AND AC",,,U,,,,,,,,,2018,Q3,Neuropathy peripheral,,2018,Q3,2,F,2015.0,20151202.0,20151210,20180815,EXP,,"US-KERYX BIOPHARMACEUTICALS, INC.-2015US001096",KERYX BIOPHARMACEUTICALS,,55.0,YR,,M,Y,75.7,KG,20180815.0,,OT,US,US,2018,Q3,Adult
118238162,11823816,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?15 IU, QHS AND AC",,,U,,,,,,,,,2018,Q3,Oedema peripheral,,2018,Q3,2,F,2015.0,20151202.0,20151210,20180815,EXP,,"US-KERYX BIOPHARMACEUTICALS, INC.-2015US001096",KERYX BIOPHARMACEUTICALS,,55.0,YR,,M,Y,75.7,KG,20180815.0,,OT,US,US,2018,Q3,Adult
120603463,12060346,14,C,Lispro,INSULIN LISPRO,1,Subcutaneous,100UNIT/ML,,,,,,,,,,INJECTION,TID,2018,Q3,Drug ineffective,,2018,Q3,3,F,2014.0,20180827.0,20160210,20180905,EXP,,US-BIOGEN-2016BI00185571,BIOGEN,,37.0,YR,,M,Y,86.26,KG,20180905.0,,MD,US,US,2018,Q3,Adult
120603463,12060346,14,C,Lispro,INSULIN LISPRO,1,Subcutaneous,100UNIT/ML,,,,,,,,,,INJECTION,TID,2018,Q3,Multiple sclerosis,,2018,Q3,3,F,2014.0,20180827.0,20160210,20180905,EXP,,US-BIOGEN-2016BI00185571,BIOGEN,,37.0,YR,,M,Y,86.26,KG,20180905.0,,MD,US,US,2018,Q3,Adult
120603463,12060346,14,C,Lispro,INSULIN LISPRO,1,Subcutaneous,100UNIT/ML,,,,,,,,,,INJECTION,TID,2018,Q3,Prescribed underdose,,2018,Q3,3,F,2014.0,20180827.0,20160210,20180905,EXP,,US-BIOGEN-2016BI00185571,BIOGEN,,37.0,YR,,M,Y,86.26,KG,20180905.0,,MD,US,US,2018,Q3,Adult
120603463,12060346,14,C,Lispro,INSULIN LISPRO,1,Subcutaneous,100UNIT/ML,,,,,,,,,,INJECTION,TID,2018,Q3,Seizure,,2018,Q3,3,F,2014.0,20180827.0,20160210,20180905,EXP,,US-BIOGEN-2016BI00185571,BIOGEN,,37.0,YR,,M,Y,86.26,KG,20180905.0,,MD,US,US,2018,Q3,Adult
1296291714,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2018,Q3,Acute respiratory failure,,2018,Q3,14,F,20160826.0,20180921.0,20161122,20180925,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180925.0,,MD,US,US,2018,Q3,Elderly
1296291714,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2018,Q3,Fluid overload,,2018,Q3,14,F,20160826.0,20180921.0,20161122,20180925,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180925.0,,MD,US,US,2018,Q3,Elderly
1296291714,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2018,Q3,Haemoptysis,,2018,Q3,14,F,20160826.0,20180921.0,20161122,20180925,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180925.0,,MD,US,US,2018,Q3,Elderly
1296291714,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2018,Q3,Hyperkalaemia,,2018,Q3,14,F,20160826.0,20180921.0,20161122,20180925,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180925.0,,MD,US,US,2018,Q3,Elderly
1296291714,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2018,Q3,Iron deficiency anaemia,,2018,Q3,14,F,20160826.0,20180921.0,20161122,20180925,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180925.0,,MD,US,US,2018,Q3,Elderly
1296291714,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2018,Q3,Pleural effusion,,2018,Q3,14,F,20160826.0,20180921.0,20161122,20180925,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180925.0,,MD,US,US,2018,Q3,Elderly
1296291714,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2018,Q3,Pneumonia,,2018,Q3,14,F,20160826.0,20180921.0,20161122,20180925,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180925.0,,MD,US,US,2018,Q3,Elderly
1296291714,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2018,Q3,Pulmonary oedema,,2018,Q3,14,F,20160826.0,20180921.0,20161122,20180925,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180925.0,,MD,US,US,2018,Q3,Elderly
1296291714,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2018,Q3,Sepsis,,2018,Q3,14,F,20160826.0,20180921.0,20161122,20180925,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180925.0,,MD,US,US,2018,Q3,Elderly
1296291714,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2018,Q3,Tumour lysis syndrome,,2018,Q3,14,F,20160826.0,20180921.0,20161122,20180925,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180925.0,,MD,US,US,2018,Q3,Elderly
1296291714,12962917,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2018,Q3,Acute respiratory failure,,2018,Q3,14,F,20160826.0,20180921.0,20161122,20180925,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180925.0,,MD,US,US,2018,Q3,Elderly
1296291714,12962917,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2018,Q3,Fluid overload,,2018,Q3,14,F,20160826.0,20180921.0,20161122,20180925,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180925.0,,MD,US,US,2018,Q3,Elderly
1296291714,12962917,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2018,Q3,Haemoptysis,,2018,Q3,14,F,20160826.0,20180921.0,20161122,20180925,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180925.0,,MD,US,US,2018,Q3,Elderly
1296291714,12962917,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2018,Q3,Hyperkalaemia,,2018,Q3,14,F,20160826.0,20180921.0,20161122,20180925,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180925.0,,MD,US,US,2018,Q3,Elderly
1296291714,12962917,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2018,Q3,Iron deficiency anaemia,,2018,Q3,14,F,20160826.0,20180921.0,20161122,20180925,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180925.0,,MD,US,US,2018,Q3,Elderly
1296291714,12962917,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2018,Q3,Pleural effusion,,2018,Q3,14,F,20160826.0,20180921.0,20161122,20180925,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180925.0,,MD,US,US,2018,Q3,Elderly
1296291714,12962917,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2018,Q3,Pneumonia,,2018,Q3,14,F,20160826.0,20180921.0,20161122,20180925,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180925.0,,MD,US,US,2018,Q3,Elderly
1296291714,12962917,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2018,Q3,Pulmonary oedema,,2018,Q3,14,F,20160826.0,20180921.0,20161122,20180925,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180925.0,,MD,US,US,2018,Q3,Elderly
1296291714,12962917,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2018,Q3,Sepsis,,2018,Q3,14,F,20160826.0,20180921.0,20161122,20180925,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180925.0,,MD,US,US,2018,Q3,Elderly
1296291714,12962917,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2018,Q3,Tumour lysis syndrome,,2018,Q3,14,F,20160826.0,20180921.0,20161122,20180925,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20180925.0,,MD,US,US,2018,Q3,Elderly
130396969,13039696,18,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2018,Q3,Constipation,,2018,Q3,9,F,20161203.0,20180905.0,20161219,20180914,EXP,,US-CELGENEUS-USA-2016123347,CELGENE,,79.0,YR,,M,Y,71.3,KG,20180914.0,,MD,US,US,2018,Q3,Elderly
130396969,13039696,18,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2018,Q3,Pleural effusion,,2018,Q3,9,F,20161203.0,20180905.0,20161219,20180914,EXP,,US-CELGENEUS-USA-2016123347,CELGENE,,79.0,YR,,M,Y,71.3,KG,20180914.0,,MD,US,US,2018,Q3,Elderly
1325990914,13259909,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"30 DF, UNK",,,,,,,,30.0,DF,INJECTION,,2018,Q3,Cholecystitis,,2018,Q3,14,F,20170212.0,20180829.0,20170222,20180907,EXP,,US-PFIZER INC-2017075056,PFIZER,,70.0,YR,,M,Y,111.9,KG,20180907.0,,MD,US,US,2018,Q3,Elderly
1336063110,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q3,Acute respiratory failure,,2018,Q3,10,F,20150120.0,20180907.0,20170322,20180917,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180917.0,,MD,US,US,2018,Q3,Elderly
1336063110,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q3,Anaemia,,2018,Q3,10,F,20150120.0,20180907.0,20170322,20180917,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180917.0,,MD,US,US,2018,Q3,Elderly
1336063110,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q3,Asthenia,,2018,Q3,10,F,20150120.0,20180907.0,20170322,20180917,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180917.0,,MD,US,US,2018,Q3,Elderly
1336063110,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q3,Bronchial secretion retention,,2018,Q3,10,F,20150120.0,20180907.0,20170322,20180917,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180917.0,,MD,US,US,2018,Q3,Elderly
1336063110,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q3,Bronchitis bacterial,,2018,Q3,10,F,20150120.0,20180907.0,20170322,20180917,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180917.0,,MD,US,US,2018,Q3,Elderly
1336063110,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q3,Bronchoalveolar lavage,,2018,Q3,10,F,20150120.0,20180907.0,20170322,20180917,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180917.0,,MD,US,US,2018,Q3,Elderly
1336063110,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q3,Candida infection,,2018,Q3,10,F,20150120.0,20180907.0,20170322,20180917,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180917.0,,MD,US,US,2018,Q3,Elderly
1336063110,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q3,Chest pain,,2018,Q3,10,F,20150120.0,20180907.0,20170322,20180917,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180917.0,,MD,US,US,2018,Q3,Elderly
1336063110,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q3,Chronic obstructive pulmonary disease,,2018,Q3,10,F,20150120.0,20180907.0,20170322,20180917,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180917.0,,MD,US,US,2018,Q3,Elderly
1336063110,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q3,Condition aggravated,,2018,Q3,10,F,20150120.0,20180907.0,20170322,20180917,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180917.0,,MD,US,US,2018,Q3,Elderly
1336063110,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q3,Cough,,2018,Q3,10,F,20150120.0,20180907.0,20170322,20180917,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180917.0,,MD,US,US,2018,Q3,Elderly
1336063110,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q3,Disease progression,,2018,Q3,10,F,20150120.0,20180907.0,20170322,20180917,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180917.0,,MD,US,US,2018,Q3,Elderly
1336063110,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q3,Drug intolerance,,2018,Q3,10,F,20150120.0,20180907.0,20170322,20180917,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180917.0,,MD,US,US,2018,Q3,Elderly
1336063110,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q3,Dyspnoea,,2018,Q3,10,F,20150120.0,20180907.0,20170322,20180917,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180917.0,,MD,US,US,2018,Q3,Elderly
1336063110,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q3,Lung adenocarcinoma recurrent,,2018,Q3,10,F,20150120.0,20180907.0,20170322,20180917,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180917.0,,MD,US,US,2018,Q3,Elderly
1336063110,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q3,Metastases to kidney,,2018,Q3,10,F,20150120.0,20180907.0,20170322,20180917,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180917.0,,MD,US,US,2018,Q3,Elderly
1336063110,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q3,Packed red blood cell transfusion,,2018,Q3,10,F,20150120.0,20180907.0,20170322,20180917,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180917.0,,MD,US,US,2018,Q3,Elderly
1336063110,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q3,Platelet transfusion,,2018,Q3,10,F,20150120.0,20180907.0,20170322,20180917,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180917.0,,MD,US,US,2018,Q3,Elderly
1336063110,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q3,Pneumonia,,2018,Q3,10,F,20150120.0,20180907.0,20170322,20180917,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180917.0,,MD,US,US,2018,Q3,Elderly
1336063110,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q3,Pneumonia pseudomonal,,2018,Q3,10,F,20150120.0,20180907.0,20170322,20180917,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180917.0,,MD,US,US,2018,Q3,Elderly
1336063110,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q3,Productive cough,,2018,Q3,10,F,20150120.0,20180907.0,20170322,20180917,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180917.0,,MD,US,US,2018,Q3,Elderly
1336063110,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q3,Pseudomonas test positive,,2018,Q3,10,F,20150120.0,20180907.0,20170322,20180917,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180917.0,,MD,US,US,2018,Q3,Elderly
1336063110,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q3,Pulmonary congestion,,2018,Q3,10,F,20150120.0,20180907.0,20170322,20180917,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180917.0,,MD,US,US,2018,Q3,Elderly
1336063110,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q3,Pulmonary mass,,2018,Q3,10,F,20150120.0,20180907.0,20170322,20180917,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180917.0,,MD,US,US,2018,Q3,Elderly
1336063110,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q3,Pyrexia,,2018,Q3,10,F,20150120.0,20180907.0,20170322,20180917,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180917.0,,MD,US,US,2018,Q3,Elderly
1336063110,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q3,Renal cell carcinoma,,2018,Q3,10,F,20150120.0,20180907.0,20170322,20180917,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180917.0,,MD,US,US,2018,Q3,Elderly
1336063110,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q3,Respiratory distress,,2018,Q3,10,F,20150120.0,20180907.0,20170322,20180917,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180917.0,,MD,US,US,2018,Q3,Elderly
1336063110,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q3,Secretion discharge,,2018,Q3,10,F,20150120.0,20180907.0,20170322,20180917,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180917.0,,MD,US,US,2018,Q3,Elderly
1336063110,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q3,Small cell lung cancer metastatic,,2018,Q3,10,F,20150120.0,20180907.0,20170322,20180917,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180917.0,,MD,US,US,2018,Q3,Elderly
1336063110,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q3,Sputum culture positive,,2018,Q3,10,F,20150120.0,20180907.0,20170322,20180917,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180917.0,,MD,US,US,2018,Q3,Elderly
1336063110,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q3,Stenotrophomonas infection,,2018,Q3,10,F,20150120.0,20180907.0,20170322,20180917,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180917.0,,MD,US,US,2018,Q3,Elderly
1336063110,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q3,Tachypnoea,,2018,Q3,10,F,20150120.0,20180907.0,20170322,20180917,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180917.0,,MD,US,US,2018,Q3,Elderly
1336063110,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q3,Transfusion,,2018,Q3,10,F,20150120.0,20180907.0,20170322,20180917,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20180917.0,,MD,US,US,2018,Q3,Elderly
135721154,13572115,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",36540.0,DF,Y,U,,,,30.0,DF,,TID,2018,Q3,Encephalopathy,,2018,Q3,4,F,20170503.0,20180720.0,20170523,20180724,EXP,,PHHO2017US008155,NOVARTIS,,66.0,YR,,F,Y,73.7,KG,20180724.0,,OT,US,US,2018,Q3,Elderly
135721154,13572115,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",36540.0,DF,Y,U,,,,30.0,DF,,TID,2018,Q3,Infectious colitis,,2018,Q3,4,F,20170503.0,20180720.0,20170523,20180724,EXP,,PHHO2017US008155,NOVARTIS,,66.0,YR,,F,Y,73.7,KG,20180724.0,,OT,US,US,2018,Q3,Elderly
135721154,13572115,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",36540.0,DF,Y,U,,,,30.0,DF,,TID,2018,Q3,Viral infection,,2018,Q3,4,F,20170503.0,20180720.0,20170523,20180724,EXP,,PHHO2017US008155,NOVARTIS,,66.0,YR,,F,Y,73.7,KG,20180724.0,,OT,US,US,2018,Q3,Elderly
137605909,13760590,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q3,Cutaneous vasculitis,,2018,Q3,9,F,20170501.0,20180805.0,20170717,20180814,EXP,,DE-TEVA-785054GER,TEVA,,76.0,YR,,M,Y,97.4,KG,20180814.0,,MD,DE,DE,2018,Q3,Elderly
137605909,13760590,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q3,Nephrotic syndrome,,2018,Q3,9,F,20170501.0,20180805.0,20170717,20180814,EXP,,DE-TEVA-785054GER,TEVA,,76.0,YR,,M,Y,97.4,KG,20180814.0,,MD,DE,DE,2018,Q3,Elderly
138293494,13829349,13,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q3,Infusion site discharge,,2018,Q3,4,F,,20180802.0,20170803,20180810,EXP,,CA-PFIZER INC-2017332361,PFIZER,,53.0,YR,,F,Y,48.0,KG,20180810.0,,PH,CA,CA,2018,Q3,Adult
138293494,13829349,13,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q3,Infusion site erythema,,2018,Q3,4,F,,20180802.0,20170803,20180810,EXP,,CA-PFIZER INC-2017332361,PFIZER,,53.0,YR,,F,Y,48.0,KG,20180810.0,,PH,CA,CA,2018,Q3,Adult
138293494,13829349,13,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q3,Neutrophil count decreased,,2018,Q3,4,F,,20180802.0,20170803,20180810,EXP,,CA-PFIZER INC-2017332361,PFIZER,,53.0,YR,,F,Y,48.0,KG,20180810.0,,PH,CA,CA,2018,Q3,Adult
138394934,13839493,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1?6 UNIT,,,,,,,,,,,,2018,Q3,Neutropenia,,2018,Q3,4,F,20170626.0,20180810.0,20170807,20180814,EXP,,US-ROCHE-1956870,ROCHE,,78.0,YR,,M,Y,67.59,KG,20180814.0,,MD,US,US,2018,Q3,Elderly
138394934,13839493,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1?6 UNIT,,,,,,,,,,,,2018,Q3,Urosepsis,,2018,Q3,4,F,20170626.0,20180810.0,20170807,20180814,EXP,,US-ROCHE-1956870,ROCHE,,78.0,YR,,M,Y,67.59,KG,20180814.0,,MD,US,US,2018,Q3,Elderly
138394934,13839493,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1?4 UNIT,,,,,,,,,,,,2018,Q3,Neutropenia,,2018,Q3,4,F,20170626.0,20180810.0,20170807,20180814,EXP,,US-ROCHE-1956870,ROCHE,,78.0,YR,,M,Y,67.59,KG,20180814.0,,MD,US,US,2018,Q3,Elderly
138394934,13839493,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1?4 UNIT,,,,,,,,,,,,2018,Q3,Urosepsis,,2018,Q3,4,F,20170626.0,20180810.0,20170807,20180814,EXP,,US-ROCHE-1956870,ROCHE,,78.0,YR,,M,Y,67.59,KG,20180814.0,,MD,US,US,2018,Q3,Elderly
139206892,13920689,11,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"30 IU, DAILY",,,,,,,,30.0,IU,,,2018,Q3,Altered state of consciousness,,2018,Q3,2,F,,20180710.0,20170830,20180716,EXP,,JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2017R3-148780,RANBAXY,KITAMOTO T. EFFICACY OF BENZODIAZEPINE IN MALIGNANT CATATONIA : REPORT OF TWO CASES. JAPANESE JOURNAL OF PSYCHIATRIC TREATMENT/(ISSN:0912?1862). 2017?32(7):969?975,48.0,YR,,F,Y,,,20180716.0,,MD,JP,JP,2018,Q3,Adult
139206892,13920689,11,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"30 IU, DAILY",,,,,,,,30.0,IU,,,2018,Q3,Catatonia,,2018,Q3,2,F,,20180710.0,20170830,20180716,EXP,,JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2017R3-148780,RANBAXY,KITAMOTO T. EFFICACY OF BENZODIAZEPINE IN MALIGNANT CATATONIA : REPORT OF TWO CASES. JAPANESE JOURNAL OF PSYCHIATRIC TREATMENT/(ISSN:0912?1862). 2017?32(7):969?975,48.0,YR,,F,Y,,,20180716.0,,MD,JP,JP,2018,Q3,Adult
139206892,13920689,11,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"30 IU, DAILY",,,,,,,,30.0,IU,,,2018,Q3,Hyponatraemia,,2018,Q3,2,F,,20180710.0,20170830,20180716,EXP,,JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2017R3-148780,RANBAXY,KITAMOTO T. EFFICACY OF BENZODIAZEPINE IN MALIGNANT CATATONIA : REPORT OF TWO CASES. JAPANESE JOURNAL OF PSYCHIATRIC TREATMENT/(ISSN:0912?1862). 2017?32(7):969?975,48.0,YR,,F,Y,,,20180716.0,,MD,JP,JP,2018,Q3,Adult
140172035,14017203,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 U, PRN",,,Y,,,,,100.0,DF,,,2018,Q3,Balance disorder,,2018,Q3,5,F,20170919.0,20180725.0,20170927,20180803,EXP,,PHHY2017US139531,NOVARTIS,,68.0,YR,,F,Y,55.8,KG,20180803.0,,MD,US,US,2018,Q3,Elderly
140172035,14017203,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 U, PRN",,,Y,,,,,100.0,DF,,,2018,Q3,Bundle branch block right,,2018,Q3,5,F,20170919.0,20180725.0,20170927,20180803,EXP,,PHHY2017US139531,NOVARTIS,,68.0,YR,,F,Y,55.8,KG,20180803.0,,MD,US,US,2018,Q3,Elderly
140172035,14017203,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 U, PRN",,,Y,,,,,100.0,DF,,,2018,Q3,Demyelination,,2018,Q3,5,F,20170919.0,20180725.0,20170927,20180803,EXP,,PHHY2017US139531,NOVARTIS,,68.0,YR,,F,Y,55.8,KG,20180803.0,,MD,US,US,2018,Q3,Elderly
140172035,14017203,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 U, PRN",,,Y,,,,,100.0,DF,,,2018,Q3,Loss of consciousness,,2018,Q3,5,F,20170919.0,20180725.0,20170927,20180803,EXP,,PHHY2017US139531,NOVARTIS,,68.0,YR,,F,Y,55.8,KG,20180803.0,,MD,US,US,2018,Q3,Elderly
140172035,14017203,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 U, PRN",,,Y,,,,,100.0,DF,,,2018,Q3,Lymphocyte count decreased,,2018,Q3,5,F,20170919.0,20180725.0,20170927,20180803,EXP,,PHHY2017US139531,NOVARTIS,,68.0,YR,,F,Y,55.8,KG,20180803.0,,MD,US,US,2018,Q3,Elderly
140172035,14017203,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 U, PRN",,,Y,,,,,100.0,DF,,,2018,Q3,Malignant melanoma in situ,,2018,Q3,5,F,20170919.0,20180725.0,20170927,20180803,EXP,,PHHY2017US139531,NOVARTIS,,68.0,YR,,F,Y,55.8,KG,20180803.0,,MD,US,US,2018,Q3,Elderly
140172035,14017203,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 U, PRN",,,Y,,,,,100.0,DF,,,2018,Q3,Syncope,,2018,Q3,5,F,20170919.0,20180725.0,20170927,20180803,EXP,,PHHY2017US139531,NOVARTIS,,68.0,YR,,F,Y,55.8,KG,20180803.0,,MD,US,US,2018,Q3,Elderly
140172035,14017203,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 U, PRN",,,Y,,,,,100.0,DF,,,2018,Q3,White blood cell count decreased,,2018,Q3,5,F,20170919.0,20180725.0,20170927,20180803,EXP,,PHHY2017US139531,NOVARTIS,,68.0,YR,,F,Y,55.8,KG,20180803.0,,MD,US,US,2018,Q3,Elderly
141481823,14148182,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,INJECTION,,2018,Q3,Acute kidney injury,,2018,Q3,3,F,20161015.0,20180719.0,20171101,20180727,EXP,,US-ASTRAZENECA-2017SF10099,ASTRAZENECA,,46.0,YR,,F,Y,,,20180727.0,,,US,US,2018,Q3,Adult
141481823,14148182,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,INJECTION,,2018,Q3,Chronic kidney disease,,2018,Q3,3,F,20161015.0,20180719.0,20171101,20180727,EXP,,US-ASTRAZENECA-2017SF10099,ASTRAZENECA,,46.0,YR,,F,Y,,,20180727.0,,,US,US,2018,Q3,Adult
141481823,14148182,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,INJECTION,,2018,Q3,End stage renal disease,,2018,Q3,3,F,20161015.0,20180719.0,20171101,20180727,EXP,,US-ASTRAZENECA-2017SF10099,ASTRAZENECA,,46.0,YR,,F,Y,,,20180727.0,,,US,US,2018,Q3,Adult
141481823,14148182,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,INJECTION,,2018,Q3,Renal failure,,2018,Q3,3,F,20161015.0,20180719.0,20171101,20180727,EXP,,US-ASTRAZENECA-2017SF10099,ASTRAZENECA,,46.0,YR,,F,Y,,,20180727.0,,,US,US,2018,Q3,Adult
141481823,14148182,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,INJECTION,,2018,Q3,Tubulointerstitial nephritis,,2018,Q3,3,F,20161015.0,20180719.0,20171101,20180727,EXP,,US-ASTRAZENECA-2017SF10099,ASTRAZENECA,,46.0,YR,,F,Y,,,20180727.0,,,US,US,2018,Q3,Adult
1424340811,14243408,11,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,100 IU (INTERNATIONAL UNIT),,,,,,,,100.0,IU,INJECTION,QD,2018,Q3,Cardiac arrest,,2018,Q3,11,F,20171115.0,20180809.0,20171201,20180817,EXP,,US-CELGENEUS-USA-20171109702,CELGENE,,76.0,YR,,M,Y,140.0,KG,20180817.0,,OT,US,US,2018,Q3,Elderly
1424340811,14243408,11,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,100 IU (INTERNATIONAL UNIT),,,,,,,,100.0,IU,INJECTION,QD,2018,Q3,Cardiogenic shock,,2018,Q3,11,F,20171115.0,20180809.0,20171201,20180817,EXP,,US-CELGENEUS-USA-20171109702,CELGENE,,76.0,YR,,M,Y,140.0,KG,20180817.0,,OT,US,US,2018,Q3,Elderly
1424340811,14243408,11,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,100 IU (INTERNATIONAL UNIT),,,,,,,,100.0,IU,INJECTION,QD,2018,Q3,Syncope,,2018,Q3,11,F,20171115.0,20180809.0,20171201,20180817,EXP,,US-CELGENEUS-USA-20171109702,CELGENE,,76.0,YR,,M,Y,140.0,KG,20180817.0,,OT,US,US,2018,Q3,Elderly
143301024,14330102,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 IU, DAILY, SOLUTION",,,D,,,,,100.0,IU,SOLUTION FOR INJECTION,QD,2018,Q3,Drug interaction,,2018,Q3,4,F,201704.0,20180709.0,20171227,20180718,EXP,,DE-MYLANLABS-2017M1082207,MYLAN,,67.0,YR,,F,Y,74.0,KG,20180718.0,,MD,DE,DE,2018,Q3,Elderly
143301024,14330102,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 IU, DAILY, SOLUTION",,,D,,,,,100.0,IU,SOLUTION FOR INJECTION,QD,2018,Q3,Rhabdomyolysis,,2018,Q3,4,F,201704.0,20180709.0,20171227,20180718,EXP,,DE-MYLANLABS-2017M1082207,MYLAN,,67.0,YR,,F,Y,74.0,KG,20180718.0,,MD,DE,DE,2018,Q3,Elderly
144422203,14442220,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,12?12?10 U (ADAPTED ACCORDING TO THE SACCHARIDES IN FOOD),,,U,U,,,,,,,,2018,Q3,Diabetes mellitus inadequate control,,2018,Q3,3,F,2006.0,20180709.0,20180125,20180719,EXP,,CZ-MYLANLABS-2018M1005550,MYLAN,,43.0,YR,,F,Y,107.5,KG,20180719.0,,MD,CZ,CZ,2018,Q3,Adult
144422203,14442220,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,12?12?10 U (ADAPTED ACCORDING TO THE SACCHARIDES IN FOOD),,,U,U,,,,,,,,2018,Q3,Drug ineffective,,2018,Q3,3,F,2006.0,20180709.0,20180125,20180719,EXP,,CZ-MYLANLABS-2018M1005550,MYLAN,,43.0,YR,,F,Y,107.5,KG,20180719.0,,MD,CZ,CZ,2018,Q3,Adult
144594384,14459438,17,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q3,Accidental overdose,,2018,Q3,4,F,20170222.0,20180827.0,20180130,20180910,EXP,,US-ACORDA-ACO_135770_2017,ACORDA,,70.0,YR,,F,Y,,,20180910.0,,PH,US,US,2018,Q3,Elderly
144594384,14459438,17,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q3,Blood glucose increased,,2018,Q3,4,F,20170222.0,20180827.0,20180130,20180910,EXP,,US-ACORDA-ACO_135770_2017,ACORDA,,70.0,YR,,F,Y,,,20180910.0,,PH,US,US,2018,Q3,Elderly
144594384,14459438,17,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q3,Creatinine renal clearance decreased,,2018,Q3,4,F,20170222.0,20180827.0,20180130,20180910,EXP,,US-ACORDA-ACO_135770_2017,ACORDA,,70.0,YR,,F,Y,,,20180910.0,,PH,US,US,2018,Q3,Elderly
144594384,14459438,17,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q3,Culture urine positive,,2018,Q3,4,F,20170222.0,20180827.0,20180130,20180910,EXP,,US-ACORDA-ACO_135770_2017,ACORDA,,70.0,YR,,F,Y,,,20180910.0,,PH,US,US,2018,Q3,Elderly
144594384,14459438,17,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q3,Escherichia urinary tract infection,,2018,Q3,4,F,20170222.0,20180827.0,20180130,20180910,EXP,,US-ACORDA-ACO_135770_2017,ACORDA,,70.0,YR,,F,Y,,,20180910.0,,PH,US,US,2018,Q3,Elderly
144594384,14459438,17,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q3,Glycosylated haemoglobin increased,,2018,Q3,4,F,20170222.0,20180827.0,20180130,20180910,EXP,,US-ACORDA-ACO_135770_2017,ACORDA,,70.0,YR,,F,Y,,,20180910.0,,PH,US,US,2018,Q3,Elderly
144594384,14459438,17,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q3,Joint injury,,2018,Q3,4,F,20170222.0,20180827.0,20180130,20180910,EXP,,US-ACORDA-ACO_135770_2017,ACORDA,,70.0,YR,,F,Y,,,20180910.0,,PH,US,US,2018,Q3,Elderly
144594384,14459438,17,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q3,Klebsiella infection,,2018,Q3,4,F,20170222.0,20180827.0,20180130,20180910,EXP,,US-ACORDA-ACO_135770_2017,ACORDA,,70.0,YR,,F,Y,,,20180910.0,,PH,US,US,2018,Q3,Elderly
144594384,14459438,17,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q3,Oesophagitis,,2018,Q3,4,F,20170222.0,20180827.0,20180130,20180910,EXP,,US-ACORDA-ACO_135770_2017,ACORDA,,70.0,YR,,F,Y,,,20180910.0,,PH,US,US,2018,Q3,Elderly
144594384,14459438,17,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q3,Pain in extremity,,2018,Q3,4,F,20170222.0,20180827.0,20180130,20180910,EXP,,US-ACORDA-ACO_135770_2017,ACORDA,,70.0,YR,,F,Y,,,20180910.0,,PH,US,US,2018,Q3,Elderly
144594384,14459438,17,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q3,Therapy cessation,,2018,Q3,4,F,20170222.0,20180827.0,20180130,20180910,EXP,,US-ACORDA-ACO_135770_2017,ACORDA,,70.0,YR,,F,Y,,,20180910.0,,PH,US,US,2018,Q3,Elderly
144594384,14459438,17,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q3,Toxicity to various agents,,2018,Q3,4,F,20170222.0,20180827.0,20180130,20180910,EXP,,US-ACORDA-ACO_135770_2017,ACORDA,,70.0,YR,,F,Y,,,20180910.0,,PH,US,US,2018,Q3,Elderly
144594384,14459438,17,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q3,Urinary tract infection,,2018,Q3,4,F,20170222.0,20180827.0,20180130,20180910,EXP,,US-ACORDA-ACO_135770_2017,ACORDA,,70.0,YR,,F,Y,,,20180910.0,,PH,US,US,2018,Q3,Elderly
144594384,14459438,17,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q3,Urinary tract infection enterococcal,,2018,Q3,4,F,20170222.0,20180827.0,20180130,20180910,EXP,,US-ACORDA-ACO_135770_2017,ACORDA,,70.0,YR,,F,Y,,,20180910.0,,PH,US,US,2018,Q3,Elderly
144594384,14459438,17,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q3,Urinary tract infection pseudomonal,,2018,Q3,4,F,20170222.0,20180827.0,20180130,20180910,EXP,,US-ACORDA-ACO_135770_2017,ACORDA,,70.0,YR,,F,Y,,,20180910.0,,PH,US,US,2018,Q3,Elderly
144594384,14459438,17,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q3,Urine analysis abnormal,,2018,Q3,4,F,20170222.0,20180827.0,20180130,20180910,EXP,,US-ACORDA-ACO_135770_2017,ACORDA,,70.0,YR,,F,Y,,,20180910.0,,PH,US,US,2018,Q3,Elderly
144741223,14474122,8,C,Insulin lispro,INSULIN LISPRO,1,Unknown,ACCORDING TO PLAN,,,U,, UNKNOWN,,,,,,,2018,Q3,Drug interaction,,2018,Q3,3,F,,20180809.0,20180201,20180817,EXP,DE-LUNDBECK-DKLU2041713,DE-TORRENT-00007704,TORRENT,,76.0,YR,E,M,Y,,,20180817.0,,MD,DE,DE,2018,Q3,Elderly
144741223,14474122,8,C,Insulin lispro,INSULIN LISPRO,1,Unknown,ACCORDING TO PLAN,,,U,, UNKNOWN,,,,,,,2018,Q3,Electrocardiogram QT prolonged,,2018,Q3,3,F,,20180809.0,20180201,20180817,EXP,DE-LUNDBECK-DKLU2041713,DE-TORRENT-00007704,TORRENT,,76.0,YR,E,M,Y,,,20180817.0,,MD,DE,DE,2018,Q3,Elderly
145681964,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2018,Q3,Clostridium difficile colitis,,2018,Q3,4,F,2017.0,20180814.0,20180223,20180828,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20180828.0,,MD,US,US,2018,Q3,Adult
145681964,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2018,Q3,Coxsackie viral infection,,2018,Q3,4,F,2017.0,20180814.0,20180223,20180828,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20180828.0,,MD,US,US,2018,Q3,Adult
145681964,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2018,Q3,Drug administration error,,2018,Q3,4,F,2017.0,20180814.0,20180223,20180828,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20180828.0,,MD,US,US,2018,Q3,Adult
145681964,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2018,Q3,Dysgeusia,,2018,Q3,4,F,2017.0,20180814.0,20180223,20180828,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20180828.0,,MD,US,US,2018,Q3,Adult
145681964,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2018,Q3,Headache,,2018,Q3,4,F,2017.0,20180814.0,20180223,20180828,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20180828.0,,MD,US,US,2018,Q3,Adult
145681964,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2018,Q3,Hypoacusis,,2018,Q3,4,F,2017.0,20180814.0,20180223,20180828,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20180828.0,,MD,US,US,2018,Q3,Adult
145681964,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2018,Q3,Hypogammaglobulinaemia,,2018,Q3,4,F,2017.0,20180814.0,20180223,20180828,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20180828.0,,MD,US,US,2018,Q3,Adult
145681964,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2018,Q3,Influenza like illness,,2018,Q3,4,F,2017.0,20180814.0,20180223,20180828,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20180828.0,,MD,US,US,2018,Q3,Adult
145681964,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2018,Q3,Neuropathy peripheral,,2018,Q3,4,F,2017.0,20180814.0,20180223,20180828,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20180828.0,,MD,US,US,2018,Q3,Adult
145681964,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2018,Q3,Pyrexia,,2018,Q3,4,F,2017.0,20180814.0,20180223,20180828,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20180828.0,,MD,US,US,2018,Q3,Adult
145681964,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2018,Q3,Rash morbilliform,,2018,Q3,4,F,2017.0,20180814.0,20180223,20180828,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20180828.0,,MD,US,US,2018,Q3,Adult
145681964,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2018,Q3,Stevens-Johnson syndrome,,2018,Q3,4,F,2017.0,20180814.0,20180223,20180828,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20180828.0,,MD,US,US,2018,Q3,Adult
145681964,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2018,Q3,Vision blurred,,2018,Q3,4,F,2017.0,20180814.0,20180223,20180828,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20180828.0,,MD,US,US,2018,Q3,Adult
145681964,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2018,Q3,Vitamin D abnormal,,2018,Q3,4,F,2017.0,20180814.0,20180223,20180828,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20180828.0,,MD,US,US,2018,Q3,Adult
145681964,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2018,Q3,Weight decreased,,2018,Q3,4,F,2017.0,20180814.0,20180223,20180828,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20180828.0,,MD,US,US,2018,Q3,Adult
146642602,14664260,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 UNITS, THRICE DAILY",,,D,U,,,,,,FORMULATION UNKNOWN,TID,2018,Q3,Cardiac disorder,,2018,Q3,2,F,20180727.0,20180731.0,20180321,20180808,EXP,,CO-ASTELLAS-2018US013861,ASTELLAS,,74.0,YR,,M,Y,,,20180808.0,,CN,CO,CO,2018,Q3,Elderly
146642602,14664260,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 UNITS, THRICE DAILY",,,D,U,,,,,,FORMULATION UNKNOWN,TID,2018,Q3,Death,,2018,Q3,2,F,20180727.0,20180731.0,20180321,20180808,EXP,,CO-ASTELLAS-2018US013861,ASTELLAS,,74.0,YR,,M,Y,,,20180808.0,,CN,CO,CO,2018,Q3,Elderly
146642602,14664260,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 UNITS, THRICE DAILY",,,D,U,,,,,,FORMULATION UNKNOWN,TID,2018,Q3,Diabetes mellitus,,2018,Q3,2,F,20180727.0,20180731.0,20180321,20180808,EXP,,CO-ASTELLAS-2018US013861,ASTELLAS,,74.0,YR,,M,Y,,,20180808.0,,CN,CO,CO,2018,Q3,Elderly
146642602,14664260,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 UNITS, THRICE DAILY",,,D,U,,,,,,FORMULATION UNKNOWN,TID,2018,Q3,Fungal infection,,2018,Q3,2,F,20180727.0,20180731.0,20180321,20180808,EXP,,CO-ASTELLAS-2018US013861,ASTELLAS,,74.0,YR,,M,Y,,,20180808.0,,CN,CO,CO,2018,Q3,Elderly
146700942,14670094,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"0.03 ML, UNK",,,,,,,,0.03,ML,,,2018,Q3,Asthenia,,2018,Q3,2,F,20180214.0,20180703.0,20180322,20180713,EXP,,US-BAYER-2018-032239,BAYER,,56.0,YR,A,M,Y,126.98,KG,20180713.0,,OT,US,US,2018,Q3,Adult
146700942,14670094,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"0.03 ML, UNK",,,,,,,,0.03,ML,,,2018,Q3,Blood pressure systolic decreased,,2018,Q3,2,F,20180214.0,20180703.0,20180322,20180713,EXP,,US-BAYER-2018-032239,BAYER,,56.0,YR,A,M,Y,126.98,KG,20180713.0,,OT,US,US,2018,Q3,Adult
146700942,14670094,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"0.03 ML, UNK",,,,,,,,0.03,ML,,,2018,Q3,Cardiac failure,,2018,Q3,2,F,20180214.0,20180703.0,20180322,20180713,EXP,,US-BAYER-2018-032239,BAYER,,56.0,YR,A,M,Y,126.98,KG,20180713.0,,OT,US,US,2018,Q3,Adult
146700942,14670094,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"0.03 ML, UNK",,,,,,,,0.03,ML,,,2018,Q3,Cardiac failure acute,,2018,Q3,2,F,20180214.0,20180703.0,20180322,20180713,EXP,,US-BAYER-2018-032239,BAYER,,56.0,YR,A,M,Y,126.98,KG,20180713.0,,OT,US,US,2018,Q3,Adult
146700942,14670094,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"0.03 ML, UNK",,,,,,,,0.03,ML,,,2018,Q3,Dyspnoea,,2018,Q3,2,F,20180214.0,20180703.0,20180322,20180713,EXP,,US-BAYER-2018-032239,BAYER,,56.0,YR,A,M,Y,126.98,KG,20180713.0,,OT,US,US,2018,Q3,Adult
146700942,14670094,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"0.03 ML, UNK",,,,,,,,0.03,ML,,,2018,Q3,Hospitalisation,,2018,Q3,2,F,20180214.0,20180703.0,20180322,20180713,EXP,,US-BAYER-2018-032239,BAYER,,56.0,YR,A,M,Y,126.98,KG,20180713.0,,OT,US,US,2018,Q3,Adult
146700942,14670094,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"0.03 ML, UNK",,,,,,,,0.03,ML,,,2018,Q3,Hypotension,,2018,Q3,2,F,20180214.0,20180703.0,20180322,20180713,EXP,,US-BAYER-2018-032239,BAYER,,56.0,YR,A,M,Y,126.98,KG,20180713.0,,OT,US,US,2018,Q3,Adult
146700942,14670094,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"0.03 ML, UNK",,,,,,,,0.03,ML,,,2018,Q3,Malaise,,2018,Q3,2,F,20180214.0,20180703.0,20180322,20180713,EXP,,US-BAYER-2018-032239,BAYER,,56.0,YR,A,M,Y,126.98,KG,20180713.0,,OT,US,US,2018,Q3,Adult
146700942,14670094,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"0.03 ML, UNK",,,,,,,,0.03,ML,,,2018,Q3,Nausea,,2018,Q3,2,F,20180214.0,20180703.0,20180322,20180713,EXP,,US-BAYER-2018-032239,BAYER,,56.0,YR,A,M,Y,126.98,KG,20180713.0,,OT,US,US,2018,Q3,Adult
146700942,14670094,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"0.03 ML, UNK",,,,,,,,0.03,ML,,,2018,Q3,Vasodilatation,,2018,Q3,2,F,20180214.0,20180703.0,20180322,20180713,EXP,,US-BAYER-2018-032239,BAYER,,56.0,YR,A,M,Y,126.98,KG,20180713.0,,OT,US,US,2018,Q3,Adult
146700942,14670094,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"0.03 ML, UNK",,,,,,,,0.03,ML,,,2018,Q3,Vomiting,,2018,Q3,2,F,20180214.0,20180703.0,20180322,20180713,EXP,,US-BAYER-2018-032239,BAYER,,56.0,YR,A,M,Y,126.98,KG,20180713.0,,OT,US,US,2018,Q3,Adult
146700942,14670094,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"0.03 ML, UNK",,,,,,,,0.03,ML,,,2018,Q3,Wheezing,,2018,Q3,2,F,20180214.0,20180703.0,20180322,20180713,EXP,,US-BAYER-2018-032239,BAYER,,56.0,YR,A,M,Y,126.98,KG,20180713.0,,OT,US,US,2018,Q3,Adult
1474477610,14744776,47,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,5.0,IU,,,2018,Q3,Pneumonia,,2018,Q3,10,F,20180330.0,20180920.0,20180411,20180924,EXP,,US-ROCHE-2103150,ROCHE,,64.0,YR,,F,Y,80.0,KG,20180925.0,,MD,US,US,2018,Q3,Adult
1474477610,14744776,47,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,5.0,IU,,,2018,Q3,Respiratory distress,,2018,Q3,10,F,20180330.0,20180920.0,20180411,20180924,EXP,,US-ROCHE-2103150,ROCHE,,64.0,YR,,F,Y,80.0,KG,20180925.0,,MD,US,US,2018,Q3,Adult
147594383,14759438,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q3,Acute kidney injury,,2018,Q3,3,F,2010.0,20180920.0,20180413,20180928,EXP,,US-ASTRAZENECA-2018SE44570,ASTRAZENECA,,52.0,YR,,M,Y,,,20180928.0,,,US,US,2018,Q3,Adult
147594383,14759438,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q3,Cardiac failure congestive,,2018,Q3,3,F,2010.0,20180920.0,20180413,20180928,EXP,,US-ASTRAZENECA-2018SE44570,ASTRAZENECA,,52.0,YR,,M,Y,,,20180928.0,,,US,US,2018,Q3,Adult
147594383,14759438,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q3,Chronic kidney disease,,2018,Q3,3,F,2010.0,20180920.0,20180413,20180928,EXP,,US-ASTRAZENECA-2018SE44570,ASTRAZENECA,,52.0,YR,,M,Y,,,20180928.0,,,US,US,2018,Q3,Adult
147594383,14759438,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q3,Diabetes mellitus,,2018,Q3,3,F,2010.0,20180920.0,20180413,20180928,EXP,,US-ASTRAZENECA-2018SE44570,ASTRAZENECA,,52.0,YR,,M,Y,,,20180928.0,,,US,US,2018,Q3,Adult
147594383,14759438,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q3,End stage renal disease,,2018,Q3,3,F,2010.0,20180920.0,20180413,20180928,EXP,,US-ASTRAZENECA-2018SE44570,ASTRAZENECA,,52.0,YR,,M,Y,,,20180928.0,,,US,US,2018,Q3,Adult
147594383,14759438,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q3,Renal disorder,,2018,Q3,3,F,2010.0,20180920.0,20180413,20180928,EXP,,US-ASTRAZENECA-2018SE44570,ASTRAZENECA,,52.0,YR,,M,Y,,,20180928.0,,,US,US,2018,Q3,Adult
147594383,14759438,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q3,Renal failure,,2018,Q3,3,F,2010.0,20180920.0,20180413,20180928,EXP,,US-ASTRAZENECA-2018SE44570,ASTRAZENECA,,52.0,YR,,M,Y,,,20180928.0,,,US,US,2018,Q3,Adult
147759953,14775995,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,5 IU (INTERNATIONAL UNIT),,,,,,,,5.0,IU,UNKNOWN,QD,2018,Q3,Squamous cell carcinoma of the tongue,,2018,Q3,3,F,20180323.0,20180726.0,20180418,20180731,EXP,,IT-CELGENEUS-ITA-20180404331,CELGENE,,46.0,YR,,M,Y,66.0,KG,20180731.0,,OT,IT,IT,2018,Q3,Adult
147759953,14775995,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,6 IU (INTERNATIONAL UNIT),,,,,,,,6.0,IU,UNKNOWN,QD,2018,Q3,Squamous cell carcinoma of the tongue,,2018,Q3,3,F,20180323.0,20180726.0,20180418,20180731,EXP,,IT-CELGENEUS-ITA-20180404331,CELGENE,,46.0,YR,,M,Y,66.0,KG,20180731.0,,OT,IT,IT,2018,Q3,Adult
147759953,14775995,12,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,4 IU (INTERNATIONAL UNIT),,,,,,,,4.0,IU,UNKNOWN,QD,2018,Q3,Squamous cell carcinoma of the tongue,,2018,Q3,3,F,20180323.0,20180726.0,20180418,20180731,EXP,,IT-CELGENEUS-ITA-20180404331,CELGENE,,46.0,YR,,M,Y,66.0,KG,20180731.0,,OT,IT,IT,2018,Q3,Adult
148277013,14827701,13,C,INSULIN LISPRO(GENETICAL RECOMBINATION),,2,Parenteral,"12 DF, TID",,,U,,,,,12.0,DF,INJECTION,TID,2018,Q3,Atrial fibrillation,,2018,Q3,3,F,20171002.0,20180508.0,20180430,20180719,EXP,,JP-009507513-1803JPN000430J,MERCK,,76.0,YR,,M,Y,73.0,KG,20180719.0,,MD,JP,JP,2018,Q3,Elderly
148277013,14827701,13,C,INSULIN LISPRO(GENETICAL RECOMBINATION),,2,Parenteral,"12 DF, TID",,,U,,,,,12.0,DF,INJECTION,TID,2018,Q3,Malignant neoplasm progression,,2018,Q3,3,F,20171002.0,20180508.0,20180430,20180719,EXP,,JP-009507513-1803JPN000430J,MERCK,,76.0,YR,,M,Y,73.0,KG,20180719.0,,MD,JP,JP,2018,Q3,Elderly
148277013,14827701,13,C,INSULIN LISPRO(GENETICAL RECOMBINATION),,2,Parenteral,"12 DF, TID",,,U,,,,,12.0,DF,INJECTION,TID,2018,Q3,Thyroiditis,,2018,Q3,3,F,20171002.0,20180508.0,20180430,20180719,EXP,,JP-009507513-1803JPN000430J,MERCK,,76.0,YR,,M,Y,73.0,KG,20180719.0,,MD,JP,JP,2018,Q3,Elderly
148381703,14838170,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,D,,,,,33.0,IU,UNSPECIFIED,TID,2018,Q3,Gastritis erosive,,2018,Q3,3,F,20161030.0,20180807.0,20180502,20180820,EXP,,DE-JNJFOC-20180424146,JOHNSON AND JOHNSON,,64.0,YR,A,M,Y,100.7,KG,20180820.0,,MD,DE,DE,2018,Q3,Adult
148381703,14838170,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,D,,,,,33.0,IU,UNSPECIFIED,TID,2018,Q3,Melaena,,2018,Q3,3,F,20161030.0,20180807.0,20180502,20180820,EXP,,DE-JNJFOC-20180424146,JOHNSON AND JOHNSON,,64.0,YR,A,M,Y,100.7,KG,20180820.0,,MD,DE,DE,2018,Q3,Adult
148429992,14842999,14,C,INSULIN LISPRO(GENETICAL RECOMBINATION),,2,Unknown,"BEFORE BREAKFAST, LUNCH, AND EVENING MEAL",,,,,,,,4.0,DF,INJECTION,TID,2018,Q3,Malaise,,2018,Q3,2,F,20180410.0,20180625.0,20180503,20180703,EXP,,JP-ASTRAZENECA-2018SE57059,ASTRAZENECA,YOSHIDA M. CLINICAL EXPERIENCE WITH BENRALIZUMAB AT FUKUOKA HOSPITAL.. BRONCHIAL ASTHMA CONFERENCE IN CHIKUSINO? 27?JUN?2018 2018?,70.0,YR,,M,Y,,,20180703.0,,MD,JP,JP,2018,Q3,Elderly
149190623,14919062,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"33 IU, 3X/DAY",,,,,,,,33.0,IU,,TID,2018,Q3,Gastritis erosive,,2018,Q3,3,F,20161030.0,20180823.0,20180521,20180828,EXP,,DE-PFIZER INC-2018205861,PFIZER,,64.0,YR,,M,Y,101.0,KG,20180828.0,,MD,DE,DE,2018,Q3,Adult
149190623,14919062,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"33 IU, 3X/DAY",,,,,,,,33.0,IU,,TID,2018,Q3,Melaena,,2018,Q3,3,F,20161030.0,20180823.0,20180521,20180828,EXP,,DE-PFIZER INC-2018205861,PFIZER,,64.0,YR,,M,Y,101.0,KG,20180828.0,,MD,DE,DE,2018,Q3,Adult
149229285,14922928,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,D,U,,,,,,FORMULATION UNKNOWN,,2018,Q3,Diarrhoea,,2018,Q3,5,F,20180514.0,20180719.0,20180522,20180730,EXP,,US-ASTELLAS-2018US023130,ASTELLAS,,68.0,YR,,M,Y,122.0,KG,20180730.0,,MD,US,US,2018,Q3,Elderly
149229285,14922928,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,D,U,,,,,,FORMULATION UNKNOWN,,2018,Q3,Extremity necrosis,,2018,Q3,5,F,20180514.0,20180719.0,20180522,20180730,EXP,,US-ASTELLAS-2018US023130,ASTELLAS,,68.0,YR,,M,Y,122.0,KG,20180730.0,,MD,US,US,2018,Q3,Elderly
149229285,14922928,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,D,U,,,,,,FORMULATION UNKNOWN,,2018,Q3,Fall,,2018,Q3,5,F,20180514.0,20180719.0,20180522,20180730,EXP,,US-ASTELLAS-2018US023130,ASTELLAS,,68.0,YR,,M,Y,122.0,KG,20180730.0,,MD,US,US,2018,Q3,Elderly
149229285,14922928,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,D,U,,,,,,FORMULATION UNKNOWN,,2018,Q3,Febrile neutropenia,,2018,Q3,5,F,20180514.0,20180719.0,20180522,20180730,EXP,,US-ASTELLAS-2018US023130,ASTELLAS,,68.0,YR,,M,Y,122.0,KG,20180730.0,,MD,US,US,2018,Q3,Elderly
149229285,14922928,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,D,U,,,,,,FORMULATION UNKNOWN,,2018,Q3,Respiratory failure,,2018,Q3,5,F,20180514.0,20180719.0,20180522,20180730,EXP,,US-ASTELLAS-2018US023130,ASTELLAS,,68.0,YR,,M,Y,122.0,KG,20180730.0,,MD,US,US,2018,Q3,Elderly
149229285,14922928,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,D,U,,,,,,FORMULATION UNKNOWN,,2018,Q3,Sepsis,,2018,Q3,5,F,20180514.0,20180719.0,20180522,20180730,EXP,,US-ASTELLAS-2018US023130,ASTELLAS,,68.0,YR,,M,Y,122.0,KG,20180730.0,,MD,US,US,2018,Q3,Elderly
149293457,14929345,7,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2018,Q3,Anaemia,,2018,Q3,7,F,20180329.0,20180910.0,20180523,20180917,EXP,,US-CELGENEUS-USA-20180507359,CELGENE,,78.0,YR,,M,Y,87.71,KG,20180917.0,,MD,US,US,2018,Q3,Elderly
149293457,14929345,7,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2018,Q3,Confusional state,,2018,Q3,7,F,20180329.0,20180910.0,20180523,20180917,EXP,,US-CELGENEUS-USA-20180507359,CELGENE,,78.0,YR,,M,Y,87.71,KG,20180917.0,,MD,US,US,2018,Q3,Elderly
149293457,14929345,7,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2018,Q3,Hypoglycaemia,,2018,Q3,7,F,20180329.0,20180910.0,20180523,20180917,EXP,,US-CELGENEUS-USA-20180507359,CELGENE,,78.0,YR,,M,Y,87.71,KG,20180917.0,,MD,US,US,2018,Q3,Elderly
149293457,14929345,7,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2018,Q3,Hypoxia,,2018,Q3,7,F,20180329.0,20180910.0,20180523,20180917,EXP,,US-CELGENEUS-USA-20180507359,CELGENE,,78.0,YR,,M,Y,87.71,KG,20180917.0,,MD,US,US,2018,Q3,Elderly
149293457,14929345,7,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2018,Q3,Platelet count decreased,,2018,Q3,7,F,20180329.0,20180910.0,20180523,20180917,EXP,,US-CELGENEUS-USA-20180507359,CELGENE,,78.0,YR,,M,Y,87.71,KG,20180917.0,,MD,US,US,2018,Q3,Elderly
149293457,14929345,7,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2018,Q3,Sepsis,,2018,Q3,7,F,20180329.0,20180910.0,20180523,20180917,EXP,,US-CELGENEUS-USA-20180507359,CELGENE,,78.0,YR,,M,Y,87.71,KG,20180917.0,,MD,US,US,2018,Q3,Elderly
149753273,14975327,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,25 UNITS TID,,,,,,,,,,,,2018,Q3,Cellulitis,,2018,Q3,3,F,20180430.0,20180817.0,20180605,20180822,EXP,,US-ASTRAZENECA-2018SE72104,ASTRAZENECA,,19478.0,DY,,M,Y,,,20180822.0,,MD,US,US,2018,Q3,Elderly
149753273,14975327,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,25 UNITS TID,,,,,,,,,,,,2018,Q3,Sepsis,,2018,Q3,3,F,20180430.0,20180817.0,20180605,20180822,EXP,,US-ASTRAZENECA-2018SE72104,ASTRAZENECA,,19478.0,DY,,M,Y,,,20180822.0,,MD,US,US,2018,Q3,Elderly
150133312,15013331,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Intradermal,"44 U, TID WITH MEALS",,,,U,,,,,,,TID,2018,Q3,Death,,2018,Q3,2,F,20180602.0,20180918.0,20180614,20180927,EXP,,US-ACTELION-A-US2018-173090,ACTELION,,59.0,YR,A,F,Y,,,20180927.0,,OT,US,US,2018,Q3,Adult
150133312,15013331,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Intradermal,"44 U, TID WITH MEALS",,,,U,,,,,,,TID,2018,Q3,Dyspnoea,,2018,Q3,2,F,20180602.0,20180918.0,20180614,20180927,EXP,,US-ACTELION-A-US2018-173090,ACTELION,,59.0,YR,A,F,Y,,,20180927.0,,OT,US,US,2018,Q3,Adult
150133312,15013331,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Intradermal,"44 U, TID WITH MEALS",,,,U,,,,,,,TID,2018,Q3,Oxygen consumption increased,,2018,Q3,2,F,20180602.0,20180918.0,20180614,20180927,EXP,,US-ACTELION-A-US2018-173090,ACTELION,,59.0,YR,A,F,Y,,,20180927.0,,OT,US,US,2018,Q3,Adult
150361732,15036173,8,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,QD",,,,,,,21081.0,,,SOLUTION FOR INJECTION,QD,2018,Q3,Epilepsy,,2018,Q3,2,F,201706.0,20180628.0,20180620,20180726,EXP,,PL-SA-2017SA171404,SANOFI AVENTIS,,8.0,YR,C,M,Y,30.0,KG,20180726.0,,MD,PL,PL,2018,Q3,Child
150361732,15036173,9,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,QD",,,,,,,21081.0,,,SOLUTION FOR INJECTION,QD,2018,Q3,Epilepsy,,2018,Q3,2,F,201706.0,20180628.0,20180620,20180726,EXP,,PL-SA-2017SA171404,SANOFI AVENTIS,,8.0,YR,C,M,Y,30.0,KG,20180726.0,,MD,PL,PL,2018,Q3,Child
150361732,15036173,18,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,PRN",,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q3,Epilepsy,,2018,Q3,2,F,201706.0,20180628.0,20180620,20180726,EXP,,PL-SA-2017SA171404,SANOFI AVENTIS,,8.0,YR,C,M,Y,30.0,KG,20180726.0,,MD,PL,PL,2018,Q3,Child
150361732,15036173,19,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,PRN",,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q3,Epilepsy,,2018,Q3,2,F,201706.0,20180628.0,20180620,20180726,EXP,,PL-SA-2017SA171404,SANOFI AVENTIS,,8.0,YR,C,M,Y,30.0,KG,20180726.0,,MD,PL,PL,2018,Q3,Child
150619982,15061998,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,Y,, UNKNOWN,,,,,,,2018,Q3,Hypoglycaemia,,2018,Q3,2,F,20180522.0,20180713.0,20180625,20180724,EXP,IT-MINISAL02-482560,IT-NOVOPROD-606642,NOVO NORDISK,,17.0,YR,T,F,Y,,,20180724.0,,CN,IT,IT,2018,Q3,Youth
150619982,15061998,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,Y,, UNKNOWN,,,,,,,2018,Q3,Hypotension,,2018,Q3,2,F,20180522.0,20180713.0,20180625,20180724,EXP,IT-MINISAL02-482560,IT-NOVOPROD-606642,NOVO NORDISK,,17.0,YR,T,F,Y,,,20180724.0,,CN,IT,IT,2018,Q3,Youth
150619982,15061998,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 DF AS NECESSARY,,,Y,, UNKNOWN,,,,,,,2018,Q3,Hypoglycaemia,,2018,Q3,2,F,20180522.0,20180713.0,20180625,20180724,EXP,IT-MINISAL02-482560,IT-NOVOPROD-606642,NOVO NORDISK,,17.0,YR,T,F,Y,,,20180724.0,,CN,IT,IT,2018,Q3,Youth
150619982,15061998,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 DF AS NECESSARY,,,Y,, UNKNOWN,,,,,,,2018,Q3,Hypotension,,2018,Q3,2,F,20180522.0,20180713.0,20180625,20180724,EXP,IT-MINISAL02-482560,IT-NOVOPROD-606642,NOVO NORDISK,,17.0,YR,T,F,Y,,,20180724.0,,CN,IT,IT,2018,Q3,Youth
150812781,15081278,8,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,,2,,,,,,,,,,,,,,2018,Q3,Hypokalaemia,,2018,Q3,1,I,20180430.0,20180614.0,20180628,20180628,EXP,,ES-ACCORD-068719,ACCORD,,68.0,YR,,M,Y,72.0,KG,20180628.0,,OT,ES,ES,2018,Q3,Elderly
150827492,15082749,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 INTERNATIONAL UNIT, DAILY",1020.0,IU,Y,U, UNK,,,15.0,IU,,,2018,Q3,Cold sweat,,2018,Q3,2,F,20180529.0,20180906.0,20180628,20180919,EXP,,IT-AUROBINDO-AUR-APL-2018-032529,AUROBINDO,,84.0,YR,,M,Y,,,20180919.0,,MD,IT,IT,2018,Q3,Elderly
150827492,15082749,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 INTERNATIONAL UNIT, DAILY",1020.0,IU,Y,U, UNK,,,15.0,IU,,,2018,Q3,Confusional state,,2018,Q3,2,F,20180529.0,20180906.0,20180628,20180919,EXP,,IT-AUROBINDO-AUR-APL-2018-032529,AUROBINDO,,84.0,YR,,M,Y,,,20180919.0,,MD,IT,IT,2018,Q3,Elderly
150827492,15082749,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 INTERNATIONAL UNIT, DAILY",1020.0,IU,Y,U, UNK,,,15.0,IU,,,2018,Q3,Hypoglycaemic coma,,2018,Q3,2,F,20180529.0,20180906.0,20180628,20180919,EXP,,IT-AUROBINDO-AUR-APL-2018-032529,AUROBINDO,,84.0,YR,,M,Y,,,20180919.0,,MD,IT,IT,2018,Q3,Elderly
150881002,15088100,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, C857068C,,,,,INJECTION,,2018,Q3,Mobility decreased,,2018,Q3,2,F,20180627.0,20180628.0,20180629,20180726,PER,,US-ELI_LILLY_AND_COMPANY-US201806013704,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20180726.0,,CN,US,US,2018,Q3,Adult
150881002,15088100,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, C857068C,,,,,INJECTION,,2018,Q3,Wrong drug administered,,2018,Q3,2,F,20180627.0,20180628.0,20180629,20180726,PER,,US-ELI_LILLY_AND_COMPANY-US201806013704,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20180726.0,,CN,US,US,2018,Q3,Adult
150881002,15088100,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, C752472C,,,,,INJECTION,,2018,Q3,Mobility decreased,,2018,Q3,2,F,20180627.0,20180628.0,20180629,20180726,PER,,US-ELI_LILLY_AND_COMPANY-US201806013704,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20180726.0,,CN,US,US,2018,Q3,Adult
150881002,15088100,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, C752472C,,,,,INJECTION,,2018,Q3,Wrong drug administered,,2018,Q3,2,F,20180627.0,20180628.0,20180629,20180726,PER,,US-ELI_LILLY_AND_COMPANY-US201806013704,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20180726.0,,CN,US,US,2018,Q3,Adult
150881002,15088100,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,UNK,,,,, C841889C,,,,,INJECTION,,2018,Q3,Mobility decreased,,2018,Q3,2,F,20180627.0,20180628.0,20180629,20180726,PER,,US-ELI_LILLY_AND_COMPANY-US201806013704,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20180726.0,,CN,US,US,2018,Q3,Adult
150881002,15088100,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,UNK,,,,, C841889C,,,,,INJECTION,,2018,Q3,Wrong drug administered,,2018,Q3,2,F,20180627.0,20180628.0,20180629,20180726,PER,,US-ELI_LILLY_AND_COMPANY-US201806013704,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20180726.0,,CN,US,US,2018,Q3,Adult
150881002,15088100,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2018,Q3,Mobility decreased,,2018,Q3,2,F,20180627.0,20180628.0,20180629,20180726,PER,,US-ELI_LILLY_AND_COMPANY-US201806013704,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20180726.0,,CN,US,US,2018,Q3,Adult
150881002,15088100,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2018,Q3,Wrong drug administered,,2018,Q3,2,F,20180627.0,20180628.0,20180629,20180726,PER,,US-ELI_LILLY_AND_COMPANY-US201806013704,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20180726.0,,CN,US,US,2018,Q3,Adult
150994171,15099417,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,NACH SCHEMA,,,U,,,,,,,,,2018,Q3,Contraindicated product administered,,2018,Q3,1,I,,20180624.0,20180702,20180702,EXP,,PHHY2018DE032844,SANDOZ,,68.0,YR,,M,Y,,,20180702.0,,OT,DE,DE,2018,Q3,Elderly
150994171,15099417,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,NACH SCHEMA,,,U,,,,,,,,,2018,Q3,Dyspnoea,,2018,Q3,1,I,,20180624.0,20180702,20180702,EXP,,PHHY2018DE032844,SANDOZ,,68.0,YR,,M,Y,,,20180702.0,,OT,DE,DE,2018,Q3,Elderly
150994171,15099417,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,NACH SCHEMA,,,U,,,,,,,,,2018,Q3,Oedema peripheral,,2018,Q3,1,I,,20180624.0,20180702,20180702,EXP,,PHHY2018DE032844,SANDOZ,,68.0,YR,,M,Y,,,20180702.0,,OT,DE,DE,2018,Q3,Elderly
151010191,15101019,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,12?12?10 U (ADAPTED ACCORDING TO THE SACCHARIDES IN FOOD),,,U,U,,,,,,,,2018,Q3,Diabetes mellitus inadequate control,,2018,Q3,1,I,2006.0,20180130.0,20180703,20180703,EXP,,PHHY2017CZ200642,SANDOZ,,43.0,YR,,F,Y,107.0,KG,20180703.0,,OT,CZ,CZ,2018,Q3,Adult
151010191,15101019,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,12?12?10 U (ADAPTED ACCORDING TO THE SACCHARIDES IN FOOD),,,U,U,,,,,,,,2018,Q3,Diabetic retinopathy,,2018,Q3,1,I,2006.0,20180130.0,20180703,20180703,EXP,,PHHY2017CZ200642,SANDOZ,,43.0,YR,,F,Y,107.0,KG,20180703.0,,OT,CZ,CZ,2018,Q3,Adult
151010191,15101019,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,12?12?10 U (ADAPTED ACCORDING TO THE SACCHARIDES IN FOOD),,,U,U,,,,,,,,2018,Q3,Drug ineffective,,2018,Q3,1,I,2006.0,20180130.0,20180703,20180703,EXP,,PHHY2017CZ200642,SANDOZ,,43.0,YR,,F,Y,107.0,KG,20180703.0,,OT,CZ,CZ,2018,Q3,Adult
151010191,15101019,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,12?12?10 U (ADAPTED ACCORDING TO THE SACCHARIDES IN FOOD),,,U,U,,,,,,,,2018,Q3,Live birth,,2018,Q3,1,I,2006.0,20180130.0,20180703,20180703,EXP,,PHHY2017CZ200642,SANDOZ,,43.0,YR,,F,Y,107.0,KG,20180703.0,,OT,CZ,CZ,2018,Q3,Adult
151010191,15101019,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,12?12?10 U (ADAPTED ACCORDING TO THE SACCHARIDES IN FOOD),,,U,U,,,,,,,,2018,Q3,Maternal exposure during pregnancy,,2018,Q3,1,I,2006.0,20180130.0,20180703,20180703,EXP,,PHHY2017CZ200642,SANDOZ,,43.0,YR,,F,Y,107.0,KG,20180703.0,,OT,CZ,CZ,2018,Q3,Adult
151032401,15103240,1,PS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"1 DF, PRN",,,Y,U,,,20563.0,1.0,DF,,,2018,Q3,Hypoglycaemia,,2018,Q3,1,I,20180522.0,20180620.0,20180703,20180703,EXP,IT-MINISAL02-482560,IT-ELI_LILLY_AND_COMPANY-IT201806009636,ELI LILLY AND CO,,17.0,YR,,F,Y,,,20180703.0,,CN,IT,IT,2018,Q3,Youth
151032401,15103240,1,PS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"1 DF, PRN",,,Y,U,,,20563.0,1.0,DF,,,2018,Q3,Hypotension,,2018,Q3,1,I,20180522.0,20180620.0,20180703,20180703,EXP,IT-MINISAL02-482560,IT-ELI_LILLY_AND_COMPANY-IT201806009636,ELI LILLY AND CO,,17.0,YR,,F,Y,,,20180703.0,,CN,IT,IT,2018,Q3,Youth
151126571,15112657,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 DF, PRN",,,Y,,,,209196.0,1.0,DF,,,2018,Q3,Hypoglycaemia,,2018,Q3,1,I,20180522.0,20180620.0,20180705,20180705,EXP,IT-MINISAL02-482560,IT-SA-2018SA167623,SANOFI AVENTIS,,17.0,YR,T,F,Y,,,20180705.0,,MD,IT,IT,2018,Q3,Youth
151126571,15112657,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 DF, PRN",,,Y,,,,209196.0,1.0,DF,,,2018,Q3,Hypotension,,2018,Q3,1,I,20180522.0,20180620.0,20180705,20180705,EXP,IT-MINISAL02-482560,IT-SA-2018SA167623,SANOFI AVENTIS,,17.0,YR,T,F,Y,,,20180705.0,,MD,IT,IT,2018,Q3,Youth
151153922,15115392,34,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q3,Enteritis,,2018,Q3,2,F,20180603.0,20180707.0,20180706,20180712,EXP,,US-ROCHE-2134808,ROCHE,,50.0,YR,,F,Y,66.3,KG,20180712.0,,MD,US,US,2018,Q3,Adult
151153922,15115392,34,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q3,Vomiting,,2018,Q3,2,F,20180603.0,20180707.0,20180706,20180712,EXP,,US-ROCHE-2134808,ROCHE,,50.0,YR,,F,Y,66.3,KG,20180712.0,,MD,US,US,2018,Q3,Adult
151153922,15115392,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q3,Enteritis,,2018,Q3,2,F,20180603.0,20180707.0,20180706,20180712,EXP,,US-ROCHE-2134808,ROCHE,,50.0,YR,,F,Y,66.3,KG,20180712.0,,MD,US,US,2018,Q3,Adult
151153922,15115392,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q3,Vomiting,,2018,Q3,2,F,20180603.0,20180707.0,20180706,20180712,EXP,,US-ROCHE-2134808,ROCHE,,50.0,YR,,F,Y,66.3,KG,20180712.0,,MD,US,US,2018,Q3,Adult
151158821,15115882,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (FERTIGSPRITZEN),,,U,,,,,,,,,2018,Q3,Electrolyte imbalance,,2018,Q3,1,I,,20180626.0,20180706,20180706,EXP,,PHHY2018DE034930,SANDOZ,,83.0,YR,,M,Y,70.0,KG,20180706.0,,OT,DE,DE,2018,Q3,Elderly
151158821,15115882,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (FERTIGSPRITZEN),,,U,,,,,,,,,2018,Q3,Pain,,2018,Q3,1,I,,20180626.0,20180706,20180706,EXP,,PHHY2018DE034930,SANDOZ,,83.0,YR,,M,Y,70.0,KG,20180706.0,,OT,DE,DE,2018,Q3,Elderly
151158821,15115882,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (FERTIGSPRITZEN),,,U,,,,,,,,,2018,Q3,Skin ulcer,,2018,Q3,1,I,,20180626.0,20180706,20180706,EXP,,PHHY2018DE034930,SANDOZ,,83.0,YR,,M,Y,70.0,KG,20180706.0,,OT,DE,DE,2018,Q3,Elderly
151189391,15118939,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2018,Q3,Infusion site discharge,,2018,Q3,1,I,,20180627.0,20180709,20180709,EXP,,CA-APOTEX-2018AP016534,APOTEX,,53.0,YR,,F,Y,48.0,KG,20180709.0,,CN,CA,CA,2018,Q3,Adult
151189391,15118939,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2018,Q3,Infusion site erythema,,2018,Q3,1,I,,20180627.0,20180709,20180709,EXP,,CA-APOTEX-2018AP016534,APOTEX,,53.0,YR,,F,Y,48.0,KG,20180709.0,,CN,CA,CA,2018,Q3,Adult
151189391,15118939,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2018,Q3,Neutrophil count decreased,,2018,Q3,1,I,,20180627.0,20180709,20180709,EXP,,CA-APOTEX-2018AP016534,APOTEX,,53.0,YR,,F,Y,48.0,KG,20180709.0,,CN,CA,CA,2018,Q3,Adult
151269304,15126930,29,C,Insulin?Lispro,,2,Unknown,,,,,,,,,,,UNKNOWN,,2018,Q3,Compression fracture,,2018,Q3,4,F,20180529.0,20180713.0,20180710,20180719,EXP,,US-CELGENEUS-USA-20180201339,CELGENE,,71.0,YR,,F,Y,56.75,KG,20180719.0,,MD,US,US,2018,Q3,Elderly
151269304,15126930,29,C,Insulin?Lispro,,2,Unknown,,,,,,,,,,,UNKNOWN,,2018,Q3,Constipation,,2018,Q3,4,F,20180529.0,20180713.0,20180710,20180719,EXP,,US-CELGENEUS-USA-20180201339,CELGENE,,71.0,YR,,F,Y,56.75,KG,20180719.0,,MD,US,US,2018,Q3,Elderly
151269304,15126930,29,C,Insulin?Lispro,,2,Unknown,,,,,,,,,,,UNKNOWN,,2018,Q3,Osteolysis,,2018,Q3,4,F,20180529.0,20180713.0,20180710,20180719,EXP,,US-CELGENEUS-USA-20180201339,CELGENE,,71.0,YR,,F,Y,56.75,KG,20180719.0,,MD,US,US,2018,Q3,Elderly
151269304,15126930,29,C,Insulin?Lispro,,2,Unknown,,,,,,,,,,,UNKNOWN,,2018,Q3,Spinal cord compression,,2018,Q3,4,F,20180529.0,20180713.0,20180710,20180719,EXP,,US-CELGENEUS-USA-20180201339,CELGENE,,71.0,YR,,F,Y,56.75,KG,20180719.0,,MD,US,US,2018,Q3,Elderly
151308463,15130846,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q3,Back pain,,2018,Q3,3,F,201807.0,20180829.0,20180711,20180910,EXP,,US-ACTELION-A-US2018-175073,ACTELION,,49.0,YR,A,F,Y,,,20180910.0,,OT,US,US,2018,Q3,Adult
151308463,15130846,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q3,Dizziness,,2018,Q3,3,F,201807.0,20180829.0,20180711,20180910,EXP,,US-ACTELION-A-US2018-175073,ACTELION,,49.0,YR,A,F,Y,,,20180910.0,,OT,US,US,2018,Q3,Adult
151308463,15130846,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q3,Drug dose omission,,2018,Q3,3,F,201807.0,20180829.0,20180711,20180910,EXP,,US-ACTELION-A-US2018-175073,ACTELION,,49.0,YR,A,F,Y,,,20180910.0,,OT,US,US,2018,Q3,Adult
151308463,15130846,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q3,Fall,,2018,Q3,3,F,201807.0,20180829.0,20180711,20180910,EXP,,US-ACTELION-A-US2018-175073,ACTELION,,49.0,YR,A,F,Y,,,20180910.0,,OT,US,US,2018,Q3,Adult
151308463,15130846,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q3,Headache,,2018,Q3,3,F,201807.0,20180829.0,20180711,20180910,EXP,,US-ACTELION-A-US2018-175073,ACTELION,,49.0,YR,A,F,Y,,,20180910.0,,OT,US,US,2018,Q3,Adult
151308463,15130846,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q3,Nausea,,2018,Q3,3,F,201807.0,20180829.0,20180711,20180910,EXP,,US-ACTELION-A-US2018-175073,ACTELION,,49.0,YR,A,F,Y,,,20180910.0,,OT,US,US,2018,Q3,Adult
151308463,15130846,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q3,Pollakiuria,,2018,Q3,3,F,201807.0,20180829.0,20180711,20180910,EXP,,US-ACTELION-A-US2018-175073,ACTELION,,49.0,YR,A,F,Y,,,20180910.0,,OT,US,US,2018,Q3,Adult
151308463,15130846,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q3,Pulmonary oedema,,2018,Q3,3,F,201807.0,20180829.0,20180711,20180910,EXP,,US-ACTELION-A-US2018-175073,ACTELION,,49.0,YR,A,F,Y,,,20180910.0,,OT,US,US,2018,Q3,Adult
151336691,15133669,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,U,,,,,,,,2018,Q3,Accidental underdose,,2018,Q3,1,I,20180614.0,20180615.0,20180712,20180712,PER,,US-ELI_LILLY_AND_COMPANY-US201806007616,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20180712.0,,CN,US,US,2018,Q3,Adult
151336691,15133669,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,U,,,,,,,,2018,Q3,Blood glucose increased,,2018,Q3,1,I,20180614.0,20180615.0,20180712,20180712,PER,,US-ELI_LILLY_AND_COMPANY-US201806007616,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20180712.0,,CN,US,US,2018,Q3,Adult
151336691,15133669,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,U,,,,,,,,2018,Q3,Visual impairment,,2018,Q3,1,I,20180614.0,20180615.0,20180712,20180712,PER,,US-ELI_LILLY_AND_COMPANY-US201806007616,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20180712.0,,CN,US,US,2018,Q3,Adult
151338041,15133804,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"6 IU, UNKNOWN",15.0,IU,U,U,,,20563.0,6.0,IU,,,2018,Q3,Hyperglycaemia,,2018,Q3,1,I,20171206.0,20180703.0,20180712,20180712,EXP,IT-MINISAL02-479328,IT-ELI_LILLY_AND_COMPANY-IT201807003057,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20180712.0,,CN,IT,IT,2018,Q3,Elderly
151338041,15133804,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"6 IU, UNKNOWN",15.0,IU,U,U,,,20563.0,6.0,IU,,,2018,Q3,Hypoglycaemia,,2018,Q3,1,I,20171206.0,20180703.0,20180712,20180712,EXP,IT-MINISAL02-479328,IT-ELI_LILLY_AND_COMPANY-IT201807003057,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20180712.0,,CN,IT,IT,2018,Q3,Elderly
151338041,15133804,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"6 IU, UNKNOWN",15.0,IU,U,U,,,20563.0,6.0,IU,,,2018,Q3,Medication error,,2018,Q3,1,I,20171206.0,20180703.0,20180712,20180712,EXP,IT-MINISAL02-479328,IT-ELI_LILLY_AND_COMPANY-IT201807003057,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20180712.0,,CN,IT,IT,2018,Q3,Elderly
151338041,15133804,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"6 IU, UNKNOWN",15.0,IU,U,U,,,20563.0,6.0,IU,,,2018,Q3,Wrong dose,,2018,Q3,1,I,20171206.0,20180703.0,20180712,20180712,EXP,IT-MINISAL02-479328,IT-ELI_LILLY_AND_COMPANY-IT201807003057,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20180712.0,,CN,IT,IT,2018,Q3,Elderly
151338041,15133804,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"15 IU, UNKNOWN",15.0,IU,U,U,,,20563.0,15.0,IU,,,2018,Q3,Hyperglycaemia,,2018,Q3,1,I,20171206.0,20180703.0,20180712,20180712,EXP,IT-MINISAL02-479328,IT-ELI_LILLY_AND_COMPANY-IT201807003057,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20180712.0,,CN,IT,IT,2018,Q3,Elderly
151338041,15133804,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"15 IU, UNKNOWN",15.0,IU,U,U,,,20563.0,15.0,IU,,,2018,Q3,Hypoglycaemia,,2018,Q3,1,I,20171206.0,20180703.0,20180712,20180712,EXP,IT-MINISAL02-479328,IT-ELI_LILLY_AND_COMPANY-IT201807003057,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20180712.0,,CN,IT,IT,2018,Q3,Elderly
151338041,15133804,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"15 IU, UNKNOWN",15.0,IU,U,U,,,20563.0,15.0,IU,,,2018,Q3,Medication error,,2018,Q3,1,I,20171206.0,20180703.0,20180712,20180712,EXP,IT-MINISAL02-479328,IT-ELI_LILLY_AND_COMPANY-IT201807003057,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20180712.0,,CN,IT,IT,2018,Q3,Elderly
151338041,15133804,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"15 IU, UNKNOWN",15.0,IU,U,U,,,20563.0,15.0,IU,,,2018,Q3,Wrong dose,,2018,Q3,1,I,20171206.0,20180703.0,20180712,20180712,EXP,IT-MINISAL02-479328,IT-ELI_LILLY_AND_COMPANY-IT201807003057,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20180712.0,,CN,IT,IT,2018,Q3,Elderly
151372412,15137241,2,SS,Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,U,,,,,,,,2018,Q3,Asthenia,,2018,Q3,2,F,20150829.0,20180711.0,20180712,20180718,EXP,IT-MINISAL02-472189,IT-ELI_LILLY_AND_COMPANY-IT201807003857,ELI LILLY AND CO,,83.0,YR,,M,Y,,,20180718.0,,CN,IT,IT,2018,Q3,Elderly
151372412,15137241,2,SS,Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,U,,,,,,,,2018,Q3,Cold sweat,,2018,Q3,2,F,20150829.0,20180711.0,20180712,20180718,EXP,IT-MINISAL02-472189,IT-ELI_LILLY_AND_COMPANY-IT201807003857,ELI LILLY AND CO,,83.0,YR,,M,Y,,,20180718.0,,CN,IT,IT,2018,Q3,Elderly
151372412,15137241,2,SS,Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,U,,,,,,,,2018,Q3,Hypoglycaemia,,2018,Q3,2,F,20150829.0,20180711.0,20180712,20180718,EXP,IT-MINISAL02-472189,IT-ELI_LILLY_AND_COMPANY-IT201807003857,ELI LILLY AND CO,,83.0,YR,,M,Y,,,20180718.0,,CN,IT,IT,2018,Q3,Elderly
151372412,15137241,2,SS,Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,U,,,,,,,,2018,Q3,Presyncope,,2018,Q3,2,F,20150829.0,20180711.0,20180712,20180718,EXP,IT-MINISAL02-472189,IT-ELI_LILLY_AND_COMPANY-IT201807003857,ELI LILLY AND CO,,83.0,YR,,M,Y,,,20180718.0,,CN,IT,IT,2018,Q3,Elderly
151372412,15137241,2,SS,Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,U,,,,,,,,2018,Q3,Vomiting,,2018,Q3,2,F,20150829.0,20180711.0,20180712,20180718,EXP,IT-MINISAL02-472189,IT-ELI_LILLY_AND_COMPANY-IT201807003857,ELI LILLY AND CO,,83.0,YR,,M,Y,,,20180718.0,,CN,IT,IT,2018,Q3,Elderly
151383161,15138316,9,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Anaemia,,2018,Q3,1,I,,20180629.0,20180713,20180713,EXP,,DE-DRREDDYS-GER/GER/18/0101708,DR REDDYS,,77.0,YR,,M,Y,,,20180713.0,,PH,DE,DE,2018,Q3,Elderly
151383161,15138316,9,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Dyspnoea,,2018,Q3,1,I,,20180629.0,20180713,20180713,EXP,,DE-DRREDDYS-GER/GER/18/0101708,DR REDDYS,,77.0,YR,,M,Y,,,20180713.0,,PH,DE,DE,2018,Q3,Elderly
151383161,15138316,9,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Haematochezia,,2018,Q3,1,I,,20180629.0,20180713,20180713,EXP,,DE-DRREDDYS-GER/GER/18/0101708,DR REDDYS,,77.0,YR,,M,Y,,,20180713.0,,PH,DE,DE,2018,Q3,Elderly
151387832,15138783,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,15 IU (INTERNATIONAL UNIT) DAILY;,1020.0,IU,Y,,,,,15.0,IU,,,2018,Q3,Cold sweat,,2018,Q3,2,F,20180529.0,20180924.0,20180713,20180925,EXP,IT-MINISAL02-482261,IT-TEVA-2018-IT-925048,TEVA,,84.0,YR,,M,Y,,,20180925.0,,MD,IT,IT,2018,Q3,Elderly
151387832,15138783,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,15 IU (INTERNATIONAL UNIT) DAILY;,1020.0,IU,Y,,,,,15.0,IU,,,2018,Q3,Confusional state,,2018,Q3,2,F,20180529.0,20180924.0,20180713,20180925,EXP,IT-MINISAL02-482261,IT-TEVA-2018-IT-925048,TEVA,,84.0,YR,,M,Y,,,20180925.0,,MD,IT,IT,2018,Q3,Elderly
151387832,15138783,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,15 IU (INTERNATIONAL UNIT) DAILY;,1020.0,IU,Y,,,,,15.0,IU,,,2018,Q3,Hypoglycaemic coma,,2018,Q3,2,F,20180529.0,20180924.0,20180713,20180925,EXP,IT-MINISAL02-482261,IT-TEVA-2018-IT-925048,TEVA,,84.0,YR,,M,Y,,,20180925.0,,MD,IT,IT,2018,Q3,Elderly
151388561,15138856,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Hypotension,,2018,Q3,1,I,20180605.0,20180709.0,20180713,20180713,PER,,US-FRESENIUS MEDICAL CARE RENAL THERAPIES GROUP-FMC-1807-001269,FRESENIUS MEDICAL CARE,,62.0,YR,,M,Y,,,20180713.0,,OT,US,US,2018,Q3,Adult
151388561,15138856,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Ileus,,2018,Q3,1,I,20180605.0,20180709.0,20180713,20180713,PER,,US-FRESENIUS MEDICAL CARE RENAL THERAPIES GROUP-FMC-1807-001269,FRESENIUS MEDICAL CARE,,62.0,YR,,M,Y,,,20180713.0,,OT,US,US,2018,Q3,Adult
151388561,15138856,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Peritonitis,,2018,Q3,1,I,20180605.0,20180709.0,20180713,20180713,PER,,US-FRESENIUS MEDICAL CARE RENAL THERAPIES GROUP-FMC-1807-001269,FRESENIUS MEDICAL CARE,,62.0,YR,,M,Y,,,20180713.0,,OT,US,US,2018,Q3,Adult
151389371,15138937,3,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,,2,Subcutaneous,,,,,,,,,36.0,KIU,,,2018,Q3,Conduct disorder,,2018,Q3,1,I,20171121.0,20180703.0,20180713,20180713,EXP,IT-MINISAL02-442954,IT-ACCORD-069426,ACCORD,,89.0,YR,,F,Y,,,20180713.0,,MD,IT,IT,2018,Q3,Elderly
151389371,15138937,3,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,,2,Subcutaneous,,,,,,,,,36.0,KIU,,,2018,Q3,Confusional state,,2018,Q3,1,I,20171121.0,20180703.0,20180713,20180713,EXP,IT-MINISAL02-442954,IT-ACCORD-069426,ACCORD,,89.0,YR,,F,Y,,,20180713.0,,MD,IT,IT,2018,Q3,Elderly
151389371,15138937,3,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,,2,Subcutaneous,,,,,,,,,36.0,KIU,,,2018,Q3,Disorientation,,2018,Q3,1,I,20171121.0,20180703.0,20180713,20180713,EXP,IT-MINISAL02-442954,IT-ACCORD-069426,ACCORD,,89.0,YR,,F,Y,,,20180713.0,,MD,IT,IT,2018,Q3,Elderly
151389371,15138937,3,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,,2,Subcutaneous,,,,,,,,,36.0,KIU,,,2018,Q3,"Hallucination, visual",,2018,Q3,1,I,20171121.0,20180703.0,20180713,20180713,EXP,IT-MINISAL02-442954,IT-ACCORD-069426,ACCORD,,89.0,YR,,F,Y,,,20180713.0,,MD,IT,IT,2018,Q3,Elderly
151447411,15144741,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 IU, DAILY",1020.0,IU,Y,U,,,,15.0,IU,,QD,2018,Q3,Cold sweat,,2018,Q3,1,I,20180529.0,20180703.0,20180713,20180713,EXP,IT-MINISAL02-482261,IT-ELI_LILLY_AND_COMPANY-IT201807003018,ELI LILLY AND CO,,84.0,YR,,M,Y,,,20180713.0,,CN,IT,IT,2018,Q3,Elderly
151447411,15144741,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 IU, DAILY",1020.0,IU,Y,U,,,,15.0,IU,,QD,2018,Q3,Confusional state,,2018,Q3,1,I,20180529.0,20180703.0,20180713,20180713,EXP,IT-MINISAL02-482261,IT-ELI_LILLY_AND_COMPANY-IT201807003018,ELI LILLY AND CO,,84.0,YR,,M,Y,,,20180713.0,,CN,IT,IT,2018,Q3,Elderly
151447411,15144741,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 IU, DAILY",1020.0,IU,Y,U,,,,15.0,IU,,QD,2018,Q3,Hypoglycaemic coma,,2018,Q3,1,I,20180529.0,20180703.0,20180713,20180713,EXP,IT-MINISAL02-482261,IT-ELI_LILLY_AND_COMPANY-IT201807003018,ELI LILLY AND CO,,84.0,YR,,M,Y,,,20180713.0,,CN,IT,IT,2018,Q3,Elderly
151516831,15151683,8,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Vision blurred,,2018,Q3,1,I,20180612.0,,20180619,20180619,DIR,,,FDA-CTU,,68.0,YR,,M,N,91.35,KG,20180619.0,N,PH,US,US,2018,Q3,Elderly
151516831,15151683,8,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Visual impairment,,2018,Q3,1,I,20180612.0,,20180619,20180619,DIR,,,FDA-CTU,,68.0,YR,,M,N,91.35,KG,20180619.0,N,PH,US,US,2018,Q3,Elderly
151564901,15156490,6,C,LISPRO 50LIS50NPL,,2,,,,,,,,,,,,,,2018,Q3,Acute generalised exanthematous pustulosis,,2018,Q3,1,I,,20180710.0,20180717,20180717,EXP,,CA-TEVA-2018-CA-924441,TEVA,,50.0,YR,,F,Y,66.0,KG,20180718.0,,MD,CA,CA,2018,Q3,Adult
151564901,15156490,6,C,LISPRO 50LIS50NPL,,2,,,,,,,,,,,,,,2018,Q3,Blood bilirubin increased,,2018,Q3,1,I,,20180710.0,20180717,20180717,EXP,,CA-TEVA-2018-CA-924441,TEVA,,50.0,YR,,F,Y,66.0,KG,20180718.0,,MD,CA,CA,2018,Q3,Adult
151564901,15156490,6,C,LISPRO 50LIS50NPL,,2,,,,,,,,,,,,,,2018,Q3,Drug hypersensitivity,,2018,Q3,1,I,,20180710.0,20180717,20180717,EXP,,CA-TEVA-2018-CA-924441,TEVA,,50.0,YR,,F,Y,66.0,KG,20180718.0,,MD,CA,CA,2018,Q3,Adult
151564901,15156490,6,C,LISPRO 50LIS50NPL,,2,,,,,,,,,,,,,,2018,Q3,Transaminases increased,,2018,Q3,1,I,,20180710.0,20180717,20180717,EXP,,CA-TEVA-2018-CA-924441,TEVA,,50.0,YR,,F,Y,66.0,KG,20180718.0,,MD,CA,CA,2018,Q3,Adult
151583331,15158333,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,100 U/ML (IL 100) AT 20?20?20 U DOSES,,,D,U,,,,,,FORMULATION UNKNOWN,,2018,Q3,Hypoglycaemia,,2018,Q3,1,I,,20180711.0,20180718,20180718,EXP,,CZ-ASTELLAS-2018US031794,ASTELLAS,ZAK P. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION. KAZUISTIKY V DIABETOLOGII. 2018?2:32?4,61.0,YR,,F,Y,,,20180718.0,,OT,CZ,CZ,2018,Q3,Adult
151583331,15158333,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,100 U/ML (IL 100) AT 20?20?20 U DOSES,,,D,U,,,,,,FORMULATION UNKNOWN,,2018,Q3,Increased insulin requirement,,2018,Q3,1,I,,20180711.0,20180718,20180718,EXP,,CZ-ASTELLAS-2018US031794,ASTELLAS,ZAK P. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION. KAZUISTIKY V DIABETOLOGII. 2018?2:32?4,61.0,YR,,F,Y,,,20180718.0,,OT,CZ,CZ,2018,Q3,Adult
151583331,15158333,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,100 U/ML (IL 100) AT 20?20?20 U DOSES,,,D,U,,,,,,FORMULATION UNKNOWN,,2018,Q3,Liver transplant rejection,,2018,Q3,1,I,,20180711.0,20180718,20180718,EXP,,CZ-ASTELLAS-2018US031794,ASTELLAS,ZAK P. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION. KAZUISTIKY V DIABETOLOGII. 2018?2:32?4,61.0,YR,,F,Y,,,20180718.0,,OT,CZ,CZ,2018,Q3,Adult
151583331,15158333,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,100 U/ML (IL 100) AT 20?20?20 U DOSES,,,D,U,,,,,,FORMULATION UNKNOWN,,2018,Q3,Nephrotic syndrome,,2018,Q3,1,I,,20180711.0,20180718,20180718,EXP,,CZ-ASTELLAS-2018US031794,ASTELLAS,ZAK P. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION. KAZUISTIKY V DIABETOLOGII. 2018?2:32?4,61.0,YR,,F,Y,,,20180718.0,,OT,CZ,CZ,2018,Q3,Adult
151583331,15158333,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,100 U/ML (IL 100) AT 20?20?20 U DOSES,,,D,U,,,,,,FORMULATION UNKNOWN,,2018,Q3,Renal failure,,2018,Q3,1,I,,20180711.0,20180718,20180718,EXP,,CZ-ASTELLAS-2018US031794,ASTELLAS,ZAK P. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION. KAZUISTIKY V DIABETOLOGII. 2018?2:32?4,61.0,YR,,F,Y,,,20180718.0,,OT,CZ,CZ,2018,Q3,Adult
151583331,15158333,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,100 U/ML (IL 100) AT 20?20?20 U DOSES,,,D,U,,,,,,FORMULATION UNKNOWN,,2018,Q3,Toxicity to various agents,,2018,Q3,1,I,,20180711.0,20180718,20180718,EXP,,CZ-ASTELLAS-2018US031794,ASTELLAS,ZAK P. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION. KAZUISTIKY V DIABETOLOGII. 2018?2:32?4,61.0,YR,,F,Y,,,20180718.0,,OT,CZ,CZ,2018,Q3,Adult
151583331,15158333,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,100 U/ML (IL 100) AT 20?20?20 U DOSES,,,D,U,,,,,,FORMULATION UNKNOWN,,2018,Q3,Weight increased,,2018,Q3,1,I,,20180711.0,20180718,20180718,EXP,,CZ-ASTELLAS-2018US031794,ASTELLAS,ZAK P. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION. KAZUISTIKY V DIABETOLOGII. 2018?2:32?4,61.0,YR,,F,Y,,,20180718.0,,OT,CZ,CZ,2018,Q3,Adult
151583331,15158333,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"(IL 200) 24?24?24 U, UNKNOWN FREQ.UNK",,,D,U,,,,,,FORMULATION UNKNOWN,,2018,Q3,Hypoglycaemia,,2018,Q3,1,I,,20180711.0,20180718,20180718,EXP,,CZ-ASTELLAS-2018US031794,ASTELLAS,ZAK P. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION. KAZUISTIKY V DIABETOLOGII. 2018?2:32?4,61.0,YR,,F,Y,,,20180718.0,,OT,CZ,CZ,2018,Q3,Adult
151583331,15158333,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"(IL 200) 24?24?24 U, UNKNOWN FREQ.UNK",,,D,U,,,,,,FORMULATION UNKNOWN,,2018,Q3,Increased insulin requirement,,2018,Q3,1,I,,20180711.0,20180718,20180718,EXP,,CZ-ASTELLAS-2018US031794,ASTELLAS,ZAK P. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION. KAZUISTIKY V DIABETOLOGII. 2018?2:32?4,61.0,YR,,F,Y,,,20180718.0,,OT,CZ,CZ,2018,Q3,Adult
151583331,15158333,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"(IL 200) 24?24?24 U, UNKNOWN FREQ.UNK",,,D,U,,,,,,FORMULATION UNKNOWN,,2018,Q3,Liver transplant rejection,,2018,Q3,1,I,,20180711.0,20180718,20180718,EXP,,CZ-ASTELLAS-2018US031794,ASTELLAS,ZAK P. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION. KAZUISTIKY V DIABETOLOGII. 2018?2:32?4,61.0,YR,,F,Y,,,20180718.0,,OT,CZ,CZ,2018,Q3,Adult
151583331,15158333,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"(IL 200) 24?24?24 U, UNKNOWN FREQ.UNK",,,D,U,,,,,,FORMULATION UNKNOWN,,2018,Q3,Nephrotic syndrome,,2018,Q3,1,I,,20180711.0,20180718,20180718,EXP,,CZ-ASTELLAS-2018US031794,ASTELLAS,ZAK P. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION. KAZUISTIKY V DIABETOLOGII. 2018?2:32?4,61.0,YR,,F,Y,,,20180718.0,,OT,CZ,CZ,2018,Q3,Adult
151583331,15158333,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"(IL 200) 24?24?24 U, UNKNOWN FREQ.UNK",,,D,U,,,,,,FORMULATION UNKNOWN,,2018,Q3,Renal failure,,2018,Q3,1,I,,20180711.0,20180718,20180718,EXP,,CZ-ASTELLAS-2018US031794,ASTELLAS,ZAK P. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION. KAZUISTIKY V DIABETOLOGII. 2018?2:32?4,61.0,YR,,F,Y,,,20180718.0,,OT,CZ,CZ,2018,Q3,Adult
151583331,15158333,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"(IL 200) 24?24?24 U, UNKNOWN FREQ.UNK",,,D,U,,,,,,FORMULATION UNKNOWN,,2018,Q3,Toxicity to various agents,,2018,Q3,1,I,,20180711.0,20180718,20180718,EXP,,CZ-ASTELLAS-2018US031794,ASTELLAS,ZAK P. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION. KAZUISTIKY V DIABETOLOGII. 2018?2:32?4,61.0,YR,,F,Y,,,20180718.0,,OT,CZ,CZ,2018,Q3,Adult
151583331,15158333,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"(IL 200) 24?24?24 U, UNKNOWN FREQ.UNK",,,D,U,,,,,,FORMULATION UNKNOWN,,2018,Q3,Weight increased,,2018,Q3,1,I,,20180711.0,20180718,20180718,EXP,,CZ-ASTELLAS-2018US031794,ASTELLAS,ZAK P. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION. KAZUISTIKY V DIABETOLOGII. 2018?2:32?4,61.0,YR,,F,Y,,,20180718.0,,OT,CZ,CZ,2018,Q3,Adult
151599001,15159900,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2018,Q3,Acute kidney injury,,2018,Q3,1,I,,20180619.0,20180718,20180718,EXP,,US-VALIDUS PHARMACEUTICALS LLC-US-2018VAL000857,VALIDUS,,64.0,YR,,M,Y,93.0,KG,20180718.0,,MD,US,US,2018,Q3,Adult
151599001,15159900,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2018,Q3,Acute myocardial infarction,,2018,Q3,1,I,,20180619.0,20180718,20180718,EXP,,US-VALIDUS PHARMACEUTICALS LLC-US-2018VAL000857,VALIDUS,,64.0,YR,,M,Y,93.0,KG,20180718.0,,MD,US,US,2018,Q3,Adult
151599001,15159900,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2018,Q3,Cellulitis,,2018,Q3,1,I,,20180619.0,20180718,20180718,EXP,,US-VALIDUS PHARMACEUTICALS LLC-US-2018VAL000857,VALIDUS,,64.0,YR,,M,Y,93.0,KG,20180718.0,,MD,US,US,2018,Q3,Adult
151599001,15159900,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2018,Q3,Disease recurrence,,2018,Q3,1,I,,20180619.0,20180718,20180718,EXP,,US-VALIDUS PHARMACEUTICALS LLC-US-2018VAL000857,VALIDUS,,64.0,YR,,M,Y,93.0,KG,20180718.0,,MD,US,US,2018,Q3,Adult
151599462,15159946,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"7 IU, TID",,,U,,,,,7.0,IU,,Q8H,2018,Q3,Blood glucose increased,,2018,Q3,2,F,20180630.0,20180717.0,20180718,20180726,EXP,,CO-SA-2018SA185951,SANOFI AVENTIS,,59.0,YR,A,F,Y,,,20180726.0,,CN,CO,CO,2018,Q3,Adult
151599462,15159946,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"7 IU, TID",,,U,,,,,7.0,IU,,Q8H,2018,Q3,Fall,,2018,Q3,2,F,20180630.0,20180717.0,20180718,20180726,EXP,,CO-SA-2018SA185951,SANOFI AVENTIS,,59.0,YR,A,F,Y,,,20180726.0,,CN,CO,CO,2018,Q3,Adult
151599462,15159946,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"7 IU, TID",,,U,,,,,7.0,IU,,Q8H,2018,Q3,Foot fracture,,2018,Q3,2,F,20180630.0,20180717.0,20180718,20180726,EXP,,CO-SA-2018SA185951,SANOFI AVENTIS,,59.0,YR,A,F,Y,,,20180726.0,,CN,CO,CO,2018,Q3,Adult
151599462,15159946,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"7 IU, TID",,,U,,,,,7.0,IU,,Q8H,2018,Q3,Pain in extremity,,2018,Q3,2,F,20180630.0,20180717.0,20180718,20180726,EXP,,CO-SA-2018SA185951,SANOFI AVENTIS,,59.0,YR,A,F,Y,,,20180726.0,,CN,CO,CO,2018,Q3,Adult
151604354,15160435,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?10 UNITS, Q6HRS",,,,U,,,,,,,QID,2018,Q3,Abdominal pain upper,,2018,Q3,4,F,20180625.0,20180829.0,20180718,20180910,EXP,,US-ACTELION-A-US2018-175420,ACTELION,,78.0,YR,E,M,Y,30.8,KG,20180910.0,,OT,US,US,2018,Q3,Elderly
151604354,15160435,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?10 UNITS, Q6HRS",,,,U,,,,,,,QID,2018,Q3,Aspiration,,2018,Q3,4,F,20180625.0,20180829.0,20180718,20180910,EXP,,US-ACTELION-A-US2018-175420,ACTELION,,78.0,YR,E,M,Y,30.8,KG,20180910.0,,OT,US,US,2018,Q3,Elderly
151604354,15160435,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?10 UNITS, Q6HRS",,,,U,,,,,,,QID,2018,Q3,Chronic lymphocytic leukaemia,,2018,Q3,4,F,20180625.0,20180829.0,20180718,20180910,EXP,,US-ACTELION-A-US2018-175420,ACTELION,,78.0,YR,E,M,Y,30.8,KG,20180910.0,,OT,US,US,2018,Q3,Elderly
151604354,15160435,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?10 UNITS, Q6HRS",,,,U,,,,,,,QID,2018,Q3,Chronic obstructive pulmonary disease,,2018,Q3,4,F,20180625.0,20180829.0,20180718,20180910,EXP,,US-ACTELION-A-US2018-175420,ACTELION,,78.0,YR,E,M,Y,30.8,KG,20180910.0,,OT,US,US,2018,Q3,Elderly
151604354,15160435,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?10 UNITS, Q6HRS",,,,U,,,,,,,QID,2018,Q3,Confusional state,,2018,Q3,4,F,20180625.0,20180829.0,20180718,20180910,EXP,,US-ACTELION-A-US2018-175420,ACTELION,,78.0,YR,E,M,Y,30.8,KG,20180910.0,,OT,US,US,2018,Q3,Elderly
151604354,15160435,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?10 UNITS, Q6HRS",,,,U,,,,,,,QID,2018,Q3,Decreased appetite,,2018,Q3,4,F,20180625.0,20180829.0,20180718,20180910,EXP,,US-ACTELION-A-US2018-175420,ACTELION,,78.0,YR,E,M,Y,30.8,KG,20180910.0,,OT,US,US,2018,Q3,Elderly
151604354,15160435,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?10 UNITS, Q6HRS",,,,U,,,,,,,QID,2018,Q3,Dysphagia,,2018,Q3,4,F,20180625.0,20180829.0,20180718,20180910,EXP,,US-ACTELION-A-US2018-175420,ACTELION,,78.0,YR,E,M,Y,30.8,KG,20180910.0,,OT,US,US,2018,Q3,Elderly
151604354,15160435,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?10 UNITS, Q6HRS",,,,U,,,,,,,QID,2018,Q3,Dyspnoea,,2018,Q3,4,F,20180625.0,20180829.0,20180718,20180910,EXP,,US-ACTELION-A-US2018-175420,ACTELION,,78.0,YR,E,M,Y,30.8,KG,20180910.0,,OT,US,US,2018,Q3,Elderly
151604354,15160435,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?10 UNITS, Q6HRS",,,,U,,,,,,,QID,2018,Q3,Fluid overload,,2018,Q3,4,F,20180625.0,20180829.0,20180718,20180910,EXP,,US-ACTELION-A-US2018-175420,ACTELION,,78.0,YR,E,M,Y,30.8,KG,20180910.0,,OT,US,US,2018,Q3,Elderly
151604354,15160435,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?10 UNITS, Q6HRS",,,,U,,,,,,,QID,2018,Q3,Lethargy,,2018,Q3,4,F,20180625.0,20180829.0,20180718,20180910,EXP,,US-ACTELION-A-US2018-175420,ACTELION,,78.0,YR,E,M,Y,30.8,KG,20180910.0,,OT,US,US,2018,Q3,Elderly
151604354,15160435,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?10 UNITS, Q6HRS",,,,U,,,,,,,QID,2018,Q3,Lung carcinoma cell type unspecified recurrent,,2018,Q3,4,F,20180625.0,20180829.0,20180718,20180910,EXP,,US-ACTELION-A-US2018-175420,ACTELION,,78.0,YR,E,M,Y,30.8,KG,20180910.0,,OT,US,US,2018,Q3,Elderly
151604354,15160435,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?10 UNITS, Q6HRS",,,,U,,,,,,,QID,2018,Q3,Pneumonia,,2018,Q3,4,F,20180625.0,20180829.0,20180718,20180910,EXP,,US-ACTELION-A-US2018-175420,ACTELION,,78.0,YR,E,M,Y,30.8,KG,20180910.0,,OT,US,US,2018,Q3,Elderly
151604354,15160435,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?10 UNITS, Q6HRS",,,,U,,,,,,,QID,2018,Q3,Pulmonary hypertension,,2018,Q3,4,F,20180625.0,20180829.0,20180718,20180910,EXP,,US-ACTELION-A-US2018-175420,ACTELION,,78.0,YR,E,M,Y,30.8,KG,20180910.0,,OT,US,US,2018,Q3,Elderly
151604354,15160435,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?10 UNITS, Q6HRS",,,,U,,,,,,,QID,2018,Q3,Renal failure,,2018,Q3,4,F,20180625.0,20180829.0,20180718,20180910,EXP,,US-ACTELION-A-US2018-175420,ACTELION,,78.0,YR,E,M,Y,30.8,KG,20180910.0,,OT,US,US,2018,Q3,Elderly
151604354,15160435,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?10 UNITS, Q6HRS",,,,U,,,,,,,QID,2018,Q3,Respiratory acidosis,,2018,Q3,4,F,20180625.0,20180829.0,20180718,20180910,EXP,,US-ACTELION-A-US2018-175420,ACTELION,,78.0,YR,E,M,Y,30.8,KG,20180910.0,,OT,US,US,2018,Q3,Elderly
151604354,15160435,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?10 UNITS, Q6HRS",,,,U,,,,,,,QID,2018,Q3,Respiratory arrest,,2018,Q3,4,F,20180625.0,20180829.0,20180718,20180910,EXP,,US-ACTELION-A-US2018-175420,ACTELION,,78.0,YR,E,M,Y,30.8,KG,20180910.0,,OT,US,US,2018,Q3,Elderly
151604354,15160435,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?10 UNITS, Q6HRS",,,,U,,,,,,,QID,2018,Q3,Respiratory failure,,2018,Q3,4,F,20180625.0,20180829.0,20180718,20180910,EXP,,US-ACTELION-A-US2018-175420,ACTELION,,78.0,YR,E,M,Y,30.8,KG,20180910.0,,OT,US,US,2018,Q3,Elderly
151638981,15163898,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,7IU BEFORE LUNCH AND 8IU BEFORE DINNER,,,D,,,,,,,,,2018,Q3,Caesarean section,,2018,Q3,1,I,,20180709.0,20180719,20180719,EXP,,IT-TEVA-2018-IT-926298,TEVA,"FORMOSO G, GINESTRA F, DI DALMAZI G, CONSOLI A. EMPAGLIFLOZIN, METFORMIN AND INSULIN DEGLUDEC, DURING PREGNANCY: A CASE REPORT. ACTA?DIABETOL 2018?55(7):759?761.",31.0,YR,,F,Y,98.0,KG,20180719.0,,OT,IT,IT,2018,Q3,Young Adult
151638981,15163898,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,7IU BEFORE LUNCH AND 8IU BEFORE DINNER,,,D,,,,,,,,,2018,Q3,Maternal exposure during pregnancy,,2018,Q3,1,I,,20180709.0,20180719,20180719,EXP,,IT-TEVA-2018-IT-926298,TEVA,"FORMOSO G, GINESTRA F, DI DALMAZI G, CONSOLI A. EMPAGLIFLOZIN, METFORMIN AND INSULIN DEGLUDEC, DURING PREGNANCY: A CASE REPORT. ACTA?DIABETOL 2018?55(7):759?761.",31.0,YR,,F,Y,98.0,KG,20180719.0,,OT,IT,IT,2018,Q3,Young Adult
151638981,15163898,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,7IU BEFORE LUNCH AND 8IU BEFORE DINNER,,,D,,,,,,,,,2018,Q3,Normal newborn,,2018,Q3,1,I,,20180709.0,20180719,20180719,EXP,,IT-TEVA-2018-IT-926298,TEVA,"FORMOSO G, GINESTRA F, DI DALMAZI G, CONSOLI A. EMPAGLIFLOZIN, METFORMIN AND INSULIN DEGLUDEC, DURING PREGNANCY: A CASE REPORT. ACTA?DIABETOL 2018?55(7):759?761.",31.0,YR,,F,Y,98.0,KG,20180719.0,,OT,IT,IT,2018,Q3,Young Adult
151638981,15163898,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,7IU BEFORE LUNCH AND 8IU BEFORE DINNER,,,D,,,,,,,,,2018,Q3,Off label use,,2018,Q3,1,I,,20180709.0,20180719,20180719,EXP,,IT-TEVA-2018-IT-926298,TEVA,"FORMOSO G, GINESTRA F, DI DALMAZI G, CONSOLI A. EMPAGLIFLOZIN, METFORMIN AND INSULIN DEGLUDEC, DURING PREGNANCY: A CASE REPORT. ACTA?DIABETOL 2018?55(7):759?761.",31.0,YR,,F,Y,98.0,KG,20180719.0,,OT,IT,IT,2018,Q3,Young Adult
151638981,15163898,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,7IU BEFORE LUNCH AND 8IU BEFORE DINNER,,,D,,,,,,,,,2018,Q3,Pregnancy,,2018,Q3,1,I,,20180709.0,20180719,20180719,EXP,,IT-TEVA-2018-IT-926298,TEVA,"FORMOSO G, GINESTRA F, DI DALMAZI G, CONSOLI A. EMPAGLIFLOZIN, METFORMIN AND INSULIN DEGLUDEC, DURING PREGNANCY: A CASE REPORT. ACTA?DIABETOL 2018?55(7):759?761.",31.0,YR,,F,Y,98.0,KG,20180719.0,,OT,IT,IT,2018,Q3,Young Adult
151638981,15163898,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,32 IU BEFORE LUNCH AND 34 IU BEFORE DINNER,,,D,,,,,,,,,2018,Q3,Caesarean section,,2018,Q3,1,I,,20180709.0,20180719,20180719,EXP,,IT-TEVA-2018-IT-926298,TEVA,"FORMOSO G, GINESTRA F, DI DALMAZI G, CONSOLI A. EMPAGLIFLOZIN, METFORMIN AND INSULIN DEGLUDEC, DURING PREGNANCY: A CASE REPORT. ACTA?DIABETOL 2018?55(7):759?761.",31.0,YR,,F,Y,98.0,KG,20180719.0,,OT,IT,IT,2018,Q3,Young Adult
151638981,15163898,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,32 IU BEFORE LUNCH AND 34 IU BEFORE DINNER,,,D,,,,,,,,,2018,Q3,Maternal exposure during pregnancy,,2018,Q3,1,I,,20180709.0,20180719,20180719,EXP,,IT-TEVA-2018-IT-926298,TEVA,"FORMOSO G, GINESTRA F, DI DALMAZI G, CONSOLI A. EMPAGLIFLOZIN, METFORMIN AND INSULIN DEGLUDEC, DURING PREGNANCY: A CASE REPORT. ACTA?DIABETOL 2018?55(7):759?761.",31.0,YR,,F,Y,98.0,KG,20180719.0,,OT,IT,IT,2018,Q3,Young Adult
151638981,15163898,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,32 IU BEFORE LUNCH AND 34 IU BEFORE DINNER,,,D,,,,,,,,,2018,Q3,Normal newborn,,2018,Q3,1,I,,20180709.0,20180719,20180719,EXP,,IT-TEVA-2018-IT-926298,TEVA,"FORMOSO G, GINESTRA F, DI DALMAZI G, CONSOLI A. EMPAGLIFLOZIN, METFORMIN AND INSULIN DEGLUDEC, DURING PREGNANCY: A CASE REPORT. ACTA?DIABETOL 2018?55(7):759?761.",31.0,YR,,F,Y,98.0,KG,20180719.0,,OT,IT,IT,2018,Q3,Young Adult
151638981,15163898,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,32 IU BEFORE LUNCH AND 34 IU BEFORE DINNER,,,D,,,,,,,,,2018,Q3,Off label use,,2018,Q3,1,I,,20180709.0,20180719,20180719,EXP,,IT-TEVA-2018-IT-926298,TEVA,"FORMOSO G, GINESTRA F, DI DALMAZI G, CONSOLI A. EMPAGLIFLOZIN, METFORMIN AND INSULIN DEGLUDEC, DURING PREGNANCY: A CASE REPORT. ACTA?DIABETOL 2018?55(7):759?761.",31.0,YR,,F,Y,98.0,KG,20180719.0,,OT,IT,IT,2018,Q3,Young Adult
151638981,15163898,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,32 IU BEFORE LUNCH AND 34 IU BEFORE DINNER,,,D,,,,,,,,,2018,Q3,Pregnancy,,2018,Q3,1,I,,20180709.0,20180719,20180719,EXP,,IT-TEVA-2018-IT-926298,TEVA,"FORMOSO G, GINESTRA F, DI DALMAZI G, CONSOLI A. EMPAGLIFLOZIN, METFORMIN AND INSULIN DEGLUDEC, DURING PREGNANCY: A CASE REPORT. ACTA?DIABETOL 2018?55(7):759?761.",31.0,YR,,F,Y,98.0,KG,20180719.0,,OT,IT,IT,2018,Q3,Young Adult
151655211,15165521,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNKNOWN,,,,,,,209196.0,,,,,2018,Q3,Polyneuropathy,,2018,Q3,1,I,,20180705.0,20180719,20180719,EXP,,DE-SA-2018SA185598,SANOFI AVENTIS,,35.0,YR,A,M,Y,,,20180719.0,,PH,DE,DE,2018,Q3,Adult
151671032,15167103,2,SS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"20 DF, DAILY",,,,,,,,20.0,DF,,QD,2018,Q3,Hypoglycaemia,,2018,Q3,2,F,20180301.0,20180718.0,20180719,20180726,EXP,IT-MINISAL02-470740,IT-ELI_LILLY_AND_COMPANY-IT201807005981,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20180726.0,,CN,IT,IT,2018,Q3,Elderly
151671032,15167103,2,SS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"20 DF, DAILY",,,,,,,,20.0,DF,,QD,2018,Q3,Loss of consciousness,,2018,Q3,2,F,20180301.0,20180718.0,20180719,20180726,EXP,IT-MINISAL02-470740,IT-ELI_LILLY_AND_COMPANY-IT201807005981,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20180726.0,,CN,IT,IT,2018,Q3,Elderly
151671032,15167103,2,SS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"20 DF, DAILY",,,,,,,,20.0,DF,,QD,2018,Q3,Nausea,,2018,Q3,2,F,20180301.0,20180718.0,20180719,20180726,EXP,IT-MINISAL02-470740,IT-ELI_LILLY_AND_COMPANY-IT201807005981,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20180726.0,,CN,IT,IT,2018,Q3,Elderly
151671032,15167103,2,SS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"20 DF, DAILY",,,,,,,,20.0,DF,,QD,2018,Q3,Orthostatic hypotension,,2018,Q3,2,F,20180301.0,20180718.0,20180719,20180726,EXP,IT-MINISAL02-470740,IT-ELI_LILLY_AND_COMPANY-IT201807005981,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20180726.0,,CN,IT,IT,2018,Q3,Elderly
151671032,15167103,2,SS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"20 DF, DAILY",,,,,,,,20.0,DF,,QD,2018,Q3,Vomiting,,2018,Q3,2,F,20180301.0,20180718.0,20180719,20180726,EXP,IT-MINISAL02-470740,IT-ELI_LILLY_AND_COMPANY-IT201807005981,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20180726.0,,CN,IT,IT,2018,Q3,Elderly
151679061,15167906,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,NACH SCHEMA,,,D,,,,,,,,,2018,Q3,Contraindicated product administered,,2018,Q3,1,I,,20180709.0,20180719,20180719,EXP,,DE-MYLANLABS-2018M1052282,MYLAN,,68.0,YR,,M,Y,,,20180719.0,,PH,DE,DE,2018,Q3,Elderly
151679061,15167906,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,NACH SCHEMA,,,D,,,,,,,,,2018,Q3,Dyspnoea,,2018,Q3,1,I,,20180709.0,20180719,20180719,EXP,,DE-MYLANLABS-2018M1052282,MYLAN,,68.0,YR,,M,Y,,,20180719.0,,PH,DE,DE,2018,Q3,Elderly
151679061,15167906,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,NACH SCHEMA,,,D,,,,,,,,,2018,Q3,Oedema peripheral,,2018,Q3,1,I,,20180709.0,20180719,20180719,EXP,,DE-MYLANLABS-2018M1052282,MYLAN,,68.0,YR,,M,Y,,,20180719.0,,PH,DE,DE,2018,Q3,Elderly
151724692,15172469,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2018,Q3,Fatigue,,2018,Q3,2,F,,20180714.0,20180720,20180720,EXP,,PHHY2018DE048941,NOVARTIS,,56.0,YR,,M,Y,,,20180720.0,,OT,DE,DE,2018,Q3,Adult
151724692,15172469,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2018,Q3,General physical health deterioration,,2018,Q3,2,F,,20180714.0,20180720,20180720,EXP,,PHHY2018DE048941,NOVARTIS,,56.0,YR,,M,Y,,,20180720.0,,OT,DE,DE,2018,Q3,Adult
151724692,15172469,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2018,Q3,Nausea,,2018,Q3,2,F,,20180714.0,20180720,20180720,EXP,,PHHY2018DE048941,NOVARTIS,,56.0,YR,,M,Y,,,20180720.0,,OT,DE,DE,2018,Q3,Adult
151781271,15178127,3,C,INSULINE LISPRO,,2,Unknown,UNK,,,,, UNK,,,,,SOLUTION FOR INJECTION,,2018,Q3,Joint swelling,,2018,Q3,1,I,20180621.0,20180706.0,20180721,20180721,EXP,,NL-AUROBINDO-AUR-APL-2018-036588,AUROBINDO,,49.0,YR,,F,Y,,,20180721.0,,MD,NL,NL,2018,Q3,Adult
151781271,15178127,3,C,INSULINE LISPRO,,2,Unknown,UNK,,,,, UNK,,,,,SOLUTION FOR INJECTION,,2018,Q3,Mobility decreased,,2018,Q3,1,I,20180621.0,20180706.0,20180721,20180721,EXP,,NL-AUROBINDO-AUR-APL-2018-036588,AUROBINDO,,49.0,YR,,F,Y,,,20180721.0,,MD,NL,NL,2018,Q3,Adult
151781271,15178127,3,C,INSULINE LISPRO,,2,Unknown,UNK,,,,, UNK,,,,,SOLUTION FOR INJECTION,,2018,Q3,Pruritus,,2018,Q3,1,I,20180621.0,20180706.0,20180721,20180721,EXP,,NL-AUROBINDO-AUR-APL-2018-036588,AUROBINDO,,49.0,YR,,F,Y,,,20180721.0,,MD,NL,NL,2018,Q3,Adult
151781271,15178127,3,C,INSULINE LISPRO,,2,Unknown,UNK,,,,, UNK,,,,,SOLUTION FOR INJECTION,,2018,Q3,Urticaria,,2018,Q3,1,I,20180621.0,20180706.0,20180721,20180721,EXP,,NL-AUROBINDO-AUR-APL-2018-036588,AUROBINDO,,49.0,YR,,F,Y,,,20180721.0,,MD,NL,NL,2018,Q3,Adult
151832301,15183230,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK NK IE, NACH BZ",,,U,,,,,,,,,2018,Q3,Anaemia,,2018,Q3,1,I,,20180714.0,20180723,20180723,EXP,,PHHY2018DE052104,SANDOZ,,77.0,YR,,M,Y,,,20180723.0,,OT,DE,DE,2018,Q3,Elderly
151832301,15183230,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK NK IE, NACH BZ",,,U,,,,,,,,,2018,Q3,Dyspnoea,,2018,Q3,1,I,,20180714.0,20180723,20180723,EXP,,PHHY2018DE052104,SANDOZ,,77.0,YR,,M,Y,,,20180723.0,,OT,DE,DE,2018,Q3,Elderly
151832301,15183230,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK NK IE, NACH BZ",,,U,,,,,,,,,2018,Q3,Haematochezia,,2018,Q3,1,I,,20180714.0,20180723,20180723,EXP,,PHHY2018DE052104,SANDOZ,,77.0,YR,,M,Y,,,20180723.0,,OT,DE,DE,2018,Q3,Elderly
151847641,15184764,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"NK IE, NACH BZ",,,U,,,,,,,,,2018,Q3,Cardiac failure,,2018,Q3,1,I,,20180714.0,20180723,20180723,EXP,,PHHY2018DE052035,SANDOZ,,77.0,YR,,M,Y,,,20180723.0,,OT,DE,DE,2018,Q3,Elderly
151847641,15184764,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"NK IE, NACH BZ",,,U,,,,,,,,,2018,Q3,Dyspnoea,,2018,Q3,1,I,,20180714.0,20180723,20180723,EXP,,PHHY2018DE052035,SANDOZ,,77.0,YR,,M,Y,,,20180723.0,,OT,DE,DE,2018,Q3,Elderly
151869831,15186983,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Fatigue,,2018,Q3,1,I,20171127.0,20171218.0,20180723,20180723,PER,,US-EXELIXIS-CABO-17011764,EXELIXIS,,63.0,YR,,F,Y,,,20180723.0,,OT,US,US,2018,Q3,Adult
151910712,15191071,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),22 IU (3 DAY),,,Y,, UNKNOWN,,,22.0,IU,,,2018,Q3,Focal dyscognitive seizures,,2018,Q3,2,F,20160427.0,20180718.0,20180724,20180805,EXP,,PHHY2016DE187012,SANDOZ,,74.0,YR,,F,Y,106.0,KG,20180805.0,,OT,DE,DE,2018,Q3,Elderly
151910712,15191071,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),22 IU (3 DAY),,,Y,, UNKNOWN,,,22.0,IU,,,2018,Q3,Product use in unapproved indication,,2018,Q3,2,F,20160427.0,20180718.0,20180724,20180805,EXP,,PHHY2016DE187012,SANDOZ,,74.0,YR,,F,Y,106.0,KG,20180805.0,,OT,DE,DE,2018,Q3,Elderly
151910712,15191071,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"67 IU, UNK",,,Y,, UNKNOWN,,,67.0,IU,,,2018,Q3,Focal dyscognitive seizures,,2018,Q3,2,F,20160427.0,20180718.0,20180724,20180805,EXP,,PHHY2016DE187012,SANDOZ,,74.0,YR,,F,Y,106.0,KG,20180805.0,,OT,DE,DE,2018,Q3,Elderly
151910712,15191071,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"67 IU, UNK",,,Y,, UNKNOWN,,,67.0,IU,,,2018,Q3,Product use in unapproved indication,,2018,Q3,2,F,20160427.0,20180718.0,20180724,20180805,EXP,,PHHY2016DE187012,SANDOZ,,74.0,YR,,F,Y,106.0,KG,20180805.0,,OT,DE,DE,2018,Q3,Elderly
151919551,15191955,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,UNK,,,U,U, UNKNOWN,,,,,,,2018,Q3,Foetal disorder,,2018,Q3,1,I,,20180713.0,20180724,20180724,EXP,FR-EMA-DD-20180712-SAMEERHPDD-190831,FR-NOVOPROD-611557,NOVO NORDISK,,1.0,DY,N,,Y,1.89,KG,20180724.0,,PH,FR,FR,2018,Q3,Child
151919551,15191955,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,UNK,,,U,U, UNKNOWN,,,,,,,2018,Q3,Foetal exposure during pregnancy,,2018,Q3,1,I,,20180713.0,20180724,20180724,EXP,FR-EMA-DD-20180712-SAMEERHPDD-190831,FR-NOVOPROD-611557,NOVO NORDISK,,1.0,DY,N,,Y,1.89,KG,20180724.0,,PH,FR,FR,2018,Q3,Child
151919551,15191955,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,UNK,,,U,U, UNKNOWN,,,,,,,2018,Q3,Low birth weight baby,,2018,Q3,1,I,,20180713.0,20180724,20180724,EXP,FR-EMA-DD-20180712-SAMEERHPDD-190831,FR-NOVOPROD-611557,NOVO NORDISK,,1.0,DY,N,,Y,1.89,KG,20180724.0,,PH,FR,FR,2018,Q3,Child
151919551,15191955,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,UNK,,,U,U, UNKNOWN,,,,,,,2018,Q3,Premature baby,,2018,Q3,1,I,,20180713.0,20180724,20180724,EXP,FR-EMA-DD-20180712-SAMEERHPDD-190831,FR-NOVOPROD-611557,NOVO NORDISK,,1.0,DY,N,,Y,1.89,KG,20180724.0,,PH,FR,FR,2018,Q3,Child
151919771,15191977,1,PS,Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2018,Q3,Arrhythmia,,2018,Q3,1,I,2016.0,20180718.0,20180724,20180724,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201807008935,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20180724.0,,CN,CN,CN,2018,Q3,Adult
151919771,15191977,1,PS,Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2018,Q3,Blood glucose abnormal,,2018,Q3,1,I,2016.0,20180718.0,20180724,20180724,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201807008935,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20180724.0,,CN,CN,CN,2018,Q3,Adult
151919771,15191977,1,PS,Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2018,Q3,Incorrect dose administered,,2018,Q3,1,I,2016.0,20180718.0,20180724,20180724,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201807008935,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20180724.0,,CN,CN,CN,2018,Q3,Adult
151949861,15194986,7,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, QD",,,,,,,21081.0,,,SOLUTION FOR INJECTION,QD,2018,Q3,Accidental overdose,,2018,Q3,1,I,20170827.0,20180714.0,20180725,20180725,PER,,US-SA-2018SA195335,SANOFI AVENTIS,,16.0,YR,T,M,Y,,,20180725.0,,MD,US,US,2018,Q3,Youth
151949861,15194986,8,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, QD",,,,,,,21081.0,,,SOLUTION FOR INJECTION,QD,2018,Q3,Accidental overdose,,2018,Q3,1,I,20170827.0,20180714.0,20180725,20180725,PER,,US-SA-2018SA195335,SANOFI AVENTIS,,16.0,YR,T,M,Y,,,20180725.0,,MD,US,US,2018,Q3,Youth
152008231,15200823,2,I,INSULINA LISPRO,INSULIN LISPRO,1,Subcutaneous,1?1?1,,,Y,U,,,,,,,,2018,Q3,Hypoglycaemia,,2018,Q3,1,I,20171122.0,20180712.0,20180726,20180726,EXP,ES-AEMPS-374469,ES-AUROBINDO-AUR-APL-2018-037156,AUROBINDO,,73.0,YR,,M,Y,,,20180726.0,,MD,ES,ES,2018,Q3,Elderly
152023322,15202332,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,UNSPECIFIED,,2018,Q3,Arthralgia,,2018,Q3,2,F,20180511.0,20180727.0,20180726,20180731,EXP,,US-JNJFOC-20180728138,JANSSEN,,62.0,YR,A,F,Y,92.4,KG,20180731.0,,OT,US,US,2018,Q3,Adult
152023322,15202332,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,UNSPECIFIED,,2018,Q3,Headache,,2018,Q3,2,F,20180511.0,20180727.0,20180726,20180731,EXP,,US-JNJFOC-20180728138,JANSSEN,,62.0,YR,A,F,Y,92.4,KG,20180731.0,,OT,US,US,2018,Q3,Adult
152023322,15202332,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,UNSPECIFIED,,2018,Q3,Myalgia,,2018,Q3,2,F,20180511.0,20180727.0,20180726,20180731,EXP,,US-JNJFOC-20180728138,JANSSEN,,62.0,YR,A,F,Y,92.4,KG,20180731.0,,OT,US,US,2018,Q3,Adult
152023322,15202332,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,UNSPECIFIED,,2018,Q3,Nausea,,2018,Q3,2,F,20180511.0,20180727.0,20180726,20180731,EXP,,US-JNJFOC-20180728138,JANSSEN,,62.0,YR,A,F,Y,92.4,KG,20180731.0,,OT,US,US,2018,Q3,Adult
152023322,15202332,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,UNSPECIFIED,,2018,Q3,Pyrexia,,2018,Q3,2,F,20180511.0,20180727.0,20180726,20180731,EXP,,US-JNJFOC-20180728138,JANSSEN,,62.0,YR,A,F,Y,92.4,KG,20180731.0,,OT,US,US,2018,Q3,Adult
152023322,15202332,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,UNSPECIFIED,,2018,Q3,Rash erythematous,,2018,Q3,2,F,20180511.0,20180727.0,20180726,20180731,EXP,,US-JNJFOC-20180728138,JANSSEN,,62.0,YR,A,F,Y,92.4,KG,20180731.0,,OT,US,US,2018,Q3,Adult
152029812,15202981,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,7 MCG/M2,,,U,,,,,,,UNKNOWN,QD,2018,Q3,Foetal disorder,,2018,Q3,2,F,20170914.0,20180918.0,20180726,20180926,EXP,,FR-FRESENIUS KABI-FK201808071,FRESENIUS KABI,,1.0,DY,,,Y,1.89,KG,20180926.0,,OT,GB,FR,2018,Q3,Child
152029812,15202981,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,7 MCG/M2,,,U,,,,,,,UNKNOWN,QD,2018,Q3,Foetal exposure during pregnancy,,2018,Q3,2,F,20170914.0,20180918.0,20180726,20180926,EXP,,FR-FRESENIUS KABI-FK201808071,FRESENIUS KABI,,1.0,DY,,,Y,1.89,KG,20180926.0,,OT,GB,FR,2018,Q3,Child
152029812,15202981,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,7 MCG/M2,,,U,,,,,,,UNKNOWN,QD,2018,Q3,Low birth weight baby,,2018,Q3,2,F,20170914.0,20180918.0,20180726,20180926,EXP,,FR-FRESENIUS KABI-FK201808071,FRESENIUS KABI,,1.0,DY,,,Y,1.89,KG,20180926.0,,OT,GB,FR,2018,Q3,Child
152029812,15202981,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,7 MCG/M2,,,U,,,,,,,UNKNOWN,QD,2018,Q3,Premature baby,,2018,Q3,2,F,20170914.0,20180918.0,20180726,20180926,EXP,,FR-FRESENIUS KABI-FK201808071,FRESENIUS KABI,,1.0,DY,,,Y,1.89,KG,20180926.0,,OT,GB,FR,2018,Q3,Child
152030921,15203092,8,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,QD",,,,,,,21081.0,,,SOLUTION FOR INJECTION,QD,2018,Q3,Appendicitis,,2018,Q3,1,I,20171230.0,20171231.0,20180726,20180726,EXP,,BG-SA-2018SA002045,SANOFI AVENTIS,,16.0,YR,T,M,Y,51.0,KG,20180726.0,,MD,BG,BG,2018,Q3,Youth
152030921,15203092,9,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,QD",,,,,,,21081.0,,,SOLUTION FOR INJECTION,QD,2018,Q3,Appendicitis,,2018,Q3,1,I,20171230.0,20171231.0,20180726,20180726,EXP,,BG-SA-2018SA002045,SANOFI AVENTIS,,16.0,YR,T,M,Y,51.0,KG,20180726.0,,MD,BG,BG,2018,Q3,Youth
152030921,15203092,18,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,PRN",,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q3,Appendicitis,,2018,Q3,1,I,20171230.0,20171231.0,20180726,20180726,EXP,,BG-SA-2018SA002045,SANOFI AVENTIS,,16.0,YR,T,M,Y,51.0,KG,20180726.0,,MD,BG,BG,2018,Q3,Youth
152030921,15203092,19,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,PRN",,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q3,Appendicitis,,2018,Q3,1,I,20171230.0,20171231.0,20180726,20180726,EXP,,BG-SA-2018SA002045,SANOFI AVENTIS,,16.0,YR,T,M,Y,51.0,KG,20180726.0,,MD,BG,BG,2018,Q3,Youth
152043271,15204327,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 DF, QD",120.0,DF,N,,,,,4.0,DF,INJECTION,QD,2018,Q3,Mental status changes,,2018,Q3,1,I,20171027.0,20171109.0,20180726,20180726,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-101982,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,107.9,KG,20180726.0,,OT,US,US,2018,Q3,Elderly
152045093,15204509,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO BLOOD GLUCOSE, INJECTION / INFUSION SOLUTION",,,D,,,,,,,SOLUTION FOR INJECTION,,2018,Q3,Acute kidney injury,,2018,Q3,3,F,,20180911.0,20180726,20180918,EXP,,DE-MYLANLABS-2018M1055198,MYLAN,,67.0,YR,,F,Y,83.0,KG,20180918.0,,MD,DE,DE,2018,Q3,Elderly
152045093,15204509,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO BLOOD GLUCOSE, INJECTION / INFUSION SOLUTION",,,D,,,,,,,SOLUTION FOR INJECTION,,2018,Q3,General physical health deterioration,,2018,Q3,3,F,,20180911.0,20180726,20180918,EXP,,DE-MYLANLABS-2018M1055198,MYLAN,,67.0,YR,,F,Y,83.0,KG,20180918.0,,MD,DE,DE,2018,Q3,Elderly
152045093,15204509,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO BLOOD GLUCOSE, INJECTION / INFUSION SOLUTION",,,D,,,,,,,SOLUTION FOR INJECTION,,2018,Q3,Renal impairment,,2018,Q3,3,F,,20180911.0,20180726,20180918,EXP,,DE-MYLANLABS-2018M1055198,MYLAN,,67.0,YR,,F,Y,83.0,KG,20180918.0,,MD,DE,DE,2018,Q3,Elderly
152067544,15206754,9,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"8?10 U, EACH MORNING",,,,,,,,,,,QD,2018,Q3,Blood glucose decreased,,2018,Q3,4,F,20180822.0,20180916.0,20180727,20180928,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201807009613,ELI LILLY AND CO,,65.0,YR,,F,Y,70.0,KG,20180928.0,,CN,CN,CN,2018,Q3,Elderly
152067544,15206754,9,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"8?10 U, EACH MORNING",,,,,,,,,,,QD,2018,Q3,Blood glucose increased,,2018,Q3,4,F,20180822.0,20180916.0,20180727,20180928,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201807009613,ELI LILLY AND CO,,65.0,YR,,F,Y,70.0,KG,20180928.0,,CN,CN,CN,2018,Q3,Elderly
152067544,15206754,9,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"8?10 U, EACH MORNING",,,,,,,,,,,QD,2018,Q3,Dizziness,,2018,Q3,4,F,20180822.0,20180916.0,20180727,20180928,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201807009613,ELI LILLY AND CO,,65.0,YR,,F,Y,70.0,KG,20180928.0,,CN,CN,CN,2018,Q3,Elderly
152067544,15206754,10,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, DAILY AT NOON",,,,,,,,10.0,IU,,QD,2018,Q3,Blood glucose decreased,,2018,Q3,4,F,20180822.0,20180916.0,20180727,20180928,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201807009613,ELI LILLY AND CO,,65.0,YR,,F,Y,70.0,KG,20180928.0,,CN,CN,CN,2018,Q3,Elderly
152067544,15206754,10,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, DAILY AT NOON",,,,,,,,10.0,IU,,QD,2018,Q3,Blood glucose increased,,2018,Q3,4,F,20180822.0,20180916.0,20180727,20180928,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201807009613,ELI LILLY AND CO,,65.0,YR,,F,Y,70.0,KG,20180928.0,,CN,CN,CN,2018,Q3,Elderly
152067544,15206754,10,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, DAILY AT NOON",,,,,,,,10.0,IU,,QD,2018,Q3,Dizziness,,2018,Q3,4,F,20180822.0,20180916.0,20180727,20180928,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201807009613,ELI LILLY AND CO,,65.0,YR,,F,Y,70.0,KG,20180928.0,,CN,CN,CN,2018,Q3,Elderly
152067544,15206754,11,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, DAILY AT NIGHT",,,,,,,,10.0,IU,,QD,2018,Q3,Blood glucose decreased,,2018,Q3,4,F,20180822.0,20180916.0,20180727,20180928,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201807009613,ELI LILLY AND CO,,65.0,YR,,F,Y,70.0,KG,20180928.0,,CN,CN,CN,2018,Q3,Elderly
152067544,15206754,11,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, DAILY AT NIGHT",,,,,,,,10.0,IU,,QD,2018,Q3,Blood glucose increased,,2018,Q3,4,F,20180822.0,20180916.0,20180727,20180928,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201807009613,ELI LILLY AND CO,,65.0,YR,,F,Y,70.0,KG,20180928.0,,CN,CN,CN,2018,Q3,Elderly
152067544,15206754,11,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, DAILY AT NIGHT",,,,,,,,10.0,IU,,QD,2018,Q3,Dizziness,,2018,Q3,4,F,20180822.0,20180916.0,20180727,20180928,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201807009613,ELI LILLY AND CO,,65.0,YR,,F,Y,70.0,KG,20180928.0,,CN,CN,CN,2018,Q3,Elderly
152134571,15213457,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,Y,,,,209196.0,22.0,IU,,QD,2018,Q3,Syncope,,2018,Q3,1,I,20180702.0,20180724.0,20180730,20180730,EXP,IT-MINISAL02-489330,IT-SA-2018SA204775,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20180730.0,,PH,IT,IT,2018,Q3,Elderly
152150201,15215020,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27 IU, DAILY",,,Y,,,,209196.0,27.0,IU,,QD,2018,Q3,Abdominal pain,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27 IU, DAILY",,,Y,,,,209196.0,27.0,IU,,QD,2018,Q3,Dizziness,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27 IU, DAILY",,,Y,,,,209196.0,27.0,IU,,QD,2018,Q3,Foetal movement disorder,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27 IU, DAILY",,,Y,,,,209196.0,27.0,IU,,QD,2018,Q3,Headache,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27 IU, DAILY",,,Y,,,,209196.0,27.0,IU,,QD,2018,Q3,Hypertension,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27 IU, DAILY",,,Y,,,,209196.0,27.0,IU,,QD,2018,Q3,Hypoglycaemic coma,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27 IU, DAILY",,,Y,,,,209196.0,27.0,IU,,QD,2018,Q3,Hypoglycaemic seizure,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27 IU, DAILY",,,Y,,,,209196.0,27.0,IU,,QD,2018,Q3,Maternal exposure during breast feeding,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27 IU, DAILY",,,Y,,,,209196.0,27.0,IU,,QD,2018,Q3,Maternal exposure during pregnancy,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27 IU, DAILY",,,Y,,,,209196.0,27.0,IU,,QD,2018,Q3,Nausea,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27 IU, DAILY",,,Y,,,,209196.0,27.0,IU,,QD,2018,Q3,Neuritis,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27 IU, DAILY",,,Y,,,,209196.0,27.0,IU,,QD,2018,Q3,Oedema peripheral,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27 IU, DAILY",,,Y,,,,209196.0,27.0,IU,,QD,2018,Q3,Vaginal haemorrhage,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27.4 IU, QD",,,Y,,,,209196.0,27.4,IU,,QD,2018,Q3,Abdominal pain,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27.4 IU, QD",,,Y,,,,209196.0,27.4,IU,,QD,2018,Q3,Dizziness,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27.4 IU, QD",,,Y,,,,209196.0,27.4,IU,,QD,2018,Q3,Foetal movement disorder,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27.4 IU, QD",,,Y,,,,209196.0,27.4,IU,,QD,2018,Q3,Headache,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27.4 IU, QD",,,Y,,,,209196.0,27.4,IU,,QD,2018,Q3,Hypertension,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27.4 IU, QD",,,Y,,,,209196.0,27.4,IU,,QD,2018,Q3,Hypoglycaemic coma,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27.4 IU, QD",,,Y,,,,209196.0,27.4,IU,,QD,2018,Q3,Hypoglycaemic seizure,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27.4 IU, QD",,,Y,,,,209196.0,27.4,IU,,QD,2018,Q3,Maternal exposure during breast feeding,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27.4 IU, QD",,,Y,,,,209196.0,27.4,IU,,QD,2018,Q3,Maternal exposure during pregnancy,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27.4 IU, QD",,,Y,,,,209196.0,27.4,IU,,QD,2018,Q3,Nausea,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27.4 IU, QD",,,Y,,,,209196.0,27.4,IU,,QD,2018,Q3,Neuritis,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27.4 IU, QD",,,Y,,,,209196.0,27.4,IU,,QD,2018,Q3,Oedema peripheral,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27.4 IU, QD",,,Y,,,,209196.0,27.4,IU,,QD,2018,Q3,Vaginal haemorrhage,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,25.8 UNK,,,Y,,,,209196.0,25.8,IU,,QD,2018,Q3,Abdominal pain,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,25.8 UNK,,,Y,,,,209196.0,25.8,IU,,QD,2018,Q3,Dizziness,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,25.8 UNK,,,Y,,,,209196.0,25.8,IU,,QD,2018,Q3,Foetal movement disorder,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,25.8 UNK,,,Y,,,,209196.0,25.8,IU,,QD,2018,Q3,Headache,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,25.8 UNK,,,Y,,,,209196.0,25.8,IU,,QD,2018,Q3,Hypertension,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,25.8 UNK,,,Y,,,,209196.0,25.8,IU,,QD,2018,Q3,Hypoglycaemic coma,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,25.8 UNK,,,Y,,,,209196.0,25.8,IU,,QD,2018,Q3,Hypoglycaemic seizure,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,25.8 UNK,,,Y,,,,209196.0,25.8,IU,,QD,2018,Q3,Maternal exposure during breast feeding,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,25.8 UNK,,,Y,,,,209196.0,25.8,IU,,QD,2018,Q3,Maternal exposure during pregnancy,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,25.8 UNK,,,Y,,,,209196.0,25.8,IU,,QD,2018,Q3,Nausea,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,25.8 UNK,,,Y,,,,209196.0,25.8,IU,,QD,2018,Q3,Neuritis,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,25.8 UNK,,,Y,,,,209196.0,25.8,IU,,QD,2018,Q3,Oedema peripheral,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,25.8 UNK,,,Y,,,,209196.0,25.8,IU,,QD,2018,Q3,Vaginal haemorrhage,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,70.8 UNK,,,Y,,,,209196.0,70.8,IU,,QD,2018,Q3,Abdominal pain,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,70.8 UNK,,,Y,,,,209196.0,70.8,IU,,QD,2018,Q3,Dizziness,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,70.8 UNK,,,Y,,,,209196.0,70.8,IU,,QD,2018,Q3,Foetal movement disorder,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,70.8 UNK,,,Y,,,,209196.0,70.8,IU,,QD,2018,Q3,Headache,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,70.8 UNK,,,Y,,,,209196.0,70.8,IU,,QD,2018,Q3,Hypertension,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,70.8 UNK,,,Y,,,,209196.0,70.8,IU,,QD,2018,Q3,Hypoglycaemic coma,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,70.8 UNK,,,Y,,,,209196.0,70.8,IU,,QD,2018,Q3,Hypoglycaemic seizure,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,70.8 UNK,,,Y,,,,209196.0,70.8,IU,,QD,2018,Q3,Maternal exposure during breast feeding,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,70.8 UNK,,,Y,,,,209196.0,70.8,IU,,QD,2018,Q3,Maternal exposure during pregnancy,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,70.8 UNK,,,Y,,,,209196.0,70.8,IU,,QD,2018,Q3,Nausea,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,70.8 UNK,,,Y,,,,209196.0,70.8,IU,,QD,2018,Q3,Neuritis,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,70.8 UNK,,,Y,,,,209196.0,70.8,IU,,QD,2018,Q3,Oedema peripheral,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152150201,15215020,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,70.8 UNK,,,Y,,,,209196.0,70.8,IU,,QD,2018,Q3,Vaginal haemorrhage,,2018,Q3,1,I,20161216.0,20180716.0,20180730,20180730,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20180730.0,,CN,DK,NL,2018,Q3,Adult
152174841,15217484,3,C,Insulin human lispro,,2,,,,,,,,,,,,,,2018,Q3,Status epilepticus,,2018,Q3,1,I,20180302.0,,20180704,20180704,DIR,,,FDA-CTU,,61.0,YR,,F,N,58.7,KG,20180704.0,N,PH,US,US,2018,Q3,Adult
152194571,15219457,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,25.0IU UNKNOWN,,,,,,,,25.0,IU,,,2018,Q3,Glomerular filtration rate decreased,,2018,Q3,1,I,20180615.0,20180710.0,20180731,20180731,PER,,US-ASTRAZENECA-2018SE90031,ASTRAZENECA,,65.0,YR,,M,Y,,,20180731.0,,MD,US,US,2018,Q3,Elderly
152194571,15219457,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,25.0IU UNKNOWN,,,,,,,,25.0,IU,,,2018,Q3,Hypertension,,2018,Q3,1,I,20180615.0,20180710.0,20180731,20180731,PER,,US-ASTRAZENECA-2018SE90031,ASTRAZENECA,,65.0,YR,,M,Y,,,20180731.0,,MD,US,US,2018,Q3,Elderly
152205532,15220553,10,C,INSULIN LISPRO DCI,,2,,UNK,,,D,,,,,,,,,2018,Q3,Myalgia,,2018,Q3,2,F,20180511.0,20180730.0,20180731,20180807,EXP,,US-MYLANLABS-2018M1055668,MYLAN,,62.0,YR,,F,Y,92.4,KG,20180804.0,,OT,US,US,2018,Q3,Adult
152205532,15220553,10,C,INSULIN LISPRO DCI,,2,,UNK,,,D,,,,,,,,,2018,Q3,Pyrexia,,2018,Q3,2,F,20180511.0,20180730.0,20180731,20180807,EXP,,US-MYLANLABS-2018M1055668,MYLAN,,62.0,YR,,F,Y,92.4,KG,20180804.0,,OT,US,US,2018,Q3,Adult
152206671,15220667,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Electrocardiogram QT prolonged,,2018,Q3,1,I,20180530.0,20180724.0,20180731,20180731,EXP,,IT-B. BRAUN MEDICAL INC.-2052997,B BRAUN,,75.0,YR,,F,Y,70.0,KG,20180731.0,,PH,IT,IT,2018,Q3,Elderly
152208611,15220861,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Bilirubin conjugated increased,,2018,Q3,1,I,20180629.0,,20180703,20180703,DIR,,,FDA-CTU,,37.0,YR,,F,N,118.4,KG,20180702.0,N,,US,US,2018,Q3,Adult
152208611,15220861,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Blood bilirubin increased,,2018,Q3,1,I,20180629.0,,20180703,20180703,DIR,,,FDA-CTU,,37.0,YR,,F,N,118.4,KG,20180702.0,N,,US,US,2018,Q3,Adult
152211691,15221169,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"22 IU, DAILY",,,Y,U,,,20563.0,22.0,IU,,QD,2018,Q3,Syncope,,2018,Q3,1,I,20180702.0,20180718.0,20180731,20180731,EXP,IT-MINISAL02-489330,IT-ELI_LILLY_AND_COMPANY-IT201807009406,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20180731.0,,CN,IT,IT,2018,Q3,Elderly
152217642,15221764,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, UNK",,,U,,,,,,,,,2018,Q3,Glaucoma,,2018,Q3,2,F,20180615.0,20180801.0,20180731,20180816,EXP,,BR-SA-2018SA192421,SANOFI AVENTIS,,57.0,YR,A,M,Y,56.0,KG,20180816.0,,CN,BR,BR,2018,Q3,Adult
152217642,15221764,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, UNK",,,U,,,,,,,,,2018,Q3,Hypoglycaemia,,2018,Q3,2,F,20180615.0,20180801.0,20180731,20180816,EXP,,BR-SA-2018SA192421,SANOFI AVENTIS,,57.0,YR,A,M,Y,56.0,KG,20180816.0,,CN,BR,BR,2018,Q3,Adult
152217642,15221764,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, UNK",,,U,,,,,,,,,2018,Q3,Product use issue,,2018,Q3,2,F,20180615.0,20180801.0,20180731,20180816,EXP,,BR-SA-2018SA192421,SANOFI AVENTIS,,57.0,YR,A,M,Y,56.0,KG,20180816.0,,CN,BR,BR,2018,Q3,Adult
152217642,15221764,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, UNK",,,U,,,,,,,,,2018,Q3,Visual impairment,,2018,Q3,2,F,20180615.0,20180801.0,20180731,20180816,EXP,,BR-SA-2018SA192421,SANOFI AVENTIS,,57.0,YR,A,M,Y,56.0,KG,20180816.0,,CN,BR,BR,2018,Q3,Adult
152272972,15227297,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 IU, QD",1020.0,IU,Y,, UNKNOWN,,,15.0,IU,,QD,2018,Q3,Cold sweat,,2018,Q3,2,F,20180529.0,20180910.0,20180801,20180914,EXP,IT-MINISAL02-482261,PHHY2018IT062154,SANDOZ,,84.0,YR,,M,Y,,,20180914.0,,OT,IT,IT,2018,Q3,Elderly
152272972,15227297,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 IU, QD",1020.0,IU,Y,, UNKNOWN,,,15.0,IU,,QD,2018,Q3,Confusional state,,2018,Q3,2,F,20180529.0,20180910.0,20180801,20180914,EXP,IT-MINISAL02-482261,PHHY2018IT062154,SANDOZ,,84.0,YR,,M,Y,,,20180914.0,,OT,IT,IT,2018,Q3,Elderly
152272972,15227297,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 IU, QD",1020.0,IU,Y,, UNKNOWN,,,15.0,IU,,QD,2018,Q3,Hypoglycaemic coma,,2018,Q3,2,F,20180529.0,20180910.0,20180801,20180914,EXP,IT-MINISAL02-482261,PHHY2018IT062154,SANDOZ,,84.0,YR,,M,Y,,,20180914.0,,OT,IT,IT,2018,Q3,Elderly
152275573,15227557,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 DF=100UNITS/ML, QD",,,,,,,,1.0,DF,,QD,2018,Q3,Acute kidney injury,,2018,Q3,3,F,20180723.0,20180830.0,20180801,20180906,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-071329,BRISTOL MYERS SQUIBB,,56.0,YR,,F,Y,64.2,KG,20180906.0,,OT,US,US,2018,Q3,Adult
152275573,15227557,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 DF=100UNITS/ML, QD",,,,,,,,1.0,DF,,QD,2018,Q3,Atrial fibrillation,,2018,Q3,3,F,20180723.0,20180830.0,20180801,20180906,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-071329,BRISTOL MYERS SQUIBB,,56.0,YR,,F,Y,64.2,KG,20180906.0,,OT,US,US,2018,Q3,Adult
152275573,15227557,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 DF=100UNITS/ML, QD",,,,,,,,1.0,DF,,QD,2018,Q3,Cardiac arrest,,2018,Q3,3,F,20180723.0,20180830.0,20180801,20180906,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-071329,BRISTOL MYERS SQUIBB,,56.0,YR,,F,Y,64.2,KG,20180906.0,,OT,US,US,2018,Q3,Adult
152275573,15227557,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 DF=100UNITS/ML, QD",,,,,,,,1.0,DF,,QD,2018,Q3,Generalised oedema,,2018,Q3,3,F,20180723.0,20180830.0,20180801,20180906,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-071329,BRISTOL MYERS SQUIBB,,56.0,YR,,F,Y,64.2,KG,20180906.0,,OT,US,US,2018,Q3,Adult
152275573,15227557,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 DF=100UNITS/ML, QD",,,,,,,,1.0,DF,,QD,2018,Q3,Hypotension,,2018,Q3,3,F,20180723.0,20180830.0,20180801,20180906,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-071329,BRISTOL MYERS SQUIBB,,56.0,YR,,F,Y,64.2,KG,20180906.0,,OT,US,US,2018,Q3,Adult
152275573,15227557,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 DF=100UNITS/ML, QD",,,,,,,,1.0,DF,,QD,2018,Q3,Sepsis,,2018,Q3,3,F,20180723.0,20180830.0,20180801,20180906,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-071329,BRISTOL MYERS SQUIBB,,56.0,YR,,F,Y,64.2,KG,20180906.0,,OT,US,US,2018,Q3,Adult
152306611,15230661,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2018,Q3,Headache,,2018,Q3,1,I,,20180725.0,20180802,20180802,PER,,US-SA-2018SA208396,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20180802.0,,CN,US,US,2018,Q3,Adult
152334581,15233458,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,"NK IE, NACH BZ",,,U,,,,,,,,,2018,Q3,Anaemia,,2018,Q3,1,I,,20180618.0,20180802,20180802,EXP,,DE-SA-2018SA164101,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20180802.0,,PH,DE,DE,2018,Q3,Elderly
152334581,15233458,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,"NK IE, NACH BZ",,,U,,,,,,,,,2018,Q3,Dyspnoea,,2018,Q3,1,I,,20180618.0,20180802,20180802,EXP,,DE-SA-2018SA164101,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20180802.0,,PH,DE,DE,2018,Q3,Elderly
152334581,15233458,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,"NK IE, NACH BZ",,,U,,,,,,,,,2018,Q3,Haematochezia,,2018,Q3,1,I,,20180618.0,20180802,20180802,EXP,,DE-SA-2018SA164101,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20180802.0,,PH,DE,DE,2018,Q3,Elderly
152353153,15235315,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,UNK,,,U,,,,,,,,,2018,Q3,Foetal disorder,,2018,Q3,3,F,,20180926.0,20180803,20180927,EXP,,FR-TEVA-2018-FR-935123,TEVA,,1.0,DY,,,Y,1.89,KG,20180927.0,,PH,FR,FR,2018,Q3,Child
152353153,15235315,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,UNK,,,U,,,,,,,,,2018,Q3,Foetal exposure during pregnancy,,2018,Q3,3,F,,20180926.0,20180803,20180927,EXP,,FR-TEVA-2018-FR-935123,TEVA,,1.0,DY,,,Y,1.89,KG,20180927.0,,PH,FR,FR,2018,Q3,Child
152353153,15235315,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,UNK,,,U,,,,,,,,,2018,Q3,Low birth weight baby,,2018,Q3,3,F,,20180926.0,20180803,20180927,EXP,,FR-TEVA-2018-FR-935123,TEVA,,1.0,DY,,,Y,1.89,KG,20180927.0,,PH,FR,FR,2018,Q3,Child
152353153,15235315,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,UNK,,,U,,,,,,,,,2018,Q3,Premature baby,,2018,Q3,3,F,,20180926.0,20180803,20180927,EXP,,FR-TEVA-2018-FR-935123,TEVA,,1.0,DY,,,Y,1.89,KG,20180927.0,,PH,FR,FR,2018,Q3,Child
152371991,15237199,15,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Blood bilirubin increased,,2018,Q3,1,I,20180629.0,,20180710,20180710,DIR,,,FDA-CTU,,37.0,YR,,F,N,118.4,KG,20180709.0,N,MD,US,US,2018,Q3,Adult
152371991,15237199,15,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Therapy cessation,,2018,Q3,1,I,20180629.0,,20180710,20180710,DIR,,,FDA-CTU,,37.0,YR,,F,N,118.4,KG,20180709.0,N,MD,US,US,2018,Q3,Adult
152374581,15237458,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,7 INTERNATIONAL UNIT,,,D,,,,,7.0,IU,,,2018,Q3,Caesarean section,,2018,Q3,1,I,,20180720.0,20180803,20180803,EXP,,IT-AUROBINDO-AUR-APL-2018-038678,AUROBINDO,,31.0,YR,,F,Y,98.0,KG,20180803.0,,OT,IT,IT,2018,Q3,Young Adult
152374581,15237458,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,7 INTERNATIONAL UNIT,,,D,,,,,7.0,IU,,,2018,Q3,Maternal exposure during pregnancy,,2018,Q3,1,I,,20180720.0,20180803,20180803,EXP,,IT-AUROBINDO-AUR-APL-2018-038678,AUROBINDO,,31.0,YR,,F,Y,98.0,KG,20180803.0,,OT,IT,IT,2018,Q3,Young Adult
152374581,15237458,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,7 INTERNATIONAL UNIT,,,D,,,,,7.0,IU,,,2018,Q3,Normal newborn,,2018,Q3,1,I,,20180720.0,20180803,20180803,EXP,,IT-AUROBINDO-AUR-APL-2018-038678,AUROBINDO,,31.0,YR,,F,Y,98.0,KG,20180803.0,,OT,IT,IT,2018,Q3,Young Adult
152374581,15237458,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,7 INTERNATIONAL UNIT,,,D,,,,,7.0,IU,,,2018,Q3,Off label use,,2018,Q3,1,I,,20180720.0,20180803,20180803,EXP,,IT-AUROBINDO-AUR-APL-2018-038678,AUROBINDO,,31.0,YR,,F,Y,98.0,KG,20180803.0,,OT,IT,IT,2018,Q3,Young Adult
152374581,15237458,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,32 INTERNATIONAL UNIT,,,D,,,,,32.0,IU,,,2018,Q3,Caesarean section,,2018,Q3,1,I,,20180720.0,20180803,20180803,EXP,,IT-AUROBINDO-AUR-APL-2018-038678,AUROBINDO,,31.0,YR,,F,Y,98.0,KG,20180803.0,,OT,IT,IT,2018,Q3,Young Adult
152374581,15237458,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,32 INTERNATIONAL UNIT,,,D,,,,,32.0,IU,,,2018,Q3,Maternal exposure during pregnancy,,2018,Q3,1,I,,20180720.0,20180803,20180803,EXP,,IT-AUROBINDO-AUR-APL-2018-038678,AUROBINDO,,31.0,YR,,F,Y,98.0,KG,20180803.0,,OT,IT,IT,2018,Q3,Young Adult
152374581,15237458,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,32 INTERNATIONAL UNIT,,,D,,,,,32.0,IU,,,2018,Q3,Normal newborn,,2018,Q3,1,I,,20180720.0,20180803,20180803,EXP,,IT-AUROBINDO-AUR-APL-2018-038678,AUROBINDO,,31.0,YR,,F,Y,98.0,KG,20180803.0,,OT,IT,IT,2018,Q3,Young Adult
152374581,15237458,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,32 INTERNATIONAL UNIT,,,D,,,,,32.0,IU,,,2018,Q3,Off label use,,2018,Q3,1,I,,20180720.0,20180803,20180803,EXP,,IT-AUROBINDO-AUR-APL-2018-038678,AUROBINDO,,31.0,YR,,F,Y,98.0,KG,20180803.0,,OT,IT,IT,2018,Q3,Young Adult
152382141,15238214,2,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Pruritus,,2018,Q3,1,I,20180630.0,,20180710,20180710,DIR,,,FDA-CTU,,36.0,YR,,F,N,52.0,KG,20180710.0,N,PH,US,US,2018,Q3,Adult
152410831,15241083,10,C,INSULIN LISPRO HUMALOG KWIKPEN,,2,,,,,,,,,,,,,,2018,Q3,Asthenia,,2018,Q3,1,I,20180405.0,,20180711,20180711,DIR,,,FDA-CTU,,79.0,YR,,M,N,,,20180711.0,N,CN,US,US,2018,Q3,Elderly
152410831,15241083,10,C,INSULIN LISPRO HUMALOG KWIKPEN,,2,,,,,,,,,,,,,,2018,Q3,Cerebrovascular accident,,2018,Q3,1,I,20180405.0,,20180711,20180711,DIR,,,FDA-CTU,,79.0,YR,,M,N,,,20180711.0,N,CN,US,US,2018,Q3,Elderly
152410831,15241083,10,C,INSULIN LISPRO HUMALOG KWIKPEN,,2,,,,,,,,,,,,,,2018,Q3,Memory impairment,,2018,Q3,1,I,20180405.0,,20180711,20180711,DIR,,,FDA-CTU,,79.0,YR,,M,N,,,20180711.0,N,CN,US,US,2018,Q3,Elderly
152410831,15241083,10,C,INSULIN LISPRO HUMALOG KWIKPEN,,2,,,,,,,,,,,,,,2018,Q3,Visual impairment,,2018,Q3,1,I,20180405.0,,20180711,20180711,DIR,,,FDA-CTU,,79.0,YR,,M,N,,,20180711.0,N,CN,US,US,2018,Q3,Elderly
152449661,15244966,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"28 U, EACH MORNING",,,Y,,,,209196.0,28.0,IU,,QD,2018,Q3,Blood glucose decreased,,2018,Q3,1,I,201708.0,20180627.0,20180806,20180806,EXP,,GR-SA-2018SA175620,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20180806.0,,CN,GR,GR,2018,Q3,Elderly
152449661,15244966,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"28 U, EACH MORNING",,,Y,,,,209196.0,28.0,IU,,QD,2018,Q3,Blood glucose increased,,2018,Q3,1,I,201708.0,20180627.0,20180806,20180806,EXP,,GR-SA-2018SA175620,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20180806.0,,CN,GR,GR,2018,Q3,Elderly
152449661,15244966,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"28 U, EACH MORNING",,,Y,,,,209196.0,28.0,IU,,QD,2018,Q3,Dyspnoea,,2018,Q3,1,I,201708.0,20180627.0,20180806,20180806,EXP,,GR-SA-2018SA175620,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20180806.0,,CN,GR,GR,2018,Q3,Elderly
152449661,15244966,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"28 U, EACH MORNING",,,Y,,,,209196.0,28.0,IU,,QD,2018,Q3,Monoplegia,,2018,Q3,1,I,201708.0,20180627.0,20180806,20180806,EXP,,GR-SA-2018SA175620,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20180806.0,,CN,GR,GR,2018,Q3,Elderly
152449661,15244966,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"28 U, EACH MORNING",,,Y,,,,209196.0,28.0,IU,,QD,2018,Q3,Oxygen saturation decreased,,2018,Q3,1,I,201708.0,20180627.0,20180806,20180806,EXP,,GR-SA-2018SA175620,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20180806.0,,CN,GR,GR,2018,Q3,Elderly
152449661,15244966,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"28 U, EACH MORNING",,,Y,,,,209196.0,28.0,IU,,QD,2018,Q3,Presyncope,,2018,Q3,1,I,201708.0,20180627.0,20180806,20180806,EXP,,GR-SA-2018SA175620,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20180806.0,,CN,GR,GR,2018,Q3,Elderly
152449661,15244966,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"28 U, EACH MORNING",,,Y,,,,209196.0,28.0,IU,,QD,2018,Q3,Vomiting,,2018,Q3,1,I,201708.0,20180627.0,20180806,20180806,EXP,,GR-SA-2018SA175620,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20180806.0,,CN,GR,GR,2018,Q3,Elderly
152449661,15244966,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"28 U, EACH MORNING",,,Y,,,,209196.0,28.0,IU,,QD,2018,Q3,Blood glucose decreased,,2018,Q3,1,I,201708.0,20180627.0,20180806,20180806,EXP,,GR-SA-2018SA175620,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20180806.0,,CN,GR,GR,2018,Q3,Elderly
152449661,15244966,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"28 U, EACH MORNING",,,Y,,,,209196.0,28.0,IU,,QD,2018,Q3,Blood glucose increased,,2018,Q3,1,I,201708.0,20180627.0,20180806,20180806,EXP,,GR-SA-2018SA175620,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20180806.0,,CN,GR,GR,2018,Q3,Elderly
152449661,15244966,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"28 U, EACH MORNING",,,Y,,,,209196.0,28.0,IU,,QD,2018,Q3,Dyspnoea,,2018,Q3,1,I,201708.0,20180627.0,20180806,20180806,EXP,,GR-SA-2018SA175620,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20180806.0,,CN,GR,GR,2018,Q3,Elderly
152449661,15244966,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"28 U, EACH MORNING",,,Y,,,,209196.0,28.0,IU,,QD,2018,Q3,Monoplegia,,2018,Q3,1,I,201708.0,20180627.0,20180806,20180806,EXP,,GR-SA-2018SA175620,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20180806.0,,CN,GR,GR,2018,Q3,Elderly
152449661,15244966,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"28 U, EACH MORNING",,,Y,,,,209196.0,28.0,IU,,QD,2018,Q3,Oxygen saturation decreased,,2018,Q3,1,I,201708.0,20180627.0,20180806,20180806,EXP,,GR-SA-2018SA175620,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20180806.0,,CN,GR,GR,2018,Q3,Elderly
152449661,15244966,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"28 U, EACH MORNING",,,Y,,,,209196.0,28.0,IU,,QD,2018,Q3,Presyncope,,2018,Q3,1,I,201708.0,20180627.0,20180806,20180806,EXP,,GR-SA-2018SA175620,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20180806.0,,CN,GR,GR,2018,Q3,Elderly
152449661,15244966,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"28 U, EACH MORNING",,,Y,,,,209196.0,28.0,IU,,QD,2018,Q3,Vomiting,,2018,Q3,1,I,201708.0,20180627.0,20180806,20180806,EXP,,GR-SA-2018SA175620,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20180806.0,,CN,GR,GR,2018,Q3,Elderly
152493681,15249368,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2018,Q3,Blood glucose increased,,2018,Q3,1,I,2017.0,20180801.0,20180807,20180807,EXP,,UY-ELI_LILLY_AND_COMPANY-UY201808001047,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20180807.0,,CN,UY,UY,2018,Q3,Elderly
152493681,15249368,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2018,Q3,Gait disturbance,,2018,Q3,1,I,2017.0,20180801.0,20180807,20180807,EXP,,UY-ELI_LILLY_AND_COMPANY-UY201808001047,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20180807.0,,CN,UY,UY,2018,Q3,Elderly
152493681,15249368,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2018,Q3,Incorrect route of drug administration,,2018,Q3,1,I,2017.0,20180801.0,20180807,20180807,EXP,,UY-ELI_LILLY_AND_COMPANY-UY201808001047,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20180807.0,,CN,UY,UY,2018,Q3,Elderly
152493681,15249368,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2018,Q3,Organ failure,,2018,Q3,1,I,2017.0,20180801.0,20180807,20180807,EXP,,UY-ELI_LILLY_AND_COMPANY-UY201808001047,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20180807.0,,CN,UY,UY,2018,Q3,Elderly
152493681,15249368,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2018,Q3,Weight decreased,,2018,Q3,1,I,2017.0,20180801.0,20180807,20180807,EXP,,UY-ELI_LILLY_AND_COMPANY-UY201808001047,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20180807.0,,CN,UY,UY,2018,Q3,Elderly
152577051,15257705,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q3,Fluid overload,,2018,Q3,1,I,20170823.0,20180731.0,20180808,20180808,EXP,,US-ACTELION-A-NJ2018-177009,ACTELION,,64.0,YR,A,M,Y,68.93,KG,20180808.0,,OT,US,US,2018,Q3,Adult
152577051,15257705,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q3,Hernia repair,,2018,Q3,1,I,20170823.0,20180731.0,20180808,20180808,EXP,,US-ACTELION-A-NJ2018-177009,ACTELION,,64.0,YR,A,M,Y,68.93,KG,20180808.0,,OT,US,US,2018,Q3,Adult
152644091,15264409,16,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Acute kidney injury,,2018,Q3,1,I,20180302.0,,20180722,20180722,DIR,,,FDA-CTU,,58.0,YR,,F,N,55.8,KG,20180722.0,N,PH,US,US,2018,Q3,Adult
152644091,15264409,16,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Asthenia,,2018,Q3,1,I,20180302.0,,20180722,20180722,DIR,,,FDA-CTU,,58.0,YR,,F,N,55.8,KG,20180722.0,N,PH,US,US,2018,Q3,Adult
152644091,15264409,16,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Cough,,2018,Q3,1,I,20180302.0,,20180722,20180722,DIR,,,FDA-CTU,,58.0,YR,,F,N,55.8,KG,20180722.0,N,PH,US,US,2018,Q3,Adult
152644091,15264409,16,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Diarrhoea,,2018,Q3,1,I,20180302.0,,20180722,20180722,DIR,,,FDA-CTU,,58.0,YR,,F,N,55.8,KG,20180722.0,N,PH,US,US,2018,Q3,Adult
152644091,15264409,16,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Dyspnoea,,2018,Q3,1,I,20180302.0,,20180722,20180722,DIR,,,FDA-CTU,,58.0,YR,,F,N,55.8,KG,20180722.0,N,PH,US,US,2018,Q3,Adult
152644091,15264409,16,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Failure to thrive,,2018,Q3,1,I,20180302.0,,20180722,20180722,DIR,,,FDA-CTU,,58.0,YR,,F,N,55.8,KG,20180722.0,N,PH,US,US,2018,Q3,Adult
152644091,15264409,16,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Pleural effusion,,2018,Q3,1,I,20180302.0,,20180722,20180722,DIR,,,FDA-CTU,,58.0,YR,,F,N,55.8,KG,20180722.0,N,PH,US,US,2018,Q3,Adult
152697241,15269724,13,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Acute kidney injury,,2018,Q3,1,I,20180508.0,,20180726,20180726,DIR,,,FDA-CTU,,50.0,YR,,F,N,122.0,KG,20180726.0,N,CN,US,US,2018,Q3,Adult
152697241,15269724,13,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Acute respiratory failure,,2018,Q3,1,I,20180508.0,,20180726,20180726,DIR,,,FDA-CTU,,50.0,YR,,F,N,122.0,KG,20180726.0,N,CN,US,US,2018,Q3,Adult
152703421,15270342,1,PS,Insulin Lispro,INSULIN LISPRO,1,,,,,Y,,,,20563.0,,,,,2018,Q3,Diabetic ketoacidosis,,2018,Q3,1,I,,20180729.0,20180813,20180813,EXP,,US-ELI_LILLY_AND_COMPANY-US201808005434,ELI LILLY AND CO,"SHETH, K.? HOUSTON, C.? COOK, F. J..LATENT AUTOIMMUNE DIABETES WITH HIGH TITER GAD ANTIBODIES MASQUERADING AS INSULIN RESISTANCE.SUN?093 2018?:.",64.0,YR,,F,Y,,,20180813.0,,MD,US,US,2018,Q3,Adult
152703421,15270342,1,PS,Insulin Lispro,INSULIN LISPRO,1,,,,,Y,,,,20563.0,,,,,2018,Q3,Hypoglycaemia,,2018,Q3,1,I,,20180729.0,20180813,20180813,EXP,,US-ELI_LILLY_AND_COMPANY-US201808005434,ELI LILLY AND CO,"SHETH, K.? HOUSTON, C.? COOK, F. J..LATENT AUTOIMMUNE DIABETES WITH HIGH TITER GAD ANTIBODIES MASQUERADING AS INSULIN RESISTANCE.SUN?093 2018?:.",64.0,YR,,F,Y,,,20180813.0,,MD,US,US,2018,Q3,Adult
152724501,15272450,8,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Pyrexia,,2018,Q3,1,I,20180714.0,,20180727,20180727,DIR,,,FDA-CTU,,57.0,YR,,M,N,57.4,KG,20180727.0,N,,US,US,2018,Q3,Adult
152794441,15279444,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"20 IU, EACH MORNING",,,D,,,,20563.0,20.0,IU,,QD,2018,Q3,Anaemia,,2018,Q3,1,I,201805.0,20180808.0,20180815,20180815,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201808003975,ELI LILLY AND CO,,88.0,YR,,M,Y,103.0,KG,20180815.0,,CN,PT,PT,2018,Q3,Elderly
152794441,15279444,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"20 IU, EACH MORNING",,,D,,,,20563.0,20.0,IU,,QD,2018,Q3,Bacteraemia,,2018,Q3,1,I,201805.0,20180808.0,20180815,20180815,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201808003975,ELI LILLY AND CO,,88.0,YR,,M,Y,103.0,KG,20180815.0,,CN,PT,PT,2018,Q3,Elderly
152794441,15279444,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"20 IU, EACH MORNING",,,D,,,,20563.0,20.0,IU,,QD,2018,Q3,Bacterial pyelonephritis,,2018,Q3,1,I,201805.0,20180808.0,20180815,20180815,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201808003975,ELI LILLY AND CO,,88.0,YR,,M,Y,103.0,KG,20180815.0,,CN,PT,PT,2018,Q3,Elderly
152794441,15279444,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"20 IU, EACH MORNING",,,D,,,,20563.0,20.0,IU,,QD,2018,Q3,Decubitus ulcer,,2018,Q3,1,I,201805.0,20180808.0,20180815,20180815,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201808003975,ELI LILLY AND CO,,88.0,YR,,M,Y,103.0,KG,20180815.0,,CN,PT,PT,2018,Q3,Elderly
152794441,15279444,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"20 IU, EACH MORNING",,,D,,,,20563.0,20.0,IU,,QD,2018,Q3,Dehydration,,2018,Q3,1,I,201805.0,20180808.0,20180815,20180815,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201808003975,ELI LILLY AND CO,,88.0,YR,,M,Y,103.0,KG,20180815.0,,CN,PT,PT,2018,Q3,Elderly
152794441,15279444,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"20 IU, EACH MORNING",,,D,,,,20563.0,20.0,IU,,QD,2018,Q3,Escherichia urinary tract infection,,2018,Q3,1,I,201805.0,20180808.0,20180815,20180815,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201808003975,ELI LILLY AND CO,,88.0,YR,,M,Y,103.0,KG,20180815.0,,CN,PT,PT,2018,Q3,Elderly
152794441,15279444,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"20 IU, EACH MORNING",,,D,,,,20563.0,20.0,IU,,QD,2018,Q3,Hypoglycaemia,,2018,Q3,1,I,201805.0,20180808.0,20180815,20180815,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201808003975,ELI LILLY AND CO,,88.0,YR,,M,Y,103.0,KG,20180815.0,,CN,PT,PT,2018,Q3,Elderly
152794441,15279444,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"20 IU, EACH MORNING",,,D,,,,20563.0,20.0,IU,,QD,2018,Q3,Infected skin ulcer,,2018,Q3,1,I,201805.0,20180808.0,20180815,20180815,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201808003975,ELI LILLY AND CO,,88.0,YR,,M,Y,103.0,KG,20180815.0,,CN,PT,PT,2018,Q3,Elderly
152794441,15279444,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"20 IU, EACH MORNING",,,D,,,,20563.0,20.0,IU,,QD,2018,Q3,Pneumonia aspiration,,2018,Q3,1,I,201805.0,20180808.0,20180815,20180815,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201808003975,ELI LILLY AND CO,,88.0,YR,,M,Y,103.0,KG,20180815.0,,CN,PT,PT,2018,Q3,Elderly
152794441,15279444,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"20 IU, EACH MORNING",,,D,,,,20563.0,20.0,IU,,QD,2018,Q3,Renal disorder,,2018,Q3,1,I,201805.0,20180808.0,20180815,20180815,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201808003975,ELI LILLY AND CO,,88.0,YR,,M,Y,103.0,KG,20180815.0,,CN,PT,PT,2018,Q3,Elderly
152794441,15279444,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"20 IU, EACH MORNING",,,D,,,,20563.0,20.0,IU,,QD,2018,Q3,Respiratory failure,,2018,Q3,1,I,201805.0,20180808.0,20180815,20180815,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201808003975,ELI LILLY AND CO,,88.0,YR,,M,Y,103.0,KG,20180815.0,,CN,PT,PT,2018,Q3,Elderly
152794441,15279444,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"20 IU, EACH MORNING",,,D,,,,20563.0,20.0,IU,,QD,2018,Q3,Skin necrosis,,2018,Q3,1,I,201805.0,20180808.0,20180815,20180815,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201808003975,ELI LILLY AND CO,,88.0,YR,,M,Y,103.0,KG,20180815.0,,CN,PT,PT,2018,Q3,Elderly
152794441,15279444,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"20 IU, EACH MORNING",,,D,,,,20563.0,20.0,IU,,QD,2018,Q3,Terminal state,,2018,Q3,1,I,201805.0,20180808.0,20180815,20180815,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201808003975,ELI LILLY AND CO,,88.0,YR,,M,Y,103.0,KG,20180815.0,,CN,PT,PT,2018,Q3,Elderly
152794441,15279444,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"24 IU, EACH EVENING",,,D,,,,20563.0,24.0,IU,,QD,2018,Q3,Anaemia,,2018,Q3,1,I,201805.0,20180808.0,20180815,20180815,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201808003975,ELI LILLY AND CO,,88.0,YR,,M,Y,103.0,KG,20180815.0,,CN,PT,PT,2018,Q3,Elderly
152794441,15279444,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"24 IU, EACH EVENING",,,D,,,,20563.0,24.0,IU,,QD,2018,Q3,Bacteraemia,,2018,Q3,1,I,201805.0,20180808.0,20180815,20180815,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201808003975,ELI LILLY AND CO,,88.0,YR,,M,Y,103.0,KG,20180815.0,,CN,PT,PT,2018,Q3,Elderly
152794441,15279444,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"24 IU, EACH EVENING",,,D,,,,20563.0,24.0,IU,,QD,2018,Q3,Bacterial pyelonephritis,,2018,Q3,1,I,201805.0,20180808.0,20180815,20180815,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201808003975,ELI LILLY AND CO,,88.0,YR,,M,Y,103.0,KG,20180815.0,,CN,PT,PT,2018,Q3,Elderly
152794441,15279444,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"24 IU, EACH EVENING",,,D,,,,20563.0,24.0,IU,,QD,2018,Q3,Decubitus ulcer,,2018,Q3,1,I,201805.0,20180808.0,20180815,20180815,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201808003975,ELI LILLY AND CO,,88.0,YR,,M,Y,103.0,KG,20180815.0,,CN,PT,PT,2018,Q3,Elderly
152794441,15279444,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"24 IU, EACH EVENING",,,D,,,,20563.0,24.0,IU,,QD,2018,Q3,Dehydration,,2018,Q3,1,I,201805.0,20180808.0,20180815,20180815,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201808003975,ELI LILLY AND CO,,88.0,YR,,M,Y,103.0,KG,20180815.0,,CN,PT,PT,2018,Q3,Elderly
152794441,15279444,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"24 IU, EACH EVENING",,,D,,,,20563.0,24.0,IU,,QD,2018,Q3,Escherichia urinary tract infection,,2018,Q3,1,I,201805.0,20180808.0,20180815,20180815,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201808003975,ELI LILLY AND CO,,88.0,YR,,M,Y,103.0,KG,20180815.0,,CN,PT,PT,2018,Q3,Elderly
152794441,15279444,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"24 IU, EACH EVENING",,,D,,,,20563.0,24.0,IU,,QD,2018,Q3,Hypoglycaemia,,2018,Q3,1,I,201805.0,20180808.0,20180815,20180815,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201808003975,ELI LILLY AND CO,,88.0,YR,,M,Y,103.0,KG,20180815.0,,CN,PT,PT,2018,Q3,Elderly
152794441,15279444,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"24 IU, EACH EVENING",,,D,,,,20563.0,24.0,IU,,QD,2018,Q3,Infected skin ulcer,,2018,Q3,1,I,201805.0,20180808.0,20180815,20180815,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201808003975,ELI LILLY AND CO,,88.0,YR,,M,Y,103.0,KG,20180815.0,,CN,PT,PT,2018,Q3,Elderly
152794441,15279444,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"24 IU, EACH EVENING",,,D,,,,20563.0,24.0,IU,,QD,2018,Q3,Pneumonia aspiration,,2018,Q3,1,I,201805.0,20180808.0,20180815,20180815,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201808003975,ELI LILLY AND CO,,88.0,YR,,M,Y,103.0,KG,20180815.0,,CN,PT,PT,2018,Q3,Elderly
152794441,15279444,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"24 IU, EACH EVENING",,,D,,,,20563.0,24.0,IU,,QD,2018,Q3,Renal disorder,,2018,Q3,1,I,201805.0,20180808.0,20180815,20180815,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201808003975,ELI LILLY AND CO,,88.0,YR,,M,Y,103.0,KG,20180815.0,,CN,PT,PT,2018,Q3,Elderly
152794441,15279444,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"24 IU, EACH EVENING",,,D,,,,20563.0,24.0,IU,,QD,2018,Q3,Respiratory failure,,2018,Q3,1,I,201805.0,20180808.0,20180815,20180815,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201808003975,ELI LILLY AND CO,,88.0,YR,,M,Y,103.0,KG,20180815.0,,CN,PT,PT,2018,Q3,Elderly
152794441,15279444,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"24 IU, EACH EVENING",,,D,,,,20563.0,24.0,IU,,QD,2018,Q3,Skin necrosis,,2018,Q3,1,I,201805.0,20180808.0,20180815,20180815,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201808003975,ELI LILLY AND CO,,88.0,YR,,M,Y,103.0,KG,20180815.0,,CN,PT,PT,2018,Q3,Elderly
152794441,15279444,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"24 IU, EACH EVENING",,,D,,,,20563.0,24.0,IU,,QD,2018,Q3,Terminal state,,2018,Q3,1,I,201805.0,20180808.0,20180815,20180815,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201808003975,ELI LILLY AND CO,,88.0,YR,,M,Y,103.0,KG,20180815.0,,CN,PT,PT,2018,Q3,Elderly
152818021,15281802,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2018,Q3,Cardiac failure,,2018,Q3,1,I,20180313.0,20180807.0,20180815,20180815,EXP,IT-MINISAL02-488222,IT-TEVA-2018-IT-941184,TEVA,,77.0,YR,,M,Y,,,20180815.0,,MD,IT,IT,2018,Q3,Elderly
152818021,15281802,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2018,Q3,Dyspnoea,,2018,Q3,1,I,20180313.0,20180807.0,20180815,20180815,EXP,IT-MINISAL02-488222,IT-TEVA-2018-IT-941184,TEVA,,77.0,YR,,M,Y,,,20180815.0,,MD,IT,IT,2018,Q3,Elderly
152840392,15284039,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,Y,,,,,,,INJECTION,,2018,Q3,Blindness transient,,2018,Q3,2,F,2010.0,20180808.0,20180816,20180820,EXP,,US-ELI_LILLY_AND_COMPANY-US201808004929,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20180820.0,,CN,US,US,2018,Q3,Adult
152840392,15284039,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,Y,,,,,,,INJECTION,,2018,Q3,Blood glucose increased,,2018,Q3,2,F,2010.0,20180808.0,20180816,20180820,EXP,,US-ELI_LILLY_AND_COMPANY-US201808004929,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20180820.0,,CN,US,US,2018,Q3,Adult
152840392,15284039,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,Y,,,,,,,INJECTION,,2018,Q3,Cataract,,2018,Q3,2,F,2010.0,20180808.0,20180816,20180820,EXP,,US-ELI_LILLY_AND_COMPANY-US201808004929,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20180820.0,,CN,US,US,2018,Q3,Adult
152840392,15284039,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,Y,,,,,,,INJECTION,,2018,Q3,Myocardial infarction,,2018,Q3,2,F,2010.0,20180808.0,20180816,20180820,EXP,,US-ELI_LILLY_AND_COMPANY-US201808004929,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20180820.0,,CN,US,US,2018,Q3,Adult
152840392,15284039,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,Y,,,,,,,INJECTION,,2018,Q3,Pain in extremity,,2018,Q3,2,F,2010.0,20180808.0,20180816,20180820,EXP,,US-ELI_LILLY_AND_COMPANY-US201808004929,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20180820.0,,CN,US,US,2018,Q3,Adult
152840392,15284039,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,Y,,,,,,,INJECTION,,2018,Q3,Peripheral swelling,,2018,Q3,2,F,2010.0,20180808.0,20180816,20180820,EXP,,US-ELI_LILLY_AND_COMPANY-US201808004929,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20180820.0,,CN,US,US,2018,Q3,Adult
152840392,15284039,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,Y,, C712597E,,,,,INJECTION,,2018,Q3,Blindness transient,,2018,Q3,2,F,2010.0,20180808.0,20180816,20180820,EXP,,US-ELI_LILLY_AND_COMPANY-US201808004929,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20180820.0,,CN,US,US,2018,Q3,Adult
152840392,15284039,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,Y,, C712597E,,,,,INJECTION,,2018,Q3,Blood glucose increased,,2018,Q3,2,F,2010.0,20180808.0,20180816,20180820,EXP,,US-ELI_LILLY_AND_COMPANY-US201808004929,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20180820.0,,CN,US,US,2018,Q3,Adult
152840392,15284039,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,Y,, C712597E,,,,,INJECTION,,2018,Q3,Cataract,,2018,Q3,2,F,2010.0,20180808.0,20180816,20180820,EXP,,US-ELI_LILLY_AND_COMPANY-US201808004929,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20180820.0,,CN,US,US,2018,Q3,Adult
152840392,15284039,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,Y,, C712597E,,,,,INJECTION,,2018,Q3,Myocardial infarction,,2018,Q3,2,F,2010.0,20180808.0,20180816,20180820,EXP,,US-ELI_LILLY_AND_COMPANY-US201808004929,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20180820.0,,CN,US,US,2018,Q3,Adult
152840392,15284039,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,Y,, C712597E,,,,,INJECTION,,2018,Q3,Pain in extremity,,2018,Q3,2,F,2010.0,20180808.0,20180816,20180820,EXP,,US-ELI_LILLY_AND_COMPANY-US201808004929,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20180820.0,,CN,US,US,2018,Q3,Adult
152840392,15284039,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,Y,, C712597E,,,,,INJECTION,,2018,Q3,Peripheral swelling,,2018,Q3,2,F,2010.0,20180808.0,20180816,20180820,EXP,,US-ELI_LILLY_AND_COMPANY-US201808004929,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20180820.0,,CN,US,US,2018,Q3,Adult
152849111,15284911,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15.45 IU, QD",,,Y,,,,209196.0,15.45,IU,,QD,2018,Q3,Diabetic retinopathy,,2018,Q3,1,I,20160621.0,20180605.0,20180816,20180816,EXP,,FR-SAKK-2018SA151194AA,SANOFI AVENTIS,,27.0,YR,A,F,Y,80.0,KG,20180816.0,,CN,DK,FR,2018,Q3,Young Adult
152849111,15284911,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15.45 IU, QD",,,Y,,,,209196.0,15.45,IU,,QD,2018,Q3,Exposure during pregnancy,,2018,Q3,1,I,20160621.0,20180605.0,20180816,20180816,EXP,,FR-SAKK-2018SA151194AA,SANOFI AVENTIS,,27.0,YR,A,F,Y,80.0,KG,20180816.0,,CN,DK,FR,2018,Q3,Young Adult
152849111,15284911,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15.45 IU, QD",,,Y,,,,209196.0,15.45,IU,,QD,2018,Q3,Failed induction of labour,,2018,Q3,1,I,20160621.0,20180605.0,20180816,20180816,EXP,,FR-SAKK-2018SA151194AA,SANOFI AVENTIS,,27.0,YR,A,F,Y,80.0,KG,20180816.0,,CN,DK,FR,2018,Q3,Young Adult
152849111,15284911,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15.45 IU, QD",,,Y,,,,209196.0,15.45,IU,,QD,2018,Q3,Hypoglycaemia,,2018,Q3,1,I,20160621.0,20180605.0,20180816,20180816,EXP,,FR-SAKK-2018SA151194AA,SANOFI AVENTIS,,27.0,YR,A,F,Y,80.0,KG,20180816.0,,CN,DK,FR,2018,Q3,Young Adult
152849111,15284911,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"19.5 IU, QD",,,Y,,,,209196.0,19.5,IU,,QD,2018,Q3,Diabetic retinopathy,,2018,Q3,1,I,20160621.0,20180605.0,20180816,20180816,EXP,,FR-SAKK-2018SA151194AA,SANOFI AVENTIS,,27.0,YR,A,F,Y,80.0,KG,20180816.0,,CN,DK,FR,2018,Q3,Young Adult
152849111,15284911,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"19.5 IU, QD",,,Y,,,,209196.0,19.5,IU,,QD,2018,Q3,Exposure during pregnancy,,2018,Q3,1,I,20160621.0,20180605.0,20180816,20180816,EXP,,FR-SAKK-2018SA151194AA,SANOFI AVENTIS,,27.0,YR,A,F,Y,80.0,KG,20180816.0,,CN,DK,FR,2018,Q3,Young Adult
152849111,15284911,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"19.5 IU, QD",,,Y,,,,209196.0,19.5,IU,,QD,2018,Q3,Failed induction of labour,,2018,Q3,1,I,20160621.0,20180605.0,20180816,20180816,EXP,,FR-SAKK-2018SA151194AA,SANOFI AVENTIS,,27.0,YR,A,F,Y,80.0,KG,20180816.0,,CN,DK,FR,2018,Q3,Young Adult
152849111,15284911,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"19.5 IU, QD",,,Y,,,,209196.0,19.5,IU,,QD,2018,Q3,Hypoglycaemia,,2018,Q3,1,I,20160621.0,20180605.0,20180816,20180816,EXP,,FR-SAKK-2018SA151194AA,SANOFI AVENTIS,,27.0,YR,A,F,Y,80.0,KG,20180816.0,,CN,DK,FR,2018,Q3,Young Adult
152877081,15287708,6,C,LISPRO INSULIN,INSULIN LISPRO,1,Intramuscular,UNK,,,U,,,,,,,,,2018,Q3,Off label use,,2018,Q3,1,I,,20180731.0,20180817,20180817,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-076053,BRISTOL MYERS SQUIBB,,17.0,YR,,F,Y,,,20180817.0,,OT,US,US,2018,Q3,Youth
152898922,15289892,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Other,UNK,,,,,,,,,,INJECTION,,2018,Q3,Angina pectoris,,2018,Q3,2,F,201605.0,20180830.0,20180817,20180910,EXP,,JP-SEATTLE GENETICS-2017SGN02047,SEATTLE GENETICS,,68.0,YR,,M,Y,65.5,KG,20180910.0,,MD,JP,JP,2018,Q3,Elderly
152898922,15289892,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Other,UNK,,,,,,,,,,INJECTION,,2018,Q3,Diabetic nephropathy,,2018,Q3,2,F,201605.0,20180830.0,20180817,20180910,EXP,,JP-SEATTLE GENETICS-2017SGN02047,SEATTLE GENETICS,,68.0,YR,,M,Y,65.5,KG,20180910.0,,MD,JP,JP,2018,Q3,Elderly
152898922,15289892,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Other,UNK,,,,,,,,,,INJECTION,,2018,Q3,Myocardial infarction,,2018,Q3,2,F,201605.0,20180830.0,20180817,20180910,EXP,,JP-SEATTLE GENETICS-2017SGN02047,SEATTLE GENETICS,,68.0,YR,,M,Y,65.5,KG,20180910.0,,MD,JP,JP,2018,Q3,Elderly
152898922,15289892,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Other,UNK,,,,,,,,,,INJECTION,,2018,Q3,Renal impairment,,2018,Q3,2,F,201605.0,20180830.0,20180817,20180910,EXP,,JP-SEATTLE GENETICS-2017SGN02047,SEATTLE GENETICS,,68.0,YR,,M,Y,65.5,KG,20180910.0,,MD,JP,JP,2018,Q3,Elderly
152913341,15291334,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Electrocardiogram QT prolonged,,2018,Q3,1,I,20180526.0,20180808.0,20180817,20180817,EXP,IT-MINISAL02-489883,IT-TEVA-2018-IT-942475,TEVA,,95.0,YR,,F,Y,53.0,KG,20180817.0,,PH,IT,IT,2018,Q3,Elderly
152946922,15294692,8,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNK",,,Y,,,,21081.0,,,SOLUTION FOR INJECTION,,2018,Q3,Hypoglycaemic seizure,,2018,Q3,2,F,20180717.0,20180830.0,20180820,20180919,EXP,,AR-SA-2018SA201415,SANOFI AVENTIS,,17.0,YR,T,F,Y,75.0,KG,20180919.0,,MD,AR,AR,2018,Q3,Youth
152946922,15294692,9,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNK",,,Y,,,,21081.0,,,SOLUTION FOR INJECTION,,2018,Q3,Hypoglycaemic seizure,,2018,Q3,2,F,20180717.0,20180830.0,20180820,20180919,EXP,,AR-SA-2018SA201415,SANOFI AVENTIS,,17.0,YR,T,F,Y,75.0,KG,20180919.0,,MD,AR,AR,2018,Q3,Youth
152952991,15295299,6,C,Insulin lispro,INSULIN LISPRO,1,,"NK IE, NACH BZ",,,U,, UNK,,,,,,,2018,Q3,Anaemia,,2018,Q3,1,I,,20180810.0,20180820,20180820,EXP,DE-ADRED-01710-02,DE-TORRENT-00009435,TORRENT,,77.0,YR,E,M,Y,,,20180820.0,,PH,DE,DE,2018,Q3,Elderly
152952991,15295299,6,C,Insulin lispro,INSULIN LISPRO,1,,"NK IE, NACH BZ",,,U,, UNK,,,,,,,2018,Q3,Dyspnoea,,2018,Q3,1,I,,20180810.0,20180820,20180820,EXP,DE-ADRED-01710-02,DE-TORRENT-00009435,TORRENT,,77.0,YR,E,M,Y,,,20180820.0,,PH,DE,DE,2018,Q3,Elderly
152952991,15295299,6,C,Insulin lispro,INSULIN LISPRO,1,,"NK IE, NACH BZ",,,U,, UNK,,,,,,,2018,Q3,Haematochezia,,2018,Q3,1,I,,20180810.0,20180820,20180820,EXP,DE-ADRED-01710-02,DE-TORRENT-00009435,TORRENT,,77.0,YR,E,M,Y,,,20180820.0,,PH,DE,DE,2018,Q3,Elderly
152971121,15297112,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"19.5 IU, QD",,,,,,,,19.5,IU,SOLUTION FOR INJECTION,QD,2018,Q3,Dawn phenomenon,,2018,Q3,1,I,20171115.0,20180807.0,20180820,20180820,EXP,,IT-SA-2018SA217406,SANOFI AVENTIS,,11.0,YR,C,F,Y,54.0,KG,20180820.0,,MD,IT,IT,2018,Q3,Child
152971121,15297112,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"19.5 IU, QD",,,,,,,,19.5,IU,SOLUTION FOR INJECTION,QD,2018,Q3,Hyperhidrosis,,2018,Q3,1,I,20171115.0,20180807.0,20180820,20180820,EXP,,IT-SA-2018SA217406,SANOFI AVENTIS,,11.0,YR,C,F,Y,54.0,KG,20180820.0,,MD,IT,IT,2018,Q3,Child
152971121,15297112,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"19.5 IU, QD",,,,,,,,19.5,IU,SOLUTION FOR INJECTION,QD,2018,Q3,Hypoglycaemia,,2018,Q3,1,I,20171115.0,20180807.0,20180820,20180820,EXP,,IT-SA-2018SA217406,SANOFI AVENTIS,,11.0,YR,C,F,Y,54.0,KG,20180820.0,,MD,IT,IT,2018,Q3,Child
152971121,15297112,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"19.5 IU, QD",,,,,,,,19.5,IU,SOLUTION FOR INJECTION,QD,2018,Q3,Pallor,,2018,Q3,1,I,20171115.0,20180807.0,20180820,20180820,EXP,,IT-SA-2018SA217406,SANOFI AVENTIS,,11.0,YR,C,F,Y,54.0,KG,20180820.0,,MD,IT,IT,2018,Q3,Child
153007031,15300703,7,C,Insulin Lispro PRN,,2,,,,,,,,,,,,,,2018,Q3,Anaphylactic reaction,,2018,Q3,1,I,20180618.0,,20180809,20180809,DIR,,,FDA-CTU,,31.0,YR,,F,N,113.85,KG,20180809.0,N,PH,US,US,2018,Q3,Young Adult
153007031,15300703,7,C,Insulin Lispro PRN,,2,,,,,,,,,,,,,,2018,Q3,Infusion related reaction,,2018,Q3,1,I,20180618.0,,20180809,20180809,DIR,,,FDA-CTU,,31.0,YR,,F,N,113.85,KG,20180809.0,N,PH,US,US,2018,Q3,Young Adult
153095322,15309532,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2018,Q3,Anorectal infection,,2018,Q3,2,F,20180816.0,20180903.0,20180823,20180910,EXP,,ES-ASTRAZENECA-2018SF05160,ASTRAZENECA,,59.0,YR,,M,Y,,,20180910.0,,MD,ES,ES,2018,Q3,Adult
153104551,15310455,7,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Cerebrovascular accident,,2018,Q3,1,I,20180806.0,,20180813,20180813,DIR,,,FDA-CTU,,52.0,YR,,M,N,134.4,KG,20180813.0,Y,PH,US,US,2018,Q3,Adult
153104551,15310455,7,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Dysarthria,,2018,Q3,1,I,20180806.0,,20180813,20180813,DIR,,,FDA-CTU,,52.0,YR,,M,N,134.4,KG,20180813.0,Y,PH,US,US,2018,Q3,Adult
153104551,15310455,7,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Facial paralysis,,2018,Q3,1,I,20180806.0,,20180813,20180813,DIR,,,FDA-CTU,,52.0,YR,,M,N,134.4,KG,20180813.0,Y,PH,US,US,2018,Q3,Adult
153104551,15310455,7,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Loss of personal independence in daily activities,,2018,Q3,1,I,20180806.0,,20180813,20180813,DIR,,,FDA-CTU,,52.0,YR,,M,N,134.4,KG,20180813.0,Y,PH,US,US,2018,Q3,Adult
153104551,15310455,7,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Mobility decreased,,2018,Q3,1,I,20180806.0,,20180813,20180813,DIR,,,FDA-CTU,,52.0,YR,,M,N,134.4,KG,20180813.0,Y,PH,US,US,2018,Q3,Adult
153127891,15312789,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, QD",3240.0,IU,U,,,,,20.0,IU,SOLUTION FOR INJECTION,QD,2018,Q3,Confusional state,,2018,Q3,1,I,20180611.0,20180809.0,20180823,20180823,EXP,IT-MINISAL02-492970,IT-SA-2018SA221855,SANOFI AVENTIS,,76.0,YR,E,M,Y,,,20180823.0,,MD,IT,IT,2018,Q3,Elderly
153127891,15312789,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, QD",3240.0,IU,U,,,,,20.0,IU,SOLUTION FOR INJECTION,QD,2018,Q3,Hypoglycaemia,,2018,Q3,1,I,20180611.0,20180809.0,20180823,20180823,EXP,IT-MINISAL02-492970,IT-SA-2018SA221855,SANOFI AVENTIS,,76.0,YR,E,M,Y,,,20180823.0,,MD,IT,IT,2018,Q3,Elderly
153164501,15316450,18,C,Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2018,Q3,Blood glucose increased,,2018,Q3,1,I,20180622.0,20180703.0,20180824,20180824,PER,,US-CELGENEUS-USA-20180701266,CELGENE,,69.0,YR,,F,Y,64.47,KG,20180824.0,,PH,US,US,2018,Q3,Elderly
153179711,15317971,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2018,Q3,Cardiac failure,,2018,Q3,1,I,20180313.0,20180816.0,20180824,20180824,EXP,,PHHY2018IT077052,SANDOZ,,77.0,YR,,M,Y,,,20180825.0,,OT,IT,IT,2018,Q3,Elderly
153179711,15317971,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2018,Q3,Dyspnoea,,2018,Q3,1,I,20180313.0,20180816.0,20180824,20180824,EXP,,PHHY2018IT077052,SANDOZ,,77.0,YR,,M,Y,,,20180825.0,,OT,IT,IT,2018,Q3,Elderly
153215383,15321538,8,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNK",,,,,,,,,,SOLUTION FOR INJECTION,,2018,Q3,Accidental overdose,,2018,Q3,3,F,20160521.0,20180804.0,20180827,20180921,EXP,,US-SA-2016SA105473,SANOFI AVENTIS,,16.0,YR,T,M,Y,62.0,KG,20180921.0,,MD,US,US,2018,Q3,Youth
153215383,15321538,8,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNK",,,,,,,,,,SOLUTION FOR INJECTION,,2018,Q3,Hypoglycaemic unconsciousness,,2018,Q3,3,F,20160521.0,20180804.0,20180827,20180921,EXP,,US-SA-2016SA105473,SANOFI AVENTIS,,16.0,YR,T,M,Y,62.0,KG,20180921.0,,MD,US,US,2018,Q3,Youth
153215383,15321538,9,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNK",,,,,,,,,,SOLUTION FOR INJECTION,,2018,Q3,Accidental overdose,,2018,Q3,3,F,20160521.0,20180804.0,20180827,20180921,EXP,,US-SA-2016SA105473,SANOFI AVENTIS,,16.0,YR,T,M,Y,62.0,KG,20180921.0,,MD,US,US,2018,Q3,Youth
153215383,15321538,9,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNK",,,,,,,,,,SOLUTION FOR INJECTION,,2018,Q3,Hypoglycaemic unconsciousness,,2018,Q3,3,F,20160521.0,20180804.0,20180827,20180921,EXP,,US-SA-2016SA105473,SANOFI AVENTIS,,16.0,YR,T,M,Y,62.0,KG,20180921.0,,MD,US,US,2018,Q3,Youth
153215383,15321538,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNK",,,,,,,,,,SOLUTION FOR INJECTION,,2018,Q3,Accidental overdose,,2018,Q3,3,F,20160521.0,20180804.0,20180827,20180921,EXP,,US-SA-2016SA105473,SANOFI AVENTIS,,16.0,YR,T,M,Y,62.0,KG,20180921.0,,MD,US,US,2018,Q3,Youth
153215383,15321538,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNK",,,,,,,,,,SOLUTION FOR INJECTION,,2018,Q3,Hypoglycaemic unconsciousness,,2018,Q3,3,F,20160521.0,20180804.0,20180827,20180921,EXP,,US-SA-2016SA105473,SANOFI AVENTIS,,16.0,YR,T,M,Y,62.0,KG,20180921.0,,MD,US,US,2018,Q3,Youth
153222761,15322276,2,I,INSULINA LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, TID (1?1?1)",,,Y,,,,,,,,TID,2018,Q3,Hypoglycaemia,,2018,Q3,1,I,20171122.0,20180816.0,20180827,20180827,EXP,,PHHY2018ES077438,SANDOZ,,73.0,YR,,M,Y,,,20180827.0,,OT,ES,ES,2018,Q3,Elderly
153260921,15326092,5,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Asthenia,,2018,Q3,1,I,20180409.0,,20180823,20180823,DIR,,,FDA-CTU,,50.0,YR,,F,N,113.6,KG,20180823.0,Y,PH,US,US,2018,Q3,Adult
153260921,15326092,5,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Cardiac death,,2018,Q3,1,I,20180409.0,,20180823,20180823,DIR,,,FDA-CTU,,50.0,YR,,F,N,113.6,KG,20180823.0,Y,PH,US,US,2018,Q3,Adult
153260921,15326092,5,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Cerebral haemorrhage,,2018,Q3,1,I,20180409.0,,20180823,20180823,DIR,,,FDA-CTU,,50.0,YR,,F,N,113.6,KG,20180823.0,Y,PH,US,US,2018,Q3,Adult
153260921,15326092,5,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Headache,,2018,Q3,1,I,20180409.0,,20180823,20180823,DIR,,,FDA-CTU,,50.0,YR,,F,N,113.6,KG,20180823.0,Y,PH,US,US,2018,Q3,Adult
153260921,15326092,5,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Hyperhidrosis,,2018,Q3,1,I,20180409.0,,20180823,20180823,DIR,,,FDA-CTU,,50.0,YR,,F,N,113.6,KG,20180823.0,Y,PH,US,US,2018,Q3,Adult
153260921,15326092,5,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Hypotension,,2018,Q3,1,I,20180409.0,,20180823,20180823,DIR,,,FDA-CTU,,50.0,YR,,F,N,113.6,KG,20180823.0,Y,PH,US,US,2018,Q3,Adult
153260921,15326092,5,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Lethargy,,2018,Q3,1,I,20180409.0,,20180823,20180823,DIR,,,FDA-CTU,,50.0,YR,,F,N,113.6,KG,20180823.0,Y,PH,US,US,2018,Q3,Adult
153260921,15326092,5,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Pulmonary embolism,,2018,Q3,1,I,20180409.0,,20180823,20180823,DIR,,,FDA-CTU,,50.0,YR,,F,N,113.6,KG,20180823.0,Y,PH,US,US,2018,Q3,Adult
153260921,15326092,5,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Vomiting,,2018,Q3,1,I,20180409.0,,20180823,20180823,DIR,,,FDA-CTU,,50.0,YR,,F,N,113.6,KG,20180823.0,Y,PH,US,US,2018,Q3,Adult
153281171,15328117,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, BID",,,,,,,20563.0,,,,BID,2018,Q3,Blood pressure increased,,2018,Q3,1,I,2017.0,20180816.0,20180828,20180828,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201808008482,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20180828.0,,CN,CN,CN,2018,Q3,Elderly
153281171,15328117,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, BID",,,,,,,20563.0,,,,BID,2018,Q3,Cerebral infarction,,2018,Q3,1,I,2017.0,20180816.0,20180828,20180828,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201808008482,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20180828.0,,CN,CN,CN,2018,Q3,Elderly
153281171,15328117,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, BID",,,,,,,20563.0,,,,BID,2018,Q3,Peripheral swelling,,2018,Q3,1,I,2017.0,20180816.0,20180828,20180828,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201808008482,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20180828.0,,CN,CN,CN,2018,Q3,Elderly
153303881,15330388,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q3,Cystic fibrosis,,2018,Q3,1,I,20180807.0,20180815.0,20180829,20180829,EXP,,US-SA-2018SA231145,SANOFI AVENTIS,,11.0,YR,C,M,Y,,,20180829.0,,CN,US,US,2018,Q3,Child
153331991,15333199,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 IU, EACH MORNING",,,,,,,20563.0,10.0,IU,,QD,2018,Q3,Diabetes mellitus inadequate control,,2018,Q3,1,I,,20180827.0,20180830,20180830,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201808013004,ELI LILLY AND CO,,75.0,YR,,M,Y,75.0,KG,20180830.0,,CN,CN,CN,2018,Q3,Elderly
153331991,15333199,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 IU, EACH MORNING",,,,,,,20563.0,10.0,IU,,QD,2018,Q3,Infection,,2018,Q3,1,I,,20180827.0,20180830,20180830,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201808013004,ELI LILLY AND CO,,75.0,YR,,M,Y,75.0,KG,20180830.0,,CN,CN,CN,2018,Q3,Elderly
153331991,15333199,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 IU, EACH MORNING",,,,,,,20563.0,10.0,IU,,QD,2018,Q3,Peripheral swelling,,2018,Q3,1,I,,20180827.0,20180830,20180830,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201808013004,ELI LILLY AND CO,,75.0,YR,,M,Y,75.0,KG,20180830.0,,CN,CN,CN,2018,Q3,Elderly
153331991,15333199,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"9 IU, DAILY",,,,,,,20563.0,9.0,IU,,QD,2018,Q3,Diabetes mellitus inadequate control,,2018,Q3,1,I,,20180827.0,20180830,20180830,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201808013004,ELI LILLY AND CO,,75.0,YR,,M,Y,75.0,KG,20180830.0,,CN,CN,CN,2018,Q3,Elderly
153331991,15333199,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"9 IU, DAILY",,,,,,,20563.0,9.0,IU,,QD,2018,Q3,Infection,,2018,Q3,1,I,,20180827.0,20180830,20180830,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201808013004,ELI LILLY AND CO,,75.0,YR,,M,Y,75.0,KG,20180830.0,,CN,CN,CN,2018,Q3,Elderly
153331991,15333199,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"9 IU, DAILY",,,,,,,20563.0,9.0,IU,,QD,2018,Q3,Peripheral swelling,,2018,Q3,1,I,,20180827.0,20180830,20180830,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201808013004,ELI LILLY AND CO,,75.0,YR,,M,Y,75.0,KG,20180830.0,,CN,CN,CN,2018,Q3,Elderly
153353501,15335350,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,7IU BEFORE LUNCH AND 8IU BEFORE DINNER,,,U,U,,,,,,,,2018,Q3,Maternal exposure during pregnancy,,2018,Q3,1,I,,20180819.0,20180830,20180830,EXP,,PHHY2018IT079863,SANDOZ,,31.0,YR,,F,Y,98.0,KG,20180830.0,,OT,IT,IT,2018,Q3,Young Adult
153353501,15335350,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,7IU BEFORE LUNCH AND 8IU BEFORE DINNER,,,U,U,,,,,,,,2018,Q3,Normal newborn,,2018,Q3,1,I,,20180819.0,20180830,20180830,EXP,,PHHY2018IT079863,SANDOZ,,31.0,YR,,F,Y,98.0,KG,20180830.0,,OT,IT,IT,2018,Q3,Young Adult
153353501,15335350,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,7IU BEFORE LUNCH AND 8IU BEFORE DINNER,,,U,U,,,,,,,,2018,Q3,Off label use,,2018,Q3,1,I,,20180819.0,20180830,20180830,EXP,,PHHY2018IT079863,SANDOZ,,31.0,YR,,F,Y,98.0,KG,20180830.0,,OT,IT,IT,2018,Q3,Young Adult
153353501,15335350,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,32 IU BEFORE LUNCH AND 34 IU BEFORE DINNER,,,U,U,,,,,,,,2018,Q3,Maternal exposure during pregnancy,,2018,Q3,1,I,,20180819.0,20180830,20180830,EXP,,PHHY2018IT079863,SANDOZ,,31.0,YR,,F,Y,98.0,KG,20180830.0,,OT,IT,IT,2018,Q3,Young Adult
153353501,15335350,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,32 IU BEFORE LUNCH AND 34 IU BEFORE DINNER,,,U,U,,,,,,,,2018,Q3,Normal newborn,,2018,Q3,1,I,,20180819.0,20180830,20180830,EXP,,PHHY2018IT079863,SANDOZ,,31.0,YR,,F,Y,98.0,KG,20180830.0,,OT,IT,IT,2018,Q3,Young Adult
153353501,15335350,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,32 IU BEFORE LUNCH AND 34 IU BEFORE DINNER,,,U,U,,,,,,,,2018,Q3,Off label use,,2018,Q3,1,I,,20180819.0,20180830,20180830,EXP,,PHHY2018IT079863,SANDOZ,,31.0,YR,,F,Y,98.0,KG,20180830.0,,OT,IT,IT,2018,Q3,Young Adult
153457711,15345771,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, PRN",,,U,U,,,,,,,,2018,Q3,Accidental overdose,,2018,Q3,1,I,20180816.0,20180822.0,20180904,20180904,PER,,US-ELI_LILLY_AND_COMPANY-US201808011383,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20180904.0,,CN,US,US,2018,Q3,Adult
153457711,15345771,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, PRN",,,U,U,,,,,,,,2018,Q3,Blood glucose increased,,2018,Q3,1,I,20180816.0,20180822.0,20180904,20180904,PER,,US-ELI_LILLY_AND_COMPANY-US201808011383,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20180904.0,,CN,US,US,2018,Q3,Adult
153457711,15345771,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, PRN",,,U,U,,,,,,,,2018,Q3,Inappropriate schedule of drug administration,,2018,Q3,1,I,20180816.0,20180822.0,20180904,20180904,PER,,US-ELI_LILLY_AND_COMPANY-US201808011383,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20180904.0,,CN,US,US,2018,Q3,Adult
153483081,15348308,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,UNKNOWN,,2018,Q3,Stem cell transplant,,2018,Q3,1,I,201707.0,20180822.0,20180904,20180904,EXP,,US-JNJFOC-20180832618,JANSSEN,,59.0,YR,A,M,Y,106.2,KG,20180904.0,,PH,US,US,2018,Q3,Adult
153514231,15351423,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Cellulitis,,2018,Q3,1,I,20180115.0,20180824.0,20180905,20180905,EXP,,US-ROCHE-2176445,ROCHE,,61.0,YR,,F,Y,,,20180905.0,,OT,US,US,2018,Q3,Adult
153514231,15351423,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Chronic obstructive pulmonary disease,,2018,Q3,1,I,20180115.0,20180824.0,20180905,20180905,EXP,,US-ROCHE-2176445,ROCHE,,61.0,YR,,F,Y,,,20180905.0,,OT,US,US,2018,Q3,Adult
153514231,15351423,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Influenza,,2018,Q3,1,I,20180115.0,20180824.0,20180905,20180905,EXP,,US-ROCHE-2176445,ROCHE,,61.0,YR,,F,Y,,,20180905.0,,OT,US,US,2018,Q3,Adult
153514231,15351423,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Skin ulcer,,2018,Q3,1,I,20180115.0,20180824.0,20180905,20180905,EXP,,US-ROCHE-2176445,ROCHE,,61.0,YR,,F,Y,,,20180905.0,,OT,US,US,2018,Q3,Adult
153514231,15351423,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Urinary tract infection,,2018,Q3,1,I,20180115.0,20180824.0,20180905,20180905,EXP,,US-ROCHE-2176445,ROCHE,,61.0,YR,,F,Y,,,20180905.0,,OT,US,US,2018,Q3,Adult
153550681,15355068,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 IU, 3X/DAY (BEFORE MEALS)",,,,,,,,10.0,IU,,TID,2018,Q3,Drug dose omission,,2018,Q3,1,I,,20160930.0,20180906,20180906,PER,,US-PFIZER INC-2016462146,PFIZER,,51.0,YR,,F,Y,,,20180906.0,,CN,US,US,2018,Q3,Adult
153550681,15355068,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 IU, 3X/DAY (BEFORE MEALS)",,,,,,,,10.0,IU,,TID,2018,Q3,Feeling abnormal,,2018,Q3,1,I,,20160930.0,20180906,20180906,PER,,US-PFIZER INC-2016462146,PFIZER,,51.0,YR,,F,Y,,,20180906.0,,CN,US,US,2018,Q3,Adult
153550681,15355068,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 IU, 3X/DAY (BEFORE MEALS)",,,,,,,,10.0,IU,,TID,2018,Q3,Headache,,2018,Q3,1,I,,20160930.0,20180906,20180906,PER,,US-PFIZER INC-2016462146,PFIZER,,51.0,YR,,F,Y,,,20180906.0,,CN,US,US,2018,Q3,Adult
153550681,15355068,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 IU, 3X/DAY (BEFORE MEALS)",,,,,,,,10.0,IU,,TID,2018,Q3,Pain,,2018,Q3,1,I,,20160930.0,20180906,20180906,PER,,US-PFIZER INC-2016462146,PFIZER,,51.0,YR,,F,Y,,,20180906.0,,CN,US,US,2018,Q3,Adult
153550681,15355068,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 IU, 3X/DAY (BEFORE MEALS)",,,,,,,,10.0,IU,,TID,2018,Q3,Pain in extremity,,2018,Q3,1,I,,20160930.0,20180906,20180906,PER,,US-PFIZER INC-2016462146,PFIZER,,51.0,YR,,F,Y,,,20180906.0,,CN,US,US,2018,Q3,Adult
153554451,15355445,3,C,Lispro Insulin,INSULIN LISPRO,1,Subcutaneous,"5 IU, 3X/DAY (TID)",51960.0,IU,,U,,,,5.0,IU,,TID,2018,Q3,Condition aggravated,,2018,Q3,1,I,20180705.0,20180828.0,20180906,20180906,EXP,,CO-UCBSA-2018039616,UCB,,69.0,YR,,F,Y,88.0,KG,20180906.0,,CN,CO,CO,2018,Q3,Elderly
153677651,15367765,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,"UNK UNK, UNK",,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q3,Amyloidosis,,2018,Q3,1,I,,20180828.0,20180910,20180910,EXP,,TR-SA-2018SA242972,SANOFI AVENTIS,"SENDUR S., KATIPOGLU K., KOCKARA O., GOKOZ O., KAYMAZ F., DAGDELEN S.. ELECTRON MICROSCOPIC FINDINGS OF INSULIN?INDUCED LOCAL AMYLOIDOSIS.. DIABETES.. 2018?67 SUPPL 1:(A278)",52.0,YR,A,M,Y,,,20180910.0,,OT,TR,TR,2018,Q3,Adult
153677651,15367765,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,"UNK UNK, UNK",,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q3,Injection site mass,,2018,Q3,1,I,,20180828.0,20180910,20180910,EXP,,TR-SA-2018SA242972,SANOFI AVENTIS,"SENDUR S., KATIPOGLU K., KOCKARA O., GOKOZ O., KAYMAZ F., DAGDELEN S.. ELECTRON MICROSCOPIC FINDINGS OF INSULIN?INDUCED LOCAL AMYLOIDOSIS.. DIABETES.. 2018?67 SUPPL 1:(A278)",52.0,YR,A,M,Y,,,20180910.0,,OT,TR,TR,2018,Q3,Adult
153683601,15368360,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, C858466,,,,,SOLUTION FOR INJECTION,,2018,Q3,Drug interaction,,2018,Q3,1,I,20180526.0,20180615.0,20180910,20180910,EXP,,PL-SA-2018SA162466,SANOFI AVENTIS,,60.0,YR,A,F,Y,52.0,KG,20180910.0,,CN,PL,PL,2018,Q3,Adult
153683601,15368360,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, C858466,,,,,SOLUTION FOR INJECTION,,2018,Q3,Hyperglycaemia,,2018,Q3,1,I,20180526.0,20180615.0,20180910,20180910,EXP,,PL-SA-2018SA162466,SANOFI AVENTIS,,60.0,YR,A,F,Y,52.0,KG,20180910.0,,CN,PL,PL,2018,Q3,Adult
153683601,15368360,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, C858466,,,,,SOLUTION FOR INJECTION,,2018,Q3,Hypoglycaemia,,2018,Q3,1,I,20180526.0,20180615.0,20180910,20180910,EXP,,PL-SA-2018SA162466,SANOFI AVENTIS,,60.0,YR,A,F,Y,52.0,KG,20180910.0,,CN,PL,PL,2018,Q3,Adult
153683601,15368360,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, C858466,,,,,SOLUTION FOR INJECTION,,2018,Q3,Osteomyelitis,,2018,Q3,1,I,20180526.0,20180615.0,20180910,20180910,EXP,,PL-SA-2018SA162466,SANOFI AVENTIS,,60.0,YR,A,F,Y,52.0,KG,20180910.0,,CN,PL,PL,2018,Q3,Adult
153683601,15368360,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, C858466,,,,,SOLUTION FOR INJECTION,,2018,Q3,Wrong drug administered,,2018,Q3,1,I,20180526.0,20180615.0,20180910,20180910,EXP,,PL-SA-2018SA162466,SANOFI AVENTIS,,60.0,YR,A,F,Y,52.0,KG,20180910.0,,CN,PL,PL,2018,Q3,Adult
153683871,15368387,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 U, EACH MORNING",,,U,U,,,20563.0,10.0,IU,,QD,2018,Q3,Blood glucose decreased,,2018,Q3,1,I,,20180904.0,20180910,20180910,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201809001332,ELI LILLY AND CO,,43.0,YR,,M,Y,,,20180910.0,,CN,CN,CN,2018,Q3,Adult
153683871,15368387,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 U, EACH MORNING",,,U,U,,,20563.0,10.0,IU,,QD,2018,Q3,Discomfort,,2018,Q3,1,I,,20180904.0,20180910,20180910,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201809001332,ELI LILLY AND CO,,43.0,YR,,M,Y,,,20180910.0,,CN,CN,CN,2018,Q3,Adult
153683871,15368387,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 U, EACH MORNING",,,U,U,,,20563.0,10.0,IU,,QD,2018,Q3,Hyperhidrosis,,2018,Q3,1,I,,20180904.0,20180910,20180910,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201809001332,ELI LILLY AND CO,,43.0,YR,,M,Y,,,20180910.0,,CN,CN,CN,2018,Q3,Adult
153683871,15368387,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 U, EACH MORNING",,,U,U,,,20563.0,10.0,IU,,QD,2018,Q3,Incorrect dose administered,,2018,Q3,1,I,,20180904.0,20180910,20180910,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201809001332,ELI LILLY AND CO,,43.0,YR,,M,Y,,,20180910.0,,CN,CN,CN,2018,Q3,Adult
153683871,15368387,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"8 U, EACH EVENING",,,U,U,,,20563.0,8.0,IU,,QD,2018,Q3,Blood glucose decreased,,2018,Q3,1,I,,20180904.0,20180910,20180910,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201809001332,ELI LILLY AND CO,,43.0,YR,,M,Y,,,20180910.0,,CN,CN,CN,2018,Q3,Adult
153683871,15368387,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"8 U, EACH EVENING",,,U,U,,,20563.0,8.0,IU,,QD,2018,Q3,Discomfort,,2018,Q3,1,I,,20180904.0,20180910,20180910,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201809001332,ELI LILLY AND CO,,43.0,YR,,M,Y,,,20180910.0,,CN,CN,CN,2018,Q3,Adult
153683871,15368387,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"8 U, EACH EVENING",,,U,U,,,20563.0,8.0,IU,,QD,2018,Q3,Hyperhidrosis,,2018,Q3,1,I,,20180904.0,20180910,20180910,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201809001332,ELI LILLY AND CO,,43.0,YR,,M,Y,,,20180910.0,,CN,CN,CN,2018,Q3,Adult
153683871,15368387,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"8 U, EACH EVENING",,,U,U,,,20563.0,8.0,IU,,QD,2018,Q3,Incorrect dose administered,,2018,Q3,1,I,,20180904.0,20180910,20180910,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201809001332,ELI LILLY AND CO,,43.0,YR,,M,Y,,,20180910.0,,CN,CN,CN,2018,Q3,Adult
153722891,15372289,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Cyanosis,,2018,Q3,1,I,,20180906.0,20180911,20180911,EXP,,US-FRESENIUS KABI-FK201809401,FRESENIUS KABI,,53.0,YR,,F,Y,,,20180911.0,,PH,US,US,2018,Q3,Adult
153722891,15372289,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Dyspnoea,,2018,Q3,1,I,,20180906.0,20180911,20180911,EXP,,US-FRESENIUS KABI-FK201809401,FRESENIUS KABI,,53.0,YR,,F,Y,,,20180911.0,,PH,US,US,2018,Q3,Adult
153722891,15372289,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Hypotension,,2018,Q3,1,I,,20180906.0,20180911,20180911,EXP,,US-FRESENIUS KABI-FK201809401,FRESENIUS KABI,,53.0,YR,,F,Y,,,20180911.0,,PH,US,US,2018,Q3,Adult
153722891,15372289,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Intentional product use issue,,2018,Q3,1,I,,20180906.0,20180911,20180911,EXP,,US-FRESENIUS KABI-FK201809401,FRESENIUS KABI,,53.0,YR,,F,Y,,,20180911.0,,PH,US,US,2018,Q3,Adult
153722891,15372289,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Wheezing,,2018,Q3,1,I,,20180906.0,20180911,20180911,EXP,,US-FRESENIUS KABI-FK201809401,FRESENIUS KABI,,53.0,YR,,F,Y,,,20180911.0,,PH,US,US,2018,Q3,Adult
153722911,15372291,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2018,Q3,Cardio-respiratory arrest,,2018,Q3,1,I,20180904.0,20180906.0,20180911,20180911,EXP,,US-FRESENIUS KABI-FK201809402,FRESENIUS KABI,,60.0,YR,,M,Y,,,20180911.0,,PH,US,US,2018,Q3,Adult
153722911,15372291,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2018,Q3,Intentional product use issue,,2018,Q3,1,I,20180904.0,20180906.0,20180911,20180911,EXP,,US-FRESENIUS KABI-FK201809402,FRESENIUS KABI,,60.0,YR,,M,Y,,,20180911.0,,PH,US,US,2018,Q3,Adult
153739501,15373950,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, PRN AT SLIDING SCALE",,,U,U,,,20563.0,,,,,2018,Q3,Diabetic ketoacidosis,,2018,Q3,1,I,20180903.0,20180905.0,20180912,20180912,EXP,,US-ELI_LILLY_AND_COMPANY-US201809002533,ELI LILLY AND CO,,34.0,YR,,M,Y,,,20180912.0,,MD,US,US,2018,Q3,Young Adult
153740641,15374064,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"18 U, EACH MORNING",,,Y,U,,,20563.0,18.0,IU,,QD,2018,Q3,Blood glucose abnormal,,2018,Q3,1,I,,20180904.0,20180912,20180912,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201809001382,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20180912.0,,CN,CN,CN,2018,Q3,Adult
153740641,15374064,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"18 U, EACH MORNING",,,Y,U,,,20563.0,18.0,IU,,QD,2018,Q3,Peripheral swelling,,2018,Q3,1,I,,20180904.0,20180912,20180912,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201809001382,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20180912.0,,CN,CN,CN,2018,Q3,Adult
153740641,15374064,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"24 U, EACH EVENING",,,Y,U,,,20563.0,24.0,IU,,QD,2018,Q3,Blood glucose abnormal,,2018,Q3,1,I,,20180904.0,20180912,20180912,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201809001382,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20180912.0,,CN,CN,CN,2018,Q3,Adult
153740641,15374064,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"24 U, EACH EVENING",,,Y,U,,,20563.0,24.0,IU,,QD,2018,Q3,Peripheral swelling,,2018,Q3,1,I,,20180904.0,20180912,20180912,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201809001382,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20180912.0,,CN,CN,CN,2018,Q3,Adult
153758581,15375858,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q3,Acute kidney injury,,2018,Q3,1,I,20141004.0,20151112.0,20180912,20180912,EXP,,US-ACTELION-A-US2015-127333,ACTELION,,54.0,YR,A,M,Y,,,20180912.0,,MD,US,US,2018,Q3,Adult
153758581,15375858,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q3,Angina unstable,,2018,Q3,1,I,20141004.0,20151112.0,20180912,20180912,EXP,,US-ACTELION-A-US2015-127333,ACTELION,,54.0,YR,A,M,Y,,,20180912.0,,MD,US,US,2018,Q3,Adult
153758581,15375858,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q3,Anxiety,,2018,Q3,1,I,20141004.0,20151112.0,20180912,20180912,EXP,,US-ACTELION-A-US2015-127333,ACTELION,,54.0,YR,A,M,Y,,,20180912.0,,MD,US,US,2018,Q3,Adult
153758581,15375858,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q3,Asthenia,,2018,Q3,1,I,20141004.0,20151112.0,20180912,20180912,EXP,,US-ACTELION-A-US2015-127333,ACTELION,,54.0,YR,A,M,Y,,,20180912.0,,MD,US,US,2018,Q3,Adult
153758581,15375858,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q3,Back pain,,2018,Q3,1,I,20141004.0,20151112.0,20180912,20180912,EXP,,US-ACTELION-A-US2015-127333,ACTELION,,54.0,YR,A,M,Y,,,20180912.0,,MD,US,US,2018,Q3,Adult
153758581,15375858,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q3,Blood bilirubin increased,,2018,Q3,1,I,20141004.0,20151112.0,20180912,20180912,EXP,,US-ACTELION-A-US2015-127333,ACTELION,,54.0,YR,A,M,Y,,,20180912.0,,MD,US,US,2018,Q3,Adult
153758581,15375858,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q3,Blood creatinine increased,,2018,Q3,1,I,20141004.0,20151112.0,20180912,20180912,EXP,,US-ACTELION-A-US2015-127333,ACTELION,,54.0,YR,A,M,Y,,,20180912.0,,MD,US,US,2018,Q3,Adult
153758581,15375858,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q3,Brain natriuretic peptide increased,,2018,Q3,1,I,20141004.0,20151112.0,20180912,20180912,EXP,,US-ACTELION-A-US2015-127333,ACTELION,,54.0,YR,A,M,Y,,,20180912.0,,MD,US,US,2018,Q3,Adult
153758581,15375858,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q3,Cardiac failure acute,,2018,Q3,1,I,20141004.0,20151112.0,20180912,20180912,EXP,,US-ACTELION-A-US2015-127333,ACTELION,,54.0,YR,A,M,Y,,,20180912.0,,MD,US,US,2018,Q3,Adult
153758581,15375858,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q3,Chest pain,,2018,Q3,1,I,20141004.0,20151112.0,20180912,20180912,EXP,,US-ACTELION-A-US2015-127333,ACTELION,,54.0,YR,A,M,Y,,,20180912.0,,MD,US,US,2018,Q3,Adult
153758581,15375858,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q3,Dizziness,,2018,Q3,1,I,20141004.0,20151112.0,20180912,20180912,EXP,,US-ACTELION-A-US2015-127333,ACTELION,,54.0,YR,A,M,Y,,,20180912.0,,MD,US,US,2018,Q3,Adult
153758581,15375858,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q3,Dyspnoea,,2018,Q3,1,I,20141004.0,20151112.0,20180912,20180912,EXP,,US-ACTELION-A-US2015-127333,ACTELION,,54.0,YR,A,M,Y,,,20180912.0,,MD,US,US,2018,Q3,Adult
153758581,15375858,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q3,Fatigue,,2018,Q3,1,I,20141004.0,20151112.0,20180912,20180912,EXP,,US-ACTELION-A-US2015-127333,ACTELION,,54.0,YR,A,M,Y,,,20180912.0,,MD,US,US,2018,Q3,Adult
153758581,15375858,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q3,Haemoglobin decreased,,2018,Q3,1,I,20141004.0,20151112.0,20180912,20180912,EXP,,US-ACTELION-A-US2015-127333,ACTELION,,54.0,YR,A,M,Y,,,20180912.0,,MD,US,US,2018,Q3,Adult
153758581,15375858,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q3,Hyperhidrosis,,2018,Q3,1,I,20141004.0,20151112.0,20180912,20180912,EXP,,US-ACTELION-A-US2015-127333,ACTELION,,54.0,YR,A,M,Y,,,20180912.0,,MD,US,US,2018,Q3,Adult
153758581,15375858,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q3,Hyperkalaemia,,2018,Q3,1,I,20141004.0,20151112.0,20180912,20180912,EXP,,US-ACTELION-A-US2015-127333,ACTELION,,54.0,YR,A,M,Y,,,20180912.0,,MD,US,US,2018,Q3,Adult
153758581,15375858,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q3,Hypertension,,2018,Q3,1,I,20141004.0,20151112.0,20180912,20180912,EXP,,US-ACTELION-A-US2015-127333,ACTELION,,54.0,YR,A,M,Y,,,20180912.0,,MD,US,US,2018,Q3,Adult
153758581,15375858,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q3,Hypotension,,2018,Q3,1,I,20141004.0,20151112.0,20180912,20180912,EXP,,US-ACTELION-A-US2015-127333,ACTELION,,54.0,YR,A,M,Y,,,20180912.0,,MD,US,US,2018,Q3,Adult
153758581,15375858,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q3,Hypoxia,,2018,Q3,1,I,20141004.0,20151112.0,20180912,20180912,EXP,,US-ACTELION-A-US2015-127333,ACTELION,,54.0,YR,A,M,Y,,,20180912.0,,MD,US,US,2018,Q3,Adult
153758581,15375858,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q3,Neurological complication associated with device,,2018,Q3,1,I,20141004.0,20151112.0,20180912,20180912,EXP,,US-ACTELION-A-US2015-127333,ACTELION,,54.0,YR,A,M,Y,,,20180912.0,,MD,US,US,2018,Q3,Adult
153758581,15375858,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q3,Non-cardiac chest pain,,2018,Q3,1,I,20141004.0,20151112.0,20180912,20180912,EXP,,US-ACTELION-A-US2015-127333,ACTELION,,54.0,YR,A,M,Y,,,20180912.0,,MD,US,US,2018,Q3,Adult
153758581,15375858,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q3,Normocytic anaemia,,2018,Q3,1,I,20141004.0,20151112.0,20180912,20180912,EXP,,US-ACTELION-A-US2015-127333,ACTELION,,54.0,YR,A,M,Y,,,20180912.0,,MD,US,US,2018,Q3,Adult
153758581,15375858,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q3,Oedema,,2018,Q3,1,I,20141004.0,20151112.0,20180912,20180912,EXP,,US-ACTELION-A-US2015-127333,ACTELION,,54.0,YR,A,M,Y,,,20180912.0,,MD,US,US,2018,Q3,Adult
153758581,15375858,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q3,Oedema peripheral,,2018,Q3,1,I,20141004.0,20151112.0,20180912,20180912,EXP,,US-ACTELION-A-US2015-127333,ACTELION,,54.0,YR,A,M,Y,,,20180912.0,,MD,US,US,2018,Q3,Adult
153758581,15375858,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q3,Oxygen saturation decreased,,2018,Q3,1,I,20141004.0,20151112.0,20180912,20180912,EXP,,US-ACTELION-A-US2015-127333,ACTELION,,54.0,YR,A,M,Y,,,20180912.0,,MD,US,US,2018,Q3,Adult
153758581,15375858,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q3,Pain,,2018,Q3,1,I,20141004.0,20151112.0,20180912,20180912,EXP,,US-ACTELION-A-US2015-127333,ACTELION,,54.0,YR,A,M,Y,,,20180912.0,,MD,US,US,2018,Q3,Adult
153758581,15375858,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q3,Pain in extremity,,2018,Q3,1,I,20141004.0,20151112.0,20180912,20180912,EXP,,US-ACTELION-A-US2015-127333,ACTELION,,54.0,YR,A,M,Y,,,20180912.0,,MD,US,US,2018,Q3,Adult
153758581,15375858,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q3,Palpitations,,2018,Q3,1,I,20141004.0,20151112.0,20180912,20180912,EXP,,US-ACTELION-A-US2015-127333,ACTELION,,54.0,YR,A,M,Y,,,20180912.0,,MD,US,US,2018,Q3,Adult
153758581,15375858,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q3,Renal failure,,2018,Q3,1,I,20141004.0,20151112.0,20180912,20180912,EXP,,US-ACTELION-A-US2015-127333,ACTELION,,54.0,YR,A,M,Y,,,20180912.0,,MD,US,US,2018,Q3,Adult
153758581,15375858,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q3,Tachycardia,,2018,Q3,1,I,20141004.0,20151112.0,20180912,20180912,EXP,,US-ACTELION-A-US2015-127333,ACTELION,,54.0,YR,A,M,Y,,,20180912.0,,MD,US,US,2018,Q3,Adult
153758581,15375858,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q3,Vomiting,,2018,Q3,1,I,20141004.0,20151112.0,20180912,20180912,EXP,,US-ACTELION-A-US2015-127333,ACTELION,,54.0,YR,A,M,Y,,,20180912.0,,MD,US,US,2018,Q3,Adult
153774831,15377483,8,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Blood creatinine increased,,2018,Q3,1,I,20180728.0,,20180906,20180906,DIR,,,FDA-CTU,,48.0,YR,,M,N,109.5,KG,20180906.0,N,PH,US,US,2018,Q3,Adult
153774831,15377483,8,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Foot amputation,,2018,Q3,1,I,20180728.0,,20180906,20180906,DIR,,,FDA-CTU,,48.0,YR,,M,N,109.5,KG,20180906.0,N,PH,US,US,2018,Q3,Adult
153774831,15377483,8,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Renal tubular necrosis,,2018,Q3,1,I,20180728.0,,20180906,20180906,DIR,,,FDA-CTU,,48.0,YR,,M,N,109.5,KG,20180906.0,N,PH,US,US,2018,Q3,Adult
153778633,15377863,11,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,10 UNITS TID,,,U,,,,,,,,,2018,Q3,Bronchitis,,2018,Q3,3,F,20180829.0,20180926.0,20180913,20180930,EXP,,CA-HLSUS-2018-CA-001342,HLS THERAPEUTICS,,54.0,YR,A,M,Y,,,20180929.0,,MD,CA,CA,2018,Q3,Adult
153778633,15377863,11,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,10 UNITS TID,,,U,,,,,,,,,2018,Q3,Death,,2018,Q3,3,F,20180829.0,20180926.0,20180913,20180930,EXP,,CA-HLSUS-2018-CA-001342,HLS THERAPEUTICS,,54.0,YR,A,M,Y,,,20180929.0,,MD,CA,CA,2018,Q3,Adult
153847641,15384764,1,PS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"15 IU, DAILY",60.0,IU,Y,U,,,20563.0,15.0,IU,,QD,2018,Q3,Eosinophilia,,2018,Q3,1,I,20180708.0,20180903.0,20180914,20180914,EXP,IT-MINISAL02-496673,IT-ELI_LILLY_AND_COMPANY-IT201809000855,ELI LILLY AND CO,,66.0,YR,,F,Y,110.0,KG,20180914.0,,CN,IT,IT,2018,Q3,Elderly
153847641,15384764,1,PS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"15 IU, DAILY",60.0,IU,Y,U,,,20563.0,15.0,IU,,QD,2018,Q3,Rash,,2018,Q3,1,I,20180708.0,20180903.0,20180914,20180914,EXP,IT-MINISAL02-496673,IT-ELI_LILLY_AND_COMPANY-IT201809000855,ELI LILLY AND CO,,66.0,YR,,F,Y,110.0,KG,20180914.0,,CN,IT,IT,2018,Q3,Elderly
153873073,15387307,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q3,Acute kidney injury,,2018,Q3,3,F,20180907.0,20180920.0,20180914,20180926,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-083932,BRISTOL MYERS SQUIBB,,59.0,YR,,M,Y,108.6,KG,20180926.0,,OT,US,US,2018,Q3,Adult
153873073,15387307,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q3,Asthenia,,2018,Q3,3,F,20180907.0,20180920.0,20180914,20180926,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-083932,BRISTOL MYERS SQUIBB,,59.0,YR,,M,Y,108.6,KG,20180926.0,,OT,US,US,2018,Q3,Adult
153873073,15387307,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q3,Encephalopathy,,2018,Q3,3,F,20180907.0,20180920.0,20180914,20180926,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-083932,BRISTOL MYERS SQUIBB,,59.0,YR,,M,Y,108.6,KG,20180926.0,,OT,US,US,2018,Q3,Adult
153873073,15387307,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q3,Hypokalaemia,,2018,Q3,3,F,20180907.0,20180920.0,20180914,20180926,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-083932,BRISTOL MYERS SQUIBB,,59.0,YR,,M,Y,108.6,KG,20180926.0,,OT,US,US,2018,Q3,Adult
153900991,15390099,4,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Bronchospasm,,2018,Q3,1,I,20180904.0,,20180907,20180907,DIR,,,FDA-CTU,,60.0,YR,,M,N,128.0,KG,20180907.0,Y,PH,US,US,2018,Q3,Adult
153900991,15390099,4,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Cardio-respiratory arrest,,2018,Q3,1,I,20180904.0,,20180907,20180907,DIR,,,FDA-CTU,,60.0,YR,,M,N,128.0,KG,20180907.0,Y,PH,US,US,2018,Q3,Adult
153900991,15390099,4,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Cyanosis,,2018,Q3,1,I,20180904.0,,20180907,20180907,DIR,,,FDA-CTU,,60.0,YR,,M,N,128.0,KG,20180907.0,Y,PH,US,US,2018,Q3,Adult
153900991,15390099,4,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Dyspnoea,,2018,Q3,1,I,20180904.0,,20180907,20180907,DIR,,,FDA-CTU,,60.0,YR,,M,N,128.0,KG,20180907.0,Y,PH,US,US,2018,Q3,Adult
153900991,15390099,4,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Hypotension,,2018,Q3,1,I,20180904.0,,20180907,20180907,DIR,,,FDA-CTU,,60.0,YR,,M,N,128.0,KG,20180907.0,Y,PH,US,US,2018,Q3,Adult
153900991,15390099,4,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Hypoxia,,2018,Q3,1,I,20180904.0,,20180907,20180907,DIR,,,FDA-CTU,,60.0,YR,,M,N,128.0,KG,20180907.0,Y,PH,US,US,2018,Q3,Adult
153900991,15390099,4,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Product quality issue,,2018,Q3,1,I,20180904.0,,20180907,20180907,DIR,,,FDA-CTU,,60.0,YR,,M,N,128.0,KG,20180907.0,Y,PH,US,US,2018,Q3,Adult
153900991,15390099,4,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Wheezing,,2018,Q3,1,I,20180904.0,,20180907,20180907,DIR,,,FDA-CTU,,60.0,YR,,M,N,128.0,KG,20180907.0,Y,PH,US,US,2018,Q3,Adult
154036141,15403614,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, BID",,,,,,,20563.0,,,,BID,2018,Q3,Blood glucose decreased,,2018,Q3,1,I,,20180911.0,20180919,20180919,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201809006027,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20180919.0,,CN,IN,IN,2018,Q3,Elderly
154036141,15403614,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, BID",,,,,,,20563.0,,,,BID,2018,Q3,Feeling cold,,2018,Q3,1,I,,20180911.0,20180919,20180919,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201809006027,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20180919.0,,CN,IN,IN,2018,Q3,Elderly
154036141,15403614,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, BID",,,,,,,20563.0,,,,BID,2018,Q3,Hyperhidrosis,,2018,Q3,1,I,,20180911.0,20180919,20180919,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201809006027,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20180919.0,,CN,IN,IN,2018,Q3,Elderly
154036141,15403614,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, BID",,,,,,,20563.0,,,,BID,2018,Q3,Hypotension,,2018,Q3,1,I,,20180911.0,20180919,20180919,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201809006027,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20180919.0,,CN,IN,IN,2018,Q3,Elderly
154036141,15403614,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, BID",,,,,,,20563.0,,,,BID,2018,Q3,Injection site swelling,,2018,Q3,1,I,,20180911.0,20180919,20180919,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201809006027,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20180919.0,,CN,IN,IN,2018,Q3,Elderly
154038771,15403877,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 U, 4?6 UU 3 X DAILY.",,,,,,,,,,,,2018,Q3,Anaemia,,2018,Q3,1,I,,20180918.0,20180919,20180919,EXP,,EE-ABBVIE-18P-221-2491320-00,ABBVIE,HEIN H. KIDNEY TRANSPLANTATION. PEREARST.. 2018 AUG 29?.,45.0,YR,,F,Y,,,20180919.0,,OT,COUNTRY NOT SPECIFIED,EE,2018,Q3,Adult
154038771,15403877,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 U, 4?6 UU 3 X DAILY.",,,,,,,,,,,,2018,Q3,Dermatitis,,2018,Q3,1,I,,20180918.0,20180919,20180919,EXP,,EE-ABBVIE-18P-221-2491320-00,ABBVIE,HEIN H. KIDNEY TRANSPLANTATION. PEREARST.. 2018 AUG 29?.,45.0,YR,,F,Y,,,20180919.0,,OT,COUNTRY NOT SPECIFIED,EE,2018,Q3,Adult
154038771,15403877,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 U, 4?6 UU 3 X DAILY.",,,,,,,,,,,,2018,Q3,Urinary tract infection,,2018,Q3,1,I,,20180918.0,20180919,20180919,EXP,,EE-ABBVIE-18P-221-2491320-00,ABBVIE,HEIN H. KIDNEY TRANSPLANTATION. PEREARST.. 2018 AUG 29?.,45.0,YR,,F,Y,,,20180919.0,,OT,COUNTRY NOT SPECIFIED,EE,2018,Q3,Adult
154194641,15419464,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"24 IU, QD",,,,,,,,24.0,IU,,QD,2018,Q3,Depressed level of consciousness,,2018,Q3,1,I,20180203.0,20180912.0,20180924,20180924,EXP,IT-MINISAL02-497583,IT-SA-2018SA257799,SANOFI AVENTIS,,72.0,YR,E,M,Y,,,20180924.0,,MD,IT,IT,2018,Q3,Elderly
154194641,15419464,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"24 IU, QD",,,,,,,,24.0,IU,,QD,2018,Q3,Dizziness,,2018,Q3,1,I,20180203.0,20180912.0,20180924,20180924,EXP,IT-MINISAL02-497583,IT-SA-2018SA257799,SANOFI AVENTIS,,72.0,YR,E,M,Y,,,20180924.0,,MD,IT,IT,2018,Q3,Elderly
154194641,15419464,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"24 IU, QD",,,,,,,,24.0,IU,,QD,2018,Q3,Hypoglycaemia,,2018,Q3,1,I,20180203.0,20180912.0,20180924,20180924,EXP,IT-MINISAL02-497583,IT-SA-2018SA257799,SANOFI AVENTIS,,72.0,YR,E,M,Y,,,20180924.0,,MD,IT,IT,2018,Q3,Elderly
154194641,15419464,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"24 IU, QD",,,,,,,,24.0,IU,,QD,2018,Q3,Malaise,,2018,Q3,1,I,20180203.0,20180912.0,20180924,20180924,EXP,IT-MINISAL02-497583,IT-SA-2018SA257799,SANOFI AVENTIS,,72.0,YR,E,M,Y,,,20180924.0,,MD,IT,IT,2018,Q3,Elderly
154194641,15419464,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"24 IU, QD",,,,,,,,24.0,IU,,QD,2018,Q3,Neurological symptom,,2018,Q3,1,I,20180203.0,20180912.0,20180924,20180924,EXP,IT-MINISAL02-497583,IT-SA-2018SA257799,SANOFI AVENTIS,,72.0,YR,E,M,Y,,,20180924.0,,MD,IT,IT,2018,Q3,Elderly
154254841,15425484,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 IU, QD",1020.0,IU,Y,,,,,15.0,IU,,QD,2018,Q3,Cold sweat,,2018,Q3,1,I,20180529.0,20180619.0,20180925,20180925,EXP,IT-MINISAL02-482261,IT-SA-2018SA165579,SANOFI AVENTIS,,84.0,YR,E,M,Y,,,20180925.0,,MD,IT,IT,2018,Q3,Elderly
154254841,15425484,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 IU, QD",1020.0,IU,Y,,,,,15.0,IU,,QD,2018,Q3,Confusional state,,2018,Q3,1,I,20180529.0,20180619.0,20180925,20180925,EXP,IT-MINISAL02-482261,IT-SA-2018SA165579,SANOFI AVENTIS,,84.0,YR,E,M,Y,,,20180925.0,,MD,IT,IT,2018,Q3,Elderly
154254841,15425484,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 IU, QD",1020.0,IU,Y,,,,,15.0,IU,,QD,2018,Q3,Hypoglycaemic coma,,2018,Q3,1,I,20180529.0,20180619.0,20180925,20180925,EXP,IT-MINISAL02-482261,IT-SA-2018SA165579,SANOFI AVENTIS,,84.0,YR,E,M,Y,,,20180925.0,,MD,IT,IT,2018,Q3,Elderly
154320441,15432044,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,U,,,,,,SOLUTION FOR INJECTION,,2018,Q3,Hypoglycaemia,,2018,Q3,1,I,,20180919.0,20180926,20180926,EXP,,FR-ELI_LILLY_AND_COMPANY-FR201809009108,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20180926.0,,CN,FR,FR,2018,Q3,Elderly
154320441,15432044,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,U,,,,,,SOLUTION FOR INJECTION,,2018,Q3,Intercepted drug prescribing error,,2018,Q3,1,I,,20180919.0,20180926,20180926,EXP,,FR-ELI_LILLY_AND_COMPANY-FR201809009108,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20180926.0,,CN,FR,FR,2018,Q3,Elderly
154320441,15432044,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,U,,,,,,SOLUTION FOR INJECTION,,2018,Q3,Throat cancer,,2018,Q3,1,I,,20180919.0,20180926,20180926,EXP,,FR-ELI_LILLY_AND_COMPANY-FR201809009108,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20180926.0,,CN,FR,FR,2018,Q3,Elderly
154402421,15440242,6,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Diabetes mellitus inadequate control,,2018,Q3,1,I,20180925.0,,20180925,20180925,DIR,,,FDA-CTU,,62.0,YR,,F,N,81.9,KG,20180925.0,N,PH,US,US,2018,Q3,Adult
154402421,15440242,6,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Glycosylated haemoglobin increased,,2018,Q3,1,I,20180925.0,,20180925,20180925,DIR,,,FDA-CTU,,62.0,YR,,F,N,81.9,KG,20180925.0,N,PH,US,US,2018,Q3,Adult
154402421,15440242,6,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q3,Weight increased,,2018,Q3,1,I,20180925.0,,20180925,20180925,DIR,,,FDA-CTU,,62.0,YR,,F,N,81.9,KG,20180925.0,N,PH,US,US,2018,Q3,Adult
101814623,10181462,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2018,Q4,Decreased appetite,,2018,Q4,3,F,2007.0,20181001.0,20140519,20181008,EXP,,US-SA-2014SA062119,SANOFI AVENTIS,,66.0,YR,E,M,Y,129.27,KG,20181008.0,,CN,US,US,2018,Q4,Elderly
101814623,10181462,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2018,Q4,Fall,,2018,Q4,3,F,2007.0,20181001.0,20140519,20181008,EXP,,US-SA-2014SA062119,SANOFI AVENTIS,,66.0,YR,E,M,Y,129.27,KG,20181008.0,,CN,US,US,2018,Q4,Elderly
101814623,10181462,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2018,Q4,Heart rate decreased,,2018,Q4,3,F,2007.0,20181001.0,20140519,20181008,EXP,,US-SA-2014SA062119,SANOFI AVENTIS,,66.0,YR,E,M,Y,129.27,KG,20181008.0,,CN,US,US,2018,Q4,Elderly
101814623,10181462,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2018,Q4,Heart rate irregular,,2018,Q4,3,F,2007.0,20181001.0,20140519,20181008,EXP,,US-SA-2014SA062119,SANOFI AVENTIS,,66.0,YR,E,M,Y,129.27,KG,20181008.0,,CN,US,US,2018,Q4,Elderly
101814623,10181462,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2018,Q4,Loss of personal independence in daily activities,,2018,Q4,3,F,2007.0,20181001.0,20140519,20181008,EXP,,US-SA-2014SA062119,SANOFI AVENTIS,,66.0,YR,E,M,Y,129.27,KG,20181008.0,,CN,US,US,2018,Q4,Elderly
101814623,10181462,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2018,Q4,Myocardial infarction,,2018,Q4,3,F,2007.0,20181001.0,20140519,20181008,EXP,,US-SA-2014SA062119,SANOFI AVENTIS,,66.0,YR,E,M,Y,129.27,KG,20181008.0,,CN,US,US,2018,Q4,Elderly
101814623,10181462,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2018,Q4,Pituitary tumour,,2018,Q4,3,F,2007.0,20181001.0,20140519,20181008,EXP,,US-SA-2014SA062119,SANOFI AVENTIS,,66.0,YR,E,M,Y,129.27,KG,20181008.0,,CN,US,US,2018,Q4,Elderly
101814623,10181462,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2018,Q4,Product use issue,,2018,Q4,3,F,2007.0,20181001.0,20140519,20181008,EXP,,US-SA-2014SA062119,SANOFI AVENTIS,,66.0,YR,E,M,Y,129.27,KG,20181008.0,,CN,US,US,2018,Q4,Elderly
101814623,10181462,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2018,Q4,Upper limb fracture,,2018,Q4,3,F,2007.0,20181001.0,20140519,20181008,EXP,,US-SA-2014SA062119,SANOFI AVENTIS,,66.0,YR,E,M,Y,129.27,KG,20181008.0,,CN,US,US,2018,Q4,Elderly
101814623,10181462,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2018,Q4,Vascular graft,,2018,Q4,3,F,2007.0,20181001.0,20140519,20181008,EXP,,US-SA-2014SA062119,SANOFI AVENTIS,,66.0,YR,E,M,Y,129.27,KG,20181008.0,,CN,US,US,2018,Q4,Elderly
101814623,10181462,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2018,Q4,Decreased appetite,,2018,Q4,3,F,2007.0,20181001.0,20140519,20181008,EXP,,US-SA-2014SA062119,SANOFI AVENTIS,,66.0,YR,E,M,Y,129.27,KG,20181008.0,,CN,US,US,2018,Q4,Elderly
101814623,10181462,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2018,Q4,Fall,,2018,Q4,3,F,2007.0,20181001.0,20140519,20181008,EXP,,US-SA-2014SA062119,SANOFI AVENTIS,,66.0,YR,E,M,Y,129.27,KG,20181008.0,,CN,US,US,2018,Q4,Elderly
101814623,10181462,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2018,Q4,Heart rate decreased,,2018,Q4,3,F,2007.0,20181001.0,20140519,20181008,EXP,,US-SA-2014SA062119,SANOFI AVENTIS,,66.0,YR,E,M,Y,129.27,KG,20181008.0,,CN,US,US,2018,Q4,Elderly
101814623,10181462,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2018,Q4,Heart rate irregular,,2018,Q4,3,F,2007.0,20181001.0,20140519,20181008,EXP,,US-SA-2014SA062119,SANOFI AVENTIS,,66.0,YR,E,M,Y,129.27,KG,20181008.0,,CN,US,US,2018,Q4,Elderly
101814623,10181462,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2018,Q4,Loss of personal independence in daily activities,,2018,Q4,3,F,2007.0,20181001.0,20140519,20181008,EXP,,US-SA-2014SA062119,SANOFI AVENTIS,,66.0,YR,E,M,Y,129.27,KG,20181008.0,,CN,US,US,2018,Q4,Elderly
101814623,10181462,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2018,Q4,Myocardial infarction,,2018,Q4,3,F,2007.0,20181001.0,20140519,20181008,EXP,,US-SA-2014SA062119,SANOFI AVENTIS,,66.0,YR,E,M,Y,129.27,KG,20181008.0,,CN,US,US,2018,Q4,Elderly
101814623,10181462,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2018,Q4,Pituitary tumour,,2018,Q4,3,F,2007.0,20181001.0,20140519,20181008,EXP,,US-SA-2014SA062119,SANOFI AVENTIS,,66.0,YR,E,M,Y,129.27,KG,20181008.0,,CN,US,US,2018,Q4,Elderly
101814623,10181462,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2018,Q4,Product use issue,,2018,Q4,3,F,2007.0,20181001.0,20140519,20181008,EXP,,US-SA-2014SA062119,SANOFI AVENTIS,,66.0,YR,E,M,Y,129.27,KG,20181008.0,,CN,US,US,2018,Q4,Elderly
101814623,10181462,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2018,Q4,Upper limb fracture,,2018,Q4,3,F,2007.0,20181001.0,20140519,20181008,EXP,,US-SA-2014SA062119,SANOFI AVENTIS,,66.0,YR,E,M,Y,129.27,KG,20181008.0,,CN,US,US,2018,Q4,Elderly
101814623,10181462,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2018,Q4,Vascular graft,,2018,Q4,3,F,2007.0,20181001.0,20140519,20181008,EXP,,US-SA-2014SA062119,SANOFI AVENTIS,,66.0,YR,E,M,Y,129.27,KG,20181008.0,,CN,US,US,2018,Q4,Elderly
121319694,12131969,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,UNSPECIFIED,,2018,Q4,Gastrointestinal haemorrhage,,2018,Q4,4,F,20150524.0,20181102.0,20160301,20181118,PER,,US-JNJFOC-20160214859,JANSSEN,,77.0,YR,E,F,Y,,,20181118.0,,CN,US,US,2018,Q4,Elderly
124218524,12421852,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q4H,2018,Q4,Haemorrhagic anaemia,,2018,Q4,4,F,20150831.0,20181128.0,20160531,20181204,PER,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-33991BI",BOEHRINGER INGELHEIM,,72.0,YR,,F,Y,124.73,KG,20181204.0,,CN,US,US,2018,Q4,Elderly
124218524,12421852,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q4H,2018,Q4,Internal haemorrhage,,2018,Q4,4,F,20150831.0,20181128.0,20160531,20181204,PER,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-33991BI",BOEHRINGER INGELHEIM,,72.0,YR,,F,Y,124.73,KG,20181204.0,,CN,US,US,2018,Q4,Elderly
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Acute respiratory distress syndrome,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Acute respiratory failure,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Anaemia,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Antimitochondrial antibody,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Antinuclear antibody increased,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Apraxia,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Arrhythmia supraventricular,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Atrial fibrillation,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Atrial flutter,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Blood alkaline phosphatase increased,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Blood creatinine increased,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Blood urea increased,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Buttock injury,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Clostridium difficile infection,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Condition aggravated,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Cor pulmonale acute,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Cough,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Deep vein thrombosis,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Dehydration,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Diarrhoea,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Dizziness,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Double stranded DNA antibody,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Dysphonia,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Dyspnoea,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Extrapyramidal disorder,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Eye disorder,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Eye movement disorder,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Hepatic congestion,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Hepatic ischaemia,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Hypotension,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Hypoxia,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,International normalised ratio increased,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Ischaemic hepatitis,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Leukocytosis,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Liver function test increased,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Metabolic acidosis,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Metabolic encephalopathy,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Oral candidiasis,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Pneumonia,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Polyneuropathy,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Pulmonary hypertension,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Pyrexia,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Renal failure,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Renal tubular necrosis,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Respiratory distress,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Respiratory tract infection,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Right ventricular failure,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Sepsis,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Septic shock,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Skin disorder,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Tachycardia,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Tachypnoea,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Thrombocytopenia,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Transaminases increased,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Transfusion,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Urinary tract infection,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Urine output decreased,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1250646510,12506465,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, Q6HRS",,,,U,,,,,,,QID,2018,Q4,Vasculitis,,2018,Q4,10,F,20160529.0,20181018.0,20160628,20181029,EXP,,US-ACTELION-A-US2016-137893,ACTELION,,61.0,YR,A,F,Y,,,20181029.0,,MD,US,US,2018,Q4,Adult
1309584221,13095842,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q4,Conjunctivitis,,2018,Q4,21,F,20161231.0,20181012.0,20170109,20181017,EXP,,US-ROCHE-1874437,ROCHE,,68.0,YR,,F,Y,51.5,KG,20181017.0,,MD,US,US,2018,Q4,Elderly
1309584221,13095842,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q4,Death,,2018,Q4,21,F,20161231.0,20181012.0,20170109,20181017,EXP,,US-ROCHE-1874437,ROCHE,,68.0,YR,,F,Y,51.5,KG,20181017.0,,MD,US,US,2018,Q4,Elderly
1309584221,13095842,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q4,Drug eruption,,2018,Q4,21,F,20161231.0,20181012.0,20170109,20181017,EXP,,US-ROCHE-1874437,ROCHE,,68.0,YR,,F,Y,51.5,KG,20181017.0,,MD,US,US,2018,Q4,Elderly
1309584221,13095842,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q4,Haemolytic uraemic syndrome,,2018,Q4,21,F,20161231.0,20181012.0,20170109,20181017,EXP,,US-ROCHE-1874437,ROCHE,,68.0,YR,,F,Y,51.5,KG,20181017.0,,MD,US,US,2018,Q4,Elderly
1309584221,13095842,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q4,Mucosal inflammation,,2018,Q4,21,F,20161231.0,20181012.0,20170109,20181017,EXP,,US-ROCHE-1874437,ROCHE,,68.0,YR,,F,Y,51.5,KG,20181017.0,,MD,US,US,2018,Q4,Elderly
130970892,13097089,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK ML,,,,,,,,,,,,2018,Q4,Ear haemorrhage,,2018,Q4,2,F,20130526.0,20181128.0,20170109,20181206,EXP,,US-BAYER-2016-233686,BAYER,,43.0,YR,A,F,Y,,,20181206.0,,CN,US,US,2018,Q4,Adult
130970892,13097089,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK ML,,,,,,,,,,,,2018,Q4,Haemoptysis,,2018,Q4,2,F,20130526.0,20181128.0,20170109,20181206,EXP,,US-BAYER-2016-233686,BAYER,,43.0,YR,A,F,Y,,,20181206.0,,CN,US,US,2018,Q4,Adult
132930682,13293068,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 UNITS/ML,,,D,,,,,,,UNSPECIFIED,,2018,Q4,Ear haemorrhage,,2018,Q4,2,F,20130526.0,20181128.0,20170303,20181210,PER,,US-JNJFOC-20161207205,JANSSEN,,43.0,YR,A,F,Y,,,20181210.0,,CN,US,US,2018,Q4,Adult
132930682,13293068,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 UNITS/ML,,,D,,,,,,,UNSPECIFIED,,2018,Q4,Haemoptysis,,2018,Q4,2,F,20130526.0,20181128.0,20170303,20181210,PER,,US-JNJFOC-20161207205,JANSSEN,,43.0,YR,A,F,Y,,,20181210.0,,CN,US,US,2018,Q4,Adult
1336063113,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q4,Acute respiratory failure,,2018,Q4,13,F,20150120.0,20181106.0,20170322,20181114,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20181114.0,,PH,US,US,2018,Q4,Elderly
1336063113,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q4,Adverse drug reaction,,2018,Q4,13,F,20150120.0,20181106.0,20170322,20181114,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20181114.0,,PH,US,US,2018,Q4,Elderly
1336063113,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q4,Anaemia,,2018,Q4,13,F,20150120.0,20181106.0,20170322,20181114,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20181114.0,,PH,US,US,2018,Q4,Elderly
1336063113,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q4,Asthenia,,2018,Q4,13,F,20150120.0,20181106.0,20170322,20181114,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20181114.0,,PH,US,US,2018,Q4,Elderly
1336063113,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q4,Bronchial secretion retention,,2018,Q4,13,F,20150120.0,20181106.0,20170322,20181114,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20181114.0,,PH,US,US,2018,Q4,Elderly
1336063113,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q4,Bronchitis bacterial,,2018,Q4,13,F,20150120.0,20181106.0,20170322,20181114,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20181114.0,,PH,US,US,2018,Q4,Elderly
1336063113,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q4,Bronchoalveolar lavage,,2018,Q4,13,F,20150120.0,20181106.0,20170322,20181114,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20181114.0,,PH,US,US,2018,Q4,Elderly
1336063113,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q4,Candida infection,,2018,Q4,13,F,20150120.0,20181106.0,20170322,20181114,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20181114.0,,PH,US,US,2018,Q4,Elderly
1336063113,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q4,Chest pain,,2018,Q4,13,F,20150120.0,20181106.0,20170322,20181114,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20181114.0,,PH,US,US,2018,Q4,Elderly
1336063113,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q4,Chronic obstructive pulmonary disease,,2018,Q4,13,F,20150120.0,20181106.0,20170322,20181114,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20181114.0,,PH,US,US,2018,Q4,Elderly
1336063113,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q4,Condition aggravated,,2018,Q4,13,F,20150120.0,20181106.0,20170322,20181114,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20181114.0,,PH,US,US,2018,Q4,Elderly
1336063113,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q4,Cough,,2018,Q4,13,F,20150120.0,20181106.0,20170322,20181114,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20181114.0,,PH,US,US,2018,Q4,Elderly
1336063113,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q4,Disease progression,,2018,Q4,13,F,20150120.0,20181106.0,20170322,20181114,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20181114.0,,PH,US,US,2018,Q4,Elderly
1336063113,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q4,Drug intolerance,,2018,Q4,13,F,20150120.0,20181106.0,20170322,20181114,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20181114.0,,PH,US,US,2018,Q4,Elderly
1336063113,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q4,Dyspnoea,,2018,Q4,13,F,20150120.0,20181106.0,20170322,20181114,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20181114.0,,PH,US,US,2018,Q4,Elderly
1336063113,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q4,Lung adenocarcinoma recurrent,,2018,Q4,13,F,20150120.0,20181106.0,20170322,20181114,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20181114.0,,PH,US,US,2018,Q4,Elderly
1336063113,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q4,Metastases to kidney,,2018,Q4,13,F,20150120.0,20181106.0,20170322,20181114,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20181114.0,,PH,US,US,2018,Q4,Elderly
1336063113,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q4,Packed red blood cell transfusion,,2018,Q4,13,F,20150120.0,20181106.0,20170322,20181114,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20181114.0,,PH,US,US,2018,Q4,Elderly
1336063113,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q4,Platelet transfusion,,2018,Q4,13,F,20150120.0,20181106.0,20170322,20181114,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20181114.0,,PH,US,US,2018,Q4,Elderly
1336063113,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q4,Pneumonia,,2018,Q4,13,F,20150120.0,20181106.0,20170322,20181114,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20181114.0,,PH,US,US,2018,Q4,Elderly
1336063113,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q4,Pneumonia pseudomonal,,2018,Q4,13,F,20150120.0,20181106.0,20170322,20181114,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20181114.0,,PH,US,US,2018,Q4,Elderly
1336063113,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q4,Productive cough,,2018,Q4,13,F,20150120.0,20181106.0,20170322,20181114,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20181114.0,,PH,US,US,2018,Q4,Elderly
1336063113,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q4,Pseudomonas infection,,2018,Q4,13,F,20150120.0,20181106.0,20170322,20181114,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20181114.0,,PH,US,US,2018,Q4,Elderly
1336063113,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q4,Pseudomonas test positive,,2018,Q4,13,F,20150120.0,20181106.0,20170322,20181114,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20181114.0,,PH,US,US,2018,Q4,Elderly
1336063113,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q4,Pulmonary congestion,,2018,Q4,13,F,20150120.0,20181106.0,20170322,20181114,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20181114.0,,PH,US,US,2018,Q4,Elderly
1336063113,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q4,Pulmonary mass,,2018,Q4,13,F,20150120.0,20181106.0,20170322,20181114,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20181114.0,,PH,US,US,2018,Q4,Elderly
1336063113,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q4,Pyrexia,,2018,Q4,13,F,20150120.0,20181106.0,20170322,20181114,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20181114.0,,PH,US,US,2018,Q4,Elderly
1336063113,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q4,Renal cell carcinoma,,2018,Q4,13,F,20150120.0,20181106.0,20170322,20181114,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20181114.0,,PH,US,US,2018,Q4,Elderly
1336063113,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q4,Respiratory distress,,2018,Q4,13,F,20150120.0,20181106.0,20170322,20181114,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20181114.0,,PH,US,US,2018,Q4,Elderly
1336063113,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q4,Secretion discharge,,2018,Q4,13,F,20150120.0,20181106.0,20170322,20181114,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20181114.0,,PH,US,US,2018,Q4,Elderly
1336063113,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q4,Small cell lung cancer metastatic,,2018,Q4,13,F,20150120.0,20181106.0,20170322,20181114,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20181114.0,,PH,US,US,2018,Q4,Elderly
1336063113,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q4,Sputum culture positive,,2018,Q4,13,F,20150120.0,20181106.0,20170322,20181114,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20181114.0,,PH,US,US,2018,Q4,Elderly
1336063113,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q4,Stenotrophomonas infection,,2018,Q4,13,F,20150120.0,20181106.0,20170322,20181114,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20181114.0,,PH,US,US,2018,Q4,Elderly
1336063113,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q4,Tachypnoea,,2018,Q4,13,F,20150120.0,20181106.0,20170322,20181114,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20181114.0,,PH,US,US,2018,Q4,Elderly
1336063113,13360631,18,C,INSULINE LISPRO,,2,,UNK,,,,U,,,,,,,,2018,Q4,Transfusion,,2018,Q4,13,F,20150120.0,20181106.0,20170322,20181114,EXP,,US-ACTELION-A-US2015-114599,ACTELION,,65.0,YR,E,M,Y,,,20181114.0,,PH,US,US,2018,Q4,Elderly
133963983,13396398,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,20 UNITS 2XDAY,,,D,,,,,,,UNSPECIFIED,,2018,Q4,Acute kidney injury,,2018,Q4,3,F,20160202.0,20181214.0,20170403,20181218,EXP,,US-JNJFOC-20170214849,JANSSEN,,48.0,YR,A,F,Y,109.32,KG,20181218.0,,CN,US,US,2018,Q4,Adult
133963983,13396398,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,20 UNITS 2XDAY,,,D,,,,,,,UNSPECIFIED,,2018,Q4,Treatment noncompliance,,2018,Q4,3,F,20160202.0,20181214.0,20170403,20181218,EXP,,US-JNJFOC-20170214849,JANSSEN,,48.0,YR,A,F,Y,109.32,KG,20181218.0,,CN,US,US,2018,Q4,Adult
137217213,13721721,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 IU/ML, AS NEEDED",,,,,,,,,,,,2018,Q4,Arthralgia,,2018,Q4,3,F,,20181003.0,20170706,20181011,PER,,US-PFIZER INC-2016536338,PFIZER,,58.0,YR,,F,Y,,,20181011.0,,MD,US,US,2018,Q4,Adult
137217213,13721721,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 IU/ML, AS NEEDED",,,,,,,,,,,,2018,Q4,Back pain,,2018,Q4,3,F,,20181003.0,20170706,20181011,PER,,US-PFIZER INC-2016536338,PFIZER,,58.0,YR,,F,Y,,,20181011.0,,MD,US,US,2018,Q4,Adult
137217213,13721721,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 IU/ML, AS NEEDED",,,,,,,,,,,,2018,Q4,Gait disturbance,,2018,Q4,3,F,,20181003.0,20170706,20181011,PER,,US-PFIZER INC-2016536338,PFIZER,,58.0,YR,,F,Y,,,20181011.0,,MD,US,US,2018,Q4,Adult
137217213,13721721,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 IU/ML, AS NEEDED",,,,,,,,,,,,2018,Q4,Headache,,2018,Q4,3,F,,20181003.0,20170706,20181011,PER,,US-PFIZER INC-2016536338,PFIZER,,58.0,YR,,F,Y,,,20181011.0,,MD,US,US,2018,Q4,Adult
137217213,13721721,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 IU/ML, AS NEEDED",,,,,,,,,,,,2018,Q4,Joint swelling,,2018,Q4,3,F,,20181003.0,20170706,20181011,PER,,US-PFIZER INC-2016536338,PFIZER,,58.0,YR,,F,Y,,,20181011.0,,MD,US,US,2018,Q4,Adult
137217213,13721721,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 IU/ML, AS NEEDED",,,,,,,,,,,,2018,Q4,Pain in extremity,,2018,Q4,3,F,,20181003.0,20170706,20181011,PER,,US-PFIZER INC-2016536338,PFIZER,,58.0,YR,,F,Y,,,20181011.0,,MD,US,US,2018,Q4,Adult
137576483,13757648,7,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,,2,,,,,,,,,,,,,,2018,Q4,Cutaneous vasculitis,,2018,Q4,3,F,20170501.0,20181204.0,20170717,20181214,EXP,DE-BFARM-17235006,DE-ACCORD-053696,ACCORD,,76.0,YR,E,M,Y,97.4,KG,20181214.0,,MD,DE,DE,2018,Q4,Elderly
137576483,13757648,7,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,,2,,,,,,,,,,,,,,2018,Q4,Nephrotic syndrome,,2018,Q4,3,F,20170501.0,20181204.0,20170717,20181214,EXP,DE-BFARM-17235006,DE-ACCORD-053696,ACCORD,,76.0,YR,E,M,Y,97.4,KG,20181214.0,,MD,DE,DE,2018,Q4,Elderly
138394938,13839493,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1-6 UNIT,,,,,,,,,,,,2018,Q4,Atrial fibrillation,,2018,Q4,8,F,20170626.0,20181113.0,20170807,20181115,EXP,,US-ROCHE-1956870,ROCHE,,78.0,YR,,M,Y,,,20181115.0,,MD,US,US,2018,Q4,Elderly
138394938,13839493,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1-6 UNIT,,,,,,,,,,,,2018,Q4,Neutropenia,,2018,Q4,8,F,20170626.0,20181113.0,20170807,20181115,EXP,,US-ROCHE-1956870,ROCHE,,78.0,YR,,M,Y,,,20181115.0,,MD,US,US,2018,Q4,Elderly
138394938,13839493,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1-6 UNIT,,,,,,,,,,,,2018,Q4,Urosepsis,,2018,Q4,8,F,20170626.0,20181113.0,20170807,20181115,EXP,,US-ROCHE-1956870,ROCHE,,78.0,YR,,M,Y,,,20181115.0,,MD,US,US,2018,Q4,Elderly
138394938,13839493,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1-4 UNIT,,,,,,,,,,,,2018,Q4,Atrial fibrillation,,2018,Q4,8,F,20170626.0,20181113.0,20170807,20181115,EXP,,US-ROCHE-1956870,ROCHE,,78.0,YR,,M,Y,,,20181115.0,,MD,US,US,2018,Q4,Elderly
138394938,13839493,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1-4 UNIT,,,,,,,,,,,,2018,Q4,Neutropenia,,2018,Q4,8,F,20170626.0,20181113.0,20170807,20181115,EXP,,US-ROCHE-1956870,ROCHE,,78.0,YR,,M,Y,,,20181115.0,,MD,US,US,2018,Q4,Elderly
138394938,13839493,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1-4 UNIT,,,,,,,,,,,,2018,Q4,Urosepsis,,2018,Q4,8,F,20170626.0,20181113.0,20170807,20181115,EXP,,US-ROCHE-1956870,ROCHE,,78.0,YR,,M,Y,,,20181115.0,,MD,US,US,2018,Q4,Elderly
139344963,13934496,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,,,,,2018,Q4,Cardiac arrest,,2018,Q4,3,F,,20181029.0,20170905,20181110,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-078879,BRISTOL MYERS SQUIBB,,54.0,YR,,F,Y,,,20181110.0,,OT,US,US,2018,Q4,Adult
139344963,13934496,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,,,,,2018,Q4,Cardiogenic shock,,2018,Q4,3,F,,20181029.0,20170905,20181110,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-078879,BRISTOL MYERS SQUIBB,,54.0,YR,,F,Y,,,20181110.0,,OT,US,US,2018,Q4,Adult
139344963,13934496,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,,,,,2018,Q4,Drug level increased,,2018,Q4,3,F,,20181029.0,20170905,20181110,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-078879,BRISTOL MYERS SQUIBB,,54.0,YR,,F,Y,,,20181110.0,,OT,US,US,2018,Q4,Adult
139344963,13934496,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,,,,,2018,Q4,Lactic acidosis,,2018,Q4,3,F,,20181029.0,20170905,20181110,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-078879,BRISTOL MYERS SQUIBB,,54.0,YR,,F,Y,,,20181110.0,,OT,US,US,2018,Q4,Adult
139344963,13934496,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,,,,,2018,Q4,Pulseless electrical activity,,2018,Q4,3,F,,20181029.0,20170905,20181110,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-078879,BRISTOL MYERS SQUIBB,,54.0,YR,,F,Y,,,20181110.0,,OT,US,US,2018,Q4,Adult
139344963,13934496,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,,,,,2018,Q4,Respiratory failure,,2018,Q4,3,F,,20181029.0,20170905,20181110,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-078879,BRISTOL MYERS SQUIBB,,54.0,YR,,F,Y,,,20181110.0,,OT,US,US,2018,Q4,Adult
140995998,14099599,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 U, TID",,,,,,,,15.0,IU,,TID,2018,Q4,Dysuria,,2018,Q4,8,F,20170930.0,20181106.0,20171017,20181109,EXP,,US-BAYER-2017-192283,BAYER,,76.0,YR,E,M,Y,89.8,KG,20181109.0,,MD,US,US,2018,Q4,Elderly
1411224614,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q4,Abdominal pain,,2018,Q4,14,F,20170708.0,20181210.0,20171020,20181221,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,A,F,Y,55.78,KG,20181221.0,,OT,US,US,2018,Q4,Adult
1411224614,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q4,Acute respiratory failure,,2018,Q4,14,F,20170708.0,20181210.0,20171020,20181221,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,A,F,Y,55.78,KG,20181221.0,,OT,US,US,2018,Q4,Adult
1411224614,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q4,Alopecia,,2018,Q4,14,F,20170708.0,20181210.0,20171020,20181221,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,A,F,Y,55.78,KG,20181221.0,,OT,US,US,2018,Q4,Adult
1411224614,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q4,Asthenia,,2018,Q4,14,F,20170708.0,20181210.0,20171020,20181221,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,A,F,Y,55.78,KG,20181221.0,,OT,US,US,2018,Q4,Adult
1411224614,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q4,Atrial fibrillation,,2018,Q4,14,F,20170708.0,20181210.0,20171020,20181221,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,A,F,Y,55.78,KG,20181221.0,,OT,US,US,2018,Q4,Adult
1411224614,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q4,Atrial flutter,,2018,Q4,14,F,20170708.0,20181210.0,20171020,20181221,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,A,F,Y,55.78,KG,20181221.0,,OT,US,US,2018,Q4,Adult
1411224614,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q4,Atrial tachycardia,,2018,Q4,14,F,20170708.0,20181210.0,20171020,20181221,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,A,F,Y,55.78,KG,20181221.0,,OT,US,US,2018,Q4,Adult
1411224614,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q4,Back pain,,2018,Q4,14,F,20170708.0,20181210.0,20171020,20181221,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,A,F,Y,55.78,KG,20181221.0,,OT,US,US,2018,Q4,Adult
1411224614,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q4,Blood urea increased,,2018,Q4,14,F,20170708.0,20181210.0,20171020,20181221,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,A,F,Y,55.78,KG,20181221.0,,OT,US,US,2018,Q4,Adult
1411224614,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q4,Brain natriuretic peptide increased,,2018,Q4,14,F,20170708.0,20181210.0,20171020,20181221,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,A,F,Y,55.78,KG,20181221.0,,OT,US,US,2018,Q4,Adult
1411224614,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q4,Cardiac failure congestive,,2018,Q4,14,F,20170708.0,20181210.0,20171020,20181221,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,A,F,Y,55.78,KG,20181221.0,,OT,US,US,2018,Q4,Adult
1411224614,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q4,Cardiomegaly,,2018,Q4,14,F,20170708.0,20181210.0,20171020,20181221,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,A,F,Y,55.78,KG,20181221.0,,OT,US,US,2018,Q4,Adult
1411224614,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q4,Cardiomyopathy,,2018,Q4,14,F,20170708.0,20181210.0,20171020,20181221,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,A,F,Y,55.78,KG,20181221.0,,OT,US,US,2018,Q4,Adult
1411224614,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q4,Cellulitis,,2018,Q4,14,F,20170708.0,20181210.0,20171020,20181221,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,A,F,Y,55.78,KG,20181221.0,,OT,US,US,2018,Q4,Adult
1411224614,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q4,Cerebrovascular accident,,2018,Q4,14,F,20170708.0,20181210.0,20171020,20181221,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,A,F,Y,55.78,KG,20181221.0,,OT,US,US,2018,Q4,Adult
1411224614,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q4,Chest pain,,2018,Q4,14,F,20170708.0,20181210.0,20171020,20181221,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,A,F,Y,55.78,KG,20181221.0,,OT,US,US,2018,Q4,Adult
1411224614,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q4,Clostridium difficile infection,,2018,Q4,14,F,20170708.0,20181210.0,20171020,20181221,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,A,F,Y,55.78,KG,20181221.0,,OT,US,US,2018,Q4,Adult
1411224614,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q4,Condition aggravated,,2018,Q4,14,F,20170708.0,20181210.0,20171020,20181221,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,A,F,Y,55.78,KG,20181221.0,,OT,US,US,2018,Q4,Adult
1411224614,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q4,Crepitations,,2018,Q4,14,F,20170708.0,20181210.0,20171020,20181221,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,A,F,Y,55.78,KG,20181221.0,,OT,US,US,2018,Q4,Adult
1411224614,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q4,Death,,2018,Q4,14,F,20170708.0,20181210.0,20171020,20181221,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,A,F,Y,55.78,KG,20181221.0,,OT,US,US,2018,Q4,Adult
1411224614,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q4,Diarrhoea,,2018,Q4,14,F,20170708.0,20181210.0,20171020,20181221,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,A,F,Y,55.78,KG,20181221.0,,OT,US,US,2018,Q4,Adult
1411224614,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q4,Dyspnoea,,2018,Q4,14,F,20170708.0,20181210.0,20171020,20181221,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,A,F,Y,55.78,KG,20181221.0,,OT,US,US,2018,Q4,Adult
1411224614,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q4,Ear pain,,2018,Q4,14,F,20170708.0,20181210.0,20171020,20181221,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,A,F,Y,55.78,KG,20181221.0,,OT,US,US,2018,Q4,Adult
1411224614,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q4,Facial paralysis,,2018,Q4,14,F,20170708.0,20181210.0,20171020,20181221,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,A,F,Y,55.78,KG,20181221.0,,OT,US,US,2018,Q4,Adult
1411224614,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q4,Fall,,2018,Q4,14,F,20170708.0,20181210.0,20171020,20181221,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,A,F,Y,55.78,KG,20181221.0,,OT,US,US,2018,Q4,Adult
1411224614,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q4,Gastric disorder,,2018,Q4,14,F,20170708.0,20181210.0,20171020,20181221,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,A,F,Y,55.78,KG,20181221.0,,OT,US,US,2018,Q4,Adult
1411224614,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q4,Haemoglobin decreased,,2018,Q4,14,F,20170708.0,20181210.0,20171020,20181221,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,A,F,Y,55.78,KG,20181221.0,,OT,US,US,2018,Q4,Adult
1411224614,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q4,Hernia repair,,2018,Q4,14,F,20170708.0,20181210.0,20171020,20181221,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,A,F,Y,55.78,KG,20181221.0,,OT,US,US,2018,Q4,Adult
1411224614,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q4,Hypokinesia,,2018,Q4,14,F,20170708.0,20181210.0,20171020,20181221,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,A,F,Y,55.78,KG,20181221.0,,OT,US,US,2018,Q4,Adult
1411224614,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q4,Hypotension,,2018,Q4,14,F,20170708.0,20181210.0,20171020,20181221,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,A,F,Y,55.78,KG,20181221.0,,OT,US,US,2018,Q4,Adult
1411224614,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q4,Nausea,,2018,Q4,14,F,20170708.0,20181210.0,20171020,20181221,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,A,F,Y,55.78,KG,20181221.0,,OT,US,US,2018,Q4,Adult
1411224614,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q4,Neutropenia,,2018,Q4,14,F,20170708.0,20181210.0,20171020,20181221,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,A,F,Y,55.78,KG,20181221.0,,OT,US,US,2018,Q4,Adult
1411224614,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q4,Non-cardiac chest pain,,2018,Q4,14,F,20170708.0,20181210.0,20171020,20181221,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,A,F,Y,55.78,KG,20181221.0,,OT,US,US,2018,Q4,Adult
1411224614,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q4,Oesophageal food impaction,,2018,Q4,14,F,20170708.0,20181210.0,20171020,20181221,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,A,F,Y,55.78,KG,20181221.0,,OT,US,US,2018,Q4,Adult
1411224614,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q4,Orthopnoea,,2018,Q4,14,F,20170708.0,20181210.0,20171020,20181221,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,A,F,Y,55.78,KG,20181221.0,,OT,US,US,2018,Q4,Adult
1411224614,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q4,Oxygen saturation decreased,,2018,Q4,14,F,20170708.0,20181210.0,20171020,20181221,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,A,F,Y,55.78,KG,20181221.0,,OT,US,US,2018,Q4,Adult
1411224614,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q4,Pain in extremity,,2018,Q4,14,F,20170708.0,20181210.0,20171020,20181221,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,A,F,Y,55.78,KG,20181221.0,,OT,US,US,2018,Q4,Adult
1411224614,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q4,Pericardial effusion,,2018,Q4,14,F,20170708.0,20181210.0,20171020,20181221,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,A,F,Y,55.78,KG,20181221.0,,OT,US,US,2018,Q4,Adult
1411224614,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q4,Pyrexia,,2018,Q4,14,F,20170708.0,20181210.0,20171020,20181221,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,A,F,Y,55.78,KG,20181221.0,,OT,US,US,2018,Q4,Adult
1411224614,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q4,Sepsis,,2018,Q4,14,F,20170708.0,20181210.0,20171020,20181221,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,A,F,Y,55.78,KG,20181221.0,,OT,US,US,2018,Q4,Adult
1411224614,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q4,Skin ulcer,,2018,Q4,14,F,20170708.0,20181210.0,20171020,20181221,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,A,F,Y,55.78,KG,20181221.0,,OT,US,US,2018,Q4,Adult
1411224614,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q4,Systemic lupus erythematosus,,2018,Q4,14,F,20170708.0,20181210.0,20171020,20181221,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,A,F,Y,55.78,KG,20181221.0,,OT,US,US,2018,Q4,Adult
1411224614,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q4,Urinary tract infection,,2018,Q4,14,F,20170708.0,20181210.0,20171020,20181221,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,A,F,Y,55.78,KG,20181221.0,,OT,US,US,2018,Q4,Adult
1411224614,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q4,Vomiting,,2018,Q4,14,F,20170708.0,20181210.0,20171020,20181221,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,A,F,Y,55.78,KG,20181221.0,,OT,US,US,2018,Q4,Adult
1411224614,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2018,Q4,Wound drainage,,2018,Q4,14,F,20170708.0,20181210.0,20171020,20181221,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,A,F,Y,55.78,KG,20181221.0,,OT,US,US,2018,Q4,Adult
1424340813,14243408,12,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,100 IU (INTERNATIONAL UNIT),,,,,,,,100.0,IU,INJECTION,QD,2018,Q4,Cardiac arrest,,2018,Q4,13,F,20171115.0,20181101.0,20171201,20181224,EXP,,US-CELGENEUS-USA-20171109702,CELGENE,,76.0,YR,,M,Y,112.1,KG,20181224.0,,OT,US,US,2018,Q4,Elderly
1424340813,14243408,12,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,100 IU (INTERNATIONAL UNIT),,,,,,,,100.0,IU,INJECTION,QD,2018,Q4,Cardiogenic shock,,2018,Q4,13,F,20171115.0,20181101.0,20171201,20181224,EXP,,US-CELGENEUS-USA-20171109702,CELGENE,,76.0,YR,,M,Y,112.1,KG,20181224.0,,OT,US,US,2018,Q4,Elderly
1424340813,14243408,12,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,100 IU (INTERNATIONAL UNIT),,,,,,,,100.0,IU,INJECTION,QD,2018,Q4,Syncope,,2018,Q4,13,F,20171115.0,20181101.0,20171201,20181224,EXP,,US-CELGENEUS-USA-20171109702,CELGENE,,76.0,YR,,M,Y,112.1,KG,20181224.0,,OT,US,US,2018,Q4,Elderly
143263042,14326304,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q4,Acute kidney injury,,2018,Q4,2,F,20140318.0,20181114.0,20171226,20181122,EXP,,US-ASTRAZENECA-2017SF30332,ASTRAZENECA,,19644.0,DY,,M,Y,,,20181122.0,,,US,US,2018,Q4,Elderly
143263042,14326304,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q4,Chronic kidney disease,,2018,Q4,2,F,20140318.0,20181114.0,20171226,20181122,EXP,,US-ASTRAZENECA-2017SF30332,ASTRAZENECA,,19644.0,DY,,M,Y,,,20181122.0,,,US,US,2018,Q4,Elderly
143263042,14326304,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q4,Type 2 diabetes mellitus,,2018,Q4,2,F,20140318.0,20181114.0,20171226,20181122,EXP,,US-ASTRAZENECA-2017SF30332,ASTRAZENECA,,19644.0,DY,,M,Y,,,20181122.0,,,US,US,2018,Q4,Elderly
143491582,14349158,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2018,Q4,Acute kidney injury,,2018,Q4,2,F,2016.0,20181112.0,20180104,20181120,EXP,,US-ASTRAZENECA-2018SE00142,ASTRAZENECA,,64.0,YR,,F,Y,90.7,KG,20181120.0,,,US,US,2018,Q4,Adult
143491582,14349158,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2018,Q4,Chronic kidney disease,,2018,Q4,2,F,2016.0,20181112.0,20180104,20181120,EXP,,US-ASTRAZENECA-2018SE00142,ASTRAZENECA,,64.0,YR,,F,Y,90.7,KG,20181120.0,,,US,US,2018,Q4,Adult
143945973,14394597,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3-18 UNITS, EVERY 4 HOURS",,,,,,,,,,,,2018,Q4,Hepatic failure,,2018,Q4,3,F,20140219.0,20181031.0,20180116,20181112,EXP,,US-PFIZER INC-2014072008,PFIZER,"LIEDTKE, M. INOTUZUMAB OZOGAMICIN: A CD22 MAB-DRUG CONJUGATE FOR ADULT RELAPSED OR REFRACTORY B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA. DRUG DESIGN, DEVELOPMENT AND THERAPY. 2018;12:2293-2300",53.0,YR,,M,Y,79.0,KG,20181112.0,,OT,US,US,2018,Q4,Adult
143945973,14394597,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3-18 UNITS, EVERY 4 HOURS",,,,,,,,,,,,2018,Q4,Venoocclusive liver disease,,2018,Q4,3,F,20140219.0,20181031.0,20180116,20181112,EXP,,US-PFIZER INC-2014072008,PFIZER,"LIEDTKE, M. INOTUZUMAB OZOGAMICIN: A CD22 MAB-DRUG CONJUGATE FOR ADULT RELAPSED OR REFRACTORY B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA. DRUG DESIGN, DEVELOPMENT AND THERAPY. 2018;12:2293-2300",53.0,YR,,M,Y,79.0,KG,20181112.0,,OT,US,US,2018,Q4,Adult
145540337,14554033,40,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2018,Q4,Diarrhoea,,2018,Q4,7,F,20180211.0,20181127.0,20180220,20181206,EXP,,CA-CELGENEUS-CAN-20180205858,CELGENE,,77.0,YR,,M,Y,67.6,KG,20181206.0,,OT,CA,CA,2018,Q4,Elderly
145540337,14554033,40,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2018,Q4,Klebsiella infection,,2018,Q4,7,F,20180211.0,20181127.0,20180220,20181206,EXP,,CA-CELGENEUS-CAN-20180205858,CELGENE,,77.0,YR,,M,Y,67.6,KG,20181206.0,,OT,CA,CA,2018,Q4,Elderly
145540337,14554033,40,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2018,Q4,Lung infection,,2018,Q4,7,F,20180211.0,20181127.0,20180220,20181206,EXP,,CA-CELGENEUS-CAN-20180205858,CELGENE,,77.0,YR,,M,Y,67.6,KG,20181206.0,,OT,CA,CA,2018,Q4,Elderly
145540337,14554033,40,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2018,Q4,Sepsis,,2018,Q4,7,F,20180211.0,20181127.0,20180220,20181206,EXP,,CA-CELGENEUS-CAN-20180205858,CELGENE,,77.0,YR,,M,Y,67.6,KG,20181206.0,,OT,CA,CA,2018,Q4,Elderly
145955553,14595555,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"SUBCUT, TID AC AND Q BEDTIME",,,D,,,,,,,UNSPECIFIED,,2018,Q4,Upper gastrointestinal haemorrhage,,2018,Q4,3,F,20161222.0,20181018.0,20180303,20181104,PER,,PR-JNJFOC-20180226522,JANSSEN,,70.0,YR,E,M,Y,,,20181104.0,,CN,US,US,2018,Q4,Elderly
145958883,14595888,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,U,,,,,,,,2018,Q4,Drug interaction,,2018,Q4,3,F,20180126.0,20181008.0,20180303,20181023,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2018RR-164193,RANBAXY,,70.0,YR,,M,Y,60.0,KG,20181023.0,,OT,GB,IT,2018,Q4,Elderly
145958883,14595888,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,U,,,,,,,,2018,Q4,Electrocardiogram QT prolonged,,2018,Q4,3,F,20180126.0,20181008.0,20180303,20181023,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2018RR-164193,RANBAXY,,70.0,YR,,M,Y,60.0,KG,20181023.0,,OT,GB,IT,2018,Q4,Elderly
146316762,14631676,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2018,Q4,Upper gastrointestinal haemorrhage,,2018,Q4,2,F,20161222.0,20181018.0,20180313,20181030,EXP,,PR-BAYER-2018-034656,BAYER,,70.0,YR,E,M,Y,,,20181030.0,,LW,PR,US,2018,Q4,Elderly
146753903,14675390,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q4,Alopecia,,2018,Q4,3,F,201310.0,20180926.0,20180323,20181113,PER,,US-PFIZER INC-2017423672,PFIZER,,66.0,YR,,F,Y,74.38,KG,20181113.0,,LW,US,US,2018,Q4,Elderly
146753903,14675390,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q4,Hair colour changes,,2018,Q4,3,F,201310.0,20180926.0,20180323,20181113,PER,,US-PFIZER INC-2017423672,PFIZER,,66.0,YR,,F,Y,74.38,KG,20181113.0,,LW,US,US,2018,Q4,Elderly
146753903,14675390,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q4,Hair disorder,,2018,Q4,3,F,201310.0,20180926.0,20180323,20181113,PER,,US-PFIZER INC-2017423672,PFIZER,,66.0,YR,,F,Y,74.38,KG,20181113.0,,LW,US,US,2018,Q4,Elderly
146753903,14675390,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q4,Hair texture abnormal,,2018,Q4,3,F,201310.0,20180926.0,20180323,20181113,PER,,US-PFIZER INC-2017423672,PFIZER,,66.0,YR,,F,Y,74.38,KG,20181113.0,,LW,US,US,2018,Q4,Elderly
147283547,14728354,45,C,INSULIN LISPRO,INSULIN LISPRO,1,Oral,UNK,,,,,,,,,,TABLET,,2018,Q4,Acute kidney injury,,2018,Q4,7,F,201706.0,20181210.0,20180406,20181220,EXP,,US-PFIZER INC-2018138901,PFIZER,,41.0,YR,,M,Y,86.2,KG,20181220.0,,OT,US,US,2018,Q4,Adult
147283547,14728354,45,C,INSULIN LISPRO,INSULIN LISPRO,1,Oral,UNK,,,,,,,,,,TABLET,,2018,Q4,Chronic kidney disease,,2018,Q4,7,F,201706.0,20181210.0,20180406,20181220,EXP,,US-PFIZER INC-2018138901,PFIZER,,41.0,YR,,M,Y,86.2,KG,20181220.0,,OT,US,US,2018,Q4,Adult
147283547,14728354,45,C,INSULIN LISPRO,INSULIN LISPRO,1,Oral,UNK,,,,,,,,,,TABLET,,2018,Q4,End stage renal disease,,2018,Q4,7,F,201706.0,20181210.0,20180406,20181220,EXP,,US-PFIZER INC-2018138901,PFIZER,,41.0,YR,,M,Y,86.2,KG,20181220.0,,OT,US,US,2018,Q4,Adult
147283547,14728354,45,C,INSULIN LISPRO,INSULIN LISPRO,1,Oral,UNK,,,,,,,,,,TABLET,,2018,Q4,Metabolic acidosis,,2018,Q4,7,F,201706.0,20181210.0,20180406,20181220,EXP,,US-PFIZER INC-2018138901,PFIZER,,41.0,YR,,M,Y,86.2,KG,20181220.0,,OT,US,US,2018,Q4,Adult
147283547,14728354,45,C,INSULIN LISPRO,INSULIN LISPRO,1,Oral,UNK,,,,,,,,,,TABLET,,2018,Q4,Renal failure,,2018,Q4,7,F,201706.0,20181210.0,20180406,20181220,EXP,,US-PFIZER INC-2018138901,PFIZER,,41.0,YR,,M,Y,86.2,KG,20181220.0,,OT,US,US,2018,Q4,Adult
147286702,14728670,55,C,INSULINE LISPRO,,2,,,,,,,,,,,,,,2018,Q4,Acute kidney injury,,2018,Q4,2,F,20130521.0,20181211.0,20180406,20181219,EXP,,US-ASTRAZENECA-2018SE40911,ASTRAZENECA,,26610.0,DY,,M,Y,100.8,KG,20181219.0,,,US,US,2018,Q4,Elderly
147286702,14728670,55,C,INSULINE LISPRO,,2,,,,,,,,,,,,,,2018,Q4,Chronic kidney disease,,2018,Q4,2,F,20130521.0,20181211.0,20180406,20181219,EXP,,US-ASTRAZENECA-2018SE40911,ASTRAZENECA,,26610.0,DY,,M,Y,100.8,KG,20181219.0,,,US,US,2018,Q4,Elderly
147286702,14728670,55,C,INSULINE LISPRO,,2,,,,,,,,,,,,,,2018,Q4,Hyperparathyroidism secondary,,2018,Q4,2,F,20130521.0,20181211.0,20180406,20181219,EXP,,US-ASTRAZENECA-2018SE40911,ASTRAZENECA,,26610.0,DY,,M,Y,100.8,KG,20181219.0,,,US,US,2018,Q4,Elderly
147286702,14728670,55,C,INSULINE LISPRO,,2,,,,,,,,,,,,,,2018,Q4,Renal failure,,2018,Q4,2,F,20130521.0,20181211.0,20180406,20181219,EXP,,US-ASTRAZENECA-2018SE40911,ASTRAZENECA,,26610.0,DY,,M,Y,100.8,KG,20181219.0,,,US,US,2018,Q4,Elderly
147287592,14728759,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Oral,,,,,,,,,,,TABLET,,2018,Q4,Acute kidney injury,,2018,Q4,2,F,201706.0,20181210.0,20180406,20181218,EXP,,US-ASTRAZENECA-2018SE40905,ASTRAZENECA,,502.0,MON,,M,Y,86.2,KG,20181218.0,,,US,US,2018,Q4,Elderly
147287592,14728759,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Oral,,,,,,,,,,,TABLET,,2018,Q4,Chronic kidney disease,,2018,Q4,2,F,201706.0,20181210.0,20180406,20181218,EXP,,US-ASTRAZENECA-2018SE40905,ASTRAZENECA,,502.0,MON,,M,Y,86.2,KG,20181218.0,,,US,US,2018,Q4,Elderly
147287592,14728759,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Oral,,,,,,,,,,,TABLET,,2018,Q4,End stage renal disease,,2018,Q4,2,F,201706.0,20181210.0,20180406,20181218,EXP,,US-ASTRAZENECA-2018SE40905,ASTRAZENECA,,502.0,MON,,M,Y,86.2,KG,20181218.0,,,US,US,2018,Q4,Elderly
147287592,14728759,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Oral,,,,,,,,,,,TABLET,,2018,Q4,Metabolic acidosis,,2018,Q4,2,F,201706.0,20181210.0,20180406,20181218,EXP,,US-ASTRAZENECA-2018SE40905,ASTRAZENECA,,502.0,MON,,M,Y,86.2,KG,20181218.0,,,US,US,2018,Q4,Elderly
147287592,14728759,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Oral,,,,,,,,,,,TABLET,,2018,Q4,Renal failure,,2018,Q4,2,F,201706.0,20181210.0,20180406,20181218,EXP,,US-ASTRAZENECA-2018SE40905,ASTRAZENECA,,502.0,MON,,M,Y,86.2,KG,20181218.0,,,US,US,2018,Q4,Elderly
147302855,14730285,64,C,INSULINE LISPRO,,2,,UNK,,,,,,,,,,,,2018,Q4,Acute kidney injury,,2018,Q4,5,F,20130521.0,20181212.0,20180406,20181221,EXP,,US-PFIZER INC-2018141170,PFIZER,,72.0,YR,,M,Y,100.8,KG,20181221.0,,OT,US,US,2018,Q4,Elderly
147302855,14730285,64,C,INSULINE LISPRO,,2,,UNK,,,,,,,,,,,,2018,Q4,Chronic kidney disease,,2018,Q4,5,F,20130521.0,20181212.0,20180406,20181221,EXP,,US-PFIZER INC-2018141170,PFIZER,,72.0,YR,,M,Y,100.8,KG,20181221.0,,OT,US,US,2018,Q4,Elderly
147302855,14730285,64,C,INSULINE LISPRO,,2,,UNK,,,,,,,,,,,,2018,Q4,Hyperparathyroidism secondary,,2018,Q4,5,F,20130521.0,20181212.0,20180406,20181221,EXP,,US-PFIZER INC-2018141170,PFIZER,,72.0,YR,,M,Y,100.8,KG,20181221.0,,OT,US,US,2018,Q4,Elderly
147302855,14730285,64,C,INSULINE LISPRO,,2,,UNK,,,,,,,,,,,,2018,Q4,Renal failure,,2018,Q4,5,F,20130521.0,20181212.0,20180406,20181221,EXP,,US-PFIZER INC-2018141170,PFIZER,,72.0,YR,,M,Y,100.8,KG,20181221.0,,OT,US,US,2018,Q4,Elderly
147695032,14769503,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,UNK",,,U,,,,,,,,,2018,Q4,Cataract,,2018,Q4,2,F,201704.0,20180705.0,20180417,20181126,EXP,,FI-SA-2018SA109408,SANOFI AVENTIS,,59.0,YR,A,F,Y,,,20181126.0,,CN,FI,FI,2018,Q4,Adult
147695032,14769503,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,UNK",,,U,,,,,,,,,2018,Q4,Dizziness,,2018,Q4,2,F,201704.0,20180705.0,20180417,20181126,EXP,,FI-SA-2018SA109408,SANOFI AVENTIS,,59.0,YR,A,F,Y,,,20181126.0,,CN,FI,FI,2018,Q4,Adult
147695032,14769503,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,UNK",,,U,,,,,,,,,2018,Q4,Fall,,2018,Q4,2,F,201704.0,20180705.0,20180417,20181126,EXP,,FI-SA-2018SA109408,SANOFI AVENTIS,,59.0,YR,A,F,Y,,,20181126.0,,CN,FI,FI,2018,Q4,Adult
147695032,14769503,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,UNK",,,U,,,,,,,,,2018,Q4,Memory impairment,,2018,Q4,2,F,201704.0,20180705.0,20180417,20181126,EXP,,FI-SA-2018SA109408,SANOFI AVENTIS,,59.0,YR,A,F,Y,,,20181126.0,,CN,FI,FI,2018,Q4,Adult
147695032,14769503,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,UNK",,,U,,,,,,,,,2018,Q4,Shock,,2018,Q4,2,F,201704.0,20180705.0,20180417,20181126,EXP,,FI-SA-2018SA109408,SANOFI AVENTIS,,59.0,YR,A,F,Y,,,20181126.0,,CN,FI,FI,2018,Q4,Adult
147695032,14769503,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,UNK",,,U,,,,,,,,,2018,Q4,Visual impairment,,2018,Q4,2,F,201704.0,20180705.0,20180417,20181126,EXP,,FI-SA-2018SA109408,SANOFI AVENTIS,,59.0,YR,A,F,Y,,,20181126.0,,CN,FI,FI,2018,Q4,Adult
147759956,14775995,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,5 IU (INTERNATIONAL UNIT),,,,,,,,5.0,IU,UNKNOWN,QD,2018,Q4,Squamous cell carcinoma of the tongue,,2018,Q4,6,F,20180323.0,20181213.0,20180418,20181220,EXP,,IT-CELGENEUS-ITA-20180404331,CELGENE,,46.0,YR,,M,Y,66.0,KG,20181220.0,,OT,IT,IT,2018,Q4,Adult
147759956,14775995,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,6 IU (INTERNATIONAL UNIT),,,,,,,,6.0,IU,UNKNOWN,QD,2018,Q4,Squamous cell carcinoma of the tongue,,2018,Q4,6,F,20180323.0,20181213.0,20180418,20181220,EXP,,IT-CELGENEUS-ITA-20180404331,CELGENE,,46.0,YR,,M,Y,66.0,KG,20181220.0,,OT,IT,IT,2018,Q4,Adult
147759956,14775995,12,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,4 IU (INTERNATIONAL UNIT),,,,,,,,4.0,IU,UNKNOWN,QD,2018,Q4,Squamous cell carcinoma of the tongue,,2018,Q4,6,F,20180323.0,20181213.0,20180418,20181220,EXP,,IT-CELGENEUS-ITA-20180404331,CELGENE,,46.0,YR,,M,Y,66.0,KG,20181220.0,,OT,IT,IT,2018,Q4,Adult
148918792,14891879,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,UNK",,,U,,,,,,,,,2018,Q4,Asthenia,,2018,Q4,2,F,20150829.0,20180607.0,20180514,20181126,EXP,IT-MINISAL02-472189,IT-SA-2018SA128726,SANOFI AVENTIS,,83.0,YR,E,M,Y,,,20181126.0,,MD,IT,IT,2018,Q4,Elderly
148918792,14891879,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,UNK",,,U,,,,,,,,,2018,Q4,Cold sweat,,2018,Q4,2,F,20150829.0,20180607.0,20180514,20181126,EXP,IT-MINISAL02-472189,IT-SA-2018SA128726,SANOFI AVENTIS,,83.0,YR,E,M,Y,,,20181126.0,,MD,IT,IT,2018,Q4,Elderly
148918792,14891879,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,UNK",,,U,,,,,,,,,2018,Q4,Hypoglycaemia,,2018,Q4,2,F,20150829.0,20180607.0,20180514,20181126,EXP,IT-MINISAL02-472189,IT-SA-2018SA128726,SANOFI AVENTIS,,83.0,YR,E,M,Y,,,20181126.0,,MD,IT,IT,2018,Q4,Elderly
148918792,14891879,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,UNK",,,U,,,,,,,,,2018,Q4,Presyncope,,2018,Q4,2,F,20150829.0,20180607.0,20180514,20181126,EXP,IT-MINISAL02-472189,IT-SA-2018SA128726,SANOFI AVENTIS,,83.0,YR,E,M,Y,,,20181126.0,,MD,IT,IT,2018,Q4,Elderly
148918792,14891879,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,UNK",,,U,,,,,,,,,2018,Q4,Vomiting,,2018,Q4,2,F,20150829.0,20180607.0,20180514,20181126,EXP,IT-MINISAL02-472189,IT-SA-2018SA128726,SANOFI AVENTIS,,83.0,YR,E,M,Y,,,20181126.0,,MD,IT,IT,2018,Q4,Elderly
1491573511,14915735,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Anaemia,,2018,Q4,11,F,20160726.0,20181121.0,20180518,20181129,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,E,F,Y,66.67,KG,20181129.0,,OT,US,US,2018,Q4,Elderly
1491573511,14915735,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Aspartate aminotransferase decreased,,2018,Q4,11,F,20160726.0,20181121.0,20180518,20181129,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,E,F,Y,66.67,KG,20181129.0,,OT,US,US,2018,Q4,Elderly
1491573511,14915735,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Asthenia,,2018,Q4,11,F,20160726.0,20181121.0,20180518,20181129,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,E,F,Y,66.67,KG,20181129.0,,OT,US,US,2018,Q4,Elderly
1491573511,14915735,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Atrial fibrillation,,2018,Q4,11,F,20160726.0,20181121.0,20180518,20181129,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,E,F,Y,66.67,KG,20181129.0,,OT,US,US,2018,Q4,Elderly
1491573511,14915735,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Chest pain,,2018,Q4,11,F,20160726.0,20181121.0,20180518,20181129,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,E,F,Y,66.67,KG,20181129.0,,OT,US,US,2018,Q4,Elderly
1491573511,14915735,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Dizziness,,2018,Q4,11,F,20160726.0,20181121.0,20180518,20181129,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,E,F,Y,66.67,KG,20181129.0,,OT,US,US,2018,Q4,Elderly
1491573511,14915735,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Dizziness postural,,2018,Q4,11,F,20160726.0,20181121.0,20180518,20181129,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,E,F,Y,66.67,KG,20181129.0,,OT,US,US,2018,Q4,Elderly
1491573511,14915735,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Dyspnoea,,2018,Q4,11,F,20160726.0,20181121.0,20180518,20181129,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,E,F,Y,66.67,KG,20181129.0,,OT,US,US,2018,Q4,Elderly
1491573511,14915735,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Fluid overload,,2018,Q4,11,F,20160726.0,20181121.0,20180518,20181129,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,E,F,Y,66.67,KG,20181129.0,,OT,US,US,2018,Q4,Elderly
1491573511,14915735,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Gastrointestinal haemorrhage,,2018,Q4,11,F,20160726.0,20181121.0,20180518,20181129,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,E,F,Y,66.67,KG,20181129.0,,OT,US,US,2018,Q4,Elderly
1491573511,14915735,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Haematocrit decreased,,2018,Q4,11,F,20160726.0,20181121.0,20180518,20181129,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,E,F,Y,66.67,KG,20181129.0,,OT,US,US,2018,Q4,Elderly
1491573511,14915735,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Haemoglobin decreased,,2018,Q4,11,F,20160726.0,20181121.0,20180518,20181129,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,E,F,Y,66.67,KG,20181129.0,,OT,US,US,2018,Q4,Elderly
1491573511,14915735,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Haemorrhage,,2018,Q4,11,F,20160726.0,20181121.0,20180518,20181129,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,E,F,Y,66.67,KG,20181129.0,,OT,US,US,2018,Q4,Elderly
1491573511,14915735,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Headache,,2018,Q4,11,F,20160726.0,20181121.0,20180518,20181129,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,E,F,Y,66.67,KG,20181129.0,,OT,US,US,2018,Q4,Elderly
1491573511,14915735,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Hypoglycaemia,,2018,Q4,11,F,20160726.0,20181121.0,20180518,20181129,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,E,F,Y,66.67,KG,20181129.0,,OT,US,US,2018,Q4,Elderly
1491573511,14915735,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Weight increased,,2018,Q4,11,F,20160726.0,20181121.0,20180518,20181129,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,E,F,Y,66.67,KG,20181129.0,,OT,US,US,2018,Q4,Elderly
149229286,14922928,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,D,U,,,,,,FORMULATION UNKNOWN,,2018,Q4,Acute respiratory failure,,2018,Q4,6,F,20180514.0,20181116.0,20180522,20181126,EXP,,US-ASTELLAS-2018US023130,ASTELLAS,,68.0,YR,,M,Y,122.0,KG,20181126.0,,MD,US,US,2018,Q4,Elderly
149229286,14922928,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,D,U,,,,,,FORMULATION UNKNOWN,,2018,Q4,Diarrhoea,,2018,Q4,6,F,20180514.0,20181116.0,20180522,20181126,EXP,,US-ASTELLAS-2018US023130,ASTELLAS,,68.0,YR,,M,Y,122.0,KG,20181126.0,,MD,US,US,2018,Q4,Elderly
149229286,14922928,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,D,U,,,,,,FORMULATION UNKNOWN,,2018,Q4,Extremity necrosis,,2018,Q4,6,F,20180514.0,20181116.0,20180522,20181126,EXP,,US-ASTELLAS-2018US023130,ASTELLAS,,68.0,YR,,M,Y,122.0,KG,20181126.0,,MD,US,US,2018,Q4,Elderly
149229286,14922928,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,D,U,,,,,,FORMULATION UNKNOWN,,2018,Q4,Fall,,2018,Q4,6,F,20180514.0,20181116.0,20180522,20181126,EXP,,US-ASTELLAS-2018US023130,ASTELLAS,,68.0,YR,,M,Y,122.0,KG,20181126.0,,MD,US,US,2018,Q4,Elderly
149229286,14922928,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,D,U,,,,,,FORMULATION UNKNOWN,,2018,Q4,Febrile neutropenia,,2018,Q4,6,F,20180514.0,20181116.0,20180522,20181126,EXP,,US-ASTELLAS-2018US023130,ASTELLAS,,68.0,YR,,M,Y,122.0,KG,20181126.0,,MD,US,US,2018,Q4,Elderly
149229286,14922928,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,D,U,,,,,,FORMULATION UNKNOWN,,2018,Q4,Sepsis,,2018,Q4,6,F,20180514.0,20181116.0,20180522,20181126,EXP,,US-ASTELLAS-2018US023130,ASTELLAS,,68.0,YR,,M,Y,122.0,KG,20181126.0,,MD,US,US,2018,Q4,Elderly
149680912,14968091,4,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,,2,,"100 IU, DAILY, SOLUTION",,,,,,,,100.0,IU,SOLUTION,,2018,Q4,Drug interaction,,2018,Q4,2,F,201704.0,20181115.0,20180604,20181126,EXP,DE-EMA-DD-20171212-AJEVHP-102703,DE-ACCORD-067834,ACCORD,,67.0,YR,E,F,Y,74.0,KG,20181127.0,,MD,DE,DE,2018,Q4,Elderly
149680912,14968091,4,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,,2,,"100 IU, DAILY, SOLUTION",,,,,,,,100.0,IU,SOLUTION,,2018,Q4,Rhabdomyolysis,,2018,Q4,2,F,201704.0,20181115.0,20180604,20181126,EXP,DE-EMA-DD-20171212-AJEVHP-102703,DE-ACCORD-067834,ACCORD,,67.0,YR,E,F,Y,74.0,KG,20181127.0,,MD,DE,DE,2018,Q4,Elderly
150021892,15002189,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"30 IU, DAILY",2910.0,IU,U,U,,,20563.0,30.0,IU,,QD,2018,Q4,Drug abuse,,2018,Q4,2,F,20180408.0,20180924.0,20180612,20181003,EXP,IT-MINISAL02-478488,IT-ELI_LILLY_AND_COMPANY-IT201805014762,ELI LILLY AND CO,,41.0,YR,,M,Y,,,20181003.0,,CN,IT,IT,2018,Q4,Adult
150021892,15002189,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"30 IU, DAILY",2910.0,IU,U,U,,,20563.0,30.0,IU,,QD,2018,Q4,Hypoglycaemia,,2018,Q4,2,F,20180408.0,20180924.0,20180612,20181003,EXP,IT-MINISAL02-478488,IT-ELI_LILLY_AND_COMPANY-IT201805014762,ELI LILLY AND CO,,41.0,YR,,M,Y,,,20181003.0,,CN,IT,IT,2018,Q4,Adult
150021892,15002189,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"30 IU, DAILY",2910.0,IU,U,U,,,20563.0,30.0,IU,,QD,2018,Q4,Road traffic accident,,2018,Q4,2,F,20180408.0,20180924.0,20180612,20181003,EXP,IT-MINISAL02-478488,IT-ELI_LILLY_AND_COMPANY-IT201805014762,ELI LILLY AND CO,,41.0,YR,,M,Y,,,20181003.0,,CN,IT,IT,2018,Q4,Adult
150021892,15002189,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"30 IU, DAILY",2910.0,IU,U,U,,,20563.0,30.0,IU,,QD,2018,Q4,Sopor,,2018,Q4,2,F,20180408.0,20180924.0,20180612,20181003,EXP,IT-MINISAL02-478488,IT-ELI_LILLY_AND_COMPANY-IT201805014762,ELI LILLY AND CO,,41.0,YR,,M,Y,,,20181003.0,,CN,IT,IT,2018,Q4,Adult
150423282,15042328,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNIT/ML,,,,,,,,,,,,2018,Q4,Chronic kidney disease,,2018,Q4,2,F,20120119.0,20181210.0,20180621,20181218,EXP,,US-ASTRAZENECA-2018SE77565,ASTRAZENECA,,26119.0,DY,,F,Y,93.0,KG,20181218.0,,,US,US,2018,Q4,Elderly
150423282,15042328,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNIT/ML,,,,,,,,,,,,2018,Q4,Chronic kidney disease-mineral and bone disorder,,2018,Q4,2,F,20120119.0,20181210.0,20180621,20181218,EXP,,US-ASTRAZENECA-2018SE77565,ASTRAZENECA,,26119.0,DY,,F,Y,93.0,KG,20181218.0,,,US,US,2018,Q4,Elderly
150997674,15099767,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q4,Acute kidney injury,,2018,Q4,4,F,20180525.0,20180918.0,20180702,20181016,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-051853,BRISTOL MYERS SQUIBB,,74.0,YR,,M,Y,,,20181016.0,,OT,US,US,2018,Q4,Elderly
150997674,15099767,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q4,Cardiac failure,,2018,Q4,4,F,20180525.0,20180918.0,20180702,20181016,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-051853,BRISTOL MYERS SQUIBB,,74.0,YR,,M,Y,,,20181016.0,,OT,US,US,2018,Q4,Elderly
150997674,15099767,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q4,Hypotension,,2018,Q4,4,F,20180525.0,20180918.0,20180702,20181016,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-051853,BRISTOL MYERS SQUIBB,,74.0,YR,,M,Y,,,20181016.0,,OT,US,US,2018,Q4,Elderly
150997674,15099767,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q4,Lactic acidosis,,2018,Q4,4,F,20180525.0,20180918.0,20180702,20181016,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-051853,BRISTOL MYERS SQUIBB,,74.0,YR,,M,Y,,,20181016.0,,OT,US,US,2018,Q4,Elderly
150997674,15099767,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q4,Sepsis,,2018,Q4,4,F,20180525.0,20180918.0,20180702,20181016,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-051853,BRISTOL MYERS SQUIBB,,74.0,YR,,M,Y,,,20181016.0,,OT,US,US,2018,Q4,Elderly
151046262,15104626,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2018,Q4,Dizziness,,2018,Q4,2,F,,20181123.0,20180703,20181129,EXP,IT-MINISAL02-483579,IT-ELI_LILLY_AND_COMPANY-IT201806010749,ELI LILLY AND CO,,59.0,YR,,M,Y,,,20181129.0,,CN,IT,IT,2018,Q4,Adult
151046262,15104626,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2018,Q4,Hypoglycaemia,,2018,Q4,2,F,,20181123.0,20180703,20181129,EXP,IT-MINISAL02-483579,IT-ELI_LILLY_AND_COMPANY-IT201806010749,ELI LILLY AND CO,,59.0,YR,,M,Y,,,20181129.0,,CN,IT,IT,2018,Q4,Adult
151142632,15114263,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"300 IU, UNKNOWN",300.0,IU,U,,,,20563.0,300.0,IU,,,2018,Q4,Drug abuse,,2018,Q4,2,F,20180607.0,20180926.0,20180706,20181008,EXP,IT-MINISAL02-484276,IT-ELI_LILLY_AND_COMPANY-IT201806011124,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20181008.0,,CN,IT,IT,2018,Q4,Adult
151142632,15114263,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"300 IU, UNKNOWN",300.0,IU,U,,,,20563.0,300.0,IU,,,2018,Q4,Intentional self-injury,,2018,Q4,2,F,20180607.0,20180926.0,20180706,20181008,EXP,IT-MINISAL02-484276,IT-ELI_LILLY_AND_COMPANY-IT201806011124,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20181008.0,,CN,IT,IT,2018,Q4,Adult
151269672,15126967,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Dizziness,,2018,Q4,2,F,20180319.0,20181128.0,20180710,20181205,EXP,IT-MINISAL02-483579,IT-SA-2018SA174461,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20181205.0,,MD,IT,IT,2018,Q4,Adult
151269672,15126967,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Hypoglycaemia,,2018,Q4,2,F,20180319.0,20181128.0,20180710,20181205,EXP,IT-MINISAL02-483579,IT-SA-2018SA174461,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20181205.0,,MD,IT,IT,2018,Q4,Adult
151289626,15128962,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q4,Pneumonitis,,2018,Q4,6,F,20180608.0,20181012.0,20180711,20181016,EXP,,DE-GILEAD-2018-0348501,GILEAD,,67.0,YR,E,M,Y,82.0,KG,20181016.0,,MD,DE,DE,2018,Q4,Elderly
151670932,15167093,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2018,Q4,Hyperglycaemia,,2018,Q4,2,F,20180306.0,20181109.0,20180719,20181115,EXP,IT-MINISAL02-476884,IT-ELI_LILLY_AND_COMPANY-IT201807005317,ELI LILLY AND CO,,61.0,YR,,M,Y,,,20181115.0,,CN,IT,IT,2018,Q4,Adult
151670932,15167093,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2018,Q4,Sopor,,2018,Q4,2,F,20180306.0,20181109.0,20180719,20181115,EXP,IT-MINISAL02-476884,IT-ELI_LILLY_AND_COMPANY-IT201807005317,ELI LILLY AND CO,,61.0,YR,,M,Y,,,20181115.0,,CN,IT,IT,2018,Q4,Adult
151907934,15190793,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q4,Alpha haemolytic streptococcal infection,,2018,Q4,4,F,20180520.0,20181002.0,20180724,20181012,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-18-05813,HIKMA,,51.0,YR,,F,Y,71.0,KG,20181012.0,,MD,US,US,2018,Q4,Adult
151907934,15190793,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q4,Bacteraemia,,2018,Q4,4,F,20180520.0,20181002.0,20180724,20181012,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-18-05813,HIKMA,,51.0,YR,,F,Y,71.0,KG,20181012.0,,MD,US,US,2018,Q4,Adult
151907934,15190793,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q4,Diarrhoea,,2018,Q4,4,F,20180520.0,20181002.0,20180724,20181012,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-18-05813,HIKMA,,51.0,YR,,F,Y,71.0,KG,20181012.0,,MD,US,US,2018,Q4,Adult
151907934,15190793,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q4,Febrile neutropenia,,2018,Q4,4,F,20180520.0,20181002.0,20180724,20181012,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-18-05813,HIKMA,,51.0,YR,,F,Y,71.0,KG,20181012.0,,MD,US,US,2018,Q4,Adult
151907934,15190793,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q4,Klebsiella bacteraemia,,2018,Q4,4,F,20180520.0,20181002.0,20180724,20181012,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-18-05813,HIKMA,,51.0,YR,,F,Y,71.0,KG,20181012.0,,MD,US,US,2018,Q4,Adult
151907934,15190793,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q4,Neutropenia,,2018,Q4,4,F,20180520.0,20181002.0,20180724,20181012,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-18-05813,HIKMA,,51.0,YR,,F,Y,71.0,KG,20181012.0,,MD,US,US,2018,Q4,Adult
151907934,15190793,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q4,Petechiae,,2018,Q4,4,F,20180520.0,20181002.0,20180724,20181012,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-18-05813,HIKMA,,51.0,YR,,F,Y,71.0,KG,20181012.0,,MD,US,US,2018,Q4,Adult
151907934,15190793,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q4,Skin wound,,2018,Q4,4,F,20180520.0,20181002.0,20180724,20181012,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-18-05813,HIKMA,,51.0,YR,,F,Y,71.0,KG,20181012.0,,MD,US,US,2018,Q4,Adult
152029815,15202981,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 ?G/M2, QD",,,U,,,,,7.0,UG/M**2,UNKNOWN,QD,2018,Q4,Foetal disorder,,2018,Q4,5,F,20170914.0,20181107.0,20180726,20181116,EXP,FR-AFSSAPS-PC20180352,FR-FRESENIUS KABI-FK201808071,FRESENIUS KABI,,1.0,DY,,M,Y,1.89,KG,20181116.0,,OT,GB,FR,2018,Q4,Child
152029815,15202981,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 ?G/M2, QD",,,U,,,,,7.0,UG/M**2,UNKNOWN,QD,2018,Q4,Foetal exposure during pregnancy,,2018,Q4,5,F,20170914.0,20181107.0,20180726,20181116,EXP,FR-AFSSAPS-PC20180352,FR-FRESENIUS KABI-FK201808071,FRESENIUS KABI,,1.0,DY,,M,Y,1.89,KG,20181116.0,,OT,GB,FR,2018,Q4,Child
152029815,15202981,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 ?G/M2, QD",,,U,,,,,7.0,UG/M**2,UNKNOWN,QD,2018,Q4,Low birth weight baby,,2018,Q4,5,F,20170914.0,20181107.0,20180726,20181116,EXP,FR-AFSSAPS-PC20180352,FR-FRESENIUS KABI-FK201808071,FRESENIUS KABI,,1.0,DY,,M,Y,1.89,KG,20181116.0,,OT,GB,FR,2018,Q4,Child
152029815,15202981,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 ?G/M2, QD",,,U,,,,,7.0,UG/M**2,UNKNOWN,QD,2018,Q4,Neutropenia neonatal,,2018,Q4,5,F,20170914.0,20181107.0,20180726,20181116,EXP,FR-AFSSAPS-PC20180352,FR-FRESENIUS KABI-FK201808071,FRESENIUS KABI,,1.0,DY,,M,Y,1.89,KG,20181116.0,,OT,GB,FR,2018,Q4,Child
152029815,15202981,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 ?G/M2, QD",,,U,,,,,7.0,UG/M**2,UNKNOWN,QD,2018,Q4,Premature baby,,2018,Q4,5,F,20170914.0,20181107.0,20180726,20181116,EXP,FR-AFSSAPS-PC20180352,FR-FRESENIUS KABI-FK201808071,FRESENIUS KABI,,1.0,DY,,M,Y,1.89,KG,20181116.0,,OT,GB,FR,2018,Q4,Child
152088181,15208818,3,C,insuline lispro 100E/ml injectievloeistof,,2,,,,,,,,,,,,,,2018,Q4,Joint swelling,,2018,Q4,1,I,20180621.0,20180719.0,20180727,20180727,EXP,NL-LRB-00289885,NL-TEVA-2018-NL-930991,TEVA,,49.0,YR,,F,Y,,,20180727.0,,MD,NL,NL,2018,Q4,Adult
152088181,15208818,3,C,insuline lispro 100E/ml injectievloeistof,,2,,,,,,,,,,,,,,2018,Q4,Mobility decreased,,2018,Q4,1,I,20180621.0,20180719.0,20180727,20180727,EXP,NL-LRB-00289885,NL-TEVA-2018-NL-930991,TEVA,,49.0,YR,,F,Y,,,20180727.0,,MD,NL,NL,2018,Q4,Adult
152088181,15208818,3,C,insuline lispro 100E/ml injectievloeistof,,2,,,,,,,,,,,,,,2018,Q4,Pruritus,,2018,Q4,1,I,20180621.0,20180719.0,20180727,20180727,EXP,NL-LRB-00289885,NL-TEVA-2018-NL-930991,TEVA,,49.0,YR,,F,Y,,,20180727.0,,MD,NL,NL,2018,Q4,Adult
152088181,15208818,3,C,insuline lispro 100E/ml injectievloeistof,,2,,,,,,,,,,,,,,2018,Q4,Urticaria,,2018,Q4,1,I,20180621.0,20180719.0,20180727,20180727,EXP,NL-LRB-00289885,NL-TEVA-2018-NL-930991,TEVA,,49.0,YR,,F,Y,,,20180727.0,,MD,NL,NL,2018,Q4,Adult
152148371,15214837,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,7IU BEFORE LUNCH AND 8IU BEFORE DINNER,,,D,,,,,,,,BID,2018,Q4,Caesarean section,,2018,Q4,1,I,,20180722.0,20180730,20180730,EXP,,IT-BAUSCH-BL-2018-020111,BAUSCH AND LOMB,"FORMOSO G, GINESTRA F, DI DALMAZI G, CONSOLI A. EMPAGLIFLOZIN, METFORMIN AND INSULIN DEGLUDEC, DURING PREGNANCY: A CASE REPORT. ACTA DIABETOLOGICA. 2018;55(7):759-761.",31.0,YR,,F,Y,98.0,KG,20180730.0,,OT,IT,IT,2018,Q4,Young Adult
152148371,15214837,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,7IU BEFORE LUNCH AND 8IU BEFORE DINNER,,,D,,,,,,,,BID,2018,Q4,Maternal exposure during pregnancy,,2018,Q4,1,I,,20180722.0,20180730,20180730,EXP,,IT-BAUSCH-BL-2018-020111,BAUSCH AND LOMB,"FORMOSO G, GINESTRA F, DI DALMAZI G, CONSOLI A. EMPAGLIFLOZIN, METFORMIN AND INSULIN DEGLUDEC, DURING PREGNANCY: A CASE REPORT. ACTA DIABETOLOGICA. 2018;55(7):759-761.",31.0,YR,,F,Y,98.0,KG,20180730.0,,OT,IT,IT,2018,Q4,Young Adult
152148371,15214837,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,7IU BEFORE LUNCH AND 8IU BEFORE DINNER,,,D,,,,,,,,BID,2018,Q4,Normal newborn,,2018,Q4,1,I,,20180722.0,20180730,20180730,EXP,,IT-BAUSCH-BL-2018-020111,BAUSCH AND LOMB,"FORMOSO G, GINESTRA F, DI DALMAZI G, CONSOLI A. EMPAGLIFLOZIN, METFORMIN AND INSULIN DEGLUDEC, DURING PREGNANCY: A CASE REPORT. ACTA DIABETOLOGICA. 2018;55(7):759-761.",31.0,YR,,F,Y,98.0,KG,20180730.0,,OT,IT,IT,2018,Q4,Young Adult
152148371,15214837,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,7IU BEFORE LUNCH AND 8IU BEFORE DINNER,,,D,,,,,,,,BID,2018,Q4,Off label use,,2018,Q4,1,I,,20180722.0,20180730,20180730,EXP,,IT-BAUSCH-BL-2018-020111,BAUSCH AND LOMB,"FORMOSO G, GINESTRA F, DI DALMAZI G, CONSOLI A. EMPAGLIFLOZIN, METFORMIN AND INSULIN DEGLUDEC, DURING PREGNANCY: A CASE REPORT. ACTA DIABETOLOGICA. 2018;55(7):759-761.",31.0,YR,,F,Y,98.0,KG,20180730.0,,OT,IT,IT,2018,Q4,Young Adult
152148371,15214837,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,32 IU BEFORE LUNCH AND 34 IU BEFORE DINNER,,,D,,,,,,,,BID,2018,Q4,Caesarean section,,2018,Q4,1,I,,20180722.0,20180730,20180730,EXP,,IT-BAUSCH-BL-2018-020111,BAUSCH AND LOMB,"FORMOSO G, GINESTRA F, DI DALMAZI G, CONSOLI A. EMPAGLIFLOZIN, METFORMIN AND INSULIN DEGLUDEC, DURING PREGNANCY: A CASE REPORT. ACTA DIABETOLOGICA. 2018;55(7):759-761.",31.0,YR,,F,Y,98.0,KG,20180730.0,,OT,IT,IT,2018,Q4,Young Adult
152148371,15214837,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,32 IU BEFORE LUNCH AND 34 IU BEFORE DINNER,,,D,,,,,,,,BID,2018,Q4,Maternal exposure during pregnancy,,2018,Q4,1,I,,20180722.0,20180730,20180730,EXP,,IT-BAUSCH-BL-2018-020111,BAUSCH AND LOMB,"FORMOSO G, GINESTRA F, DI DALMAZI G, CONSOLI A. EMPAGLIFLOZIN, METFORMIN AND INSULIN DEGLUDEC, DURING PREGNANCY: A CASE REPORT. ACTA DIABETOLOGICA. 2018;55(7):759-761.",31.0,YR,,F,Y,98.0,KG,20180730.0,,OT,IT,IT,2018,Q4,Young Adult
152148371,15214837,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,32 IU BEFORE LUNCH AND 34 IU BEFORE DINNER,,,D,,,,,,,,BID,2018,Q4,Normal newborn,,2018,Q4,1,I,,20180722.0,20180730,20180730,EXP,,IT-BAUSCH-BL-2018-020111,BAUSCH AND LOMB,"FORMOSO G, GINESTRA F, DI DALMAZI G, CONSOLI A. EMPAGLIFLOZIN, METFORMIN AND INSULIN DEGLUDEC, DURING PREGNANCY: A CASE REPORT. ACTA DIABETOLOGICA. 2018;55(7):759-761.",31.0,YR,,F,Y,98.0,KG,20180730.0,,OT,IT,IT,2018,Q4,Young Adult
152148371,15214837,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,32 IU BEFORE LUNCH AND 34 IU BEFORE DINNER,,,D,,,,,,,,BID,2018,Q4,Off label use,,2018,Q4,1,I,,20180722.0,20180730,20180730,EXP,,IT-BAUSCH-BL-2018-020111,BAUSCH AND LOMB,"FORMOSO G, GINESTRA F, DI DALMAZI G, CONSOLI A. EMPAGLIFLOZIN, METFORMIN AND INSULIN DEGLUDEC, DURING PREGNANCY: A CASE REPORT. ACTA DIABETOLOGICA. 2018;55(7):759-761.",31.0,YR,,F,Y,98.0,KG,20180730.0,,OT,IT,IT,2018,Q4,Young Adult
152150202,15215020,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27 IU, DAILY",,,Y,,,,209196.0,27.0,IU,,QD,2018,Q4,Abdominal pain,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27 IU, DAILY",,,Y,,,,209196.0,27.0,IU,,QD,2018,Q4,Dizziness,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27 IU, DAILY",,,Y,,,,209196.0,27.0,IU,,QD,2018,Q4,Foetal movement disorder,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27 IU, DAILY",,,Y,,,,209196.0,27.0,IU,,QD,2018,Q4,Headache,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27 IU, DAILY",,,Y,,,,209196.0,27.0,IU,,QD,2018,Q4,Hypertension,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27 IU, DAILY",,,Y,,,,209196.0,27.0,IU,,QD,2018,Q4,Hypoglycaemic coma,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27 IU, DAILY",,,Y,,,,209196.0,27.0,IU,,QD,2018,Q4,Hypoglycaemic seizure,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27 IU, DAILY",,,Y,,,,209196.0,27.0,IU,,QD,2018,Q4,Maternal exposure during breast feeding,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27 IU, DAILY",,,Y,,,,209196.0,27.0,IU,,QD,2018,Q4,Maternal exposure during pregnancy,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27 IU, DAILY",,,Y,,,,209196.0,27.0,IU,,QD,2018,Q4,Nausea,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27 IU, DAILY",,,Y,,,,209196.0,27.0,IU,,QD,2018,Q4,Neuritis,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27 IU, DAILY",,,Y,,,,209196.0,27.0,IU,,QD,2018,Q4,Oedema peripheral,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27 IU, DAILY",,,Y,,,,209196.0,27.0,IU,,QD,2018,Q4,Vaginal haemorrhage,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27.4 IU, QD",,,Y,,,,209196.0,27.4,IU,,QD,2018,Q4,Abdominal pain,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27.4 IU, QD",,,Y,,,,209196.0,27.4,IU,,QD,2018,Q4,Dizziness,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27.4 IU, QD",,,Y,,,,209196.0,27.4,IU,,QD,2018,Q4,Foetal movement disorder,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27.4 IU, QD",,,Y,,,,209196.0,27.4,IU,,QD,2018,Q4,Headache,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27.4 IU, QD",,,Y,,,,209196.0,27.4,IU,,QD,2018,Q4,Hypertension,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27.4 IU, QD",,,Y,,,,209196.0,27.4,IU,,QD,2018,Q4,Hypoglycaemic coma,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27.4 IU, QD",,,Y,,,,209196.0,27.4,IU,,QD,2018,Q4,Hypoglycaemic seizure,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27.4 IU, QD",,,Y,,,,209196.0,27.4,IU,,QD,2018,Q4,Maternal exposure during breast feeding,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27.4 IU, QD",,,Y,,,,209196.0,27.4,IU,,QD,2018,Q4,Maternal exposure during pregnancy,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27.4 IU, QD",,,Y,,,,209196.0,27.4,IU,,QD,2018,Q4,Nausea,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27.4 IU, QD",,,Y,,,,209196.0,27.4,IU,,QD,2018,Q4,Neuritis,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27.4 IU, QD",,,Y,,,,209196.0,27.4,IU,,QD,2018,Q4,Oedema peripheral,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"27.4 IU, QD",,,Y,,,,209196.0,27.4,IU,,QD,2018,Q4,Vaginal haemorrhage,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,25.8 UNK,,,Y,,,,209196.0,25.8,IU,,QD,2018,Q4,Abdominal pain,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,25.8 UNK,,,Y,,,,209196.0,25.8,IU,,QD,2018,Q4,Dizziness,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,25.8 UNK,,,Y,,,,209196.0,25.8,IU,,QD,2018,Q4,Foetal movement disorder,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,25.8 UNK,,,Y,,,,209196.0,25.8,IU,,QD,2018,Q4,Headache,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,25.8 UNK,,,Y,,,,209196.0,25.8,IU,,QD,2018,Q4,Hypertension,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,25.8 UNK,,,Y,,,,209196.0,25.8,IU,,QD,2018,Q4,Hypoglycaemic coma,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,25.8 UNK,,,Y,,,,209196.0,25.8,IU,,QD,2018,Q4,Hypoglycaemic seizure,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,25.8 UNK,,,Y,,,,209196.0,25.8,IU,,QD,2018,Q4,Maternal exposure during breast feeding,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,25.8 UNK,,,Y,,,,209196.0,25.8,IU,,QD,2018,Q4,Maternal exposure during pregnancy,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,25.8 UNK,,,Y,,,,209196.0,25.8,IU,,QD,2018,Q4,Nausea,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,25.8 UNK,,,Y,,,,209196.0,25.8,IU,,QD,2018,Q4,Neuritis,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,25.8 UNK,,,Y,,,,209196.0,25.8,IU,,QD,2018,Q4,Oedema peripheral,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,25.8 UNK,,,Y,,,,209196.0,25.8,IU,,QD,2018,Q4,Vaginal haemorrhage,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,70.8 UNK,,,Y,,,,209196.0,70.8,IU,,QD,2018,Q4,Abdominal pain,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,70.8 UNK,,,Y,,,,209196.0,70.8,IU,,QD,2018,Q4,Dizziness,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,70.8 UNK,,,Y,,,,209196.0,70.8,IU,,QD,2018,Q4,Foetal movement disorder,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,70.8 UNK,,,Y,,,,209196.0,70.8,IU,,QD,2018,Q4,Headache,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,70.8 UNK,,,Y,,,,209196.0,70.8,IU,,QD,2018,Q4,Hypertension,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,70.8 UNK,,,Y,,,,209196.0,70.8,IU,,QD,2018,Q4,Hypoglycaemic coma,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,70.8 UNK,,,Y,,,,209196.0,70.8,IU,,QD,2018,Q4,Hypoglycaemic seizure,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,70.8 UNK,,,Y,,,,209196.0,70.8,IU,,QD,2018,Q4,Maternal exposure during breast feeding,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,70.8 UNK,,,Y,,,,209196.0,70.8,IU,,QD,2018,Q4,Maternal exposure during pregnancy,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,70.8 UNK,,,Y,,,,209196.0,70.8,IU,,QD,2018,Q4,Nausea,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,70.8 UNK,,,Y,,,,209196.0,70.8,IU,,QD,2018,Q4,Neuritis,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,70.8 UNK,,,Y,,,,209196.0,70.8,IU,,QD,2018,Q4,Oedema peripheral,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152150202,15215020,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,70.8 UNK,,,Y,,,,209196.0,70.8,IU,,QD,2018,Q4,Vaginal haemorrhage,,2018,Q4,2,F,20161216.0,20180716.0,20180730,20181130,EXP,,NL-SA-2018SA194929,SANOFI AVENTIS,,42.0,YR,A,F,Y,85.0,KG,20181130.0,,CN,DK,NL,2018,Q4,Adult
152275574,15227557,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 DF=100UNITS/ML, QD",,,,,,,,1.0,DF,,QD,2018,Q4,Acute kidney injury,,2018,Q4,4,F,20180723.0,20181031.0,20180801,20181110,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-071329,BRISTOL MYERS SQUIBB,,56.0,YR,,F,Y,64.2,KG,20181110.0,,OT,US,US,2018,Q4,Adult
152275574,15227557,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 DF=100UNITS/ML, QD",,,,,,,,1.0,DF,,QD,2018,Q4,Atrial fibrillation,,2018,Q4,4,F,20180723.0,20181031.0,20180801,20181110,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-071329,BRISTOL MYERS SQUIBB,,56.0,YR,,F,Y,64.2,KG,20181110.0,,OT,US,US,2018,Q4,Adult
152275574,15227557,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 DF=100UNITS/ML, QD",,,,,,,,1.0,DF,,QD,2018,Q4,Cardiac arrest,,2018,Q4,4,F,20180723.0,20181031.0,20180801,20181110,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-071329,BRISTOL MYERS SQUIBB,,56.0,YR,,F,Y,64.2,KG,20181110.0,,OT,US,US,2018,Q4,Adult
152275574,15227557,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 DF=100UNITS/ML, QD",,,,,,,,1.0,DF,,QD,2018,Q4,Generalised oedema,,2018,Q4,4,F,20180723.0,20181031.0,20180801,20181110,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-071329,BRISTOL MYERS SQUIBB,,56.0,YR,,F,Y,64.2,KG,20181110.0,,OT,US,US,2018,Q4,Adult
152275574,15227557,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 DF=100UNITS/ML, QD",,,,,,,,1.0,DF,,QD,2018,Q4,Hypotension,,2018,Q4,4,F,20180723.0,20181031.0,20180801,20181110,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-071329,BRISTOL MYERS SQUIBB,,56.0,YR,,F,Y,64.2,KG,20181110.0,,OT,US,US,2018,Q4,Adult
152275574,15227557,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 DF=100UNITS/ML, QD",,,,,,,,1.0,DF,,QD,2018,Q4,Sepsis,,2018,Q4,4,F,20180723.0,20181031.0,20180801,20181110,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-071329,BRISTOL MYERS SQUIBB,,56.0,YR,,F,Y,64.2,KG,20181110.0,,OT,US,US,2018,Q4,Adult
152280402,15228040,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,900.0,DF,U,,,,,12.0,DF,SOLUTION FOR INJECTION,QD,2018,Q4,Hyperhidrosis,,2018,Q4,2,F,20180316.0,20181128.0,20180801,20181205,EXP,IT-MINISAL02-482988,IT-SA-2018SA170795,SANOFI AVENTIS,,48.0,YR,A,F,Y,,,20181205.0,,MD,IT,IT,2018,Q4,Adult
152280402,15228040,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,900.0,DF,U,,,,,12.0,DF,SOLUTION FOR INJECTION,QD,2018,Q4,Loss of consciousness,,2018,Q4,2,F,20180316.0,20181128.0,20180801,20181205,EXP,IT-MINISAL02-482988,IT-SA-2018SA170795,SANOFI AVENTIS,,48.0,YR,A,F,Y,,,20181205.0,,MD,IT,IT,2018,Q4,Adult
152295111,15229511,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,,,,U,U,,,,,,,,2018,Q4,Foetal disorder,,2018,Q4,1,I,,20180719.0,20180802,20180802,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2018RR-180169,RANBAXY,,1.0,DY,,,Y,1.89,KG,20180802.0,,OT,GB,FR,2018,Q4,Child
152295111,15229511,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,,,,U,U,,,,,,,,2018,Q4,Foetal exposure during pregnancy,,2018,Q4,1,I,,20180719.0,20180802,20180802,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2018RR-180169,RANBAXY,,1.0,DY,,,Y,1.89,KG,20180802.0,,OT,GB,FR,2018,Q4,Child
152295111,15229511,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,,,,U,U,,,,,,,,2018,Q4,Low birth weight baby,,2018,Q4,1,I,,20180719.0,20180802,20180802,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2018RR-180169,RANBAXY,,1.0,DY,,,Y,1.89,KG,20180802.0,,OT,GB,FR,2018,Q4,Child
152295111,15229511,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,,,,U,U,,,,,,,,2018,Q4,Premature baby,,2018,Q4,1,I,,20180719.0,20180802,20180802,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2018RR-180169,RANBAXY,,1.0,DY,,,Y,1.89,KG,20180802.0,,OT,GB,FR,2018,Q4,Child
152349791,15234979,2,I,INSULINA LISPRO (7320A),INSULIN LISPRO,1,Subcutaneous,1-1-1,,,Y,,,,,,,,,2018,Q4,Drug interaction,,2018,Q4,1,I,20171122.0,20180726.0,20180803,20180803,EXP,ES-AEMPS-374469,ES-TEVA-2018-ES-934304,TEVA,,73.0,YR,,M,Y,,,20180803.0,,MD,ES,ES,2018,Q4,Elderly
152349791,15234979,2,I,INSULINA LISPRO (7320A),INSULIN LISPRO,1,Subcutaneous,1-1-1,,,Y,,,,,,,,,2018,Q4,Hypoglycaemia,,2018,Q4,1,I,20171122.0,20180726.0,20180803,20180803,EXP,ES-AEMPS-374469,ES-TEVA-2018-ES-934304,TEVA,,73.0,YR,,M,Y,,,20180803.0,,MD,ES,ES,2018,Q4,Elderly
152400107,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Abdominal pain,,2018,Q4,7,F,201807.0,20181120.0,20180803,20181130,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,A,F,Y,,,20181130.0,,OT,US,US,2018,Q4,Adult
152400107,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Atelectasis,,2018,Q4,7,F,201807.0,20181120.0,20180803,20181130,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,A,F,Y,,,20181130.0,,OT,US,US,2018,Q4,Adult
152400107,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Cervix carcinoma,,2018,Q4,7,F,201807.0,20181120.0,20180803,20181130,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,A,F,Y,,,20181130.0,,OT,US,US,2018,Q4,Adult
152400107,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Chest pain,,2018,Q4,7,F,201807.0,20181120.0,20180803,20181130,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,A,F,Y,,,20181130.0,,OT,US,US,2018,Q4,Adult
152400107,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Constipation,,2018,Q4,7,F,201807.0,20181120.0,20180803,20181130,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,A,F,Y,,,20181130.0,,OT,US,US,2018,Q4,Adult
152400107,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Dizziness,,2018,Q4,7,F,201807.0,20181120.0,20180803,20181130,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,A,F,Y,,,20181130.0,,OT,US,US,2018,Q4,Adult
152400107,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Dyspnoea,,2018,Q4,7,F,201807.0,20181120.0,20180803,20181130,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,A,F,Y,,,20181130.0,,OT,US,US,2018,Q4,Adult
152400107,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Explorative laparotomy,,2018,Q4,7,F,201807.0,20181120.0,20180803,20181130,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,A,F,Y,,,20181130.0,,OT,US,US,2018,Q4,Adult
152400107,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Fluid retention,,2018,Q4,7,F,201807.0,20181120.0,20180803,20181130,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,A,F,Y,,,20181130.0,,OT,US,US,2018,Q4,Adult
152400107,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Genital disorder female,,2018,Q4,7,F,201807.0,20181120.0,20180803,20181130,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,A,F,Y,,,20181130.0,,OT,US,US,2018,Q4,Adult
152400107,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Hypotension,,2018,Q4,7,F,201807.0,20181120.0,20180803,20181130,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,A,F,Y,,,20181130.0,,OT,US,US,2018,Q4,Adult
152400107,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Hypoxia,,2018,Q4,7,F,201807.0,20181120.0,20180803,20181130,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,A,F,Y,,,20181130.0,,OT,US,US,2018,Q4,Adult
152400107,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Neoplasm,,2018,Q4,7,F,201807.0,20181120.0,20180803,20181130,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,A,F,Y,,,20181130.0,,OT,US,US,2018,Q4,Adult
152400107,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Ovarian epithelial cancer,,2018,Q4,7,F,201807.0,20181120.0,20180803,20181130,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,A,F,Y,,,20181130.0,,OT,US,US,2018,Q4,Adult
152400107,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Pain management,,2018,Q4,7,F,201807.0,20181120.0,20180803,20181130,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,A,F,Y,,,20181130.0,,OT,US,US,2018,Q4,Adult
152400107,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Pelvic mass,,2018,Q4,7,F,201807.0,20181120.0,20180803,20181130,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,A,F,Y,,,20181130.0,,OT,US,US,2018,Q4,Adult
152400107,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Peripheral swelling,,2018,Q4,7,F,201807.0,20181120.0,20180803,20181130,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,A,F,Y,,,20181130.0,,OT,US,US,2018,Q4,Adult
152400107,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Presyncope,,2018,Q4,7,F,201807.0,20181120.0,20180803,20181130,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,A,F,Y,,,20181130.0,,OT,US,US,2018,Q4,Adult
152400107,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Pulmonary arterial hypertension,,2018,Q4,7,F,201807.0,20181120.0,20180803,20181130,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,A,F,Y,,,20181130.0,,OT,US,US,2018,Q4,Adult
152400107,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Pulmonary hypertension,,2018,Q4,7,F,201807.0,20181120.0,20180803,20181130,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,A,F,Y,,,20181130.0,,OT,US,US,2018,Q4,Adult
152400107,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Right ventricular failure,,2018,Q4,7,F,201807.0,20181120.0,20180803,20181130,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,A,F,Y,,,20181130.0,,OT,US,US,2018,Q4,Adult
152400107,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Salpingo-oophorectomy bilateral,,2018,Q4,7,F,201807.0,20181120.0,20180803,20181130,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,A,F,Y,,,20181130.0,,OT,US,US,2018,Q4,Adult
152400107,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Tumour excision,,2018,Q4,7,F,201807.0,20181120.0,20180803,20181130,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,A,F,Y,,,20181130.0,,OT,US,US,2018,Q4,Adult
152400107,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Urinary retention,,2018,Q4,7,F,201807.0,20181120.0,20180803,20181130,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,A,F,Y,,,20181130.0,,OT,US,US,2018,Q4,Adult
152400107,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Vena cava filter insertion,,2018,Q4,7,F,201807.0,20181120.0,20180803,20181130,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,A,F,Y,,,20181130.0,,OT,US,US,2018,Q4,Adult
152400107,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Weight increased,,2018,Q4,7,F,201807.0,20181120.0,20180803,20181130,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,A,F,Y,,,20181130.0,,OT,US,US,2018,Q4,Adult
152441221,15244122,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,U,,,,209196.0,,,,,2018,Q4,Bone pain,,2018,Q4,1,I,,20180620.0,20180806,20180806,EXP,,DE-SA-2018SA166909,SANOFI AVENTIS,,43.0,YR,A,M,Y,,,20180806.0,,CN,DE,DE,2018,Q4,Adult
152441221,15244122,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,U,,,,209196.0,,,,,2018,Q4,Cartilage injury,,2018,Q4,1,I,,20180620.0,20180806,20180806,EXP,,DE-SA-2018SA166909,SANOFI AVENTIS,,43.0,YR,A,M,Y,,,20180806.0,,CN,DE,DE,2018,Q4,Adult
152441221,15244122,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,U,,,,209196.0,,,,,2018,Q4,Diabetes mellitus inadequate control,,2018,Q4,1,I,,20180620.0,20180806,20180806,EXP,,DE-SA-2018SA166909,SANOFI AVENTIS,,43.0,YR,A,M,Y,,,20180806.0,,CN,DE,DE,2018,Q4,Adult
152441221,15244122,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,U,,,,209196.0,,,,,2018,Q4,Injection site haematoma,,2018,Q4,1,I,,20180620.0,20180806,20180806,EXP,,DE-SA-2018SA166909,SANOFI AVENTIS,,43.0,YR,A,M,Y,,,20180806.0,,CN,DE,DE,2018,Q4,Adult
152550222,15255022,8,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,QD",,,Y,,,,,,,SOLUTION FOR INJECTION,QD,2018,Q4,Hypoglycaemic seizure,,2018,Q4,2,F,20180506.0,20180717.0,20180808,20181004,EXP,,IL-SA-2018SA133812,SANOFI AVENTIS,,12.0,YR,T,F,Y,42.0,KG,20181004.0,,MD,IL,IL,2018,Q4,Child
152550222,15255022,9,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,QD",,,Y,,,,,,,SOLUTION FOR INJECTION,QD,2018,Q4,Hypoglycaemic seizure,,2018,Q4,2,F,20180506.0,20180717.0,20180808,20181004,EXP,,IL-SA-2018SA133812,SANOFI AVENTIS,,12.0,YR,T,F,Y,42.0,KG,20181004.0,,MD,IL,IL,2018,Q4,Child
152550222,15255022,18,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,Y,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Hypoglycaemic seizure,,2018,Q4,2,F,20180506.0,20180717.0,20180808,20181004,EXP,,IL-SA-2018SA133812,SANOFI AVENTIS,,12.0,YR,T,F,Y,42.0,KG,20181004.0,,MD,IL,IL,2018,Q4,Child
152550222,15255022,19,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,Y,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Hypoglycaemic seizure,,2018,Q4,2,F,20180506.0,20180717.0,20180808,20181004,EXP,,IL-SA-2018SA133812,SANOFI AVENTIS,,12.0,YR,T,F,Y,42.0,KG,20181004.0,,MD,IL,IL,2018,Q4,Child
152550222,15255022,28,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,Y,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Hypoglycaemic seizure,,2018,Q4,2,F,20180506.0,20180717.0,20180808,20181004,EXP,,IL-SA-2018SA133812,SANOFI AVENTIS,,12.0,YR,T,F,Y,42.0,KG,20181004.0,,MD,IL,IL,2018,Q4,Child
152550222,15255022,29,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,Y,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Hypoglycaemic seizure,,2018,Q4,2,F,20180506.0,20180717.0,20180808,20181004,EXP,,IL-SA-2018SA133812,SANOFI AVENTIS,,12.0,YR,T,F,Y,42.0,KG,20181004.0,,MD,IL,IL,2018,Q4,Child
152550222,15255022,38,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, UNK",,,Y,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Hypoglycaemic seizure,,2018,Q4,2,F,20180506.0,20180717.0,20180808,20181004,EXP,,IL-SA-2018SA133812,SANOFI AVENTIS,,12.0,YR,T,F,Y,42.0,KG,20181004.0,,MD,IL,IL,2018,Q4,Child
152550222,15255022,39,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, UNK",,,Y,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Hypoglycaemic seizure,,2018,Q4,2,F,20180506.0,20180717.0,20180808,20181004,EXP,,IL-SA-2018SA133812,SANOFI AVENTIS,,12.0,YR,T,F,Y,42.0,KG,20181004.0,,MD,IL,IL,2018,Q4,Child
152623401,15262340,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,10.0,IU,,,2018,Q4,Acute kidney injury,,2018,Q4,1,I,20180723.0,20180802.0,20180809,20180809,EXP,IT-MINISAL02-491705,IT-BAUSCH-BL-2018-021315,BAUSCH AND LOMB,,65.0,YR,,F,Y,70.0,KG,20180809.0,,PH,IT,IT,2018,Q4,Elderly
152623401,15262340,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,10.0,IU,,,2018,Q4,Electrolyte imbalance,,2018,Q4,1,I,20180723.0,20180802.0,20180809,20180809,EXP,IT-MINISAL02-491705,IT-BAUSCH-BL-2018-021315,BAUSCH AND LOMB,,65.0,YR,,F,Y,70.0,KG,20180809.0,,PH,IT,IT,2018,Q4,Elderly
152623401,15262340,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,10.0,IU,,,2018,Q4,Renal tubular disorder,,2018,Q4,1,I,20180723.0,20180802.0,20180809,20180809,EXP,IT-MINISAL02-491705,IT-BAUSCH-BL-2018-021315,BAUSCH AND LOMB,,65.0,YR,,F,Y,70.0,KG,20180809.0,,PH,IT,IT,2018,Q4,Elderly
152665353,15266535,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2018,Q4,Renal failure,,2018,Q4,3,F,20180723.0,20181005.0,20180810,20181017,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-072342,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,70.0,KG,20181017.0,,PH,IT,IT,2018,Q4,Elderly
152665353,15266535,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2018,Q4,Tubulointerstitial nephritis,,2018,Q4,3,F,20180723.0,20181005.0,20180810,20181017,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-072342,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,70.0,KG,20181017.0,,PH,IT,IT,2018,Q4,Elderly
152761532,15276153,3,C,insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q4,Electrocardiogram QT prolonged,,2018,Q4,2,F,20180530.0,20180921.0,20180814,20181001,EXP,IT-MINISAL02-490375,IT-BAXTER-2018BAX021241,BAXTER,,75.0,YR,,F,Y,70.0,KG,20181001.0,,PH,IT,IT,2018,Q4,Elderly
152766752,15276675,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"19.5 IU, DAILY",1209.0,IU,,,,,20563.0,19.5,IU,,QD,2018,Q4,Dawn phenomenon,,2018,Q4,2,F,20171115.0,20181004.0,20180814,20181010,EXP,IT-MINISAL02-492142,IT-ELI_LILLY_AND_COMPANY-IT201808001491,ELI LILLY AND CO,,11.0,YR,,F,Y,54.0,KG,20181010.0,,CN,IT,IT,2018,Q4,Child
152766752,15276675,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"19.5 IU, DAILY",1209.0,IU,,,,,20563.0,19.5,IU,,QD,2018,Q4,Hyperhidrosis,,2018,Q4,2,F,20171115.0,20181004.0,20180814,20181010,EXP,IT-MINISAL02-492142,IT-ELI_LILLY_AND_COMPANY-IT201808001491,ELI LILLY AND CO,,11.0,YR,,F,Y,54.0,KG,20181010.0,,CN,IT,IT,2018,Q4,Child
152766752,15276675,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"19.5 IU, DAILY",1209.0,IU,,,,,20563.0,19.5,IU,,QD,2018,Q4,Hypoglycaemia,,2018,Q4,2,F,20171115.0,20181004.0,20180814,20181010,EXP,IT-MINISAL02-492142,IT-ELI_LILLY_AND_COMPANY-IT201808001491,ELI LILLY AND CO,,11.0,YR,,F,Y,54.0,KG,20181010.0,,CN,IT,IT,2018,Q4,Child
152766752,15276675,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"19.5 IU, DAILY",1209.0,IU,,,,,20563.0,19.5,IU,,QD,2018,Q4,Pallor,,2018,Q4,2,F,20171115.0,20181004.0,20180814,20181010,EXP,IT-MINISAL02-492142,IT-ELI_LILLY_AND_COMPANY-IT201808001491,ELI LILLY AND CO,,11.0,YR,,F,Y,54.0,KG,20181010.0,,CN,IT,IT,2018,Q4,Child
152818022,15281802,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2018,Q4,Cardiac failure,,2018,Q4,2,F,20180313.0,20181018.0,20180815,20181022,EXP,IT-MINISAL02-488222,IT-TEVA-2018-IT-941184,TEVA,,77.0,YR,,M,Y,,,20181022.0,,MD,IT,IT,2018,Q4,Elderly
152818022,15281802,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2018,Q4,Dyspnoea,,2018,Q4,2,F,20180313.0,20181018.0,20180815,20181022,EXP,IT-MINISAL02-488222,IT-TEVA-2018-IT-941184,TEVA,,77.0,YR,,M,Y,,,20181022.0,,MD,IT,IT,2018,Q4,Elderly
152937385,15293738,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,10.0,IU,,,2018,Q4,Acute kidney injury,,2018,Q4,5,F,20180723.0,20181022.0,20180820,20181024,EXP,IT-MINISAL02-491705,IT-TEVA-2018-IT-944361,TEVA,,65.0,YR,,F,Y,70.0,KG,20181024.0,,PH,IT,IT,2018,Q4,Elderly
152937385,15293738,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,10.0,IU,,,2018,Q4,Electrolyte imbalance,,2018,Q4,5,F,20180723.0,20181022.0,20180820,20181024,EXP,IT-MINISAL02-491705,IT-TEVA-2018-IT-944361,TEVA,,65.0,YR,,F,Y,70.0,KG,20181024.0,,PH,IT,IT,2018,Q4,Elderly
152937385,15293738,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,10.0,IU,,,2018,Q4,Renal tubular disorder,,2018,Q4,5,F,20180723.0,20181022.0,20180820,20181024,EXP,IT-MINISAL02-491705,IT-TEVA-2018-IT-944361,TEVA,,65.0,YR,,F,Y,70.0,KG,20181024.0,,PH,IT,IT,2018,Q4,Elderly
153092692,15309269,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q4,Body temperature increased,,2018,Q4,2,F,20180330.0,20180405.0,20180823,20180921,PER,,CA-IGSA-SR10006131,GRIFOLS,,81.0,YR,,F,Y,79.5,KG,20180921.0,,OT,CA,CA,2018,Q4,Elderly
153092692,15309269,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q4,Flushing,,2018,Q4,2,F,20180330.0,20180405.0,20180823,20180921,PER,,CA-IGSA-SR10006131,GRIFOLS,,81.0,YR,,F,Y,79.5,KG,20180921.0,,OT,CA,CA,2018,Q4,Elderly
153092692,15309269,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q4,Hypotension,,2018,Q4,2,F,20180330.0,20180405.0,20180823,20180921,PER,,CA-IGSA-SR10006131,GRIFOLS,,81.0,YR,,F,Y,79.5,KG,20180921.0,,OT,CA,CA,2018,Q4,Elderly
153092692,15309269,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q4,Pruritus,,2018,Q4,2,F,20180330.0,20180405.0,20180823,20180921,PER,,CA-IGSA-SR10006131,GRIFOLS,,81.0,YR,,F,Y,79.5,KG,20180921.0,,OT,CA,CA,2018,Q4,Elderly
153092692,15309269,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q4,Rash,,2018,Q4,2,F,20180330.0,20180405.0,20180823,20180921,PER,,CA-IGSA-SR10006131,GRIFOLS,,81.0,YR,,F,Y,79.5,KG,20180921.0,,OT,CA,CA,2018,Q4,Elderly
153353233,15335323,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 IU, UNK",,,U,, UNKNOWN,,,10.0,IU,,,2018,Q4,Electrolyte imbalance,,2018,Q4,3,F,20180723.0,20181008.0,20180830,20181011,EXP,,PHHY2018IT082135,SANDOZ,,65.0,YR,,F,Y,70.0,KG,20181011.0,,OT,IT,IT,2018,Q4,Elderly
153353233,15335323,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 IU, UNK",,,U,, UNKNOWN,,,10.0,IU,,,2018,Q4,Renal failure,,2018,Q4,3,F,20180723.0,20181008.0,20180830,20181011,EXP,,PHHY2018IT082135,SANDOZ,,65.0,YR,,F,Y,70.0,KG,20181011.0,,OT,IT,IT,2018,Q4,Elderly
153353233,15335323,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 IU, UNK",,,U,, UNKNOWN,,,10.0,IU,,,2018,Q4,Tubulointerstitial nephritis,,2018,Q4,3,F,20180723.0,20181008.0,20180830,20181011,EXP,,PHHY2018IT082135,SANDOZ,,65.0,YR,,F,Y,70.0,KG,20181011.0,,OT,IT,IT,2018,Q4,Elderly
153495488,15349548,37,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,4 IU (INTERNATIONAL UNIT),,,,,,,,4.0,IU,INJECTION,TID,2018,Q4,Cardiac failure congestive,,2018,Q4,8,F,2018.0,20181016.0,20180904,20181023,EXP,,US-CELGENEUS-USA-20180808141,CELGENE,,71.0,YR,,M,Y,89.89,KG,20181023.0,,MD,US,US,2018,Q4,Elderly
153495488,15349548,37,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,4 IU (INTERNATIONAL UNIT),,,,,,,,4.0,IU,INJECTION,TID,2018,Q4,Death,,2018,Q4,8,F,2018.0,20181016.0,20180904,20181023,EXP,,US-CELGENEUS-USA-20180808141,CELGENE,,71.0,YR,,M,Y,89.89,KG,20181023.0,,MD,US,US,2018,Q4,Elderly
153495488,15349548,37,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,4 IU (INTERNATIONAL UNIT),,,,,,,,4.0,IU,INJECTION,TID,2018,Q4,Dysphagia,,2018,Q4,8,F,2018.0,20181016.0,20180904,20181023,EXP,,US-CELGENEUS-USA-20180808141,CELGENE,,71.0,YR,,M,Y,89.89,KG,20181023.0,,MD,US,US,2018,Q4,Elderly
153495488,15349548,37,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,4 IU (INTERNATIONAL UNIT),,,,,,,,4.0,IU,INJECTION,TID,2018,Q4,Febrile neutropenia,,2018,Q4,8,F,2018.0,20181016.0,20180904,20181023,EXP,,US-CELGENEUS-USA-20180808141,CELGENE,,71.0,YR,,M,Y,89.89,KG,20181023.0,,MD,US,US,2018,Q4,Elderly
153495488,15349548,37,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,4 IU (INTERNATIONAL UNIT),,,,,,,,4.0,IU,INJECTION,TID,2018,Q4,Pancytopenia,,2018,Q4,8,F,2018.0,20181016.0,20180904,20181023,EXP,,US-CELGENEUS-USA-20180808141,CELGENE,,71.0,YR,,M,Y,89.89,KG,20181023.0,,MD,US,US,2018,Q4,Elderly
153613932,15361393,7,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"100 U/ML, UNK ((IL 100) AT 20?-20?-20 U DOSES) ((IL 200) 24-?24?-24 U)",,,U,,,,,100.0,DF,,,2018,Q4,Hypoglycaemia,,2018,Q4,2,F,2013.0,20181210.0,20180907,20181217,EXP,,PHHY2018CZ092274,SANDOZ,,61.0,YR,,F,Y,,,20181217.0,,OT,CZ,CZ,2018,Q4,Adult
153613932,15361393,7,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"100 U/ML, UNK ((IL 100) AT 20?-20?-20 U DOSES) ((IL 200) 24-?24?-24 U)",,,U,,,,,100.0,DF,,,2018,Q4,Increased insulin requirement,,2018,Q4,2,F,2013.0,20181210.0,20180907,20181217,EXP,,PHHY2018CZ092274,SANDOZ,,61.0,YR,,F,Y,,,20181217.0,,OT,CZ,CZ,2018,Q4,Adult
153613932,15361393,7,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"100 U/ML, UNK ((IL 100) AT 20?-20?-20 U DOSES) ((IL 200) 24-?24?-24 U)",,,U,,,,,100.0,DF,,,2018,Q4,Insulin resistance,,2018,Q4,2,F,2013.0,20181210.0,20180907,20181217,EXP,,PHHY2018CZ092274,SANDOZ,,61.0,YR,,F,Y,,,20181217.0,,OT,CZ,CZ,2018,Q4,Adult
153613932,15361393,7,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"100 U/ML, UNK ((IL 100) AT 20?-20?-20 U DOSES) ((IL 200) 24-?24?-24 U)",,,U,,,,,100.0,DF,,,2018,Q4,Nephrotic syndrome,,2018,Q4,2,F,2013.0,20181210.0,20180907,20181217,EXP,,PHHY2018CZ092274,SANDOZ,,61.0,YR,,F,Y,,,20181217.0,,OT,CZ,CZ,2018,Q4,Adult
153613932,15361393,7,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"100 U/ML, UNK ((IL 100) AT 20?-20?-20 U DOSES) ((IL 200) 24-?24?-24 U)",,,U,,,,,100.0,DF,,,2018,Q4,Proteinuria,,2018,Q4,2,F,2013.0,20181210.0,20180907,20181217,EXP,,PHHY2018CZ092274,SANDOZ,,61.0,YR,,F,Y,,,20181217.0,,OT,CZ,CZ,2018,Q4,Adult
153613932,15361393,7,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"100 U/ML, UNK ((IL 100) AT 20?-20?-20 U DOSES) ((IL 200) 24-?24?-24 U)",,,U,,,,,100.0,DF,,,2018,Q4,Renal failure,,2018,Q4,2,F,2013.0,20181210.0,20180907,20181217,EXP,,PHHY2018CZ092274,SANDOZ,,61.0,YR,,F,Y,,,20181217.0,,OT,CZ,CZ,2018,Q4,Adult
153613932,15361393,7,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"100 U/ML, UNK ((IL 100) AT 20?-20?-20 U DOSES) ((IL 200) 24-?24?-24 U)",,,U,,,,,100.0,DF,,,2018,Q4,Toxicity to various agents,,2018,Q4,2,F,2013.0,20181210.0,20180907,20181217,EXP,,PHHY2018CZ092274,SANDOZ,,61.0,YR,,F,Y,,,20181217.0,,OT,CZ,CZ,2018,Q4,Adult
153613932,15361393,7,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"100 U/ML, UNK ((IL 100) AT 20?-20?-20 U DOSES) ((IL 200) 24-?24?-24 U)",,,U,,,,,100.0,DF,,,2018,Q4,Weight increased,,2018,Q4,2,F,2013.0,20181210.0,20180907,20181217,EXP,,PHHY2018CZ092274,SANDOZ,,61.0,YR,,F,Y,,,20181217.0,,OT,CZ,CZ,2018,Q4,Adult
153663472,15366347,14,C,Lispro,INSULIN LISPRO,1,Unknown,36 IU (INTERNATIONAL UNIT),,,,,,,,12.0,IU,UNKNOWN,TID,2018,Q4,Epistaxis,,2018,Q4,2,F,20180901.0,20181023.0,20180910,20181030,PER,,US-CELGENEUS-USA-20180901005,CELGENE,,69.0,YR,,M,Y,,,20181030.0,,MD,US,US,2018,Q4,Elderly
153946621,15394662,5,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,,2,,"10 U, 4-6 UU 3 X DAILY.",,,,,,,,,,,,2018,Q4,Anaemia,,2018,Q4,1,I,,20180904.0,20180918,20180918,EXP,,EE-ACCORD-072018,ACCORD,"HEIN H, KIDNEY TRANSPLANTATION. PEREARST. 2018 AUG: 29.",45.0,YR,,F,Y,,,20180918.0,,OT,EE,EE,2018,Q4,Adult
153946621,15394662,5,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,,2,,"10 U, 4-6 UU 3 X DAILY.",,,,,,,,,,,,2018,Q4,Dermatitis,,2018,Q4,1,I,,20180904.0,20180918,20180918,EXP,,EE-ACCORD-072018,ACCORD,"HEIN H, KIDNEY TRANSPLANTATION. PEREARST. 2018 AUG: 29.",45.0,YR,,F,Y,,,20180918.0,,OT,EE,EE,2018,Q4,Adult
153946621,15394662,5,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,,2,,"10 U, 4-6 UU 3 X DAILY.",,,,,,,,,,,,2018,Q4,Urinary tract infection,,2018,Q4,1,I,,20180904.0,20180918,20180918,EXP,,EE-ACCORD-072018,ACCORD,"HEIN H, KIDNEY TRANSPLANTATION. PEREARST. 2018 AUG: 29.",45.0,YR,,F,Y,,,20180918.0,,OT,EE,EE,2018,Q4,Adult
154038772,15403877,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,4-6 UNITS THREE TIMES A DAY,,,,,,,,,,,,2018,Q4,Anaemia,,2018,Q4,2,F,,20181107.0,20180919,20181114,EXP,,EE-ABBVIE-18P-221-2491320-00,ABBVIE,HEIN H. KIDNEY TRANSPLANTATION. PEREARST.. 2018 AUG 29;26-29.,45.0,YR,,F,Y,,,20181114.0,,OT,COUNTRY NOT SPECIFIED,EE,2018,Q4,Adult
154038772,15403877,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,4-6 UNITS THREE TIMES A DAY,,,,,,,,,,,,2018,Q4,Bronchitis,,2018,Q4,2,F,,20181107.0,20180919,20181114,EXP,,EE-ABBVIE-18P-221-2491320-00,ABBVIE,HEIN H. KIDNEY TRANSPLANTATION. PEREARST.. 2018 AUG 29;26-29.,45.0,YR,,F,Y,,,20181114.0,,OT,COUNTRY NOT SPECIFIED,EE,2018,Q4,Adult
154038772,15403877,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,4-6 UNITS THREE TIMES A DAY,,,,,,,,,,,,2018,Q4,Dermatitis,,2018,Q4,2,F,,20181107.0,20180919,20181114,EXP,,EE-ABBVIE-18P-221-2491320-00,ABBVIE,HEIN H. KIDNEY TRANSPLANTATION. PEREARST.. 2018 AUG 29;26-29.,45.0,YR,,F,Y,,,20181114.0,,OT,COUNTRY NOT SPECIFIED,EE,2018,Q4,Adult
154038772,15403877,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,4-6 UNITS THREE TIMES A DAY,,,,,,,,,,,,2018,Q4,Pathogen resistance,,2018,Q4,2,F,,20181107.0,20180919,20181114,EXP,,EE-ABBVIE-18P-221-2491320-00,ABBVIE,HEIN H. KIDNEY TRANSPLANTATION. PEREARST.. 2018 AUG 29;26-29.,45.0,YR,,F,Y,,,20181114.0,,OT,COUNTRY NOT SPECIFIED,EE,2018,Q4,Adult
154038772,15403877,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,4-6 UNITS THREE TIMES A DAY,,,,,,,,,,,,2018,Q4,Respiratory tract infection viral,,2018,Q4,2,F,,20181107.0,20180919,20181114,EXP,,EE-ABBVIE-18P-221-2491320-00,ABBVIE,HEIN H. KIDNEY TRANSPLANTATION. PEREARST.. 2018 AUG 29;26-29.,45.0,YR,,F,Y,,,20181114.0,,OT,COUNTRY NOT SPECIFIED,EE,2018,Q4,Adult
154038772,15403877,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,4-6 UNITS THREE TIMES A DAY,,,,,,,,,,,,2018,Q4,Sinusitis,,2018,Q4,2,F,,20181107.0,20180919,20181114,EXP,,EE-ABBVIE-18P-221-2491320-00,ABBVIE,HEIN H. KIDNEY TRANSPLANTATION. PEREARST.. 2018 AUG 29;26-29.,45.0,YR,,F,Y,,,20181114.0,,OT,COUNTRY NOT SPECIFIED,EE,2018,Q4,Adult
154038772,15403877,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,4-6 UNITS THREE TIMES A DAY,,,,,,,,,,,,2018,Q4,Urinary tract infection,,2018,Q4,2,F,,20181107.0,20180919,20181114,EXP,,EE-ABBVIE-18P-221-2491320-00,ABBVIE,HEIN H. KIDNEY TRANSPLANTATION. PEREARST.. 2018 AUG 29;26-29.,45.0,YR,,F,Y,,,20181114.0,,OT,COUNTRY NOT SPECIFIED,EE,2018,Q4,Adult
154043152,15404315,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"24 IU, DAILY",,,,,,,20563.0,24.0,IU,,QD,2018,Q4,Depressed level of consciousness,,2018,Q4,2,F,20180203.0,20181126.0,20180919,20181129,EXP,IT-MINISAL02-497583,IT-ELI_LILLY_AND_COMPANY-IT201809003571,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20181129.0,,CN,IT,IT,2018,Q4,Elderly
154043152,15404315,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"24 IU, DAILY",,,,,,,20563.0,24.0,IU,,QD,2018,Q4,Dizziness,,2018,Q4,2,F,20180203.0,20181126.0,20180919,20181129,EXP,IT-MINISAL02-497583,IT-ELI_LILLY_AND_COMPANY-IT201809003571,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20181129.0,,CN,IT,IT,2018,Q4,Elderly
154043152,15404315,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"24 IU, DAILY",,,,,,,20563.0,24.0,IU,,QD,2018,Q4,Hypoglycaemia,,2018,Q4,2,F,20180203.0,20181126.0,20180919,20181129,EXP,IT-MINISAL02-497583,IT-ELI_LILLY_AND_COMPANY-IT201809003571,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20181129.0,,CN,IT,IT,2018,Q4,Elderly
154043152,15404315,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"24 IU, DAILY",,,,,,,20563.0,24.0,IU,,QD,2018,Q4,Malaise,,2018,Q4,2,F,20180203.0,20181126.0,20180919,20181129,EXP,IT-MINISAL02-497583,IT-ELI_LILLY_AND_COMPANY-IT201809003571,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20181129.0,,CN,IT,IT,2018,Q4,Elderly
154043152,15404315,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"24 IU, DAILY",,,,,,,20563.0,24.0,IU,,QD,2018,Q4,Neurological symptom,,2018,Q4,2,F,20180203.0,20181126.0,20180919,20181129,EXP,IT-MINISAL02-497583,IT-ELI_LILLY_AND_COMPANY-IT201809003571,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20181129.0,,CN,IT,IT,2018,Q4,Elderly
154073723,15407372,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"26 IU, DAILY",,,U,U,,,20563.0,26.0,IU,,QD,2018,Q4,Hypoglycaemia,,2018,Q4,3,F,20180831.0,20181126.0,20180920,20181206,EXP,IT-MINISAL02-498222,IT-ELI_LILLY_AND_COMPANY-IT201809006379,ELI LILLY AND CO,,25.0,YR,,M,Y,,,20181206.0,,CN,IT,IT,2018,Q4,Young Adult
154073723,15407372,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"26 IU, DAILY",,,U,U,,,20563.0,26.0,IU,,QD,2018,Q4,Seizure,,2018,Q4,3,F,20180831.0,20181126.0,20180920,20181206,EXP,IT-MINISAL02-498222,IT-ELI_LILLY_AND_COMPANY-IT201809006379,ELI LILLY AND CO,,25.0,YR,,M,Y,,,20181206.0,,CN,IT,IT,2018,Q4,Young Adult
154073723,15407372,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"26 IU, DAILY",,,U,U,,,20563.0,26.0,IU,,QD,2018,Q4,Tongue biting,,2018,Q4,3,F,20180831.0,20181126.0,20180920,20181206,EXP,IT-MINISAL02-498222,IT-ELI_LILLY_AND_COMPANY-IT201809006379,ELI LILLY AND CO,,25.0,YR,,M,Y,,,20181206.0,,CN,IT,IT,2018,Q4,Young Adult
154170653,15417065,4,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Transplacental,,,,U,,,,,,,,,2018,Q4,Foetal disorder,,2018,Q4,3,F,20170920.0,20181213.0,20180924,20181228,EXP,FR-EMA-DD-20180712-SAMEERHPDD-190831,FR-ZYDUS-027032,ZYDUS PHARM,,1.0,DY,,,Y,1.89,KG,20181228.0,,PH,FR,FR,2018,Q4,Child
154170653,15417065,4,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Transplacental,,,,U,,,,,,,,,2018,Q4,Foetal exposure during pregnancy,,2018,Q4,3,F,20170920.0,20181213.0,20180924,20181228,EXP,FR-EMA-DD-20180712-SAMEERHPDD-190831,FR-ZYDUS-027032,ZYDUS PHARM,,1.0,DY,,,Y,1.89,KG,20181228.0,,PH,FR,FR,2018,Q4,Child
154170653,15417065,4,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Transplacental,,,,U,,,,,,,,,2018,Q4,Low birth weight baby,,2018,Q4,3,F,20170920.0,20181213.0,20180924,20181228,EXP,FR-EMA-DD-20180712-SAMEERHPDD-190831,FR-ZYDUS-027032,ZYDUS PHARM,,1.0,DY,,,Y,1.89,KG,20181228.0,,PH,FR,FR,2018,Q4,Child
154170653,15417065,4,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Transplacental,,,,U,,,,,,,,,2018,Q4,Neutropenia neonatal,,2018,Q4,3,F,20170920.0,20181213.0,20180924,20181228,EXP,FR-EMA-DD-20180712-SAMEERHPDD-190831,FR-ZYDUS-027032,ZYDUS PHARM,,1.0,DY,,,Y,1.89,KG,20181228.0,,PH,FR,FR,2018,Q4,Child
154170653,15417065,4,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Transplacental,,,,U,,,,,,,,,2018,Q4,Premature baby,,2018,Q4,3,F,20170920.0,20181213.0,20180924,20181228,EXP,FR-EMA-DD-20180712-SAMEERHPDD-190831,FR-ZYDUS-027032,ZYDUS PHARM,,1.0,DY,,,Y,1.89,KG,20181228.0,,PH,FR,FR,2018,Q4,Child
154238563,15423856,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK (NK IE, NACH BZ) (IU, ACCORDING TO BLOOD GLUCOSE)",,,D,,,,,,,,,2018,Q4,Cardiac failure,,2018,Q4,3,F,,20181004.0,20180925,20181010,EXP,,DE-MYLANLABS-2018M1069454,MYLAN,,77.0,YR,,M,Y,59.0,KG,20181010.0,,PH,DE,DE,2018,Q4,Elderly
154238563,15423856,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK (NK IE, NACH BZ) (IU, ACCORDING TO BLOOD GLUCOSE)",,,D,,,,,,,,,2018,Q4,Cardiac failure chronic,,2018,Q4,3,F,,20181004.0,20180925,20181010,EXP,,DE-MYLANLABS-2018M1069454,MYLAN,,77.0,YR,,M,Y,59.0,KG,20181010.0,,PH,DE,DE,2018,Q4,Elderly
154238563,15423856,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK (NK IE, NACH BZ) (IU, ACCORDING TO BLOOD GLUCOSE)",,,D,,,,,,,,,2018,Q4,Chest discomfort,,2018,Q4,3,F,,20181004.0,20180925,20181010,EXP,,DE-MYLANLABS-2018M1069454,MYLAN,,77.0,YR,,M,Y,59.0,KG,20181010.0,,PH,DE,DE,2018,Q4,Elderly
154238563,15423856,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK (NK IE, NACH BZ) (IU, ACCORDING TO BLOOD GLUCOSE)",,,D,,,,,,,,,2018,Q4,Dizziness,,2018,Q4,3,F,,20181004.0,20180925,20181010,EXP,,DE-MYLANLABS-2018M1069454,MYLAN,,77.0,YR,,M,Y,59.0,KG,20181010.0,,PH,DE,DE,2018,Q4,Elderly
154238563,15423856,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK (NK IE, NACH BZ) (IU, ACCORDING TO BLOOD GLUCOSE)",,,D,,,,,,,,,2018,Q4,Dyspnoea,,2018,Q4,3,F,,20181004.0,20180925,20181010,EXP,,DE-MYLANLABS-2018M1069454,MYLAN,,77.0,YR,,M,Y,59.0,KG,20181010.0,,PH,DE,DE,2018,Q4,Elderly
154238563,15423856,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK (NK IE, NACH BZ) (IU, ACCORDING TO BLOOD GLUCOSE)",,,D,,,,,,,,,2018,Q4,Dyspnoea exertional,,2018,Q4,3,F,,20181004.0,20180925,20181010,EXP,,DE-MYLANLABS-2018M1069454,MYLAN,,77.0,YR,,M,Y,59.0,KG,20181010.0,,PH,DE,DE,2018,Q4,Elderly
154244453,15424445,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 UNIT/ML 3 ML PEN,,,,,,,,,,,,2018,Q4,Syncope,,2018,Q4,3,F,20180918.0,20180925.0,20180925,20181231,EXP,,US-ROCHE-2187602,ROCHE,,70.0,YR,,M,Y,101.2,KG,20181231.0,,MD,US,US,2018,Q4,Elderly
154244492,15424449,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,, UNKNOWN,,,10.0,IU,,,2018,Q4,Acute kidney injury,,2018,Q4,2,F,20180723.0,20181005.0,20180925,20181010,EXP,IT-MINISAL02-491705,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-086965,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,70.0,KG,20181010.0,,PH,IT,IT,2018,Q4,Elderly
154244492,15424449,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,, UNKNOWN,,,10.0,IU,,,2018,Q4,Electrolyte imbalance,,2018,Q4,2,F,20180723.0,20181005.0,20180925,20181010,EXP,IT-MINISAL02-491705,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-086965,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,70.0,KG,20181010.0,,PH,IT,IT,2018,Q4,Elderly
154244492,15424449,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,, UNKNOWN,,,10.0,IU,,,2018,Q4,Renal tubular disorder,,2018,Q4,2,F,20180723.0,20181005.0,20180925,20181010,EXP,IT-MINISAL02-491705,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-086965,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,70.0,KG,20181010.0,,PH,IT,IT,2018,Q4,Elderly
154244492,15424449,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,, UNKNOWN,,,10.0,IU,,,2018,Q4,Tubulointerstitial nephritis,,2018,Q4,2,F,20180723.0,20181005.0,20180925,20181010,EXP,IT-MINISAL02-491705,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-086965,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,70.0,KG,20181010.0,,PH,IT,IT,2018,Q4,Elderly
154244492,15424449,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q4,Acute kidney injury,,2018,Q4,2,F,20180723.0,20181005.0,20180925,20181010,EXP,IT-MINISAL02-491705,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-086965,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,70.0,KG,20181010.0,,PH,IT,IT,2018,Q4,Elderly
154244492,15424449,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q4,Electrolyte imbalance,,2018,Q4,2,F,20180723.0,20181005.0,20180925,20181010,EXP,IT-MINISAL02-491705,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-086965,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,70.0,KG,20181010.0,,PH,IT,IT,2018,Q4,Elderly
154244492,15424449,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q4,Renal tubular disorder,,2018,Q4,2,F,20180723.0,20181005.0,20180925,20181010,EXP,IT-MINISAL02-491705,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-086965,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,70.0,KG,20181010.0,,PH,IT,IT,2018,Q4,Elderly
154244492,15424449,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q4,Tubulointerstitial nephritis,,2018,Q4,2,F,20180723.0,20181005.0,20180925,20181010,EXP,IT-MINISAL02-491705,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-086965,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,70.0,KG,20181010.0,,PH,IT,IT,2018,Q4,Elderly
154244492,15424449,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q4,Acute kidney injury,,2018,Q4,2,F,20180723.0,20181005.0,20180925,20181010,EXP,IT-MINISAL02-491705,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-086965,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,70.0,KG,20181010.0,,PH,IT,IT,2018,Q4,Elderly
154244492,15424449,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q4,Electrolyte imbalance,,2018,Q4,2,F,20180723.0,20181005.0,20180925,20181010,EXP,IT-MINISAL02-491705,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-086965,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,70.0,KG,20181010.0,,PH,IT,IT,2018,Q4,Elderly
154244492,15424449,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q4,Renal tubular disorder,,2018,Q4,2,F,20180723.0,20181005.0,20180925,20181010,EXP,IT-MINISAL02-491705,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-086965,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,70.0,KG,20181010.0,,PH,IT,IT,2018,Q4,Elderly
154244492,15424449,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q4,Tubulointerstitial nephritis,,2018,Q4,2,F,20180723.0,20181005.0,20180925,20181010,EXP,IT-MINISAL02-491705,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-086965,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,70.0,KG,20181010.0,,PH,IT,IT,2018,Q4,Elderly
154268902,15426890,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Abdominal discomfort,,2018,Q4,2,F,201803.0,20180921.0,20180925,20181002,EXP,,US-ACTELION-A-NJ2018-170545,ACTELION,,57.0,YR,A,F,Y,,,20181002.0,,PH,US,US,2018,Q4,Adult
154268902,15426890,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Acute respiratory failure,,2018,Q4,2,F,201803.0,20180921.0,20180925,20181002,EXP,,US-ACTELION-A-NJ2018-170545,ACTELION,,57.0,YR,A,F,Y,,,20181002.0,,PH,US,US,2018,Q4,Adult
154268902,15426890,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Diarrhoea,,2018,Q4,2,F,201803.0,20180921.0,20180925,20181002,EXP,,US-ACTELION-A-NJ2018-170545,ACTELION,,57.0,YR,A,F,Y,,,20181002.0,,PH,US,US,2018,Q4,Adult
154268902,15426890,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Eye swelling,,2018,Q4,2,F,201803.0,20180921.0,20180925,20181002,EXP,,US-ACTELION-A-NJ2018-170545,ACTELION,,57.0,YR,A,F,Y,,,20181002.0,,PH,US,US,2018,Q4,Adult
154268902,15426890,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Gastroenteritis,,2018,Q4,2,F,201803.0,20180921.0,20180925,20181002,EXP,,US-ACTELION-A-NJ2018-170545,ACTELION,,57.0,YR,A,F,Y,,,20181002.0,,PH,US,US,2018,Q4,Adult
154268902,15426890,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Headache,,2018,Q4,2,F,201803.0,20180921.0,20180925,20181002,EXP,,US-ACTELION-A-NJ2018-170545,ACTELION,,57.0,YR,A,F,Y,,,20181002.0,,PH,US,US,2018,Q4,Adult
154268902,15426890,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Infection,,2018,Q4,2,F,201803.0,20180921.0,20180925,20181002,EXP,,US-ACTELION-A-NJ2018-170545,ACTELION,,57.0,YR,A,F,Y,,,20181002.0,,PH,US,US,2018,Q4,Adult
154268902,15426890,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Insomnia,,2018,Q4,2,F,201803.0,20180921.0,20180925,20181002,EXP,,US-ACTELION-A-NJ2018-170545,ACTELION,,57.0,YR,A,F,Y,,,20181002.0,,PH,US,US,2018,Q4,Adult
154268902,15426890,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Loss of personal independence in daily activities,,2018,Q4,2,F,201803.0,20180921.0,20180925,20181002,EXP,,US-ACTELION-A-NJ2018-170545,ACTELION,,57.0,YR,A,F,Y,,,20181002.0,,PH,US,US,2018,Q4,Adult
154268902,15426890,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Nausea,,2018,Q4,2,F,201803.0,20180921.0,20180925,20181002,EXP,,US-ACTELION-A-NJ2018-170545,ACTELION,,57.0,YR,A,F,Y,,,20181002.0,,PH,US,US,2018,Q4,Adult
154268902,15426890,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Neuropathy peripheral,,2018,Q4,2,F,201803.0,20180921.0,20180925,20181002,EXP,,US-ACTELION-A-NJ2018-170545,ACTELION,,57.0,YR,A,F,Y,,,20181002.0,,PH,US,US,2018,Q4,Adult
154268902,15426890,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Pain in extremity,,2018,Q4,2,F,201803.0,20180921.0,20180925,20181002,EXP,,US-ACTELION-A-NJ2018-170545,ACTELION,,57.0,YR,A,F,Y,,,20181002.0,,PH,US,US,2018,Q4,Adult
154268902,15426890,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Paraesthesia,,2018,Q4,2,F,201803.0,20180921.0,20180925,20181002,EXP,,US-ACTELION-A-NJ2018-170545,ACTELION,,57.0,YR,A,F,Y,,,20181002.0,,PH,US,US,2018,Q4,Adult
154268902,15426890,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Pericardial effusion,,2018,Q4,2,F,201803.0,20180921.0,20180925,20181002,EXP,,US-ACTELION-A-NJ2018-170545,ACTELION,,57.0,YR,A,F,Y,,,20181002.0,,PH,US,US,2018,Q4,Adult
154268902,15426890,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Pulmonary hypertension,,2018,Q4,2,F,201803.0,20180921.0,20180925,20181002,EXP,,US-ACTELION-A-NJ2018-170545,ACTELION,,57.0,YR,A,F,Y,,,20181002.0,,PH,US,US,2018,Q4,Adult
154268902,15426890,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Sleep disorder,,2018,Q4,2,F,201803.0,20180921.0,20180925,20181002,EXP,,US-ACTELION-A-NJ2018-170545,ACTELION,,57.0,YR,A,F,Y,,,20181002.0,,PH,US,US,2018,Q4,Adult
154268902,15426890,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2018,Q4,Surgery,,2018,Q4,2,F,201803.0,20180921.0,20180925,20181002,EXP,,US-ACTELION-A-NJ2018-170545,ACTELION,,57.0,YR,A,F,Y,,,20181002.0,,PH,US,US,2018,Q4,Adult
154316632,15431663,38,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 UNIT/ML, 3ML PEN",,,,,,,,,,,,2018,Q4,Syncope,,2018,Q4,2,F,20180918.0,20180925.0,20180926,20181003,EXP,,US-ABBVIE-18P-163-2498343-00,ABBVIE,,70.0,YR,,M,Y,,,20181003.0,,MD,US,US,2018,Q4,Elderly
154529881,15452988,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"12 U, DAILY",,,U,,,,,12.0,IU,,QD,2018,Q4,Blood glucose increased,,2018,Q4,1,I,201808.0,20180919.0,20181001,20181001,EXP,,PL-ELI_LILLY_AND_COMPANY-PL201809009152,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20181001.0,,CN,PL,PL,2018,Q4,Adult
154529881,15452988,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"12 U, DAILY",,,U,,,,,12.0,IU,,QD,2018,Q4,Drug ineffective,,2018,Q4,1,I,201808.0,20180919.0,20181001,20181001,EXP,,PL-ELI_LILLY_AND_COMPANY-PL201809009152,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20181001.0,,CN,PL,PL,2018,Q4,Adult
154529881,15452988,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"12 U, DAILY",,,U,,,,,12.0,IU,,QD,2018,Q4,Feeling abnormal,,2018,Q4,1,I,201808.0,20180919.0,20181001,20181001,EXP,,PL-ELI_LILLY_AND_COMPANY-PL201809009152,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20181001.0,,CN,PL,PL,2018,Q4,Adult
154529881,15452988,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"12 U, DAILY",,,U,,,,,12.0,IU,,QD,2018,Q4,Ischaemic stroke,,2018,Q4,1,I,201808.0,20180919.0,20181001,20181001,EXP,,PL-ELI_LILLY_AND_COMPANY-PL201809009152,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20181001.0,,CN,PL,PL,2018,Q4,Adult
154529881,15452988,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 U, DAILY",,,U,,,,,10.0,IU,,QD,2018,Q4,Blood glucose increased,,2018,Q4,1,I,201808.0,20180919.0,20181001,20181001,EXP,,PL-ELI_LILLY_AND_COMPANY-PL201809009152,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20181001.0,,CN,PL,PL,2018,Q4,Adult
154529881,15452988,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 U, DAILY",,,U,,,,,10.0,IU,,QD,2018,Q4,Drug ineffective,,2018,Q4,1,I,201808.0,20180919.0,20181001,20181001,EXP,,PL-ELI_LILLY_AND_COMPANY-PL201809009152,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20181001.0,,CN,PL,PL,2018,Q4,Adult
154529881,15452988,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 U, DAILY",,,U,,,,,10.0,IU,,QD,2018,Q4,Feeling abnormal,,2018,Q4,1,I,201808.0,20180919.0,20181001,20181001,EXP,,PL-ELI_LILLY_AND_COMPANY-PL201809009152,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20181001.0,,CN,PL,PL,2018,Q4,Adult
154529881,15452988,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 U, DAILY",,,U,,,,,10.0,IU,,QD,2018,Q4,Ischaemic stroke,,2018,Q4,1,I,201808.0,20180919.0,20181001,20181001,EXP,,PL-ELI_LILLY_AND_COMPANY-PL201809009152,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20181001.0,,CN,PL,PL,2018,Q4,Adult
154529881,15452988,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 U, DAILY",,,U,,,,,10.0,IU,,QD,2018,Q4,Blood glucose increased,,2018,Q4,1,I,201808.0,20180919.0,20181001,20181001,EXP,,PL-ELI_LILLY_AND_COMPANY-PL201809009152,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20181001.0,,CN,PL,PL,2018,Q4,Adult
154529881,15452988,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 U, DAILY",,,U,,,,,10.0,IU,,QD,2018,Q4,Drug ineffective,,2018,Q4,1,I,201808.0,20180919.0,20181001,20181001,EXP,,PL-ELI_LILLY_AND_COMPANY-PL201809009152,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20181001.0,,CN,PL,PL,2018,Q4,Adult
154529881,15452988,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 U, DAILY",,,U,,,,,10.0,IU,,QD,2018,Q4,Feeling abnormal,,2018,Q4,1,I,201808.0,20180919.0,20181001,20181001,EXP,,PL-ELI_LILLY_AND_COMPANY-PL201809009152,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20181001.0,,CN,PL,PL,2018,Q4,Adult
154529881,15452988,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 U, DAILY",,,U,,,,,10.0,IU,,QD,2018,Q4,Ischaemic stroke,,2018,Q4,1,I,201808.0,20180919.0,20181001,20181001,EXP,,PL-ELI_LILLY_AND_COMPANY-PL201809009152,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20181001.0,,CN,PL,PL,2018,Q4,Adult
154559421,15455942,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,4760.0,IU,,,,,,28.0,IU,SOLUTION FOR INJECTION,QD,2018,Q4,Hypoglycaemia,,2018,Q4,1,I,20180620.0,20180926.0,20181002,20181002,EXP,IT-MINISAL02-499954,IT-SA-2018SA269371,SANOFI AVENTIS,,70.0,YR,E,M,Y,,,20181002.0,,MD,IT,IT,2018,Q4,Elderly
154559421,15455942,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,4760.0,IU,,,,,,28.0,IU,SOLUTION FOR INJECTION,QD,2018,Q4,Sopor,,2018,Q4,1,I,20180620.0,20180926.0,20181002,20181002,EXP,IT-MINISAL02-499954,IT-SA-2018SA269371,SANOFI AVENTIS,,70.0,YR,E,M,Y,,,20181002.0,,MD,IT,IT,2018,Q4,Elderly
154568891,15456889,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 U, 4-6 UU 3 X DAILY",,,D,,,,,,,,,2018,Q4,Anaemia,,2018,Q4,1,I,,20180924.0,20181002,20181002,EXP,,EE-VALIDUS PHARMACEUTICALS LLC-EE-2018VAL000927,VALIDUS,HEIN H. KIDNEY TRANSPLANTATION. PEREARST. 2018;29,45.0,YR,,F,Y,,,20181002.0,,OT,EE,EE,2018,Q4,Adult
154568891,15456889,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 U, 4-6 UU 3 X DAILY",,,D,,,,,,,,,2018,Q4,Dermatitis,,2018,Q4,1,I,,20180924.0,20181002,20181002,EXP,,EE-VALIDUS PHARMACEUTICALS LLC-EE-2018VAL000927,VALIDUS,HEIN H. KIDNEY TRANSPLANTATION. PEREARST. 2018;29,45.0,YR,,F,Y,,,20181002.0,,OT,EE,EE,2018,Q4,Adult
154568891,15456889,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 U, 4-6 UU 3 X DAILY",,,D,,,,,,,,,2018,Q4,Urinary tract infection,,2018,Q4,1,I,,20180924.0,20181002,20181002,EXP,,EE-VALIDUS PHARMACEUTICALS LLC-EE-2018VAL000927,VALIDUS,HEIN H. KIDNEY TRANSPLANTATION. PEREARST. 2018;29,45.0,YR,,F,Y,,,20181002.0,,OT,EE,EE,2018,Q4,Adult
154572002,15457200,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 U, 4-6 UU 3 X DAILY.",,,U,,,,,,,,,2018,Q4,Anaemia,,2018,Q4,2,F,,20180924.0,20181002,20181003,EXP,,PHHY2018EE109628,SANDOZ,,45.0,YR,,F,Y,,,20181003.0,,OT,EE,EE,2018,Q4,Adult
154572002,15457200,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 U, 4-6 UU 3 X DAILY.",,,U,,,,,,,,,2018,Q4,Dermatitis,,2018,Q4,2,F,,20180924.0,20181002,20181003,EXP,,PHHY2018EE109628,SANDOZ,,45.0,YR,,F,Y,,,20181003.0,,OT,EE,EE,2018,Q4,Adult
154572002,15457200,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 U, 4-6 UU 3 X DAILY.",,,U,,,,,,,,,2018,Q4,Urinary tract infection,,2018,Q4,2,F,,20180924.0,20181002,20181003,EXP,,PHHY2018EE109628,SANDOZ,,45.0,YR,,F,Y,,,20181003.0,,OT,EE,EE,2018,Q4,Adult
154580292,15458029,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 INTERNATIONAL UNIT,,,U,U, UNK,,,10.0,IU,,,2018,Q4,Acute kidney injury,,2018,Q4,2,F,20180723.0,20181005.0,20181003,20181019,EXP,,IT-AUROBINDO-AUR-APL-2018-047675,AUROBINDO,,65.0,YR,,F,Y,70.0,KG,20181019.0,,PH,IT,IT,2018,Q4,Elderly
154580292,15458029,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 INTERNATIONAL UNIT,,,U,U, UNK,,,10.0,IU,,,2018,Q4,Electrolyte imbalance,,2018,Q4,2,F,20180723.0,20181005.0,20181003,20181019,EXP,,IT-AUROBINDO-AUR-APL-2018-047675,AUROBINDO,,65.0,YR,,F,Y,70.0,KG,20181019.0,,PH,IT,IT,2018,Q4,Elderly
154580292,15458029,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 INTERNATIONAL UNIT,,,U,U, UNK,,,10.0,IU,,,2018,Q4,Renal tubular disorder,,2018,Q4,2,F,20180723.0,20181005.0,20181003,20181019,EXP,,IT-AUROBINDO-AUR-APL-2018-047675,AUROBINDO,,65.0,YR,,F,Y,70.0,KG,20181019.0,,PH,IT,IT,2018,Q4,Elderly
154580292,15458029,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 INTERNATIONAL UNIT,,,U,U, UNK,,,10.0,IU,,,2018,Q4,Tubulointerstitial nephritis,,2018,Q4,2,F,20180723.0,20181005.0,20181003,20181019,EXP,,IT-AUROBINDO-AUR-APL-2018-047675,AUROBINDO,,65.0,YR,,F,Y,70.0,KG,20181019.0,,PH,IT,IT,2018,Q4,Elderly
154647371,15464737,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,INJECT 144 UNITS UNDER THE SKIN TID WITH MEALIS,,,,,,,,,,,,2018,Q4,Catheterisation cardiac,,2018,Q4,1,I,20180523.0,20180604.0,20181004,20181004,EXP,,US-BAYER-2018-107557,BAYER,,59.0,YR,A,F,Y,,,20181004.0,,OT,US,US,2018,Q4,Adult
154647371,15464737,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,INJECT 144 UNITS UNDER THE SKIN TID WITH MEALIS,,,,,,,,,,,,2018,Q4,Chest pain,,2018,Q4,1,I,20180523.0,20180604.0,20181004,20181004,EXP,,US-BAYER-2018-107557,BAYER,,59.0,YR,A,F,Y,,,20181004.0,,OT,US,US,2018,Q4,Adult
154647371,15464737,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,INJECT 144 UNITS UNDER THE SKIN TID WITH MEALIS,,,,,,,,,,,,2018,Q4,Death,,2018,Q4,1,I,20180523.0,20180604.0,20181004,20181004,EXP,,US-BAYER-2018-107557,BAYER,,59.0,YR,A,F,Y,,,20181004.0,,OT,US,US,2018,Q4,Adult
154647371,15464737,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,INJECT 144 UNITS UNDER THE SKIN TID WITH MEALIS,,,,,,,,,,,,2018,Q4,Dizziness,,2018,Q4,1,I,20180523.0,20180604.0,20181004,20181004,EXP,,US-BAYER-2018-107557,BAYER,,59.0,YR,A,F,Y,,,20181004.0,,OT,US,US,2018,Q4,Adult
154647371,15464737,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,INJECT 144 UNITS UNDER THE SKIN TID WITH MEALIS,,,,,,,,,,,,2018,Q4,Dyspnoea,,2018,Q4,1,I,20180523.0,20180604.0,20181004,20181004,EXP,,US-BAYER-2018-107557,BAYER,,59.0,YR,A,F,Y,,,20181004.0,,OT,US,US,2018,Q4,Adult
154647371,15464737,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,INJECT 144 UNITS UNDER THE SKIN TID WITH MEALIS,,,,,,,,,,,,2018,Q4,Headache,,2018,Q4,1,I,20180523.0,20180604.0,20181004,20181004,EXP,,US-BAYER-2018-107557,BAYER,,59.0,YR,A,F,Y,,,20181004.0,,OT,US,US,2018,Q4,Adult
154657452,15465745,15,C,insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2018,Q4,Jejunal ulcer,,2018,Q4,2,F,20180719.0,20181025.0,20181004,20181031,EXP,,HU-CELGENEUS-HUN-20180909306,CELGENE,,63.0,YR,,M,Y,74.0,KG,20181031.0,,MD,HU,HU,2018,Q4,Adult
154657452,15465745,15,C,insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2018,Q4,Metastases to bone,,2018,Q4,2,F,20180719.0,20181025.0,20181004,20181031,EXP,,HU-CELGENEUS-HUN-20180909306,CELGENE,,63.0,YR,,M,Y,74.0,KG,20181031.0,,MD,HU,HU,2018,Q4,Adult
154703112,15470311,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"IU, ACCORDING TO BLOOD GLUCOSE",,,D,,,,,,,,,2018,Q4,Anaemia,,2018,Q4,2,F,,20181008.0,20181005,20181011,EXP,,DE-MYLANLABS-2018M1073075,MYLAN,,77.0,YR,,M,Y,,,20181009.0,,PH,DE,DE,2018,Q4,Elderly
154703112,15470311,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"IU, ACCORDING TO BLOOD GLUCOSE",,,D,,,,,,,,,2018,Q4,Dyspnoea,,2018,Q4,2,F,,20181008.0,20181005,20181011,EXP,,DE-MYLANLABS-2018M1073075,MYLAN,,77.0,YR,,M,Y,,,20181009.0,,PH,DE,DE,2018,Q4,Elderly
154703112,15470311,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"IU, ACCORDING TO BLOOD GLUCOSE",,,D,,,,,,,,,2018,Q4,Haematochezia,,2018,Q4,2,F,,20181008.0,20181005,20181011,EXP,,DE-MYLANLABS-2018M1073075,MYLAN,,77.0,YR,,M,Y,,,20181009.0,,PH,DE,DE,2018,Q4,Elderly
154735291,15473529,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"23 IU, EACH MORNING",,,Y,U,,,20563.0,23.0,IU,,QD,2018,Q4,Blood glucose increased,,2018,Q4,1,I,,20180926.0,20181008,20181008,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201809012092,ELI LILLY AND CO,,57.0,YR,,F,Y,58.0,KG,20181008.0,,CN,CN,CN,2018,Q4,Adult
154735291,15473529,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"23 IU, EACH MORNING",,,Y,U,,,20563.0,23.0,IU,,QD,2018,Q4,Face oedema,,2018,Q4,1,I,,20180926.0,20181008,20181008,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201809012092,ELI LILLY AND CO,,57.0,YR,,F,Y,58.0,KG,20181008.0,,CN,CN,CN,2018,Q4,Adult
154735291,15473529,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"23 IU, EACH MORNING",,,Y,U,,,20563.0,23.0,IU,,QD,2018,Q4,Oedema peripheral,,2018,Q4,1,I,,20180926.0,20181008,20181008,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201809012092,ELI LILLY AND CO,,57.0,YR,,F,Y,58.0,KG,20181008.0,,CN,CN,CN,2018,Q4,Adult
154735291,15473529,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"20 IU, EACH EVENING",,,Y,U,,,20563.0,20.0,IU,,QD,2018,Q4,Blood glucose increased,,2018,Q4,1,I,,20180926.0,20181008,20181008,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201809012092,ELI LILLY AND CO,,57.0,YR,,F,Y,58.0,KG,20181008.0,,CN,CN,CN,2018,Q4,Adult
154735291,15473529,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"20 IU, EACH EVENING",,,Y,U,,,20563.0,20.0,IU,,QD,2018,Q4,Face oedema,,2018,Q4,1,I,,20180926.0,20181008,20181008,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201809012092,ELI LILLY AND CO,,57.0,YR,,F,Y,58.0,KG,20181008.0,,CN,CN,CN,2018,Q4,Adult
154735291,15473529,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"20 IU, EACH EVENING",,,Y,U,,,20563.0,20.0,IU,,QD,2018,Q4,Oedema peripheral,,2018,Q4,1,I,,20180926.0,20181008,20181008,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201809012092,ELI LILLY AND CO,,57.0,YR,,F,Y,58.0,KG,20181008.0,,CN,CN,CN,2018,Q4,Adult
154739061,15473906,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,209196.0,,,SOLUTION FOR INJECTION,,2018,Q4,Urticaria,,2018,Q4,1,I,,20180921.0,20181008,20181008,PER,,US-SA-2018SA268817,SANOFI AVENTIS,,11.0,YR,C,F,Y,,,20181008.0,,CN,US,US,2018,Q4,Child
154793501,15479350,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"22 IU, Q3D",22.0,IU,D,,,,,22.0,IU,,,2018,Q4,Partial seizures,,2018,Q4,1,I,20160427.0,20180723.0,20181009,20181009,EXP,,DE-MYLANLABS-2018M1057737,MYLAN,,74.0,YR,,F,Y,106.0,KG,20181009.0,,MD,DE,DE,2018,Q4,Elderly
154793501,15479350,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"22 IU, Q3D",22.0,IU,D,,,,,22.0,IU,,,2018,Q4,Product use in unapproved indication,,2018,Q4,1,I,20160427.0,20180723.0,20181009,20181009,EXP,,DE-MYLANLABS-2018M1057737,MYLAN,,74.0,YR,,F,Y,106.0,KG,20181009.0,,MD,DE,DE,2018,Q4,Elderly
154793501,15479350,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"67 IU, UNK",22.0,IU,D,,,,,67.0,IU,,,2018,Q4,Partial seizures,,2018,Q4,1,I,20160427.0,20180723.0,20181009,20181009,EXP,,DE-MYLANLABS-2018M1057737,MYLAN,,74.0,YR,,F,Y,106.0,KG,20181009.0,,MD,DE,DE,2018,Q4,Elderly
154793501,15479350,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"67 IU, UNK",22.0,IU,D,,,,,67.0,IU,,,2018,Q4,Product use in unapproved indication,,2018,Q4,1,I,20160427.0,20180723.0,20181009,20181009,EXP,,DE-MYLANLABS-2018M1057737,MYLAN,,74.0,YR,,F,Y,106.0,KG,20181009.0,,MD,DE,DE,2018,Q4,Elderly
154870811,15487081,19,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q4,Abdominal pain lower,,2018,Q4,1,I,20180930.0,,20181010,20181010,DIR,,,FDA-CTU,,70.0,YR,,M,N,75.7,KG,20181010.0,N,PH,US,US,2018,Q4,Elderly
154870811,15487081,19,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q4,Blood pressure increased,,2018,Q4,1,I,20180930.0,,20181010,20181010,DIR,,,FDA-CTU,,70.0,YR,,M,N,75.7,KG,20181010.0,N,PH,US,US,2018,Q4,Elderly
154870811,15487081,19,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q4,Dyspnoea,,2018,Q4,1,I,20180930.0,,20181010,20181010,DIR,,,FDA-CTU,,70.0,YR,,M,N,75.7,KG,20181010.0,N,PH,US,US,2018,Q4,Elderly
154870811,15487081,19,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q4,Large intestinal haemorrhage,,2018,Q4,1,I,20180930.0,,20181010,20181010,DIR,,,FDA-CTU,,70.0,YR,,M,N,75.7,KG,20181010.0,N,PH,US,US,2018,Q4,Elderly
154870811,15487081,19,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q4,Nausea,,2018,Q4,1,I,20180930.0,,20181010,20181010,DIR,,,FDA-CTU,,70.0,YR,,M,N,75.7,KG,20181010.0,N,PH,US,US,2018,Q4,Elderly
154870811,15487081,19,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q4,Vomiting,,2018,Q4,1,I,20180930.0,,20181010,20181010,DIR,,,FDA-CTU,,70.0,YR,,M,N,75.7,KG,20181010.0,N,PH,US,US,2018,Q4,Elderly
154891092,15489109,7,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,SLIDING SCALE,,,,,,,,,,UNKNOWN,QD,2018,Q4,Myelodysplastic syndrome,,2018,Q4,2,F,20180922.0,20181130.0,20181011,20181205,EXP,,US-CELGENEUS-USA-20181002015,CELGENE,,75.0,YR,,M,Y,,,20181205.0,,MD,US,US,2018,Q4,Elderly
154911752,15491175,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 IU, UNK",,,U,U,,,,10.0,IU,,,2018,Q4,Acute kidney injury,,2018,Q4,2,F,20180723.0,20180927.0,20181012,20181012,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2018RR-186279,RANBAXY,,65.0,YR,,F,Y,70.0,KG,20181012.0,,OT,GB,IT,2018,Q4,Elderly
154911752,15491175,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 IU, UNK",,,U,U,,,,10.0,IU,,,2018,Q4,Renal tubular disorder,,2018,Q4,2,F,20180723.0,20180927.0,20181012,20181012,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2018RR-186279,RANBAXY,,65.0,YR,,F,Y,70.0,KG,20181012.0,,OT,GB,IT,2018,Q4,Elderly
154934327,15493432,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2018,Q4,Acute kidney injury,,2018,Q4,7,F,20180419.0,20181123.0,20181012,20181129,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20181129.0,,MD,DE,DE,2018,Q4,Elderly
154934327,15493432,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2018,Q4,Colitis,,2018,Q4,7,F,20180419.0,20181123.0,20181012,20181129,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20181129.0,,MD,DE,DE,2018,Q4,Elderly
154934327,15493432,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2018,Q4,Device related infection,,2018,Q4,7,F,20180419.0,20181123.0,20181012,20181129,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20181129.0,,MD,DE,DE,2018,Q4,Elderly
154934327,15493432,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2018,Q4,Heparin-induced thrombocytopenia,,2018,Q4,7,F,20180419.0,20181123.0,20181012,20181129,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20181129.0,,MD,DE,DE,2018,Q4,Elderly
154934327,15493432,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2018,Q4,Hyperglycaemia,,2018,Q4,7,F,20180419.0,20181123.0,20181012,20181129,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20181129.0,,MD,DE,DE,2018,Q4,Elderly
154934327,15493432,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2018,Q4,Malignant neoplasm progression,,2018,Q4,7,F,20180419.0,20181123.0,20181012,20181129,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20181129.0,,MD,DE,DE,2018,Q4,Elderly
154934327,15493432,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2018,Q4,Meningitis,,2018,Q4,7,F,20180419.0,20181123.0,20181012,20181129,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20181129.0,,MD,DE,DE,2018,Q4,Elderly
154934327,15493432,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2018,Q4,Metastases to meninges,,2018,Q4,7,F,20180419.0,20181123.0,20181012,20181129,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20181129.0,,MD,DE,DE,2018,Q4,Elderly
154934327,15493432,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2018,Q4,Retinal detachment,,2018,Q4,7,F,20180419.0,20181123.0,20181012,20181129,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20181129.0,,MD,DE,DE,2018,Q4,Elderly
154934327,15493432,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2018,Q4,Retinopathy,,2018,Q4,7,F,20180419.0,20181123.0,20181012,20181129,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20181129.0,,MD,DE,DE,2018,Q4,Elderly
154934327,15493432,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2018,Q4,Urosepsis,,2018,Q4,7,F,20180419.0,20181123.0,20181012,20181129,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20181129.0,,MD,DE,DE,2018,Q4,Elderly
154969603,15496960,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q4,Addison's disease,,2018,Q4,3,F,20180819.0,20181127.0,20181015,20181130,EXP,,US-ROCHE-2186872,ROCHE,,56.0,YR,,F,Y,73.5,KG,20181130.0,,MD,US,US,2018,Q4,Adult
154969603,15496960,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q4,Hyperthyroidism,,2018,Q4,3,F,20180819.0,20181127.0,20181015,20181130,EXP,,US-ROCHE-2186872,ROCHE,,56.0,YR,,F,Y,73.5,KG,20181130.0,,MD,US,US,2018,Q4,Adult
154969603,15496960,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q4,Hypothyroidism,,2018,Q4,3,F,20180819.0,20181127.0,20181015,20181130,EXP,,US-ROCHE-2186872,ROCHE,,56.0,YR,,F,Y,73.5,KG,20181130.0,,MD,US,US,2018,Q4,Adult
155007211,15500721,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"1 IU, DAILY",,,U,U,,,20563.0,1.0,IU,,QD,2018,Q4,Aphasia,,2018,Q4,1,I,20180817.0,20181005.0,20181015,20181015,EXP,IT-MINISAL02-502645,IT-ELI_LILLY_AND_COMPANY-IT201810003294,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20181015.0,,CN,IT,IT,2018,Q4,Elderly
155007211,15500721,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"1 IU, DAILY",,,U,U,,,20563.0,1.0,IU,,QD,2018,Q4,Confusional state,,2018,Q4,1,I,20180817.0,20181005.0,20181015,20181015,EXP,IT-MINISAL02-502645,IT-ELI_LILLY_AND_COMPANY-IT201810003294,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20181015.0,,CN,IT,IT,2018,Q4,Elderly
155007211,15500721,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"1 IU, DAILY",,,U,U,,,20563.0,1.0,IU,,QD,2018,Q4,Extra dose administered,,2018,Q4,1,I,20180817.0,20181005.0,20181015,20181015,EXP,IT-MINISAL02-502645,IT-ELI_LILLY_AND_COMPANY-IT201810003294,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20181015.0,,CN,IT,IT,2018,Q4,Elderly
155007211,15500721,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"1 IU, DAILY",,,U,U,,,20563.0,1.0,IU,,QD,2018,Q4,Hyperhidrosis,,2018,Q4,1,I,20180817.0,20181005.0,20181015,20181015,EXP,IT-MINISAL02-502645,IT-ELI_LILLY_AND_COMPANY-IT201810003294,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20181015.0,,CN,IT,IT,2018,Q4,Elderly
155007211,15500721,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"1 IU, DAILY",,,U,U,,,20563.0,1.0,IU,,QD,2018,Q4,Hypoglycaemia,,2018,Q4,1,I,20180817.0,20181005.0,20181015,20181015,EXP,IT-MINISAL02-502645,IT-ELI_LILLY_AND_COMPANY-IT201810003294,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20181015.0,,CN,IT,IT,2018,Q4,Elderly
155007241,15500724,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"30 DF, TOTAL, OVERDOSE",,,,,,,20563.0,30.0,DF,,,2018,Q4,Extra dose administered,,2018,Q4,1,I,20180926.0,20181003.0,20181015,20181015,EXP,IT-MINISAL02-502124,IT-ELI_LILLY_AND_COMPANY-IT201810002391,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20181015.0,,CN,IT,IT,2018,Q4,Elderly
155007241,15500724,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"30 DF, TOTAL, OVERDOSE",,,,,,,20563.0,30.0,DF,,,2018,Q4,Hyperhidrosis,,2018,Q4,1,I,20180926.0,20181003.0,20181015,20181015,EXP,IT-MINISAL02-502124,IT-ELI_LILLY_AND_COMPANY-IT201810002391,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20181015.0,,CN,IT,IT,2018,Q4,Elderly
155007241,15500724,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"30 DF, TOTAL, OVERDOSE",,,,,,,20563.0,30.0,DF,,,2018,Q4,Hypokinesia,,2018,Q4,1,I,20180926.0,20181003.0,20181015,20181015,EXP,IT-MINISAL02-502124,IT-ELI_LILLY_AND_COMPANY-IT201810002391,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20181015.0,,CN,IT,IT,2018,Q4,Elderly
155007241,15500724,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"30 DF, TOTAL, OVERDOSE",,,,,,,20563.0,30.0,DF,,,2018,Q4,Mental impairment,,2018,Q4,1,I,20180926.0,20181003.0,20181015,20181015,EXP,IT-MINISAL02-502124,IT-ELI_LILLY_AND_COMPANY-IT201810002391,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20181015.0,,CN,IT,IT,2018,Q4,Elderly
155007751,15500775,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q4,Seizure,,2018,Q4,1,I,20180910.0,20181009.0,20181015,20181015,EXP,,JP-PFIZER INC-2018411149,PFIZER,,68.0,YR,,M,Y,59.3,KG,20181015.0,,MD,JP,JP,2018,Q4,Elderly
155013382,15501338,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q4,Hypertension,,2018,Q4,2,F,20180927.0,20181017.0,20181015,20181022,EXP,,PHHY2018IT122036,SANDOZ,,82.0,YR,,F,Y,,,20181022.0,,OT,IT,IT,2018,Q4,Elderly
155013382,15501338,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q4,Hypoglycaemia,,2018,Q4,2,F,20180927.0,20181017.0,20181015,20181022,EXP,,PHHY2018IT122036,SANDOZ,,82.0,YR,,F,Y,,,20181022.0,,OT,IT,IT,2018,Q4,Elderly
155013382,15501338,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q4,Overdose,,2018,Q4,2,F,20180927.0,20181017.0,20181015,20181022,EXP,,PHHY2018IT122036,SANDOZ,,82.0,YR,,F,Y,,,20181022.0,,OT,IT,IT,2018,Q4,Elderly
155096241,15509624,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q4,Death,,2018,Q4,1,I,2018.0,20181012.0,20181016,20181016,EXP,,US-OTSUKA-2018_033519,OTSUKA,,75.0,YR,,F,Y,,,20181016.0,,CN,US,US,2018,Q4,Elderly
155096241,15509624,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q4,Hospice care,,2018,Q4,1,I,2018.0,20181012.0,20181016,20181016,EXP,,US-OTSUKA-2018_033519,OTSUKA,,75.0,YR,,F,Y,,,20181016.0,,CN,US,US,2018,Q4,Elderly
155184601,15518460,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q4,Death,,2018,Q4,1,I,20180826.0,20180119.0,20181017,20181017,EXP,,US-EXELIXIS-CABO-18012116,EXELIXIS,,61.0,YR,,M,Y,,,20181017.0,,CN,US,US,2018,Q4,Adult
155184632,15518463,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q4,Hypertension,,2018,Q4,2,F,20180927.0,20181015.0,20181017,20181023,EXP,IT-MINISAL02-502630,IT-MYLANLABS-2018M1077439,MYLAN,,82.0,YR,,F,Y,,,20181023.0,,OT,IT,IT,2018,Q4,Elderly
155184632,15518463,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q4,Hypoglycaemia,,2018,Q4,2,F,20180927.0,20181015.0,20181017,20181023,EXP,IT-MINISAL02-502630,IT-MYLANLABS-2018M1077439,MYLAN,,82.0,YR,,F,Y,,,20181023.0,,OT,IT,IT,2018,Q4,Elderly
155184632,15518463,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q4,Medication error,,2018,Q4,2,F,20180927.0,20181015.0,20181017,20181023,EXP,IT-MINISAL02-502630,IT-MYLANLABS-2018M1077439,MYLAN,,82.0,YR,,F,Y,,,20181023.0,,OT,IT,IT,2018,Q4,Elderly
155184632,15518463,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q4,Overdose,,2018,Q4,2,F,20180927.0,20181015.0,20181017,20181023,EXP,IT-MINISAL02-502630,IT-MYLANLABS-2018M1077439,MYLAN,,82.0,YR,,F,Y,,,20181023.0,,OT,IT,IT,2018,Q4,Elderly
155237181,15523718,2,SS,Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,U, C883580C,,,,,INJECTION,,2018,Q4,Blood glucose increased,,2018,Q4,1,I,20181014.0,20181015.0,20181018,20181018,PER,,US-ELI_LILLY_AND_COMPANY-US201810007293,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20181018.0,,CN,US,US,2018,Q4,Elderly
155237181,15523718,2,SS,Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,U, C883580C,,,,,INJECTION,,2018,Q4,Wrong product administered,,2018,Q4,1,I,20181014.0,20181015.0,20181018,20181018,PER,,US-ELI_LILLY_AND_COMPANY-US201810007293,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20181018.0,,CN,US,US,2018,Q4,Elderly
155268192,15526819,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,,,,,209196.0,,,,,2018,Q4,Hypertension,,2018,Q4,2,F,20180927.0,20181018.0,20181018,20181023,EXP,IT-MINISAL02-502630,IT-SA-2018SA284269,SANOFI AVENTIS,,82.0,YR,E,F,Y,,,20181023.0,,PH,IT,IT,2018,Q4,Elderly
155268192,15526819,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,,,,,209196.0,,,,,2018,Q4,Hypoglycaemia,,2018,Q4,2,F,20180927.0,20181018.0,20181018,20181023,EXP,IT-MINISAL02-502630,IT-SA-2018SA284269,SANOFI AVENTIS,,82.0,YR,E,F,Y,,,20181023.0,,PH,IT,IT,2018,Q4,Elderly
155268192,15526819,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,,,,,209196.0,,,,,2018,Q4,Overdose,,2018,Q4,2,F,20180927.0,20181018.0,20181018,20181023,EXP,IT-MINISAL02-502630,IT-SA-2018SA284269,SANOFI AVENTIS,,82.0,YR,E,F,Y,,,20181023.0,,PH,IT,IT,2018,Q4,Elderly
155308882,15530888,36,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q4,Adenovirus infection,,2018,Q4,2,F,20171019.0,20181016.0,20181020,20181205,EXP,,US-AMGEN-USASP2018146187,AMGEN,,40.0,YR,A,F,Y,50.3,KG,20181205.0,,OT,US,US,2018,Q4,Adult
155308882,15530888,36,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q4,Ascites,,2018,Q4,2,F,20171019.0,20181016.0,20181020,20181205,EXP,,US-AMGEN-USASP2018146187,AMGEN,,40.0,YR,A,F,Y,50.3,KG,20181205.0,,OT,US,US,2018,Q4,Adult
155308882,15530888,36,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q4,Bacteraemia,,2018,Q4,2,F,20171019.0,20181016.0,20181020,20181205,EXP,,US-AMGEN-USASP2018146187,AMGEN,,40.0,YR,A,F,Y,50.3,KG,20181205.0,,OT,US,US,2018,Q4,Adult
155308882,15530888,36,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q4,Blood bilirubin increased,,2018,Q4,2,F,20171019.0,20181016.0,20181020,20181205,EXP,,US-AMGEN-USASP2018146187,AMGEN,,40.0,YR,A,F,Y,50.3,KG,20181205.0,,OT,US,US,2018,Q4,Adult
155308882,15530888,36,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q4,Bone marrow transplant,,2018,Q4,2,F,20171019.0,20181016.0,20181020,20181205,EXP,,US-AMGEN-USASP2018146187,AMGEN,,40.0,YR,A,F,Y,50.3,KG,20181205.0,,OT,US,US,2018,Q4,Adult
155308882,15530888,36,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q4,Candida sepsis,,2018,Q4,2,F,20171019.0,20181016.0,20181020,20181205,EXP,,US-AMGEN-USASP2018146187,AMGEN,,40.0,YR,A,F,Y,50.3,KG,20181205.0,,OT,US,US,2018,Q4,Adult
155308882,15530888,36,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q4,Cholestasis,,2018,Q4,2,F,20171019.0,20181016.0,20181020,20181205,EXP,,US-AMGEN-USASP2018146187,AMGEN,,40.0,YR,A,F,Y,50.3,KG,20181205.0,,OT,US,US,2018,Q4,Adult
155308882,15530888,36,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q4,Fluid overload,,2018,Q4,2,F,20171019.0,20181016.0,20181020,20181205,EXP,,US-AMGEN-USASP2018146187,AMGEN,,40.0,YR,A,F,Y,50.3,KG,20181205.0,,OT,US,US,2018,Q4,Adult
155308882,15530888,36,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q4,Graft versus host disease in gastrointestinal tract,,2018,Q4,2,F,20171019.0,20181016.0,20181020,20181205,EXP,,US-AMGEN-USASP2018146187,AMGEN,,40.0,YR,A,F,Y,50.3,KG,20181205.0,,OT,US,US,2018,Q4,Adult
155308882,15530888,36,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q4,Graft versus host disease in liver,,2018,Q4,2,F,20171019.0,20181016.0,20181020,20181205,EXP,,US-AMGEN-USASP2018146187,AMGEN,,40.0,YR,A,F,Y,50.3,KG,20181205.0,,OT,US,US,2018,Q4,Adult
155308882,15530888,36,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q4,Graft versus host disease in skin,,2018,Q4,2,F,20171019.0,20181016.0,20181020,20181205,EXP,,US-AMGEN-USASP2018146187,AMGEN,,40.0,YR,A,F,Y,50.3,KG,20181205.0,,OT,US,US,2018,Q4,Adult
155308882,15530888,36,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q4,Hypertension,,2018,Q4,2,F,20171019.0,20181016.0,20181020,20181205,EXP,,US-AMGEN-USASP2018146187,AMGEN,,40.0,YR,A,F,Y,50.3,KG,20181205.0,,OT,US,US,2018,Q4,Adult
155308882,15530888,36,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q4,Multiple organ dysfunction syndrome,,2018,Q4,2,F,20171019.0,20181016.0,20181020,20181205,EXP,,US-AMGEN-USASP2018146187,AMGEN,,40.0,YR,A,F,Y,50.3,KG,20181205.0,,OT,US,US,2018,Q4,Adult
155308882,15530888,36,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q4,Pancytopenia,,2018,Q4,2,F,20171019.0,20181016.0,20181020,20181205,EXP,,US-AMGEN-USASP2018146187,AMGEN,,40.0,YR,A,F,Y,50.3,KG,20181205.0,,OT,US,US,2018,Q4,Adult
155308882,15530888,36,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q4,Pneumonia aspiration,,2018,Q4,2,F,20171019.0,20181016.0,20181020,20181205,EXP,,US-AMGEN-USASP2018146187,AMGEN,,40.0,YR,A,F,Y,50.3,KG,20181205.0,,OT,US,US,2018,Q4,Adult
155308882,15530888,36,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q4,Portal hypertension,,2018,Q4,2,F,20171019.0,20181016.0,20181020,20181205,EXP,,US-AMGEN-USASP2018146187,AMGEN,,40.0,YR,A,F,Y,50.3,KG,20181205.0,,OT,US,US,2018,Q4,Adult
155312691,15531269,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q4,Gastritis erosive,,2018,Q4,1,I,,20180924.0,20181019,20181019,EXP,,US-ROCHE-2192556,ROCHE,"HEITZ M, YANG T, JORDAN S, VO A, AND NAST C ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE IN AN HIV-INFECTED PATIENT. NAT CLIN PRACT NEPHROL 2008;4 (3):167-171.",55.0,YR,,M,Y,,,20181019.0,,OT,US,US,2018,Q4,Adult
155312691,15531269,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q4,Oesophageal candidiasis,,2018,Q4,1,I,,20180924.0,20181019,20181019,EXP,,US-ROCHE-2192556,ROCHE,"HEITZ M, YANG T, JORDAN S, VO A, AND NAST C ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE IN AN HIV-INFECTED PATIENT. NAT CLIN PRACT NEPHROL 2008;4 (3):167-171.",55.0,YR,,M,Y,,,20181019.0,,OT,US,US,2018,Q4,Adult
155312691,15531269,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q4,Tubulointerstitial nephritis,,2018,Q4,1,I,,20180924.0,20181019,20181019,EXP,,US-ROCHE-2192556,ROCHE,"HEITZ M, YANG T, JORDAN S, VO A, AND NAST C ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE IN AN HIV-INFECTED PATIENT. NAT CLIN PRACT NEPHROL 2008;4 (3):167-171.",55.0,YR,,M,Y,,,20181019.0,,OT,US,US,2018,Q4,Adult
155315501,15531550,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2018,Q4,Blood creatine phosphokinase MB increased,,2018,Q4,1,I,20040427.0,20040908.0,20181019,20181019,EXP,,SE-009507513-0409SWE00011,MERCK,,44.0,YR,,M,Y,,,20181019.0,,CN,US,SE,2018,Q4,Adult
155315501,15531550,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2018,Q4,Drug interaction,,2018,Q4,1,I,20040427.0,20040908.0,20181019,20181019,EXP,,SE-009507513-0409SWE00011,MERCK,,44.0,YR,,M,Y,,,20181019.0,,CN,US,SE,2018,Q4,Adult
155315501,15531550,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2018,Q4,Renal failure,,2018,Q4,1,I,20040427.0,20040908.0,20181019,20181019,EXP,,SE-009507513-0409SWE00011,MERCK,,44.0,YR,,M,Y,,,20181019.0,,CN,US,SE,2018,Q4,Adult
155315501,15531550,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2018,Q4,Rhabdomyolysis,,2018,Q4,1,I,20040427.0,20040908.0,20181019,20181019,EXP,,SE-009507513-0409SWE00011,MERCK,,44.0,YR,,M,Y,,,20181019.0,,CN,US,SE,2018,Q4,Adult
155315501,15531550,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2018,Q4,Troponin I increased,,2018,Q4,1,I,20040427.0,20040908.0,20181019,20181019,EXP,,SE-009507513-0409SWE00011,MERCK,,44.0,YR,,M,Y,,,20181019.0,,CN,US,SE,2018,Q4,Adult
155315501,15531550,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2018,Q4,Type 1 diabetes mellitus,,2018,Q4,1,I,20040427.0,20040908.0,20181019,20181019,EXP,,SE-009507513-0409SWE00011,MERCK,,44.0,YR,,M,Y,,,20181019.0,,CN,US,SE,2018,Q4,Adult
155318692,15531869,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNK,,,,,,,2018,Q4,Hypertension,,2018,Q4,2,F,20180927.0,20181014.0,20181019,20181026,EXP,,IT-AUROBINDO-AUR-APL-2018-050851,AUROBINDO,,82.0,YR,,F,Y,,,20181026.0,,PH,IT,IT,2018,Q4,Elderly
155318692,15531869,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNK,,,,,,,2018,Q4,Hypoglycaemia,,2018,Q4,2,F,20180927.0,20181014.0,20181019,20181026,EXP,,IT-AUROBINDO-AUR-APL-2018-050851,AUROBINDO,,82.0,YR,,F,Y,,,20181026.0,,PH,IT,IT,2018,Q4,Elderly
155318692,15531869,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNK,,,,,,,2018,Q4,Overdose,,2018,Q4,2,F,20180927.0,20181014.0,20181019,20181026,EXP,,IT-AUROBINDO-AUR-APL-2018-050851,AUROBINDO,,82.0,YR,,F,Y,,,20181026.0,,PH,IT,IT,2018,Q4,Elderly
155339082,15533908,2,SS,insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q4,Hypertension,,2018,Q4,2,F,20180927.0,20181017.0,20181019,20181029,EXP,IT-MINISAL02-502630,IT-BAXTER-2018BAX025506,BAXTER,,82.0,YR,,F,Y,,,20181029.0,,PH,IT,IT,2018,Q4,Elderly
155339082,15533908,2,SS,insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q4,Hypoglycaemia,,2018,Q4,2,F,20180927.0,20181017.0,20181019,20181029,EXP,IT-MINISAL02-502630,IT-BAXTER-2018BAX025506,BAXTER,,82.0,YR,,F,Y,,,20181029.0,,PH,IT,IT,2018,Q4,Elderly
155339082,15533908,2,SS,insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q4,Overdose,,2018,Q4,2,F,20180927.0,20181017.0,20181019,20181029,EXP,IT-MINISAL02-502630,IT-BAXTER-2018BAX025506,BAXTER,,82.0,YR,,F,Y,,,20181029.0,,PH,IT,IT,2018,Q4,Elderly
155354161,15535416,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q4,Cerebral haemorrhage,,2018,Q4,1,I,20181012.0,20181015.0,20181022,20181022,EXP,,CO-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-098162,BRISTOL MYERS SQUIBB,,89.0,YR,,F,Y,,,20181022.0,,OT,CO,CO,2018,Q4,Elderly
155354161,15535416,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q4,Fall,,2018,Q4,1,I,20181012.0,20181015.0,20181022,20181022,EXP,,CO-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-098162,BRISTOL MYERS SQUIBB,,89.0,YR,,F,Y,,,20181022.0,,OT,CO,CO,2018,Q4,Elderly
155354161,15535416,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q4,Hypertension,,2018,Q4,1,I,20181012.0,20181015.0,20181022,20181022,EXP,,CO-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-098162,BRISTOL MYERS SQUIBB,,89.0,YR,,F,Y,,,20181022.0,,OT,CO,CO,2018,Q4,Elderly
155379281,15537928,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Blood glucose increased,,2018,Q4,1,I,,20181015.0,20181022,20181022,PER,,US-SA-2018SA288203,SANOFI AVENTIS,,48.0,YR,A,M,Y,,,20181022.0,,CN,US,US,2018,Q4,Adult
155379281,15537928,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Constipation,,2018,Q4,1,I,,20181015.0,20181022,20181022,PER,,US-SA-2018SA288203,SANOFI AVENTIS,,48.0,YR,A,M,Y,,,20181022.0,,CN,US,US,2018,Q4,Adult
155379281,15537928,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Dyspnoea,,2018,Q4,1,I,,20181015.0,20181022,20181022,PER,,US-SA-2018SA288203,SANOFI AVENTIS,,48.0,YR,A,M,Y,,,20181022.0,,CN,US,US,2018,Q4,Adult
155379281,15537928,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Expired product administered,,2018,Q4,1,I,,20181015.0,20181022,20181022,PER,,US-SA-2018SA288203,SANOFI AVENTIS,,48.0,YR,A,M,Y,,,20181022.0,,CN,US,US,2018,Q4,Adult
155379281,15537928,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Vision blurred,,2018,Q4,1,I,,20181015.0,20181022,20181022,PER,,US-SA-2018SA288203,SANOFI AVENTIS,,48.0,YR,A,M,Y,,,20181022.0,,CN,US,US,2018,Q4,Adult
155422971,15542297,3,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,,, UNKNOWN,,,,,,,2018,Q4,Hypertension,,2018,Q4,1,I,20180927.0,20181008.0,20181023,20181023,EXP,IT-MINISAL02-502630,IT-MIST-TIR-2018-1087,MIST PHARMACEUTICALS,,82.0,YR,,F,Y,,,20181022.0,,PH,IT,IT,2018,Q4,Elderly
155422971,15542297,3,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,,, UNKNOWN,,,,,,,2018,Q4,Hypoglycaemia,,2018,Q4,1,I,20180927.0,20181008.0,20181023,20181023,EXP,IT-MINISAL02-502630,IT-MIST-TIR-2018-1087,MIST PHARMACEUTICALS,,82.0,YR,,F,Y,,,20181022.0,,PH,IT,IT,2018,Q4,Elderly
155428264,15542826,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q4,Ejection fraction decreased,,2018,Q4,4,F,20180921.0,20181128.0,20181023,20181204,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-097353,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,103.0,KG,20181204.0,,OT,US,US,2018,Q4,Adult
155467121,15546712,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 IU, QD",1020.0,IU,U,,,,,10.0,IU,SOLUTION FOR INJECTION,QD,2018,Q4,Confusional state,,2018,Q4,1,I,20180413.0,20181022.0,20181024,20181024,EXP,IT-MINISAL02-504720,IT-SAKK-2018SA293185AA,SANOFI AVENTIS,,80.0,YR,E,M,Y,,,20181024.0,,MD,IT,IT,2018,Q4,Elderly
155467121,15546712,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 IU, QD",1020.0,IU,U,,,,,10.0,IU,SOLUTION FOR INJECTION,QD,2018,Q4,Hypoglycaemia,,2018,Q4,1,I,20180413.0,20181022.0,20181024,20181024,EXP,IT-MINISAL02-504720,IT-SAKK-2018SA293185AA,SANOFI AVENTIS,,80.0,YR,E,M,Y,,,20181024.0,,MD,IT,IT,2018,Q4,Elderly
155471602,15547160,3,SS,Lispro,INSULIN LISPRO,1,Subcutaneous,"12 IU, DAILY",,,U,U,,,,12.0,IU,,QD,2018,Q4,Hyperglycaemia,,2018,Q4,2,F,,20181015.0,20181024,20181025,EXP,,SK-ELI_LILLY_AND_COMPANY-SK201810010116,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20181025.0,,OT,SK,SK,2018,Q4,Elderly
155471602,15547160,4,SS,Lispro,INSULIN LISPRO,1,Subcutaneous,"10 IU, DAILY",,,U,U,,,,10.0,IU,,QD,2018,Q4,Hyperglycaemia,,2018,Q4,2,F,,20181015.0,20181024,20181025,EXP,,SK-ELI_LILLY_AND_COMPANY-SK201810010116,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20181025.0,,OT,SK,SK,2018,Q4,Elderly
155496922,15549692,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q4,Hypertension,,2018,Q4,2,F,20180927.0,20181029.0,20181025,20181102,EXP,IT-MINISAL02-502630,IT-TEVA-2018-IT-968325,TEVA,,82.0,YR,,F,Y,,,20181103.0,,PH,IT,IT,2018,Q4,Elderly
155496922,15549692,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q4,Hypoglycaemia,,2018,Q4,2,F,20180927.0,20181029.0,20181025,20181102,EXP,IT-MINISAL02-502630,IT-TEVA-2018-IT-968325,TEVA,,82.0,YR,,F,Y,,,20181103.0,,PH,IT,IT,2018,Q4,Elderly
155496922,15549692,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q4,Overdose,,2018,Q4,2,F,20180927.0,20181029.0,20181025,20181102,EXP,IT-MINISAL02-502630,IT-TEVA-2018-IT-968325,TEVA,,82.0,YR,,F,Y,,,20181103.0,,PH,IT,IT,2018,Q4,Elderly
155499151,15549915,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,12.0,IU,,QD,2018,Q4,Hyperglycaemia,,2018,Q4,1,I,,20181015.0,20181025,20181025,EXP,,SK-BAUSCH-BL-2018-028577,BAUSCH AND LOMB,PECIK M. THERAPEUTIC PRIORITIES IN CLINICAL PRACTICE. COMPATIBLE MEDICINE. 2018;13:32-33.,69.0,YR,,F,Y,,,20181025.0,,MD,SK,SK,2018,Q4,Elderly
155499151,15549915,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,10.0,IU,,QD,2018,Q4,Hyperglycaemia,,2018,Q4,1,I,,20181015.0,20181025,20181025,EXP,,SK-BAUSCH-BL-2018-028577,BAUSCH AND LOMB,PECIK M. THERAPEUTIC PRIORITIES IN CLINICAL PRACTICE. COMPATIBLE MEDICINE. 2018;13:32-33.,69.0,YR,,F,Y,,,20181025.0,,MD,SK,SK,2018,Q4,Elderly
155525912,15552591,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ML,,,,,,,,,,,,2018,Q4,Normocytic anaemia,,2018,Q4,2,F,20171024.0,20181022.0,20181025,20181029,EXP,IT-MINISAL02-503520,IT-FRESENIUS KABI-FK201810992,FRESENIUS KABI,,52.0,YR,,M,Y,,,20181025.0,,OT,GB,IT,2018,Q4,Adult
155525912,15552591,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ML,,,,,,,,,,,,2018,Q4,Pancytopenia,,2018,Q4,2,F,20171024.0,20181022.0,20181025,20181029,EXP,IT-MINISAL02-503520,IT-FRESENIUS KABI-FK201810992,FRESENIUS KABI,,52.0,YR,,M,Y,,,20181025.0,,OT,GB,IT,2018,Q4,Adult
155527431,15552743,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 IU, DAILY",1020.0,IU,Y,U,,,20563.0,10.0,IU,,QD,2018,Q4,Confusional state,,2018,Q4,1,I,20180413.0,20181018.0,20181025,20181025,EXP,IT-MINISAL02-504720,IT-ELI_LILLY_AND_COMPANY-IT201810009461,ELI LILLY AND CO,,80.0,YR,,M,Y,,,20181025.0,,CN,IT,IT,2018,Q4,Elderly
155527431,15552743,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 IU, DAILY",1020.0,IU,Y,U,,,20563.0,10.0,IU,,QD,2018,Q4,Hypoglycaemia,,2018,Q4,1,I,20180413.0,20181018.0,20181025,20181025,EXP,IT-MINISAL02-504720,IT-ELI_LILLY_AND_COMPANY-IT201810009461,ELI LILLY AND CO,,80.0,YR,,M,Y,,,20181025.0,,CN,IT,IT,2018,Q4,Elderly
155550061,15555006,4,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q4,Metabolic encephalopathy,,2018,Q4,1,I,20181008.0,,20181026,20181026,DIR,,,FDA-CTU,,77.0,YR,,F,N,67.0,KG,20181026.0,N,PH,US,US,2018,Q4,Elderly
155591911,15559191,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"25 U, PRN",,,,,,,20563.0,25.0,IU,INJECTION,,2018,Q4,Blood glucose increased,,2018,Q4,1,I,20181022.0,20181023.0,20181029,20181029,PER,,US-ELI_LILLY_AND_COMPANY-US201810011889,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20181029.0,,CN,US,US,2018,Q4,Elderly
155591911,15559191,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,,,,INJECTION,,2018,Q4,Blood glucose increased,,2018,Q4,1,I,20181022.0,20181023.0,20181029,20181029,PER,,US-ELI_LILLY_AND_COMPANY-US201810011889,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20181029.0,,CN,US,US,2018,Q4,Elderly
155653701,15565370,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q4,Hypertension,,2018,Q4,1,I,20180927.0,20181007.0,20181030,20181030,EXP,IT-MINISAL02-502630,IT-BAUSCH-BL-2018-027874,BAUSCH AND LOMB,,82.0,YR,,F,Y,,,20181030.0,,PH,IT,IT,2018,Q4,Elderly
155653701,15565370,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q4,Hypoglycaemia,,2018,Q4,1,I,20180927.0,20181007.0,20181030,20181030,EXP,IT-MINISAL02-502630,IT-BAUSCH-BL-2018-027874,BAUSCH AND LOMB,,82.0,YR,,F,Y,,,20181030.0,,PH,IT,IT,2018,Q4,Elderly
155653701,15565370,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q4,Overdose,,2018,Q4,1,I,20180927.0,20181007.0,20181030,20181030,EXP,IT-MINISAL02-502630,IT-BAUSCH-BL-2018-027874,BAUSCH AND LOMB,,82.0,YR,,F,Y,,,20181030.0,,PH,IT,IT,2018,Q4,Elderly
155654921,15565492,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2018,Q4,Azotaemia,,2018,Q4,1,I,20180417.0,20181017.0,20181030,20181030,EXP,,PHHY2018US137932,NOVARTIS,,40.0,YR,,F,Y,50.3,KG,20181030.0,,MD,US,US,2018,Q4,Adult
155654921,15565492,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2018,Q4,Candida sepsis,,2018,Q4,1,I,20180417.0,20181017.0,20181030,20181030,EXP,,PHHY2018US137932,NOVARTIS,,40.0,YR,,F,Y,50.3,KG,20181030.0,,MD,US,US,2018,Q4,Adult
155654921,15565492,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2018,Q4,Hypoxia,,2018,Q4,1,I,20180417.0,20181017.0,20181030,20181030,EXP,,PHHY2018US137932,NOVARTIS,,40.0,YR,,F,Y,50.3,KG,20181030.0,,MD,US,US,2018,Q4,Adult
155654921,15565492,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2018,Q4,Lactic acidosis,,2018,Q4,1,I,20180417.0,20181017.0,20181030,20181030,EXP,,PHHY2018US137932,NOVARTIS,,40.0,YR,,F,Y,50.3,KG,20181030.0,,MD,US,US,2018,Q4,Adult
155654921,15565492,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2018,Q4,Multiple organ dysfunction syndrome,,2018,Q4,1,I,20180417.0,20181017.0,20181030,20181030,EXP,,PHHY2018US137932,NOVARTIS,,40.0,YR,,F,Y,50.3,KG,20181030.0,,MD,US,US,2018,Q4,Adult
155654921,15565492,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2018,Q4,Pneumonia aspiration,,2018,Q4,1,I,20180417.0,20181017.0,20181030,20181030,EXP,,PHHY2018US137932,NOVARTIS,,40.0,YR,,F,Y,50.3,KG,20181030.0,,MD,US,US,2018,Q4,Adult
155674912,15567491,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2018,Q4,Urosepsis,,2018,Q4,2,F,20180818.0,20181215.0,20181030,20181217,EXP,,PHHO2018US009569,NOVARTIS,,74.0,YR,,F,Y,105.0,KG,20181217.0,,MD,US,US,2018,Q4,Elderly
155675963,15567596,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16-30 UNITS, QD",,,Y,,,,,,,SOLUTION FOR INJECTION,QD,2018,Q4,Alanine aminotransferase increased,,2018,Q4,3,F,20180109.0,20181211.0,20181030,20181213,EXP,,JP-SA-2018SA294428,SANOFI AVENTIS,"NISHI Y, MIYATA K, FURUTA K. 1-10-24 A CASE OF SUSPECTED DRUG-INDUCED LIVER INJURY DUE TO MULTIPLE INSULIN ANALOGUE PREPARATIONS IN A PATIENT WITH TYPE 2 DIABETES MELLITUS. THE 56TH KYUSHU REGIONAL MEETING OF THE JAPAN DIABETES SOCIETY (12-, 13-OCT-2018. 2018;UNK:228",61.0,YR,A,F,Y,,,20181213.0,,MD,JP,JP,2018,Q4,Adult
155675963,15567596,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16-30 UNITS, QD",,,Y,,,,,,,SOLUTION FOR INJECTION,QD,2018,Q4,Aspartate aminotransferase increased,,2018,Q4,3,F,20180109.0,20181211.0,20181030,20181213,EXP,,JP-SA-2018SA294428,SANOFI AVENTIS,"NISHI Y, MIYATA K, FURUTA K. 1-10-24 A CASE OF SUSPECTED DRUG-INDUCED LIVER INJURY DUE TO MULTIPLE INSULIN ANALOGUE PREPARATIONS IN A PATIENT WITH TYPE 2 DIABETES MELLITUS. THE 56TH KYUSHU REGIONAL MEETING OF THE JAPAN DIABETES SOCIETY (12-, 13-OCT-2018. 2018;UNK:228",61.0,YR,A,F,Y,,,20181213.0,,MD,JP,JP,2018,Q4,Adult
155675963,15567596,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16-30 UNITS, QD",,,Y,,,,,,,SOLUTION FOR INJECTION,QD,2018,Q4,Drug-induced liver injury,,2018,Q4,3,F,20180109.0,20181211.0,20181030,20181213,EXP,,JP-SA-2018SA294428,SANOFI AVENTIS,"NISHI Y, MIYATA K, FURUTA K. 1-10-24 A CASE OF SUSPECTED DRUG-INDUCED LIVER INJURY DUE TO MULTIPLE INSULIN ANALOGUE PREPARATIONS IN A PATIENT WITH TYPE 2 DIABETES MELLITUS. THE 56TH KYUSHU REGIONAL MEETING OF THE JAPAN DIABETES SOCIETY (12-, 13-OCT-2018. 2018;UNK:228",61.0,YR,A,F,Y,,,20181213.0,,MD,JP,JP,2018,Q4,Adult
155688881,15568888,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"4 UNITS BEFORE BREAKFAST, 8 UNITS BEFORE LUNCH, AND 11",,,U,U,,,,,,,,2018,Q4,Neuropathy peripheral,,2018,Q4,1,I,,20181021.0,20181031,20181031,PER,,US-APOTEX-2018AP023758,APOTEX,"ESTOFAN LJF, NAYDIN S, GLIEBUS G. QUINOLONE-INDUCED PAINFUL PERIPHERAL NEUROPATHY: A CASE REPORT AND LITERATURE REVIEW DOI: 10.1177/2324709617752736. JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS. 2018;6:1-3",20.0,YR,,M,Y,,,20181031.0,,MD,US,US,2018,Q4,Youth
155689561,15568956,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,BEFORE LUNCH,,,U,,,,,8.0,IU,,,2018,Q4,Blood pressure increased,,2018,Q4,1,I,,20181023.0,20181031,20181031,EXP,,US-DRREDDYS-USA/USA/18/0105073,DR REDDYS,"ESTOFAN L, NAYDIN S, GLIEBUS G. QUINOLONE-INDUCED PAINFUL PERIPHERAL NEUROPATHY: A CASE REPORT AND LITERATURE REVIEW. J INVESTIG MED HIGH IMPACT CASE REP. 2018;6:1-3.",20.0,YR,,M,Y,51.8,KG,20181031.0,,MD,COUNTRY NOT SPECIFIED,US,2018,Q4,Youth
155689561,15568956,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,BEFORE LUNCH,,,U,,,,,8.0,IU,,,2018,Q4,Hyperhidrosis,,2018,Q4,1,I,,20181023.0,20181031,20181031,EXP,,US-DRREDDYS-USA/USA/18/0105073,DR REDDYS,"ESTOFAN L, NAYDIN S, GLIEBUS G. QUINOLONE-INDUCED PAINFUL PERIPHERAL NEUROPATHY: A CASE REPORT AND LITERATURE REVIEW. J INVESTIG MED HIGH IMPACT CASE REP. 2018;6:1-3.",20.0,YR,,M,Y,51.8,KG,20181031.0,,MD,COUNTRY NOT SPECIFIED,US,2018,Q4,Youth
155689561,15568956,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,BEFORE LUNCH,,,U,,,,,8.0,IU,,,2018,Q4,Neuropathy peripheral,,2018,Q4,1,I,,20181023.0,20181031,20181031,EXP,,US-DRREDDYS-USA/USA/18/0105073,DR REDDYS,"ESTOFAN L, NAYDIN S, GLIEBUS G. QUINOLONE-INDUCED PAINFUL PERIPHERAL NEUROPATHY: A CASE REPORT AND LITERATURE REVIEW. J INVESTIG MED HIGH IMPACT CASE REP. 2018;6:1-3.",20.0,YR,,M,Y,51.8,KG,20181031.0,,MD,COUNTRY NOT SPECIFIED,US,2018,Q4,Youth
155689561,15568956,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,BEFORE LUNCH,,,U,,,,,8.0,IU,,,2018,Q4,Pain,,2018,Q4,1,I,,20181023.0,20181031,20181031,EXP,,US-DRREDDYS-USA/USA/18/0105073,DR REDDYS,"ESTOFAN L, NAYDIN S, GLIEBUS G. QUINOLONE-INDUCED PAINFUL PERIPHERAL NEUROPATHY: A CASE REPORT AND LITERATURE REVIEW. J INVESTIG MED HIGH IMPACT CASE REP. 2018;6:1-3.",20.0,YR,,M,Y,51.8,KG,20181031.0,,MD,COUNTRY NOT SPECIFIED,US,2018,Q4,Youth
155689561,15568956,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,BEFORE LUNCH,,,U,,,,,8.0,IU,,,2018,Q4,Tachycardia,,2018,Q4,1,I,,20181023.0,20181031,20181031,EXP,,US-DRREDDYS-USA/USA/18/0105073,DR REDDYS,"ESTOFAN L, NAYDIN S, GLIEBUS G. QUINOLONE-INDUCED PAINFUL PERIPHERAL NEUROPATHY: A CASE REPORT AND LITERATURE REVIEW. J INVESTIG MED HIGH IMPACT CASE REP. 2018;6:1-3.",20.0,YR,,M,Y,51.8,KG,20181031.0,,MD,COUNTRY NOT SPECIFIED,US,2018,Q4,Youth
155689561,15568956,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,BEFORE LUNCH,,,U,,,,,8.0,IU,,,2018,Q4,Temperature regulation disorder,,2018,Q4,1,I,,20181023.0,20181031,20181031,EXP,,US-DRREDDYS-USA/USA/18/0105073,DR REDDYS,"ESTOFAN L, NAYDIN S, GLIEBUS G. QUINOLONE-INDUCED PAINFUL PERIPHERAL NEUROPATHY: A CASE REPORT AND LITERATURE REVIEW. J INVESTIG MED HIGH IMPACT CASE REP. 2018;6:1-3.",20.0,YR,,M,Y,51.8,KG,20181031.0,,MD,COUNTRY NOT SPECIFIED,US,2018,Q4,Youth
155689561,15568956,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,BEFORE BREAKFAST,,,U,,,,,4.0,IU,,,2018,Q4,Blood pressure increased,,2018,Q4,1,I,,20181023.0,20181031,20181031,EXP,,US-DRREDDYS-USA/USA/18/0105073,DR REDDYS,"ESTOFAN L, NAYDIN S, GLIEBUS G. QUINOLONE-INDUCED PAINFUL PERIPHERAL NEUROPATHY: A CASE REPORT AND LITERATURE REVIEW. J INVESTIG MED HIGH IMPACT CASE REP. 2018;6:1-3.",20.0,YR,,M,Y,51.8,KG,20181031.0,,MD,COUNTRY NOT SPECIFIED,US,2018,Q4,Youth
155689561,15568956,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,BEFORE BREAKFAST,,,U,,,,,4.0,IU,,,2018,Q4,Hyperhidrosis,,2018,Q4,1,I,,20181023.0,20181031,20181031,EXP,,US-DRREDDYS-USA/USA/18/0105073,DR REDDYS,"ESTOFAN L, NAYDIN S, GLIEBUS G. QUINOLONE-INDUCED PAINFUL PERIPHERAL NEUROPATHY: A CASE REPORT AND LITERATURE REVIEW. J INVESTIG MED HIGH IMPACT CASE REP. 2018;6:1-3.",20.0,YR,,M,Y,51.8,KG,20181031.0,,MD,COUNTRY NOT SPECIFIED,US,2018,Q4,Youth
155689561,15568956,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,BEFORE BREAKFAST,,,U,,,,,4.0,IU,,,2018,Q4,Neuropathy peripheral,,2018,Q4,1,I,,20181023.0,20181031,20181031,EXP,,US-DRREDDYS-USA/USA/18/0105073,DR REDDYS,"ESTOFAN L, NAYDIN S, GLIEBUS G. QUINOLONE-INDUCED PAINFUL PERIPHERAL NEUROPATHY: A CASE REPORT AND LITERATURE REVIEW. J INVESTIG MED HIGH IMPACT CASE REP. 2018;6:1-3.",20.0,YR,,M,Y,51.8,KG,20181031.0,,MD,COUNTRY NOT SPECIFIED,US,2018,Q4,Youth
155689561,15568956,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,BEFORE BREAKFAST,,,U,,,,,4.0,IU,,,2018,Q4,Pain,,2018,Q4,1,I,,20181023.0,20181031,20181031,EXP,,US-DRREDDYS-USA/USA/18/0105073,DR REDDYS,"ESTOFAN L, NAYDIN S, GLIEBUS G. QUINOLONE-INDUCED PAINFUL PERIPHERAL NEUROPATHY: A CASE REPORT AND LITERATURE REVIEW. J INVESTIG MED HIGH IMPACT CASE REP. 2018;6:1-3.",20.0,YR,,M,Y,51.8,KG,20181031.0,,MD,COUNTRY NOT SPECIFIED,US,2018,Q4,Youth
155689561,15568956,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,BEFORE BREAKFAST,,,U,,,,,4.0,IU,,,2018,Q4,Tachycardia,,2018,Q4,1,I,,20181023.0,20181031,20181031,EXP,,US-DRREDDYS-USA/USA/18/0105073,DR REDDYS,"ESTOFAN L, NAYDIN S, GLIEBUS G. QUINOLONE-INDUCED PAINFUL PERIPHERAL NEUROPATHY: A CASE REPORT AND LITERATURE REVIEW. J INVESTIG MED HIGH IMPACT CASE REP. 2018;6:1-3.",20.0,YR,,M,Y,51.8,KG,20181031.0,,MD,COUNTRY NOT SPECIFIED,US,2018,Q4,Youth
155689561,15568956,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,BEFORE BREAKFAST,,,U,,,,,4.0,IU,,,2018,Q4,Temperature regulation disorder,,2018,Q4,1,I,,20181023.0,20181031,20181031,EXP,,US-DRREDDYS-USA/USA/18/0105073,DR REDDYS,"ESTOFAN L, NAYDIN S, GLIEBUS G. QUINOLONE-INDUCED PAINFUL PERIPHERAL NEUROPATHY: A CASE REPORT AND LITERATURE REVIEW. J INVESTIG MED HIGH IMPACT CASE REP. 2018;6:1-3.",20.0,YR,,M,Y,51.8,KG,20181031.0,,MD,COUNTRY NOT SPECIFIED,US,2018,Q4,Youth
155689561,15568956,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,BEFORE DINNER,,,U,,,,,11.0,IU,,,2018,Q4,Blood pressure increased,,2018,Q4,1,I,,20181023.0,20181031,20181031,EXP,,US-DRREDDYS-USA/USA/18/0105073,DR REDDYS,"ESTOFAN L, NAYDIN S, GLIEBUS G. QUINOLONE-INDUCED PAINFUL PERIPHERAL NEUROPATHY: A CASE REPORT AND LITERATURE REVIEW. J INVESTIG MED HIGH IMPACT CASE REP. 2018;6:1-3.",20.0,YR,,M,Y,51.8,KG,20181031.0,,MD,COUNTRY NOT SPECIFIED,US,2018,Q4,Youth
155689561,15568956,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,BEFORE DINNER,,,U,,,,,11.0,IU,,,2018,Q4,Hyperhidrosis,,2018,Q4,1,I,,20181023.0,20181031,20181031,EXP,,US-DRREDDYS-USA/USA/18/0105073,DR REDDYS,"ESTOFAN L, NAYDIN S, GLIEBUS G. QUINOLONE-INDUCED PAINFUL PERIPHERAL NEUROPATHY: A CASE REPORT AND LITERATURE REVIEW. J INVESTIG MED HIGH IMPACT CASE REP. 2018;6:1-3.",20.0,YR,,M,Y,51.8,KG,20181031.0,,MD,COUNTRY NOT SPECIFIED,US,2018,Q4,Youth
155689561,15568956,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,BEFORE DINNER,,,U,,,,,11.0,IU,,,2018,Q4,Neuropathy peripheral,,2018,Q4,1,I,,20181023.0,20181031,20181031,EXP,,US-DRREDDYS-USA/USA/18/0105073,DR REDDYS,"ESTOFAN L, NAYDIN S, GLIEBUS G. QUINOLONE-INDUCED PAINFUL PERIPHERAL NEUROPATHY: A CASE REPORT AND LITERATURE REVIEW. J INVESTIG MED HIGH IMPACT CASE REP. 2018;6:1-3.",20.0,YR,,M,Y,51.8,KG,20181031.0,,MD,COUNTRY NOT SPECIFIED,US,2018,Q4,Youth
155689561,15568956,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,BEFORE DINNER,,,U,,,,,11.0,IU,,,2018,Q4,Pain,,2018,Q4,1,I,,20181023.0,20181031,20181031,EXP,,US-DRREDDYS-USA/USA/18/0105073,DR REDDYS,"ESTOFAN L, NAYDIN S, GLIEBUS G. QUINOLONE-INDUCED PAINFUL PERIPHERAL NEUROPATHY: A CASE REPORT AND LITERATURE REVIEW. J INVESTIG MED HIGH IMPACT CASE REP. 2018;6:1-3.",20.0,YR,,M,Y,51.8,KG,20181031.0,,MD,COUNTRY NOT SPECIFIED,US,2018,Q4,Youth
155689561,15568956,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,BEFORE DINNER,,,U,,,,,11.0,IU,,,2018,Q4,Tachycardia,,2018,Q4,1,I,,20181023.0,20181031,20181031,EXP,,US-DRREDDYS-USA/USA/18/0105073,DR REDDYS,"ESTOFAN L, NAYDIN S, GLIEBUS G. QUINOLONE-INDUCED PAINFUL PERIPHERAL NEUROPATHY: A CASE REPORT AND LITERATURE REVIEW. J INVESTIG MED HIGH IMPACT CASE REP. 2018;6:1-3.",20.0,YR,,M,Y,51.8,KG,20181031.0,,MD,COUNTRY NOT SPECIFIED,US,2018,Q4,Youth
155689561,15568956,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,BEFORE DINNER,,,U,,,,,11.0,IU,,,2018,Q4,Temperature regulation disorder,,2018,Q4,1,I,,20181023.0,20181031,20181031,EXP,,US-DRREDDYS-USA/USA/18/0105073,DR REDDYS,"ESTOFAN L, NAYDIN S, GLIEBUS G. QUINOLONE-INDUCED PAINFUL PERIPHERAL NEUROPATHY: A CASE REPORT AND LITERATURE REVIEW. J INVESTIG MED HIGH IMPACT CASE REP. 2018;6:1-3.",20.0,YR,,M,Y,51.8,KG,20181031.0,,MD,COUNTRY NOT SPECIFIED,US,2018,Q4,Youth
155742991,15574299,1,PS,Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,Y,U,,,20563.0,,,,,2018,Q4,Cataract,,2018,Q4,1,I,20181022.0,20181030.0,20181101,20181101,EXP,,ES-ELI_LILLY_AND_COMPANY-ES201810015073,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20181101.0,,CN,ES,ES,2018,Q4,Elderly
155742991,15574299,1,PS,Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,Y,U,,,20563.0,,,,,2018,Q4,Hyperglycaemia,,2018,Q4,1,I,20181022.0,20181030.0,20181101,20181101,EXP,,ES-ELI_LILLY_AND_COMPANY-ES201810015073,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20181101.0,,CN,ES,ES,2018,Q4,Elderly
155742991,15574299,1,PS,Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,Y,U,,,20563.0,,,,,2018,Q4,Oropharyngeal pain,,2018,Q4,1,I,20181022.0,20181030.0,20181101,20181101,EXP,,ES-ELI_LILLY_AND_COMPANY-ES201810015073,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20181101.0,,CN,ES,ES,2018,Q4,Elderly
155786851,15578685,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS WITH MEALS,,,D,,,,,,,INJECTION,,2018,Q4,Drug interaction,,2018,Q4,1,I,,20181022.0,20181102,20181102,EXP,,CA-MYLANLABS-2018M1081520,MYLAN,,56.0,YR,,M,Y,,,20181102.0,,OT,CA,CA,2018,Q4,Adult
155786851,15578685,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS WITH MEALS,,,D,,,,,,,INJECTION,,2018,Q4,Hallucination,,2018,Q4,1,I,,20181022.0,20181102,20181102,EXP,,CA-MYLANLABS-2018M1081520,MYLAN,,56.0,YR,,M,Y,,,20181102.0,,OT,CA,CA,2018,Q4,Adult
155786851,15578685,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS WITH MEALS,,,D,,,,,,,INJECTION,,2018,Q4,Hypoglycaemia,,2018,Q4,1,I,,20181022.0,20181102,20181102,EXP,,CA-MYLANLABS-2018M1081520,MYLAN,,56.0,YR,,M,Y,,,20181102.0,,OT,CA,CA,2018,Q4,Adult
155786851,15578685,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS WITH MEALS,,,D,,,,,,,INJECTION,,2018,Q4,Immunodeficiency,,2018,Q4,1,I,,20181022.0,20181102,20181102,EXP,,CA-MYLANLABS-2018M1081520,MYLAN,,56.0,YR,,M,Y,,,20181102.0,,OT,CA,CA,2018,Q4,Adult
155786851,15578685,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS WITH MEALS,,,D,,,,,,,INJECTION,,2018,Q4,Pneumonia fungal,,2018,Q4,1,I,,20181022.0,20181102,20181102,EXP,,CA-MYLANLABS-2018M1081520,MYLAN,,56.0,YR,,M,Y,,,20181102.0,,OT,CA,CA,2018,Q4,Adult
155786851,15578685,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS WITH MEALS,,,D,,,,,,,INJECTION,,2018,Q4,Toxicity to various agents,,2018,Q4,1,I,,20181022.0,20181102,20181102,EXP,,CA-MYLANLABS-2018M1081520,MYLAN,,56.0,YR,,M,Y,,,20181102.0,,OT,CA,CA,2018,Q4,Adult
155787141,15578714,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q4,Hypertension,,2018,Q4,1,I,20180927.0,20181019.0,20181102,20181102,EXP,,IT-APOTEX-2018AP023710,APOTEX,,82.0,YR,,F,Y,,,20181102.0,,CN,IT,IT,2018,Q4,Elderly
155787141,15578714,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q4,Hypoglycaemia,,2018,Q4,1,I,20180927.0,20181019.0,20181102,20181102,EXP,,IT-APOTEX-2018AP023710,APOTEX,,82.0,YR,,F,Y,,,20181102.0,,CN,IT,IT,2018,Q4,Elderly
155787141,15578714,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q4,Overdose,,2018,Q4,1,I,20180927.0,20181019.0,20181102,20181102,EXP,,IT-APOTEX-2018AP023710,APOTEX,,82.0,YR,,F,Y,,,20181102.0,,CN,IT,IT,2018,Q4,Elderly
155792572,15579257,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Blood glucose increased,,2018,Q4,2,F,,20181109.0,20181102,20181119,PER,,US-SA-2016SA017188,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20181119.0,,CN,US,US,2018,Q4,Elderly
155792572,15579257,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Chills,,2018,Q4,2,F,,20181109.0,20181102,20181119,PER,,US-SA-2016SA017188,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20181119.0,,CN,US,US,2018,Q4,Elderly
155792572,15579257,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Night sweats,,2018,Q4,2,F,,20181109.0,20181102,20181119,PER,,US-SA-2016SA017188,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20181119.0,,CN,US,US,2018,Q4,Elderly
155792572,15579257,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Off label use,,2018,Q4,2,F,,20181109.0,20181102,20181119,PER,,US-SA-2016SA017188,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20181119.0,,CN,US,US,2018,Q4,Elderly
155792572,15579257,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Tremor,,2018,Q4,2,F,,20181109.0,20181102,20181119,PER,,US-SA-2016SA017188,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20181119.0,,CN,US,US,2018,Q4,Elderly
155792572,15579257,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Wrong technique in product usage process,,2018,Q4,2,F,,20181109.0,20181102,20181119,PER,,US-SA-2016SA017188,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20181119.0,,CN,US,US,2018,Q4,Elderly
155799641,15579964,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"11 IU, QD",3036.0,IU,,,,,,11.0,IU,SOLUTION FOR INJECTION,QD,2018,Q4,Cold sweat,,2018,Q4,1,I,20181004.0,20181029.0,20181102,20181102,EXP,IT-MINISAL02-506089,IT-SAKK-2018SA299541AA,SANOFI AVENTIS,,13.0,YR,T,M,Y,55.0,KG,20181102.0,,MD,IT,IT,2018,Q4,Child
155799641,15579964,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"11 IU, QD",3036.0,IU,,,,,,11.0,IU,SOLUTION FOR INJECTION,QD,2018,Q4,Hypoglycaemia,,2018,Q4,1,I,20181004.0,20181029.0,20181102,20181102,EXP,IT-MINISAL02-506089,IT-SAKK-2018SA299541AA,SANOFI AVENTIS,,13.0,YR,T,M,Y,55.0,KG,20181102.0,,MD,IT,IT,2018,Q4,Child
155799641,15579964,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"11 IU, QD",3036.0,IU,,,,,,11.0,IU,SOLUTION FOR INJECTION,QD,2018,Q4,Vertigo,,2018,Q4,1,I,20181004.0,20181029.0,20181102,20181102,EXP,IT-MINISAL02-506089,IT-SAKK-2018SA299541AA,SANOFI AVENTIS,,13.0,YR,T,M,Y,55.0,KG,20181102.0,,MD,IT,IT,2018,Q4,Child
155799641,15579964,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"11 IU, QD",3036.0,IU,,,,,,11.0,IU,SOLUTION FOR INJECTION,QD,2018,Q4,Vision blurred,,2018,Q4,1,I,20181004.0,20181029.0,20181102,20181102,EXP,IT-MINISAL02-506089,IT-SAKK-2018SA299541AA,SANOFI AVENTIS,,13.0,YR,T,M,Y,55.0,KG,20181102.0,,MD,IT,IT,2018,Q4,Child
155849153,15584915,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q4,Dysphagia,,2018,Q4,3,F,,20181218.0,20181102,20181221,EXP,,US-GILEAD-2018-0369323,GILEAD,,62.0,YR,A,M,Y,,,20181221.0,,MD,US,US,2018,Q4,Adult
155849153,15584915,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q4,Feeding tube user,,2018,Q4,3,F,,20181218.0,20181102,20181221,EXP,,US-GILEAD-2018-0369323,GILEAD,,62.0,YR,A,M,Y,,,20181221.0,,MD,US,US,2018,Q4,Adult
155849153,15584915,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q4,Mitral valve stenosis,,2018,Q4,3,F,,20181218.0,20181102,20181221,EXP,,US-GILEAD-2018-0369323,GILEAD,,62.0,YR,A,M,Y,,,20181221.0,,MD,US,US,2018,Q4,Adult
155849153,15584915,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q4,Tricuspid valve incompetence,,2018,Q4,3,F,,20181218.0,20181102,20181221,EXP,,US-GILEAD-2018-0369323,GILEAD,,62.0,YR,A,M,Y,,,20181221.0,,MD,US,US,2018,Q4,Adult
155864422,15586442,34,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q4,Bacteraemia,,2018,Q4,2,F,20180906.0,20181102.0,20181105,20181113,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-084777,BRISTOL MYERS SQUIBB,,48.0,YR,,M,Y,61.41,KG,20181113.0,,OT,US,US,2018,Q4,Adult
155864422,15586442,34,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q4,Colitis,,2018,Q4,2,F,20180906.0,20181102.0,20181105,20181113,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-084777,BRISTOL MYERS SQUIBB,,48.0,YR,,M,Y,61.41,KG,20181113.0,,OT,US,US,2018,Q4,Adult
155864422,15586442,34,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q4,Vomiting,,2018,Q4,2,F,20180906.0,20181102.0,20181105,20181113,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-084777,BRISTOL MYERS SQUIBB,,48.0,YR,,M,Y,61.41,KG,20181113.0,,OT,US,US,2018,Q4,Adult
155864531,15586453,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"4 UNITS BEFORE BREAKFAST, 8 UNITS BEFORE LUNCH, AND 11UNITS BEFORE DINNER",,,,,,,,,,,,2018,Q4,Small fibre neuropathy,,2018,Q4,1,I,,20181022.0,20181105,20181105,EXP,,US-JUBILANT CADISTA PHARMACEUTICALS-2018JUB00449,JUBILANT,"ESTOFAN LJF, NAYDIN S, GLIEBUS G.. QUINOLONE-INDUCED PAINFUL PERIPHERAL NEUROPATHY: A CASE REPORT AND LITERATURE REVIEW.. J INVESTIG MED HIGH IMPACT CASE REP.. 2018;6",20.0,YR,,M,Y,51.8,KG,20181105.0,,MD,US,US,2018,Q4,Youth
155870161,15587016,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"9 KIU, QD",120192.0,KIU,U,,,,209196.0,9.0,KIU,,QD,2018,Q4,Acute kidney injury,,2018,Q4,1,I,20180606.0,20181031.0,20181105,20181105,EXP,IT-MINISAL02-506831,IT-SA-2018SA302262,SANOFI AVENTIS,,85.0,YR,E,F,Y,,,20181105.0,,PH,IT,IT,2018,Q4,Elderly
155870161,15587016,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"9 KIU, QD",120192.0,KIU,U,,,,209196.0,9.0,KIU,,QD,2018,Q4,Dyspnoea,,2018,Q4,1,I,20180606.0,20181031.0,20181105,20181105,EXP,IT-MINISAL02-506831,IT-SA-2018SA302262,SANOFI AVENTIS,,85.0,YR,E,F,Y,,,20181105.0,,PH,IT,IT,2018,Q4,Elderly
155870161,15587016,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"9 KIU, QD",120192.0,KIU,U,,,,209196.0,9.0,KIU,,QD,2018,Q4,Electrolyte imbalance,,2018,Q4,1,I,20180606.0,20181031.0,20181105,20181105,EXP,IT-MINISAL02-506831,IT-SA-2018SA302262,SANOFI AVENTIS,,85.0,YR,E,F,Y,,,20181105.0,,PH,IT,IT,2018,Q4,Elderly
155870161,15587016,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"9 KIU, QD",120192.0,KIU,U,,,,209196.0,9.0,KIU,,QD,2018,Q4,Hypoglycaemia,,2018,Q4,1,I,20180606.0,20181031.0,20181105,20181105,EXP,IT-MINISAL02-506831,IT-SA-2018SA302262,SANOFI AVENTIS,,85.0,YR,E,F,Y,,,20181105.0,,PH,IT,IT,2018,Q4,Elderly
155870161,15587016,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"9 KIU, QD",120192.0,KIU,U,,,,209196.0,9.0,KIU,,QD,2018,Q4,Hypothermia,,2018,Q4,1,I,20180606.0,20181031.0,20181105,20181105,EXP,IT-MINISAL02-506831,IT-SA-2018SA302262,SANOFI AVENTIS,,85.0,YR,E,F,Y,,,20181105.0,,PH,IT,IT,2018,Q4,Elderly
155872221,15587222,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"4 UNITS BEFORE BREAKFAST, 8 UNITS BEFORE LUNCH, AND 11UNITS BEFORE DINNER",,,,,,,,,,,,2018,Q4,Small fibre neuropathy,,2018,Q4,1,I,,20181022.0,20181105,20181105,EXP,,"US-RISING PHARMACEUTICALS, INC.-2018RIS00487",RISING PHARMACEUTICALS,"ESTOFAN LJF, NAYDIN S, GLIEBUS G.. QUINOLONE-INDUCED PAINFUL PERIPHERAL NEUROPATHY: A CASE REPORT AND LITERATURE REVIEW.. J INVESTIG MED HIGH IMPACT CASE REP.. 2018;6",20.0,YR,,M,Y,,,20181105.0,,MD,US,US,2018,Q4,Youth
155877061,15587706,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNIT WITH MEALS,,,,,,,,,,,,2018,Q4,Accidental overdose,,2018,Q4,1,I,,20181023.0,20181105,20181105,EXP,,CA-LUPIN PHARMACEUTICALS INC.-2018-07573,LUPIN,,56.0,YR,,M,Y,,,20181106.0,,OT,CA,CA,2018,Q4,Adult
155877061,15587706,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNIT WITH MEALS,,,,,,,,,,,,2018,Q4,Drug interaction,,2018,Q4,1,I,,20181023.0,20181105,20181105,EXP,,CA-LUPIN PHARMACEUTICALS INC.-2018-07573,LUPIN,,56.0,YR,,M,Y,,,20181106.0,,OT,CA,CA,2018,Q4,Adult
155877061,15587706,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNIT WITH MEALS,,,,,,,,,,,,2018,Q4,Drug intolerance,,2018,Q4,1,I,,20181023.0,20181105,20181105,EXP,,CA-LUPIN PHARMACEUTICALS INC.-2018-07573,LUPIN,,56.0,YR,,M,Y,,,20181106.0,,OT,CA,CA,2018,Q4,Adult
155877061,15587706,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNIT WITH MEALS,,,,,,,,,,,,2018,Q4,Hallucination,,2018,Q4,1,I,,20181023.0,20181105,20181105,EXP,,CA-LUPIN PHARMACEUTICALS INC.-2018-07573,LUPIN,,56.0,YR,,M,Y,,,20181106.0,,OT,CA,CA,2018,Q4,Adult
155877061,15587706,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNIT WITH MEALS,,,,,,,,,,,,2018,Q4,Hypoglycaemia,,2018,Q4,1,I,,20181023.0,20181105,20181105,EXP,,CA-LUPIN PHARMACEUTICALS INC.-2018-07573,LUPIN,,56.0,YR,,M,Y,,,20181106.0,,OT,CA,CA,2018,Q4,Adult
155877061,15587706,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNIT WITH MEALS,,,,,,,,,,,,2018,Q4,Lethargy,,2018,Q4,1,I,,20181023.0,20181105,20181105,EXP,,CA-LUPIN PHARMACEUTICALS INC.-2018-07573,LUPIN,,56.0,YR,,M,Y,,,20181106.0,,OT,CA,CA,2018,Q4,Adult
155877061,15587706,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNIT WITH MEALS,,,,,,,,,,,,2018,Q4,Toxicity to various agents,,2018,Q4,1,I,,20181023.0,20181105,20181105,EXP,,CA-LUPIN PHARMACEUTICALS INC.-2018-07573,LUPIN,,56.0,YR,,M,Y,,,20181106.0,,OT,CA,CA,2018,Q4,Adult
155877061,15587706,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNIT WITH MEALS,,,,,,,,,,,,2018,Q4,Visual impairment,,2018,Q4,1,I,,20181023.0,20181105,20181105,EXP,,CA-LUPIN PHARMACEUTICALS INC.-2018-07573,LUPIN,,56.0,YR,,M,Y,,,20181106.0,,OT,CA,CA,2018,Q4,Adult
155908832,15590883,4,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,6 UNITS WITH MEALS,,,,,,,,,,,,2018,Q4,Immunodeficiency,,2018,Q4,2,F,,20181029.0,20181107,20181113,EXP,,CA-TEVA-2018-CA-973422,TEVA,"GUNARATNE K, AUSTIN E, WU PE. UNINTENTIONAL SULFONYLUREA TOXICITY DUE TO A DRUG-DRUG INTERACTION: A CASE REPORT. BMC-RES-NOTES 2018;11(1):331.",56.0,YR,,M,Y,,,20181114.0,,OT,CA,CA,2018,Q4,Adult
155908832,15590883,4,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,6 UNITS WITH MEALS,,,,,,,,,,,,2018,Q4,Pneumonia fungal,,2018,Q4,2,F,,20181029.0,20181107,20181113,EXP,,CA-TEVA-2018-CA-973422,TEVA,"GUNARATNE K, AUSTIN E, WU PE. UNINTENTIONAL SULFONYLUREA TOXICITY DUE TO A DRUG-DRUG INTERACTION: A CASE REPORT. BMC-RES-NOTES 2018;11(1):331.",56.0,YR,,M,Y,,,20181114.0,,OT,CA,CA,2018,Q4,Adult
155909121,15590912,6,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,6 UNITS WITH MEALS,,,Y,,,,,,,,,2018,Q4,Drug interaction,,2018,Q4,1,I,,20181029.0,20181107,20181107,EXP,,CA-TEVA-2018-CA-972682,TEVA,"GUNARATNE K, AUSTIN E, WU PE. UNINTENTIONAL SULFONYLUREA TOXICITY DUE TO A DRUG-DRUG INTERACTION: A CASE REPORT. BMC-RES-NOTES 2018;11(1):331.",56.0,YR,,M,Y,,,20181107.0,,OT,CA,CA,2018,Q4,Adult
155909121,15590912,6,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,6 UNITS WITH MEALS,,,Y,,,,,,,,,2018,Q4,Hallucination,,2018,Q4,1,I,,20181029.0,20181107,20181107,EXP,,CA-TEVA-2018-CA-972682,TEVA,"GUNARATNE K, AUSTIN E, WU PE. UNINTENTIONAL SULFONYLUREA TOXICITY DUE TO A DRUG-DRUG INTERACTION: A CASE REPORT. BMC-RES-NOTES 2018;11(1):331.",56.0,YR,,M,Y,,,20181107.0,,OT,CA,CA,2018,Q4,Adult
155909121,15590912,6,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,6 UNITS WITH MEALS,,,Y,,,,,,,,,2018,Q4,Hypoglycaemia,,2018,Q4,1,I,,20181029.0,20181107,20181107,EXP,,CA-TEVA-2018-CA-972682,TEVA,"GUNARATNE K, AUSTIN E, WU PE. UNINTENTIONAL SULFONYLUREA TOXICITY DUE TO A DRUG-DRUG INTERACTION: A CASE REPORT. BMC-RES-NOTES 2018;11(1):331.",56.0,YR,,M,Y,,,20181107.0,,OT,CA,CA,2018,Q4,Adult
155909121,15590912,6,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,6 UNITS WITH MEALS,,,Y,,,,,,,,,2018,Q4,Overdose,,2018,Q4,1,I,,20181029.0,20181107,20181107,EXP,,CA-TEVA-2018-CA-972682,TEVA,"GUNARATNE K, AUSTIN E, WU PE. UNINTENTIONAL SULFONYLUREA TOXICITY DUE TO A DRUG-DRUG INTERACTION: A CASE REPORT. BMC-RES-NOTES 2018;11(1):331.",56.0,YR,,M,Y,,,20181107.0,,OT,CA,CA,2018,Q4,Adult
155909121,15590912,6,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,6 UNITS WITH MEALS,,,Y,,,,,,,,,2018,Q4,Toxicity to various agents,,2018,Q4,1,I,,20181029.0,20181107,20181107,EXP,,CA-TEVA-2018-CA-972682,TEVA,"GUNARATNE K, AUSTIN E, WU PE. UNINTENTIONAL SULFONYLUREA TOXICITY DUE TO A DRUG-DRUG INTERACTION: A CASE REPORT. BMC-RES-NOTES 2018;11(1):331.",56.0,YR,,M,Y,,,20181107.0,,OT,CA,CA,2018,Q4,Adult
155945391,15594539,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,, UNKNOWN,,,,,,,2018,Q4,Acute coronary syndrome,,2018,Q4,1,I,20180821.0,20181101.0,20181106,20181106,EXP,FR-AFSSAPS-AM20181485,FR-SEATTLE GENETICS-2018SGN02834,SEATTLE GENETICS,,68.0,YR,,M,Y,98.0,KG,20181106.0,,OT,FR,FR,2018,Q4,Elderly
155945391,15594539,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,, UNKNOWN,,,,,,,2018,Q4,Acute kidney injury,,2018,Q4,1,I,20180821.0,20181101.0,20181106,20181106,EXP,FR-AFSSAPS-AM20181485,FR-SEATTLE GENETICS-2018SGN02834,SEATTLE GENETICS,,68.0,YR,,M,Y,98.0,KG,20181106.0,,OT,FR,FR,2018,Q4,Elderly
155945391,15594539,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,, UNKNOWN,,,,,,,2018,Q4,Hypotension,,2018,Q4,1,I,20180821.0,20181101.0,20181106,20181106,EXP,FR-AFSSAPS-AM20181485,FR-SEATTLE GENETICS-2018SGN02834,SEATTLE GENETICS,,68.0,YR,,M,Y,98.0,KG,20181106.0,,OT,FR,FR,2018,Q4,Elderly
155950961,15595096,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"19 IU, DAILY",23503.0,IU,,,,,20563.0,19.0,IU,,QD,2018,Q4,Hyperhidrosis,,2018,Q4,1,I,20180907.0,20181102.0,20181107,20181107,EXP,IT-MINISAL02-508138,IT-ELI_LILLY_AND_COMPANY-IT201811001296,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20181106.0,,CN,IT,IT,2018,Q4,Adult
155950961,15595096,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"19 IU, DAILY",23503.0,IU,,,,,20563.0,19.0,IU,,QD,2018,Q4,Hypoglycaemia,,2018,Q4,1,I,20180907.0,20181102.0,20181107,20181107,EXP,IT-MINISAL02-508138,IT-ELI_LILLY_AND_COMPANY-IT201811001296,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20181106.0,,CN,IT,IT,2018,Q4,Adult
155950961,15595096,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"19 IU, DAILY",23503.0,IU,,,,,20563.0,19.0,IU,,QD,2018,Q4,Slow speech,,2018,Q4,1,I,20180907.0,20181102.0,20181107,20181107,EXP,IT-MINISAL02-508138,IT-ELI_LILLY_AND_COMPANY-IT201811001296,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20181106.0,,CN,IT,IT,2018,Q4,Adult
155975771,15597577,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0-18 UNITS, THRICE DAILY",,,D,U,,,,,,INJECTION,TID,2018,Q4,Acute kidney injury,,2018,Q4,1,I,20170619.0,20170620.0,20181108,20181108,EXP,,US-ASTELLAS-2017US024508,ASTELLAS,,49.0,YR,,M,Y,,,20181108.0,,MD,US,US,2018,Q4,Adult
155975771,15597577,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0-18 UNITS, THRICE DAILY",,,D,U,,,,,,INJECTION,TID,2018,Q4,Death,,2018,Q4,1,I,20170619.0,20170620.0,20181108,20181108,EXP,,US-ASTELLAS-2017US024508,ASTELLAS,,49.0,YR,,M,Y,,,20181108.0,,MD,US,US,2018,Q4,Adult
155975771,15597577,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0-18 UNITS, THRICE DAILY",,,D,U,,,,,,INJECTION,TID,2018,Q4,Respiratory failure,,2018,Q4,1,I,20170619.0,20170620.0,20181108,20181108,EXP,,US-ASTELLAS-2017US024508,ASTELLAS,,49.0,YR,,M,Y,,,20181108.0,,MD,US,US,2018,Q4,Adult
155975771,15597577,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0-18 UNITS, THRICE DAILY",,,D,U,,,,,,INJECTION,TID,2018,Q4,Sepsis,,2018,Q4,1,I,20170619.0,20170620.0,20181108,20181108,EXP,,US-ASTELLAS-2017US024508,ASTELLAS,,49.0,YR,,M,Y,,,20181108.0,,MD,US,US,2018,Q4,Adult
155975991,15597599,3,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"4 UNITS BEFORE BREAKFAST, 8 UNITS BEFORE LUNCH, AND 11 UNITS BEFORE DINNER",,,U,,,,,,,,,2018,Q4,Small fibre neuropathy,,2018,Q4,1,I,,20181029.0,20181108,20181108,EXP,,US-TEVA-2018-US-972703,TEVA,"ESTOFAN LJF, NAYDIN S, GLIEBUS G. QUINOLONE-INDUCED PAINFUL PERIPHERAL NEUROPATHY: A CASE REPORT AND LITERATURE REVIEW. J-INVESTIG-MED-HIGH-IMPACT-CASE-REP 2018;:.",20.0,YR,,M,Y,51.8,KG,20181108.0,,MD,US,US,2018,Q4,Youth
155999861,15599986,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,,,,,QD,2018,Q4,Abdominal discomfort,,2018,Q4,1,I,20171111.0,20181031.0,20181108,20181108,EXP,,US-ABBVIE-18K-163-2543224-00,ABBVIE,,70.0,YR,,M,Y,75.0,KG,20181108.0,,MD,US,US,2018,Q4,Elderly
155999861,15599986,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,,,,,QD,2018,Q4,Bacterial test positive,,2018,Q4,1,I,20171111.0,20181031.0,20181108,20181108,EXP,,US-ABBVIE-18K-163-2543224-00,ABBVIE,,70.0,YR,,M,Y,75.0,KG,20181108.0,,MD,US,US,2018,Q4,Elderly
155999861,15599986,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,,,,,QD,2018,Q4,Bilirubin conjugated increased,,2018,Q4,1,I,20171111.0,20181031.0,20181108,20181108,EXP,,US-ABBVIE-18K-163-2543224-00,ABBVIE,,70.0,YR,,M,Y,75.0,KG,20181108.0,,MD,US,US,2018,Q4,Elderly
155999861,15599986,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,,,,,QD,2018,Q4,Bladder discomfort,,2018,Q4,1,I,20171111.0,20181031.0,20181108,20181108,EXP,,US-ABBVIE-18K-163-2543224-00,ABBVIE,,70.0,YR,,M,Y,75.0,KG,20181108.0,,MD,US,US,2018,Q4,Elderly
155999861,15599986,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,,,,,QD,2018,Q4,Blood chloride decreased,,2018,Q4,1,I,20171111.0,20181031.0,20181108,20181108,EXP,,US-ABBVIE-18K-163-2543224-00,ABBVIE,,70.0,YR,,M,Y,75.0,KG,20181108.0,,MD,US,US,2018,Q4,Elderly
155999861,15599986,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,,,,,QD,2018,Q4,Bone marrow failure,,2018,Q4,1,I,20171111.0,20181031.0,20181108,20181108,EXP,,US-ABBVIE-18K-163-2543224-00,ABBVIE,,70.0,YR,,M,Y,75.0,KG,20181108.0,,MD,US,US,2018,Q4,Elderly
155999861,15599986,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,,,,,QD,2018,Q4,Chills,,2018,Q4,1,I,20171111.0,20181031.0,20181108,20181108,EXP,,US-ABBVIE-18K-163-2543224-00,ABBVIE,,70.0,YR,,M,Y,75.0,KG,20181108.0,,MD,US,US,2018,Q4,Elderly
155999861,15599986,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,,,,,QD,2018,Q4,Clostridium difficile infection,,2018,Q4,1,I,20171111.0,20181031.0,20181108,20181108,EXP,,US-ABBVIE-18K-163-2543224-00,ABBVIE,,70.0,YR,,M,Y,75.0,KG,20181108.0,,MD,US,US,2018,Q4,Elderly
155999861,15599986,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,,,,,QD,2018,Q4,Constipation,,2018,Q4,1,I,20171111.0,20181031.0,20181108,20181108,EXP,,US-ABBVIE-18K-163-2543224-00,ABBVIE,,70.0,YR,,M,Y,75.0,KG,20181108.0,,MD,US,US,2018,Q4,Elderly
155999861,15599986,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,,,,,QD,2018,Q4,Dyspnoea exertional,,2018,Q4,1,I,20171111.0,20181031.0,20181108,20181108,EXP,,US-ABBVIE-18K-163-2543224-00,ABBVIE,,70.0,YR,,M,Y,75.0,KG,20181108.0,,MD,US,US,2018,Q4,Elderly
155999861,15599986,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,,,,,QD,2018,Q4,Escherichia bacteraemia,,2018,Q4,1,I,20171111.0,20181031.0,20181108,20181108,EXP,,US-ABBVIE-18K-163-2543224-00,ABBVIE,,70.0,YR,,M,Y,75.0,KG,20181108.0,,MD,US,US,2018,Q4,Elderly
155999861,15599986,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,,,,,QD,2018,Q4,Fatigue,,2018,Q4,1,I,20171111.0,20181031.0,20181108,20181108,EXP,,US-ABBVIE-18K-163-2543224-00,ABBVIE,,70.0,YR,,M,Y,75.0,KG,20181108.0,,MD,US,US,2018,Q4,Elderly
155999861,15599986,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,,,,,QD,2018,Q4,Febrile neutropenia,,2018,Q4,1,I,20171111.0,20181031.0,20181108,20181108,EXP,,US-ABBVIE-18K-163-2543224-00,ABBVIE,,70.0,YR,,M,Y,75.0,KG,20181108.0,,MD,US,US,2018,Q4,Elderly
155999861,15599986,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,,,,,QD,2018,Q4,Food intolerance,,2018,Q4,1,I,20171111.0,20181031.0,20181108,20181108,EXP,,US-ABBVIE-18K-163-2543224-00,ABBVIE,,70.0,YR,,M,Y,75.0,KG,20181108.0,,MD,US,US,2018,Q4,Elderly
155999861,15599986,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,,,,,QD,2018,Q4,Hyponatraemia,,2018,Q4,1,I,20171111.0,20181031.0,20181108,20181108,EXP,,US-ABBVIE-18K-163-2543224-00,ABBVIE,,70.0,YR,,M,Y,75.0,KG,20181108.0,,MD,US,US,2018,Q4,Elderly
155999861,15599986,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,,,,,QD,2018,Q4,Lymphoma,,2018,Q4,1,I,20171111.0,20181031.0,20181108,20181108,EXP,,US-ABBVIE-18K-163-2543224-00,ABBVIE,,70.0,YR,,M,Y,75.0,KG,20181108.0,,MD,US,US,2018,Q4,Elderly
155999861,15599986,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,,,,,QD,2018,Q4,Neutropenic sepsis,,2018,Q4,1,I,20171111.0,20181031.0,20181108,20181108,EXP,,US-ABBVIE-18K-163-2543224-00,ABBVIE,,70.0,YR,,M,Y,75.0,KG,20181108.0,,MD,US,US,2018,Q4,Elderly
155999861,15599986,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,,,,,QD,2018,Q4,Oropharyngeal pain,,2018,Q4,1,I,20171111.0,20181031.0,20181108,20181108,EXP,,US-ABBVIE-18K-163-2543224-00,ABBVIE,,70.0,YR,,M,Y,75.0,KG,20181108.0,,MD,US,US,2018,Q4,Elderly
155999861,15599986,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,,,,,QD,2018,Q4,Pancytopenia,,2018,Q4,1,I,20171111.0,20181031.0,20181108,20181108,EXP,,US-ABBVIE-18K-163-2543224-00,ABBVIE,,70.0,YR,,M,Y,75.0,KG,20181108.0,,MD,US,US,2018,Q4,Elderly
155999861,15599986,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,,,,,QD,2018,Q4,Pollakiuria,,2018,Q4,1,I,20171111.0,20181031.0,20181108,20181108,EXP,,US-ABBVIE-18K-163-2543224-00,ABBVIE,,70.0,YR,,M,Y,75.0,KG,20181108.0,,MD,US,US,2018,Q4,Elderly
155999861,15599986,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,,,,,QD,2018,Q4,Productive cough,,2018,Q4,1,I,20171111.0,20181031.0,20181108,20181108,EXP,,US-ABBVIE-18K-163-2543224-00,ABBVIE,,70.0,YR,,M,Y,75.0,KG,20181108.0,,MD,US,US,2018,Q4,Elderly
155999861,15599986,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,,,,,QD,2018,Q4,Suprapubic pain,,2018,Q4,1,I,20171111.0,20181031.0,20181108,20181108,EXP,,US-ABBVIE-18K-163-2543224-00,ABBVIE,,70.0,YR,,M,Y,75.0,KG,20181108.0,,MD,US,US,2018,Q4,Elderly
155999861,15599986,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,,,,,QD,2018,Q4,Thrombocytopenia,,2018,Q4,1,I,20171111.0,20181031.0,20181108,20181108,EXP,,US-ABBVIE-18K-163-2543224-00,ABBVIE,,70.0,YR,,M,Y,75.0,KG,20181108.0,,MD,US,US,2018,Q4,Elderly
155999861,15599986,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,,,,,QD,2018,Q4,Urinary retention,,2018,Q4,1,I,20171111.0,20181031.0,20181108,20181108,EXP,,US-ABBVIE-18K-163-2543224-00,ABBVIE,,70.0,YR,,M,Y,75.0,KG,20181108.0,,MD,US,US,2018,Q4,Elderly
156030261,15603026,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Blood glucose abnormal,,2018,Q4,1,I,,20181101.0,20181109,20181109,EXP,,US-SA-2018SA304218,SANOFI AVENTIS,,51.0,YR,A,F,Y,,,20181109.0,,CN,US,US,2018,Q4,Adult
156030261,15603026,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Dehydration,,2018,Q4,1,I,,20181101.0,20181109,20181109,EXP,,US-SA-2018SA304218,SANOFI AVENTIS,,51.0,YR,A,F,Y,,,20181109.0,,CN,US,US,2018,Q4,Adult
156030261,15603026,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Device operational issue,,2018,Q4,1,I,,20181101.0,20181109,20181109,EXP,,US-SA-2018SA304218,SANOFI AVENTIS,,51.0,YR,A,F,Y,,,20181109.0,,CN,US,US,2018,Q4,Adult
156045062,15604506,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD (25/75: + 20U 20U / D)",,,U,U,,,,,,,QD,2018,Q4,Chest pain,,2018,Q4,2,F,,20181203.0,20181110,20181210,EXP,,PHHY2018PT147150,SANDOZ,,54.0,YR,,F,Y,,,20181211.0,,OT,PT,PT,2018,Q4,Adult
156045062,15604506,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD (25/75: + 20U 20U / D)",,,U,U,,,,,,,QD,2018,Q4,Ischaemic stroke,,2018,Q4,2,F,,20181203.0,20181110,20181210,EXP,,PHHY2018PT147150,SANDOZ,,54.0,YR,,F,Y,,,20181211.0,,OT,PT,PT,2018,Q4,Adult
156061131,15606113,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"8 IU, DAILY",4720.0,IU,Y,U,,,20563.0,8.0,IU,,QD,2018,Q4,Confusional state,,2018,Q4,1,I,20180919.0,20181106.0,20181112,20181112,EXP,IT-MINISAL02-508732,IT-ELI_LILLY_AND_COMPANY-IT201811002814,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20181112.0,,CN,IT,IT,2018,Q4,Elderly
156061131,15606113,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"8 IU, DAILY",4720.0,IU,Y,U,,,20563.0,8.0,IU,,QD,2018,Q4,Headache,,2018,Q4,1,I,20180919.0,20181106.0,20181112,20181112,EXP,IT-MINISAL02-508732,IT-ELI_LILLY_AND_COMPANY-IT201811002814,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20181112.0,,CN,IT,IT,2018,Q4,Elderly
156061131,15606113,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"8 IU, DAILY",4720.0,IU,Y,U,,,20563.0,8.0,IU,,QD,2018,Q4,Hypoglycaemia,,2018,Q4,1,I,20180919.0,20181106.0,20181112,20181112,EXP,IT-MINISAL02-508732,IT-ELI_LILLY_AND_COMPANY-IT201811002814,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20181112.0,,CN,IT,IT,2018,Q4,Elderly
156061131,15606113,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"8 IU, DAILY",4720.0,IU,Y,U,,,20563.0,8.0,IU,,QD,2018,Q4,Malaise,,2018,Q4,1,I,20180919.0,20181106.0,20181112,20181112,EXP,IT-MINISAL02-508732,IT-ELI_LILLY_AND_COMPANY-IT201811002814,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20181112.0,,CN,IT,IT,2018,Q4,Elderly
156061131,15606113,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"8 IU, DAILY",4720.0,IU,Y,U,,,20563.0,8.0,IU,,QD,2018,Q4,Syncope,,2018,Q4,1,I,20180919.0,20181106.0,20181112,20181112,EXP,IT-MINISAL02-508732,IT-ELI_LILLY_AND_COMPANY-IT201811002814,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20181112.0,,CN,IT,IT,2018,Q4,Elderly
156100431,15610043,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subdermal,,,,U,, UNKNOWN,,,,,,,2018,Q4,Acute kidney injury,,2018,Q4,1,I,20181012.0,20181029.0,20181113,20181113,EXP,FR-AFSSAPS-LY20182467,FR-ZYDUS-029617,ZYDUS PHARM,,71.0,YR,,F,Y,83.0,KG,20181113.0,,PH,FR,FR,2018,Q4,Elderly
156114601,15611460,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,,,,20563.0,,,,,2018,Q4,Headache,,2018,Q4,1,I,,20181108.0,20181113,20181113,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201811004569,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20181113.0,,CN,CN,CN,2018,Q4,Adult
156114601,15611460,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,,,,20563.0,,,,,2018,Q4,Hyperhidrosis,,2018,Q4,1,I,,20181108.0,20181113,20181113,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201811004569,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20181113.0,,CN,CN,CN,2018,Q4,Adult
156114601,15611460,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,,,,20563.0,,,,,2018,Q4,Peripheral swelling,,2018,Q4,1,I,,20181108.0,20181113,20181113,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201811004569,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20181113.0,,CN,CN,CN,2018,Q4,Adult
156131701,15613170,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 IU, QD",1020.0,IU,Y,U,,,,15.0,IU,,QD,2018,Q4,Cold sweat,,2018,Q4,1,I,20180529.0,20181108.0,20181113,20181113,EXP,IT-MINISAL02-482261,IT-MYLANLABS-2018M1086068,MYLAN,,84.0,YR,,M,Y,,,20181113.0,,MD,IT,IT,2018,Q4,Elderly
156131701,15613170,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 IU, QD",1020.0,IU,Y,U,,,,15.0,IU,,QD,2018,Q4,Confusional state,,2018,Q4,1,I,20180529.0,20181108.0,20181113,20181113,EXP,IT-MINISAL02-482261,IT-MYLANLABS-2018M1086068,MYLAN,,84.0,YR,,M,Y,,,20181113.0,,MD,IT,IT,2018,Q4,Elderly
156131701,15613170,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 IU, QD",1020.0,IU,Y,U,,,,15.0,IU,,QD,2018,Q4,Hypoglycaemic coma,,2018,Q4,1,I,20180529.0,20181108.0,20181113,20181113,EXP,IT-MINISAL02-482261,IT-MYLANLABS-2018M1086068,MYLAN,,84.0,YR,,M,Y,,,20181113.0,,MD,IT,IT,2018,Q4,Elderly
156176191,15617619,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q4,Asthenia,,2018,Q4,1,I,20181109.0,20181113.0,20181114,20181114,PER,,US-EISAI MEDICAL RESEARCH-EC-2018-047713,EISAI,,66.0,YR,,F,Y,82.7,KG,20181114.0,,MD,US,US,2018,Q4,Elderly
156176191,15617619,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q4,Hyperglycaemia,,2018,Q4,1,I,20181109.0,20181113.0,20181114,20181114,PER,,US-EISAI MEDICAL RESEARCH-EC-2018-047713,EISAI,,66.0,YR,,F,Y,82.7,KG,20181114.0,,MD,US,US,2018,Q4,Elderly
156176191,15617619,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q4,Neutropenia,,2018,Q4,1,I,20181109.0,20181113.0,20181114,20181114,PER,,US-EISAI MEDICAL RESEARCH-EC-2018-047713,EISAI,,66.0,YR,,F,Y,82.7,KG,20181114.0,,MD,US,US,2018,Q4,Elderly
156198771,15619877,1,PS,Insulin Lispro,INSULIN LISPRO,1,,"28 U, DAILY (PLUS BOLUS)",,,,, C918221A,,20563.0,28.0,IU,SOLUTION FOR INJECTION,QD,2018,Q4,Feeling abnormal,,2018,Q4,1,I,20181101.0,20181102.0,20181115,20181115,PER,,US-ELI_LILLY_AND_COMPANY-US201811000996,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20181115.0,,CN,US,US,2018,Q4,Elderly
156198771,15619877,1,PS,Insulin Lispro,INSULIN LISPRO,1,,"28 U, DAILY (PLUS BOLUS)",,,,, C918221A,,20563.0,28.0,IU,SOLUTION FOR INJECTION,QD,2018,Q4,Nasopharyngitis,,2018,Q4,1,I,20181101.0,20181102.0,20181115,20181115,PER,,US-ELI_LILLY_AND_COMPANY-US201811000996,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20181115.0,,CN,US,US,2018,Q4,Elderly
156261581,15626158,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 U, BID",,,U,,,,,,,SOLUTION FOR INJECTION,Q12H,2018,Q4,Eye disorder,,2018,Q4,1,I,20181103.0,20181107.0,20181116,20181116,EXP,,ES-SA-2018SA308512,SANOFI AVENTIS,,59.0,YR,A,F,Y,59.0,KG,20181116.0,,CN,ES,ES,2018,Q4,Adult
156261581,15626158,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 U, BID",,,U,,,,,,,SOLUTION FOR INJECTION,Q12H,2018,Q4,Hyperglycaemia,,2018,Q4,1,I,20181103.0,20181107.0,20181116,20181116,EXP,,ES-SA-2018SA308512,SANOFI AVENTIS,,59.0,YR,A,F,Y,59.0,KG,20181116.0,,CN,ES,ES,2018,Q4,Adult
156267582,15626758,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 IU, QD",4720.0,IU,,,,,,8.0,IU,SOLUTION FOR INJECTION,QD,2018,Q4,Confusional state,,2018,Q4,2,F,20180919.0,20181114.0,20181116,20181126,EXP,IT-MINISAL02-508732,IT-SA-2018SA310418,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20181126.0,,MD,IT,IT,2018,Q4,Elderly
156267582,15626758,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 IU, QD",4720.0,IU,,,,,,8.0,IU,SOLUTION FOR INJECTION,QD,2018,Q4,Headache,,2018,Q4,2,F,20180919.0,20181114.0,20181116,20181126,EXP,IT-MINISAL02-508732,IT-SA-2018SA310418,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20181126.0,,MD,IT,IT,2018,Q4,Elderly
156267582,15626758,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 IU, QD",4720.0,IU,,,,,,8.0,IU,SOLUTION FOR INJECTION,QD,2018,Q4,Hypoglycaemia,,2018,Q4,2,F,20180919.0,20181114.0,20181116,20181126,EXP,IT-MINISAL02-508732,IT-SA-2018SA310418,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20181126.0,,MD,IT,IT,2018,Q4,Elderly
156267582,15626758,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 IU, QD",4720.0,IU,,,,,,8.0,IU,SOLUTION FOR INJECTION,QD,2018,Q4,Malaise,,2018,Q4,2,F,20180919.0,20181114.0,20181116,20181126,EXP,IT-MINISAL02-508732,IT-SA-2018SA310418,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20181126.0,,MD,IT,IT,2018,Q4,Elderly
156267582,15626758,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 IU, QD",4720.0,IU,,,,,,8.0,IU,SOLUTION FOR INJECTION,QD,2018,Q4,Syncope,,2018,Q4,2,F,20180919.0,20181114.0,20181116,20181126,EXP,IT-MINISAL02-508732,IT-SA-2018SA310418,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20181126.0,,MD,IT,IT,2018,Q4,Elderly
156267601,15626760,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU, QD",822.0,IU,U,,,,,6.0,IU,SOLUTION FOR INJECTION,QD,2018,Q4,Hypoglycaemia,,2018,Q4,1,I,20180906.0,20181108.0,20181116,20181116,EXP,IT-MINISAL02-508218,IT-SA-2018SA310041,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20181116.0,,OT,IT,IT,2018,Q4,Elderly
156267601,15626760,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU, QD",822.0,IU,U,,,,,6.0,IU,SOLUTION FOR INJECTION,QD,2018,Q4,Syncope,,2018,Q4,1,I,20180906.0,20181108.0,20181116,20181116,EXP,IT-MINISAL02-508218,IT-SA-2018SA310041,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20181116.0,,OT,IT,IT,2018,Q4,Elderly
156300511,15630051,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 INTERNATIONAL UNIT, DAILY BEFORE LUNCH",,,U,, UNK,,,8.0,IU,,,2018,Q4,Abdominal pain lower,,2018,Q4,1,I,,20181023.0,20181118,20181118,EXP,,US-AUROBINDO-AUR-APL-2018-052993,AUROBINDO,,20.0,YR,,M,Y,51.8,KG,20181118.0,,MD,US,US,2018,Q4,Youth
156300511,15630051,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 INTERNATIONAL UNIT, DAILY BEFORE LUNCH",,,U,, UNK,,,8.0,IU,,,2018,Q4,Back pain,,2018,Q4,1,I,,20181023.0,20181118,20181118,EXP,,US-AUROBINDO-AUR-APL-2018-052993,AUROBINDO,,20.0,YR,,M,Y,51.8,KG,20181118.0,,MD,US,US,2018,Q4,Youth
156300511,15630051,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 INTERNATIONAL UNIT, DAILY BEFORE LUNCH",,,U,, UNK,,,8.0,IU,,,2018,Q4,Burning sensation,,2018,Q4,1,I,,20181023.0,20181118,20181118,EXP,,US-AUROBINDO-AUR-APL-2018-052993,AUROBINDO,,20.0,YR,,M,Y,51.8,KG,20181118.0,,MD,US,US,2018,Q4,Youth
156300511,15630051,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 INTERNATIONAL UNIT, DAILY BEFORE LUNCH",,,U,, UNK,,,8.0,IU,,,2018,Q4,Muscle tightness,,2018,Q4,1,I,,20181023.0,20181118,20181118,EXP,,US-AUROBINDO-AUR-APL-2018-052993,AUROBINDO,,20.0,YR,,M,Y,51.8,KG,20181118.0,,MD,US,US,2018,Q4,Youth
156300511,15630051,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 INTERNATIONAL UNIT, DAILY BEFORE LUNCH",,,U,, UNK,,,8.0,IU,,,2018,Q4,Muscular weakness,,2018,Q4,1,I,,20181023.0,20181118,20181118,EXP,,US-AUROBINDO-AUR-APL-2018-052993,AUROBINDO,,20.0,YR,,M,Y,51.8,KG,20181118.0,,MD,US,US,2018,Q4,Youth
156300511,15630051,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 INTERNATIONAL UNIT, DAILY BEFORE LUNCH",,,U,, UNK,,,8.0,IU,,,2018,Q4,Neuropathy peripheral,,2018,Q4,1,I,,20181023.0,20181118,20181118,EXP,,US-AUROBINDO-AUR-APL-2018-052993,AUROBINDO,,20.0,YR,,M,Y,51.8,KG,20181118.0,,MD,US,US,2018,Q4,Youth
156300511,15630051,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 INTERNATIONAL UNIT, DAILY BEFORE LUNCH",,,U,, UNK,,,8.0,IU,,,2018,Q4,Pain,,2018,Q4,1,I,,20181023.0,20181118,20181118,EXP,,US-AUROBINDO-AUR-APL-2018-052993,AUROBINDO,,20.0,YR,,M,Y,51.8,KG,20181118.0,,MD,US,US,2018,Q4,Youth
156300511,15630051,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 INTERNATIONAL UNIT, DAILY BEFORE LUNCH",,,U,, UNK,,,8.0,IU,,,2018,Q4,Peripheral coldness,,2018,Q4,1,I,,20181023.0,20181118,20181118,EXP,,US-AUROBINDO-AUR-APL-2018-052993,AUROBINDO,,20.0,YR,,M,Y,51.8,KG,20181118.0,,MD,US,US,2018,Q4,Youth
156300511,15630051,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 INTERNATIONAL UNIT, DAILY BEFORE LUNCH",,,U,, UNK,,,8.0,IU,,,2018,Q4,Tendon pain,,2018,Q4,1,I,,20181023.0,20181118,20181118,EXP,,US-AUROBINDO-AUR-APL-2018-052993,AUROBINDO,,20.0,YR,,M,Y,51.8,KG,20181118.0,,MD,US,US,2018,Q4,Youth
156300511,15630051,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,4 INTERNATIONAL UNIT BEFORE BREAKFAST,,,U,, UNK,,,4.0,IU,,,2018,Q4,Abdominal pain lower,,2018,Q4,1,I,,20181023.0,20181118,20181118,EXP,,US-AUROBINDO-AUR-APL-2018-052993,AUROBINDO,,20.0,YR,,M,Y,51.8,KG,20181118.0,,MD,US,US,2018,Q4,Youth
156300511,15630051,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,4 INTERNATIONAL UNIT BEFORE BREAKFAST,,,U,, UNK,,,4.0,IU,,,2018,Q4,Back pain,,2018,Q4,1,I,,20181023.0,20181118,20181118,EXP,,US-AUROBINDO-AUR-APL-2018-052993,AUROBINDO,,20.0,YR,,M,Y,51.8,KG,20181118.0,,MD,US,US,2018,Q4,Youth
156300511,15630051,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,4 INTERNATIONAL UNIT BEFORE BREAKFAST,,,U,, UNK,,,4.0,IU,,,2018,Q4,Burning sensation,,2018,Q4,1,I,,20181023.0,20181118,20181118,EXP,,US-AUROBINDO-AUR-APL-2018-052993,AUROBINDO,,20.0,YR,,M,Y,51.8,KG,20181118.0,,MD,US,US,2018,Q4,Youth
156300511,15630051,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,4 INTERNATIONAL UNIT BEFORE BREAKFAST,,,U,, UNK,,,4.0,IU,,,2018,Q4,Muscle tightness,,2018,Q4,1,I,,20181023.0,20181118,20181118,EXP,,US-AUROBINDO-AUR-APL-2018-052993,AUROBINDO,,20.0,YR,,M,Y,51.8,KG,20181118.0,,MD,US,US,2018,Q4,Youth
156300511,15630051,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,4 INTERNATIONAL UNIT BEFORE BREAKFAST,,,U,, UNK,,,4.0,IU,,,2018,Q4,Muscular weakness,,2018,Q4,1,I,,20181023.0,20181118,20181118,EXP,,US-AUROBINDO-AUR-APL-2018-052993,AUROBINDO,,20.0,YR,,M,Y,51.8,KG,20181118.0,,MD,US,US,2018,Q4,Youth
156300511,15630051,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,4 INTERNATIONAL UNIT BEFORE BREAKFAST,,,U,, UNK,,,4.0,IU,,,2018,Q4,Neuropathy peripheral,,2018,Q4,1,I,,20181023.0,20181118,20181118,EXP,,US-AUROBINDO-AUR-APL-2018-052993,AUROBINDO,,20.0,YR,,M,Y,51.8,KG,20181118.0,,MD,US,US,2018,Q4,Youth
156300511,15630051,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,4 INTERNATIONAL UNIT BEFORE BREAKFAST,,,U,, UNK,,,4.0,IU,,,2018,Q4,Pain,,2018,Q4,1,I,,20181023.0,20181118,20181118,EXP,,US-AUROBINDO-AUR-APL-2018-052993,AUROBINDO,,20.0,YR,,M,Y,51.8,KG,20181118.0,,MD,US,US,2018,Q4,Youth
156300511,15630051,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,4 INTERNATIONAL UNIT BEFORE BREAKFAST,,,U,, UNK,,,4.0,IU,,,2018,Q4,Peripheral coldness,,2018,Q4,1,I,,20181023.0,20181118,20181118,EXP,,US-AUROBINDO-AUR-APL-2018-052993,AUROBINDO,,20.0,YR,,M,Y,51.8,KG,20181118.0,,MD,US,US,2018,Q4,Youth
156300511,15630051,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,4 INTERNATIONAL UNIT BEFORE BREAKFAST,,,U,, UNK,,,4.0,IU,,,2018,Q4,Tendon pain,,2018,Q4,1,I,,20181023.0,20181118,20181118,EXP,,US-AUROBINDO-AUR-APL-2018-052993,AUROBINDO,,20.0,YR,,M,Y,51.8,KG,20181118.0,,MD,US,US,2018,Q4,Youth
156300511,15630051,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"11 INTERNATIONAL UNIT, DAILY BEFORE DINNER",,,U,, UNK,,,11.0,IU,,,2018,Q4,Abdominal pain lower,,2018,Q4,1,I,,20181023.0,20181118,20181118,EXP,,US-AUROBINDO-AUR-APL-2018-052993,AUROBINDO,,20.0,YR,,M,Y,51.8,KG,20181118.0,,MD,US,US,2018,Q4,Youth
156300511,15630051,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"11 INTERNATIONAL UNIT, DAILY BEFORE DINNER",,,U,, UNK,,,11.0,IU,,,2018,Q4,Back pain,,2018,Q4,1,I,,20181023.0,20181118,20181118,EXP,,US-AUROBINDO-AUR-APL-2018-052993,AUROBINDO,,20.0,YR,,M,Y,51.8,KG,20181118.0,,MD,US,US,2018,Q4,Youth
156300511,15630051,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"11 INTERNATIONAL UNIT, DAILY BEFORE DINNER",,,U,, UNK,,,11.0,IU,,,2018,Q4,Burning sensation,,2018,Q4,1,I,,20181023.0,20181118,20181118,EXP,,US-AUROBINDO-AUR-APL-2018-052993,AUROBINDO,,20.0,YR,,M,Y,51.8,KG,20181118.0,,MD,US,US,2018,Q4,Youth
156300511,15630051,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"11 INTERNATIONAL UNIT, DAILY BEFORE DINNER",,,U,, UNK,,,11.0,IU,,,2018,Q4,Muscle tightness,,2018,Q4,1,I,,20181023.0,20181118,20181118,EXP,,US-AUROBINDO-AUR-APL-2018-052993,AUROBINDO,,20.0,YR,,M,Y,51.8,KG,20181118.0,,MD,US,US,2018,Q4,Youth
156300511,15630051,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"11 INTERNATIONAL UNIT, DAILY BEFORE DINNER",,,U,, UNK,,,11.0,IU,,,2018,Q4,Muscular weakness,,2018,Q4,1,I,,20181023.0,20181118,20181118,EXP,,US-AUROBINDO-AUR-APL-2018-052993,AUROBINDO,,20.0,YR,,M,Y,51.8,KG,20181118.0,,MD,US,US,2018,Q4,Youth
156300511,15630051,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"11 INTERNATIONAL UNIT, DAILY BEFORE DINNER",,,U,, UNK,,,11.0,IU,,,2018,Q4,Neuropathy peripheral,,2018,Q4,1,I,,20181023.0,20181118,20181118,EXP,,US-AUROBINDO-AUR-APL-2018-052993,AUROBINDO,,20.0,YR,,M,Y,51.8,KG,20181118.0,,MD,US,US,2018,Q4,Youth
156300511,15630051,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"11 INTERNATIONAL UNIT, DAILY BEFORE DINNER",,,U,, UNK,,,11.0,IU,,,2018,Q4,Pain,,2018,Q4,1,I,,20181023.0,20181118,20181118,EXP,,US-AUROBINDO-AUR-APL-2018-052993,AUROBINDO,,20.0,YR,,M,Y,51.8,KG,20181118.0,,MD,US,US,2018,Q4,Youth
156300511,15630051,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"11 INTERNATIONAL UNIT, DAILY BEFORE DINNER",,,U,, UNK,,,11.0,IU,,,2018,Q4,Peripheral coldness,,2018,Q4,1,I,,20181023.0,20181118,20181118,EXP,,US-AUROBINDO-AUR-APL-2018-052993,AUROBINDO,,20.0,YR,,M,Y,51.8,KG,20181118.0,,MD,US,US,2018,Q4,Youth
156300511,15630051,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"11 INTERNATIONAL UNIT, DAILY BEFORE DINNER",,,U,, UNK,,,11.0,IU,,,2018,Q4,Tendon pain,,2018,Q4,1,I,,20181023.0,20181118,20181118,EXP,,US-AUROBINDO-AUR-APL-2018-052993,AUROBINDO,,20.0,YR,,M,Y,51.8,KG,20181118.0,,MD,US,US,2018,Q4,Youth
156315612,15631561,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q4,Gastroenteritis viral,,2018,Q4,2,F,2018.0,20181121.0,20181119,20181126,PER,,US-VERTEX PHARMACEUTICALS-2018-008177,VERTEX,,28.0,YR,,F,Y,,,20181126.0,,OT,US,US,2018,Q4,Young Adult
156315612,15631561,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q4,Headache,,2018,Q4,2,F,2018.0,20181121.0,20181119,20181126,PER,,US-VERTEX PHARMACEUTICALS-2018-008177,VERTEX,,28.0,YR,,F,Y,,,20181126.0,,OT,US,US,2018,Q4,Young Adult
156315612,15631561,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q4,Oropharyngeal pain,,2018,Q4,2,F,2018.0,20181121.0,20181119,20181126,PER,,US-VERTEX PHARMACEUTICALS-2018-008177,VERTEX,,28.0,YR,,F,Y,,,20181126.0,,OT,US,US,2018,Q4,Young Adult
156333321,15633332,2,SS,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,Subcutaneous,"26 U, QD (14 U IN THE MORNING, 12 U IN THE EVENING)",26.0,DF,Y,U, C786336A,,,26.0,DF,,QD,2018,Q4,Pruritus,,2018,Q4,1,I,20180824.0,20181109.0,20181119,20181119,EXP,,CN-NOVOPROD-632525,NOVO NORDISK,,67.0,YR,E,F,Y,68.0,KG,20181119.0,,OT,CN,CN,2018,Q4,Elderly
156333321,15633332,2,SS,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,Subcutaneous,"26 U, QD (14 U IN THE MORNING, 12 U IN THE EVENING)",26.0,DF,Y,U, C786336A,,,26.0,DF,,QD,2018,Q4,Rash,,2018,Q4,1,I,20180824.0,20181109.0,20181119,20181119,EXP,,CN-NOVOPROD-632525,NOVO NORDISK,,67.0,YR,E,F,Y,68.0,KG,20181119.0,,OT,CN,CN,2018,Q4,Elderly
156336953,15633695,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Cholelithiasis,,2018,Q4,3,F,201411.0,20181113.0,20181119,20181127,PER,,US-SA-2018SA315877,SANOFI AVENTIS,,65.0,YR,E,F,Y,,,20181128.0,,CN,US,US,2018,Q4,Elderly
156336953,15633695,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Drug hypersensitivity,,2018,Q4,3,F,201411.0,20181113.0,20181119,20181127,PER,,US-SA-2018SA315877,SANOFI AVENTIS,,65.0,YR,E,F,Y,,,20181128.0,,CN,US,US,2018,Q4,Elderly
156336953,15633695,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Drug ineffective,,2018,Q4,3,F,201411.0,20181113.0,20181119,20181127,PER,,US-SA-2018SA315877,SANOFI AVENTIS,,65.0,YR,E,F,Y,,,20181128.0,,CN,US,US,2018,Q4,Elderly
156336953,15633695,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Hepatitis B,,2018,Q4,3,F,201411.0,20181113.0,20181119,20181127,PER,,US-SA-2018SA315877,SANOFI AVENTIS,,65.0,YR,E,F,Y,,,20181128.0,,CN,US,US,2018,Q4,Elderly
156336953,15633695,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Hospitalisation,,2018,Q4,3,F,201411.0,20181113.0,20181119,20181127,PER,,US-SA-2018SA315877,SANOFI AVENTIS,,65.0,YR,E,F,Y,,,20181128.0,,CN,US,US,2018,Q4,Elderly
156336953,15633695,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Injection site bruising,,2018,Q4,3,F,201411.0,20181113.0,20181119,20181127,PER,,US-SA-2018SA315877,SANOFI AVENTIS,,65.0,YR,E,F,Y,,,20181128.0,,CN,US,US,2018,Q4,Elderly
156336953,15633695,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Injection site indentation,,2018,Q4,3,F,201411.0,20181113.0,20181119,20181127,PER,,US-SA-2018SA315877,SANOFI AVENTIS,,65.0,YR,E,F,Y,,,20181128.0,,CN,US,US,2018,Q4,Elderly
156336953,15633695,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Pancreatitis,,2018,Q4,3,F,201411.0,20181113.0,20181119,20181127,PER,,US-SA-2018SA315877,SANOFI AVENTIS,,65.0,YR,E,F,Y,,,20181128.0,,CN,US,US,2018,Q4,Elderly
156336953,15633695,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Walking aid user,,2018,Q4,3,F,201411.0,20181113.0,20181119,20181127,PER,,US-SA-2018SA315877,SANOFI AVENTIS,,65.0,YR,E,F,Y,,,20181128.0,,CN,US,US,2018,Q4,Elderly
156344141,15634414,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNK",,,U,,,,,,,,,2018,Q4,Fracture,,2018,Q4,1,I,20181105.0,20181110.0,20181119,20181119,EXP,,IN-SA-2018SA311243,SANOFI AVENTIS,,61.0,YR,A,F,Y,70.0,KG,20181119.0,,CN,IN,IN,2018,Q4,Adult
156344141,15634414,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNK",,,U,,,,,,,,,2018,Q4,Hypoglycaemia,,2018,Q4,1,I,20181105.0,20181110.0,20181119,20181119,EXP,,IN-SA-2018SA311243,SANOFI AVENTIS,,61.0,YR,A,F,Y,70.0,KG,20181119.0,,CN,IN,IN,2018,Q4,Adult
156350121,15635012,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"13U OR 15 U, PRN",,,,,,,20563.0,15.0,IU,,,2018,Q4,Asthenia,,2018,Q4,1,I,,20181112.0,20181119,20181119,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201811006259,ELI LILLY AND CO,,45.0,YR,,M,Y,65.0,KG,20181119.0,,CN,CN,CN,2018,Q4,Adult
156350121,15635012,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"13U OR 15 U, PRN",,,,,,,20563.0,15.0,IU,,,2018,Q4,Blood glucose abnormal,,2018,Q4,1,I,,20181112.0,20181119,20181119,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201811006259,ELI LILLY AND CO,,45.0,YR,,M,Y,65.0,KG,20181119.0,,CN,CN,CN,2018,Q4,Adult
156350121,15635012,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"13U OR 15 U, PRN",,,,,,,20563.0,15.0,IU,,,2018,Q4,Limb discomfort,,2018,Q4,1,I,,20181112.0,20181119,20181119,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201811006259,ELI LILLY AND CO,,45.0,YR,,M,Y,65.0,KG,20181119.0,,CN,CN,CN,2018,Q4,Adult
156350121,15635012,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"13U OR 15 U, PRN",,,,,,,20563.0,15.0,IU,,,2018,Q4,Peripheral swelling,,2018,Q4,1,I,,20181112.0,20181119,20181119,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201811006259,ELI LILLY AND CO,,45.0,YR,,M,Y,65.0,KG,20181119.0,,CN,CN,CN,2018,Q4,Adult
156350121,15635012,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"13U OR 15 U, PRN",,,,,,,20563.0,15.0,IU,,,2018,Q4,Protein urine present,,2018,Q4,1,I,,20181112.0,20181119,20181119,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201811006259,ELI LILLY AND CO,,45.0,YR,,M,Y,65.0,KG,20181119.0,,CN,CN,CN,2018,Q4,Adult
156350121,15635012,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"13U OR 15 U, PRN",,,,,,,20563.0,15.0,IU,,,2018,Q4,Urine abnormality,,2018,Q4,1,I,,20181112.0,20181119,20181119,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201811006259,ELI LILLY AND CO,,45.0,YR,,M,Y,65.0,KG,20181119.0,,CN,CN,CN,2018,Q4,Adult
156350121,15635012,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"16 U, PRN (15U OR 16 U, EACH MORNING)",,,,,,,20563.0,16.0,IU,,,2018,Q4,Asthenia,,2018,Q4,1,I,,20181112.0,20181119,20181119,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201811006259,ELI LILLY AND CO,,45.0,YR,,M,Y,65.0,KG,20181119.0,,CN,CN,CN,2018,Q4,Adult
156350121,15635012,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"16 U, PRN (15U OR 16 U, EACH MORNING)",,,,,,,20563.0,16.0,IU,,,2018,Q4,Blood glucose abnormal,,2018,Q4,1,I,,20181112.0,20181119,20181119,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201811006259,ELI LILLY AND CO,,45.0,YR,,M,Y,65.0,KG,20181119.0,,CN,CN,CN,2018,Q4,Adult
156350121,15635012,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"16 U, PRN (15U OR 16 U, EACH MORNING)",,,,,,,20563.0,16.0,IU,,,2018,Q4,Limb discomfort,,2018,Q4,1,I,,20181112.0,20181119,20181119,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201811006259,ELI LILLY AND CO,,45.0,YR,,M,Y,65.0,KG,20181119.0,,CN,CN,CN,2018,Q4,Adult
156350121,15635012,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"16 U, PRN (15U OR 16 U, EACH MORNING)",,,,,,,20563.0,16.0,IU,,,2018,Q4,Peripheral swelling,,2018,Q4,1,I,,20181112.0,20181119,20181119,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201811006259,ELI LILLY AND CO,,45.0,YR,,M,Y,65.0,KG,20181119.0,,CN,CN,CN,2018,Q4,Adult
156350121,15635012,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"16 U, PRN (15U OR 16 U, EACH MORNING)",,,,,,,20563.0,16.0,IU,,,2018,Q4,Protein urine present,,2018,Q4,1,I,,20181112.0,20181119,20181119,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201811006259,ELI LILLY AND CO,,45.0,YR,,M,Y,65.0,KG,20181119.0,,CN,CN,CN,2018,Q4,Adult
156350121,15635012,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"16 U, PRN (15U OR 16 U, EACH MORNING)",,,,,,,20563.0,16.0,IU,,,2018,Q4,Urine abnormality,,2018,Q4,1,I,,20181112.0,20181119,20181119,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201811006259,ELI LILLY AND CO,,45.0,YR,,M,Y,65.0,KG,20181119.0,,CN,CN,CN,2018,Q4,Adult
156350121,15635012,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"15 U, PRN (14U OR 15 U, DAILY AT NIGHT)",,,,,,,20563.0,15.0,IU,,,2018,Q4,Asthenia,,2018,Q4,1,I,,20181112.0,20181119,20181119,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201811006259,ELI LILLY AND CO,,45.0,YR,,M,Y,65.0,KG,20181119.0,,CN,CN,CN,2018,Q4,Adult
156350121,15635012,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"15 U, PRN (14U OR 15 U, DAILY AT NIGHT)",,,,,,,20563.0,15.0,IU,,,2018,Q4,Blood glucose abnormal,,2018,Q4,1,I,,20181112.0,20181119,20181119,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201811006259,ELI LILLY AND CO,,45.0,YR,,M,Y,65.0,KG,20181119.0,,CN,CN,CN,2018,Q4,Adult
156350121,15635012,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"15 U, PRN (14U OR 15 U, DAILY AT NIGHT)",,,,,,,20563.0,15.0,IU,,,2018,Q4,Limb discomfort,,2018,Q4,1,I,,20181112.0,20181119,20181119,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201811006259,ELI LILLY AND CO,,45.0,YR,,M,Y,65.0,KG,20181119.0,,CN,CN,CN,2018,Q4,Adult
156350121,15635012,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"15 U, PRN (14U OR 15 U, DAILY AT NIGHT)",,,,,,,20563.0,15.0,IU,,,2018,Q4,Peripheral swelling,,2018,Q4,1,I,,20181112.0,20181119,20181119,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201811006259,ELI LILLY AND CO,,45.0,YR,,M,Y,65.0,KG,20181119.0,,CN,CN,CN,2018,Q4,Adult
156350121,15635012,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"15 U, PRN (14U OR 15 U, DAILY AT NIGHT)",,,,,,,20563.0,15.0,IU,,,2018,Q4,Protein urine present,,2018,Q4,1,I,,20181112.0,20181119,20181119,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201811006259,ELI LILLY AND CO,,45.0,YR,,M,Y,65.0,KG,20181119.0,,CN,CN,CN,2018,Q4,Adult
156350121,15635012,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"15 U, PRN (14U OR 15 U, DAILY AT NIGHT)",,,,,,,20563.0,15.0,IU,,,2018,Q4,Urine abnormality,,2018,Q4,1,I,,20181112.0,20181119,20181119,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201811006259,ELI LILLY AND CO,,45.0,YR,,M,Y,65.0,KG,20181119.0,,CN,CN,CN,2018,Q4,Adult
156383791,15638379,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q4,Chest pain,,2018,Q4,1,I,2018.0,20181113.0,20181120,20181120,EXP,,PT-AMGEN-PRTSP2018165248,AMGEN,,54.0,YR,A,F,Y,110.0,KG,20181120.0,,PH,PT,PT,2018,Q4,Adult
156383791,15638379,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q4,Ischaemic stroke,,2018,Q4,1,I,2018.0,20181113.0,20181120,20181120,EXP,,PT-AMGEN-PRTSP2018165248,AMGEN,,54.0,YR,A,F,Y,110.0,KG,20181120.0,,PH,PT,PT,2018,Q4,Adult
156406151,15640615,6,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 IU, QD",,,,,,,209196.0,24.0,IU,,QD,2018,Q4,Agranulocytosis,,2018,Q4,1,I,20181024.0,20181112.0,20181120,20181120,EXP,FR-AFSSAPS-TS20180923,FR-SA-2018SA312502,SANOFI AVENTIS,,63.0,YR,A,M,Y,,,20181120.0,,MD,FR,FR,2018,Q4,Adult
156408032,15640803,32,C,Lispro,INSULIN LISPRO,1,Unknown,24 IU (INTERNATIONAL UNIT),,,,,,,,8.0,IU,UNKNOWN,TID,2018,Q4,Acute hepatic failure,,2018,Q4,2,F,20181112.0,20181212.0,20181120,20181218,EXP,,US-CELGENEUS-USA-20181104603,CELGENE,,50.0,YR,,M,Y,131.0,KG,20181218.0,,MD,US,US,2018,Q4,Adult
156408032,15640803,32,C,Lispro,INSULIN LISPRO,1,Unknown,24 IU (INTERNATIONAL UNIT),,,,,,,,8.0,IU,UNKNOWN,TID,2018,Q4,Acute myeloid leukaemia,,2018,Q4,2,F,20181112.0,20181212.0,20181120,20181218,EXP,,US-CELGENEUS-USA-20181104603,CELGENE,,50.0,YR,,M,Y,131.0,KG,20181218.0,,MD,US,US,2018,Q4,Adult
156408032,15640803,32,C,Lispro,INSULIN LISPRO,1,Unknown,24 IU (INTERNATIONAL UNIT),,,,,,,,8.0,IU,UNKNOWN,TID,2018,Q4,Hepatic encephalopathy,,2018,Q4,2,F,20181112.0,20181212.0,20181120,20181218,EXP,,US-CELGENEUS-USA-20181104603,CELGENE,,50.0,YR,,M,Y,131.0,KG,20181218.0,,MD,US,US,2018,Q4,Adult
156431911,15643191,9,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q4,Cytokine release syndrome,,2018,Q4,1,I,20180625.0,,20181120,20181120,DIR,,,FDA-CTU,,42.0,YR,,F,N,99.45,KG,20181120.0,N,OT,US,US,2018,Q4,Adult
156435241,15643524,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"11 U, EACH MORNING",,,,,,,20563.0,11.0,IU,,QD,2018,Q4,Hypertension,,2018,Q4,1,I,,20181115.0,20181121,20181121,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201811008035,ELI LILLY AND CO,,66.0,YR,,F,Y,55.0,KG,20181121.0,,CN,CN,CN,2018,Q4,Elderly
156435241,15643524,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"11 U, EACH MORNING",,,,,,,20563.0,11.0,IU,,QD,2018,Q4,Swelling,,2018,Q4,1,I,,20181115.0,20181121,20181121,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201811008035,ELI LILLY AND CO,,66.0,YR,,F,Y,55.0,KG,20181121.0,,CN,CN,CN,2018,Q4,Elderly
156435241,15643524,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"4 U, DAILY AT NOON",,,,,,,20563.0,4.0,IU,,QD,2018,Q4,Hypertension,,2018,Q4,1,I,,20181115.0,20181121,20181121,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201811008035,ELI LILLY AND CO,,66.0,YR,,F,Y,55.0,KG,20181121.0,,CN,CN,CN,2018,Q4,Elderly
156435241,15643524,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"4 U, DAILY AT NOON",,,,,,,20563.0,4.0,IU,,QD,2018,Q4,Swelling,,2018,Q4,1,I,,20181115.0,20181121,20181121,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201811008035,ELI LILLY AND CO,,66.0,YR,,F,Y,55.0,KG,20181121.0,,CN,CN,CN,2018,Q4,Elderly
156435241,15643524,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"8 U, DAILY AT NIGHT",,,,,,,20563.0,8.0,IU,,QD,2018,Q4,Hypertension,,2018,Q4,1,I,,20181115.0,20181121,20181121,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201811008035,ELI LILLY AND CO,,66.0,YR,,F,Y,55.0,KG,20181121.0,,CN,CN,CN,2018,Q4,Elderly
156435241,15643524,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"8 U, DAILY AT NIGHT",,,,,,,20563.0,8.0,IU,,QD,2018,Q4,Swelling,,2018,Q4,1,I,,20181115.0,20181121,20181121,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201811008035,ELI LILLY AND CO,,66.0,YR,,F,Y,55.0,KG,20181121.0,,CN,CN,CN,2018,Q4,Elderly
156444342,15644434,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,25/75: + 20U 20U /DAILY,,,U,,,,,,,,,2018,Q4,Chest pain,,2018,Q4,2,F,,20181211.0,20181121,20181217,EXP,,PT-ASTRAZENECA-2018SF50815,ASTRAZENECA,,54.0,YR,,F,Y,,,20181218.0,,CN,PT,PT,2018,Q4,Adult
156444342,15644434,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,25/75: + 20U 20U /DAILY,,,U,,,,,,,,,2018,Q4,Ischaemic stroke,,2018,Q4,2,F,,20181211.0,20181121,20181217,EXP,,PT-ASTRAZENECA-2018SF50815,ASTRAZENECA,,54.0,YR,,F,Y,,,20181218.0,,CN,PT,PT,2018,Q4,Adult
156447072,15644707,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,,,,,,,INJECTION,,2018,Q4,Arthritis,,2018,Q4,2,F,20180813.0,20181126.0,20181121,20181204,EXP,,US-ELI_LILLY_AND_COMPANY-US201811007385,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20181204.0,,CN,CN,US,2018,Q4,Elderly
156447072,15644707,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,,,,,,,INJECTION,,2018,Q4,Blood glucose decreased,,2018,Q4,2,F,20180813.0,20181126.0,20181121,20181204,EXP,,US-ELI_LILLY_AND_COMPANY-US201811007385,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20181204.0,,CN,CN,US,2018,Q4,Elderly
156447072,15644707,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,,,,,,,INJECTION,,2018,Q4,Hypoglycaemia unawareness,,2018,Q4,2,F,20180813.0,20181126.0,20181121,20181204,EXP,,US-ELI_LILLY_AND_COMPANY-US201811007385,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20181204.0,,CN,CN,US,2018,Q4,Elderly
156447072,15644707,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,,,,,,,INJECTION,,2018,Q4,Seizure,,2018,Q4,2,F,20180813.0,20181126.0,20181121,20181204,EXP,,US-ELI_LILLY_AND_COMPANY-US201811007385,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20181204.0,,CN,CN,US,2018,Q4,Elderly
156447072,15644707,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,,,,INJECTION,,2018,Q4,Arthritis,,2018,Q4,2,F,20180813.0,20181126.0,20181121,20181204,EXP,,US-ELI_LILLY_AND_COMPANY-US201811007385,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20181204.0,,CN,CN,US,2018,Q4,Elderly
156447072,15644707,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,,,,INJECTION,,2018,Q4,Blood glucose decreased,,2018,Q4,2,F,20180813.0,20181126.0,20181121,20181204,EXP,,US-ELI_LILLY_AND_COMPANY-US201811007385,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20181204.0,,CN,CN,US,2018,Q4,Elderly
156447072,15644707,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,,,,INJECTION,,2018,Q4,Hypoglycaemia unawareness,,2018,Q4,2,F,20180813.0,20181126.0,20181121,20181204,EXP,,US-ELI_LILLY_AND_COMPANY-US201811007385,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20181204.0,,CN,CN,US,2018,Q4,Elderly
156447072,15644707,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,,,,INJECTION,,2018,Q4,Seizure,,2018,Q4,2,F,20180813.0,20181126.0,20181121,20181204,EXP,,US-ELI_LILLY_AND_COMPANY-US201811007385,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20181204.0,,CN,CN,US,2018,Q4,Elderly
156447072,15644707,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, C849842D,,,,,INJECTION,,2018,Q4,Arthritis,,2018,Q4,2,F,20180813.0,20181126.0,20181121,20181204,EXP,,US-ELI_LILLY_AND_COMPANY-US201811007385,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20181204.0,,CN,CN,US,2018,Q4,Elderly
156447072,15644707,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, C849842D,,,,,INJECTION,,2018,Q4,Blood glucose decreased,,2018,Q4,2,F,20180813.0,20181126.0,20181121,20181204,EXP,,US-ELI_LILLY_AND_COMPANY-US201811007385,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20181204.0,,CN,CN,US,2018,Q4,Elderly
156447072,15644707,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, C849842D,,,,,INJECTION,,2018,Q4,Hypoglycaemia unawareness,,2018,Q4,2,F,20180813.0,20181126.0,20181121,20181204,EXP,,US-ELI_LILLY_AND_COMPANY-US201811007385,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20181204.0,,CN,CN,US,2018,Q4,Elderly
156447072,15644707,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, C849842D,,,,,INJECTION,,2018,Q4,Seizure,,2018,Q4,2,F,20180813.0,20181126.0,20181121,20181204,EXP,,US-ELI_LILLY_AND_COMPANY-US201811007385,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20181204.0,,CN,CN,US,2018,Q4,Elderly
156473392,15647339,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,D,,,,,,,INJECTION,,2018,Q4,Epstein-Barr virus infection,,2018,Q4,2,F,20181002.0,20181126.0,20181122,20181130,EXP,,US-ASTELLAS-2018US049005,ASTELLAS,,66.0,YR,,M,Y,,,20181130.0,,CN,US,US,2018,Q4,Elderly
156473392,15647339,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,D,,,,,,,INJECTION,,2018,Q4,Graft versus host disease,,2018,Q4,2,F,20181002.0,20181126.0,20181122,20181130,EXP,,US-ASTELLAS-2018US049005,ASTELLAS,,66.0,YR,,M,Y,,,20181130.0,,CN,US,US,2018,Q4,Elderly
156473392,15647339,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,D,,,,,,,INJECTION,,2018,Q4,Septic shock,,2018,Q4,2,F,20181002.0,20181126.0,20181122,20181130,EXP,,US-ASTELLAS-2018US049005,ASTELLAS,,66.0,YR,,M,Y,,,20181130.0,,CN,US,US,2018,Q4,Elderly
156507182,15650718,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,,"UNK, UNKNOWN",,,,,,,,,,INJECTION,,2018,Q4,Blood glucose increased,,2018,Q4,2,F,20181119.0,20181126.0,20181123,20181127,PER,,US-ELI_LILLY_AND_COMPANY-US201811009836,ELI LILLY AND CO,,61.0,YR,,M,Y,,,20181127.0,,CN,US,US,2018,Q4,Adult
156532772,15653277,34,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q4,Headache,,2018,Q4,2,F,2017.0,20181113.0,20181123,20181130,EXP,,US-009507513-1811USA005685,MERCK,,58.0,YR,,F,Y,97.51,KG,20181130.0,,CN,US,US,2018,Q4,Adult
156532772,15653277,34,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q4,Pemphigoid,,2018,Q4,2,F,2017.0,20181113.0,20181123,20181130,EXP,,US-009507513-1811USA005685,MERCK,,58.0,YR,,F,Y,97.51,KG,20181130.0,,CN,US,US,2018,Q4,Adult
156532772,15653277,34,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q4,Vertigo,,2018,Q4,2,F,2017.0,20181113.0,20181123,20181130,EXP,,US-009507513-1811USA005685,MERCK,,58.0,YR,,F,Y,97.51,KG,20181130.0,,CN,US,US,2018,Q4,Adult
156554773,15655477,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 IU (INTERNATIONAL UNIT) DAILY;,,,,,,,,6.0,IU,,QD,2018,Q4,Accidental overdose,,2018,Q4,3,F,,20181217.0,20181126,20181229,EXP,,CA-TEVA-2018-CA-979432,TEVA,,56.0,YR,,M,Y,,,20181229.0,,CN,CA,CA,2018,Q4,Adult
156554773,15655477,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 IU (INTERNATIONAL UNIT) DAILY;,,,,,,,,6.0,IU,,QD,2018,Q4,Corneal perforation,,2018,Q4,3,F,,20181217.0,20181126,20181229,EXP,,CA-TEVA-2018-CA-979432,TEVA,,56.0,YR,,M,Y,,,20181229.0,,CN,CA,CA,2018,Q4,Adult
156554773,15655477,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 IU (INTERNATIONAL UNIT) DAILY;,,,,,,,,6.0,IU,,QD,2018,Q4,Drug interaction,,2018,Q4,3,F,,20181217.0,20181126,20181229,EXP,,CA-TEVA-2018-CA-979432,TEVA,,56.0,YR,,M,Y,,,20181229.0,,CN,CA,CA,2018,Q4,Adult
156554773,15655477,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 IU (INTERNATIONAL UNIT) DAILY;,,,,,,,,6.0,IU,,QD,2018,Q4,Enzyme inhibition,,2018,Q4,3,F,,20181217.0,20181126,20181229,EXP,,CA-TEVA-2018-CA-979432,TEVA,,56.0,YR,,M,Y,,,20181229.0,,CN,CA,CA,2018,Q4,Adult
156554773,15655477,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 IU (INTERNATIONAL UNIT) DAILY;,,,,,,,,6.0,IU,,QD,2018,Q4,Hallucination,,2018,Q4,3,F,,20181217.0,20181126,20181229,EXP,,CA-TEVA-2018-CA-979432,TEVA,,56.0,YR,,M,Y,,,20181229.0,,CN,CA,CA,2018,Q4,Adult
156554773,15655477,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 IU (INTERNATIONAL UNIT) DAILY;,,,,,,,,6.0,IU,,QD,2018,Q4,Hypoglycaemia,,2018,Q4,3,F,,20181217.0,20181126,20181229,EXP,,CA-TEVA-2018-CA-979432,TEVA,,56.0,YR,,M,Y,,,20181229.0,,CN,CA,CA,2018,Q4,Adult
156554773,15655477,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 IU (INTERNATIONAL UNIT) DAILY;,,,,,,,,6.0,IU,,QD,2018,Q4,Keratitis fungal,,2018,Q4,3,F,,20181217.0,20181126,20181229,EXP,,CA-TEVA-2018-CA-979432,TEVA,,56.0,YR,,M,Y,,,20181229.0,,CN,CA,CA,2018,Q4,Adult
156554773,15655477,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 IU (INTERNATIONAL UNIT) DAILY;,,,,,,,,6.0,IU,,QD,2018,Q4,Labelled drug-drug interaction medication error,,2018,Q4,3,F,,20181217.0,20181126,20181229,EXP,,CA-TEVA-2018-CA-979432,TEVA,,56.0,YR,,M,Y,,,20181229.0,,CN,CA,CA,2018,Q4,Adult
156554773,15655477,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 IU (INTERNATIONAL UNIT) DAILY;,,,,,,,,6.0,IU,,QD,2018,Q4,Lethargy,,2018,Q4,3,F,,20181217.0,20181126,20181229,EXP,,CA-TEVA-2018-CA-979432,TEVA,,56.0,YR,,M,Y,,,20181229.0,,CN,CA,CA,2018,Q4,Adult
156554773,15655477,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 IU (INTERNATIONAL UNIT) DAILY;,,,,,,,,6.0,IU,,QD,2018,Q4,Potentiating drug interaction,,2018,Q4,3,F,,20181217.0,20181126,20181229,EXP,,CA-TEVA-2018-CA-979432,TEVA,,56.0,YR,,M,Y,,,20181229.0,,CN,CA,CA,2018,Q4,Adult
156554773,15655477,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 IU (INTERNATIONAL UNIT) DAILY;,,,,,,,,6.0,IU,,QD,2018,Q4,Product use in unapproved indication,,2018,Q4,3,F,,20181217.0,20181126,20181229,EXP,,CA-TEVA-2018-CA-979432,TEVA,,56.0,YR,,M,Y,,,20181229.0,,CN,CA,CA,2018,Q4,Adult
156554773,15655477,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 IU (INTERNATIONAL UNIT) DAILY;,,,,,,,,6.0,IU,,QD,2018,Q4,Toxicity to various agents,,2018,Q4,3,F,,20181217.0,20181126,20181229,EXP,,CA-TEVA-2018-CA-979432,TEVA,,56.0,YR,,M,Y,,,20181229.0,,CN,CA,CA,2018,Q4,Adult
156554773,15655477,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 IU (INTERNATIONAL UNIT) DAILY;,,,,,,,,6.0,IU,,QD,2018,Q4,Visual impairment,,2018,Q4,3,F,,20181217.0,20181126,20181229,EXP,,CA-TEVA-2018-CA-979432,TEVA,,56.0,YR,,M,Y,,,20181229.0,,CN,CA,CA,2018,Q4,Adult
156569161,15656916,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 KIU, QD",34440.0,KIU,Y,,,,,20.0,KIU,SOLUTION FOR INJECTION,QD,2018,Q4,Electrolyte imbalance,,2018,Q4,1,I,20180606.0,20181115.0,20181126,20181126,EXP,IT-MINISAL02-509605,IT-SAKK-2018SA316725AA,SANOFI AVENTIS,,76.0,YR,E,M,Y,,,20181126.0,,PH,IT,IT,2018,Q4,Elderly
156569161,15656916,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 KIU, QD",34440.0,KIU,Y,,,,,20.0,KIU,SOLUTION FOR INJECTION,QD,2018,Q4,Hypoglycaemia,,2018,Q4,1,I,20180606.0,20181115.0,20181126,20181126,EXP,IT-MINISAL02-509605,IT-SAKK-2018SA316725AA,SANOFI AVENTIS,,76.0,YR,E,M,Y,,,20181126.0,,PH,IT,IT,2018,Q4,Elderly
156569161,15656916,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 KIU, QD",34440.0,KIU,Y,,,,,20.0,KIU,SOLUTION FOR INJECTION,QD,2018,Q4,Sinus bradycardia,,2018,Q4,1,I,20180606.0,20181115.0,20181126,20181126,EXP,IT-MINISAL02-509605,IT-SAKK-2018SA316725AA,SANOFI AVENTIS,,76.0,YR,E,M,Y,,,20181126.0,,PH,IT,IT,2018,Q4,Elderly
156569161,15656916,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 KIU, QD",34440.0,KIU,Y,,,,,20.0,KIU,SOLUTION FOR INJECTION,QD,2018,Q4,Syncope,,2018,Q4,1,I,20180606.0,20181115.0,20181126,20181126,EXP,IT-MINISAL02-509605,IT-SAKK-2018SA316725AA,SANOFI AVENTIS,,76.0,YR,E,M,Y,,,20181126.0,,PH,IT,IT,2018,Q4,Elderly
156578452,15657845,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,5406.0,IU,U,,,,,17.0,IU,SOLUTION FOR INJECTION,QD,2018,Q4,Fall,,2018,Q4,2,F,20171114.0,20181126.0,20181126,20181205,EXP,IT-MINISAL02-477128,IT-SAKK-2018SA169229AA,SANOFI AVENTIS,,87.0,YR,E,F,Y,,,20181205.0,,MD,IT,IT,2018,Q4,Elderly
156578452,15657845,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,5406.0,IU,U,,,,,17.0,IU,SOLUTION FOR INJECTION,QD,2018,Q4,Hypoglycaemia,,2018,Q4,2,F,20171114.0,20181126.0,20181126,20181205,EXP,IT-MINISAL02-477128,IT-SAKK-2018SA169229AA,SANOFI AVENTIS,,87.0,YR,E,F,Y,,,20181205.0,,MD,IT,IT,2018,Q4,Elderly
156579641,15657964,10,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,25/75: + 20U 20 U/ D),,,U,,,,209196.0,,,,QD,2018,Q4,Chest pain,,2018,Q4,1,I,,20181114.0,20181126,20181126,EXP,,PT-SA-2018SA322867,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20181126.0,,PH,PT,PT,2018,Q4,Adult
156579641,15657964,10,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,25/75: + 20U 20 U/ D),,,U,,,,209196.0,,,,QD,2018,Q4,Ischaemic stroke,,2018,Q4,1,I,,20181114.0,20181126,20181126,EXP,,PT-SA-2018SA322867,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20181126.0,,PH,PT,PT,2018,Q4,Adult
156590401,15659040,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"22 IU, TOTAL",22.0,IU,D,,,,,22.0,IU,,,2018,Q4,Hypoglycaemic coma,,2018,Q4,1,I,20171101.0,20181113.0,20181127,20181127,EXP,IT-MINISAL02-509244,IT-SA-2018SA313825,SANOFI AVENTIS,,50.0,YR,A,M,Y,,,20181127.0,,MD,IT,IT,2018,Q4,Adult
156590401,15659040,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"22 IU, TOTAL",22.0,IU,D,,,,,22.0,IU,,,2018,Q4,Intentional product misuse,,2018,Q4,1,I,20171101.0,20181113.0,20181127,20181127,EXP,IT-MINISAL02-509244,IT-SA-2018SA313825,SANOFI AVENTIS,,50.0,YR,A,M,Y,,,20181127.0,,MD,IT,IT,2018,Q4,Adult
156590661,15659066,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Cataract,,2018,Q4,1,I,,20181116.0,20181127,20181127,EXP,,US-SA-2018SA319279,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20181127.0,,CN,US,US,2018,Q4,Elderly
156590661,15659066,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Device operational issue,,2018,Q4,1,I,,20181116.0,20181127,20181127,EXP,,US-SA-2018SA319279,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20181127.0,,CN,US,US,2018,Q4,Elderly
156590661,15659066,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Macular hole,,2018,Q4,1,I,,20181116.0,20181127,20181127,EXP,,US-SA-2018SA319279,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20181127.0,,CN,US,US,2018,Q4,Elderly
156590661,15659066,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Product use issue,,2018,Q4,1,I,,20181116.0,20181127,20181127,EXP,,US-SA-2018SA319279,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20181127.0,,CN,US,US,2018,Q4,Elderly
156598893,15659889,17,C,INSULIN LISPRO DCI,,2,Unknown,,,,U,,,,,,,,,2018,Q4,Ascites,,2018,Q4,3,F,20181119.0,20181218.0,20181127,20181225,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-110183,BRISTOL MYERS SQUIBB,,55.0,YR,,M,Y,96.6,KG,20181225.0,,OT,US,US,2018,Q4,Adult
156598893,15659889,17,C,INSULIN LISPRO DCI,,2,Unknown,,,,U,,,,,,,,,2018,Q4,Jaundice,,2018,Q4,3,F,20181119.0,20181218.0,20181127,20181225,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-110183,BRISTOL MYERS SQUIBB,,55.0,YR,,M,Y,96.6,KG,20181225.0,,OT,US,US,2018,Q4,Adult
156598893,15659889,17,C,INSULIN LISPRO DCI,,2,Unknown,,,,U,,,,,,,,,2018,Q4,Nausea,,2018,Q4,3,F,20181119.0,20181218.0,20181127,20181225,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-110183,BRISTOL MYERS SQUIBB,,55.0,YR,,M,Y,96.6,KG,20181225.0,,OT,US,US,2018,Q4,Adult
156598893,15659889,17,C,INSULIN LISPRO DCI,,2,Unknown,,,,U,,,,,,,,,2018,Q4,Oedema peripheral,,2018,Q4,3,F,20181119.0,20181218.0,20181127,20181225,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-110183,BRISTOL MYERS SQUIBB,,55.0,YR,,M,Y,96.6,KG,20181225.0,,OT,US,US,2018,Q4,Adult
156598893,15659889,17,C,INSULIN LISPRO DCI,,2,Unknown,,,,U,,,,,,,,,2018,Q4,Oesophageal candidiasis,,2018,Q4,3,F,20181119.0,20181218.0,20181127,20181225,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-110183,BRISTOL MYERS SQUIBB,,55.0,YR,,M,Y,96.6,KG,20181225.0,,OT,US,US,2018,Q4,Adult
156598893,15659889,17,C,INSULIN LISPRO DCI,,2,Unknown,,,,U,,,,,,,,,2018,Q4,Pneumonia klebsiella,,2018,Q4,3,F,20181119.0,20181218.0,20181127,20181225,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-110183,BRISTOL MYERS SQUIBB,,55.0,YR,,M,Y,96.6,KG,20181225.0,,OT,US,US,2018,Q4,Adult
156619291,15661929,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q4,Acute kidney injury,,2018,Q4,1,I,20180920.0,20181120.0,20181127,20181127,EXP,,US-PFIZER INC-2018481534,PFIZER,,53.0,YR,,F,Y,91.6,KG,20181127.0,,MD,US,US,2018,Q4,Adult
156619291,15661929,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q4,Encephalopathy,,2018,Q4,1,I,20180920.0,20181120.0,20181127,20181127,EXP,,US-PFIZER INC-2018481534,PFIZER,,53.0,YR,,F,Y,91.6,KG,20181127.0,,MD,US,US,2018,Q4,Adult
156619291,15661929,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q4,Enterovirus infection,,2018,Q4,1,I,20180920.0,20181120.0,20181127,20181127,EXP,,US-PFIZER INC-2018481534,PFIZER,,53.0,YR,,F,Y,91.6,KG,20181127.0,,MD,US,US,2018,Q4,Adult
156619291,15661929,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q4,Hyperglycaemia,,2018,Q4,1,I,20180920.0,20181120.0,20181127,20181127,EXP,,US-PFIZER INC-2018481534,PFIZER,,53.0,YR,,F,Y,91.6,KG,20181127.0,,MD,US,US,2018,Q4,Adult
156619291,15661929,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q4,Rhinovirus infection,,2018,Q4,1,I,20180920.0,20181120.0,20181127,20181127,EXP,,US-PFIZER INC-2018481534,PFIZER,,53.0,YR,,F,Y,91.6,KG,20181127.0,,MD,US,US,2018,Q4,Adult
156619291,15661929,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q4,Shock,,2018,Q4,1,I,20180920.0,20181120.0,20181127,20181127,EXP,,US-PFIZER INC-2018481534,PFIZER,,53.0,YR,,F,Y,91.6,KG,20181127.0,,MD,US,US,2018,Q4,Adult
156653163,15665316,37,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4 UNITS,,,,,,,,,,,QD,2018,Q4,Mental status changes,,2018,Q4,3,F,20181115.0,20181203.0,20181128,20181206,EXP,,US-ROCHE-2218548,ROCHE,,75.0,YR,,M,Y,68.0,KG,20181206.0,,MD,US,US,2018,Q4,Elderly
156653163,15665316,38,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0-8 UNITS,,,,,,,,,,,TID,2018,Q4,Mental status changes,,2018,Q4,3,F,20181115.0,20181203.0,20181128,20181206,EXP,,US-ROCHE-2218548,ROCHE,,75.0,YR,,M,Y,68.0,KG,20181206.0,,MD,US,US,2018,Q4,Elderly
156659132,15665913,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD (25/75: PLUS 20U 20U / D)",,,U,,,,,,,UNKNOWN,QD,2018,Q4,Chest pain,,2018,Q4,2,F,,20181210.0,20181128,20181212,EXP,PT-002147023-PHHY2018PT147150,PT-FRESENIUS KABI-FK201812057,FRESENIUS KABI,,54.0,YR,,F,Y,,,20181212.0,,OT,GB,PT,2018,Q4,Adult
156659132,15665913,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD (25/75: PLUS 20U 20U / D)",,,U,,,,,,,UNKNOWN,QD,2018,Q4,Ischaemic stroke,,2018,Q4,2,F,,20181210.0,20181128,20181212,EXP,PT-002147023-PHHY2018PT147150,PT-FRESENIUS KABI-FK201812057,FRESENIUS KABI,,54.0,YR,,F,Y,,,20181212.0,,OT,GB,PT,2018,Q4,Adult
156677772,15667777,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"1 DF, DAILY",,,Y,U,,,20563.0,1.0,DF,,QD,2018,Q4,Confusional state,,2018,Q4,2,F,20180422.0,20181126.0,20181128,20181206,EXP,IT-MINISAL02-512458,IT-ELI_LILLY_AND_COMPANY-IT201811010899,ELI LILLY AND CO,,84.0,YR,,M,Y,,,20181206.0,,CN,IT,IT,2018,Q4,Elderly
156677772,15667777,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"1 DF, DAILY",,,Y,U,,,20563.0,1.0,DF,,QD,2018,Q4,Hypoglycaemia,,2018,Q4,2,F,20180422.0,20181126.0,20181128,20181206,EXP,IT-MINISAL02-512458,IT-ELI_LILLY_AND_COMPANY-IT201811010899,ELI LILLY AND CO,,84.0,YR,,M,Y,,,20181206.0,,CN,IT,IT,2018,Q4,Elderly
156693651,15669365,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,U,,,,,,,,2018,Q4,Blood glucose abnormal,,2018,Q4,1,I,201811.0,20181127.0,20181129,20181129,PER,,US-ELI_LILLY_AND_COMPANY-US201811013167,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20181129.0,,CN,US,US,2018,Q4,Elderly
156693651,15669365,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,U,,,,,,,,2018,Q4,Hypoacusis,,2018,Q4,1,I,201811.0,20181127.0,20181129,20181129,PER,,US-ELI_LILLY_AND_COMPANY-US201811013167,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20181129.0,,CN,US,US,2018,Q4,Elderly
156693651,15669365,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,U,,,,,,,,2018,Q4,Product dose omission,,2018,Q4,1,I,201811.0,20181127.0,20181129,20181129,PER,,US-ELI_LILLY_AND_COMPANY-US201811013167,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20181129.0,,CN,US,US,2018,Q4,Elderly
156705361,15670536,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2018,Q4,Drug reaction with eosinophilia and systemic symptoms,,2018,Q4,1,I,,20181122.0,20181129,20181129,EXP,,"TR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-BI-056928",BOEHRINGER INGELHEIM,"CIHAN S, R D, R U, A A. ALLOPURINOLUN TETIKLEDII DRESS SENDROMU.",89.0,YR,,M,Y,,,20181129.0,,MD,TR,TR,2018,Q4,Elderly
156710191,15671019,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Glycosylated haemoglobin increased,,2018,Q4,1,I,2014.0,20181120.0,20181129,20181129,EXP,,US-SAKK-2018SA321607AA,SANOFI AVENTIS,,61.0,YR,A,M,Y,,,20181129.0,,CN,US,US,2018,Q4,Adult
156710191,15671019,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Lip swelling,,2018,Q4,1,I,2014.0,20181120.0,20181129,20181129,EXP,,US-SAKK-2018SA321607AA,SANOFI AVENTIS,,61.0,YR,A,M,Y,,,20181129.0,,CN,US,US,2018,Q4,Adult
156710191,15671019,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Sepsis,,2018,Q4,1,I,2014.0,20181120.0,20181129,20181129,EXP,,US-SAKK-2018SA321607AA,SANOFI AVENTIS,,61.0,YR,A,M,Y,,,20181129.0,,CN,US,US,2018,Q4,Adult
156778271,15677827,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"6 DF, BID",,,U,U,,,20563.0,6.0,DF,,BID,2018,Q4,Eye disorder,,2018,Q4,1,I,20181103.0,20181119.0,20181130,20181130,EXP,,ES-ELI_LILLY_AND_COMPANY-ES201811008913,ELI LILLY AND CO,,59.0,YR,,F,Y,59.0,KG,20181130.0,,CN,ES,ES,2018,Q4,Adult
156778271,15677827,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"6 DF, BID",,,U,U,,,20563.0,6.0,DF,,BID,2018,Q4,Hyperglycaemia,,2018,Q4,1,I,20181103.0,20181119.0,20181130,20181130,EXP,,ES-ELI_LILLY_AND_COMPANY-ES201811008913,ELI LILLY AND CO,,59.0,YR,,F,Y,59.0,KG,20181130.0,,CN,ES,ES,2018,Q4,Adult
156784292,15678429,18,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,3-10 UNITS,,,,,,,,,,INJECTION,QD,2018,Q4,Renal impairment,,2018,Q4,2,F,20181126.0,20181205.0,20181201,20181214,PER,,US-CELGENEUS-USA-20181109657,CELGENE,,75.0,YR,,M,Y,,,20181214.0,,MD,US,US,2018,Q4,Elderly
156803292,15680329,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q4,Decreased appetite,,2018,Q4,2,F,,20181221.0,20181203,20181228,EXP,,JP-PFIZER INC-2018494607,PFIZER,"OHGUCHI, H.. AN AUTOPSY CASE OF PULMONARY TUMOR THROMBOTIC MICROANGIOPATHY DUE TO RAPIDLY PROGRESSING COLON CANCER IN A PATIENT WITH TYPE 2 DIABETES. INTERNAL MEDICINE. 2018;57(17):2533-2539",61.0,YR,,M,Y,,,20181228.0,,OT,JP,JP,2018,Q4,Adult
156803292,15680329,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q4,Dyspnoea,,2018,Q4,2,F,,20181221.0,20181203,20181228,EXP,,JP-PFIZER INC-2018494607,PFIZER,"OHGUCHI, H.. AN AUTOPSY CASE OF PULMONARY TUMOR THROMBOTIC MICROANGIOPATHY DUE TO RAPIDLY PROGRESSING COLON CANCER IN A PATIENT WITH TYPE 2 DIABETES. INTERNAL MEDICINE. 2018;57(17):2533-2539",61.0,YR,,M,Y,,,20181228.0,,OT,JP,JP,2018,Q4,Adult
156803292,15680329,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q4,Hypoxia,,2018,Q4,2,F,,20181221.0,20181203,20181228,EXP,,JP-PFIZER INC-2018494607,PFIZER,"OHGUCHI, H.. AN AUTOPSY CASE OF PULMONARY TUMOR THROMBOTIC MICROANGIOPATHY DUE TO RAPIDLY PROGRESSING COLON CANCER IN A PATIENT WITH TYPE 2 DIABETES. INTERNAL MEDICINE. 2018;57(17):2533-2539",61.0,YR,,M,Y,,,20181228.0,,OT,JP,JP,2018,Q4,Adult
156803292,15680329,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q4,Pulmonary tumour thrombotic microangiopathy,,2018,Q4,2,F,,20181221.0,20181203,20181228,EXP,,JP-PFIZER INC-2018494607,PFIZER,"OHGUCHI, H.. AN AUTOPSY CASE OF PULMONARY TUMOR THROMBOTIC MICROANGIOPATHY DUE TO RAPIDLY PROGRESSING COLON CANCER IN A PATIENT WITH TYPE 2 DIABETES. INTERNAL MEDICINE. 2018;57(17):2533-2539",61.0,YR,,M,Y,,,20181228.0,,OT,JP,JP,2018,Q4,Adult
156803292,15680329,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q4,Tachycardia,,2018,Q4,2,F,,20181221.0,20181203,20181228,EXP,,JP-PFIZER INC-2018494607,PFIZER,"OHGUCHI, H.. AN AUTOPSY CASE OF PULMONARY TUMOR THROMBOTIC MICROANGIOPATHY DUE TO RAPIDLY PROGRESSING COLON CANCER IN A PATIENT WITH TYPE 2 DIABETES. INTERNAL MEDICINE. 2018;57(17):2533-2539",61.0,YR,,M,Y,,,20181228.0,,OT,JP,JP,2018,Q4,Adult
156816372,15681637,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,200 UNITS/ML,,,,,,,,,,,TID,2018,Q4,Asthenia,,2018,Q4,2,F,201811.0,20181211.0,20181203,20181217,EXP,,US-BIODELIVERY SCIENCES INTERNATIONAL-2018BDSI0645,BIODELIVERY SCIENCES INTERNATIONAL,,68.0,YR,,M,Y,,,20181213.0,,MD,US,US,2018,Q4,Elderly
156816372,15681637,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,200 UNITS/ML,,,,,,,,,,,TID,2018,Q4,Fatigue,,2018,Q4,2,F,201811.0,20181211.0,20181203,20181217,EXP,,US-BIODELIVERY SCIENCES INTERNATIONAL-2018BDSI0645,BIODELIVERY SCIENCES INTERNATIONAL,,68.0,YR,,M,Y,,,20181213.0,,MD,US,US,2018,Q4,Elderly
156816372,15681637,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,200 UNITS/ML,,,,,,,,,,,TID,2018,Q4,Headache,,2018,Q4,2,F,201811.0,20181211.0,20181203,20181217,EXP,,US-BIODELIVERY SCIENCES INTERNATIONAL-2018BDSI0645,BIODELIVERY SCIENCES INTERNATIONAL,,68.0,YR,,M,Y,,,20181213.0,,MD,US,US,2018,Q4,Elderly
156816372,15681637,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,200 UNITS/ML,,,,,,,,,,,TID,2018,Q4,Small intestinal obstruction,,2018,Q4,2,F,201811.0,20181211.0,20181203,20181217,EXP,,US-BIODELIVERY SCIENCES INTERNATIONAL-2018BDSI0645,BIODELIVERY SCIENCES INTERNATIONAL,,68.0,YR,,M,Y,,,20181213.0,,MD,US,US,2018,Q4,Elderly
156821281,15682128,2,SS,Insulin  Lispro,INSULIN LISPRO,1,Unknown,"UNK, TID",,,U,U,,,,,,,TID,2018,Q4,Diabetic ketoacidosis,,2018,Q4,1,I,20181119.0,20181121.0,20181203,20181203,EXP,,BR-ELI_LILLY_AND_COMPANY-BR201811010569,ELI LILLY AND CO,,22.0,YR,,M,Y,,,20181203.0,,CN,BR,BR,2018,Q4,Youth
156844021,15684402,3,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,,,,U,U,,,,,,,,2018,Q4,Joint swelling,,2018,Q4,1,I,20180621.0,20181122.0,20181204,20181204,EXP,NL-LRB-00289885,NL-APOTEX-2018AP025728,APOTEX,,49.0,YR,,F,Y,,,20181204.0,,CN,NL,NL,2018,Q4,Adult
156844021,15684402,3,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,,,,U,U,,,,,,,,2018,Q4,Mobility decreased,,2018,Q4,1,I,20180621.0,20181122.0,20181204,20181204,EXP,NL-LRB-00289885,NL-APOTEX-2018AP025728,APOTEX,,49.0,YR,,F,Y,,,20181204.0,,CN,NL,NL,2018,Q4,Adult
156844021,15684402,3,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,,,,U,U,,,,,,,,2018,Q4,Pruritus,,2018,Q4,1,I,20180621.0,20181122.0,20181204,20181204,EXP,NL-LRB-00289885,NL-APOTEX-2018AP025728,APOTEX,,49.0,YR,,F,Y,,,20181204.0,,CN,NL,NL,2018,Q4,Adult
156844021,15684402,3,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,,,,U,U,,,,,,,,2018,Q4,Urticaria,,2018,Q4,1,I,20180621.0,20181122.0,20181204,20181204,EXP,NL-LRB-00289885,NL-APOTEX-2018AP025728,APOTEX,,49.0,YR,,F,Y,,,20181204.0,,CN,NL,NL,2018,Q4,Adult
156862191,15686219,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"30 IU, UNK",,,,,,,,30.0,IU,,,2018,Q4,Mental status changes,,2018,Q4,1,I,20180223.0,20181127.0,20181204,20181204,EXP,,PHHY2018US171835,NOVARTIS,,65.0,YR,,M,Y,66.1,KG,20181204.0,,CN,US,US,2018,Q4,Elderly
156869691,15686969,1,PS,Insulin Lispro,INSULIN LISPRO,1,,"2 IU, EACH MORNING",,,U,U,,,20563.0,2.0,IU,,QD,2018,Q4,Diabetic metabolic decompensation,,2018,Q4,1,I,201411.0,20181121.0,20181204,20181204,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,MAULE P..FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCEMIA / FIASP - NOVA MOZNOST OVLIVNENI POSTPRANDIALNI GLYKEMIE..KAZUISTIKY V DIABETOLOGII 2018;16(3):30-32.,47.0,YR,,M,Y,,,20181204.0,,OT,CZ,CZ,2018,Q4,Adult
156869691,15686969,1,PS,Insulin Lispro,INSULIN LISPRO,1,,"2 IU, EACH MORNING",,,U,U,,,20563.0,2.0,IU,,QD,2018,Q4,Hypoglycaemia,,2018,Q4,1,I,201411.0,20181121.0,20181204,20181204,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,MAULE P..FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCEMIA / FIASP - NOVA MOZNOST OVLIVNENI POSTPRANDIALNI GLYKEMIE..KAZUISTIKY V DIABETOLOGII 2018;16(3):30-32.,47.0,YR,,M,Y,,,20181204.0,,OT,CZ,CZ,2018,Q4,Adult
156869691,15686969,1,PS,Insulin Lispro,INSULIN LISPRO,1,,"2 IU, EACH MORNING",,,U,U,,,20563.0,2.0,IU,,QD,2018,Q4,Pancreatitis,,2018,Q4,1,I,201411.0,20181121.0,20181204,20181204,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,MAULE P..FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCEMIA / FIASP - NOVA MOZNOST OVLIVNENI POSTPRANDIALNI GLYKEMIE..KAZUISTIKY V DIABETOLOGII 2018;16(3):30-32.,47.0,YR,,M,Y,,,20181204.0,,OT,CZ,CZ,2018,Q4,Adult
156869691,15686969,1,PS,Insulin Lispro,INSULIN LISPRO,1,,"2 IU, EACH MORNING",,,U,U,,,20563.0,2.0,IU,,QD,2018,Q4,Weight increased,,2018,Q4,1,I,201411.0,20181121.0,20181204,20181204,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,MAULE P..FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCEMIA / FIASP - NOVA MOZNOST OVLIVNENI POSTPRANDIALNI GLYKEMIE..KAZUISTIKY V DIABETOLOGII 2018;16(3):30-32.,47.0,YR,,M,Y,,,20181204.0,,OT,CZ,CZ,2018,Q4,Adult
156869691,15686969,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"2 IU, EACH EVENING",,,U,U,,,20563.0,2.0,IU,,QD,2018,Q4,Diabetic metabolic decompensation,,2018,Q4,1,I,201411.0,20181121.0,20181204,20181204,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,MAULE P..FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCEMIA / FIASP - NOVA MOZNOST OVLIVNENI POSTPRANDIALNI GLYKEMIE..KAZUISTIKY V DIABETOLOGII 2018;16(3):30-32.,47.0,YR,,M,Y,,,20181204.0,,OT,CZ,CZ,2018,Q4,Adult
156869691,15686969,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"2 IU, EACH EVENING",,,U,U,,,20563.0,2.0,IU,,QD,2018,Q4,Hypoglycaemia,,2018,Q4,1,I,201411.0,20181121.0,20181204,20181204,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,MAULE P..FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCEMIA / FIASP - NOVA MOZNOST OVLIVNENI POSTPRANDIALNI GLYKEMIE..KAZUISTIKY V DIABETOLOGII 2018;16(3):30-32.,47.0,YR,,M,Y,,,20181204.0,,OT,CZ,CZ,2018,Q4,Adult
156869691,15686969,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"2 IU, EACH EVENING",,,U,U,,,20563.0,2.0,IU,,QD,2018,Q4,Pancreatitis,,2018,Q4,1,I,201411.0,20181121.0,20181204,20181204,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,MAULE P..FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCEMIA / FIASP - NOVA MOZNOST OVLIVNENI POSTPRANDIALNI GLYKEMIE..KAZUISTIKY V DIABETOLOGII 2018;16(3):30-32.,47.0,YR,,M,Y,,,20181204.0,,OT,CZ,CZ,2018,Q4,Adult
156869691,15686969,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"2 IU, EACH EVENING",,,U,U,,,20563.0,2.0,IU,,QD,2018,Q4,Weight increased,,2018,Q4,1,I,201411.0,20181121.0,20181204,20181204,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,MAULE P..FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCEMIA / FIASP - NOVA MOZNOST OVLIVNENI POSTPRANDIALNI GLYKEMIE..KAZUISTIKY V DIABETOLOGII 2018;16(3):30-32.,47.0,YR,,M,Y,,,20181204.0,,OT,CZ,CZ,2018,Q4,Adult
156869691,15686969,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"2 IU, EACH EVENING",,,U,U,,,20563.0,2.0,IU,,QD,2018,Q4,Diabetic metabolic decompensation,,2018,Q4,1,I,201411.0,20181121.0,20181204,20181204,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,MAULE P..FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCEMIA / FIASP - NOVA MOZNOST OVLIVNENI POSTPRANDIALNI GLYKEMIE..KAZUISTIKY V DIABETOLOGII 2018;16(3):30-32.,47.0,YR,,M,Y,,,20181204.0,,OT,CZ,CZ,2018,Q4,Adult
156869691,15686969,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"2 IU, EACH EVENING",,,U,U,,,20563.0,2.0,IU,,QD,2018,Q4,Hypoglycaemia,,2018,Q4,1,I,201411.0,20181121.0,20181204,20181204,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,MAULE P..FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCEMIA / FIASP - NOVA MOZNOST OVLIVNENI POSTPRANDIALNI GLYKEMIE..KAZUISTIKY V DIABETOLOGII 2018;16(3):30-32.,47.0,YR,,M,Y,,,20181204.0,,OT,CZ,CZ,2018,Q4,Adult
156869691,15686969,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"2 IU, EACH EVENING",,,U,U,,,20563.0,2.0,IU,,QD,2018,Q4,Pancreatitis,,2018,Q4,1,I,201411.0,20181121.0,20181204,20181204,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,MAULE P..FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCEMIA / FIASP - NOVA MOZNOST OVLIVNENI POSTPRANDIALNI GLYKEMIE..KAZUISTIKY V DIABETOLOGII 2018;16(3):30-32.,47.0,YR,,M,Y,,,20181204.0,,OT,CZ,CZ,2018,Q4,Adult
156869691,15686969,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"2 IU, EACH EVENING",,,U,U,,,20563.0,2.0,IU,,QD,2018,Q4,Weight increased,,2018,Q4,1,I,201411.0,20181121.0,20181204,20181204,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,MAULE P..FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCEMIA / FIASP - NOVA MOZNOST OVLIVNENI POSTPRANDIALNI GLYKEMIE..KAZUISTIKY V DIABETOLOGII 2018;16(3):30-32.,47.0,YR,,M,Y,,,20181204.0,,OT,CZ,CZ,2018,Q4,Adult
156869691,15686969,4,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"4 IU, EACH MORNING",,,U,U,,,20563.0,4.0,IU,,QD,2018,Q4,Diabetic metabolic decompensation,,2018,Q4,1,I,201411.0,20181121.0,20181204,20181204,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,MAULE P..FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCEMIA / FIASP - NOVA MOZNOST OVLIVNENI POSTPRANDIALNI GLYKEMIE..KAZUISTIKY V DIABETOLOGII 2018;16(3):30-32.,47.0,YR,,M,Y,,,20181204.0,,OT,CZ,CZ,2018,Q4,Adult
156869691,15686969,4,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"4 IU, EACH MORNING",,,U,U,,,20563.0,4.0,IU,,QD,2018,Q4,Hypoglycaemia,,2018,Q4,1,I,201411.0,20181121.0,20181204,20181204,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,MAULE P..FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCEMIA / FIASP - NOVA MOZNOST OVLIVNENI POSTPRANDIALNI GLYKEMIE..KAZUISTIKY V DIABETOLOGII 2018;16(3):30-32.,47.0,YR,,M,Y,,,20181204.0,,OT,CZ,CZ,2018,Q4,Adult
156869691,15686969,4,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"4 IU, EACH MORNING",,,U,U,,,20563.0,4.0,IU,,QD,2018,Q4,Pancreatitis,,2018,Q4,1,I,201411.0,20181121.0,20181204,20181204,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,MAULE P..FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCEMIA / FIASP - NOVA MOZNOST OVLIVNENI POSTPRANDIALNI GLYKEMIE..KAZUISTIKY V DIABETOLOGII 2018;16(3):30-32.,47.0,YR,,M,Y,,,20181204.0,,OT,CZ,CZ,2018,Q4,Adult
156869691,15686969,4,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"4 IU, EACH MORNING",,,U,U,,,20563.0,4.0,IU,,QD,2018,Q4,Weight increased,,2018,Q4,1,I,201411.0,20181121.0,20181204,20181204,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,MAULE P..FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCEMIA / FIASP - NOVA MOZNOST OVLIVNENI POSTPRANDIALNI GLYKEMIE..KAZUISTIKY V DIABETOLOGII 2018;16(3):30-32.,47.0,YR,,M,Y,,,20181204.0,,OT,CZ,CZ,2018,Q4,Adult
156869691,15686969,5,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"6 IU, EACH EVENING",,,U,U,,,20563.0,6.0,IU,,QD,2018,Q4,Diabetic metabolic decompensation,,2018,Q4,1,I,201411.0,20181121.0,20181204,20181204,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,MAULE P..FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCEMIA / FIASP - NOVA MOZNOST OVLIVNENI POSTPRANDIALNI GLYKEMIE..KAZUISTIKY V DIABETOLOGII 2018;16(3):30-32.,47.0,YR,,M,Y,,,20181204.0,,OT,CZ,CZ,2018,Q4,Adult
156869691,15686969,5,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"6 IU, EACH EVENING",,,U,U,,,20563.0,6.0,IU,,QD,2018,Q4,Hypoglycaemia,,2018,Q4,1,I,201411.0,20181121.0,20181204,20181204,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,MAULE P..FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCEMIA / FIASP - NOVA MOZNOST OVLIVNENI POSTPRANDIALNI GLYKEMIE..KAZUISTIKY V DIABETOLOGII 2018;16(3):30-32.,47.0,YR,,M,Y,,,20181204.0,,OT,CZ,CZ,2018,Q4,Adult
156869691,15686969,5,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"6 IU, EACH EVENING",,,U,U,,,20563.0,6.0,IU,,QD,2018,Q4,Pancreatitis,,2018,Q4,1,I,201411.0,20181121.0,20181204,20181204,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,MAULE P..FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCEMIA / FIASP - NOVA MOZNOST OVLIVNENI POSTPRANDIALNI GLYKEMIE..KAZUISTIKY V DIABETOLOGII 2018;16(3):30-32.,47.0,YR,,M,Y,,,20181204.0,,OT,CZ,CZ,2018,Q4,Adult
156869691,15686969,5,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"6 IU, EACH EVENING",,,U,U,,,20563.0,6.0,IU,,QD,2018,Q4,Weight increased,,2018,Q4,1,I,201411.0,20181121.0,20181204,20181204,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,MAULE P..FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCEMIA / FIASP - NOVA MOZNOST OVLIVNENI POSTPRANDIALNI GLYKEMIE..KAZUISTIKY V DIABETOLOGII 2018;16(3):30-32.,47.0,YR,,M,Y,,,20181204.0,,OT,CZ,CZ,2018,Q4,Adult
156869691,15686969,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"6 IU, EACH EVENING",,,U,U,,,20563.0,6.0,IU,,QD,2018,Q4,Diabetic metabolic decompensation,,2018,Q4,1,I,201411.0,20181121.0,20181204,20181204,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,MAULE P..FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCEMIA / FIASP - NOVA MOZNOST OVLIVNENI POSTPRANDIALNI GLYKEMIE..KAZUISTIKY V DIABETOLOGII 2018;16(3):30-32.,47.0,YR,,M,Y,,,20181204.0,,OT,CZ,CZ,2018,Q4,Adult
156869691,15686969,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"6 IU, EACH EVENING",,,U,U,,,20563.0,6.0,IU,,QD,2018,Q4,Hypoglycaemia,,2018,Q4,1,I,201411.0,20181121.0,20181204,20181204,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,MAULE P..FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCEMIA / FIASP - NOVA MOZNOST OVLIVNENI POSTPRANDIALNI GLYKEMIE..KAZUISTIKY V DIABETOLOGII 2018;16(3):30-32.,47.0,YR,,M,Y,,,20181204.0,,OT,CZ,CZ,2018,Q4,Adult
156869691,15686969,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"6 IU, EACH EVENING",,,U,U,,,20563.0,6.0,IU,,QD,2018,Q4,Pancreatitis,,2018,Q4,1,I,201411.0,20181121.0,20181204,20181204,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,MAULE P..FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCEMIA / FIASP - NOVA MOZNOST OVLIVNENI POSTPRANDIALNI GLYKEMIE..KAZUISTIKY V DIABETOLOGII 2018;16(3):30-32.,47.0,YR,,M,Y,,,20181204.0,,OT,CZ,CZ,2018,Q4,Adult
156869691,15686969,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"6 IU, EACH EVENING",,,U,U,,,20563.0,6.0,IU,,QD,2018,Q4,Weight increased,,2018,Q4,1,I,201411.0,20181121.0,20181204,20181204,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,MAULE P..FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCEMIA / FIASP - NOVA MOZNOST OVLIVNENI POSTPRANDIALNI GLYKEMIE..KAZUISTIKY V DIABETOLOGII 2018;16(3):30-32.,47.0,YR,,M,Y,,,20181204.0,,OT,CZ,CZ,2018,Q4,Adult
156869691,15686969,7,SS,Insulin Lispro,INSULIN LISPRO,1,,"5 IU, EACH MORNING",,,U,U,,,20563.0,5.0,IU,,QD,2018,Q4,Diabetic metabolic decompensation,,2018,Q4,1,I,201411.0,20181121.0,20181204,20181204,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,MAULE P..FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCEMIA / FIASP - NOVA MOZNOST OVLIVNENI POSTPRANDIALNI GLYKEMIE..KAZUISTIKY V DIABETOLOGII 2018;16(3):30-32.,47.0,YR,,M,Y,,,20181204.0,,OT,CZ,CZ,2018,Q4,Adult
156869691,15686969,7,SS,Insulin Lispro,INSULIN LISPRO,1,,"5 IU, EACH MORNING",,,U,U,,,20563.0,5.0,IU,,QD,2018,Q4,Hypoglycaemia,,2018,Q4,1,I,201411.0,20181121.0,20181204,20181204,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,MAULE P..FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCEMIA / FIASP - NOVA MOZNOST OVLIVNENI POSTPRANDIALNI GLYKEMIE..KAZUISTIKY V DIABETOLOGII 2018;16(3):30-32.,47.0,YR,,M,Y,,,20181204.0,,OT,CZ,CZ,2018,Q4,Adult
156869691,15686969,7,SS,Insulin Lispro,INSULIN LISPRO,1,,"5 IU, EACH MORNING",,,U,U,,,20563.0,5.0,IU,,QD,2018,Q4,Pancreatitis,,2018,Q4,1,I,201411.0,20181121.0,20181204,20181204,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,MAULE P..FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCEMIA / FIASP - NOVA MOZNOST OVLIVNENI POSTPRANDIALNI GLYKEMIE..KAZUISTIKY V DIABETOLOGII 2018;16(3):30-32.,47.0,YR,,M,Y,,,20181204.0,,OT,CZ,CZ,2018,Q4,Adult
156869691,15686969,7,SS,Insulin Lispro,INSULIN LISPRO,1,,"5 IU, EACH MORNING",,,U,U,,,20563.0,5.0,IU,,QD,2018,Q4,Weight increased,,2018,Q4,1,I,201411.0,20181121.0,20181204,20181204,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,MAULE P..FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCEMIA / FIASP - NOVA MOZNOST OVLIVNENI POSTPRANDIALNI GLYKEMIE..KAZUISTIKY V DIABETOLOGII 2018;16(3):30-32.,47.0,YR,,M,Y,,,20181204.0,,OT,CZ,CZ,2018,Q4,Adult
156869691,15686969,8,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"7 IU, EACH AFTERNOON",,,U,U,,,20563.0,7.0,IU,,,2018,Q4,Diabetic metabolic decompensation,,2018,Q4,1,I,201411.0,20181121.0,20181204,20181204,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,MAULE P..FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCEMIA / FIASP - NOVA MOZNOST OVLIVNENI POSTPRANDIALNI GLYKEMIE..KAZUISTIKY V DIABETOLOGII 2018;16(3):30-32.,47.0,YR,,M,Y,,,20181204.0,,OT,CZ,CZ,2018,Q4,Adult
156869691,15686969,8,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"7 IU, EACH AFTERNOON",,,U,U,,,20563.0,7.0,IU,,,2018,Q4,Hypoglycaemia,,2018,Q4,1,I,201411.0,20181121.0,20181204,20181204,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,MAULE P..FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCEMIA / FIASP - NOVA MOZNOST OVLIVNENI POSTPRANDIALNI GLYKEMIE..KAZUISTIKY V DIABETOLOGII 2018;16(3):30-32.,47.0,YR,,M,Y,,,20181204.0,,OT,CZ,CZ,2018,Q4,Adult
156869691,15686969,8,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"7 IU, EACH AFTERNOON",,,U,U,,,20563.0,7.0,IU,,,2018,Q4,Pancreatitis,,2018,Q4,1,I,201411.0,20181121.0,20181204,20181204,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,MAULE P..FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCEMIA / FIASP - NOVA MOZNOST OVLIVNENI POSTPRANDIALNI GLYKEMIE..KAZUISTIKY V DIABETOLOGII 2018;16(3):30-32.,47.0,YR,,M,Y,,,20181204.0,,OT,CZ,CZ,2018,Q4,Adult
156869691,15686969,8,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"7 IU, EACH AFTERNOON",,,U,U,,,20563.0,7.0,IU,,,2018,Q4,Weight increased,,2018,Q4,1,I,201411.0,20181121.0,20181204,20181204,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,MAULE P..FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCEMIA / FIASP - NOVA MOZNOST OVLIVNENI POSTPRANDIALNI GLYKEMIE..KAZUISTIKY V DIABETOLOGII 2018;16(3):30-32.,47.0,YR,,M,Y,,,20181204.0,,OT,CZ,CZ,2018,Q4,Adult
156869691,15686969,9,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"7 IU, EACH EVENING",,,U,U,,,20563.0,7.0,IU,,QD,2018,Q4,Diabetic metabolic decompensation,,2018,Q4,1,I,201411.0,20181121.0,20181204,20181204,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,MAULE P..FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCEMIA / FIASP - NOVA MOZNOST OVLIVNENI POSTPRANDIALNI GLYKEMIE..KAZUISTIKY V DIABETOLOGII 2018;16(3):30-32.,47.0,YR,,M,Y,,,20181204.0,,OT,CZ,CZ,2018,Q4,Adult
156869691,15686969,9,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"7 IU, EACH EVENING",,,U,U,,,20563.0,7.0,IU,,QD,2018,Q4,Hypoglycaemia,,2018,Q4,1,I,201411.0,20181121.0,20181204,20181204,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,MAULE P..FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCEMIA / FIASP - NOVA MOZNOST OVLIVNENI POSTPRANDIALNI GLYKEMIE..KAZUISTIKY V DIABETOLOGII 2018;16(3):30-32.,47.0,YR,,M,Y,,,20181204.0,,OT,CZ,CZ,2018,Q4,Adult
156869691,15686969,9,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"7 IU, EACH EVENING",,,U,U,,,20563.0,7.0,IU,,QD,2018,Q4,Pancreatitis,,2018,Q4,1,I,201411.0,20181121.0,20181204,20181204,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,MAULE P..FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCEMIA / FIASP - NOVA MOZNOST OVLIVNENI POSTPRANDIALNI GLYKEMIE..KAZUISTIKY V DIABETOLOGII 2018;16(3):30-32.,47.0,YR,,M,Y,,,20181204.0,,OT,CZ,CZ,2018,Q4,Adult
156869691,15686969,9,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"7 IU, EACH EVENING",,,U,U,,,20563.0,7.0,IU,,QD,2018,Q4,Weight increased,,2018,Q4,1,I,201411.0,20181121.0,20181204,20181204,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,MAULE P..FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCEMIA / FIASP - NOVA MOZNOST OVLIVNENI POSTPRANDIALNI GLYKEMIE..KAZUISTIKY V DIABETOLOGII 2018;16(3):30-32.,47.0,YR,,M,Y,,,20181204.0,,OT,CZ,CZ,2018,Q4,Adult
156869691,15686969,10,SS,Insulin Lispro,INSULIN LISPRO,1,,"8 IU, EACH MORNING",,,U,U,,,20563.0,8.0,IU,,QD,2018,Q4,Diabetic metabolic decompensation,,2018,Q4,1,I,201411.0,20181121.0,20181204,20181204,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,MAULE P..FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCEMIA / FIASP - NOVA MOZNOST OVLIVNENI POSTPRANDIALNI GLYKEMIE..KAZUISTIKY V DIABETOLOGII 2018;16(3):30-32.,47.0,YR,,M,Y,,,20181204.0,,OT,CZ,CZ,2018,Q4,Adult
156869691,15686969,10,SS,Insulin Lispro,INSULIN LISPRO,1,,"8 IU, EACH MORNING",,,U,U,,,20563.0,8.0,IU,,QD,2018,Q4,Hypoglycaemia,,2018,Q4,1,I,201411.0,20181121.0,20181204,20181204,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,MAULE P..FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCEMIA / FIASP - NOVA MOZNOST OVLIVNENI POSTPRANDIALNI GLYKEMIE..KAZUISTIKY V DIABETOLOGII 2018;16(3):30-32.,47.0,YR,,M,Y,,,20181204.0,,OT,CZ,CZ,2018,Q4,Adult
156869691,15686969,10,SS,Insulin Lispro,INSULIN LISPRO,1,,"8 IU, EACH MORNING",,,U,U,,,20563.0,8.0,IU,,QD,2018,Q4,Pancreatitis,,2018,Q4,1,I,201411.0,20181121.0,20181204,20181204,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,MAULE P..FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCEMIA / FIASP - NOVA MOZNOST OVLIVNENI POSTPRANDIALNI GLYKEMIE..KAZUISTIKY V DIABETOLOGII 2018;16(3):30-32.,47.0,YR,,M,Y,,,20181204.0,,OT,CZ,CZ,2018,Q4,Adult
156869691,15686969,10,SS,Insulin Lispro,INSULIN LISPRO,1,,"8 IU, EACH MORNING",,,U,U,,,20563.0,8.0,IU,,QD,2018,Q4,Weight increased,,2018,Q4,1,I,201411.0,20181121.0,20181204,20181204,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,MAULE P..FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCEMIA / FIASP - NOVA MOZNOST OVLIVNENI POSTPRANDIALNI GLYKEMIE..KAZUISTIKY V DIABETOLOGII 2018;16(3):30-32.,47.0,YR,,M,Y,,,20181204.0,,OT,CZ,CZ,2018,Q4,Adult
156869691,15686969,11,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"8 IU, EACH AFTERNOON",,,U,U,,,20563.0,8.0,IU,,,2018,Q4,Diabetic metabolic decompensation,,2018,Q4,1,I,201411.0,20181121.0,20181204,20181204,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,MAULE P..FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCEMIA / FIASP - NOVA MOZNOST OVLIVNENI POSTPRANDIALNI GLYKEMIE..KAZUISTIKY V DIABETOLOGII 2018;16(3):30-32.,47.0,YR,,M,Y,,,20181204.0,,OT,CZ,CZ,2018,Q4,Adult
156869691,15686969,11,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"8 IU, EACH AFTERNOON",,,U,U,,,20563.0,8.0,IU,,,2018,Q4,Hypoglycaemia,,2018,Q4,1,I,201411.0,20181121.0,20181204,20181204,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,MAULE P..FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCEMIA / FIASP - NOVA MOZNOST OVLIVNENI POSTPRANDIALNI GLYKEMIE..KAZUISTIKY V DIABETOLOGII 2018;16(3):30-32.,47.0,YR,,M,Y,,,20181204.0,,OT,CZ,CZ,2018,Q4,Adult
156869691,15686969,11,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"8 IU, EACH AFTERNOON",,,U,U,,,20563.0,8.0,IU,,,2018,Q4,Pancreatitis,,2018,Q4,1,I,201411.0,20181121.0,20181204,20181204,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,MAULE P..FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCEMIA / FIASP - NOVA MOZNOST OVLIVNENI POSTPRANDIALNI GLYKEMIE..KAZUISTIKY V DIABETOLOGII 2018;16(3):30-32.,47.0,YR,,M,Y,,,20181204.0,,OT,CZ,CZ,2018,Q4,Adult
156869691,15686969,11,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"8 IU, EACH AFTERNOON",,,U,U,,,20563.0,8.0,IU,,,2018,Q4,Weight increased,,2018,Q4,1,I,201411.0,20181121.0,20181204,20181204,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,MAULE P..FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCEMIA / FIASP - NOVA MOZNOST OVLIVNENI POSTPRANDIALNI GLYKEMIE..KAZUISTIKY V DIABETOLOGII 2018;16(3):30-32.,47.0,YR,,M,Y,,,20181204.0,,OT,CZ,CZ,2018,Q4,Adult
156869691,15686969,12,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"8 IU, EACH EVENING",,,U,U,,,20563.0,8.0,IU,,QD,2018,Q4,Diabetic metabolic decompensation,,2018,Q4,1,I,201411.0,20181121.0,20181204,20181204,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,MAULE P..FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCEMIA / FIASP - NOVA MOZNOST OVLIVNENI POSTPRANDIALNI GLYKEMIE..KAZUISTIKY V DIABETOLOGII 2018;16(3):30-32.,47.0,YR,,M,Y,,,20181204.0,,OT,CZ,CZ,2018,Q4,Adult
156869691,15686969,12,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"8 IU, EACH EVENING",,,U,U,,,20563.0,8.0,IU,,QD,2018,Q4,Hypoglycaemia,,2018,Q4,1,I,201411.0,20181121.0,20181204,20181204,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,MAULE P..FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCEMIA / FIASP - NOVA MOZNOST OVLIVNENI POSTPRANDIALNI GLYKEMIE..KAZUISTIKY V DIABETOLOGII 2018;16(3):30-32.,47.0,YR,,M,Y,,,20181204.0,,OT,CZ,CZ,2018,Q4,Adult
156869691,15686969,12,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"8 IU, EACH EVENING",,,U,U,,,20563.0,8.0,IU,,QD,2018,Q4,Pancreatitis,,2018,Q4,1,I,201411.0,20181121.0,20181204,20181204,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,MAULE P..FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCEMIA / FIASP - NOVA MOZNOST OVLIVNENI POSTPRANDIALNI GLYKEMIE..KAZUISTIKY V DIABETOLOGII 2018;16(3):30-32.,47.0,YR,,M,Y,,,20181204.0,,OT,CZ,CZ,2018,Q4,Adult
156869691,15686969,12,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"8 IU, EACH EVENING",,,U,U,,,20563.0,8.0,IU,,QD,2018,Q4,Weight increased,,2018,Q4,1,I,201411.0,20181121.0,20181204,20181204,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,MAULE P..FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCEMIA / FIASP - NOVA MOZNOST OVLIVNENI POSTPRANDIALNI GLYKEMIE..KAZUISTIKY V DIABETOLOGII 2018;16(3):30-32.,47.0,YR,,M,Y,,,20181204.0,,OT,CZ,CZ,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Acidosis,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Acute kidney injury,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Acute respiratory distress syndrome,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Alkalosis hypochloraemic,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Anaemia,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Asthenia,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Bandaemia,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Blood creatinine increased,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Blood urea increased,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Bronchial haemorrhage,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Bronchitis chronic,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Concomitant disease aggravated,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Constipation,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Cough,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Cystic fibrosis,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Diarrhoea,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Dysphagia,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Dyspnoea,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Fungal disease carrier,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Gastroenteritis norovirus,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Gastrointestinal disorder,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Generalised oedema,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Glucose tolerance impaired,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Granulocytosis,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Haematuria,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Haemoptysis,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Hypercapnia,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Hyperglycaemia,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Hypernatraemia,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Hypertension,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Hypertriglyceridaemia,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Hypervolaemia,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Hypokalaemia,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Hypoxia,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Ill-defined disorder,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Infective exacerbation of bronchiectasis,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Infective pulmonary exacerbation of cystic fibrosis,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Insomnia,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Intensive care unit acquired weakness,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Iron deficiency,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Leukocytosis,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Metabolic acidosis,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Muscle atrophy,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Paresis,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Pneumonia,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Pyrexia,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Respiratory failure,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Sepsis,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Stenotrophomonas test positive,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Tachycardia,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Thrombocytosis,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156873571,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2018,Q4,Weight decreased,,2018,Q4,1,I,20160303.0,20171128.0,20181205,20181205,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156884341,15688434,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"13 UNIT, TID",,,U,,,,,13.0,DF,,TID,2018,Q4,Drug ineffective,,2018,Q4,1,I,20180821.0,20181127.0,20181205,20181205,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-111921,BRISTOL MYERS SQUIBB,,55.0,YR,,F,Y,79.8,KG,20181205.0,,PH,US,US,2018,Q4,Adult
156886781,15688678,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONGOING,,,,,,,,,,,,2018,Q4,Ascites,,2018,Q4,1,I,20171220.0,20181121.0,20181205,20181205,EXP,,US-ROCHE-2221419,ROCHE,,40.0,YR,,F,Y,50.3,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156886781,15688678,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONGOING,,,,,,,,,,,,2018,Q4,Azotaemia,,2018,Q4,1,I,20171220.0,20181121.0,20181205,20181205,EXP,,US-ROCHE-2221419,ROCHE,,40.0,YR,,F,Y,50.3,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156886781,15688678,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONGOING,,,,,,,,,,,,2018,Q4,Bacteraemia,,2018,Q4,1,I,20171220.0,20181121.0,20181205,20181205,EXP,,US-ROCHE-2221419,ROCHE,,40.0,YR,,F,Y,50.3,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156886781,15688678,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONGOING,,,,,,,,,,,,2018,Q4,Blood bilirubin increased,,2018,Q4,1,I,20171220.0,20181121.0,20181205,20181205,EXP,,US-ROCHE-2221419,ROCHE,,40.0,YR,,F,Y,50.3,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156886781,15688678,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONGOING,,,,,,,,,,,,2018,Q4,Candida sepsis,,2018,Q4,1,I,20171220.0,20181121.0,20181205,20181205,EXP,,US-ROCHE-2221419,ROCHE,,40.0,YR,,F,Y,50.3,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156886781,15688678,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONGOING,,,,,,,,,,,,2018,Q4,Cholestasis,,2018,Q4,1,I,20171220.0,20181121.0,20181205,20181205,EXP,,US-ROCHE-2221419,ROCHE,,40.0,YR,,F,Y,50.3,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156886781,15688678,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONGOING,,,,,,,,,,,,2018,Q4,Fluid overload,,2018,Q4,1,I,20171220.0,20181121.0,20181205,20181205,EXP,,US-ROCHE-2221419,ROCHE,,40.0,YR,,F,Y,50.3,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156886781,15688678,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONGOING,,,,,,,,,,,,2018,Q4,Lactic acidosis,,2018,Q4,1,I,20171220.0,20181121.0,20181205,20181205,EXP,,US-ROCHE-2221419,ROCHE,,40.0,YR,,F,Y,50.3,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156886781,15688678,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONGOING,,,,,,,,,,,,2018,Q4,Multiple organ dysfunction syndrome,,2018,Q4,1,I,20171220.0,20181121.0,20181205,20181205,EXP,,US-ROCHE-2221419,ROCHE,,40.0,YR,,F,Y,50.3,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156886781,15688678,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONGOING,,,,,,,,,,,,2018,Q4,Pneumonia aspiration,,2018,Q4,1,I,20171220.0,20181121.0,20181205,20181205,EXP,,US-ROCHE-2221419,ROCHE,,40.0,YR,,F,Y,50.3,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156886781,15688678,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONGOING,,,,,,,,,,,,2018,Q4,Portal hypertension,,2018,Q4,1,I,20171220.0,20181121.0,20181205,20181205,EXP,,US-ROCHE-2221419,ROCHE,,40.0,YR,,F,Y,50.3,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156886781,15688678,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONGOING,,,,,,,,,,,,2018,Q4,Septic shock,,2018,Q4,1,I,20171220.0,20181121.0,20181205,20181205,EXP,,US-ROCHE-2221419,ROCHE,,40.0,YR,,F,Y,50.3,KG,20181205.0,,MD,US,US,2018,Q4,Adult
156892661,15689266,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, QD",3520.0,IU,U,,,,,20.0,IU,SOLUTION FOR INJECTION,QD,2018,Q4,Generalised tonic-clonic seizure,,2018,Q4,1,I,20180626.0,20181123.0,20181205,20181205,EXP,IT-MINISAL02-510999,IT-SAKK-2018SA324335AA,SANOFI AVENTIS,,74.0,YR,E,M,Y,,,20181205.0,,MD,IT,IT,2018,Q4,Elderly
156892661,15689266,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, QD",3520.0,IU,U,,,,,20.0,IU,SOLUTION FOR INJECTION,QD,2018,Q4,Hypoglycaemia,,2018,Q4,1,I,20180626.0,20181123.0,20181205,20181205,EXP,IT-MINISAL02-510999,IT-SAKK-2018SA324335AA,SANOFI AVENTIS,,74.0,YR,E,M,Y,,,20181205.0,,MD,IT,IT,2018,Q4,Elderly
156900872,15690087,14,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, 3X/DAY (TIDWM)",,,,,,,,,,INJECTION,TID,2018,Q4,Cardio-respiratory arrest,,2018,Q4,2,F,,20181226.0,20181205,20181231,EXP,,US-PFIZER INC-2018323545,PFIZER,,95.0,YR,,F,Y,,,20181231.0,,OT,US,US,2018,Q4,Elderly
156900872,15690087,14,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, 3X/DAY (TIDWM)",,,,,,,,,,INJECTION,TID,2018,Q4,Condition aggravated,,2018,Q4,2,F,,20181226.0,20181205,20181231,EXP,,US-PFIZER INC-2018323545,PFIZER,,95.0,YR,,F,Y,,,20181231.0,,OT,US,US,2018,Q4,Elderly
156900872,15690087,14,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, 3X/DAY (TIDWM)",,,,,,,,,,INJECTION,TID,2018,Q4,Influenza,,2018,Q4,2,F,,20181226.0,20181205,20181231,EXP,,US-PFIZER INC-2018323545,PFIZER,,95.0,YR,,F,Y,,,20181231.0,,OT,US,US,2018,Q4,Elderly
156900872,15690087,14,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, 3X/DAY (TIDWM)",,,,,,,,,,INJECTION,TID,2018,Q4,Multiple organ dysfunction syndrome,,2018,Q4,2,F,,20181226.0,20181205,20181231,EXP,,US-PFIZER INC-2018323545,PFIZER,,95.0,YR,,F,Y,,,20181231.0,,OT,US,US,2018,Q4,Elderly
156900872,15690087,14,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, 3X/DAY (TIDWM)",,,,,,,,,,INJECTION,TID,2018,Q4,Product use issue,,2018,Q4,2,F,,20181226.0,20181205,20181231,EXP,,US-PFIZER INC-2018323545,PFIZER,,95.0,YR,,F,Y,,,20181231.0,,OT,US,US,2018,Q4,Elderly
156900872,15690087,14,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, 3X/DAY (TIDWM)",,,,,,,,,,INJECTION,TID,2018,Q4,Pulmonary hypertension,,2018,Q4,2,F,,20181226.0,20181205,20181231,EXP,,US-PFIZER INC-2018323545,PFIZER,,95.0,YR,,F,Y,,,20181231.0,,OT,US,US,2018,Q4,Elderly
156914823,15691482,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,14-24 IU PER DAY ACCORDING NEED,,,,,,,,,,,,2018,Q4,Drug ineffective,,2018,Q4,3,F,20180315.0,20181214.0,20181205,20181221,EXP,,"CZ-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-BI-058120",BOEHRINGER INGELHEIM,"CHLUP R, KANA R, SVOBODOVA J, ZALESAKOVA H, KOCHTOVA J. IDEGLIRA - NADEJNA PERSPEKTIVA LECBY DIABETU 2. TYPU. KAZUISTIKY V DIABETOLOGII.",37.0,YR,,F,Y,73.0,KG,20181221.0,,MD,CZ,CZ,2018,Q4,Adult
156914823,15691482,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,14-24 IU PER DAY ACCORDING NEED,,,,,,,,,,,,2018,Q4,Treatment noncompliance,,2018,Q4,3,F,20180315.0,20181214.0,20181205,20181221,EXP,,"CZ-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-BI-058120",BOEHRINGER INGELHEIM,"CHLUP R, KANA R, SVOBODOVA J, ZALESAKOVA H, KOCHTOVA J. IDEGLIRA - NADEJNA PERSPEKTIVA LECBY DIABETU 2. TYPU. KAZUISTIKY V DIABETOLOGII.",37.0,YR,,F,Y,73.0,KG,20181221.0,,MD,CZ,CZ,2018,Q4,Adult
156942863,15694286,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Blood glucose increased,,2018,Q4,3,F,,20181210.0,20181206,20181220,PER,,US-SA-2018SA329303,SANOFI AVENTIS,,69.0,YR,E,F,Y,,,20181220.0,,CN,US,US,2018,Q4,Elderly
156942863,15694286,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Device operational issue,,2018,Q4,3,F,,20181210.0,20181206,20181220,PER,,US-SA-2018SA329303,SANOFI AVENTIS,,69.0,YR,E,F,Y,,,20181220.0,,CN,US,US,2018,Q4,Elderly
156942863,15694286,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Drug ineffective,,2018,Q4,3,F,,20181210.0,20181206,20181220,PER,,US-SA-2018SA329303,SANOFI AVENTIS,,69.0,YR,E,F,Y,,,20181220.0,,CN,US,US,2018,Q4,Elderly
156956782,15695678,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10-12 UNIT,,,,,,,,,,,TID,2018,Q4,Angina unstable,,2018,Q4,2,F,20181024.0,20181210.0,20181206,20181220,EXP,,PL-ABBVIE-18P-129-2545323-00,ABBVIE,,74.0,YR,,F,Y,89.0,KG,20181220.0,,MD,PL,PL,2018,Q4,Elderly
156956782,15695678,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10-12 UNIT,,,,,,,,,,,TID,2018,Q4,Atrial fibrillation,,2018,Q4,2,F,20181024.0,20181210.0,20181206,20181220,EXP,,PL-ABBVIE-18P-129-2545323-00,ABBVIE,,74.0,YR,,F,Y,89.0,KG,20181220.0,,MD,PL,PL,2018,Q4,Elderly
156956782,15695678,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10-12 UNIT,,,,,,,,,,,TID,2018,Q4,Chronic kidney disease,,2018,Q4,2,F,20181024.0,20181210.0,20181206,20181220,EXP,,PL-ABBVIE-18P-129-2545323-00,ABBVIE,,74.0,YR,,F,Y,89.0,KG,20181220.0,,MD,PL,PL,2018,Q4,Elderly
157004702,15700470,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,QD,2018,Q4,Arteriovenous fistula thrombosis,,2018,Q4,2,F,201811.0,20181224.0,20181207,20181228,EXP,,CO-ABBVIE-18S-036-2582192-00,ABBVIE,,25.0,YR,,M,Y,60.0,KG,20181228.0,,MD,CO,CO,2018,Q4,Young Adult
157004702,15700470,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,QD,2018,Q4,Infected fistula,,2018,Q4,2,F,201811.0,20181224.0,20181207,20181228,EXP,,CO-ABBVIE-18S-036-2582192-00,ABBVIE,,25.0,YR,,M,Y,60.0,KG,20181228.0,,MD,CO,CO,2018,Q4,Young Adult
157035621,15703562,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, DAILY (25/75: + 20U 20 U/ D)",,,U,U,,,,,,,,2018,Q4,Chest pain,,2018,Q4,1,I,,20181127.0,20181210,20181210,EXP,,PT-AUROBINDO-AUR-APL-2018-059436,AUROBINDO,,54.0,YR,,F,Y,,,20181210.0,,PH,PT,PT,2018,Q4,Adult
157035621,15703562,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, DAILY (25/75: + 20U 20 U/ D)",,,U,U,,,,,,,,2018,Q4,Ischaemic stroke,,2018,Q4,1,I,,20181127.0,20181210,20181210,EXP,,PT-AUROBINDO-AUR-APL-2018-059436,AUROBINDO,,54.0,YR,,F,Y,,,20181210.0,,PH,PT,PT,2018,Q4,Adult
157041061,15704106,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, QD",,,U,U,,,,,,,QD,2018,Q4,Chest pain,,2018,Q4,1,I,,20181130.0,20181210,20181210,EXP,,PHHY2018PT173656,SANDOZ,,54.0,YR,,F,Y,,,20181210.0,,OT,PT,PT,2018,Q4,Adult
157041061,15704106,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, QD",,,U,U,,,,,,,QD,2018,Q4,Ischaemic stroke,,2018,Q4,1,I,,20181130.0,20181210,20181210,EXP,,PHHY2018PT173656,SANDOZ,,54.0,YR,,F,Y,,,20181210.0,,OT,PT,PT,2018,Q4,Adult
157052251,15705225,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,INJECTION,,2018,Q4,Dehydration,,2018,Q4,1,I,2018.0,20181126.0,20181210,20181210,EXP,,US-JUBILANT CADISTA PHARMACEUTICALS-2018JUB00488,JUBILANT,,66.0,YR,,M,Y,92.89,KG,20181210.0,,CN,US,US,2018,Q4,Elderly
157052251,15705225,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,INJECTION,,2018,Q4,Enterovirus infection,,2018,Q4,1,I,2018.0,20181126.0,20181210,20181210,EXP,,US-JUBILANT CADISTA PHARMACEUTICALS-2018JUB00488,JUBILANT,,66.0,YR,,M,Y,92.89,KG,20181210.0,,CN,US,US,2018,Q4,Elderly
157052251,15705225,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,INJECTION,,2018,Q4,Epstein-Barr virus infection,,2018,Q4,1,I,2018.0,20181126.0,20181210,20181210,EXP,,US-JUBILANT CADISTA PHARMACEUTICALS-2018JUB00488,JUBILANT,,66.0,YR,,M,Y,92.89,KG,20181210.0,,CN,US,US,2018,Q4,Elderly
157052251,15705225,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,INJECTION,,2018,Q4,Graft versus host disease,,2018,Q4,1,I,2018.0,20181126.0,20181210,20181210,EXP,,US-JUBILANT CADISTA PHARMACEUTICALS-2018JUB00488,JUBILANT,,66.0,YR,,M,Y,92.89,KG,20181210.0,,CN,US,US,2018,Q4,Elderly
157052251,15705225,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,INJECTION,,2018,Q4,Hypogammaglobulinaemia,,2018,Q4,1,I,2018.0,20181126.0,20181210,20181210,EXP,,US-JUBILANT CADISTA PHARMACEUTICALS-2018JUB00488,JUBILANT,,66.0,YR,,M,Y,92.89,KG,20181210.0,,CN,US,US,2018,Q4,Elderly
157052251,15705225,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,INJECTION,,2018,Q4,Hypotension,,2018,Q4,1,I,2018.0,20181126.0,20181210,20181210,EXP,,US-JUBILANT CADISTA PHARMACEUTICALS-2018JUB00488,JUBILANT,,66.0,YR,,M,Y,92.89,KG,20181210.0,,CN,US,US,2018,Q4,Elderly
157052251,15705225,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,INJECTION,,2018,Q4,Rhinovirus infection,,2018,Q4,1,I,2018.0,20181126.0,20181210,20181210,EXP,,US-JUBILANT CADISTA PHARMACEUTICALS-2018JUB00488,JUBILANT,,66.0,YR,,M,Y,92.89,KG,20181210.0,,CN,US,US,2018,Q4,Elderly
157052251,15705225,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,INJECTION,,2018,Q4,Septic shock,,2018,Q4,1,I,2018.0,20181126.0,20181210,20181210,EXP,,US-JUBILANT CADISTA PHARMACEUTICALS-2018JUB00488,JUBILANT,,66.0,YR,,M,Y,92.89,KG,20181210.0,,CN,US,US,2018,Q4,Elderly
157052251,15705225,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,INJECTION,,2018,Q4,Urinary tract infection,,2018,Q4,1,I,2018.0,20181126.0,20181210,20181210,EXP,,US-JUBILANT CADISTA PHARMACEUTICALS-2018JUB00488,JUBILANT,,66.0,YR,,M,Y,92.89,KG,20181210.0,,CN,US,US,2018,Q4,Elderly
157054981,15705498,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 TO 40 UNITS, TID",,,U,,,,,,,SOLUTION FOR INJECTION,Q8H,2018,Q4,Dyspnoea exertional,,2018,Q4,1,I,,20181130.0,20181210,20181210,EXP,,US-SA-2018SA332855,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20181210.0,,CN,US,US,2018,Q4,Elderly
157054981,15705498,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 TO 40 UNITS, TID",,,U,,,,,,,SOLUTION FOR INJECTION,Q8H,2018,Q4,Left ventricular failure,,2018,Q4,1,I,,20181130.0,20181210,20181210,EXP,,US-SA-2018SA332855,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20181210.0,,CN,US,US,2018,Q4,Elderly
157054981,15705498,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 TO 40 UNITS, TID",,,U,,,,,,,SOLUTION FOR INJECTION,Q8H,2018,Q4,Product use issue,,2018,Q4,1,I,,20181130.0,20181210,20181210,EXP,,US-SA-2018SA332855,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20181210.0,,CN,US,US,2018,Q4,Elderly
157089501,15708950,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q4,Colon cancer,,2018,Q4,1,I,,20181203.0,20181211,20181211,EXP,,JP-009507513-1812JPN004671,MERCK,"HIDEOMI OHGUCHI, ET AL.. AN AUTOPSY CASE OF PULMONARY TUMOR THROMBOTIC MICROANGIOPATHY DUE TO RAPIDLY PROGRESSING COLON CANCER IN A PATIENT WITH TYPE 2 DIABETES. INTERNAL MEDICINE. 2018;57(17):2533-9",61.0,YR,,M,Y,,,20181211.0,,OT,JP,JP,2018,Q4,Adult
157089501,15708950,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2018,Q4,Pulmonary tumour thrombotic microangiopathy,,2018,Q4,1,I,,20181203.0,20181211,20181211,EXP,,JP-009507513-1812JPN004671,MERCK,"HIDEOMI OHGUCHI, ET AL.. AN AUTOPSY CASE OF PULMONARY TUMOR THROMBOTIC MICROANGIOPATHY DUE TO RAPIDLY PROGRESSING COLON CANCER IN A PATIENT WITH TYPE 2 DIABETES. INTERNAL MEDICINE. 2018;57(17):2533-9",61.0,YR,,M,Y,,,20181211.0,,OT,JP,JP,2018,Q4,Adult
157106801,15710680,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Confusional state,,2018,Q4,1,I,,20181127.0,20181211,20181211,EXP,,US-SAKK-2018SA326876AA,SANOFI AVENTIS,,51.0,YR,A,M,Y,,,20181211.0,,CN,US,US,2018,Q4,Adult
157106801,15710680,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Dizziness,,2018,Q4,1,I,,20181127.0,20181211,20181211,EXP,,US-SAKK-2018SA326876AA,SANOFI AVENTIS,,51.0,YR,A,M,Y,,,20181211.0,,CN,US,US,2018,Q4,Adult
157106801,15710680,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Feeling abnormal,,2018,Q4,1,I,,20181127.0,20181211,20181211,EXP,,US-SAKK-2018SA326876AA,SANOFI AVENTIS,,51.0,YR,A,M,Y,,,20181211.0,,CN,US,US,2018,Q4,Adult
157106801,15710680,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Nervousness,,2018,Q4,1,I,,20181127.0,20181211,20181211,EXP,,US-SAKK-2018SA326876AA,SANOFI AVENTIS,,51.0,YR,A,M,Y,,,20181211.0,,CN,US,US,2018,Q4,Adult
157106801,15710680,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Neuropathy peripheral,,2018,Q4,1,I,,20181127.0,20181211,20181211,EXP,,US-SAKK-2018SA326876AA,SANOFI AVENTIS,,51.0,YR,A,M,Y,,,20181211.0,,CN,US,US,2018,Q4,Adult
157106801,15710680,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Pain in extremity,,2018,Q4,1,I,,20181127.0,20181211,20181211,EXP,,US-SAKK-2018SA326876AA,SANOFI AVENTIS,,51.0,YR,A,M,Y,,,20181211.0,,CN,US,US,2018,Q4,Adult
157106801,15710680,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Tremor,,2018,Q4,1,I,,20181127.0,20181211,20181211,EXP,,US-SAKK-2018SA326876AA,SANOFI AVENTIS,,51.0,YR,A,M,Y,,,20181211.0,,CN,US,US,2018,Q4,Adult
157106831,15710683,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 DF, QD",,,Y,,,,,1.0,DF,SOLUTION FOR INJECTION,QD,2018,Q4,Confusional state,,2018,Q4,1,I,20180422.0,20181128.0,20181211,20181211,EXP,IT-MINISAL02-512458,IT-SAKK-2018SA327674AA,SANOFI AVENTIS,,84.0,YR,E,M,Y,,,20181211.0,,MD,IT,IT,2018,Q4,Elderly
157106831,15710683,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 DF, QD",,,Y,,,,,1.0,DF,SOLUTION FOR INJECTION,QD,2018,Q4,Hypoglycaemia,,2018,Q4,1,I,20180422.0,20181128.0,20181211,20181211,EXP,IT-MINISAL02-512458,IT-SAKK-2018SA327674AA,SANOFI AVENTIS,,84.0,YR,E,M,Y,,,20181211.0,,MD,IT,IT,2018,Q4,Elderly
157108711,15710871,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Blood glucose decreased,,2018,Q4,1,I,,20181203.0,20181211,20181211,PER,,US-SA-2018SA334763,SANOFI AVENTIS,,62.0,YR,A,F,Y,,,20181211.0,,CN,US,US,2018,Q4,Adult
157108711,15710871,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Intentional product use issue,,2018,Q4,1,I,,20181203.0,20181211,20181211,PER,,US-SA-2018SA334763,SANOFI AVENTIS,,62.0,YR,A,F,Y,,,20181211.0,,CN,US,US,2018,Q4,Adult
157108711,15710871,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Weight decreased,,2018,Q4,1,I,,20181203.0,20181211,20181211,PER,,US-SA-2018SA334763,SANOFI AVENTIS,,62.0,YR,A,F,Y,,,20181211.0,,CN,US,US,2018,Q4,Adult
157108921,15710892,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Abdominal discomfort,,2018,Q4,1,I,,20181204.0,20181211,20181211,PER,,US-SA-2018SA335583,SANOFI AVENTIS,,70.0,YR,E,M,Y,,,20181211.0,,CN,US,US,2018,Q4,Elderly
157108921,15710892,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Blood glucose increased,,2018,Q4,1,I,,20181204.0,20181211,20181211,PER,,US-SA-2018SA335583,SANOFI AVENTIS,,70.0,YR,E,M,Y,,,20181211.0,,CN,US,US,2018,Q4,Elderly
157236481,15723648,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD",,,U,,,,,,,,QD,2018,Q4,Chest pain,,2018,Q4,1,I,,20181212.0,20181214,20181214,EXP,,PT-BAYER-2018-233039,BAYER,,54.0,YR,A,F,Y,,,20181214.0,,OT,GB,PT,2018,Q4,Adult
157236481,15723648,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD",,,U,,,,,,,,QD,2018,Q4,Ischaemic stroke,,2018,Q4,1,I,,20181212.0,20181214,20181214,EXP,,PT-BAYER-2018-233039,BAYER,,54.0,YR,A,F,Y,,,20181214.0,,OT,GB,PT,2018,Q4,Adult
157302981,15730298,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Underdose,,2018,Q4,1,I,,20181205.0,20181217,20181217,PER,,US-SA-2018SA337511,SANOFI AVENTIS,,61.0,YR,A,M,Y,,,20181217.0,,CN,US,US,2018,Q4,Adult
157304363,15730436,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Blood glucose decreased,,2018,Q4,3,F,,20181214.0,20181217,20181228,PER,,US-SA-2018SA337919,SANOFI AVENTIS,,65.0,YR,E,F,Y,,,20181228.0,,CN,US,US,2018,Q4,Elderly
157304363,15730436,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,SOLUTION FOR INJECTION,,2018,Q4,Weight decreased,,2018,Q4,3,F,,20181214.0,20181217,20181228,PER,,US-SA-2018SA337919,SANOFI AVENTIS,,65.0,YR,E,F,Y,,,20181228.0,,CN,US,US,2018,Q4,Elderly
157325061,15732506,8,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q4,Bradycardia,,2018,Q4,1,I,20181109.0,,20181217,20181217,DIR,,,FDA-CTU,,58.0,YR,,M,N,90.0,KG,20181217.0,N,PH,US,US,2018,Q4,Adult
157325061,15732506,8,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2018,Q4,Extrasystoles,,2018,Q4,1,I,20181109.0,,20181217,20181217,DIR,,,FDA-CTU,,58.0,YR,,M,N,90.0,KG,20181217.0,N,PH,US,US,2018,Q4,Adult
157353311,15735331,4,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,"7 IU BEFORE LUNCH, 8 IU BEFORE DINNER",,,D,, UNKNOWN,,,,,,,2018,Q4,Exposure during pregnancy,,2018,Q4,1,I,,20180405.0,20181218,20181218,PER,,IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2018-02365,ALKEM,"FORMOSO G, GINESTRA F, DALMAZI GD AND CONSOLI A.. EMPAGLIFLOZIN, METFORMIN AND INSULIN DEGLUDEC, DURING PREGNANCY: A CASE REPORT. ACTA DIABETOLOGICA.. 2018;55(7):759-761",31.0,YR,,F,Y,,,20181218.0,,OT,IT,IT,2018,Q4,Young Adult
157353311,15735331,5,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,"66 IU, (32 IU BEFORE LUNCH AND 34 IU BEFORE DINNER)",,,D,, UNKNOWN,,,66.0,IU,,,2018,Q4,Exposure during pregnancy,,2018,Q4,1,I,,20180405.0,20181218,20181218,PER,,IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2018-02365,ALKEM,"FORMOSO G, GINESTRA F, DALMAZI GD AND CONSOLI A.. EMPAGLIFLOZIN, METFORMIN AND INSULIN DEGLUDEC, DURING PREGNANCY: A CASE REPORT. ACTA DIABETOLOGICA.. 2018;55(7):759-761",31.0,YR,,F,Y,,,20181218.0,,OT,IT,IT,2018,Q4,Young Adult
157391171,15739117,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2018,Q4,Dysphagia,,2018,Q4,1,I,20181209.0,20181211.0,20181219,20181219,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,E,M,Y,79.0,KG,20181219.0,,MD,SE,SE,2018,Q4,Elderly
157391171,15739117,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2018,Q4,Dyspnoea,,2018,Q4,1,I,20181209.0,20181211.0,20181219,20181219,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,E,M,Y,79.0,KG,20181219.0,,MD,SE,SE,2018,Q4,Elderly
157409871,15740987,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,AS NECESSARY,,,Y,,,,,1.0,DF,,,2018,Q4,Coma,,2018,Q4,1,I,20181004.0,20181211.0,20181219,20181219,EXP,IT-MINISAL02-514823,IT-SA-2018SA341867,SANOFI AVENTIS,,73.0,YR,E,M,Y,,,20181219.0,,MD,IT,IT,2018,Q4,Elderly
157409871,15740987,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,AS NECESSARY,,,Y,,,,,1.0,DF,,,2018,Q4,Hypoglycaemia,,2018,Q4,1,I,20181004.0,20181211.0,20181219,20181219,EXP,IT-MINISAL02-514823,IT-SA-2018SA341867,SANOFI AVENTIS,,73.0,YR,E,M,Y,,,20181219.0,,MD,IT,IT,2018,Q4,Elderly
157409871,15740987,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,AS NECESSARY,,,Y,,,,,1.0,DF,,,2018,Q4,Loss of consciousness,,2018,Q4,1,I,20181004.0,20181211.0,20181219,20181219,EXP,IT-MINISAL02-514823,IT-SA-2018SA341867,SANOFI AVENTIS,,73.0,YR,E,M,Y,,,20181219.0,,MD,IT,IT,2018,Q4,Elderly
157409871,15740987,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,AS NECESSARY,,,Y,,,,,1.0,DF,,,2018,Q4,Malaise,,2018,Q4,1,I,20181004.0,20181211.0,20181219,20181219,EXP,IT-MINISAL02-514823,IT-SA-2018SA341867,SANOFI AVENTIS,,73.0,YR,E,M,Y,,,20181219.0,,MD,IT,IT,2018,Q4,Elderly
157452632,15745263,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"4 MG, BID",,,U,,,,,4.0,MG,,Q12H,2018,Q4,Metastasis,,2018,Q4,2,F,,20181211.0,20181220,20181227,EXP,,US-SA-2018SA344318,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20181227.0,,CN,US,US,2018,Q4,Adult
157452632,15745263,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"4 MG, BID",,,U,,,,,4.0,MG,,Q12H,2018,Q4,Pancreatic carcinoma,,2018,Q4,2,F,,20181211.0,20181220,20181227,EXP,,US-SA-2018SA344318,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20181227.0,,CN,US,US,2018,Q4,Adult
157468452,15746845,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 IU, QD",,,U,U,,,,40.0,IU,,QD,2018,Q4,Chest pain,,2018,Q4,2,F,,20181214.0,20181220,20181220,EXP,,PHHY2018PT189318,NOVARTIS,,54.0,YR,,F,Y,,,20181220.0,,OT,PT,PT,2018,Q4,Adult
157468452,15746845,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 IU, QD",,,U,U,,,,40.0,IU,,QD,2018,Q4,Headache,,2018,Q4,2,F,,20181214.0,20181220,20181220,EXP,,PHHY2018PT189318,NOVARTIS,,54.0,YR,,F,Y,,,20181220.0,,OT,PT,PT,2018,Q4,Adult
157468452,15746845,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 IU, QD",,,U,U,,,,40.0,IU,,QD,2018,Q4,Ischaemic stroke,,2018,Q4,2,F,,20181214.0,20181220,20181220,EXP,,PHHY2018PT189318,NOVARTIS,,54.0,YR,,F,Y,,,20181220.0,,OT,PT,PT,2018,Q4,Adult
157488621,15748862,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,40.0,IU,,QD,2018,Q4,Chest pain,,2018,Q4,1,I,,20181214.0,20181221,20181221,EXP,,PT-ASTRAZENECA-2018SF64436,ASTRAZENECA,,54.0,YR,,F,Y,,,20181221.0,,MD,PT,PT,2018,Q4,Adult
157488621,15748862,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,40.0,IU,,QD,2018,Q4,Headache,,2018,Q4,1,I,,20181214.0,20181221,20181221,EXP,,PT-ASTRAZENECA-2018SF64436,ASTRAZENECA,,54.0,YR,,F,Y,,,20181221.0,,MD,PT,PT,2018,Q4,Adult
157488621,15748862,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,40.0,IU,,QD,2018,Q4,Ischaemic stroke,,2018,Q4,1,I,,20181214.0,20181221,20181221,EXP,,PT-ASTRAZENECA-2018SF64436,ASTRAZENECA,,54.0,YR,,F,Y,,,20181221.0,,MD,PT,PT,2018,Q4,Adult
157496311,15749631,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2018,Q4,Hospitalisation,,2018,Q4,1,I,201812.0,20181214.0,20181221,20181221,EXP,,CA-AMGEN-CANSP2018180553,AMGEN,,71.0,YR,E,F,Y,,,20181221.0,,MD,CA,CA,2018,Q4,Elderly
157522533,15752253,11,SS,Lispro,INSULIN LISPRO,1,Unknown,"40 IU, QD",,,U,,,,,40.0,IU,SOLUTION FOR INJECTION,,2018,Q4,Chest pain,,2018,Q4,3,F,,20181214.0,20181221,20181228,EXP,,PT-PFIZER INC-2018527501,PFIZER,,54.0,YR,,F,Y,,,20181228.0,,MD,PT,PT,2018,Q4,Adult
157522533,15752253,11,SS,Lispro,INSULIN LISPRO,1,Unknown,"40 IU, QD",,,U,,,,,40.0,IU,SOLUTION FOR INJECTION,,2018,Q4,Headache,,2018,Q4,3,F,,20181214.0,20181221,20181228,EXP,,PT-PFIZER INC-2018527501,PFIZER,,54.0,YR,,F,Y,,,20181228.0,,MD,PT,PT,2018,Q4,Adult
157522533,15752253,11,SS,Lispro,INSULIN LISPRO,1,Unknown,"40 IU, QD",,,U,,,,,40.0,IU,SOLUTION FOR INJECTION,,2018,Q4,Ischaemic stroke,,2018,Q4,3,F,,20181214.0,20181221,20181228,EXP,,PT-PFIZER INC-2018527501,PFIZER,,54.0,YR,,F,Y,,,20181228.0,,MD,PT,PT,2018,Q4,Adult
157592471,15759247,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 IU, PER DAY",,,U,,,,,40.0,IU,,,2018,Q4,Chest pain,,2018,Q4,1,I,,20181212.0,20181226,20181226,EXP,,PT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-120927,BRISTOL MYERS SQUIBB,,54.0,YR,,F,Y,,,20181226.0,,MD,PT,PT,2018,Q4,Adult
157592471,15759247,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 IU, PER DAY",,,U,,,,,40.0,IU,,,2018,Q4,Headache,,2018,Q4,1,I,,20181212.0,20181226,20181226,EXP,,PT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-120927,BRISTOL MYERS SQUIBB,,54.0,YR,,F,Y,,,20181226.0,,MD,PT,PT,2018,Q4,Adult
157592471,15759247,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 IU, PER DAY",,,U,,,,,40.0,IU,,,2018,Q4,Ischaemic stroke,,2018,Q4,1,I,,20181212.0,20181226,20181226,EXP,,PT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-120927,BRISTOL MYERS SQUIBB,,54.0,YR,,F,Y,,,20181226.0,,MD,PT,PT,2018,Q4,Adult
157595991,15759599,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 INTERNATIONAL UNIT, DAILY",,,U,U,,,,40.0,IU,,,2018,Q4,Chest pain,,2018,Q4,1,I,,20181212.0,20181226,20181226,EXP,,PT-AUROBINDO-AUR-APL-2018-062670,AUROBINDO,,54.0,YR,,F,Y,,,20181226.0,,MD,PT,PT,2018,Q4,Adult
157595991,15759599,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 INTERNATIONAL UNIT, DAILY",,,U,U,,,,40.0,IU,,,2018,Q4,Headache,,2018,Q4,1,I,,20181212.0,20181226,20181226,EXP,,PT-AUROBINDO-AUR-APL-2018-062670,AUROBINDO,,54.0,YR,,F,Y,,,20181226.0,,MD,PT,PT,2018,Q4,Adult
157595991,15759599,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 INTERNATIONAL UNIT, DAILY",,,U,U,,,,40.0,IU,,,2018,Q4,Ischaemic stroke,,2018,Q4,1,I,,20181212.0,20181226,20181226,EXP,,PT-AUROBINDO-AUR-APL-2018-062670,AUROBINDO,,54.0,YR,,F,Y,,,20181226.0,,MD,PT,PT,2018,Q4,Adult
157603991,15760399,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 INTERNATIONAL UNIT, QD",,,U,U, UNK,,,40.0,IU,,QD,2018,Q4,Chest pain,,2018,Q4,1,I,,20181214.0,20181226,20181226,EXP,,PT-MYLANLABS-2018M1095482,MYLAN,,54.0,YR,,F,Y,,,20181226.0,,OT,PT,PT,2018,Q4,Adult
157603991,15760399,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 INTERNATIONAL UNIT, QD",,,U,U, UNK,,,40.0,IU,,QD,2018,Q4,Headache,,2018,Q4,1,I,,20181214.0,20181226,20181226,EXP,,PT-MYLANLABS-2018M1095482,MYLAN,,54.0,YR,,F,Y,,,20181226.0,,OT,PT,PT,2018,Q4,Adult
157603991,15760399,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 INTERNATIONAL UNIT, QD",,,U,U, UNK,,,40.0,IU,,QD,2018,Q4,Ischaemic stroke,,2018,Q4,1,I,,20181214.0,20181226,20181226,EXP,,PT-MYLANLABS-2018M1095482,MYLAN,,54.0,YR,,F,Y,,,20181226.0,,OT,PT,PT,2018,Q4,Adult
157613411,15761341,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q4,Acute kidney injury,,2018,Q4,1,I,20181025.0,20181218.0,20181226,20181226,PER,,PHHY2018US195276,SANDOZ,,86.0,YR,,M,Y,,,20181226.0,,CN,US,US,2018,Q4,Elderly
157613411,15761341,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2018,Q4,Dehydration,,2018,Q4,1,I,20181025.0,20181218.0,20181226,20181226,PER,,PHHY2018US195276,SANDOZ,,86.0,YR,,M,Y,,,20181226.0,,CN,US,US,2018,Q4,Elderly
157674391,15767439,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"40 IU, QD",,,U,,,,209196.0,40.0,IU,SOLUTION FOR INJECTION,QD,2018,Q4,Chest pain,,2018,Q4,1,I,,20181214.0,20181227,20181227,EXP,,PT-SA-2018SA394394,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20181227.0,,MD,PT,PT,2018,Q4,Adult
157674391,15767439,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"40 IU, QD",,,U,,,,209196.0,40.0,IU,SOLUTION FOR INJECTION,QD,2018,Q4,Headache,,2018,Q4,1,I,,20181214.0,20181227,20181227,EXP,,PT-SA-2018SA394394,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20181227.0,,MD,PT,PT,2018,Q4,Adult
157674391,15767439,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"40 IU, QD",,,U,,,,209196.0,40.0,IU,SOLUTION FOR INJECTION,QD,2018,Q4,Ischaemic stroke,,2018,Q4,1,I,,20181214.0,20181227,20181227,EXP,,PT-SA-2018SA394394,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20181227.0,,MD,PT,PT,2018,Q4,Adult
157784551,15778455,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"18 U, EACH MORNING",,,,,,,20563.0,18.0,IU,,QD,2018,Q4,Anaemia,,2018,Q4,1,I,,20181224.0,20181231,20181231,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201812011525,ELI LILLY AND CO,,31.0,YR,,F,Y,,,20181231.0,,CN,CN,CN,2018,Q4,Young Adult
157784551,15778455,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"18 U, EACH MORNING",,,,,,,20563.0,18.0,IU,,QD,2018,Q4,Blood glucose increased,,2018,Q4,1,I,,20181224.0,20181231,20181231,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201812011525,ELI LILLY AND CO,,31.0,YR,,F,Y,,,20181231.0,,CN,CN,CN,2018,Q4,Young Adult
157784551,15778455,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"18 U, EACH MORNING",,,,,,,20563.0,18.0,IU,,QD,2018,Q4,Cough,,2018,Q4,1,I,,20181224.0,20181231,20181231,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201812011525,ELI LILLY AND CO,,31.0,YR,,F,Y,,,20181231.0,,CN,CN,CN,2018,Q4,Young Adult
157784551,15778455,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"18 U, EACH MORNING",,,,,,,20563.0,18.0,IU,,QD,2018,Q4,Hypertension,,2018,Q4,1,I,,20181224.0,20181231,20181231,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201812011525,ELI LILLY AND CO,,31.0,YR,,F,Y,,,20181231.0,,CN,CN,CN,2018,Q4,Young Adult
157784551,15778455,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"18 U, EACH MORNING",,,,,,,20563.0,18.0,IU,,QD,2018,Q4,Hypoalbuminaemia,,2018,Q4,1,I,,20181224.0,20181231,20181231,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201812011525,ELI LILLY AND CO,,31.0,YR,,F,Y,,,20181231.0,,CN,CN,CN,2018,Q4,Young Adult
157784551,15778455,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"18 U, EACH MORNING",,,,,,,20563.0,18.0,IU,,QD,2018,Q4,Nasopharyngitis,,2018,Q4,1,I,,20181224.0,20181231,20181231,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201812011525,ELI LILLY AND CO,,31.0,YR,,F,Y,,,20181231.0,,CN,CN,CN,2018,Q4,Young Adult
157784551,15778455,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"18 U, EACH MORNING",,,,,,,20563.0,18.0,IU,,QD,2018,Q4,Oedema,,2018,Q4,1,I,,20181224.0,20181231,20181231,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201812011525,ELI LILLY AND CO,,31.0,YR,,F,Y,,,20181231.0,,CN,CN,CN,2018,Q4,Young Adult
157784551,15778455,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"18 U, EACH MORNING",,,,,,,20563.0,18.0,IU,,QD,2018,Q4,Pneumonitis,,2018,Q4,1,I,,20181224.0,20181231,20181231,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201812011525,ELI LILLY AND CO,,31.0,YR,,F,Y,,,20181231.0,,CN,CN,CN,2018,Q4,Young Adult
157784551,15778455,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"18 U, EACH MORNING",,,,,,,20563.0,18.0,IU,,QD,2018,Q4,Spinal pain,,2018,Q4,1,I,,20181224.0,20181231,20181231,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201812011525,ELI LILLY AND CO,,31.0,YR,,F,Y,,,20181231.0,,CN,CN,CN,2018,Q4,Young Adult
157784551,15778455,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"16 U, EACH EVENING",,,,,,,20563.0,16.0,IU,,QD,2018,Q4,Anaemia,,2018,Q4,1,I,,20181224.0,20181231,20181231,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201812011525,ELI LILLY AND CO,,31.0,YR,,F,Y,,,20181231.0,,CN,CN,CN,2018,Q4,Young Adult
157784551,15778455,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"16 U, EACH EVENING",,,,,,,20563.0,16.0,IU,,QD,2018,Q4,Blood glucose increased,,2018,Q4,1,I,,20181224.0,20181231,20181231,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201812011525,ELI LILLY AND CO,,31.0,YR,,F,Y,,,20181231.0,,CN,CN,CN,2018,Q4,Young Adult
157784551,15778455,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"16 U, EACH EVENING",,,,,,,20563.0,16.0,IU,,QD,2018,Q4,Cough,,2018,Q4,1,I,,20181224.0,20181231,20181231,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201812011525,ELI LILLY AND CO,,31.0,YR,,F,Y,,,20181231.0,,CN,CN,CN,2018,Q4,Young Adult
157784551,15778455,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"16 U, EACH EVENING",,,,,,,20563.0,16.0,IU,,QD,2018,Q4,Hypertension,,2018,Q4,1,I,,20181224.0,20181231,20181231,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201812011525,ELI LILLY AND CO,,31.0,YR,,F,Y,,,20181231.0,,CN,CN,CN,2018,Q4,Young Adult
157784551,15778455,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"16 U, EACH EVENING",,,,,,,20563.0,16.0,IU,,QD,2018,Q4,Hypoalbuminaemia,,2018,Q4,1,I,,20181224.0,20181231,20181231,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201812011525,ELI LILLY AND CO,,31.0,YR,,F,Y,,,20181231.0,,CN,CN,CN,2018,Q4,Young Adult
157784551,15778455,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"16 U, EACH EVENING",,,,,,,20563.0,16.0,IU,,QD,2018,Q4,Nasopharyngitis,,2018,Q4,1,I,,20181224.0,20181231,20181231,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201812011525,ELI LILLY AND CO,,31.0,YR,,F,Y,,,20181231.0,,CN,CN,CN,2018,Q4,Young Adult
157784551,15778455,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"16 U, EACH EVENING",,,,,,,20563.0,16.0,IU,,QD,2018,Q4,Oedema,,2018,Q4,1,I,,20181224.0,20181231,20181231,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201812011525,ELI LILLY AND CO,,31.0,YR,,F,Y,,,20181231.0,,CN,CN,CN,2018,Q4,Young Adult
157784551,15778455,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"16 U, EACH EVENING",,,,,,,20563.0,16.0,IU,,QD,2018,Q4,Pneumonitis,,2018,Q4,1,I,,20181224.0,20181231,20181231,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201812011525,ELI LILLY AND CO,,31.0,YR,,F,Y,,,20181231.0,,CN,CN,CN,2018,Q4,Young Adult
157784551,15778455,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"16 U, EACH EVENING",,,,,,,20563.0,16.0,IU,,QD,2018,Q4,Spinal pain,,2018,Q4,1,I,,20181224.0,20181231,20181231,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201812011525,ELI LILLY AND CO,,31.0,YR,,F,Y,,,20181231.0,,CN,CN,CN,2018,Q4,Young Adult
80128904,8012890,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,U,U,,,,,,INJECTION,,2018,Q4,Blindness,,2018,Q4,4,F,1980.0,20181114.0,20110628,20181126,EXP,,US-ELI_LILLY_AND_COMPANY-US201106006006,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20181126.0,,CN,US,US,2018,Q4,Elderly
80128904,8012890,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,U,U,,,,,,INJECTION,,2018,Q4,Blood glucose increased,,2018,Q4,4,F,1980.0,20181114.0,20110628,20181126,EXP,,US-ELI_LILLY_AND_COMPANY-US201106006006,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20181126.0,,CN,US,US,2018,Q4,Elderly
80128904,8012890,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,U,U,,,,,,INJECTION,,2018,Q4,Macular degeneration,,2018,Q4,4,F,1980.0,20181114.0,20110628,20181126,EXP,,US-ELI_LILLY_AND_COMPANY-US201106006006,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20181126.0,,CN,US,US,2018,Q4,Elderly
80128904,8012890,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,U,U,,,,,,INJECTION,,2018,Q4,Visual impairment,,2018,Q4,4,F,1980.0,20181114.0,20110628,20181126,EXP,,US-ELI_LILLY_AND_COMPANY-US201106006006,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20181126.0,,CN,US,US,2018,Q4,Elderly
80128904,8012890,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,U,U, C728461D,,,,,INJECTION,,2018,Q4,Blindness,,2018,Q4,4,F,1980.0,20181114.0,20110628,20181126,EXP,,US-ELI_LILLY_AND_COMPANY-US201106006006,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20181126.0,,CN,US,US,2018,Q4,Elderly
80128904,8012890,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,U,U, C728461D,,,,,INJECTION,,2018,Q4,Blood glucose increased,,2018,Q4,4,F,1980.0,20181114.0,20110628,20181126,EXP,,US-ELI_LILLY_AND_COMPANY-US201106006006,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20181126.0,,CN,US,US,2018,Q4,Elderly
80128904,8012890,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,U,U, C728461D,,,,,INJECTION,,2018,Q4,Macular degeneration,,2018,Q4,4,F,1980.0,20181114.0,20110628,20181126,EXP,,US-ELI_LILLY_AND_COMPANY-US201106006006,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20181126.0,,CN,US,US,2018,Q4,Elderly
80128904,8012890,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,U,U, C728461D,,,,,INJECTION,,2018,Q4,Visual impairment,,2018,Q4,4,F,1980.0,20181114.0,20110628,20181126,EXP,,US-ELI_LILLY_AND_COMPANY-US201106006006,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20181126.0,,CN,US,US,2018,Q4,Elderly
80128904,8012890,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,U,U, C878110C,,,,,INJECTION,,2018,Q4,Blindness,,2018,Q4,4,F,1980.0,20181114.0,20110628,20181126,EXP,,US-ELI_LILLY_AND_COMPANY-US201106006006,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20181126.0,,CN,US,US,2018,Q4,Elderly
80128904,8012890,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,U,U, C878110C,,,,,INJECTION,,2018,Q4,Blood glucose increased,,2018,Q4,4,F,1980.0,20181114.0,20110628,20181126,EXP,,US-ELI_LILLY_AND_COMPANY-US201106006006,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20181126.0,,CN,US,US,2018,Q4,Elderly
80128904,8012890,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,U,U, C878110C,,,,,INJECTION,,2018,Q4,Macular degeneration,,2018,Q4,4,F,1980.0,20181114.0,20110628,20181126,EXP,,US-ELI_LILLY_AND_COMPANY-US201106006006,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20181126.0,,CN,US,US,2018,Q4,Elderly
80128904,8012890,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,U,U, C878110C,,,,,INJECTION,,2018,Q4,Visual impairment,,2018,Q4,4,F,1980.0,20181114.0,20110628,20181126,EXP,,US-ELI_LILLY_AND_COMPANY-US201106006006,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20181126.0,,CN,US,US,2018,Q4,Elderly
